<SEC-DOCUMENT>0000920148-23-000030.txt : 20230504
<SEC-HEADER>0000920148-23-000030.hdr.sgml : 20230504
<ACCEPTANCE-DATETIME>20230504133826
ACCESSION NUMBER:		0000920148-23-000030
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		58
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230504
DATE AS OF CHANGE:		20230504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LABORATORY CORP OF AMERICA HOLDINGS
		CENTRAL INDEX KEY:			0000920148
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133757370
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11353
		FILM NUMBER:		23887794

	BUSINESS ADDRESS:	
		STREET 1:		358 S MAIN ST
		CITY:			BURLINGTON
		STATE:			NC
		ZIP:			27215
		BUSINESS PHONE:		3362291127

	MAIL ADDRESS:	
		STREET 1:		358 S MAIN ST
		CITY:			BURLINGTON
		STATE:			NC
		ZIP:			27215

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NATIONAL HEALTH LABORATORIES HOLDINGS INC
		DATE OF NAME CHANGE:	19940314
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lh-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:6517acae-4533-4b41-af86-61933115c4be,g:534dcbed-da35-4848-959c-5965c7debeab,d:63596bd8d89a4cde970ba8cf74db2b44--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:lh="http://www.labcorp.com/20230331" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lh-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMy9mcmFnOjZiY2FiMmQ1ODliZjRmYTg4OTk1MDUyZjAxZjE5NDk4L3RhYmxlOmJkMDkwNDVjMzE5NjQ1NTI5NDY0ZTcyMDEzMGFlYWY1L3RhYmxlcmFuZ2U6YmQwOTA0NWMzMTk2NDU1Mjk0NjRlNzIwMTMwYWVhZjVfMi0xLTEtMS0yMzgzNjk_0e1a2564-08f3-425b-b2c6-06c76083e7d8">52.8</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMy9mcmFnOjZiY2FiMmQ1ODliZjRmYTg4OTk1MDUyZjAxZjE5NDk4L3RhYmxlOmJkMDkwNDVjMzE5NjQ1NTI5NDY0ZTcyMDEzMGFlYWY1L3RhYmxlcmFuZ2U6YmQwOTA0NWMzMTk2NDU1Mjk0NjRlNzIwMTMwYWVhZjVfMi0zLTEtMS0yMzgzNjk_598061ae-1a36-48ee-b04b-2f91702e9750">43.5</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMy9mcmFnOjZiY2FiMmQ1ODliZjRmYTg4OTk1MDUyZjAxZjE5NDk4L3RhYmxlOmJkMDkwNDVjMzE5NjQ1NTI5NDY0ZTcyMDEzMGFlYWY1L3RhYmxlcmFuZ2U6YmQwOTA0NWMzMTk2NDU1Mjk0NjRlNzIwMTMwYWVhZjVfNS0xLTEtMS0yMzgzNjk_89720163-ded8-44e7-a397-1924284a305b">88.6</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMy9mcmFnOjZiY2FiMmQ1ODliZjRmYTg4OTk1MDUyZjAxZjE5NDk4L3RhYmxlOmJkMDkwNDVjMzE5NjQ1NTI5NDY0ZTcyMDEzMGFlYWY1L3RhYmxlcmFuZ2U6YmQwOTA0NWMzMTk2NDU1Mjk0NjRlNzIwMTMwYWVhZjVfNS0zLTEtMS0yMzgzNjk_955d127d-58c9-457a-9e90-cdbc012fe8d8">88.2</ix:nonFraction><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzQtMS0xLTEtMjM4MzY5_e801cc9f-1192-4b43-adde-c7542207ab41">0000920148</ix:nonNumeric><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzUtMS0xLTEtMjM4MzY5_6ebec811-418b-4efd-8501-6884d20ce599">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzktMS0xLTEtMjM4MzY5_025ba8c4-dcef-4ae6-99c2-4f1310401868">2023</ix:nonNumeric><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzEwLTEtMS0xLTIzODM2OQ_7ae7302f-a302-4505-acdf-74241b35d9ac">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzExLTEtMS0xLTIzODM2OQ_be60ef53-c31e-492d-8ec3-03362cd2c9a8">false</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="i365d61b777464aaab66fcd10574468cc_I20230503" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzEyLTItMS0xLTIzODM2OQ_86dc1a90-85c1-4d93-aa69-39d6e35d2b25">88.6</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lh-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i365d61b777464aaab66fcd10574468cc_I20230503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i5e096d4685af481291993afb05e8af6b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i257716c5617f4dfab266cec980a32b4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i592357016e3744b0843e011607824ca7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7b2a106b08c45d985ad0f96dfe28f03_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b88c64ad7e840059120244f7ab99191_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab0be29e60e441bcb12bb35cda780ac7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a3cf3470c541cc9a118ee99a72dc93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e919ac92261428e9543c34107b41625_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a88e44b8153492fa26e6001e07825e2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d394a1bebee4deb80055b47b3c9939c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee01e81aeb6c470fbf0fa4ce9effd856_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia77d30f9f579417baf43564777a5e162_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a678436da9f4a5c9f9ed83b04c8b718_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e8d94fd31974fedaa85761a4645a643_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2315342e2c9b4bd884f72b1ee5577f16_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4474976eb0346d7aaa75e127d476d81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4ffa52a16e9418bb2cddabfd8decd27_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82fb222d072d44719a76345469b56366_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie723babf6fae4a8189eb1eb7a43344b8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3913ba65e0f24cc486f2b663bc2bfe42_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if448ca8645d54e68b69cc0d387de5c41_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f54403307748858e4d8146c668ecff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c104cf850a34b9ab0663d78cddac33d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i3605655f09a54bc3b18dc7d96c8a489b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9295a7e1205642f8b24132fc40048aeb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ede9219684c4c19ac6c4f99ed4deac1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie24b2776ffcf4549877584c826d752c8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i420fa3c3695d41f8bc45444f2f622072_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb964f0c745b4194b5a6bef32f88de19_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9484d4c8e1854e87b159b80a497984f0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1165052aa834b059bcaad7ef272c1a1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2c1b84276324a28b731ff53e9def3cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i763ecc59a2844e22891e55687fd0a3d7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53c76d8608624e4787674cc6ed63818e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie12432610ca742daadc4501b48c54075_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a6cf78d4b3f4e31be29df0ab4867707_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6850c8d1a9b4abf91d4f9240163b33f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icacac42c54284702ac2e69d39cc15335_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fe6cefd2840440fa73bfb36cce0bd02_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i729d22ace90f47c0bf2e6fbda82b64d1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13d3320c4e2540a49733a84c90104543_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b5749f29ed746cdb1f7e7ba300fc7af_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93500e8506494c54ae50c563bf13de61_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06441b394eb04c088df79a7c58d41d8a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2145777bf514c2e9428b3441b58838b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacd5ed46262f4edaa5d4b50ba7ade997_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i584d55d88fdb45efa9af2b586e5f217a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f171369cd5d4f90a4563adeddadf605_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie99422763a4d440c9debb245667d5c41_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59328318fd8940bd8ba57a503380a716_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd2467eb6a74cf5b4b1a1777f3e3c55_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8926ca56ad6743998548a7c630959f43_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83ad11debbb84aae9ca83d5b2709beed_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32d7e51ee9b74366914cac24045ae494_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1155708282e748aaaff745d85150e533_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca751f2ef6a46ceac258b5c894deab2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7f05b08fb1b4715baffe092dc0385b6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if082ac4f47484ed49056b4d69e51b488_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia692ca467d2b4ff09e04d7def5d0b93e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59031632d0a84142b11e9d2945f5de0f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia39e375cc4ad48c9a8271a3d25fb7540_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id173b34dc6f448f8b51cff3f364679f9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if123dbe50a0b4e038bf1d42c09d499b9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i740b7ad7e54746128e1e05e9e772c494_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf86457793f94a1b89374df236a0d4a9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieed2b69216414061a0dc9a748b771a88_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96175b5db8d347f9ba27cd093b4b2434_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4bade9216bd42b7ab400fd587eb531b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i737f59dcfb5f48afb10f07bd9e8526be_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d5f0fe941da4ed7a8226c737f6ca3c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa1d29b542f64e46af9c4c2e0dd7e139_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c16890448b482a8f57a9fd32911696_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff417091e8e144259990a3a8694217a3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib827e60cff174c63b54f562a198031e9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e1b39c14cd47d3a1f23f6197f735e7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideec54047acb41c88dff0ba4c5caa519_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i088eb4baf0c54c1caafe41e5b7e00385_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00562d863b694bb2921bab984ac7c461_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id971d73602324ea2bbed87722254241d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92fdaba98ae04990b80e40e7597fce48_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4435b03d249448678d58b9a5c5fdc669_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0679350b3d0345839defcd1fbdc1ca18_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie379b002992b4ac9a015d0de8f522228_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a7d8dea373148a28d09ed326eb7865a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00f94c3f1730467bb46c0d213ccf9893_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c13ae2d4e342baafe38aef77715bf2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">lh:UnbilledContractsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6958f3490b214ab3abf0a9756949e010_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c7c606b647f41e58ee112be251877bf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27b2961f942e4288b255e63e16d547a7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c8e22062d044e07b6b22b1dcd5a0364_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb9b1e876bfb460880c08cb5c95f0b7b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d5821a314134dd49949999c2e5b3f19_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia20524cf106845889acba917cc6c2f53_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i478a2df8586f43a4ac24ced9bb357651_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea4f8105f7c2473fb04f52c1cf307161_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367717bee21446d7b41b04f4afdd53da_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic62e9f64e0a74bcf8ed85655910238e6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3837e5c114d143df8e230ad612f6111f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca5e7f0071c4897a17282d5246502a9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc11c37c41af470b99edcf92d0ddfa5a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f25ab7e1594456ab575b107b00dff07_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic37cab27c9924e55b43d4eca1de9ed08_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d2fb16eef474b76b17de5a95e7d2063_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f98a37fdff54bff858d9b633c7df6fd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a694aae86a041dba12584e655a56786_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79a415a626ce4907ab55886ae221d3b5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b7965b44dc64133b06b8e8418e9e63f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05b34a492ae347f5a0f4fbab882117b4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i208b4414a820456bb72360fbc55747f7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b60b6004a24ba48579fb56cf93d751_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cf79c7c336c4856b02a1b0a7ac3802c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bda848179204f8dbc6ca502a1e6b162_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:InProcessRAAndMediaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69d6d91a822b4e58a4a30b0ed4b82bf0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:InProcessRAAndMediaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i772840f5d04344f4a44ed5da9d0e53d7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ff0a49f62ff41469cd1280087a38dc2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fc48bf4132447b5ad6ad22c82427c71_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if61be0038474449a8767e2be7c9aad81_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i3899295744f647ccb8f7d75b5d3d2193_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f6d9f778de347038d4db29292220d70_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i509a25f9cde744a08f771cef00ab8b88_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iade5794fdb2048c4b1367089794b02d2_D20230406-20230406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-06</xbrli:startDate><xbrli:endDate>2023-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i434e0492f16b458782fd7bad1f0165fc_I20230406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64a241cba18148d68b58c63f94a86b0d_D20230608-20230608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-08</xbrli:startDate><xbrli:endDate>2023-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i318e19e3163b4d77b9fdcb41be6651b3_D20230518-20230518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-18</xbrli:startDate><xbrli:endDate>2023-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9726d7960c36403697c0c1aecbad306a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">lh:ForeignCurrencyTranslationAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b622134b2644c41b2459aca36262ef0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedd64678d4f54800a0093c44f20de7a6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if889505bd2b3447a9d92c961bc85f69a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebf9eccd27c5482a9a25b7aa0413e304_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47a4691325d94666bc3851c13c2a2d39_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i769724f534fd42d5b074271dafd50c33_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed01ecd53ff440bb094c068361e773d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2018SwapAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic501f2ab3f824f5e99cea8fef7c2e388_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2022SwapAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i217de76c0e02473688390d39aec04505_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc9c5675189343c08478b612cc0f2f08_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia98902be646a4c90b5a714ef8b40c97e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88dc2a3d6e8c4967802600e7ff248849_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78627350409f4353bd6bb72edb530c2d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i236653e26bcc49638d6df006253bc8bd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e2835bbadb5437a96546e64b63d52bc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bab97c15b1644c996b81336ef6af0a2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i511043ecd4a749f784a8ec71a6c55a7b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2399bfbb9764cbfb9d758e73036dd39_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C.&#160;&#160;20549</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjY5_d0b85cfb-c856-45fa-95aa-2420af7b92d1">10-Q</ix:nonNumeric> </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc3_0205b97e-840f-4fc9-83bd-803231492c97">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMTE_01c825ca-71bb-4c59-a968-af22cc4fc956">March 31, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjcw_f62b1ea8-c5e6-41d0-8417-568066e87ede">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from ______ to&#160;&#160;______</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc4_813393a1-6e0f-44fb-b05f-fcc10b3a254e">1-11353</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjcx_b51a7bdd-b1d0-4143-9ec0-1aac78ec8549">LABORATORY CORPORATION OF AMERICA HOLDINGS</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6OGY2NmZlOTg1MDY3NDAzMjk4MmQwNWMyNDk2ZDFlNzkvdGFibGVyYW5nZTo4ZjY2ZmU5ODUwNjc0MDMyOTgyZDA1YzI0OTZkMWU3OV8wLTAtMS0xLTIzODM2OQ_f3ece0e5-fcdc-4f02-a3e7-55fbe8f96414">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6OGY2NmZlOTg1MDY3NDAzMjk4MmQwNWMyNDk2ZDFlNzkvdGFibGVyYW5nZTo4ZjY2ZmU5ODUwNjc0MDMyOTgyZDA1YzI0OTZkMWU3OV8wLTItMS0xLTIzODM2OQ_adc3e9ae-db93-40b3-bf4a-9c1a8e755dec">13-3757370</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6YWFkYjUwNzA4MDRiNDhiMTlkZTExNmI0MmEzN2UyMmEvdGFibGVyYW5nZTphYWRiNTA3MDgwNGI0OGIxOWRlMTE2YjQyYTM3ZTIyYV8wLTAtMS0xLTIzODM2OQ_2016a8c7-687e-4fce-9f02-16eb5e178de0">358 South Main Street</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6YWFkYjUwNzA4MDRiNDhiMTlkZTExNmI0MmEzN2UyMmEvdGFibGVyYW5nZTphYWRiNTA3MDgwNGI0OGIxOWRlMTE2YjQyYTM3ZTIyYV8xLTAtMS0xLTIzODM2OQ_3fe6880f-dee5-491b-85aa-2f03cf34e0e2">Burlington,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6YWFkYjUwNzA4MDRiNDhiMTlkZTExNmI0MmEzN2UyMmEvdGFibGVyYW5nZTphYWRiNTA3MDgwNGI0OGIxOWRlMTE2YjQyYTM3ZTIyYV8xLTEtMS0xLTIzODM2OQ_ca138010-aded-4dc7-bb8a-925d98189018">North Carolina</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6YWFkYjUwNzA4MDRiNDhiMTlkZTExNmI0MmEzN2UyMmEvdGFibGVyYW5nZTphYWRiNTA3MDgwNGI0OGIxOWRlMTE2YjQyYTM3ZTIyYV8xLTMtMS0xLTIzODM2OQ_253d3410-39a4-4f21-b506-bd6ce287ab25">27215</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjcy_882fab33-38e8-4b62-834b-cda72a402f39">336</ix:nonNumeric>-<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjcz_a57e274b-ad8d-4740-9d4e-8b0aa16845f8">229-1127</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of Each Class&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trading Symbol&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name of exchange on which registered</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc0_3ee6c578-bb7a-4745-af84-9469a2226f9e">Common Stock, $0.10 par value</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc1_ea564c2b-c8b0-4609-8d76-5af9ddf166df">LH</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc5_2a43fa3e-8b57-49b4-822a-0c0b448698cd">New York Stock Exchange</ix:nonNumeric>  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjY4_e75b9ea4-fdba-4839-b252-b45fa298a6d5">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjgw_f1a57fac-312e-4863-aad4-5017a1b70168">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:44.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6MGUyMTBjZGFkNzdiNDZmZGE2NzBlMjNkZjI1OTdlZTkvdGFibGVyYW5nZTowZTIxMGNkYWQ3N2I0NmZkYTY3MGUyM2RmMjU5N2VlOV8wLTAtMS0xLTIzODM2OQ_ce13a201-8776-41ae-b2ac-c3609e029b48">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6MGUyMTBjZGFkNzdiNDZmZGE2NzBlMjNkZjI1OTdlZTkvdGFibGVyYW5nZTowZTIxMGNkYWQ3N2I0NmZkYTY3MGUyM2RmMjU5N2VlOV8xLTMtMS0xLTIzODM2OQ_3149738a-63d2-42a9-9b82-4ab7bbc519bf">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6MGUyMTBjZGFkNzdiNDZmZGE2NzBlMjNkZjI1OTdlZTkvdGFibGVyYW5nZTowZTIxMGNkYWQ3N2I0NmZkYTY3MGUyM2RmMjU5N2VlOV8yLTMtMS0xLTIzODM2OQ_e126eba3-b20e-40ae-afec-4839c30fafaf">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc2_09978c2a-fcfe-4712-8bcd-d49e932f905a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of the issuer's common stock is <ix:nonFraction unitRef="shares" contextRef="i365d61b777464aaab66fcd10574468cc_I20230503" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjQy_86dc1a90-85c1-4d93-aa69-39d6e35d2b25">88.6</ix:nonFraction> million shares as of May&#160;3, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_7">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_10">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_10">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023 and December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_16">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2023 and 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_19">Condensed Consolidated Statements of Comprehensive Earnings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2023 and 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_22">Condensed Consolidated Statements of Changes in Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2023 and 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_25">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2023 and 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_28">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_64">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_64">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_76">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_76">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_79">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_79">28</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_85">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_85">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_88">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_88">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_91">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_91">30</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_94">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_94">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_94">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_94">30</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#160;&#8211;&#160;FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements (unaudited)</span></div><div><span><br/></span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_10"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMy0xLTEtMS0yMzgzNjk_d9fe515b-159e-4397-bb42-a99ef3f9ba7b">393.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMy0zLTEtMS0yMzgzNjk_b50b8bc9-25ac-42d3-add0-4b762a0a2b82">430.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNC0xLTEtMS0yMzgzNjk_2349b7c8-9af9-432f-b687-531cef3bd995">2,344.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNC0zLTEtMS0yMzgzNjk_fa55f496-bdb4-42ec-9489-3250e64a7a8b">2,222.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNS0xLTEtMS0yMzgzNjk_695f4f6f-827e-4545-b9e3-17f7dd2d6982">705.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNS0zLTEtMS0yMzgzNjk_1776c4ce-b6cd-4757-a089-9806e7b0408e">795.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNi0xLTEtMS0yMzgzNjk_432aa1df-e86b-42b0-be9a-0df41d884ae4">481.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNi0zLTEtMS0yMzgzNjk_8ff2cf34-4ecb-4494-b9f3-4b0280cd35c1">470.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNy0xLTEtMS0yMzgzNjk_d3e49558-df03-4ff8-8728-0eff9b62e394">769.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNy0zLTEtMS0yMzgzNjk_148e08c2-65b8-4301-9b3b-3f5d5bc5e26f">707.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfOS0xLTEtMS0yMzgzNjk_bb43654e-756f-4294-a9e9-0960d7cb2097">4,695.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfOS0zLTEtMS0yMzgzNjk_14ba1e04-f24e-44fe-9261-c7645e821474">4,625.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTAtMS0xLTEtMjM4MzY5_f5c98d7e-44df-402e-9b55-b57e3ac2de9a">2,944.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTAtMy0xLTEtMjM4MzY5_b98b2963-c699-47a8-8269-bf49f1fd1dc3">2,956.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTEtMS0xLTEtMjM4MzY5_26264a9d-7010-4366-a993-2d30f7c34dfb">8,116.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTEtMy0xLTEtMjM4MzY5_9cb7c89d-e43f-4b0b-83a7-e8a6e97cd277">8,121.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTItMS0xLTEtMjM4MzY5_fb17ccee-5d02-49e2-9c96-c00d36c8a465">3,912.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTItMy0xLTEtMjM4MzY5_c0b10e96-999d-49ec-8c20-5abcd61bc846">3,946.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint venture partnerships and equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTMtMS0xLTEtMjM4MzY5_92f4c762-55cf-40f2-9bcb-e3a9f129b177">65.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTMtMy0xLTEtMjM4MzY5_0b13c317-8893-4000-a5a1-1b343ea65a9e">65.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTQtMS0xLTEtMjM4MzY5_872da90f-0b1f-494c-a85a-c57c993065fc">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTQtMy0xLTEtMjM4MzY5_2af45147-07cf-4702-b93e-2cddaa2b385a">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTUtMS0xLTEtMjM4MzY5_348c93e8-7601-42b1-80d4-157390cd06cd">459.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTUtMy0xLTEtMjM4MzY5_24ae8a0b-afde-4484-bc86-22341b38bb60">432.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTctMS0xLTEtMjM4MzY5_5d6378f1-fe32-41cd-8fc5-24af111f53ec">20,200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTctMy0xLTEtMjM4MzY5_12423a93-159d-4eb5-ac14-865aac799051">20,155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjEtMS0xLTEtMjM4MzY5_c30dfe1b-7352-48b6-bbc9-4bc979d033af">880.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjEtMy0xLTEtMjM4MzY5_45d7eb1f-20f9-4fca-b698-4a2df004c5c4">934.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjItMS0xLTEtMjM4MzY5_aecc1788-b3ac-4f0b-850f-6c1c540c431e">929.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjItMy0xLTEtMjM4MzY5_9307e040-0e61-463b-a3fd-f178bbcb357e">1,068.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjMtMS0xLTEtMjM4MzY5_39a93331-6a85-4633-87eb-60a06970c746">586.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjMtMy0xLTEtMjM4MzY5_ceb3fe38-00b5-455b-b890-858d2dbc591e">582.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjQtMS0xLTEtMjM4MzY5_5bf34d9a-cac2-45d3-ba79-0b1f15829c79">181.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjQtMy0xLTEtMjM4MzY5_07e6619d-b62e-4457-8e6d-7faf86d704b8">185.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjUtMS0xLTEtMjM4MzY5_52932789-3bcc-45d1-9828-d560d5a792b7">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjUtMy0xLTEtMjM4MzY5_7d31831a-7494-4ed0-9e0e-88e5ab2436a1">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:CurrentDebtExcludingFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjYtMS0xLTEtMjM4MzY5_708192e2-03a5-4a94-9af7-79e2d0db151a">301.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:CurrentDebtExcludingFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjYtMy0xLTEtMjM4MzY5_ec58bcd7-c99b-45c1-9d9d-d694f0414915">301.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjgtMS0xLTEtMjM4MzY5_6cb444ec-be19-4543-ad87-3990dcaf6e4d">2,885.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjgtMy0xLTEtMjM4MzY5_d6d6c74d-0e34-4136-925b-eac3abfe3c9b">3,078.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjktMS0xLTEtMjM4MzY5_9f0345a9-85da-4107-8a85-83d5111e7d76">5,052.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjktMy0xLTEtMjM4MzY5_593d825a-7060-4926-9fbe-fbf27d8e96c3">5,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzAtMS0xLTEtMjM4MzY5_45199c55-418b-41a9-a9de-d3192621ddfe">668.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzAtMy0xLTEtMjM4MzY5_0120356c-2475-40bd-b006-f4a943f5f1aa">679.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzEtMS0xLTEtMjM4MzY5_d316fd15-f5c9-4f0a-a71b-97654a48039c">82.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzEtMy0xLTEtMjM4MzY5_27bdcb34-faa5-4722-ab57-17acaa82cf64">83.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:DeferredIncomeTaxesAndOtherTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzItMS0xLTEtMjM4MzY5_6baca851-8b73-4638-8078-a076752d211b">737.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:DeferredIncomeTaxesAndOtherTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzItMy0xLTEtMjM4MzY5_fa797bb2-576e-477a-9e82-56737cb3767b">736.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzMtMS0xLTEtMjM4MzY5_a0a0c4b7-a030-4056-a27b-ec177f928fec">413.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzMtMy0xLTEtMjM4MzY5_b61e7146-730e-457d-a81d-3a7f30f0aed5">422.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzUtMS0xLTEtMjM4MzY5_ac9a63ba-1233-4c38-b244-99aa5180ce3d">9,839.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzUtMy0xLTEtMjM4MzY5_cadf8a77-6718-4b01-8aa1-d2689af13a27">10,039.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:NoncontrollingInterestMezzanineEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzctMS0xLTEtMjM4MzY5_63559433-8c97-4806-824a-53709017fc58">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:NoncontrollingInterestMezzanineEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzctMy0xLTEtMjM4MzY5_58e04720-d467-41c0-b3ff-c74a1960169e">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, 88.6 and 88.2 shares outstanding at March 31, 2023, and December 31, 2022, respectively</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzktMS0xLTEtMjM4MzY5_4602e501-3e7c-4377-be5d-6c22201dc8f7">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzktMy0xLTEtMjM4MzY5_c741708c-fe58-4b03-b3e1-0f1aca65d8e9">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDAtMS0xLTEtMjM4MzY5_e50b89dc-3af1-46ee-a866-bdeac7e06307">47.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDAtMy0xLTEtMjM4MzY5_bdad204c-3357-4d97-bd08-e491734209c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDEtMS0xLTEtMjM4MzY5_426d4ec6-0852-4d0a-b963-c96e4ab7b537">10,729.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDEtMy0xLTEtMjM4MzY5_fe1f089b-ce87-45f0-b39e-8e3221c42980">10,581.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="INF" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDMtMS0xLTEtMjM4MzY5_98741ea6-527b-4b1a-8bae-c2a0d48da75c">444.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDMtMy0xLTEtMjM4MzY5_d9f795c6-3d04-4c60-b8af-f16a0fba4201">493.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDQtMS0xLTEtMjM4MzY5_e97dc8a5-1168-475e-812b-3372d1eeb732">10,341.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDQtMy0xLTEtMjM4MzY5_94af5ced-a439-4ede-90b6-56ad2b8da5df">10,096.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDUtMS0xLTEtMjM4MzY5_352dd746-9e6c-4ffa-889f-372ee7dc3a40">20,200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDUtMy0xLTEtMjM4MzY5_36284955-833f-4f98-a3a5-f252363ca46a">20,155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:75.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.358%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMi0xLTEtMS0yMzgzNjk_369b8453-d730-4803-bf70-d636b0fe83ef">3,777.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMi0zLTEtMS0yMzgzNjk_aa3ce91d-3d1e-45ff-973d-668aed4d42f1">3,899.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMy0xLTEtMS0yMzgzNjk_e22633fc-a2e5-4e2e-be81-4c857879a8e2">2,803.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMy0zLTEtMS0yMzgzNjk_5ec0b594-8b4b-4835-8b9f-705647780fe6">2,666.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNS0xLTEtMS0yMzgzNjk_5c037f6b-dfbf-4e17-972a-1d065c1b82b8">974.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNS0zLTEtMS0yMzgzNjk_754c428b-d51f-407d-a589-66e31d811ca2">1,232.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNi0xLTEtMS0yMzgzNjk_6c2daf85-8d87-4540-ab67-cbd1429621c5">553.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNi0zLTEtMS0yMzgzNjk_cb121834-85d1-4a23-8247-5588f43d34a4">464.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNy0xLTEtMS0yMzgzNjk_d3eda484-b617-4c49-8f40-8e75bc647613">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNy0zLTEtMS0yMzgzNjk_fbc0b55f-ed63-405c-b4fd-cb9a3b4df906">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfOC0xLTEtMS0yMzgzNjk_2aa6015a-db05-4d15-985f-9eafa32d79ac">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfOC0zLTEtMS0yMzgzNjk_79b9cb87-bb7f-4690-aae9-e6b40715cb27">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:NetRestructuringAndOtherSpecialCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfOS0xLTEtMS0yMzgzNjk_b3e5d702-4364-4bba-9c6f-97e359c787ad">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:NetRestructuringAndOtherSpecialCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfOS0zLTEtMS0yMzgzNjk_293946ea-df77-482c-a13b-266c3d001335">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTAtMS0xLTEtMjM4MzY5_21733e62-2668-4398-80e0-caefce9949c0">341.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTAtMy0xLTEtMjM4MzY5_69d0f994-4695-43a7-a332-12395d43e57d">687.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTItMS0xLTEtMjM4MzY5_9520b222-ed12-4981-a6e5-4915820fc912">50.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTItMy0xLTEtMjM4MzY5_94f3eac4-0b07-40ce-a934-3d640504f78e">42.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTMtMS0xLTEtMjM4MzY5_c6fae561-55a4-4b30-8b91-5b44a3cec26d">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTMtMy0xLTEtMjM4MzY5_5f861015-9aac-494d-9cf1-561ce8412ca9">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTQtMS0xLTEtMjM4MzY5_279a6756-3fd3-4c11-978e-cafd867ce2cd">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTQtMy0xLTEtMjM4MzY5_b0f8353e-2f5f-46e0-b46a-c688657ab865">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTUtMS0xLTEtMjM4MzY5_4ff8f83c-2798-4314-a8bd-f99a7af96d51">12.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTUtMy0xLTEtMjM4MzY5_6277ff44-1087-47c1-8a58-39ba49136dfc">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTYtMS0xLTEtMjM4MzY5_e8843dbf-d5c9-4f5a-b0dd-b4ebf0262932">277.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTYtMy0xLTEtMjM4MzY5_cfde7190-a018-43a0-a8c5-c21cf1fcfbda">640.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTctMS0xLTEtMjM4MzY5_44166eb4-c4ec-4069-a0a7-38425bb2d825">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTctMy0xLTEtMjM4MzY5_eeb01a2f-ff94-484f-bef7-b9d6c91523b0">148.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTgtMS0xLTEtMjM4MzY5_6205f042-2220-4aa6-bbea-e5a0a0500a87">213.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTgtMy0xLTEtMjM4MzY5_a63989ee-c326-4906-bb71-11117e62326e">492.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTktMS0xLTEtMjM4MzY5_c15ba9f6-d78a-43fb-85ff-94b5cbdf5ffd">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTktMy0xLTEtMjM4MzY5_fdfa2dee-6098-403a-be6a-6c5039de3b64">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjAtMS0xLTEtMjM4MzY5_3d10a62f-c72c-432c-ae2a-e90d3d14df4f">212.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjAtMy0xLTEtMjM4MzY5_2be8501a-14f9-4fc1-bd58-469f63e50c1b">491.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjItMS0xLTEtMjM4MzY5_ea478cd5-02c4-4281-9249-3535120d4075">2.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjItMy0xLTEtMjM4MzY5_8c01b0e9-f1de-4155-b567-c3f5abaaf126">5.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjMtMS0xLTEtMjM4MzY5_6ddeace1-55d8-4c78-a737-9b918316e239">2.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjMtMy0xLTEtMjM4MzY5_767b4875-572e-4538-b6b5-edfaa52100a8">5.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"></td><td style="width:73.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.324%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMy0xLTEtMS0yMzgzNjk_c4ab6d5d-a2d7-419c-84f3-a0ae44a0fef3">213.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMy0zLTEtMS0yMzgzNjk_76776216-83b7-4856-becf-4478f9ddb90a">492.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNC0xLTEtMS0yMzgzNjk_05941122-031a-43dc-99f1-41b46e535203">48.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNC0zLTEtMS0yMzgzNjk_40eefe92-f128-41d5-988c-75a187d1cabe">74.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit plan adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNS0xLTEtMS0yMzgzNjk_36ea3806-9f3a-412c-be3b-b99173940cf5">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNS0zLTEtMS0yMzgzNjk_947f7478-2ee5-4105-80e3-92369bf58749">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNy0xLTEtMS0yMzgzNjk_a77ae78f-d714-4b08-9262-e746b7a7af86">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNy0zLTEtMS0yMzgzNjk_0f1519d8-913e-4474-ae46-79df958793ab">72.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income tax related to items of comprehensive earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfOC0xLTEtMS0yMzgzNjk_0e21b5ed-5f76-4789-81e7-2d39cbbac4fc">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfOC0zLTEtMS0yMzgzNjk_199897c3-6ba7-483e-8c65-6fd5cfb66da8">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfOS0xLTEtMS0yMzgzNjk_3c3fc37f-8c76-420a-a907-e76671a4aa31">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfOS0zLTEtMS0yMzgzNjk_0e0ad227-9cdc-463d-8e2b-5db2ad0351b1">73.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTAtMS0xLTEtMjM4MzY5_1de9d237-abff-4364-9a12-25766018ed20">262.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTAtMy0xLTEtMjM4MzY5_8b6a6b27-1b0d-48e7-8d16-bb9734f44fd5">419.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTEtMS0xLTEtMjM4MzY5_140675ad-f836-4fa6-8be5-d2313562abfd">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTEtMy0xLTEtMjM4MzY5_24f781f7-129c-41c0-859c-334564614273">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTItMS0xLTEtMjM4MzY5_f18f979d-5869-41c0-9b56-96a39cff36fe">261.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTItMy0xLTEtMjM4MzY5_fc0abf22-515f-454a-91fe-c0705072376e">418.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:51.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER 31, 2021</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i592357016e3744b0843e011607824ca7_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtMS0xLTEtMjM4MzY5_ac9d379b-f773-49c0-88f2-c5d070d1dce5">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7b2a106b08c45d985ad0f96dfe28f03_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtMy0xLTEtMjM4MzY5_8d3732ae-6ce6-4a90-85ab-38b28ba85d23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b88c64ad7e840059120244f7ab99191_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtNS0xLTEtMjM4MzY5_fe0335bc-be6d-4e48-8758-0edea5910bc0">10,456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab0be29e60e441bcb12bb35cda780ac7_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtNy0xLTEtMjM4MzY5_8a79c1c3-83b2-4a13-90e9-a724e7ef7d33">191.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a3cf3470c541cc9a118ee99a72dc93_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtOS0xLTEtMjM4MzY5_74d3fe84-4d82-4840-be85-a2c32edbe61c">10,273.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctMS0xLTEtMjM4MzY5_48910792-e685-4a99-bfc3-54967a089d81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctMy0xLTEtMjM4MzY5_7791c603-0989-4c74-8be2-098b5df4ca4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctNS0xLTEtMjM4MzY5_7cecab3a-68fa-43d3-88d8-4a0b20bc6edb">491.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctNy0xLTEtMjM4MzY5_d9e1de2f-9ac7-4437-9884-1a551401f3b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctOS0xLTEtMjM4MzY5_7f96201d-ddc0-4c11-b3ea-206baa681c1f">491.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtMS0xLTEtMjM4MzY5_7fd037ef-cff3-4bf6-951a-df019188a84d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtMy0xLTEtMjM4MzY5_5ab4bf69-bb56-417a-82ae-786676c74ed6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtNS0xLTEtMjM4MzY5_0b84f6c5-15fa-41c6-a73b-1f316e165f0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtNy0xLTEtMjM4MzY5_1507df1c-3496-4500-81e3-5eaf87c39bed">73.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtOS0xLTEtMjM4MzY5_b8753ec0-d341-4ef6-900f-6ac9b344e4bf">73.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktMS0xLTEtMjM4MzY5_57a51057-0aca-46ff-956d-d4aa125e1840">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktMy0xLTEtMjM4MzY5_7fb2fba7-e4ac-4dd6-9981-3e7e543f73fa">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktNS0xLTEtMjM4MzY5_c58a7a20-4328-44b6-865a-f017b89bc509">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktNy0xLTEtMjM4MzY5_d8761cd1-222c-45f6-b154-ecfd8c526689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktOS0xLTEtMjM4MzY5_2492fbfd-1605-4cf1-b727-cb1926f15d4e">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtMS0xLTEtMjM4MzY5_45754e98-35db-411c-9ecf-ba5b67c78d49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtMy0xLTEtMjM4MzY5_08ff3c1b-f476-4bdb-bccc-6b5624be2a20">27.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtNS0xLTEtMjM4MzY5_da20810a-bc9a-47e9-a2ac-bc90f3246d38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtNy0xLTEtMjM4MzY5_efa0aeb7-20ef-48e7-a2e5-db2e962ad9b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtOS0xLTEtMjM4MzY5_37d55fd9-f37b-4164-bf3f-da2091b55020">27.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtMS0xLTEtMjM4MzY5_d769c8b5-9fff-4cf3-ad64-de0e915cf999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtMy0xLTEtMjM4MzY5_162ac98c-ffaf-4ba2-a768-39b176a92d21">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtNS0xLTEtMjM4MzY5_e51832b5-65cb-460a-ab1c-2dbe08d5770f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtNy0xLTEtMjM4MzY5_26219922-ae4b-4f26-9d7c-204d4b08af87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtOS0xLTEtMjM4MzY5_f0e22a15-3620-4fa2-ace1-6d16aee8a533">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT MARCH 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a88e44b8153492fa26e6001e07825e2_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtMS0xLTEtMjM4MzY5_74cd06ba-92d7-4f3f-b7cc-ed7338519847">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d394a1bebee4deb80055b47b3c9939c_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtMy0xLTEtMjM4MzY5_188551d7-b064-4049-a464-0ba722d44326">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee01e81aeb6c470fbf0fa4ce9effd856_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtNS0xLTEtMjM4MzY5_11f707ee-995a-4c0d-b580-f270a77c2939">10,948.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia77d30f9f579417baf43564777a5e162_I20220331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtNy0xLTEtMjM4MzY5_3e5ef327-9ad6-40cc-9259-19413462daa7">264.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a678436da9f4a5c9f9ed83b04c8b718_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtOS0xLTEtMjM4MzY5_db70e429-4ae7-4746-920f-51eeae589e4a">10,721.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e8d94fd31974fedaa85761a4645a643_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctMS0xLTEtMjUxNjEy_ec883339-ec30-4896-a8ba-f4e5ce0c61ab">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2315342e2c9b4bd884f72b1ee5577f16_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctMy0xLTEtMjUxNjEy_224227a7-f5ec-4482-ac3b-6147af9a831b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4474976eb0346d7aaa75e127d476d81_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctNS0xLTEtMjUxNjEy_0ae375f4-cc81-4fc0-8568-0b0d81c74c2a">10,581.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4ffa52a16e9418bb2cddabfd8decd27_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctNy0xLTEtMjUxNjEy_50ffc2a6-8faf-4d66-8a1e-a4cf5dfd2736">493.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctOS0xLTEtMjUxNjEy_e7ad4d9f-7aaa-424d-8ed1-b52a1abf416c">10,096.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtMS0xLTEtMjUxNjM5_25a15823-ab60-4d89-bb98-ed5f7c92a308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtMy0xLTEtMjUxNjM5_5a0ef232-c565-465c-b51c-4f7239204c0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtNS0xLTEtMjUxNjM5_9fb2991b-b72b-4eac-8692-7d2447e5e9d0">212.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtNy0xLTEtMjUxNjQ4_7ad899aa-fc8d-4913-a1b6-8beeca666f92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtOS0xLTEtMjUxNjQ4_56e96c18-5c72-42f1-9ecc-8a0929ba2bae">212.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktMS0xLTEtMjUxNjM5_5aa1d271-78cd-4eb3-accc-0eef36dabd02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktMy0xLTEtMjUxNjM5_8710cb20-d1ca-46fb-86d8-714f6012ee50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktNS0xLTEtMjUxNjM5_c7416a51-1585-47b4-8389-cb05ff61ebe6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktNy0xLTEtMjUxNjQ4_c6ca0959-bf2f-4d1f-bd61-c993ff84a869">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktOS0xLTEtMjUxNjQ4_e1c2a73c-11da-4958-bbaa-5539c9459d47">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331" decimals="-5" name="us-gaap:Dividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtMS0xLTEtMjUxNjM5_9d03b545-d335-4462-acd8-d4d294ad0771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331" decimals="-5" name="us-gaap:Dividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtMy0xLTEtMjUxNjM5_1d96d27c-6506-4abd-8ba5-4dfae195abe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331" decimals="-5" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtNS0xLTEtMjUxNjM5_af401ebc-c977-47c7-af64-1acdeaca8c28">64.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331" decimals="-5" name="us-gaap:Dividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtNy0xLTEtMjUxNjQ4_511c8990-e84e-485f-b9c0-9f8fe533ca1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtOS0xLTEtMjUxNjQ4_27451071-2a52-489e-af0d-af3122e1406c">64.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtMS0xLTEtMjUxNjM5_e218f14c-c650-418e-965f-cac49b4b8306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtMy0xLTEtMjUxNjM5_8a13ae09-826b-4001-a560-83464ee62275">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtNS0xLTEtMjUxNjM5_218fb033-0735-4fc1-a372-bd2c39078a76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtNy0xLTEtMjUxNjQ4_81740c2c-30b9-4ef9-85ce-15fab4a787f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:Issuanceofcommonstockunderemployeeplans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtOS0xLTEtMjUxNjQ4_c9dc9220-0009-436d-8a60-f4154313a9df">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItMS0xLTEtMjUxNjM5_13e571f7-625b-4fb6-93e9-9d46cd24c3e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItMy0xLTEtMjUxNjM5_b483effe-364c-4042-9a16-3c551f588bec">20.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItNS0xLTEtMjUxNjM5_8df56ff1-345c-47b4-9a39-1589a22ec686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItNy0xLTEtMjUxNjQ4_bd6ee1fd-59bf-4645-b539-bd37aff2dd55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItOS0xLTEtMjUxNjQ4_9826db9f-342d-4a58-bd22-c76a51bedc99">20.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtMS0xLTEtMjUxNjM5_2820004a-fb0c-4545-aa56-58ddd6d6faa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtMy0xLTEtMjUxNjM5_36b0bb67-bb6f-4aba-bd22-e27d41d90c16">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtNS0xLTEtMjUxNjM5_5c76f133-9bc9-49a2-9ba7-a71b0fbaa06f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtNy0xLTEtMjUxNjQ4_41defd56-3e77-434c-9ddd-8f2fded3ca6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtOS0xLTEtMjUxNjQ4_ed26901d-1937-426f-9975-fea3833c663d">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT MARCH 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie723babf6fae4a8189eb1eb7a43344b8_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtMS0xLTEtMjUxNjM5_95855c6b-230a-482d-acb3-47fdc2058211">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3913ba65e0f24cc486f2b663bc2bfe42_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtMy0xLTEtMjUxNjM5_488e7c3e-b173-41ee-9d83-6a0fb49b514b">47.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if448ca8645d54e68b69cc0d387de5c41_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtNS0xLTEtMjUxNjM5_ec966341-25e0-421a-b177-e77c03411e59">10,729.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25f54403307748858e4d8146c668ecff_I20230331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtNy0xLTEtMjUxNjQ4_7082d30a-74f4-4f3d-a8c5-36f263d3fcec">444.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtOS0xLTEtMjUxNjQ4_be2de5ac-5003-4459-b57e-6c9dbc765af4">10,341.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMy0xLTEtMS0yMzgzNjk_a9f8d038-07bf-44ab-b9f2-7dc74cf0cfae">213.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMy0zLTEtMS0yMzgzNjk_e6888685-621d-4926-bc15-d5b33809e91b">492.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNS0xLTEtMS0yMzgzNjk_335b84fc-e3f3-4130-8390-fcdc7926dabb">165.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNS0zLTEtMS0yMzgzNjk_2d3b0c01-3627-463b-a17f-ac693d887e50">161.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNi0xLTEtMS0yMzgzNjk_5d434139-1cf2-4540-a5ef-2bd20e594896">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNi0zLTEtMS0yMzgzNjk_674ffc8e-86ed-46c4-b3a0-69334d992f7f">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:DepreciationAndAmortizationOfLeasedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNy0xLTEtMS0yMzgzNjk_0f87c6a5-c7e2-4158-a4ae-5d97a1e8c859">47.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:DepreciationAndAmortizationOfLeasedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNy0zLTEtMS0yMzgzNjk_2f6b5880-007a-4f6a-8c5a-e02da02a11f6">48.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfOC0xLTEtMS0yMzgzNjk_843d8118-14e2-4062-9119-ef6b37f78bcf">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfOC0zLTEtMS0yMzgzNjk_007fa0f0-56b5-4c02-be7c-74333a4a7dcd">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfOS0xLTEtMS0yMzgzNjk_1efad66e-c8bb-4ad4-b00f-f895de77d22f">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfOS0zLTEtMS0yMzgzNjk_25f4e116-61db-4b55-a892-8480df9636b6">19.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTAtMS0xLTEtMjM4MzY5_84c8f912-172d-4b1d-a6f7-064fa3043912">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTAtMy0xLTEtMjM4MzY5_335ff882-89e4-49bc-bf81-79f088b0ec36">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in assets and liabilities (net of effects of acquisitions and divestitures):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTItMS0xLTEtMjM4MzY5_9dcda950-eb0b-4f46-823c-154c0f788d50">117.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTItMy0xLTEtMjM4MzY5_60eb3540-782e-4e0d-9f99-a63ba7ad14df">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="lh:IncreaseDecreaseinUnbilledContractReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTMtMS0xLTEtMjM4MzY5_bc3028fc-12ec-4172-8b91-0fe46d27a778">91.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:IncreaseDecreaseinUnbilledContractReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTMtMy0xLTEtMjM4MzY5_ba8e6b57-e111-42e4-a2b1-99e4c37f7f42">84.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in supplies inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTQtMS0xLTEtMjM4MzY5_eb0de0e4-160b-4ffc-829e-f914b686cff7">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTQtMy0xLTEtMjM4MzY5_b6d11ed2-3eb9-4474-8241-a0ec152387b1">37.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTUtMS0xLTEtMjM4MzY5_9516c02b-d58f-4146-9de5-c14525c6a9f8">59.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTUtMy0xLTEtMjM4MzY5_28133372-060f-4f41-a75e-bdc723bb4b93">41.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTYtMS0xLTEtMjM4MzY5_f4a247e7-a160-44d0-a479-4204fe9183cf">56.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTYtMy0xLTEtMjM4MzY5_a8adf1fe-1080-4db7-8ed7-018c2011ddbc">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTctMS0xLTEtMjM4MzY5_a21e7241-f9bc-44d7-80c2-b827183a6a49">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTctMy0xLTEtMjM4MzY5_8caeea10-d2ea-4ace-9a16-447de077a306">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTgtMS0xLTEtMjM4MzY5_0d464420-8122-47ff-89cc-d36673efd593">206.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTgtMy0xLTEtMjM4MzY5_2f50e7b1-370c-448d-a59c-592a6d7ae501">212.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTktMS0xLTEtMjM4MzY5_221a18d7-ef7a-4a81-a538-94c091473776">121.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTktMy0xLTEtMjM4MzY5_282bb61e-cbfb-4aa3-90db-7f2ab618a32f">356.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjEtMS0xLTEtMjM4MzY5_60857ada-0100-4ae3-a548-8d71aa0732b0">93.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjEtMy0xLTEtMjM4MzY5_e4957a04-3932-4754-95b9-5701f4376b14">117.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjItMS0xLTEtMjM4MzY5_bbbf753a-3edb-4135-bcde-7a969525c514">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjItMy0xLTEtMjM4MzY5_6ec2e19c-2788-441e-b93c-2890461d5c46">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale or distribution of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjQtMS0xLTEtMjM4MzY5_f11b2967-c313-489c-bb00-5ca5c3135bfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjQtMy0xLTEtMjM4MzY5_a28314b5-7096-4d12-830f-dee97f3597b9">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjYtMS0xLTEtMjM4MzY5_839c968b-e618-4af5-8448-9b444d31a9de">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjYtMy0xLTEtMjM4MzY5_a555a225-504b-41b3-ad9b-a68cab99c522">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjctMS0xLTEtMjM4MzY5_24a81b22-4b25-41cd-8417-c91b86b4f984">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjctMy0xLTEtMjM4MzY5_cce0b451-b34a-45f8-aeac-648a983015c9">455.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="INF" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjgtMS0xLTEtMjM4MzY5_fb9d2aab-ce8d-4aab-84ad-8c818b89b08d">99.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjgtMy0xLTEtMjM4MzY5_44fa54b9-60b3-4fd4-baec-08b863788033">573.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving credit facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzQtMS0xLTEtMjM4MzY5_4433ef98-0343-4e0c-87e1-f56f3d31f9f3">827.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzQtMy0xLTEtMjM4MzY5_0816a619-6e42-477d-88ef-d9639ce41cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzUtMS0xLTEtMjM4MzY5_8b760ad6-3914-4e9b-a5ec-b7d6ceb6f8ca">827.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzUtMy0xLTEtMjM4MzY5_445094ce-f552-49c7-bd61-025e554d1d81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzgtMS0xLTEtMjM4MzY5_f5a106f6-bf72-4979-9539-332515863429">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzgtMy0xLTEtMjM4MzY5_3c738481-a29a-4284-8d2e-46b8092952ae">27.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds from issuance of stock to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:NetProceedsFromIssuanceOfStockToEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzktMS0xLTEtMjM4MzY5_23432aef-3a6a-44e7-b312-46ae0215d62f">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:NetProceedsFromIssuanceOfStockToEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzktMy0xLTEtMjM4MzY5_5acb0934-6968-496c-8c4a-4bde038cbf82">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDAtMS0xLTEtMjM4MzY5_0e84a35f-5d59-492a-bc90-b36d60de4c25">64.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDAtMy0xLTEtMjM4MzY5_a35bec01-c2cb-42af-af47-47b3a840d394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:OtherFinancingCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDItMS0xLTEtMjM4MzY5_4e564440-5e2a-45c9-831f-69c8d2b98ae0">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:OtherFinancingCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDItMy0xLTEtMjM4MzY5_cc2edcc2-dd6a-4d14-852a-8a1e2f3db38f">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDMtMS0xLTEtMjM4MzY5_322fb725-3895-43e1-9d29-d940e9ca8ee9">60.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDMtMy0xLTEtMjM4MzY5_ffe1c7d9-0019-41cf-9061-55012c4a120f">17.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDQtMS0xLTEtMjM4MzY5_5da30d5d-2efa-4ce7-b5a4-a5545e9d4c92">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDQtMy0xLTEtMjM4MzY5_841995cc-15f7-4b04-96f8-94f85766c393">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDUtMS0xLTEtMjM4MzY5_fcedd8fa-692f-411b-a5b5-0c6e82841079">36.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDUtMy0xLTEtMjM4MzY5_9ec42451-0bc9-4aff-96ba-dba64046fed6">239.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDYtMS0xLTEtMjM4MzY5_64f6ec12-76c4-4ddf-9d92-80acd128e3a1">430.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a3cf3470c541cc9a118ee99a72dc93_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDYtMy0xLTEtMjM4MzY5_a76a1c15-d4c9-47e5-a9fa-91583a22546c">1,472.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDgtMS0xLTEtMjM4MzY5_0b19432a-67e4-4af1-9157-317c2ddc5735">393.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a678436da9f4a5c9f9ed83b04c8b718_I20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDgtMy0xLTEtMjM4MzY5_074fbcc3-f248-47b1-b901-e65d30b7cd65">1,233.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div><span><br/></span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_31"></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfNTM1OQ_9665d897-7993-471a-82e5-1eb1d42b4860" continuedAt="i22139e4ef67d4edfb193dfdab1f4511d" escape="true"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfNTM2MQ_9e0b4416-3ef0-4c33-b07b-8c2ca2d63ec8" continuedAt="ia333f9ca8dec41b6a54c0262f649aa2f" escape="true">BASIS OF FINANCIAL STATEMENT PRESENTATION</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i22139e4ef67d4edfb193dfdab1f4511d"><ix:continuation id="ia333f9ca8dec41b6a54c0262f649aa2f"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings (Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its strong diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, see Note 11 (Business Segment Information) to the Condensed Consolidated Financial Statements. During the three months ended March&#160;31, 2023, Dx and DD contributed approximately <ix:nonFraction unitRef="number" contextRef="i2c104cf850a34b9ab0663d78cddac33d_D20230101-20230331" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfODEw_041b77a0-4a8a-4385-a9f4-197f7fec87fa">63</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3605655f09a54bc3b18dc7d96c8a489b_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfODE3_1171acb8-181c-456f-a780-d7c0249df845">37</ix:nonFraction>%, respectively, of revenues to the Company.</span></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, the Company announced that its board of directors authorized the Company to pursue a spin-off of its wholly owned Clinical Development and Commercialization Services business, which includes parts of its DD segment focused on providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations. The planned spin-off will result in two independent, publicly traded companies. The spin-off is intended to be a tax-free transaction to the Company and its stockholders for United States (U.S.) federal income tax purposes and is expected to be effected through a dividend of the Clinical Development business&#8217; shares to the Company's shareholders. The Company anticipates that, consistent with any applicable legal and tax requirements, there will be ongoing transitional and commercial arrangements to provide for a seamless delivery of services to the customers and other stakeholders of the independent companies following the spin-off. The Company is targeting completion of the spin-off with an accelerated timeframe of mid-2023. The spin-off will be subject to the satisfaction of certain customary conditions, including, among others, the receipt of final approval by the Company's board of directors, the receipt of appropriate assurances regarding the tax-free nature of the separation, and the effectiveness of any required filings with the U.S. Securities and Exchange Commission (SEC). </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than <ix:nonFraction unitRef="number" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="3" name="lh:CostMethodInvestmentsMaximumOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfMjg4MQ_ba4cad39-b299-436e-a0de-c9b762d70f2b">20.0</ix:nonFraction>% and no representation on the investee's board of directors) are accounted for at fair value, or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the  condensed consolidated financial statements. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income (loss).&#8221;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company&#8217;s fiscal year 2022 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s Annual Report.</span></div></ix:continuation></ix:continuation><div id="i63596bd8d89a4cde970ba8cf74db2b44_34"></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-bottom:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjMzMw_d0d6a130-4c1a-4ca2-ab7c-98c29e3590f9" continuedAt="i8a1cc6b88d0346a3a2b880a5be17d51a" escape="true">REVENUES</ix:nonNumeric></span></div><ix:continuation id="i8a1cc6b88d0346a3a2b880a5be17d51a" continuedAt="if580cc7f582244cc8dbbd1e3eb2e70c3"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjMyMw_cf702533-437b-47b8-b3a0-d13c6497840a" escape="true"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and by payers/customer groups for the three months ended March&#160;31, 2023, and 2022, were as follows:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9295a7e1205642f8b24132fc40048aeb_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0xLTEtMS0yMzgzNjk_e93b980e-1f10-42c2-acab-d8fc63ab7d90">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ede9219684c4c19ac6c4f99ed4deac1_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0zLTEtMS0yMzgzNjk_985e2780-7c44-4736-89c9-42cf402c351e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie24b2776ffcf4549877584c826d752c8_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC01LTEtMS0yMzgzNjk_99e06267-dab3-4f50-af8d-44521d960236">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i420fa3c3695d41f8bc45444f2f622072_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC03LTEtMS0yMzgzNjk_f9d38692-70be-413b-8483-d647e03b4acc">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb964f0c745b4194b5a6bef32f88de19_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC05LTEtMS0yMzgzNjk_bc22249a-3171-4c52-8333-a5e07a672134">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9484d4c8e1854e87b159b80a497984f0_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0xMS0xLTEtMjM4MzY5_7bc0dd3c-bf11-4b83-85ea-a9aae8b1a689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie1165052aa834b059bcaad7ef272c1a1_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0xMy0xLTEtMjM4MzY5_e207c2ed-ed09-42d0-861e-b3786f8fba54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2c1b84276324a28b731ff53e9def3cd_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0xNS0xLTEtMjM4MzY5_97219afe-54b9-4638-a426-8f7ef49bfb4a">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i763ecc59a2844e22891e55687fd0a3d7_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0xLTEtMS0yMzgzNjk_705d7302-289b-497f-9281-48776f326e52">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53c76d8608624e4787674cc6ed63818e_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0zLTEtMS0yMzgzNjk_bc785a56-748c-42a0-88f8-851cef6222c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie12432610ca742daadc4501b48c54075_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS01LTEtMS0yMzgzNjk_59496cc2-8a65-45b3-9341-1d25a9371159">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a6cf78d4b3f4e31be29df0ab4867707_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS03LTEtMS0yMzgzNjk_e2f92deb-2620-4ee5-a3b9-996548914b23">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6850c8d1a9b4abf91d4f9240163b33f_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS05LTEtMS0yMzgzNjk_bbe3b56e-91bb-4414-80b7-a5dbdd9d8b6d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icacac42c54284702ac2e69d39cc15335_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0xMS0xLTEtMjM4MzY5_fb43457b-df26-45bd-91dc-ec9b20b936a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7fe6cefd2840440fa73bfb36cce0bd02_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0xMy0xLTEtMjM4MzY5_641edc02-aa56-4c9f-a0ac-4ad1da5cf188">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i729d22ace90f47c0bf2e6fbda82b64d1_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0xNS0xLTEtMjM4MzY5_5e858270-1d59-4459-88d4-b6d3172b2245">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13d3320c4e2540a49733a84c90104543_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0xLTEtMS0yMzgzNjk_f62e2c94-c37c-401b-95c8-9ed789c4a3da">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b5749f29ed746cdb1f7e7ba300fc7af_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0zLTEtMS0yMzgzNjk_2f5ac677-23a1-4b30-bf7d-9b65814ad1cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93500e8506494c54ae50c563bf13de61_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi01LTEtMS0yMzgzNjk_cf4ff671-01e9-4320-9a03-d0acdd49e60a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06441b394eb04c088df79a7c58d41d8a_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi03LTEtMS0yMzgzNjk_8788e188-7b45-494c-91a6-8d79f2f9ac60">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2145777bf514c2e9428b3441b58838b_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi05LTEtMS0yMzgzNjk_5e3ca03c-0afb-4f0e-a406-c573ce7bdc7f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iacd5ed46262f4edaa5d4b50ba7ade997_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0xMS0xLTEtMjM4MzY5_fcb1fc6c-9079-489a-afec-5c77fa5fc6f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i584d55d88fdb45efa9af2b586e5f217a_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0xMy0xLTEtMjM4MzY5_7624f1b1-2ac2-496a-b99b-d029e81233aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f171369cd5d4f90a4563adeddadf605_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0xNS0xLTEtMjM4MzY5_33b7a07b-f6f7-4a98-ad43-693599605159">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third party</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie99422763a4d440c9debb245667d5c41_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0xLTEtMS0yMzgzNjk_ea5baf6b-3269-4bb7-9dd2-b37c177edb6b">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59328318fd8940bd8ba57a503380a716_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0zLTEtMS0yMzgzNjk_cce1129d-6c98-4d7f-9051-0f57c1bbb707">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4dd2467eb6a74cf5b4b1a1777f3e3c55_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy01LTEtMS0yMzgzNjk_845421b6-ebe3-4a2c-826b-26b768e856a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8926ca56ad6743998548a7c630959f43_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy03LTEtMS0yMzgzNjk_31b077d6-1795-4eca-9c1f-8edd7ed17fb7">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83ad11debbb84aae9ca83d5b2709beed_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy05LTEtMS0yMzgzNjk_1d26389d-3ec4-4e72-b8c0-0a145efce454">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32d7e51ee9b74366914cac24045ae494_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0xMS0xLTEtMjM4MzY5_18f99e4f-b069-42dd-9c8c-edb1378ada30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1155708282e748aaaff745d85150e533_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0xMy0xLTEtMjM4MzY5_487eb275-bc14-4e17-a303-876b7cdc582b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ca751f2ef6a46ceac258b5c894deab2_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0xNS0xLTEtMjM4MzY5_b96b8492-8da0-44be-bba5-4f747a11a586">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Total Dx revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7f05b08fb1b4715baffe092dc0385b6_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0xLTEtMS0yMzgzNjk_55891094-d773-402f-9d41-12a314c7a517">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if082ac4f47484ed49056b4d69e51b488_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0zLTEtMS0yMzgzNjk_3bdbf66c-1f82-4711-95df-d570ac7a5718">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia692ca467d2b4ff09e04d7def5d0b93e_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC01LTEtMS0yMzgzNjk_3ea305d8-0b7a-4ec4-9431-2ce2cf4aa0cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59031632d0a84142b11e9d2945f5de0f_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC03LTEtMS0yMzgzNjk_b719701b-8aae-4761-8929-304d744f8237">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia39e375cc4ad48c9a8271a3d25fb7540_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC05LTEtMS0yMzgzNjk_5b19dd0f-2dfd-40d5-993e-35079ff1ce77">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id173b34dc6f448f8b51cff3f364679f9_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0xMS0xLTEtMjM4MzY5_d47a6331-0e4b-414e-bdba-d431572a697b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if123dbe50a0b4e038bf1d42c09d499b9_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0xMy0xLTEtMjM4MzY5_9a026829-4d3c-4310-9e50-bdd5b6b55396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i740b7ad7e54746128e1e05e9e772c494_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0xNS0xLTEtMjM4MzY5_d8e1e4e5-40d2-4203-b60c-f687bd107e88">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical, biotechnology and medical device companies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf86457793f94a1b89374df236a0d4a9_D20230101-20230331" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMS0xLTEtMjM4MzY5_f43cf01e-f333-4cc0-9cfc-7f0eb89ac175">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieed2b69216414061a0dc9a748b771a88_D20230101-20230331" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMy0xLTEtMjM4MzY5_7014660a-8c27-4794-93b2-952b6a7e9a41">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i96175b5db8d347f9ba27cd093b4b2434_D20230101-20230331" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtNS0xLTEtMjM4MzY5_658f2c1b-cdf8-430e-b2c1-2687dc59938c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4bade9216bd42b7ab400fd587eb531b_D20230101-20230331" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtNy0xLTEtMjM4MzY5_4c1702d4-dc57-4bab-9c86-20d823f9297f">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i737f59dcfb5f48afb10f07bd9e8526be_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtOS0xLTEtMjM4MzY5_f442c1ba-4065-43ca-b04e-67cb0a744ec3">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d5f0fe941da4ed7a8226c737f6ca3c1_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMTEtMS0xLTIzODM2OQ_975bbcf2-e85c-46fe-aeaf-0a8886dbf7bb">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa1d29b542f64e46af9c4c2e0dd7e139_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMTMtMS0xLTIzODM2OQ_32825379-125b-4863-95a2-a02babb70290">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2c16890448b482a8f57a9fd32911696_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMTUtMS0xLTIzODM2OQ_822e2be5-98d2-4d31-be07-cf7f22d41b12">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff417091e8e144259990a3a8694217a3_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMS0xLTEtMjM4MzY5_0e287b17-6038-4a3c-b682-dfb1de9ab850">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib827e60cff174c63b54f562a198031e9_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMy0xLTEtMjM4MzY5_dd7f6d95-9773-4585-9df6-3f8b6517737b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4e1b39c14cd47d3a1f23f6197f735e7_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtNS0xLTEtMjM4MzY5_e9d775b2-e463-48ee-ad0e-b3a07cfcc1d1">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtNy0xLTEtMjM4MzY5_20718618-56af-4d5c-8b7b-a3a50baa28c7">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ideec54047acb41c88dff0ba4c5caa519_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtOS0xLTEtMjM4MzY5_811f51a1-70fe-4499-b1f2-ba25dc97f158">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i088eb4baf0c54c1caafe41e5b7e00385_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMTEtMS0xLTIzODM2OQ_ce4a0c3e-1b2a-4815-8130-4b9ade19a054">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00562d863b694bb2921bab984ac7c461_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMTMtMS0xLTIzODM2OQ_bcbe7840-ca63-4f42-844c-9b3143ec5dfd">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMTUtMS0xLTIzODM2OQ_fd5da63a-d740-4458-82d3-0f83674b124b">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues in the U.S. were $<ix:nonFraction unitRef="usd" contextRef="id971d73602324ea2bbed87722254241d_D20230101-20230331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTUy_56547218-033e-4d0b-a068-652c35075fa6">2,959.2</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="id971d73602324ea2bbed87722254241d_D20230101-20230331" decimals="INF" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTU2_049b11a1-3823-4e94-8768-a6cd4ffb337e">78.3</ix:nonFraction>%) and $<ix:nonFraction unitRef="usd" contextRef="i92fdaba98ae04990b80e40e7597fce48_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTY0_1a7657df-082b-47c2-96bf-5f187f660325">3,000.5</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="i92fdaba98ae04990b80e40e7597fce48_D20220101-20220331" decimals="INF" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTY4_3efda136-085c-472c-bf9f-422ca7faa0c1">76.9</ix:nonFraction>%) for the three months ended March&#160;31, 2023, and 2022, respectively.</span></div><div style="margin-bottom:7pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">DD Contract costs</span></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD incurs costs to fulfill contracts with customers. Contract fulfillment costs include software implementation costs and setup costs for certain market access solutions. </span></div><div style="margin-bottom:7pt;margin-top:5pt"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:CapitalizedContractCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjM0MQ_c6f5feae-5b02-4082-bdf1-df48334c92d0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:60.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.136%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMS0xLTEtMS0yMzgzNjk_9c3a7e2b-984a-4892-94fc-cbd1bcf848dc">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMS0zLTEtMS0yMzgzNjk_67aa4e54-0f5a-4ecc-afed-6ece4796ecb6">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMi0xLTEtMS0yMzgzNjk_427284ba-e232-4dab-8ad2-0f90bd0a807b">14.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMi0zLTEtMS0yMzgzNjk_2e433b1a-67d9-4993-bda0-25d17436354e">15.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMy0xLTEtMS0yMzgzNjk_4ef35213-f215-4d4f-ab26-98014ad2fd29">52.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMy0zLTEtMS0yMzgzNjk_46f7f606-e09d-4a4e-9efd-a255f3fc9618">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization related to sales commission assets and associated payroll taxes for the three months ended March&#160;31, 2023, and 2022, was $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNTcy_1857de03-66b7-4551-963e-fe0b64181689">8.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNTc5_858c0e2f-bbc1-4508-9eba-e3ad2a6ec671">7.2</ix:nonFraction>, respectively. Amortization related to deferred contract fulfillment costs for the three months ended March&#160;31, 2023, and 2022, was $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNzQw_973f8db5-12fa-44bb-b633-c8c3ade87017">2.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNzQ3_cdf8ca02-f4ff-4c14-ac5a-f5e029c5be8f">3.1</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Accounts Receivable, Unbilled Services and Unearned Revenue</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about accounts receivable, unbilled services, and unearned revenue from contracts with customers:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjMzMQ_33a97cfb-a73d-47fa-85af-d41d60e5e0f1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4435b03d249448678d58b9a5c5fdc669_I20230331" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMS0xLTEtMS0yMzgzNjk_515b4ffb-6534-4d7f-8885-a1f3188c4154">1,131.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0679350b3d0345839defcd1fbdc1ca18_I20221231" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMS0zLTEtMS0yMzgzNjk_b72a2d49-529c-4277-af2f-4326d78440dd">1,046.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie379b002992b4ac9a015d0de8f522228_I20230331" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMi0xLTEtMS0yMzgzNjk_3e8d785e-49e4-4e14-ba3d-b3697828116c">1,266.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a7d8dea373148a28d09ed326eb7865a_I20221231" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMi0zLTEtMS0yMzgzNjk_83e5dd0c-b1db-42b4-a328-bbeb505b20b5">1,218.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less DD allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMy0xLTEtMS0yMzgzNjk_ccdd65e3-4913-4218-863a-74930a07f2fe">52.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMy0zLTEtMS0yMzgzNjk_1d958d01-5d6a-4c67-9898-a07ec2f91f51">43.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNC0xLTEtMS0yMzgzNjk_23c3837e-ee62-4888-9917-3831a0f2547e">2,344.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNC0zLTEtMS0yMzgzNjk_4f264459-f1a0-477c-be78-19df2a9fac20">2,222.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unbilled services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNi0xLTEtMS0yMzgzNjk_aa99b03a-ce77-40c0-b215-e14dc5f893f3">715.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNi0zLTEtMS0yMzgzNjk_ce1c735f-2f82-4ab3-8824-02a4ebd97fad">805.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reserve for unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNy0xLTEtMS0yMzgzNjk_620abd0d-d2d0-4526-830d-f9c3cc9ba0a6">10.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNy0zLTEtMS0yMzgzNjk_0d4a59f6-bc94-4d50-a8ba-f182de956648">10.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfOC0xLTEtMS0yMzgzNjk_70a11d5d-1107-491d-bc1c-3850e8e0fa35">705.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfOC0zLTEtMS0yMzgzNjk_fecb8b25-9d20-49d5-acbc-b1b20423c6ac">795.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMTAtMS0xLTEtMjM4MzY5_d0d607c2-7648-48b3-b12d-00b100dfa774">586.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMTAtMy0xLTEtMjM4MzY5_d86f6a14-aecc-457e-a706-2f36734231f1">582.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized during the period that were included in the unearned revenue balance at the beginning of the period were $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTE1MQ_a04c927b-ad2d-41a5-a2b2-dbc85ad60e79">165.3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTE1OA_3d678459-dd7b-4fba-943a-eccb4ffd791b">163.8</ix:nonFraction> for the three months ended March&#160;31, 2023, and 2022, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="if580cc7f582244cc8dbbd1e3eb2e70c3"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Loss Rollforward</span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. <ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjMyNw_100d13dc-c9bb-44bd-8833-016e9e15a2e2" continuedAt="i644ab0df19fc4e01a904ea9a007c6c09" escape="true">The rollforward for the allowance for credit losses for the three months ended March&#160;31, 2023, is as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i644ab0df19fc4e01a904ea9a007c6c09"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMS0xLTEtMS0yMzgzNjk_598061ae-1a36-48ee-b04b-2f91702e9750">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:UnbilledServicesAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMS0zLTEtMS0yMzgzNjk_41ac633d-99e9-4349-aa8e-f34a2d496f6e">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:NoteReceivableAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMS01LTEtMS0yMzgzNjk_573e50c0-af07-4d76-9a3e-e8bdbfe1e042">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:AllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMS03LTEtMS0yMzgzNjk_25370d79-78b0-4536-bb0e-2b0698091fce">54.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus, credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00f94c3f1730467bb46c0d213ccf9893_D20230101-20230331" decimals="-5" name="lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMi0xLTEtMS0yMzgzNjk_73d4b62e-bac9-4b39-bacd-a996aeb0a6e9">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c13ae2d4e342baafe38aef77715bf2_D20230101-20230331" decimals="-5" name="lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMi0zLTEtMS0yMzgzNjk_acb8d37c-f76e-4436-b7f6-d3d69e085431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6958f3490b214ab3abf0a9756949e010_D20230101-20230331" decimals="-5" name="lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMi01LTEtMS0yMzgzNjk_d45c62ff-be91-407b-8333-8f169295ce13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMi03LTEtMS0yMzgzNjk_23033d28-63cc-4dbb-bd6a-113139ecc3c8">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less, write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00f94c3f1730467bb46c0d213ccf9893_D20230101-20230331" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNC0xLTEtMS0yMzgzNjk_6ec8f6af-7973-4464-b460-18fd0bca4315">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c13ae2d4e342baafe38aef77715bf2_D20230101-20230331" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNC0zLTEtMS0yMzgzNjk_07ca059e-0129-4e57-9d6a-fd164d8fe963">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6958f3490b214ab3abf0a9756949e010_D20230101-20230331" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNC01LTEtMS0yMzgzNjk_69d81e8c-ec11-4f19-83bd-d95c5f7a70b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNC03LTEtMS0yMzgzNjk_05a9ee3b-57cd-46f2-b271-b8045d545783">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNS0xLTEtMS0yMzgzNjk_0e1a2564-08f3-425b-b2c6-06c76083e7d8">52.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:UnbilledServicesAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNS0zLTEtMS0yMzgzNjk_0f8a50f2-af45-4eef-89fb-1485399f29e2">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:NoteReceivableAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNS01LTEtMS0yMzgzNjk_9bcbbedd-3f91-47a8-8e25-f6b60074bff1">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:AllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNS03LTEtMS0yMzgzNjk_a62c7c29-0bc5-47db-b4a5-9bcff906cfe5">64.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit loss expense in the first quarter primarily related to the the collection risk from several biotech receivable balances.</span></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations Under Long-Term Contracts</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term contracts at the Company consist primarily of fully managed clinical studies within DD. The amount of existing performance obligations unsatisfied under such long-term contracts were $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTcxMw_cbbc1f28-afb9-47c8-866f-efc7c74ee3a5">4,720.0</ix:nonFraction> as of March&#160;31, 2023. DD expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="INF" name="lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNTQ5NzU1ODE3MjM4_e39314c6-19c3-4afe-adfd-feb180298739">30.0</ix:nonFraction>% of the remaining performance obligations as of March 31, 2023, as revenue over the next 12 months. DD's long-term contracts generally range from <ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="lh:LongTermContractsDurationMinimum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTkwMA_70ff7c55-2306-4154-b6e1-04ef5638bd0b">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="lh:LongTermContractsDurationMaximum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTkwNg_a8f3456c-dd72-433e-b6c9-cf420f2675bd">8</ix:nonNumeric> years.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within DD, revenues of $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTkzOQ_9e03a111-4bf6-402d-9aa0-0ea8a4747015">10.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTk0Ng_df353207-455a-4479-9b8d-5a4d43144b39">31.7</ix:nonFraction> were recognized during the three months ended March&#160;31, 2023 and 2022, respectively, from performance obligations that were satisfied in previous periods. This revenue primarily relates to adjustments related to changes in scope in full service clinical studies, and to a lesser extent, changes in estimates.</span></div></ix:continuation><div id="i63596bd8d89a4cde970ba8cf74db2b44_37"></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfMjY5MA_526bb2d0-2a2e-44c6-bf73-8eeef4724d9d" continuedAt="i336a0eb8497e4bf5a8a1f190a9a9952d" escape="true">BUSINESS ACQUISITIONS </ix:nonNumeric></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i336a0eb8497e4bf5a8a1f190a9a9952d">During the three months ended March 31, 2023, the Company recorded several measurement period adjustments for 2022 acquisitions, relating to final valuations and deferred tax true-ups. The adjustments include the following:</ix:continuation></span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.005%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:31.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments During Three Months Ended March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331" decimals="-5" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMS01LTEtMS0yNjI4MDQ_872e966f-131d-441e-8a40-9c2f76b343a3">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c7c606b647f41e58ee112be251877bf_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfOC01LTEtMS0yMzgzNjk_37f38f4d-b4c9-4067-9b17-16eb0746b3f6">30.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331" decimals="-5" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfOS01LTEtMS0yMzgzNjk_63fffa46-1579-4110-a118-6a52aa60952f">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTEtNS0xLTEtMjM4MzY5_ea52349b-9c49-4d2b-8f99-e848a7e7a545">10.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b2961f942e4288b255e63e16d547a7_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTMtNS0xLTEtMjM4MzY5_cbb4e2f3-2deb-4fee-9d90-a4098ce4a25c">8.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c8e22062d044e07b6b22b1dcd5a0364_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTUtNS0xLTEtMjM4MzY5_1a0691e6-cfc9-4e1a-ac0d-daf2765750c6">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTgtNS0xLTEtMjM4MzY5_f1465330-334f-4265-a879-777801ce1639">10.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9b1e876bfb460880c08cb5c95f0b7b_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTktNS0xLTEtMjM4MzY5_b032a5f2-0062-4a64-91d3-6838b74f2ec1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, the Company closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products, for approximately $<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfMTUxMg_100c3fad-c411-40c2-a66d-37d82b605dae">455.1</ix:nonFraction> in cash. The preliminary purchase considerations for this acquisition were allocated under the acquisition method of accounting to the estimated fair market value of the net assets acquired, including approximately $<ix:nonFraction unitRef="usd" contextRef="i6d5821a314134dd49949999c2e5b3f19_D20220101-20220331" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfMTczNA_04d7240d-2a96-4b7e-909d-2593654b2c68">270.0</ix:nonFraction> in identifiable intangible assets and a residual amount of non-tax deductible goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="i6d5821a314134dd49949999c2e5b3f19_D20220101-20220331" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfMTg0MQ_343d6010-9cfb-476d-bf50-5dd65fb9971c">286.2</ix:nonFraction>. Inclusive of measurement period adjustments, approximately $<ix:nonFraction unitRef="usd" contextRef="ia20524cf106845889acba917cc6c2f53_D20221001-20221231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfNTQ5NzU1ODIzMjk1_c1970956-edb9-4007-a875-4dc6df49a180">136.6</ix:nonFraction> in identifiable intangible assets and a residual amount of non-tax deductible goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="ia20524cf106845889acba917cc6c2f53_D20221001-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfNTQ5NzU1ODIzMjk5_a54cb3b2-2fa4-4c64-9ea8-d3361112aaef">346.8</ix:nonFraction> were recorded as of March&#160;31, 2023. The amortization period for technology intangible assets acquired from this business is <ix:nonNumeric contextRef="i478a2df8586f43a4ac24ced9bb357651_D20220101-20220331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfNTQ5NzU1ODE4MjM2_cbb38c3d-2a13-4157-9486-91c5da814bfe">15</ix:nonNumeric> years. The acquisition was made primarily to complement and accelerate the Company&#8217;s existing liquid biopsy capabilities and expand the Company&#8217;s leading oncology portfolio of next-generation sequencing (NGS)-based genomic profiling capabilities. The transaction includes two milestone earnout payments, with one based on the successful development of the in-process testing and the other based on revenue. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. The Company has several other acquisitions for which the purchase price allocation have not been finalized as of March 31, 2023.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma Information</span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Had the Company's total 2022 acquisitions been completed as of January 1, 2022, the Company's pro forma results would have been as follows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:27.702%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOmEyNDE0NmZiNTg1MzRiNWNhZWIyNWE1Y2JjZjdjOWRiL3RhYmxlcmFuZ2U6YTI0MTQ2ZmI1ODUzNGI1Y2FlYjI1YTVjYmNmN2M5ZGJfMi0yLTEtMS0yMzgzNjk_cab04a0c-42a8-4ab6-bae3-a5b12dd92e92">3,943.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOmEyNDE0NmZiNTg1MzRiNWNhZWIyNWE1Y2JjZjdjOWRiL3RhYmxlcmFuZ2U6YTI0MTQ2ZmI1ODUzNGI1Y2FlYjI1YTVjYmNmN2M5ZGJfMy0yLTEtMS0yMzgzNjk_0444e29a-33e0-4554-b684-f4f67a9512f4">490.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_40"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RleHRyZWdpb246ODQxMWZjMjVkOWEzNDhmNWE0NzM5ZmFjZjM5M2Y1OTJfMTI1OA_ac1caa38-10be-4627-b94e-e6218fee883b" continuedAt="i9768c2bbe07d4048914204d1de8daf23" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i9768c2bbe07d4048914204d1de8daf23"><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#8217;s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.</span></div><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RleHRyZWdpb246ODQxMWZjMjVkOWEzNDhmNWE0NzM5ZmFjZjM5M2Y1OTJfMTI0Nw_20f9427a-83ef-4cb3-bcc0-a313f2a7e4ad" escape="true"><div style="margin-bottom:7.1pt;margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.579%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC0xLTEtMS0yMzgzNjk_3d10a62f-c72c-432c-ae2a-e90d3d14df4f">212.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC0zLTEtMS0yMzgzNjk_b3bf8053-3271-4dd3-ae98-6c40844e5caf">88.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC01LTEtMS0yMzgzNjk_ea478cd5-02c4-4281-9249-3535120d4075">2.41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC03LTEtMS0yMzgzNjk_2be8501a-14f9-4fc1-bd58-469f63e50c1b">491.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC05LTEtMS0yMzgzNjk_4e232db8-bb8a-404f-bc70-dad43fefa781">93.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC0xMS0xLTEtMjM4MzY5_8c01b0e9-f1de-4155-b567-c3f5abaaf126">5.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of employee&#160;stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNS0zLTEtMS0yMzgzNjk_b2c1e3ca-00be-4256-b01f-52d3d9fd1892">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNS05LTEtMS0yMzgzNjk_58e9d4fc-5e1f-4fd8-8411-4ba963e75447">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings including impact of dilutive adjustments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC0xLTEtMS0yMzgzNjk_f34ffccf-78df-4cf3-a60b-6ee053fc9b78">212.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC0zLTEtMS0yMzgzNjk_221c072b-adb7-4036-a115-a50bf8d6df13">89.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC01LTEtMS0yMzgzNjk_6ddeace1-55d8-4c78-a737-9b918316e239">2.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC03LTEtMS0yMzgzNjk_dee4fe6b-830d-430b-9265-3ea37c12dae0">491.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC05LTEtMS0yMzgzNjk_fcf2f8c2-607a-48ce-b3f2-da358ff53804">94.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC0xMS0xLTEtMjM4MzY5_767b4875-572e-4538-b6b5-edfaa52100a8">5.23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. <ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RleHRyZWdpb246ODQxMWZjMjVkOWEzNDhmNWE0NzM5ZmFjZjM5M2Y1OTJfMTI3OQ_82ed3236-051d-4946-a53a-a4238753408b" continuedAt="ie1c5e33dc9314daead0b9ca87adba114" escape="true">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ie1c5e33dc9314daead0b9ca87adba114"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.961%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjkzMTM3YjkyYWZmMzRlNzFhMGI5YmU2MTM4Y2VmYmU3L3RhYmxlcmFuZ2U6OTMxMzdiOTJhZmYzNGU3MWEwYjliZTYxMzhjZWZiZTdfMi0xLTEtMS0yMzgzNjk_c4c810b9-ffe0-40f6-93e4-de08fd8b89a1">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjkzMTM3YjkyYWZmMzRlNzFhMGI5YmU2MTM4Y2VmYmU3L3RhYmxlcmFuZ2U6OTMxMzdiOTJhZmYzNGU3MWEwYjliZTYxMzhjZWZiZTdfMi0zLTEtMS0yMzgzNjk_d024f46d-4089-46d2-989f-2d0d9a9bc0ad">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div id="i63596bd8d89a4cde970ba8cf74db2b44_43"></div><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjIwMQ_500ef434-b290-4103-81db-a4a409ac3741" continuedAt="i8a6001e4a69744abb0c3c1b9269fb885" escape="true"><div style="margin-bottom:6pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;GOODWILL AND INTANGIBLE ASSETS</span></div><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjIxNg_27d5fbeb-6288-4741-a12e-a1b1dda22e33" escape="true"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea4f8105f7c2473fb04f52c1cf307161_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfMy0xLTEtMS0yMzgzNjk_52c8ed44-aee4-42b9-b6f9-701dff2639ca">4,533.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367717bee21446d7b41b04f4afdd53da_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfMy01LTEtMS0yMzgzNjk_ca6c3971-8fc5-4792-b814-3d48a856e2ef">3,587.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfMy05LTEtMS0yMzgzNjk_522a8a79-b57c-4449-96be-f612f3abb7cb">8,121.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59031632d0a84142b11e9d2945f5de0f_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOC0xLTEtMS0yMzgzNjk_a5e98b81-749c-4c2e-ae4a-5b82e26ac6e4">19.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic62e9f64e0a74bcf8ed85655910238e6_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOC01LTEtMS0yMzgzNjk_09ec3335-de92-49af-bee3-13cc28e733a1">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOC05LTEtMS0yMzgzNjk_7bdbf5eb-9af7-45dd-9cdb-d90c973ae9f3">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3837e5c114d143df8e230ad612f6111f_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOS0xLTEtMS0yMzgzNjk_6948953d-49ff-433f-ae7f-73fcc083359d">4,514.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca5e7f0071c4897a17282d5246502a9_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOS01LTEtMS0yMzgzNjk_e1131c99-90ad-42da-89ef-62cc81c4f126">3,601.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOS05LTEtMS0yMzgzNjk_d81aad36-702d-46a3-8ec6-90ae759c4a52">8,116.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, the Company's business could be impacted by unfavorable changes, including those that impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily a worsening economic environment and protracted economic downturn and related impacts, including delays in revenue from new customers; increases in customer termination activity; or increases in operating costs. </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i8a6001e4a69744abb0c3c1b9269fb885"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to monitor the financial performance of, and assumptions for, its reporting units. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin, or substantial reductions in end markets and volume assumptions, could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjIwMA_744dc634-fe90-466f-a879-4fa8d5102cfd" continuedAt="if0b76f2bd52644f5a6235d5d283dd837" escape="true">he components of identifiable intangible assets are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:7pt;margin-top:5pt"><ix:continuation id="if0b76f2bd52644f5a6235d5d283dd837"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc11c37c41af470b99edcf92d0ddfa5a_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi0xLTEtMS0yMzgzNjk_24882a05-61f0-4c38-a570-8530ef287f57">4,723.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc11c37c41af470b99edcf92d0ddfa5a_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi0zLTEtMS0yMzgzNjk_01bba141-b112-497c-adce-f70329c0f810">1,605.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc11c37c41af470b99edcf92d0ddfa5a_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi01LTEtMS0yMzgzNjk_3431f552-078c-4050-94db-061a786666d5">3,118.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f25ab7e1594456ab575b107b00dff07_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi03LTEtMS0yMzgzNjk_df01b126-0a7e-4714-bac7-ac640b406f14">4,681.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f25ab7e1594456ab575b107b00dff07_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi05LTEtMS0yMzgzNjk_c0d7a7b5-8019-414d-8dff-eb2574368c84">1,546.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f25ab7e1594456ab575b107b00dff07_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi0xMS0xLTEtMjM4MzY5_a08e7a40-3e9b-4a94-9c64-5cebd5125cda">3,134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic37cab27c9924e55b43d4eca1de9ed08_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy0xLTEtMS0yMzgzNjk_08190433-ff4c-4253-ba47-990312ede7e0">574.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic37cab27c9924e55b43d4eca1de9ed08_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy0zLTEtMS0yMzgzNjk_7187252c-0568-4837-b817-4d9049d7ff1b">298.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic37cab27c9924e55b43d4eca1de9ed08_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy01LTEtMS0yMzgzNjk_76fd6f6a-ef45-49bb-8c1e-a07c47647205">276.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d2fb16eef474b76b17de5a95e7d2063_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy03LTEtMS0yMzgzNjk_42d2a148-230f-4f4d-b2a2-c95d97912813">574.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d2fb16eef474b76b17de5a95e7d2063_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy05LTEtMS0yMzgzNjk_8160bdb5-0057-4961-a43c-c6c1d31422cc">291.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d2fb16eef474b76b17de5a95e7d2063_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy0xMS0xLTEtMjM4MzY5_6f436950-3dc2-4ec0-9cc1-af60a43dab42">283.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f98a37fdff54bff858d9b633c7df6fd_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC0xLTEtMS0yMzgzNjk_cd6cc2e4-8d16-4572-9694-b1c7d1389052">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f98a37fdff54bff858d9b633c7df6fd_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC0zLTEtMS0yMzgzNjk_9ccb47c7-ed6e-4035-8318-08b625979ba6">56.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f98a37fdff54bff858d9b633c7df6fd_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC01LTEtMS0yMzgzNjk_d318997b-6bb0-4b36-89cc-def4b3d19614">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a694aae86a041dba12584e655a56786_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC03LTEtMS0yMzgzNjk_6b128d53-e233-47d0-8324-d9c50d435462">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a694aae86a041dba12584e655a56786_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC05LTEtMS0yMzgzNjk_adfb279c-65be-4c62-b85c-e351d09cc717">50.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a694aae86a041dba12584e655a56786_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC0xMS0xLTEtMjM4MzY5_c3904f3e-89a4-4d35-885a-767e2e974c18">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79a415a626ce4907ab55886ae221d3b5_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS0xLTEtMS0yMzgzNjk_8cd14ce3-b46e-4269-bc97-75d1d8646abc">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79a415a626ce4907ab55886ae221d3b5_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS0zLTEtMS0yMzgzNjk_5259329c-a711-43d6-8b2b-bd5fbfce206f">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79a415a626ce4907ab55886ae221d3b5_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS01LTEtMS0yMzgzNjk_ed730fbb-3181-4236-bf04-32ab62cc1ad5">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7965b44dc64133b06b8e8418e9e63f_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS03LTEtMS0yMzgzNjk_667883c7-0dc8-417d-8c17-3c3313718be6">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b7965b44dc64133b06b8e8418e9e63f_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS05LTEtMS0yMzgzNjk_a6f1b7e5-d21c-41ac-ac51-752ba06a38db">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7965b44dc64133b06b8e8418e9e63f_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS0xMS0xLTEtMjM4MzY5_685908f9-3a07-4e70-b760-7ae61ae3e94c">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use right</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b34a492ae347f5a0f4fbab882117b4_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi0xLTEtMS0yMzgzNjk_7721a5f2-fcb3-4a76-968d-7f0d4f7d9b88">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05b34a492ae347f5a0f4fbab882117b4_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi0zLTEtMS0yMzgzNjk_a7a5351a-fb29-4159-978c-955d93dea19f">9.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b34a492ae347f5a0f4fbab882117b4_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi01LTEtMS0yMzgzNjk_3ef71b93-87c9-4b96-8e7c-58f80fed1087">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208b4414a820456bb72360fbc55747f7_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi03LTEtMS0yMzgzNjk_2d59c370-d318-48c1-b52e-af6b0f62bc2e">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208b4414a820456bb72360fbc55747f7_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi05LTEtMS0yMzgzNjk_99103adb-5de0-478c-8514-434b703ef363">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208b4414a820456bb72360fbc55747f7_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi0xMS0xLTEtMjM4MzY5_ccc21c3a-7d3f-4023-9948-f8f619104f65">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b60b6004a24ba48579fb56cf93d751_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy0xLTEtMS0yMzgzNjk_ab633fb5-53c0-46a1-a39a-c4243eb9622d">468.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b60b6004a24ba48579fb56cf93d751_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy0zLTEtMS0yMzgzNjk_d4e29576-d450-4807-861c-a14c002545a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b60b6004a24ba48579fb56cf93d751_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy01LTEtMS0yMzgzNjk_a8d67030-f9f2-428e-a360-3f4868bbceb9">468.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf79c7c336c4856b02a1b0a7ac3802c_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy03LTEtMS0yMzgzNjk_ec38a658-5f9b-4de1-85cd-34b930d3c1fb">468.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf79c7c336c4856b02a1b0a7ac3802c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy05LTEtMS0yMzgzNjk_940c9354-56d3-40bd-89a5-ce18398ac250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf79c7c336c4856b02a1b0a7ac3802c_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy0xMS0xLTEtMjM4MzY5_f85523b0-aaa7-4abf-a32e-d6d5cc6aaf25">468.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bda848179204f8dbc6ca502a1e6b162_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC0xLTEtMS0yMzgzNjk_6fc9ef23-94be-4d62-ad19-9f3e17d44cb0">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bda848179204f8dbc6ca502a1e6b162_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC0zLTEtMS0yMzgzNjk_b25baf4e-73b2-422c-9579-db19be2d0fd3">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bda848179204f8dbc6ca502a1e6b162_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC01LTEtMS0yMzgzNjk_c0789009-4e35-441c-980d-e012f3c7f0c4">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d6d91a822b4e58a4a30b0ed4b82bf0_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC03LTEtMS0yMzgzNjk_a3674e24-df85-48d0-aa31-46dbb94049ac">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d6d91a822b4e58a4a30b0ed4b82bf0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC05LTEtMS0yMzgzNjk_69461fd7-1eb4-4b4c-b84b-27ed979ae66b">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d6d91a822b4e58a4a30b0ed4b82bf0_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC0xMS0xLTEtMjM4MzY5_1bd162d5-37fd-4db7-b446-82e93491a25b">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS0xLTEtMS0yMzgzNjk_2fe6f536-e7b9-4492-b93c-a4b59b8bca5f">5,891.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS0zLTEtMS0yMzgzNjk_c75c18db-3d1d-4cb9-8327-b1511aa2827e">1,979.5</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS01LTEtMS0yMzgzNjk_c6664cce-d7fd-41e8-8126-b550d5b68ca9">3,912.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS03LTEtMS0yMzgzNjk_23f2e85f-0a55-4116-b46c-badfac449c32">5,851.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS05LTEtMS0yMzgzNjk_6d94a123-dd0c-4f8f-b739-62430eacd1df">1,904.5</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS0xMS0xLTEtMjM4MzY5_9e3cebff-e3f7-4118-bce9-4eb174db7096">3,946.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets for the three months ended March&#160;31, 2023, and 2022, was $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMTk0NQ_d3eda484-b617-4c49-8f40-8e75bc647613">69.3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMTk1Mg_fbc0b55f-ed63-405c-b4fd-cb9a3b4df906">67.1</ix:nonFraction>, respectively. The amortization expense for the net carrying amount of intangible assets is estimated to be $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjA3Nw_96dbad43-1437-42bb-863b-a4d99f6f1bef">206.2</ix:nonFraction> for the remainder of fiscal 2023, $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjExMw_0446fde0-268d-47c8-a8a6-4d5c14030072">267.5</ix:nonFraction> in fiscal 2024, $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjEzMA_8d6d2351-459b-48fa-b3f2-05375f29c915">255.3</ix:nonFraction> in fiscal 2025, $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjE0Nw_bcbd6db3-303f-4935-bf79-afcf21b11844">245.5</ix:nonFraction> in fiscal 2026, $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjE2NA_c627598c-2a7c-481c-90c0-f99b19d7f95a">233.9</ix:nonFraction> in fiscal 2027, and $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjE4NQ_dad793c7-99b7-41f4-8d88-24994b123f30">2,141.3</ix:nonFraction> thereafter.</span></div></ix:continuation><div id="i63596bd8d89a4cde970ba8cf74db2b44_46"></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;DEBT </span></div><div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and the current portion of long-term debt at March&#160;31, 2023, and December 31, 2022, consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A400SeniorNotesDue2023" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfMi0xLTEtMS0yMzgzNjk_39fe1edf-d79e-4915-a1e1-10e3f0f46202">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:A400SeniorNotesDue2023" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfMi0zLTEtMS0yMzgzNjk_b827db4e-4933-402c-b05d-afb14e960048">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:Shorttermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfMy0xLTEtMS0yMzgzNjk_b39a8b83-5e37-4d6e-bdd0-c7732695d8b3">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:Shorttermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfMy0zLTEtMS0yMzgzNjk_115892d7-19b7-4783-a0ee-4cc928c2d0e1">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:NotesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfNS0xLTEtMS0yMzgzNjk_70a82e6a-79e1-483c-9cc7-ccaa2fd29988">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:NotesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfNS0zLTEtMS0yMzgzNjk_6aebf867-c70b-4ce4-a489-70c2d4bf15b1">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:CurrentDebtExcludingFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfNi0xLTEtMS0yMzgzNjk_df1f18d9-099b-416e-b33c-50ec4795e614">301.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:CurrentDebtExcludingFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfNi0zLTEtMS0yMzgzNjk_2e65a1df-b03e-48b9-901d-7b5e637e0062">301.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt at March&#160;31, 2023, and December 31, 2022, consisted of the following:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30% senior notes due 2024</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A2.30seniornotesdue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOC0xLTEtMS0yMzgzNjk_0cca5a13-d699-4905-977b-8cd04e97d6d6">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:A2.30seniornotesdue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOC0zLTEtMS0yMzgzNjk_4371b34e-884a-44b1-aa39-56c1f5fcd0a9">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25% senior notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A325SeniorNotesDue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOS0xLTEtMS0yNjU5Njg_01892d37-3157-4e92-8c7d-a1760d0ee3be">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:A325SeniorNotesDue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOS0zLTEtMS0yNjU5Njg_e3b16a5d-e394-41ce-8aa4-5852cfebb4cb">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A360SeniorNotesDue2025" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOS0xLTEtMS0yMzgzNjk_a0842ec8-fead-46f2-bb82-ed8e2a95e1fd">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:A360SeniorNotesDue2025" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOS0zLTEtMS0yMzgzNjk_04e226b4-2ca6-4dc2-9eac-125ec7a22af6">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55% senior notes due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A155SeniorNotesDue2026" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTAtMS0xLTEtMjM4MzY5_d0e513e3-04c5-4c4e-8b2d-6f9f15db42fd">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:A155SeniorNotesDue2026" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTAtMy0xLTEtMjM4MzY5_73b0a181-69fa-45ca-806f-6ba603a6cc9c">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A360SeniorNotesDue2027" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTEtMS0xLTEtMjM4MzY5_f9287bc9-cc56-4964-be4d-cff09d673c05">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:A360SeniorNotesDue2027" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTEtMy0xLTEtMjM4MzY5_d05d74ab-39a6-4ac8-b9a5-d0f8c8cf0b43">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% senior notes due 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A2.95seniornotesdue2029" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTItMS0xLTEtMjM4MzY5_f0d70338-e085-47c6-8997-cd334b3376d0">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:A2.95seniornotesdue2029" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTItMy0xLTEtMjM4MzY5_314df6fc-3be7-4888-b89e-3ddd31ba80d7">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% senior notes due 2031</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i772840f5d04344f4a44ed5da9d0e53d7_I20230331" decimals="-5" name="lh:A270SeniorNotesDue2031" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTMtMS0xLTEtMjM4MzY5_a175f1c5-401c-4a94-a56c-41270cbcb4a3">432.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff0a49f62ff41469cd1280087a38dc2_I20221231" decimals="-5" name="lh:A270SeniorNotesDue2031" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTMtMy0xLTEtMjM4MzY5_a66dbf4f-7b34-43fb-8dce-2c4e8a87e2dd">420.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% senior notes due 2045</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A470SeniorNotesDue2045" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTQtMS0xLTEtMjM4MzY5_a934183b-6bc2-49c7-8709-9c2f5bfc2852">900.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:A470SeniorNotesDue2045" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTQtMy0xLTEtMjM4MzY5_f6fe0723-8bc3-432c-a83c-b65e15768d73">900.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:Longtermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTctMS0xLTEtMjM4MzY5_86fac6e2-169f-4131-8fdf-760fa5c9e0e6">32.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:Longtermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTctMy0xLTEtMjM4MzY5_ef99d840-1834-4fe4-bdf6-8d4b0f76ac08">33.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:LongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTktMS0xLTEtMjM4MzY5_21d530fd-2c32-4300-aaf2-6798eee4ab8b">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:LongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTktMy0xLTEtMjM4MzY5_24f63f6e-8b8a-4175-a8f8-3a7a5dfc5920">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMjAtMS0xLTEtMjM4MzY5_26808393-815d-4514-a034-9290cf8fbc8f">5,052.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMjAtMy0xLTEtMjM4MzY5_ec02a3d4-e014-4513-9259-8cb108b76c54">5,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into fixed-to-variable interest rate swap agreements for its <ix:nonFraction unitRef="number" contextRef="i2fc48bf4132447b5ad6ad22c82427c71_D20230101-20230331" decimals="INF" name="us-gaap:SubordinatedBorrowingInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfOTU0_24c6d08b-c8c7-4a97-8faf-8a88424212ea">2.70</ix:nonFraction>% senior notes due 2031 with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:A270SeniorNotesDue2031" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTAxNg_99e3c406-f04a-4e66-99fb-ed64c2a2f633">500.0</ix:nonFraction> and variable interest rates based on three-month LIBOR plus <ix:nonFraction unitRef="number" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="INF" name="lh:ThreeMonthLIBOR" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTA3OQ_d8657640-4270-4237-ac2a-5bf222e49f55">1.0706</ix:nonFraction>% to hedge against changes in the fair value of a portion of the Company's long-term debt. These interest rate swaps are included in other long-term liabilities and deducted from the value of the senior notes with an aggregate fair value of $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTMyMQ_b4b77ee3-b9f9-44f5-b45a-b73afb123532">67.3</ix:nonFraction> at March&#160;31, 2023.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a senior revolving credit facility, which was amended and restated on April 30, 2021. It consists of a five-year facility in the principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTUyOA_1f1b2351-645a-471b-8448-b483855964c0">1,000.0</ix:nonFraction>, with the option of increasing the facility by up to an additional $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:CreditFacilityOptiontoIncrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTU5OA_366c1747-e7b2-4c4d-bb83-ab90e30116f5">500.0</ix:nonFraction>, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions. The revolving credit facility also provides for a subfacility of up to $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:CreditFacilityMaximumSwingLineBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTgxMg_c1e546a7-5b74-48d3-bac7-8669df81f526">100.0</ix:nonFraction> for swing line borrowings and a subfacility of up to $<ix:nonFraction unitRef="usd" contextRef="if61be0038474449a8767e2be7c9aad81_I20230331" decimals="-5" name="lh:CreditFacilityMaximumLettersofCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTg2OA_56961ebe-901f-41de-9066-048dd90bf8ce">150.0</ix:nonFraction> for issuances of letters of credit. The Company is required to pay a facility fee on the aggregate commitments under the revolving credit facility, at a per annum rate ranging from <ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:LineOfCreditFacilityCommitmentFeeDescription" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMjA1Mg_f6a7e0a1-71b8-4f40-adb0-c1fdf02c9c83">0.10% to 0.225%</ix:nonNumeric>, depending on the Company's debt ratings. The revolving credit facility is permitted to be used for general corporate purposes, including working capital, capital expenditures, funding of share repurchases and certain other payments, acquisitions, and other investments. The revolving credit facility also provides for the issuance of letters of credit without a reduction of the availability of borrowings under the facility. There were no balances outstanding on the Company's current revolving credit facility as of March&#160;31, 2023 and December 31, 2022. As of March&#160;31, 2023, the effective interest rate on the revolving credit facility was <ix:nonFraction unitRef="rate" contextRef="if61be0038474449a8767e2be7c9aad81_I20230331" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMjY2MA_2ee3f49b-a495-4e3e-8921-f94e52842652">5.63</ix:nonFraction>%. The credit facility expires on April 30, 2026. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers, and the Company is required to maintain certain leverage ratios. The Company was in compliance with all covenants in the revolving credit facility at March&#160;31, 2023, and expects that it will remain in compliance with its existing debt covenants for the next twelve months. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="0" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMzE3NA_0793759e-2dfd-4815-9126-2824a36e4944">84.5</ix:nonFraction> in outstanding letters of credit as of March&#160;31, 2023.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_49"></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjIxMw_eb0d0b83-795c-40bf-9a6a-867db318d8ae" continuedAt="i994bde087f464b86ab101c680e5855a1" escape="true">PREFERRED STOCK AND COMMON SHAREHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i994bde087f464b86ab101c680e5855a1"><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfOTc_1b300d2d-8e62-469b-949e-995e7d65165c">265.0</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTM0_a8cff4b6-5c3e-4523-8d24-d6d61e4acb05">0.10</ix:nonFraction> per share. The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTg5_7e4f0e5d-7e3e-4d11-90b1-b55268a869ec">30.0</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjI5_bbddd56d-0d64-46fa-b4e4-78e36c25ff95">0.10</ix:nonFraction> per share. There were <ix:nonFraction unitRef="shares" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjU0_2290290b-dc60-4a23-b11e-7932624d4bed">no</ix:nonFraction> preferred shares outstanding as of March&#160;31, 2023, and December 31, 2022. </span></div><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjIwMQ_685056c5-8c8d-45e6-a1a6-2b93e79e39a7" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued are summarized below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.634%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and Outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3899295744f647ccb8f7d75b5d3d2193_I20221231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOjliNDE0ZWQwOGZkNDQ3ZmZhOGM1YzgwZWUyODY3ZjU4L3RhYmxlcmFuZ2U6OWI0MTRlZDA4ZmQ0NDdmZmE4YzVjODBlZTI4NjdmNThfMS0xLTEtMS0yMzgzNjk_6aab4af2-86b5-4f69-af32-1b209cfb7fa6">88.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f6d9f778de347038d4db29292220d70_D20230101-20230331" decimals="-5" name="lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOjliNDE0ZWQwOGZkNDQ3ZmZhOGM1YzgwZWUyODY3ZjU4L3RhYmxlcmFuZ2U6OWI0MTRlZDA4ZmQ0NDdmZmE4YzVjODBlZTI4NjdmNThfMi0xLTEtMS0yMzgzNjk_2d807376-789d-466e-a6ab-82804206b7b0">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i509a25f9cde744a08f771cef00ab8b88_I20230331" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOjliNDE0ZWQwOGZkNDQ3ZmZhOGM1YzgwZWUyODY3ZjU4L3RhYmxlcmFuZ2U6OWI0MTRlZDA4ZmQ0NDdmZmE4YzVjODBlZTI4NjdmNThfNy0xLTEtMS0yMzgzNjk_b37d0303-d152-4631-8efc-9346a93c6116">88.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had outstanding authorization from the board of directors to purchase up to $<ix:nonFraction unitRef="shares" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="8" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTQ5Mw_410a48ad-1793-4352-a09d-92a202a3a5f7">1,531.5</ix:nonFraction> of the Company's common stock. The repurchase authorization has no expiration.</span></div><div style="margin-bottom:3pt;margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTYxNw_245020b1-c305-4d83-889c-bc61db6bf8f3">64.4</ix:nonFraction> in common stock dividends. On <ix:nonNumeric contextRef="iade5794fdb2048c4b1367089794b02d2_D20230406-20230406" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTY1MA_e2cd721e-1a5e-4ded-bb5b-1c4160e23c3e">April 6, 2023</ix:nonNumeric>, the Company announced a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i434e0492f16b458782fd7bad1f0165fc_I20230406" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTY5NQ_1e4e1df4-4aa8-4004-89aa-ccb5479c3797">0.72</ix:nonFraction> per share of common stock for the second quarter, or approximately $<ix:nonFraction unitRef="usd" contextRef="iade5794fdb2048c4b1367089794b02d2_D20230406-20230406" decimals="INF" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTc2MQ_1991ae62-dd1c-4e71-aefd-45a3bdbd0f48">64.7</ix:nonFraction> in the aggregate. The dividend will be payable on <ix:nonNumeric contextRef="i64a241cba18148d68b58c63f94a86b0d_D20230608-20230608" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTgxNA_a075f88c-0416-458c-bc2e-cb148f437c97">June 8, 2023</ix:nonNumeric>, to stockholders of record of all issued and outstanding shares of common stock as of the close of business on <ix:nonNumeric contextRef="i318e19e3163b4d77b9fdcb41be6651b3_D20230518-20230518" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTkyOA_7c1b1e53-79b0-4d70-8af8-92d053046fb1">May 18, 2023</ix:nonNumeric>. The declaration and payment of any future dividends will be at the discretion of the Company's board of directors.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Earnings (Loss)</span></div><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjIwNQ_00c73de5-0a28-4a6c-8630-4ca4784dc7eb" escape="true"><div style="margin-top:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive earnings (loss) are as follows:</span></div><div style="margin-bottom:3pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.334%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Earnings (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMS0xLTEtMS0yMzgzNjk_2239208e-9180-4f4e-bf87-994e69b4157b">462.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMS0zLTEtMS0yMzgzNjk_694db505-fc93-4750-8540-afe3d0f7bd2d">30.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMS03LTEtMS0yMzgzNjk_baf10e03-f529-41e8-ba28-26ca99b0c816">493.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMi0xLTEtMS0yMzgzNjk_6622dbd6-dc5d-406e-b5eb-6e0419b6df2f">48.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMi0zLTEtMS0yMzgzNjk_001baf0f-b62b-4fac-b259-3c10681573b7">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMi03LTEtMS0yMzgzNjk_fa773bb3-4d03-42d8-9701-8c64ff70a66c">58.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9726d7960c36403697c0c1aecbad306a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMy0xLTEtMS0yMzgzNjk_5160d4f3-11ff-4c31-af18-458399b1660c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMy0zLTEtMS0yMzgzNjk_4bc593fe-5b86-44d8-a9d6-f948bc1f0306">7.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMy03LTEtMS0yMzgzNjk_4ed6305d-4416-407d-aed8-e088615ca132">7.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="7" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNC0xLTEtMS0yMzgzNjk_460ee82c-b1a0-4425-9c8c-25557eedac60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNC0zLTEtMS0yMzgzNjk_2b64a817-d684-499a-a852-6b0dea080eda">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNC03LTEtMS0yMzgzNjk_0a56dd0e-1f76-439c-afd4-37019f672014">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNS0xLTEtMS0yMzgzNjk_d7a5fbbe-670c-41f9-8ccb-4895938c450a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNS0zLTEtMS0yMzgzNjk_7a136ba8-e20d-48e1-ba6d-90822c4d2bb8">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNS03LTEtMS0yMzgzNjk_556a3cc8-bd38-4d64-ac0d-225e76fc3e3b">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNi0xLTEtMS0yMzgzNjk_af65384a-6d2a-47e0-82c5-b21171888896">414.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNi0zLTEtMS0yMzgzNjk_f0076210-ca83-44f2-a414-dfe55933a3b6">30.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNi03LTEtMS0yMzgzNjk_262ebbbd-d744-4a24-b0ed-27ac46b87c3b">444.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81Mi9mcmFnOmQzMjcxYzdkMjBhZTRhMWFhOGIyMDA2MTBhZjYxOTU3L3RleHRyZWdpb246ZDMyNzFjN2QyMGFlNGExYWE4YjIwMDYxMGFmNjE5NTdfMjkwNzE_ae5972d7-b230-4de0-85c5-0921b11589dc" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation (including those described in more detail below), arising in the ordinary course of business. Some of these actions involve claims that are substantial in amount. These matters include, but are not limited to, intellectual property disputes, commercial and contract disputes, professional liability claims, employee-related matters, transaction related disputes, securities and corporate law matters, and inquiries, including subpoenas and other civil investigative demands, from governmental agencies, Medicare or Medicaid payers and MCOs reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. The Company receives civil investigative demands or other inquiries from various governmental bodies in the ordinary course of its business. Such inquiries can relate to the Company or other parties, including physicians and other health care providers. The Company works cooperatively to respond to appropriate requests for information.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also is named from time to time in suits brought under the qui tam provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from U.S. federal or state healthcare programs. The suits may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the qui tam plaintiff. Such claims are an inevitable part of doing business in the healthcare field today.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its commercial laboratory operations and drug development support services. The healthcare diagnostics and drug development industries are, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, additional liabilities from third-party claims, and/or exclusion from participation in government programs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the current claims and legal actions against the Company are in preliminary stages, and many of these cases seek an indeterminate amount of damages. The Company records an aggregate legal reserve, which is determined using calculations based on historical loss rates and assessment of trends experienced in settlements and defense costs. In accordance with FASB Accounting Standards Codification Topic 450 &#8220;Contingencies,&#8221; the Company establishes reserves for judicial, regulatory, and arbitration matters outside the aggregate legal reserve if and when those matters present loss contingencies that are both probable and estimable and would exceed the aggregate legal reserve. When loss contingencies are not both probable and estimable, the Company does not establish separate reserves.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is unable to estimate a range of reasonably probable loss for the proceedings described in more detail below in which damages either have not been specified or, in the Company's judgment, are unsupported and/or exaggerated and (i) the proceedings are in early stages, (ii) there is uncertainty as to the outcome of pending appeals or motions, (iii) there are significant factual issues to be resolved, and/or (iv) there are novel legal issues to be presented. For these proceedings, however, the Company does not believe, based on currently available information, that the adverse outcomes are probable and estimable, and it does not believe they will have a material adverse effect on the Company's financial statements. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received various subpoenas and other civil investigative demands related to Medicaid billing. In October 2009, the Company received a subpoena from the State of Michigan Department of Attorney General seeking documents related to its billing to Michigan Medicaid. The Company cooperated with this request. In October 2013, the Company received a Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On October 5, 2018, the Company received a second Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On January 26, 2021, the Company was notified that a qui tam Petition was pending under seal in the District Court, 250th Judicial District, Travis County, Texas, and that the State of Texas has intervened. On April 14, 2021, the Petition was unsealed. The Petition alleges that the Company submitted claims for reimbursement to Texas Medicaid that were higher than permitted under Texas Medicaid&#8217;s alleged &#8220;best price&#8221; regulations, and that the Company offered remuneration to Texas health care providers in the form of discounted pricing for certain laboratory testing services in exchange for the providers&#8217; referral of Texas Medicaid business to the Company. The Petition seeks actual and double damages and civil penalties, as well as recovery of costs, attorney's fees, and legal expenses. On August 1, 2022, the District Court entered an order granting the Company's Motion for Partial Summary Judgment with respect to the claim that the Company submitted claims for reimbursement to Texas Medicaid that were higher than permitted under Texas Medicaid's alleged &#8220;best price&#8221; regulations. Plaintiffs filed a Notice of Non-Suit and Motion for Entry of Final Judgment and, on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 11, 2022, the court entered a Judgment. Plaintiffs filed a Notice of Appeal with respect to the court's order granting the Company's Motion for Partial Summary Judgment, referenced above. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2015, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patty Davis v. Laboratory Corporation of America, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Circuit Court of the Thirteenth Judicial Circuit for Hillsborough County, Florida. The complaint alleges that the Company violated the Florida Consumer Collection Practices Act by billing patients who were collecting benefits under the Workers' Compensation Statutes. The lawsuit seeks injunctive relief and actual and statutory damages, as well as recovery of attorney's fees and legal expenses. In April 2017, the Circuit Court granted the Company&#8217;s Motion for Judgment on the Pleadings. The Plaintiff appealed the Circuit Court&#8217;s ruling to the Florida Second District Court of Appeal. On October 16, 2019, the Florida Second District Court of Appeal reversed the Circuit Court&#8217;s dismissal, but certified a controlling issue of Florida law to the Florida Supreme Court. On February 17, 2020, the Florida Supreme Court accepted jurisdiction of the lawsuit. The court held oral arguments on December 9, 2020. On May 26, 2022, the Florida Supreme Court issued an opinion approving the result of the Florida Second District Court of Appeal in favor of the Plaintiff. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Victoria Bouffard, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient list prices unlawfully exceed the rates negotiated for the same services with private and public health insurers in violation of various state consumer protection laws. The lawsuit also alleges breach of implied contract or quasi-contract, unjust enrichment, and fraud. The lawsuit seeks statutory, exemplary, and punitive damages, injunctive relief, and recovery of attorney's fees and costs. In May 2017, the Company filed a Motion to Dismiss Plaintiffs' Complaint and Strike Class Allegations; the Motion to Dismiss was granted in March 2018 without prejudice. On October 10, 2017, a second putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheryl Anderson, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint contained similar allegations and sought similar relief to the Bouffard complaint, and added additional counts regarding state consumer protection laws. On August 10, 2018, the Plaintiffs filed an Amended Complaint, which consolidated the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anderson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions. On September 10, 2018, the Company filed a Motion to Dismiss Plaintiffs' Amended Complaint and Strike Class Allegations. On August 16, 2019, the court entered an order granting in part and denying in part the Motion to Dismiss the Amended Complaint, and denying the Motion to Strike the Class Allegations. On August 26, 2021, Plaintiffs filed a Motion for Class Certification. On February 13, 2023, the court entered an order denying Plaintiffs' Motion for Class Certification. On February 27, 2023, Plaintiffs filed a Petition for Permission to Appeal the court&#8217;s order with the U.S. Court of Appeals for the Fourth Circuit. On April 5, 2023, the Fourth Circuit denied Plaintiffs&#8217; Petition.On December 29, 2021, a related lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nathaniel J. Nolan, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient acknowledgement of estimated financial responsibility form is misleading. The lawsuit seeks a declaratory judgment under the consumer protection laws of Nevada and Florida that the form is materially misleading and deceptive, an injunction barring the use of the form, damages on behalf of an alleged class, and attorney's fees and expenses. On February 28, 2022, the Company filed a Motion to Dismiss all claims. On February 13, 2023, the court entered an order granting the Company's Motion to Dismiss. On March 13, 2023, Plaintiffs filed a Notice of Appeal. The Company will vigorously defend the lawsuits.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019, Covance Research Products was served with a Grand Jury Subpoena issued by the Department of Justice (DOJ) in Miami, Florida requiring the production of documents related to the importation into the United States of live non-human primate shipments originating from or transiting through China, Cambodia, and/or Vietnam from April 1, 2014 through March 28, 2019. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2019, Retrieval-Masters Creditors Bureau, Inc. d/b/a American Medical Collection Agency (AMCA), an external collection agency, notified the Company about a security incident AMCA experienced that may have involved certain personal information about some of the Company&#8217;s patients (the AMCA Incident). The Company referred patient balances to AMCA only when direct collection efforts were unsuccessful. The Company&#8217;s systems were not impacted by the AMCA Incident. Upon learning of the AMCA Incident, the Company promptly stopped sending new collection requests to AMCA and stopped AMCA from continuing to work on any pending collection requests from the Company. AMCA informed the Company that it appeared that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018, and March 30, 2019, and that AMCA could not rule out the possibility that personal information on AMCA&#8217;s system was at risk during that time period. Information on AMCA&#8217;s affected system from the Company may have included name, address, and balance information for the patient and person responsible for payment, along with the patient&#8217;s phone number, date of birth, referring physician, and date of service. The Company was later informed by AMCA that health insurance information may have been included for some individuals, and because some insurance carriers utilize the Social Security Number as a subscriber identification number, the Social Security Number for some individuals may also have been affected. No ordered tests, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">laboratory test results, or diagnostic information from the Company were in the AMCA affected system. The Company notified individuals for whom it had a valid mailing address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that was provided free of charge for 24 months.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Twenty-three putative class action lawsuits were filed against the Company related to the AMCA Incident in various U.S. District Courts. Numerous similar lawsuits have been filed against other health care providers who used AMCA. These lawsuits were consolidated into a multidistrict litigation in the District of New Jersey. On November 15, 2019, the Plaintiffs filed a Consolidated Class Action Complaint in the U.S. District Court of New Jersey. On January 22, 2020, the Company filed Motions to Dismiss all claims. The consolidated Complaint generally alleged that the Company did not adequately protect its patients&#8217; data and failed to timely notify those patients of the AMCA Incident. The Complaint asserted various causes of action, including but not limited to negligence, breach of implied contract, unjust enrichment, and the violation of state data protection statutes. The Complaint sought damages on behalf of a class of all affected Company customers. On December 16, 2021, the court granted in part and denied in part the Company's Motion to Dismiss. On March 31, 2022, the Plaintiffs filed an Amended Complaint alleging claims for negligence, negligence </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">per se</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, breach of confidence, invasion of privacy, and various state statutory claims, including a claim under the California Confidentiality of Medical Information Act. The Company filed a Motion to Dismiss certain claims of the Amended Complaint. The Company will vigorously defend the remaining claims in the multi-district litigation.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was served with a shareholder derivative lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Raymond Eugenio, Derivatively on Behalf of Nominal Defendant, Laboratory Corporation of America Holdings v. Lance Berberian, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Court of Chancery of the State of Delaware on April 23, 2020.&#160;The complaint asserts derivative claims on the Company&#8217;s behalf against the Company&#8217;s board of directors and certain executive officers.&#160;The complaint generally alleges that the defendants failed to ensure that the Company utilized proper cybersecurity safeguards and failed to implement a sufficient response to data security incidents, including the AMCA Incident.&#160;The complaint asserts derivative claims for breach of fiduciary duty and seeks relief including damages, certain disclosures, and certain changes to the Company&#8217;s internal governance practices. On June 2, 2020, the Company filed a Motion to Stay the lawsuit due to its overlap with the multi-district litigation referenced above. On July 2, 2020, the Company filed a Motion to Dismiss. On July 14, 2020, the court entered an order staying the lawsuit pending the resolution of the multi-district litigation. The lawsuit will be vigorously defended.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain governmental entities have requested information from the Company related to the AMCA Incident. The Company received a request for information from the Office for Civil Rights (OCR) of the Department of Health and Human Services.&#160;On April 28, 2020, OCR notified the Company of the closure of its inquiry. The Company has also received requests from a multi-state group of state Attorneys General and is cooperating with these requests for information.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Luke Davis and Julian Vargas, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Central District of California. The lawsuit alleges that visually impaired patients are unable to use the Company's touchscreen kiosks at Company patient service centers in violation of the Americans with Disabilities Act and similar California statutes. The lawsuit seeks statutory damages, injunctive relief, and attorney's fees and costs. On March 20, 2020, the Company filed a Motion to Dismiss Plaintiffs' Complaint and to Strike Class Allegations. In August 2020, the Plaintiffs filed an Amended Complaint. On April 26, 2021, the Plaintiffs and the Company each filed Motions for Summary Judgment and the Plaintiffs filed a Motion for Class Certification. On May 23, 2022, the court entered an order granting Plaintiffs&#8217; Motion for Class Certification. On June 6, 2022, the Company filed a Petition for Permission to Appeal the Order Granting Class Certification with the U.S. Court of Appeals for the Ninth Circuit. On September 22, 2022, the Ninth Circuit granted the Company's Petition for Permission to Appeal the Order Granting Class Certification. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 16, 2020, Ravgen Inc. filed a patent infringement lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ravgen Inc. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the U.S. District Court&#8239;for the Western District of&#8239;Texas, alleging infringement of two Ravgen-owned U.S. patents.  The lawsuit seeks monetary damages, enhancement of those damages for willfulness, and recovery of attorney&#8217;s fees and costs. On September 28, 2022, a jury rendered a verdict in favor of the Plaintiff on the remaining patent at issue, finding that the Company willfully infringed Ravgen's patent, and awarded damages of $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81Mi9mcmFnOmQzMjcxYzdkMjBhZTRhMWFhOGIyMDA2MTBhZjYxOTU3L3RleHRyZWdpb246ZDMyNzFjN2QyMGFlNGExYWE4YjIwMDYxMGFmNjE5NTdfNTQ5NzU1OTA3NzUw_f91abd00-d4b8-492a-ac84-c0b0179578a7">272.0</ix:nonFraction>. Plaintiff has filed post-trial motions seeking enhanced damages of up to $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81Mi9mcmFnOmQzMjcxYzdkMjBhZTRhMWFhOGIyMDA2MTBhZjYxOTU3L3RleHRyZWdpb246ZDMyNzFjN2QyMGFlNGExYWE4YjIwMDYxMGFmNjE5NTdfNTQ5NzU1OTA4Njkz_8fe09434-c5ac-4b2e-a958-c374a5fcf321">817.0</ix:nonFraction> based on the finding of willfulness, as well as attorney's fees and costs. The Company strongly disagrees with the verdict, based on a number of legal factors, and will vigorously defend the lawsuit through the appeal process. On June 4, 2021, the Company also instituted proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office challenging the validity of the Ravgen patent at issue in the trial. In November 2022, the Patent Trial and Appeal Board issued a decision upholding the validity of the Ravgen patent, and the Company has filed an appeal of this decision.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory Corporation of America (Bermejo I)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain non-exempt California-based employees were not properly compensated for driving time or properly paid wages upon termination of employment. The Plaintiff asserts these actions violate various California Labor Code provisions and Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#8217;s fees and costs. On June 15, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. On June 16, 2020, the Company was served with a Private Attorney General Act lawsuit by the same plaintiff in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory Corporation of America (Bermejo II), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain Company practices violated California Labor Code penalty provisions related to unpaid and minimum wages, unpaid overtime, unpaid meal and rest break premiums, untimely payment of wages following separation of employment, failure to maintain accurate pay records, and non-reimbursement of business expenses. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. On October 28, 2020, the court issued an order staying proceedings in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pending resolution of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. On February 24, 2022, the parties entered into a Memorandum of Understanding of the terms of a settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits and on March 17, 2023, the court issued a preliminary approval of the parties&#8217; settlement agreement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit, but the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit settlement is still pending Court approval.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, a single plaintiff filed a Private Attorney General Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becker v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the Superior Court of California, County of Orange, alleging various violations of the California Labor Code, including that the Plaintiff was not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, and received inaccurate wage statements. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#8217;s fees and costs. A settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, if approved by the court, will resolve the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becker</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 23, 2021, the Company was served with a single plaintiff Private Attorney General Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poole v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Superior Court of California, County of Kern, alleging various violations of the California Labor Code, including that Plaintiff was not properly paid wages owed, not properly paid meal and rest break premiums, not reimbursed for certain business related expenses, and other allegations including the untimely payment of wages and receipt of inaccurate wage statements. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney's fees and costs. The case was removed to the U.S. District Court for the Eastern District of California. A settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, if approved by the court, will resolve the portion of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poole</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit relating to service representatives and senior service representatives.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 5, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Williams v. LabCorp Employer Services, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Superior Court of California, County of Los Angeles, alleging that certain non-exempt California-based employees were not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, not properly paid for driving or wait times, and received inaccurate wage statements. The Plaintiff also asserts claims for unfair competition under Section 17200 of the Business and Professional Code. On November 4, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. The lawsuit seeks monetary damages, liquidated damages, civil penalties, and recovery of attorney's fees and costs. On June 24, 2021, the District Court remanded the case to the Superior Court of California, County of Los Angeles on the grounds that potential damages did not meet the Class Action Fairness Act (CAFA), 28 U.S.C. &#167; 1332(d), jurisdictional threshold. The parties entered into a settlement agreement dated September 9, 2022, which is pending court approval.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2020, the Company was served with a Subpoena Duces Tecum issued by the State of Colorado Office of the Attorney General requiring the production of documents related to urine drug testing in all states. The Company is cooperating with this request.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2022, the Company was served with a Subpoena Duces Tecum issued by the DOJ in Camden, New Jersey requiring the production of documents related to non-invasive prenatal screening tests. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2022, the Company was served with a Subpoena Duces Tecum issued by the DOJ in Boston, Massachusetts requiring the production of documents related to urine drug testing. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, the Company received Civil Investigative Demands issued by the DOJ in Washington, D.C. requiring the production of information related to the Medicare billing rule regarding reimbursement for laboratory testing performed for hospital patients.  The Company is cooperating with the DOJ.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are various other pending legal proceedings involving the Company including, but not limited to, additional employment-related lawsuits, professional liability lawsuits, and commercial lawsuits. While it is not feasible to predict the outcome of such proceedings, in the opinion of the Company, the likelihood of loss is remote and any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#8217;s financial condition, results of operations, or cash flows, either individually or in the aggregate.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's present insurance programs, coverage is obtained for catastrophic exposure as well as those risks required to be insured by law or contract. The Company is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_55"></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzkzNw_84b749f9-7e15-43a7-85dd-4c5d0a079719" continuedAt="ie09b865674af44c59f83b39b211386b7" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="ie09b865674af44c59f83b39b211386b7" continuedAt="i499df3ca6dca4390868a60059e5a9fef"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzkyNw_76807c55-ba4f-4e27-8a98-1fd036c18cb5" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of March&#160;31, 2023, and December 31, 2022, is as follows:</span></div><div style="margin-bottom:3pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:36.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.024%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNC0zLTEtMS0yMzgzNjk_91ef54b6-9dfc-4a54-8b3a-adce626f9cc4">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNC01LTEtMS0yMzgzNjk_11899713-6621-4b07-811f-5c5401907df8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNC03LTEtMS0yMzgzNjk_07541642-83f0-48f9-a00e-65f7f82fa9ec">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNC05LTEtMS0yMzgzNjk_b7186277-acfe-470b-8c8a-292ccc4de1e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNS0zLTEtMS0yMzgzNjk_e6e9abf7-5c97-4bb9-9d02-ebee1121bff2">48.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNS01LTEtMS0yMzgzNjk_09c00043-e5d9-4ab0-8d8d-42975040c862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNS03LTEtMS0yMzgzNjk_acc6aea1-f9a8-4cae-9c2c-115f848d6141">48.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNS05LTEtMS0yMzgzNjk_b725c743-4d52-4c17-9ede-f00bd8127990">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNi0zLTEtMS0yMzgzNjk_dbfb7abe-80e7-47ac-b419-62c9ae5e12c9">67.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNi01LTEtMS0yMzgzNjk_a8df086b-6ccd-4eeb-ae12-a5f0a665b7c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNi03LTEtMS0yMzgzNjk_aec6d359-cb6c-4322-aee9-44776ec5e0fe">67.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNi05LTEtMS0yMzgzNjk_1cd5e762-78fe-4661-9730-54ac0ad53c1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfOS0zLTEtMS0yMzgzNjk_6691509a-58e2-421f-b704-69597de7a6da">106.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfOS01LTEtMS0yMzgzNjk_5b245c48-2adf-40f8-831d-a56962fd85f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfOS03LTEtMS0yMzgzNjk_757a24d1-f2f7-4768-9ce8-acf9daea1b7c">106.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfOS05LTEtMS0yMzgzNjk_e74ba897-b55d-4cd8-82ed-388c5be2960d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTAtMy0xLTEtMjM4MzY5_bf9628e0-34ce-409a-b1ba-9d34bac01269">102.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTAtNS0xLTEtMjM4MzY5_70d639d3-e72d-4cc8-866a-dac897ef2112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTAtNy0xLTEtMjM4MzY5_cb614b23-344b-46cd-a4ad-e9f3d7ef1889">102.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTAtOS0xLTEtMjM4MzY5_375b5dc7-6ea7-4c2d-8094-13850c38e3a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTItMy0xLTEtMjM4MzY5_ec92aafa-74e8-42f5-8834-8f8ae51820c0">69.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTItNS0xLTEtMjM4MzY5_70c303cc-a240-4feb-ac11-f50d4420537b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTItNy0xLTEtMjM4MzY5_8b60357d-9076-4daa-af63-4539c816c854">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTItOS0xLTEtMjM4MzY5_e1f4a035-c2d2-4ec1-876c-b5ec83186751">69.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:36.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNC0zLTEtMS0yMzgzNjk_c594ed05-ba4f-4c10-87d9-971949633e04">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNC01LTEtMS0yMzgzNjk_22a7945d-c3c3-4399-a359-1937e771bcdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNC03LTEtMS0yMzgzNjk_f05bd064-fdc3-4ab9-898c-e99cfd34c1c6">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNC05LTEtMS0yMzgzNjk_307b950c-8880-459b-8140-ce24654709fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNS0zLTEtMS0yMzgzNjk_c5e10e16-00a7-44e3-87d2-8b3d400360d4">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNS01LTEtMS0yMzgzNjk_0be8f7b7-7175-44b6-b852-96406b80ccea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNS03LTEtMS0yMzgzNjk_52fc7cd0-f9a9-4552-8848-1852d511f09b">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNS05LTEtMS0yMzgzNjk_3ae30296-2cc1-46be-9275-e9b28da0e340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNi0zLTEtMS0yMzgzNjk_8c06f55b-78b1-4784-ac6d-82f8a4915b7d">79.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNi01LTEtMS0yMzgzNjk_cfd51615-b7fb-4ff5-b441-18b772051905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNi03LTEtMS0yMzgzNjk_f17fd23f-5609-4c5b-8b85-8b59dd785d04">79.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231" decimals="-5" name="us-gaap:FairValueHedgesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNi05LTEtMS0yMzgzNjk_44878f3c-04f0-45b0-b258-ef82bec3e3a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNy0zLTEtMS0yMzgzNjk_1a894dc8-fe2e-4add-9f77-a7b73046bf61">100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNy01LTEtMS0yMzgzNjk_14f7f790-f97b-469c-9a98-c13300347ed8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNy03LTEtMS0yMzgzNjk_8658dbcd-809e-41bf-887a-b1bc473e27ce">100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNy05LTEtMS0yMzgzNjk_d72671c5-a3ad-4037-b4d6-265e3866c0de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfOC0zLTEtMS0yMzgzNjk_cf7f76b1-7440-4795-87e2-985306b64b16">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfOC01LTEtMS0yMzgzNjk_047c9239-f93f-469a-a573-ba315cf3e697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfOC03LTEtMS0yMzgzNjk_065a2b21-60c0-441f-bede-86acf6d706ee">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfOC05LTEtMS0yMzgzNjk_c1c8551f-2b15-4b02-b9c7-eb1c5965bae5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfMTAtMy0xLTEtMjM4MzY5_4621fb29-efa2-41eb-95bb-e63383f9a90f">77.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfMTAtNS0xLTEtMjM4MzY5_917e8cf7-ac73-49d7-ad32-563f6ce7c1cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfMTAtNy0xLTEtMjM4MzY5_fac5ec7d-c0c2-40da-a490-62004dadbad6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfMTAtOS0xLTEtMjM4MzY5_b641131f-8745-498b-b01b-139c33a12428">77.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzkyOA_d26629db-5c81-457c-b13b-8b2bb05a04a9" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjY1MGJmOTg0MjJlZTQ5YzQ4NjA4NmUyOTIzNjBjNWYxL3RhYmxlcmFuZ2U6NjUwYmY5ODQyMmVlNDljNDg2MDg2ZTI5MjM2MGM1ZjFfMS0yLTEtMS0yMzgzNjk_087b7b0f-1509-4f6c-b58d-c16f5974734a">77.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:Contingentconsiderationadjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjY1MGJmOTg0MjJlZTQ5YzQ4NjA4NmUyOTIzNjBjNWYxL3RhYmxlcmFuZ2U6NjUwYmY5ODQyMmVlNDljNDg2MDg2ZTI5MjM2MGM1ZjFfMy0yLTEtMS0yMzgzNjk_ca8d5d43-e14e-4e20-b7ba-9cecc8218d8a">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjY1MGJmOTg0MjJlZTQ5YzQ4NjA4NmUyOTIzNjBjNWYxL3RhYmxlcmFuZ2U6NjUwYmY5ODQyMmVlNDljNDg2MDg2ZTI5MjM2MGM1ZjFfNS0yLTEtMS0yMzgzNjk_735186dd-1d0c-4704-acd6-d4975959ea47">69.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#8217;s condensed consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers certain employees the opportunity to participate in an employee-funded deferred compensation plan (DCP). A participant's deferrals are allocated by the participant to one or more of <ix:nonFraction unitRef="number" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="0" name="lh:NumberofMeasurementFundsAvailableForParticipantElection" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfNjYz_74a0d0ae-538c-4b13-b5ad-5a221558117d">26</ix:nonFraction> measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participant's allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><ix:continuation id="i499df3ca6dca4390868a60059e5a9fef"><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent accrued earn-out business acquisition consideration liabilities are measured at fair value using Level 3 valuations. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the senior notes, based on market pricing, was approximately $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="lh:SeniorNotesFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMjQ2NA_b38527e5-ff66-4522-966e-089ad0e45de2">5,082.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="lh:SeniorNotesFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMjQ3MQ_de07886f-8e32-488d-96a4-9df09e6fab6e">4,973.9</ix:nonFraction> as of March&#160;31, 2023, and December 31, 2022, respectively. The Company's note and debt instruments are classified as Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.</span></div></ix:continuation><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cross Currency Swap</span></div><div style="margin-bottom:13.1pt;margin-top:3pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into U.S. Dollar (USD) to Swiss Franc cross-currency swap agreements with an aggregate notional value of $<ix:nonFraction unitRef="usd" contextRef="i769724f534fd42d5b074271dafd50c33_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMjg1OA_acfbba95-ccb1-42d0-9dda-4a3f1568408e">600.0</ix:nonFraction>. During the second quarter of 2022, the Company terminated $<ix:nonFraction unitRef="usd" contextRef="i6ed01ecd53ff440bb094c068361e773d_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMjkxNA_aaae7557-e81b-40e1-b54a-f87dab70332d">300.0</ix:nonFraction> of those cross-currency swap agreements and entered into new USD to Swiss Franc cross-currency swap agreements with an aggregate notional value of $<ix:nonFraction unitRef="usd" contextRef="ic501f2ab3f824f5e99cea8fef7c2e388_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzA2NA_b4b98a3a-61c1-4234-825e-cf0c0856ba32">300.0</ix:nonFraction> that mature in 2024. These cross currency swaps are included in other long-term liabilities as appropriate with an aggregate fair value of $<ix:nonFraction unitRef="usd" contextRef="i5e096d4685af481291993afb05e8af6b_I20230331" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzUxNw_e6e9abf7-5c97-4bb9-9d02-ebee1121bff2">48.5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzUyNA_c5e10e16-00a7-44e3-87d2-8b3d400360d4">45.7</ix:nonFraction> as of March 31, 2023 and December 31, 2022, respectively. Changes in the fair value of the cross-currency swaps are charged or credited through accumulated other comprehensive income in the Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustments are recognized as currency translation within the Consolidated Statement of Comprehensive Earnings.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_58"></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RleHRyZWdpb246MDkwYmVkNDUxZmVkNDAzNWIyOWUwYmIxNTRmZWJiNTFfNDc_88ae12a3-07db-4e43-95c0-d6bbcee1d20d" continuedAt="i991c361ddcc44353a624cef8776ec534" escape="true">SUPPLEMENTAL CASH FLOW INFORMATION</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i991c361ddcc44353a624cef8776ec534"><ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RleHRyZWdpb246MDkwYmVkNDUxZmVkNDAzNWIyOWUwYmIxNTRmZWJiNTFfNDk_fab4a67f-16fd-44fc-805d-442b1d4a1845" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:InterestPaidInCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfNC0xLTEtMS0yMzgzNjk_516c2730-53e7-4c03-ba2e-7e8b16ee6dec">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:InterestPaidInCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfNC0zLTEtMS0yMzgzNjk_7de64273-7791-4a0a-ac52-c58da4ca4455">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfNS0xLTEtMS0yMzgzNjk_f8c29119-9cf1-4b30-bead-26109005198f">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfNS0zLTEtMS0yMzgzNjk_be4520e8-9b84-4abe-86f0-737dd037e0c0">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:IncreaseInCapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfMTAtMS0xLTEtMjM4MzY5_d544fe6c-ccd0-40b4-82d9-5b62bcf95f7c">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfMTAtMy0xLTEtMjM4MzY5_91ed5dec-6e5e-487d-8c12-8a2d2ef8599d">9.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_61"></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RleHRyZWdpb246MDFiYmVhNzhhZjIxNDYzZGI0MTkwYmE5Mzk3MThmODlfMTAwMg_5b1952c0-6517-4b26-ad2a-cb921a172961" continuedAt="i85e5019d4cc4431882adaed2faae84ff" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i85e5019d4cc4431882adaed2faae84ff">The following table is a summary of segment information for the three months ended March&#160;31, 2023, and 2022. The &#8220;management approach&#8221; has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#8217;s chief executive officer has been identified as the CODM. Segment asset information is not presented because it is not used by the CODM at the segment level.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in millions, except per share data)</span></div></div><div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate costs not allocated to segments include the costs of centralized functions other charges such as acquisition expenses, spin off costs and COVID-19 related costs not deemed to relate to segment. Centralized functions include corporate governance, executive management and related human resources, finance, legal, risk management, and information technology functions.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:67.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.608%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i217de76c0e02473688390d39aec04505_D20230101-20230331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMy0yLTEtMS0yNzA0OTA_44e35bb1-b53e-402f-ab60-bcd3dd912879">2,382.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc9c5675189343c08478b612cc0f2f08_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMy00LTEtMS0yNzA0OTA_6aa2fd56-da16-4238-bd83-8b01d1a5dbee">2,454.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98902be646a4c90b5a714ef8b40c97e_D20230101-20230331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNC0yLTEtMS0yNzA0OTA_9a5f5304-671d-46b0-9a8e-0b0851957781">1,401.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88dc2a3d6e8c4967802600e7ff248849_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNC00LTEtMS0yNzA0OTA_8ad11286-553a-49f5-b959-cb8421045af8">1,459.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78627350409f4353bd6bb72edb530c2d_D20230101-20230331" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNS0yLTEtMS0yNzA0OTA_6666eb72-c200-48cf-a008-e761b1748b07">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236653e26bcc49638d6df006253bc8bd_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNS00LTEtMS0yNzA0OTA_1865cab5-2640-4859-8729-7376bf43446e">13.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNi0yLTEtMS0yNzA0OTA_6d28d6bd-540b-45ea-b3e8-0f8f9980e471">3,777.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNi00LTEtMS0yNzA0OTA_ea465c05-475b-4528-8f73-de64babc6456">3,899.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Earnings:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i217de76c0e02473688390d39aec04505_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfOS0yLTEtMS0yNzA0OTA_bc5de254-445d-4adc-9b49-ff50698c293d">441.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc9c5675189343c08478b612cc0f2f08_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfOS00LTEtMS0yNzA0OTA_10f10222-e223-4ef2-a3ab-c709159f4b0e">683.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98902be646a4c90b5a714ef8b40c97e_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTAtMi0xLTEtMjcwNDkw_5004849d-6dc6-4ad0-9ebe-9b0330837010">123.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88dc2a3d6e8c4967802600e7ff248849_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTAtNC0xLTEtMjcwNDkw_36b2ffa7-2834-4bb1-80d5-9092005aa031">168.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e2835bbadb5437a96546e64b63d52bc_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTEtMi0xLTEtMjcwNTAw_82ef34c9-47cf-4a1c-9576-4090058537f6">565.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bab97c15b1644c996b81336ef6af0a2_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTEtNC0xLTEtMjcwNTAz_847e5de7-e096-452d-8e97-1b5c11998d44">851.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and unallocated expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i511043ecd4a749f784a8ec71a6c55a7b_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTItMi0xLTEtMjcwNDkw_eb9ae63e-f594-40cf-8fe0-0e4b5a6fd13b">144.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2399bfbb9764cbfb9d758e73036dd39_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTItNC0xLTEtMjcwNDkw_55b3ce70-bd26-4083-b0aa-49a873c63ee0">82.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTMtMi0xLTEtMjcwNDkw_2adc379c-e5b8-45ca-b040-867567a87c57">69.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTMtNC0xLTEtMjcwNDkw_14415135-56fc-49c3-b82b-d1c8c220c734">67.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTQtMi0xLTEtMjcwNDkw_e07dc5a6-6bc8-4c6c-b33c-b51dedef6a67">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTQtNC0xLTEtMjcwNDkw_9ecee27e-311a-49d5-aae4-883f969d82d7">12.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTUtMi0xLTEtMjcwNDkw_d123670a-50ce-424f-83e5-2893135bcd3a">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTUtNC0xLTEtMjcwNDkw_3994dc0a-060b-4335-824e-df0b7b98eb8e">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTYtMi0xLTEtMjcwNDkw_63e35aa8-3cc6-4523-a64f-1e5896a4be3f">341.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTYtNC0xLTEtMjcwNDkw_48a2f15f-7db9-40b1-ab4a-805b4ffb1a19">687.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_967"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;<ix:nonNumeric contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF85NjcvZnJhZzowNGVjNDhkYmUyNjM0NTRhYjFhNTg0ZGNjNjY2NjE4Yy90ZXh0cmVnaW9uOjA0ZWM0OGRiZTI2MzQ1NGFiMWE1ODRkY2M2NjY2MThjXzU0OTc1NTgxNzU0NQ_1a72e562-322e-48ac-a33d-34614089026a" continuedAt="i128cf50dd0c045cebb3ec6e88fb4b25f" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i128cf50dd0c045cebb3ec6e88fb4b25f">On May 3, 2023, the Company entered into agreements to create a comprehensive strategic relationship with Jefferson Health (Jefferson), the largest health system serving the greater Philadelphia area and Southern New Jersey. When complete, the arrangements between Jefferson and the Company will serve to build academic collaborations around teaching and the development of innovative tests. The new strategic collaboration will deliver efficiency and comprehensive laboratory aspects of healthcare for the communities served by Jefferson through the Company's leading clinical laboratory services, robust data and digital tools and extensive network of patient service centers. The transaction is expected to close by mid-year 2023, subject to customary closing conditions and applicable regulatory approvals.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made in this report, and from time to time may otherwise make in its public filings, press releases, and discussions by Company management, forward-looking statements concerning the Company&#8217;s operations, performance, and financial condition, as well as its strategic objectives.&#160;Some of these forward-looking statements relate to future events and expectations and can be identified by the use of forward-looking words such as &#8220;believes&#8221;, &#8220;expects&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;seeks&#8221;, &#8220;approximately&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;estimates&#8221;, or &#8220;anticipates&#8221; or the negative of those words or other comparable terminology. Such forward-looking statements speak only as of the time they are made and are subject to various risks and uncertainties and the Company claims the protection afforded by the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those currently anticipated due to a number of factors in addition to those discussed elsewhere herein, including in the &#8220;Summary of Material Risks&#8221; and &#8220;Risk Factors&#8221; section of the Annual Report on Form 10-K, and in the Company&#8217;s other public filings, press releases, and discussions with Company management, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">changes in government and third-party payer regulations, reimbursement, or coverage policies or other future reforms in the U.S. healthcare system (or in the interpretation of current regulations), new insurance or payment systems, including state, regional or private insurance cooperatives (e.g., health insurance exchanges) affecting governmental and third-party coverage or reimbursement for commercial laboratory testing, including the impact of the U.S. Protecting Access to Medicare Act of 2014 (PAMA);</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">significant monetary damages, fines, penalties, assessments, refunds, repayments, damage to the Company's reputation, unanticipated compliance expenditures, and/or exclusion or debarment from or ineligibility to participate in government programs, among other adverse consequences, arising from enforcement of anti-fraud and abuse laws and other laws applicable to the Company in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">significant fines, penalties, costs, unanticipated compliance expenditures, and/or damage to the Company&#8217;s reputation arising from the failure to comply with applicable privacy and security laws and regulations, including the U.S. Health Insurance Portability and Accountability Act of 1996, the U.S. Health Information Technology for Economic and Clinical Health Act, the European Union's General Data Protection Regulation and similar laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">loss or suspension of a license or imposition of fines or penalties under, or future changes in, or interpretations of applicable licensing laws or regulations regarding the operation of clinical laboratories and the delivery of clinical laboratory test results, including, but not limited to, the U.S. Clinical Laboratory Improvement Act of 1967 and the U.S. Clinical Laboratory Improvement Amendments of 1988 and similar laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">penalties or loss of license arising from the failure to comply with applicable occupational and workplace safety laws and regulations, including the U.S. Occupational Safety and Health Administration requirements, the U.S. Needlestick Safety and Prevention Act, and similar laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">fines, unanticipated compliance expenditures, suspension of manufacturing, enforcement actions, damage to the Company's reputation, injunctions, or criminal prosecution arising from failure to maintain compliance with current good manufacturing practice regulations and similar requirements of various regulatory agencies in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">sanctions or other remedies, including fines, unanticipated compliance expenditures, enforcement actions, injunctions or criminal prosecution arising from failure to comply with the Animal Welfare Act or applicable national, state and local laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">changes in testing guidelines or recommendations by government agencies, medical specialty societies, and other authoritative bodies affecting the utilization of laboratory tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">changes in applicable government regulations or policies affecting the approval, availability of, and the selling and marketing of diagnostic tests, drug development, or the conduct of drug development and medical device and diagnostic studies and trials, including regulations and policies of the U.S. Food and Drug Administration, the U.S. Department of Agriculture, the Medicine and Healthcare products Regulatory Agency in the United Kingdom, the National Medical Products Administration in China, the Pharmaceutical and Medical Devices Agency in Japan, the European Medicines Agency, the European Union and similar regulations and policies of agencies in other jurisdictions in which the Company conducts business;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in government regulations or reimbursement pertaining to the pharmaceutical, biotechnology and medical device and diagnostic industries, changes in reimbursement of pharmaceutical products, or reduced spending on research and development by pharmaceutical, biotechnology and medical device and diagnostic customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">liabilities that result from the failure to comply with corporate governance requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increased competition, including price competition, potential reduction in rates in response to price transparency initiatives and consumerism, competitive bidding and/or changes or reductions to fee schedules, and competition from companies that do not comply with existing laws or regulations or otherwise disregard compliance standards in the industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in payer mix or payment structure or process, including insurance carrier participation in health insurance exchanges, an increase in capitated reimbursement mechanisms, the impact of clearinghouses on the claims reimbursement process, the impact of a shift to consumer-driven health plans or plans carrying an increased level of member cost-sharing, and adverse changes in payer reimbursement or payer coverage policies (implemented directly or through a third-party utilization management organization) related to specific diagnostic tests, categories of testing or testing methodologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to retain or attract MCO business as a result of changes in business models, including risk based or network approaches, out-sourced laboratory network management or utilization management companies, or other changes in strategy or business models by MCOs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to obtain and retain new customers, an unfavorable change in the mix of testing services ordered, or a reduction in tests ordered, specimens submitted, or services requested by existing customers, and delays in payments from customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">consolidation and convergence of customers, competitors, and suppliers, potentially causing material shifts in insourcing, utilization, pricing, reimbursement and supply chain access;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to effectively develop and deploy new systems, system modifications or enhancements required in response to evolving market and business needs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">customers choosing to insource services that are or could be purchased from the Company;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to identify, successfully close and effectively integrate and/or manage acquisitions of new businesses or failure to maintain key customers and/or employees as a result of uncertainty surrounding the integration of acquisitions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inability to achieve the expected benefits and synergies of newly-acquired businesses, including due to items not discovered in the due diligence process, and the impact on the Company's cash position, levels of indebtedness and stock price;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">termination, loss, delay, reduction in scope or increased costs of contracts, including large contracts and multiple contracts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">liability arising from errors or omissions in the performance of testing services, contract research services or other contractual arrangements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes or disruption in the provision or transportation of services or supplies provided by third parties; or their termination for failure to follow the Company's performance standards and requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">damage or disruption to the Company's facilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">damage to the Company's reputation, loss of business, or other harm from acts of animal rights activists or potential harm and/or liability arising from animal research activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">adverse results in litigation matters;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inability to attract and retain experienced and qualified personnel or the loss of significant personnel as a result of illness, increased competition for talent, wage growth, or other market factors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to develop or acquire licenses for new or improved technologies, such as point-of-care testing, mobile health technologies, and digital pathology, or potential use of new technologies by customers and/or consumers to perform their own tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">substantial costs arising from the inability to commercialize newly licensed tests or technologies or to obtain appropriate coverage or reimbursement for such tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to obtain, maintain, and enforce intellectual property rights for protection of the Company's products and services and defend against challenges to those rights;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">scope, validity, and enforceability of patents and other proprietary rights held by third parties that may impact the Company's ability to develop, perform, or market the Company's products or services or operate its business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">business interruption, receivables impairment, delays in cash collection impacting days sales outstanding, supply chain disruptions or inventory obsolescence, increases in material cost or other operating costs, or other impacts on the business due to natural disasters, including adverse weather, fires and earthquakes; political crises, including terrorism and war; public health crises and disease epidemics and pandemics; changes in the global economy; and other events outside of the Company's control;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">discontinuation or recalls of existing testing products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a failure in the Company's information technology systems, including with respect to testing turnaround time and billing processes, or the failure of the Company or its third-party suppliers and vendors to maintain the security of business information or systems or to protect against cybersecurity attacks such as denial of service attacks, malware, ransomware, and computer viruses, or delays or failures in the development and implementation of the Company&#8217;s automation platforms, any of which could result in a negative effect on the Company&#8217;s performance of services, a loss of business or increased costs, damages to the Company&#8217;s reputation, significant litigation exposure, an inability to meet required financial reporting deadlines, or the failure to meet future regulatory or customer information technology, data security and connectivity requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">business interruption, increased costs, and other adverse effects on the Company's operations due to the unionization of employees, union strikes, work stoppages, general labor unrest or failure to comply with labor or employment laws;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to maintain the Company's days sales outstanding levels, cash collections (in light of increasing levels of patient responsibility), profitability and/or reimbursement arising from unfavorable changes in third-party payer policies, payment delays introduced by third-party utilization management organizations, and increasing levels of patient payment responsibility;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">impact on the Company's revenues, cash collections, and the availability of credit for general liquidity or other financing needs arising from a significant deterioration in the economy or financial markets or in the Company's credit ratings by Standard &amp; Poor's and/or Moody's;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to maintain the expected capital structure for the Company, including failure to maintain the Company's investment grade rating, or leverage ratio covenants under its revolving credit facility;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in reimbursement by foreign governments and foreign currency fluctuations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inability to obtain certain billing information from physicians, resulting in increased costs and complexity, a temporary disruption in receipts, and ongoing reductions in reimbursements and revenues;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expenses and risks associated with international operations, including, but not limited to, compliance with the U.S. Foreign Corrupt Practices Act (FPCA), the U.K. Bribery Act, other applicable anti-corruption laws and regulations, trade sanction laws and regulations, and economic, political, legal and other operational risks associated with foreign jurisdictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to achieve expected efficiencies and savings in connection with the Company's business process improvement initiatives;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in tax laws and regulations or changes in their interpretation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global economic conditions and government and regulatory changes; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">risks associated with the impact, timing, expected benefits and costs, or terms of the planned spin-off of the Company&#8217;s Clinical Development and Commercialization Services (CDCS) business, which includes the parts of its DD segment focused on providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations, including but not limited to (i) uncertainties as to the completion and timing of the transaction; (ii) the failure to obtain appropriate assurances regarding the tax-free nature of the spin-off; (iii) the failure to obtain receipt of required regulatory approvals; (iv) the effect of the announcement or pendency of the transaction on the Company&#8217;s business relationships, operating results, and business generally; (v) unexpected issues that arise in the continued planning for the transaction; (vi) the failure to have the Form 10 registration statement that will be filed with the SEC declared effective on a timely basis, or at all; (vii) risks that the proposed transaction disrupts current plans and operations of Labcorp or CDCS; (viii) potential difficulties attracting or retaining Company or CDCS employees as a result of the spin-off announcement, pendency or completion of the spin-off; (ix) risks related to diverting management&#8217;s attention from the Company and CDCS&#8217; ongoing business operations; (x) the ability of the Company to successfully separate CDCS operations from the Company&#8217;s ongoing operations; (xi) market </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receptiveness to effect transactions in the capital markets; and (xii) market reaction to the announcement and planning for the transaction; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the effects, duration, and severity of the ongoing COVID-19 pandemic, including the impact on operations, personnel, supplies, liquidity, and collections, as well as the impact of past or future actions or omissions by the Company or governments in response to the COVID-19 pandemic including, but not limited to, the end of the federal Public Health Emergency, and damage to the Company's reputation or loss of business resulting from the perception of the Company's response to the COVID-19 pandemic.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as may be required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Given these uncertainties, one should not put undue reliance on any forward-looking statements.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_67"></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GENERAL (dollars in millions, except per share data)</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the three months ended March 31, 2023, were $3,777.9, a decrease of 3.1% from $3,899.6 during the three months ended March&#160;31, 2022. The decrease was due to organic revenue of 3.6% and unfavorable foreign currency translation of 0.7%, partially offset by acquisitions, net of divestitures, of 1.2%. The 3.6% decrease in organic revenue was driven by a 11.6% decrease in COVID-19 PCR and antibody testing (COVID-19 Testing), partially offset by a 7.9% increase in the company's organic Base Business. Base Business includes Labcorp's operations except for COVID-19 Testing.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company defines organic growth as the increase in revenue excluding the year-over-year impact of acquisitions, divestitures, and currency. Acquisition and divestiture impact is considered for a twelve month period following the close of each transaction.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Spin-Off of the Company's CDCS Business</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, the Company announced that the Board of Directors authorized the Company to pursue a spin-off of the Company&#8217;s wholly owned CDCS business to its shareholders through a tax-free transaction. The planned spin-off will result in two independent companies, each poised for strong, sustainable growth. On January 9, 2023, Thomas (Tom) Pike joined the Company as president and chief executive officer of its DD Clinical Development business unit, and when the planned spin-off is complete, Mr. Pike will become the chief executive officer and chairman of the board of directors of the independent, publicly listed company. On February 9, 2023, the Company announced that the name of the CDCS business will become Fortrea in connection with the planned spin-off.     </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is targeting completion of the planned spin-off in mid-2023. The planned spin-off will be subject to the satisfaction of certain customary conditions, including, among others, the receipt of final approval by the Company's Board, the receipt of appropriate assurances regarding the tax-free nature of the separation and effectiveness of any required filings with the U.S. Securities and Exchange Commission (SEC). There can be no assurances regarding the ultimate timing of the transaction or that the spin-off will be completed.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the transaction is complete, the resulting companies will be Labcorp, comprising the Company&#8217;s routine and esoteric labs, central labs and early development research labs, and Fortrea, a global contract research organization (CRO) providing Phase I-IV clinical trial management, market access and technology solutions to pharmaceutical and biotechnology organizations.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The planned spin-off is expected to provide each company with:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthened strategic flexibility and operational focus to pursue specific market opportunities and better meet customer needs;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">focused capital structures and capital allocation strategies to drive innovation and growth; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a more targeted investment opportunity for different investor bases; and </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to align its particular incentive compensation with its financial performance.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the planned spin-off, the Company believes that Labcorp will be positioned to:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in R&amp;D and innovation to develop and launch diagnostic advancements globally in key clinical areas including oncology, Alzheimer's, and autoimmune and liver disease through organic and inorganic opportunities; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bring together its global health and patient data and provide insights to enable customers to innovate; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">utilize its worldwide laboratory network to serve a broad, growing and global customer base including pharmaceutical and biotechnology companies, physicians, health systems, consumers, and other start-ups and laboratories that require lab services or diagnostic testing; and</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">launch innovative tests globally, providing patients, physicians, health systems and pharmaceutical companies with access to its advanced science, technology and diagnostic capabilities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the planned spin-off, the Company believes that Fortrea will be positioned to:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capitalize on growth opportunities across Phases I-IV clinical trials and extend its leadership in oncology, cell and gene therapy, rare disease, and other emerging therapeutic areas;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase agility with large pharmaceutical and biotechnology clients to better serve customers and advance life-saving therapies;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">access to unique data sets and insights through an arrangement with the Company for a defined period of time which will enable Fortrea to provide enhanced trial execution and a differentiated value proposition; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in capabilities, technologies, diverse talent and innovation to enhance trial execution and better serve all of its customers; and</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement a capital structure that is tailored to support its growth strategy and enhance stakeholder value.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The planned spin-off is intended to qualify as a tax-free transaction for U.S. federal income tax purposes.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_70"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RESULTS OF OPERATIONS (dollars in millions)</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three months ended March&#160;31, 2023, compared with three months ended March&#160;31, 2022 </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Revenues </span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,382.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,454.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,777.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,899.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues for the three months ended March&#160;31, 2023, were $3,777.9, a decrease of 3.1% over $3,899.6 in the first quarter of 2022. The decrease was due to lower organic revenue of 3.6% and unfavorable foreign currency translation of 0.7%, partially offset by acquisitions net of divestitures of 1.2%. The 3.6% decrease in organic revenue was driven by a 11.6% decrease in COVID-19 Testing, partially offset by a 7.9% increase in the Company's organic Base Business.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx revenues for the three months ended March&#160;31, 2023, were $2,382.8, a decrease of 2.9% over $2,454.1 in the first quarter of 2022. The decrease was due to organic revenue of 4.7% and unfavorable foreign currency translation of 0.3%, partially offset by acquisitions of 2.0%. The 4.7% decrease in organic revenue was due to a 18.4% decrease in COVID-19 Testing, partially offset by a 13.7% increase in the Base Business. Total Base Business growth compared to the Base Business in the prior year was 19.8%, which includes the benefit from the Ascension lab management agreement of approximately 7% as well as the positive impact from weather and revenue days of approximately 2%.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx total volume (measured by requisitions) for the three months ended March&#160;31, 2023, decreased by 3.3% as organic volume decreased by 5.6% and acquisition volume contributed 2.3%. Organic volume was impacted by a 12.7% decrease in COVID-19 Testing, partially offset by a 7.1% increase in Base Business. Price/mix increased by 0.4% due to Base Business growth of 6.6%, partially offset by a decrease in COVID-19 Testing of 5.7%, unfavorable foreign currency translation of 0.3%, and lower acquisitions of 0.2%. Base Business volume was up 11.0% compared to the Base Business last year, which includes the combined favorable impact from weather and revenue days of approximately 2%. Price/mix was up 8.8% in the Base Business compared to the Base Business last year, which includes the benefit of the Ascension lab management agreement.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">DD revenues for the three months ended March&#160;31, 2023, were $1,401.3, a decrease of 4.0% over $1,459.3 in the first quarter of 2022. The decrease was primarily due to an organic decline of 2.4%, unfavorable foreign currency translation of 1.5%, and unfavorable acquisitions net of divestitures of 0.1%. The decrease in organic revenue was negatively impacted by approximately 8.0% due to non-human primate (NHP) related constraints, reduced COVID-19 vaccine and therapeutic work, and the loss of a functional services provider (FSP) contract. Our backlog expected to be recognized in the next 12 months decreased from approximately 30% at December 31, 2022, to approximately 29.5% at March 31, 2023, as a result of an increase in the average contract length.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cost of Revenues</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,666.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues as a % of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues increased 5.1% during the three months ended March&#160;31, 2023, as compared with the corresponding period in 2022. Cost of revenues as a percentage of revenues during the three months ended March&#160;31, 2023, increased to 74.2% as compared to 68.4% in the corresponding period in 2022. This increase in cost of revenues as a percent of revenues </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was primarily due to a reduction in COVID-19 Testing revenues, the impact of the Ascension Management Service Agreement, and higher personnel expenses, partially offset by organic Base Business growth and LaunchPad savings.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Selling, General and Administrative Expenses</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses as a % of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses as a percentage of revenues were 14.7% and 11.9% during the three months ended March&#160;31, 2023, and 2022, respectively. The increase is primarily due to a reduction in COVID-19 Testing revenues and spin off transaction costs.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Amortization of Intangibles and Other Assets</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in amortization of intangibles and other assets primarily reflects additional amortization for assets acquired subsequent to March 31, 2022.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Goodwill and Other Asset Impairments</span></div><div style="margin-bottom:7.1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded impairment charges of $2.2 in capitalized software costs during the three months ended March&#160;31, 2023. The Company recorded impairment charges of $1.2 in other assets in Ukraine and Russia during the three months ended March&#160;31, 2022.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Restructuring and Other Charges</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company recorded net restructuring and other charges of $8.6. The charges were comprised of $4.9 related to severance and other personnel costs and $4.7 in facility closures, lease terminations, and general integration activities. The charges were adjusted by the increase of $0.7 of previously established severance liabilities and the reversal of previously established liability of $0.3 in unused facility-related costs.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, the Company recorded net restructuring and other charges of $12.6. The charges were comprised of $5.4 related to severance and other personnel costs and $7.7 in facility closures, lease terminations, and general integration activities. The charges were adjusted by the reversal of a previously established liability of $0.4 in unused severance costs and $0.1 in unused facility-related costs.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Expense</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.7)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in interest expense for the three months ended March&#160;31, 2023, as compared with the corresponding period in 2022, is primarily due to the increased interest rates on variable rate debt and higher borrowings under the Credit Facility.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Equity Method Income</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method income, net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160.2)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Equity method income represents the Company's ownership share in joint venture partnerships along with equity investments in other companies in the health care industry. The decrease in income for the three months ended March&#160;31, 2023, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as compared with the corresponding period in 2022, was primarily due to the decreased profitability of the Company's joint ventures in 2023.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other, net</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The change in Other, net for the three months ended March&#160;31, 2023, as compared to the three months ended March&#160;31, 2022, is primarily due to investment losses of $1.5 for the three months ended March&#160;31, 2023 compared to investment gains of $8.0 for the corresponding period of 2022. In addition, foreign currency transaction losses of $2.9 were recognized for the three months ended March&#160;31, 2023 as compared to losses of $2.6 for the corresponding period of 2022.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Tax Expense</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense as a % of earnings before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current year effective tax rate differs from the U.S. federal statutory rate of 21.0% primarily due to state income taxes and the disallowance of certain executive compensation which are partially offset by research and development tax credits and favorable foreign rate differentials. The prior year effective tax rate differed from the U.S. federal statutory rate of 21.0% primarily due to state income taxes which were partially offset by windfall stock compensation deductions and favorable foreign rate differentials.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Operating Income by Segment</span></div><div style="margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company modified the segment performance measure to exclude the amortization of intangibles and other assets, restructuring and other charges, goodwill and other asset impairments, and certain corporate charges for items such as transaction costs, COVID-19-related costs, and other special items. These changes align with how the CODM now evaluates segment performance and allocates resources. Prior periods have been conformed for comparability.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and unallocated expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx operating income was $441.5 for the three months ended March&#160;31, 2023, a decrease of $241.6 over operating income of $683.1 in the corresponding period of 2022, and Dx operating margin decreased 930 basis points year-over-year. The decrease in adjusted operating income and adjusted operating margin was due to a reduction in COVID-19 Testing. Excluding COVID-19 Testing, operating income and margin were up due to the benefit of Base Business organic growth and LaunchPad savings, which were partially offset by higher personnel expense.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD operating income was $123.9 for the three months ended March&#160;31, 2023, a decrease of $44.7 over operating income of $168.6 in the corresponding period of 2022. The decrease was due to NHP-related constraints, reduced COVID-19 vaccine and therapeutic work, the FSP contract loss, and a provision for credit losses on certain biotech receivables, partially offset by demand growth and LaunchPad savings.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General corporate expenses are comprised primarily of administrative services such as executive management, human resources, legal, finance, corporate affairs, and information technology. Corporate expenses were $144.3 for the three months ended March&#160;31, 2023, an increase of $61.4 over corporate expenses of $82.9 in the corresponding period of 2022, primarily due to spin transaction costs, personnel costs, bonus allocation, and research and development costs.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remains on track to deliver approximately $350.0 of net savings from its three-year LaunchPad initiative by the end of 2024.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LIQUIDITY AND CAPITAL RESOURCES (dollars and shares in millions)</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's cash-generating ability and financial condition typically have provided ready access to capital markets. The Company's principal source of liquidity is operating cash flow, supplemented by proceeds from debt offerings. The Company believes that its balances of cash and cash equivalents and borrowing capacity, along with cash generated from operations, will be sufficient to satisfy its cash requirements, cash dividends, and share repurchases over the next twelve months. The Company's senior unsecured revolving credit facility is further discussed in Note 6 (Debt) to the Company's condensed consolidated financial statements.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, the Company's cash flows were as follows for the three months ended March&#160;31, 2023, and 2022, respectively:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at March&#160;31, 2023, and 2022, totaled $393.9 and $1,233.5, respectively. Cash and cash equivalents consist of highly liquid instruments, such as time deposits, commercial paper, and other money market investments, which have original maturities of three months or less.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company's operations provided $121.2 of cash as compared to $356.0 during the same period in 2022. The $234.8 decrease in cash provided from operations in 2023 as compared with the corresponding 2022 period is primarily due to lower cash earnings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for investing activities for the three months ended March&#160;31, 2023, was $99.7 as compared to $573.1 for the three months ended March&#160;31, 2022. The change in cash used for investing activities was primarily due to a decrease in business acquisitions and lower capital expenditures during the three months ended March&#160;31, 2023. Capital expenditures were $93.9 and $117.2 for the three months ended March&#160;31, 2023, and 2022, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used by financing activities for the three months ended March&#160;31, 2023, was $60.6 as compared to $17.7 for the three months ended March&#160;31, 2022. The change in cash flows from financing activities for the three months ended March&#160;31, 2023, as compared to the three months ended March&#160;31, 2022, was primarily due to the payment of dividends of $64.4 in 2023. </span></div><div style="margin-bottom:7pt;margin-top:7.1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, the Company had $393.9 of cash and $1,000.0 of available borrowings under its revolving credit facility, which does not mature until 2026. Under the Company's revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers and the Company is required to maintain certain leverage ratios. The Company was in compliance with all covenants under the revolving credit facility at March&#160;31, 2023, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, the Company did not repurchase any of the Company's common stock.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company had an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> outstanding authorization from the board of directors to purchase up to $1,531.5 more of the Company's common stock with no expiration date.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, the Company paid $64.4 in common stock dividends. On April 6, 2023, the Company announced a cash dividend of $0.72 per share of common stock for the second quarter, or approximately $64.7 in the aggregate. The dividend will be payable on June 8, 2023, to stockholders of record of all issued and outstanding shares of common stock as of the close of business on May 18, 2023. The declaration and payment of any future dividends will be at the discretion of the Company's board of directors.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Ratings</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment grade debt ratings from Moody&#8217;s and from Standard and Poor&#8217;s (S&amp;P) contribute to its ability to access capital markets. </span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_76"></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. Quantitative and Qualitative Disclosures about Market Risk (dollars in millions)</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the potential loss arising from adverse changes in market rates and prices, such as foreign currency exchange rates, interest rates, and other relevant market rate or price changes. In the ordinary course of business, the Company is exposed to various market risks, including changes in foreign currency exchange and interest rates, and the Company regularly evaluates its exposure to such changes. The Company addresses its exposure to market risks, principally the market risks associated with changes in foreign currency exchange rates and interest rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments such as foreign currency forward contracts, and interest rate and cross currency swap agreements.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rates</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 14.2% of the Company's revenues for the three months ended March&#160;31, 2023, and approximately 15.7% of the Company's revenue for the three months ended March&#160;31, 2022, were denominated in currencies other than the U.S. Dollar (USD). The Company's financial statements are reported in USD and, accordingly, fluctuations in exchange rates will affect the translation of revenues and expenses denominated in foreign currencies into USD for purposes of reporting the Company's consolidated financial results. In the first quarter of 2023 and the year ended December 31, 2022, the most significant currency exchange rate exposures were to the Canadian dollar, Swiss Franc, Euro and British Pound. Excluding the impacts from any outstanding or future hedging transactions, a hypothetical change of 10% in average exchange rates used to translate all foreign currencies to USD would have impacted income before income taxes for the three months ended March&#160;31, 2023, by approximately $6.1. Gross accumulated currency translation adjustments recorded as a separate component of shareholders&#8217; equity were $<ix:nonFraction unitRef="usd" contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF83Ni9mcmFnOjI1NDhmZTVhMWU3NTQwYmQ4ZDZhZDNkNjQ2MDNlMzhkL3RleHRyZWdpb246MjU0OGZlNWExZTc1NDBiZDhkNmFkM2Q2NDYwM2UzOGRfNTQ5NzU1ODE4Mjg2_05941122-031a-43dc-99f1-41b46e535203">48.1</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF83Ni9mcmFnOjI1NDhmZTVhMWU3NTQwYmQ4ZDZhZDNkNjQ2MDNlMzhkL3RleHRyZWdpb246MjU0OGZlNWExZTc1NDBiZDhkNmFkM2Q2NDYwM2UzOGRfNTQ5NzU1ODE4Mjkx_40eefe92-f128-41d5-988c-75a187d1cabe">74.6</ix:nonFraction>) at March&#160;31, 2023 and 2022, respectively. The Company does not have significant operations in countries in which the economy is considered to be highly inflationary.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company earns revenue from service contracts over a period of time, ranging from months to years. Accordingly, exchange rate fluctuations during this period may affect the Company's profitability with respect to such contracts. The Company is also subject to foreign currency transaction risk for fluctuations in exchange rates during the period of time between the consummation and cash settlement of transactions. The Company limits its foreign currency transaction risk through exchange rate fluctuation provisions stated in some of its contracts with customers, or it may hedge transaction risk with foreign currency forward contracts. At March&#160;31, 2023, the Company had 28 open foreign exchange forward contracts with various amounts maturing monthly through April 2023 with a notional value totaling approximately $663.5. At December 31, 2022, the Company had 27 open foreign exchange forward contracts with various amounts maturing monthly through January 2023 with a notional value totaling approximately $629.5.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party to U.S. to Swiss Franc cross-currency swap agreements with an aggregate notional amount of $600.0, $<ix:nonFraction unitRef="usd" contextRef="ic501f2ab3f824f5e99cea8fef7c2e388_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF83Ni9mcmFnOjI1NDhmZTVhMWU3NTQwYmQ4ZDZhZDNkNjQ2MDNlMzhkL3RleHRyZWdpb246MjU0OGZlNWExZTc1NDBiZDhkNmFkM2Q2NDYwM2UzOGRfMzIzMQ_b4b98a3a-61c1-4234-825e-cf0c0856ba32">300.0</ix:nonFraction> maturing in 2024 and $300.0 maturing in 2025, as a hedge against the impact of foreign exchange movements on its net investment in a Swiss Franc functional currency subsidiary.</span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rates</span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's debt from time to time is subject to interest at variable rates. As a result, fluctuations in interest rates can affect the business. The Company attempts to manage interest rate risk and overall borrowing costs through an appropriate mix of fixed and variable rate debt including by the utilization of derivative financial instruments, primarily interest rate swaps. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Company's term loan credit facility, now repaid, and revolving credit facility are subject to variable interest rates, unless fixed through interest rate swaps or other agreements.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, to hedge against changes in the fair value portion of the Company's long-term debt, the Company entered into fixed-to-variable interest rate swap agreements for the 2.70% senior notes due 2031 with an aggregate notional value of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706%.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_79"></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. Controls and Procedures</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out, under the supervision and with the participation of the Company&#8217;s management, including the Company&#8217;s principal executive officer and principal financial officer, an evaluation of the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Rules13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based upon this evaluation, the Company&#8217;s principal executive officer and principal financial officer concluded that the Company&#8217;s disclosure controls and procedures were effective as of March&#160;31, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the Company&#8217;s internal control over financial reporting (as defined in Rules13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) that occurred during the quarter ended March&#160;31, 2023, that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_85"></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 (Commitments and Contingencies) to the Company&#8217;s condensed consolidated financial statements, above, which is incorporated herein by reference.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_88"></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk factors set forth below revise and supplement the corresponding risk factors set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2022. With the exception of the following, there have been no material changes in the risk factors that appear in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company depends on a variety of U.S. and international financial institutions to provide us with banking services. The default or failure of one or more of the financial institutions that we rely on may adversely affect the Company's business and financial condition. </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the majority of its cash and cash equivalents in accounts with major U.S. and international financial institutions, and our deposits at certain of these institutions exceed insured limits. Market conditions can impact the viability of these institutions. In the event of failure of any of the financial institutions where the Company maintains its cash and cash equivalents, there can be no assurance that the Company would be able to access uninsured funds in a timely manner or at all. Additionally, bank payment processes could become unavailable which could temporarily impact the Company's ability to conduct business with suppliers and pay its employees on a timely basis. Any inability to access or delay in accessing these funds could adversely affect the Company's business and financial condition.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_91"></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds (dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7.1pt;margin-top:8pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Board of Directors has authorized the repurchase of specified amounts of the Company's stock since 2007. During the three months ended March&#160;31, 2023, the Company did not repurchase any of its common stock. As of March&#160;31, 2023, the Company had outstanding authorization from the board of directors to purchase up to $1,531.5 of the Company's common stock. The repurchase authorization has no expiration date.</span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_94"></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_97"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014823000017/exhibit1012thirdarcreditag.htm">Amendment No. 1, dated as of January 13, 2023, to the Third Amended and Restated Credit Agreement (originally dated as of April 30, 2021), among the Company, Bank of America, N.A., as administrative agent, and lenders party thereto (incorporated by reference to Exhibit 10.18 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014823000017/exhibit1018thomaspikeemplo.htm">Executive Employment Agreement, dated January 4, 2023, by and between Laboratory Corporation of America and Thomas Pike (incorporated by reference to Exhibit 10.12 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="ex311q12023.htm">Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex312q12023.htm">Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32q12023.htm">Written Statement of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">furnished herewith</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i63596bd8d89a4cde970ba8cf74db2b44_4">INDEX</a></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><span><br/></span></div><div id="i63596bd8d89a4cde970ba8cf74db2b44_100"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LABORATORY CORPORATION OF AMERICA HOLDINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.093%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ ADAM H. SCHECHTER</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.093%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ GLENN A. EISENBERG</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;4, 2023 </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex311q12023.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibb4841f6aa8f4e6095a5d8cc3a6a09af_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 31.1</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Adam H. Schechter, certify that&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Laboratory Corporation of America Holdings&#59;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;  and</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;padding-right:22.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:5.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; ADAM H. SCHECHTER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex312q12023.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i02dbb98366e9489194fa434b6b0d5125_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 31.2</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Glenn A. Eisenberg, certify that&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Laboratory Corporation of America Holdings&#59;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;  and</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:9pt;padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;padding-right:22.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:5.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; GLENN A. EISENBERG</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>ex32q12023.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic8ca37c0c22b462f8ca6f7bddf2a931a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 32</font></div><div style="padding-right:45pt"><font><br></font></div><div style="padding-right:45pt"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written Statement of</font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chief Financial Officer</font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The undersigned, the Chief Executive Officer and the Chief Financial Officer of Laboratory Corporation of America Holdings (the &#8220;Company&#8221;), each hereby certifies that, to his knowledge on the date hereof&#58;</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     (a)  the Form 10-Q of the Company for the Period Ended March&#160;31, 2023, filed on the date hereof with the Securities and Exchange Commission (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     (b)  information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;padding-right:22.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.935%"><tr><td style="width:1.0%"></td><td style="width:52.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; ADAM H. SCHECHTER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2023</font></td></tr></table></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-right:45pt;text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;padding-right:22.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.935%"><tr><td style="width:1.0%"></td><td style="width:52.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; GLENN A. EISENBERG</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2023</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Laboratory Corporation of America Holdings and will be retained by Laboratory Corporation of America Holdings and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lh-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6517acae-4533-4b41-af86-61933115c4be,g:534dcbed-da35-4848-959c-5965c7debeab-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lh="http://www.labcorp.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.labcorp.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.labcorp.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementofCashFlowsStatement" roleURI="http://www.labcorp.com/role/StatementofCashFlowsStatement">
        <link:definition>0000007 - Statement - Statement of Cash Flows (Statement)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementofCashFlowsSupplementalDisclosures" roleURI="http://www.labcorp.com/role/StatementofCashFlowsSupplementalDisclosures">
        <link:definition>0000009 - Statement - Statement of Cash Flows, Supplemental Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements">
        <link:definition>0000010 - Statement - BASIS OF FINANCIAL STATEMENT PRESENTATION Restated Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation">
        <link:definition>0000011 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Description Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATION" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION">
        <link:definition>0000012 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.labcorp.com/role/EARNINGSPERSHARE">
        <link:definition>0000013 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NONCONTROLLINGINTERESTPUTS" roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS">
        <link:definition>0000014 - Disclosure - NONCONTROLLING INTEREST PUTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>0000015 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.labcorp.com/role/DEBT">
        <link:definition>0000016 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY">
        <link:definition>0000017 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000019 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONS">
        <link:definition>0000020 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONNotes" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes">
        <link:definition>0000021 - Disclosure - BUSINESS SEGMENT INFORMATION (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes">
        <link:definition>0000022 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment information (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENotes" roleURI="http://www.labcorp.com/role/REVENUENotes">
        <link:definition>0000023 - Disclosure - REVENUE (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.labcorp.com/role/SubsequentEvents">
        <link:definition>0000024 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsGoodwillandOtherPolicies" roleURI="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies">
        <link:definition>0000025 - Disclosure - Intangible Assets, Goodwill and Other (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractwithCustomerPolicies" roleURI="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies">
        <link:definition>0000026 - Disclosure - Revenue from Contract with Customer (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.labcorp.com/role/EARNINGSPERSHARETables">
        <link:definition>0000027 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>0000028 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>0000029 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>0000030 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.labcorp.com/role/REVENUETables">
        <link:definition>0000031 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsTables" roleURI="http://www.labcorp.com/role/SubsequentEventsTables">
        <link:definition>0000032 - Disclosure - Subsequent Events (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails">
        <link:definition>0000033 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails">
        <link:definition>0000034 - Disclosure - EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails">
        <link:definition>0000035 - Disclosure - EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NONCONTROLLINGINTERESTPUTSDetails" roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails">
        <link:definition>0000036 - Disclosure - NONCONTROLLING INTEREST PUTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails">
        <link:definition>0000037 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails">
        <link:definition>0000038 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
        <link:definition>0000039 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" roleURI="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails">
        <link:definition>0000040 - Disclosure - DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTLongtermdebtDetails" roleURI="http://www.labcorp.com/role/DEBTLongtermdebtDetails">
        <link:definition>0000041 - Disclosure - DEBT (Long-term debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSeniorNotesDetails" roleURI="http://www.labcorp.com/role/DEBTSeniorNotesDetails">
        <link:definition>0000042 - Disclosure - DEBT (Senior Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCreditFacilitiesDetails" roleURI="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails">
        <link:definition>0000043 - Disclosure - DEBT (Credit Facilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails">
        <link:definition>0000044 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails">
        <link:definition>0000045 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>0000046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSDetails" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails">
        <link:definition>0000047 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>0000048 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails">
        <link:definition>0000049 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDetails" roleURI="http://www.labcorp.com/role/REVENUEDetails">
        <link:definition>0000050 - Disclosure - REVENUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDisaggregatedRevenueTableDetails" roleURI="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails">
        <link:definition>0000051 - Disclosure - REVENUE Disaggregated Revenue Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.labcorp.com/role/SubsequentEventsDetails">
        <link:definition>0000052 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lh_InProcessRAAndMediaMember" abstract="true" name="InProcessRAAndMediaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_ThirdpartyMember" abstract="true" name="ThirdpartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_PerShareAmountAbstract" abstract="true" name="PerShareAmountAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_DrugDevelopmentMember" abstract="true" name="DrugDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_NetRestructuringAndOtherSpecialCharges" abstract="false" name="NetRestructuringAndOtherSpecialCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A2.30seniornotesdue2024" abstract="false" name="A2.30seniornotesdue2024" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SeniorNotesDue2031Member" abstract="true" name="SeniorNotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_Contingentconsiderationadjustment" abstract="false" name="Contingentconsiderationadjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_MedicareandMedicaidMember" abstract="true" name="MedicareandMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_Seniornotesdue2027Member" abstract="true" name="Seniornotesdue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_NumberofMeasurementFundsAvailableForParticipantElection" abstract="false" name="NumberofMeasurementFundsAvailableForParticipantElection" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lh_CashPaidDuringPeriodForAbstract" abstract="true" name="CashPaidDuringPeriodForAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_CommonSharesIssuedRollforwardAbstract" abstract="true" name="CommonSharesIssuedRollforwardAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_CovanceDrugDevelopmentMember" abstract="true" name="CovanceDrugDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SwapTypeAxis" abstract="true" name="SwapTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_OtheracquireesMember" abstract="true" name="OtheracquireesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_Longtermdebtissuancecosts" abstract="false" name="Longtermdebtissuancecosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" abstract="true" name="ScheduleOfOtherIntangibleAssetsByMajorClassAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_A400SeniorNotesDue2023" abstract="false" name="A400SeniorNotesDue2023" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A360SeniorNotesDue2027" abstract="false" name="A360SeniorNotesDue2027" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_A360SeniorNotesDue2025" abstract="false" name="A360SeniorNotesDue2025" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A2018SwapAgreementsMember" abstract="true" name="A2018SwapAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SeniorNotesDue2022Member" abstract="true" name="SeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SeniorNotesFairValue" abstract="false" name="SeniorNotesFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" abstract="true" name="ScheduleOfOtherIntangibleAssetsByMajorClassDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_A2022SwapAgreementsMember" abstract="true" name="A2022SwapAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_UnbilledContractsReceivableMember" abstract="true" name="UnbilledContractsReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_A325SeniorNotesDue2024" abstract="false" name="A325SeniorNotesDue2024" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ForeignCurrencyTranslationAdjustmentsMember" abstract="true" name="ForeignCurrencyTranslationAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_A155SeniorNotesDue2026" abstract="false" name="A155SeniorNotesDue2026" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" abstract="false" name="Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_IncreaseDecreaseinUnbilledContractReceivable" abstract="false" name="IncreaseDecreaseinUnbilledContractReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_UnbilledServicesAllowanceforCreditLoss" abstract="false" name="UnbilledServicesAllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" abstract="false" name="CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lh_CommonSharesHeldInTreasuryRollforwardAbstract" abstract="true" name="CommonSharesHeldInTreasuryRollforwardAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_OthercountriesMember" abstract="true" name="OthercountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_NetRestructuringCharges" abstract="false" name="NetRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" abstract="true" name="SegmentReconciliationofOperatingIncometoConsolidatedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_AccumulatedOtherComprehensiveEarningsRollForward" abstract="true" name="AccumulatedOtherComprehensiveEarningsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CurrentDebtExcludingFinanceLeaseLiability" abstract="false" name="CurrentDebtExcludingFinanceLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_PercentofRevenueContributed" abstract="false" name="PercentofRevenueContributed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_CreditFacilityMaximumLettersofCredit" abstract="false" name="CreditFacilityMaximumLettersofCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NoteReceivableAllowanceforCreditLoss" abstract="false" name="NoteReceivableAllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ThreeMonthLIBOR" abstract="false" name="ThreeMonthLIBOR" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_OtherFinancingCashFlows" abstract="false" name="OtherFinancingCashFlows" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_PatentsLicensesAndTechnologyMember" abstract="true" name="PatentsLicensesAndTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_InterestPaidInCash" abstract="false" name="InterestPaidInCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid" abstract="false" name="IncreaseInCapitalExpendituresIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_AllowanceforCreditLoss" abstract="false" name="AllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_IncomeAbstract" abstract="true" name="IncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_CommonSharesOutstandingRollforwardAbstract" abstract="true" name="CommonSharesOutstandingRollforwardAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_SeniorNotesDue2024Member" abstract="true" name="SeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" abstract="false" name="IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_LongTermContractsDurationMaximum" abstract="false" name="LongTermContractsDurationMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_ClientMember" abstract="true" name="ClientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_A270SeniorNotesDue2031" abstract="false" name="A270SeniorNotesDue2031" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CashFlowLocationDomain" abstract="true" name="CashFlowLocationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_AllowanceforCreditLossWriteOff" abstract="false" name="AllowanceforCreditLossWriteOff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A2.95seniornotesdue2029" abstract="false" name="A2.95seniornotesdue2029" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NoncontrollingInterestPutsAbstract" abstract="true" name="NoncontrollingInterestPutsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" abstract="false" name="CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DepreciationAndAmortizationOfLeasedAssets" abstract="false" name="DepreciationAndAmortizationOfLeasedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A470SeniorNotesDue2045" abstract="false" name="A470SeniorNotesDue2045" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Issuanceofcommonstockunderemployeeplans" abstract="false" name="Issuanceofcommonstockunderemployeeplans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_LongTermContractsDurationMinimum" abstract="false" name="LongTermContractsDurationMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_CashFlowLocationAxis" abstract="true" name="CashFlowLocationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_Shorttermdebtissuancecosts" abstract="false" name="Shorttermdebtissuancecosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NoncontrollingInterestMezzanineEquity" abstract="false" name="NoncontrollingInterestMezzanineEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SwapTypeDomain" abstract="true" name="SwapTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_OutstandingStockRepurchaseAuthorizationAbstract" abstract="true" name="OutstandingStockRepurchaseAuthorizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_SharesAbstract" abstract="true" name="SharesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_CreditFacilityMaximumSwingLineBorrowings" abstract="false" name="CreditFacilityMaximumSwingLineBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_BiopharmaceuticalandmedicaldevicecompaniesMember" abstract="true" name="BiopharmaceuticalandmedicaldevicecompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_CostMethodInvestmentsMaximumOwnershipPercentage" abstract="false" name="CostMethodInvestmentsMaximumOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_DeferredIncomeTaxesAndOtherTaxLiabilities" abstract="false" name="DeferredIncomeTaxesAndOtherTaxLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_LabCorpDiagnosticsMember" abstract="true" name="LabCorpDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_NetProceedsFromIssuanceOfStockToEmployees" abstract="false" name="NetProceedsFromIssuanceOfStockToEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CreditFacilityOptiontoIncrease" abstract="false" name="CreditFacilityOptiontoIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" abstract="false" name="ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>lh-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6517acae-4533-4b41-af86-61933115c4be,g:534dcbed-da35-4848-959c-5965c7debeab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_949a20dc-a97b-4880-90e6-29780ef567d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_34e733f3-f483-4c60-9d1b-6bd62b274c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_949a20dc-a97b-4880-90e6-29780ef567d7" xlink:to="loc_us-gaap_AssetsCurrent_34e733f3-f483-4c60-9d1b-6bd62b274c83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4496e0e0-dfaa-477f-8880-d7ccb6399bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_949a20dc-a97b-4880-90e6-29780ef567d7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4496e0e0-dfaa-477f-8880-d7ccb6399bc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cfeac60e-2a7e-460b-a905-3ec029f0fc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_949a20dc-a97b-4880-90e6-29780ef567d7" xlink:to="loc_us-gaap_Goodwill_cfeac60e-2a7e-460b-a905-3ec029f0fc98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b3640be0-3182-47bb-82a4-146fd78489d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_949a20dc-a97b-4880-90e6-29780ef567d7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b3640be0-3182-47bb-82a4-146fd78489d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4db677d4-8671-4af4-80dd-7f62b57bb6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_949a20dc-a97b-4880-90e6-29780ef567d7" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4db677d4-8671-4af4-80dd-7f62b57bb6e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_f3a344f7-76f8-467e-b8fd-155a1f078841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_949a20dc-a97b-4880-90e6-29780ef567d7" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_f3a344f7-76f8-467e-b8fd-155a1f078841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_384df3b1-3ed8-442f-9e25-965ffbc556a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_949a20dc-a97b-4880-90e6-29780ef567d7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_384df3b1-3ed8-442f-9e25-965ffbc556a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_74c1983c-856c-49a6-8363-85092e2f7a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_25b8fd1d-7d17-4918-9e10-142336b92f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_74c1983c-856c-49a6-8363-85092e2f7a77" xlink:to="loc_us-gaap_CommonStockValue_25b8fd1d-7d17-4918-9e10-142336b92f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7c608d4a-7ffe-4947-885d-2650447374b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_74c1983c-856c-49a6-8363-85092e2f7a77" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7c608d4a-7ffe-4947-885d-2650447374b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_275ad770-1584-4697-90a5-f4565c1beabf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_74c1983c-856c-49a6-8363-85092e2f7a77" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_275ad770-1584-4697-90a5-f4565c1beabf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7e86d8fb-be7e-4714-b8c1-2b3453673b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_74c1983c-856c-49a6-8363-85092e2f7a77" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7e86d8fb-be7e-4714-b8c1-2b3453673b24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ab42eac1-5103-408c-8e03-8418ff77af7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_36b5d48a-b9b9-4646-a563-ca836e6e1023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab42eac1-5103-408c-8e03-8418ff77af7c" xlink:to="loc_us-gaap_AccountsPayableCurrent_36b5d48a-b9b9-4646-a563-ca836e6e1023" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9b98d7f7-f980-4719-a5ca-2816cd0114b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab42eac1-5103-408c-8e03-8418ff77af7c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9b98d7f7-f980-4719-a5ca-2816cd0114b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_fa5ffcc8-6fff-4dff-b11c-a130998820c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab42eac1-5103-408c-8e03-8418ff77af7c" xlink:to="loc_us-gaap_DeferredRevenueCurrent_fa5ffcc8-6fff-4dff-b11c-a130998820c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b65dcf39-c483-46b2-8d51-f3c944598113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab42eac1-5103-408c-8e03-8418ff77af7c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b65dcf39-c483-46b2-8d51-f3c944598113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentDebtExcludingFinanceLeaseLiability_1d956bf1-e7df-4a2d-8904-5ee92f681c75" xlink:href="lh-20230331.xsd#lh_CurrentDebtExcludingFinanceLeaseLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab42eac1-5103-408c-8e03-8418ff77af7c" xlink:to="loc_lh_CurrentDebtExcludingFinanceLeaseLiability_1d956bf1-e7df-4a2d-8904-5ee92f681c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0ceb9324-d295-4e3f-973a-c9c6bffaedd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab42eac1-5103-408c-8e03-8418ff77af7c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0ceb9324-d295-4e3f-973a-c9c6bffaedd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_00f3a061-7266-41b2-84a4-3e157f6e99de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_60b9d3b4-bcd4-40aa-9b5a-0ba50c8115c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_00f3a061-7266-41b2-84a4-3e157f6e99de" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_60b9d3b4-bcd4-40aa-9b5a-0ba50c8115c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_40a0f439-a43b-43d9-a7aa-9e38269cf983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_00f3a061-7266-41b2-84a4-3e157f6e99de" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_40a0f439-a43b-43d9-a7aa-9e38269cf983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_81d6bdd6-8fbd-4a2f-b3fd-d368689e79a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_00f3a061-7266-41b2-84a4-3e157f6e99de" xlink:to="loc_us-gaap_UnbilledContractsReceivable_81d6bdd6-8fbd-4a2f-b3fd-d368689e79a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0f43955f-a499-41d6-bb87-2089defcb50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_00f3a061-7266-41b2-84a4-3e157f6e99de" xlink:to="loc_us-gaap_InventoryNet_0f43955f-a499-41d6-bb87-2089defcb50c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_b4d49d63-436e-45c4-a869-21e591401cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_00f3a061-7266-41b2-84a4-3e157f6e99de" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_b4d49d63-436e-45c4-a869-21e591401cec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_17b42348-0f61-4aca-a188-e632b1b16537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_51a52c4a-524a-4519-9122-d6378d38325b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17b42348-0f61-4aca-a188-e632b1b16537" xlink:to="loc_us-gaap_LiabilitiesCurrent_51a52c4a-524a-4519-9122-d6378d38325b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f246aa2c-c0bd-432a-81a5-1df9e1adcb25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17b42348-0f61-4aca-a188-e632b1b16537" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f246aa2c-c0bd-432a-81a5-1df9e1adcb25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b05b516a-20ca-476b-bfb3-6a78360a6324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17b42348-0f61-4aca-a188-e632b1b16537" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b05b516a-20ca-476b-bfb3-6a78360a6324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_55449ffb-cf21-48ca-b0c3-6be25823e5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17b42348-0f61-4aca-a188-e632b1b16537" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_55449ffb-cf21-48ca-b0c3-6be25823e5ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_55207d7b-9d54-4483-8d78-27ad4b62af9b" xlink:href="lh-20230331.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17b42348-0f61-4aca-a188-e632b1b16537" xlink:to="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_55207d7b-9d54-4483-8d78-27ad4b62af9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a94872bf-cfdc-426e-9cd2-af8457c3746e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17b42348-0f61-4aca-a188-e632b1b16537" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a94872bf-cfdc-426e-9cd2-af8457c3746e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_94c3d391-dde8-488c-b684-82dbe9d283e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity_bc0ad6a3-2d03-4a56-8093-869f38d5d9da" xlink:href="lh-20230331.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94c3d391-dde8-488c-b684-82dbe9d283e7" xlink:to="loc_lh_NoncontrollingInterestMezzanineEquity_bc0ad6a3-2d03-4a56-8093-869f38d5d9da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_af3205cd-e430-4e87-b87e-7a67fbf60979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94c3d391-dde8-488c-b684-82dbe9d283e7" xlink:to="loc_us-gaap_Liabilities_af3205cd-e430-4e87-b87e-7a67fbf60979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_aaa9c3e8-dfb7-4b66-a4de-dd2df586273a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94c3d391-dde8-488c-b684-82dbe9d283e7" xlink:to="loc_us-gaap_StockholdersEquity_aaa9c3e8-dfb7-4b66-a4de-dd2df586273a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_722029f3-090d-42c1-9a7b-eae1757e53a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_735e9d24-2414-4488-8cfd-cd58cf92e596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_722029f3-090d-42c1-9a7b-eae1757e53a7" xlink:to="loc_us-gaap_ProfitLoss_735e9d24-2414-4488-8cfd-cd58cf92e596" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_02b95034-0fe9-4343-af68-ec01485bc443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_722029f3-090d-42c1-9a7b-eae1757e53a7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_02b95034-0fe9-4343-af68-ec01485bc443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_932b02f7-fb8a-4b0f-a749-10990742c94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8d140d00-43fe-405e-9b2c-bac062970bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_932b02f7-fb8a-4b0f-a749-10990742c94c" xlink:to="loc_us-gaap_GrossProfit_8d140d00-43fe-405e-9b2c-bac062970bdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8a2fc85b-0214-4015-a4e3-6bd4c47db476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_932b02f7-fb8a-4b0f-a749-10990742c94c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8a2fc85b-0214-4015-a4e3-6bd4c47db476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_cbdb3ea0-56ab-4baf-95da-f3ae5ec27277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_932b02f7-fb8a-4b0f-a749-10990742c94c" xlink:to="loc_us-gaap_AssetImpairmentCharges_cbdb3ea0-56ab-4baf-95da-f3ae5ec27277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_eb09ad3f-9ec4-426b-9256-66bdfb4bef4e" xlink:href="lh-20230331.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_932b02f7-fb8a-4b0f-a749-10990742c94c" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_eb09ad3f-9ec4-426b-9256-66bdfb4bef4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d6cf5b62-d0c3-415a-88ec-d4cd30c5ecc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_932b02f7-fb8a-4b0f-a749-10990742c94c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d6cf5b62-d0c3-415a-88ec-d4cd30c5ecc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5a8964b4-a772-45e8-9ad6-387da04eb18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_996f353a-83ca-4b8e-9a9e-205ffdf7d26e" xlink:href="lh-20230331.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5a8964b4-a772-45e8-9ad6-387da04eb18a" xlink:to="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_996f353a-83ca-4b8e-9a9e-205ffdf7d26e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3e586934-31c9-4b65-a62d-65aeb44d36ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5a8964b4-a772-45e8-9ad6-387da04eb18a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3e586934-31c9-4b65-a62d-65aeb44d36ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_f990237b-705a-420c-b461-69ea55b544cd" xlink:href="lh-20230331.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1b265d6d-b8be-4368-bf6a-ead2c53fbe40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_f990237b-705a-420c-b461-69ea55b544cd" xlink:to="loc_us-gaap_OperatingIncomeLoss_1b265d6d-b8be-4368-bf6a-ead2c53fbe40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ca86eb01-35c9-437f-9840-793a6afc04f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_f990237b-705a-420c-b461-69ea55b544cd" xlink:to="loc_us-gaap_InterestExpense_ca86eb01-35c9-437f-9840-793a6afc04f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8dda90ca-63aa-463d-af9b-1c64bb710b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_f990237b-705a-420c-b461-69ea55b544cd" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8dda90ca-63aa-463d-af9b-1c64bb710b73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_508a2747-c900-4702-8f86-57e9bc516472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_f990237b-705a-420c-b461-69ea55b544cd" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_508a2747-c900-4702-8f86-57e9bc516472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_913b36f0-30e3-4a7e-a687-8d24fddfff1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_f990237b-705a-420c-b461-69ea55b544cd" xlink:to="loc_us-gaap_InvestmentIncomeNet_913b36f0-30e3-4a7e-a687-8d24fddfff1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d510fd70-cf0c-4a54-ba94-8d0b61182da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6fed8242-ca53-4955-bf99-b91e9bc7a983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d510fd70-cf0c-4a54-ba94-8d0b61182da5" xlink:to="loc_us-gaap_Revenues_6fed8242-ca53-4955-bf99-b91e9bc7a983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_69b2793f-204c-40b4-b6b4-4913da55a6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d510fd70-cf0c-4a54-ba94-8d0b61182da5" xlink:to="loc_us-gaap_CostOfRevenue_69b2793f-204c-40b4-b6b4-4913da55a6dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_32d0ac6d-541b-400c-aef3-34414daf63be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_9ddc66f9-41a8-4dcb-af64-a34ec4a82d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_32d0ac6d-541b-400c-aef3-34414daf63be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_9ddc66f9-41a8-4dcb-af64-a34ec4a82d48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_49b6ad09-82c3-4a0b-a053-4a8b0c8821b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_32d0ac6d-541b-400c-aef3-34414daf63be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_49b6ad09-82c3-4a0b-a053-4a8b0c8821b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7076fd87-3c44-4500-a4f3-7a6a38088be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_52755f99-3352-4b9b-8763-e5e45a30c5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7076fd87-3c44-4500-a4f3-7a6a38088be3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_52755f99-3352-4b9b-8763-e5e45a30c5c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_70b8623f-4619-4ac8-a4e7-971ad1b67d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7076fd87-3c44-4500-a4f3-7a6a38088be3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_70b8623f-4619-4ac8-a4e7-971ad1b67d96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_522845ee-55e9-44a5-afd5-65eddcca2b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_e9a2fc5e-55ef-49b1-8002-351091d6fc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_522845ee-55e9-44a5-afd5-65eddcca2b74" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_e9a2fc5e-55ef-49b1-8002-351091d6fc65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_0320ae2e-00d6-4adc-97f5-67ac57f69df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_522845ee-55e9-44a5-afd5-65eddcca2b74" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_0320ae2e-00d6-4adc-97f5-67ac57f69df6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_902cb645-8051-4dc5-8151-35776f4dda60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cd9a1e3b-32f4-4426-8b1a-129e830637a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_902cb645-8051-4dc5-8151-35776f4dda60" xlink:to="loc_us-gaap_ProfitLoss_cd9a1e3b-32f4-4426-8b1a-129e830637a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_801895ff-c28b-47d5-97c0-6c41751db8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_902cb645-8051-4dc5-8151-35776f4dda60" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_801895ff-c28b-47d5-97c0-6c41751db8b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6a396d6e-cbf3-4c4d-8d4f-ccec43d08e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b7df2d3e-17ad-4553-9639-3160f40daf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6a396d6e-cbf3-4c4d-8d4f-ccec43d08e34" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b7df2d3e-17ad-4553-9639-3160f40daf6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_30bc3f65-1aa8-4616-a195-329183d37c1c" xlink:href="lh-20230331.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6a396d6e-cbf3-4c4d-8d4f-ccec43d08e34" xlink:to="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_30bc3f65-1aa8-4616-a195-329183d37c1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtherFinancingCashFlows_899732fd-3182-439a-8bdb-a2c9308ae598" xlink:href="lh-20230331.xsd#lh_OtherFinancingCashFlows"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6a396d6e-cbf3-4c4d-8d4f-ccec43d08e34" xlink:to="loc_lh_OtherFinancingCashFlows_899732fd-3182-439a-8bdb-a2c9308ae598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_b28c0a04-2615-4fb8-8c9f-4d7570fdd8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6a396d6e-cbf3-4c4d-8d4f-ccec43d08e34" xlink:to="loc_us-gaap_PaymentsOfDividends_b28c0a04-2615-4fb8-8c9f-4d7570fdd8e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_b134bd38-6081-4fff-9f9b-0c6db48eaabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6a396d6e-cbf3-4c4d-8d4f-ccec43d08e34" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_b134bd38-6081-4fff-9f9b-0c6db48eaabd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_434d4963-42dc-4f67-a474-2812f73f75b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6a396d6e-cbf3-4c4d-8d4f-ccec43d08e34" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_434d4963-42dc-4f67-a474-2812f73f75b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_396365f6-5faa-4336-a9c7-db066dd44a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_ProfitLoss_396365f6-5faa-4336-a9c7-db066dd44a6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5c3ccc0a-64de-4d11-85b6-b0718aea4cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5c3ccc0a-64de-4d11-85b6-b0718aea4cfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_85e448bd-ffd4-4118-ac54-1121f0279611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_ShareBasedCompensation_85e448bd-ffd4-4118-ac54-1121f0279611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets_1c22c295-f2ca-4920-bd7d-b986c80610cb" xlink:href="lh-20230331.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_lh_DepreciationAndAmortizationOfLeasedAssets_1c22c295-f2ca-4920-bd7d-b986c80610cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5069ac3b-2097-45b4-b73a-3e72fed83b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5069ac3b-2097-45b4-b73a-3e72fed83b2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_49473b3c-5fd8-4336-bb67-d43cd2098b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_49473b3c-5fd8-4336-bb67-d43cd2098b5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_3c4d06b7-b8f6-4467-b1b0-2f4463d05ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_3c4d06b7-b8f6-4467-b1b0-2f4463d05ed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_78dbb8df-bcbf-4ff3-bb51-a92b2220186f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_78dbb8df-bcbf-4ff3-bb51-a92b2220186f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseinUnbilledContractReceivable_d7fa8ce5-d6a8-4c5f-b5de-a25bb646bf9e" xlink:href="lh-20230331.xsd#lh_IncreaseDecreaseinUnbilledContractReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_lh_IncreaseDecreaseinUnbilledContractReceivable_d7fa8ce5-d6a8-4c5f-b5de-a25bb646bf9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_4f912c9c-1d61-4122-800f-cdc6922f6534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_4f912c9c-1d61-4122-800f-cdc6922f6534" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_75ff7808-08be-45cf-ab9c-c1c7399ea97d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_75ff7808-08be-45cf-ab9c-c1c7399ea97d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_93147fce-bb93-42c2-bb79-4dd074532ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_93147fce-bb93-42c2-bb79-4dd074532ff4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_1a0dd432-ba18-4d9e-b8ec-b631d6a52ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_1a0dd432-ba18-4d9e-b8ec-b631d6a52ad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_093d46c6-cfad-47c7-886f-f967d8c50c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3e7fa61-b570-473f-a6ae-d0e6d2555ee6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_093d46c6-cfad-47c7-886f-f967d8c50c58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_82bdb3c6-32aa-4853-80e2-459838e0c6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7095b77-f9a6-4fd5-b475-f0220029e617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_82bdb3c6-32aa-4853-80e2-459838e0c6b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7095b77-f9a6-4fd5-b475-f0220029e617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_21b9e0b8-ee94-45e5-95a3-feb83a75d598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_82bdb3c6-32aa-4853-80e2-459838e0c6b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_21b9e0b8-ee94-45e5-95a3-feb83a75d598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21f5f8d2-0312-478b-b5d1-e60e341489f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_82bdb3c6-32aa-4853-80e2-459838e0c6b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_21f5f8d2-0312-478b-b5d1-e60e341489f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_daf0206e-3487-4b58-8296-e7429de69f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_82bdb3c6-32aa-4853-80e2-459838e0c6b5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_daf0206e-3487-4b58-8296-e7429de69f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_19ca71d2-158e-495a-aacb-3e76f8c1e583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d73053d0-7b5f-4e05-9e93-7ff916af3654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_19ca71d2-158e-495a-aacb-3e76f8c1e583" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d73053d0-7b5f-4e05-9e93-7ff916af3654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a38cf18e-99f4-4214-a524-504059de71af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_19ca71d2-158e-495a-aacb-3e76f8c1e583" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a38cf18e-99f4-4214-a524-504059de71af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_6beb6f82-8fed-4202-b613-ff2620d1f878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_19ca71d2-158e-495a-aacb-3e76f8c1e583" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_6beb6f82-8fed-4202-b613-ff2620d1f878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_be2621cf-0678-41b7-a647-0ce58c084c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_19ca71d2-158e-495a-aacb-3e76f8c1e583" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_be2621cf-0678-41b7-a647-0ce58c084c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f0fc0905-3b7d-4098-8716-37a7fad8b9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_19ca71d2-158e-495a-aacb-3e76f8c1e583" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f0fc0905-3b7d-4098-8716-37a7fad8b9dc" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lh-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6517acae-4533-4b41-af86-61933115c4be,g:534dcbed-da35-4848-959c-5965c7debeab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/CoverPage" xlink:type="simple" xlink:href="lh-20230331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CoverPage" xlink:type="extended" id="i3cb2e229f2c547c6a0f48f6096c8cb59_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_b359c5b9-979d-4e8f-aacd-7c537f6a7c54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4c8d0138-93f5-487d-ad1a-b97293902858" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_b359c5b9-979d-4e8f-aacd-7c537f6a7c54" xlink:to="loc_dei_DocumentInformationTable_4c8d0138-93f5-487d-ad1a-b97293902858" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_395684a0-3bbe-4762-8593-8aa7e8d1e83b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_4c8d0138-93f5-487d-ad1a-b97293902858" xlink:to="loc_dei_DocumentInformationDocumentAxis_395684a0-3bbe-4762-8593-8aa7e8d1e83b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_395684a0-3bbe-4762-8593-8aa7e8d1e83b_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_395684a0-3bbe-4762-8593-8aa7e8d1e83b" xlink:to="loc_dei_DocumentDomain_395684a0-3bbe-4762-8593-8aa7e8d1e83b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_f2e628c2-86e0-493c-9de5-27e2773196dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_395684a0-3bbe-4762-8593-8aa7e8d1e83b" xlink:to="loc_dei_DocumentDomain_f2e628c2-86e0-493c-9de5-27e2773196dc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="extended" id="i4b1be7c67dfb48f18527db8981efe81f_CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7cf33190-5409-492d-b202-f97513d136b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_a27b3217-76dd-4fd9-a54d-95813246876d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7cf33190-5409-492d-b202-f97513d136b2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_a27b3217-76dd-4fd9-a54d-95813246876d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7cf33190-5409-492d-b202-f97513d136b2" xlink:to="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_304feb84-b139-4bd9-9774-fbc390154241" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:to="loc_srt_RestatementAxis_304feb84-b139-4bd9-9774-fbc390154241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_304feb84-b139-4bd9-9774-fbc390154241_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_304feb84-b139-4bd9-9774-fbc390154241" xlink:to="loc_srt_RestatementDomain_304feb84-b139-4bd9-9774-fbc390154241_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c36ddc89-e04c-473b-a226-7388eea5c57c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_304feb84-b139-4bd9-9774-fbc390154241" xlink:to="loc_srt_RestatementDomain_c36ddc89-e04c-473b-a226-7388eea5c57c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5562677a-e5ab-42ed-aee1-ae84e3e98d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5562677a-e5ab-42ed-aee1-ae84e3e98d10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5562677a-e5ab-42ed-aee1-ae84e3e98d10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5562677a-e5ab-42ed-aee1-ae84e3e98d10" xlink:to="loc_us-gaap_ClassOfStockDomain_5562677a-e5ab-42ed-aee1-ae84e3e98d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8538564a-5765-4f9f-8b51-8fb0c4c53608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5562677a-e5ab-42ed-aee1-ae84e3e98d10" xlink:to="loc_us-gaap_ClassOfStockDomain_8538564a-5765-4f9f-8b51-8fb0c4c53608" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended" id="if77265759ca14ff8927153948214a190_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_d412e97a-8aa0-4d37-9c30-65876c349920" xlink:href="lh-20230331.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_d412e97a-8aa0-4d37-9c30-65876c349920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0a119534-e565-4017-b548-df407fc7618b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_OperatingIncomeLoss_0a119534-e565-4017-b548-df407fc7618b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ae0da1c7-7fc6-4bea-9a05-ffb85d9c8874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_InterestExpense_ae0da1c7-7fc6-4bea-9a05-ffb85d9c8874" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dac90c0b-56bb-4333-af37-9fbe9085412e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dac90c0b-56bb-4333-af37-9fbe9085412e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_52ab9baf-1170-408d-b99d-717bcc40d7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_InvestmentIncomeNet_52ab9baf-1170-408d-b99d-717bcc40d7aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0a966bed-4e72-4595-9e1d-5f72bc7da6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0a966bed-4e72-4595-9e1d-5f72bc7da6d3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_e81bf4c5-dc73-4d1c-b43d-d172b0e9f773" xlink:href="lh-20230331.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_e81bf4c5-dc73-4d1c-b43d-d172b0e9f773" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c0048a67-db0f-4eab-b72b-ce319a51c119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c0048a67-db0f-4eab-b72b-ce319a51c119" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8f203423-b83d-40e0-a89c-e729784037e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_ProfitLoss_8f203423-b83d-40e0-a89c-e729784037e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_55f17ebc-14b3-48af-9ce2-5d3413c2d42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_55f17ebc-14b3-48af-9ce2-5d3413c2d42e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_617f0d18-06db-433d-82f7-db141f439728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_NetIncomeLoss_617f0d18-06db-433d-82f7-db141f439728" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_efbf81f9-e061-4d76-99f2-0c85b07ab5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_Revenues_efbf81f9-e061-4d76-99f2-0c85b07ab5e6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_01224699-2dd1-442d-8f08-40ed1a215819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_CostOfRevenue_01224699-2dd1-442d-8f08-40ed1a215819" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b3791fc9-6498-42b4-8945-2ef21ad7c65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_GrossProfit_b3791fc9-6498-42b4-8945-2ef21ad7c65c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b11ea52f-7215-4280-b1d1-857c4d00a070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b11ea52f-7215-4280-b1d1-857c4d00a070" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9f40cd63-fe8f-49e7-89d2-08971c7201c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9f40cd63-fe8f-49e7-89d2-08971c7201c3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5d69678b-653b-461c-8d41-965b86d36f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_AssetImpairmentCharges_5d69678b-653b-461c-8d41-965b86d36f07" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_30caae87-d814-4c61-874c-d93f09d7f4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_StatementTable_30caae87-d814-4c61-874c-d93f09d7f4b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_30caae87-d814-4c61-874c-d93f09d7f4b4" xlink:to="loc_srt_StatementScenarioAxis_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2dabacf5-4fbb-4b81-9aed-528879f1452f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2dabacf5-4fbb-4b81-9aed-528879f1452f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="extended" id="i84a7763c4b4c4cca9d769fedae7a3953_CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_35d3b499-bd97-447b-a1b6-eda9d9d1ca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0a36f159-02a0-4343-969a-7f96736b566e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_35d3b499-bd97-447b-a1b6-eda9d9d1ca9f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0a36f159-02a0-4343-969a-7f96736b566e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_546201c7-f584-4215-a547-e4f1057cf45c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_35d3b499-bd97-447b-a1b6-eda9d9d1ca9f" xlink:to="loc_us-gaap_StatementTable_546201c7-f584-4215-a547-e4f1057cf45c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_45b658fa-d35e-4b68-b0a7-8b230c72a624" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_546201c7-f584-4215-a547-e4f1057cf45c" xlink:to="loc_srt_StatementScenarioAxis_45b658fa-d35e-4b68-b0a7-8b230c72a624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_45b658fa-d35e-4b68-b0a7-8b230c72a624_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_45b658fa-d35e-4b68-b0a7-8b230c72a624" xlink:to="loc_srt_ScenarioUnspecifiedDomain_45b658fa-d35e-4b68-b0a7-8b230c72a624_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4acea676-3059-4cdd-b949-f5ffe612263d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_45b658fa-d35e-4b68-b0a7-8b230c72a624" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4acea676-3059-4cdd-b949-f5ffe612263d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="extended" id="ife5ceee4ac764b558fd08caa4a352a07_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1d7bcaf1-a4c6-4174-95cd-96cfeeb4314d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_StockholdersEquity_1d7bcaf1-a4c6-4174-95cd-96cfeeb4314d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f9759e8f-31bc-4315-8ef0-cd4d14f90d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_NetIncomeLoss_f9759e8f-31bc-4315-8ef0-cd4d14f90d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a373f99e-8944-49d7-bac2-88111a05bceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a373f99e-8944-49d7-bac2-88111a05bceb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_4ba6f1c5-64e7-4ee4-80fc-0512d08034c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_Dividends_4ba6f1c5-64e7-4ee4-80fc-0512d08034c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Issuanceofcommonstockunderemployeeplans_de9e8a95-2023-4e1c-bd29-bab71ca3cf32" xlink:href="lh-20230331.xsd#lh_Issuanceofcommonstockunderemployeeplans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_lh_Issuanceofcommonstockunderemployeeplans_de9e8a95-2023-4e1c-bd29-bab71ca3cf32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_3a38cdf4-0019-44b4-9221-5175733fcd64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_3a38cdf4-0019-44b4-9221-5175733fcd64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_69a85b81-4349-40cd-87be-ad0d705f3c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_69a85b81-4349-40cd-87be-ad0d705f3c24" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_396c73fb-bbfe-49a3-988c-45b78d7d1e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c8f78ffc-3900-4aac-9340-3bfa478ecf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c8f78ffc-3900-4aac-9340-3bfa478ecf77" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b0e53247-14c4-437a-89c2-db040d17cf64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_StatementTable_b0e53247-14c4-437a-89c2-db040d17cf64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1138edf3-c6a9-4559-b283-3f18bfa5d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b0e53247-14c4-437a-89c2-db040d17cf64" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1138edf3-c6a9-4559-b283-3f18bfa5d37d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1138edf3-c6a9-4559-b283-3f18bfa5d37d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1138edf3-c6a9-4559-b283-3f18bfa5d37d" xlink:to="loc_us-gaap_EquityComponentDomain_1138edf3-c6a9-4559-b283-3f18bfa5d37d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1138edf3-c6a9-4559-b283-3f18bfa5d37d" xlink:to="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bd13ddb8-4acf-4b83-8317-4529acccb8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:to="loc_us-gaap_CommonStockMember_bd13ddb8-4acf-4b83-8317-4529acccb8d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ffc00f9c-723c-4fc0-b903-2dd2d9403272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ffc00f9c-723c-4fc0-b903-2dd2d9403272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6f6a9676-b747-46ca-9389-fd728752ab28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:to="loc_us-gaap_RetainedEarningsMember_6f6a9676-b747-46ca-9389-fd728752ab28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c35752e4-4e6e-4a70-b2f3-368ebad785c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c35752e4-4e6e-4a70-b2f3-368ebad785c5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended" id="ifb8224a084d24465b479f5cf80772a68_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_44b04036-9304-40f3-96a0-6aca33045f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47b5b1ad-5d66-43e1-bb07-39d366da1852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_44b04036-9304-40f3-96a0-6aca33045f3b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47b5b1ad-5d66-43e1-bb07-39d366da1852" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ab49113-33fb-45e8-8855-3ff46853b210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_44b04036-9304-40f3-96a0-6aca33045f3b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ab49113-33fb-45e8-8855-3ff46853b210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6b4bf57-5861-4dbe-bab3-c75b9ed20934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_44b04036-9304-40f3-96a0-6aca33045f3b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6b4bf57-5861-4dbe-bab3-c75b9ed20934" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f8561515-e752-4f4a-9f91-46833d63bf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6b4bf57-5861-4dbe-bab3-c75b9ed20934" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f8561515-e752-4f4a-9f91-46833d63bf05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f8561515-e752-4f4a-9f91-46833d63bf05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f8561515-e752-4f4a-9f91-46833d63bf05" xlink:to="loc_us-gaap_EquityComponentDomain_f8561515-e752-4f4a-9f91-46833d63bf05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f055d006-aede-45ed-bef5-61078437df18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f8561515-e752-4f4a-9f91-46833d63bf05" xlink:to="loc_us-gaap_EquityComponentDomain_f055d006-aede-45ed-bef5-61078437df18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_15f2da1d-dbb4-4b6a-b2c0-9d809d490146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f055d006-aede-45ed-bef5-61078437df18" xlink:to="loc_us-gaap_CommonStockMember_15f2da1d-dbb4-4b6a-b2c0-9d809d490146" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bbd05276-cf32-4b57-9e30-3484ff02775e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f055d006-aede-45ed-bef5-61078437df18" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bbd05276-cf32-4b57-9e30-3484ff02775e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="simple" xlink:href="lh-20230331.xsd#SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="extended" id="i25d47d97f03f4d33a7bb8f3da3599fd9_SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8a0bd857-e872-4580-8368-47f577ab7d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8a0bd857-e872-4580-8368-47f577ab7d3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid_c3b2be57-9c4b-4030-a9eb-da96da5ee656" xlink:href="lh-20230331.xsd#lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid_c3b2be57-9c4b-4030-a9eb-da96da5ee656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_82c098b7-f387-47d6-8eb3-5c13b2297503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_82c098b7-f387-47d6-8eb3-5c13b2297503" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3f18add6-004a-4dec-a176-b9d2c61bc10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3f18add6-004a-4dec-a176-b9d2c61bc10a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable_706f5a77-127e-4250-90cb-a85953b7e5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_us-gaap_DebtConversionTable_706f5a77-127e-4250-90cb-a85953b7e5a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_68df9d93-d462-4267-b4ba-9cad740cc06f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtConversionTable_706f5a77-127e-4250-90cb-a85953b7e5a6" xlink:to="loc_us-gaap_DebtInstrumentAxis_68df9d93-d462-4267-b4ba-9cad740cc06f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_68df9d93-d462-4267-b4ba-9cad740cc06f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_68df9d93-d462-4267-b4ba-9cad740cc06f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_68df9d93-d462-4267-b4ba-9cad740cc06f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8a49146-b58e-45d4-b170-98a9cb39f4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_68df9d93-d462-4267-b4ba-9cad740cc06f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8a49146-b58e-45d4-b170-98a9cb39f4a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="lh-20230331.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="extended" id="i7d0afb625cf04c58b77259d43d424f1b_PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31240de9-c120-4a10-bc72-e1b9d24ea96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e2632479-f516-4ebc-9fb6-d54e8977ce07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31240de9-c120-4a10-bc72-e1b9d24ea96a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e2632479-f516-4ebc-9fb6-d54e8977ce07" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e77f1065-0b1e-4e59-86d6-4f405eedd048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e2632479-f516-4ebc-9fb6-d54e8977ce07" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e77f1065-0b1e-4e59-86d6-4f405eedd048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e77f1065-0b1e-4e59-86d6-4f405eedd048_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e77f1065-0b1e-4e59-86d6-4f405eedd048" xlink:to="loc_us-gaap_EquityComponentDomain_e77f1065-0b1e-4e59-86d6-4f405eedd048_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6b79622e-0211-4ac9-abd7-e7e1f5e4fc86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e77f1065-0b1e-4e59-86d6-4f405eedd048" xlink:to="loc_us-gaap_EquityComponentDomain_6b79622e-0211-4ac9-abd7-e7e1f5e4fc86" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="extended" id="i30b259243068449f9e0d498bec9cdc18_BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_55f95a07-b9fc-4bca-a611-0fc00d74911c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_3d9fc73c-4cc0-4bed-a098-cee95744de92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_55f95a07-b9fc-4bca-a611-0fc00d74911c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_3d9fc73c-4cc0-4bed-a098-cee95744de92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e0404960-b641-49d3-bd2d-b5c92eabc1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_55f95a07-b9fc-4bca-a611-0fc00d74911c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e0404960-b641-49d3-bd2d-b5c92eabc1f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_13629900-80c0-4e2a-bfc3-ed15e8ece58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e0404960-b641-49d3-bd2d-b5c92eabc1f0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_13629900-80c0-4e2a-bfc3-ed15e8ece58b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_13629900-80c0-4e2a-bfc3-ed15e8ece58b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13629900-80c0-4e2a-bfc3-ed15e8ece58b" xlink:to="loc_us-gaap_SegmentDomain_13629900-80c0-4e2a-bfc3-ed15e8ece58b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d7710c4-256e-4e8f-af25-3d444b750f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13629900-80c0-4e2a-bfc3-ed15e8ece58b" xlink:to="loc_us-gaap_SegmentDomain_6d7710c4-256e-4e8f-af25-3d444b750f83" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUETables" xlink:type="simple" xlink:href="lh-20230331.xsd#REVENUETables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/REVENUETables" xlink:type="extended" id="i58ad537f9b3343f8a0f49ce16b43b3bb_REVENUETables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_ac120260-881c-41cd-9007-6d609eaf010f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_ac120260-881c-41cd-9007-6d609eaf010f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9b563fb6-5664-488a-beb3-cec1d1f8b51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9b563fb6-5664-488a-beb3-cec1d1f8b51f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1d732dff-f9a9-41bb-b38c-ae8123be475b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1d732dff-f9a9-41bb-b38c-ae8123be475b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostTableTextBlock_027bd788-7075-4a14-99d1-d82ba0b97c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_CapitalizedContractCostTableTextBlock_027bd788-7075-4a14-99d1-d82ba0b97c31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_84e81e23-9c96-4ff6-aae0-560cbdae595d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_84e81e23-9c96-4ff6-aae0-560cbdae595d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_84e81e23-9c96-4ff6-aae0-560cbdae595d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_84e81e23-9c96-4ff6-aae0-560cbdae595d" xlink:to="loc_us-gaap_SegmentDomain_84e81e23-9c96-4ff6-aae0-560cbdae595d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f549173c-6a17-4ce6-a2e4-81cdfe787d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_84e81e23-9c96-4ff6-aae0-560cbdae595d" xlink:to="loc_us-gaap_SegmentDomain_f549173c-6a17-4ce6-a2e4-81cdfe787d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_7cbe4fd5-eb9e-4d23-a401-033fc65f1637" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f549173c-6a17-4ce6-a2e4-81cdfe787d35" xlink:to="loc_lh_CovanceDrugDevelopmentMember_7cbe4fd5-eb9e-4d23-a401-033fc65f1637" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_994d2987-8800-4bec-b4e4-1be9fbf27896" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f549173c-6a17-4ce6-a2e4-81cdfe787d35" xlink:to="loc_lh_LabCorpDiagnosticsMember_994d2987-8800-4bec-b4e4-1be9fbf27896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_272f6d82-6e11-43f5-a97d-862037057ce0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:to="loc_srt_StatementGeographicalAxis_272f6d82-6e11-43f5-a97d-862037057ce0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_272f6d82-6e11-43f5-a97d-862037057ce0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_272f6d82-6e11-43f5-a97d-862037057ce0" xlink:to="loc_srt_SegmentGeographicalDomain_272f6d82-6e11-43f5-a97d-862037057ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8c34f259-35f6-4854-b866-bce8dc7e66a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_272f6d82-6e11-43f5-a97d-862037057ce0" xlink:to="loc_srt_SegmentGeographicalDomain_8c34f259-35f6-4854-b866-bce8dc7e66a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_f2276865-1e7b-4287-8f83-823d3b348ac7" xlink:href="lh-20230331.xsd#lh_OthercountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8c34f259-35f6-4854-b866-bce8dc7e66a4" xlink:to="loc_lh_OthercountriesMember_f2276865-1e7b-4287-8f83-823d3b348ac7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_5a7958ee-c75c-4bab-9337-b2ce9ff2f992" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8c34f259-35f6-4854-b866-bce8dc7e66a4" xlink:to="loc_srt_EuropeMember_5a7958ee-c75c-4bab-9337-b2ce9ff2f992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_86cbe630-45f6-4d60-8f0e-09473fa406b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_86cbe630-45f6-4d60-8f0e-09473fa406b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86cbe630-45f6-4d60-8f0e-09473fa406b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_86cbe630-45f6-4d60-8f0e-09473fa406b9" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_86cbe630-45f6-4d60-8f0e-09473fa406b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_86cbe630-45f6-4d60-8f0e-09473fa406b9" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_0502b984-c36b-47e2-8857-94c80344ec44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfPayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_us-gaap_SelfPayMember_0502b984-c36b-47e2-8857-94c80344ec44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_35995954-09fc-4498-b3ea-c15b28f37fb7" xlink:href="lh-20230331.xsd#lh_ClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_lh_ClientMember_35995954-09fc-4498-b3ea-c15b28f37fb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_e2deecc3-74fd-4b00-947b-b2a889717adf" xlink:href="lh-20230331.xsd#lh_MedicareandMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_lh_MedicareandMedicaidMember_e2deecc3-74fd-4b00-947b-b2a889717adf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_4909d2be-5c5a-456c-8e02-ff5ff9e75dea" xlink:href="lh-20230331.xsd#lh_ThirdpartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_lh_ThirdpartyMember_4909d2be-5c5a-456c-8e02-ff5ff9e75dea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_745f663a-ab08-4619-b0e2-a94b2b3e1662" xlink:href="lh-20230331.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_745f663a-ab08-4619-b0e2-a94b2b3e1662" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="extended" id="i893e44e9206c4a098d070d07ff706271_BASISOFFINANCIALSTATEMENTPRESENTATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1785656b-9fe7-42d8-95fe-2ed1d26d20bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_AssetImpairmentCharges_1785656b-9fe7-42d8-95fe-2ed1d26d20bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_44158e37-9a81-429d-b380-f9766b5d0a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_Revenues_44158e37-9a81-429d-b380-f9766b5d0a69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c143e705-43cb-4d28-9bf3-89449e92bad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c143e705-43cb-4d28-9bf3-89449e92bad9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_ed714864-6522-48ac-9910-d5e3948f995e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_ed714864-6522-48ac-9910-d5e3948f995e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_b0420257-1335-4168-b492-78048c18a3de" xlink:href="lh-20230331.xsd#lh_PercentofRevenueContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_lh_PercentofRevenueContributed_b0420257-1335-4168-b492-78048c18a3de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e361542e-d535-4045-9b84-96789cf240ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e361542e-d535-4045-9b84-96789cf240ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bb45ae1f-9686-4c93-be62-a0a874a049a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_ProfitLoss_bb45ae1f-9686-4c93-be62-a0a874a049a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1307c006-c5fa-4383-add5-3b5487a3325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_NetIncomeLoss_1307c006-c5fa-4383-add5-3b5487a3325e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8c49214e-78b7-4c71-9884-633101d31d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_StockholdersEquity_8c49214e-78b7-4c71-9884-633101d31d45" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_34ece523-0b6e-4d3f-ad1e-6d5a0720304e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_34ece523-0b6e-4d3f-ad1e-6d5a0720304e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_1e8a53d3-bfc5-4e3e-9f5c-e3fd4855f645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_1e8a53d3-bfc5-4e3e-9f5c-e3fd4855f645" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_4f15a50b-8b19-426a-a591-0d8164a41812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_4f15a50b-8b19-426a-a591-0d8164a41812" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_5cc401c8-1cee-49f4-bcb9-db551c911329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_5cc401c8-1cee-49f4-bcb9-db551c911329" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_94817937-27b5-49be-bc1a-00a66257e099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_94817937-27b5-49be-bc1a-00a66257e099" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c66bf49b-0934-4080-b553-e6e8585925e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c66bf49b-0934-4080-b553-e6e8585925e7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7ccf17be-f67c-47b7-9d87-87b2ba9c500d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7ccf17be-f67c-47b7-9d87-87b2ba9c500d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7ccf17be-f67c-47b7-9d87-87b2ba9c500d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7ccf17be-f67c-47b7-9d87-87b2ba9c500d" xlink:to="loc_us-gaap_EquityComponentDomain_7ccf17be-f67c-47b7-9d87-87b2ba9c500d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a2ca1534-c965-4acb-aef7-4f83d4b065af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7ccf17be-f67c-47b7-9d87-87b2ba9c500d" xlink:to="loc_us-gaap_EquityComponentDomain_a2ca1534-c965-4acb-aef7-4f83d4b065af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eb2d8015-1c74-4d6a-a22d-13ff2b8704b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a2ca1534-c965-4acb-aef7-4f83d4b065af" xlink:to="loc_us-gaap_RetainedEarningsMember_eb2d8015-1c74-4d6a-a22d-13ff2b8704b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationAxis_5cf428ba-1426-449b-8c09-7bd10cc08bdd" xlink:href="lh-20230331.xsd#lh_CashFlowLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_lh_CashFlowLocationAxis_5cf428ba-1426-449b-8c09-7bd10cc08bdd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationDomain_5cf428ba-1426-449b-8c09-7bd10cc08bdd_default" xlink:href="lh-20230331.xsd#lh_CashFlowLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_CashFlowLocationAxis_5cf428ba-1426-449b-8c09-7bd10cc08bdd" xlink:to="loc_lh_CashFlowLocationDomain_5cf428ba-1426-449b-8c09-7bd10cc08bdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationDomain_26c70510-6867-42c3-b678-7d6e9725dfb1" xlink:href="lh-20230331.xsd#lh_CashFlowLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_CashFlowLocationAxis_5cf428ba-1426-449b-8c09-7bd10cc08bdd" xlink:to="loc_lh_CashFlowLocationDomain_26c70510-6867-42c3-b678-7d6e9725dfb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8235e062-b11c-4ad0-917d-fc29940c25e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8235e062-b11c-4ad0-917d-fc29940c25e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8235e062-b11c-4ad0-917d-fc29940c25e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8235e062-b11c-4ad0-917d-fc29940c25e6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8235e062-b11c-4ad0-917d-fc29940c25e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0745ae3d-192e-41b0-9518-ab6d94cea2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8235e062-b11c-4ad0-917d-fc29940c25e6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0745ae3d-192e-41b0-9518-ab6d94cea2fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5619c43e-adc9-4d4c-a9b7-48b390ca0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5619c43e-adc9-4d4c-a9b7-48b390ca0245" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5619c43e-adc9-4d4c-a9b7-48b390ca0245_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5619c43e-adc9-4d4c-a9b7-48b390ca0245" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5619c43e-adc9-4d4c-a9b7-48b390ca0245_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_abd7727c-286b-4e07-a20f-3cd90b3835fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5619c43e-adc9-4d4c-a9b7-48b390ca0245" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_abd7727c-286b-4e07-a20f-3cd90b3835fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e3ef33ff-46c5-41c0-a212-85c9e807aa74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e3ef33ff-46c5-41c0-a212-85c9e807aa74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e3ef33ff-46c5-41c0-a212-85c9e807aa74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e3ef33ff-46c5-41c0-a212-85c9e807aa74" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e3ef33ff-46c5-41c0-a212-85c9e807aa74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83ea0068-ff19-4cde-9182-1f7b0d43b68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e3ef33ff-46c5-41c0-a212-85c9e807aa74" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83ea0068-ff19-4cde-9182-1f7b0d43b68f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_90183b45-f219-42e6-8764-49ea14800677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_90183b45-f219-42e6-8764-49ea14800677" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_90183b45-f219-42e6-8764-49ea14800677_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_90183b45-f219-42e6-8764-49ea14800677" xlink:to="loc_us-gaap_SegmentDomain_90183b45-f219-42e6-8764-49ea14800677_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a18464e1-642d-4c60-be8e-14587b71c0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_90183b45-f219-42e6-8764-49ea14800677" xlink:to="loc_us-gaap_SegmentDomain_a18464e1-642d-4c60-be8e-14587b71c0ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_532b5fbf-ffd0-4345-90b7-6c969d92e08a" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a18464e1-642d-4c60-be8e-14587b71c0ff" xlink:to="loc_lh_LabCorpDiagnosticsMember_532b5fbf-ffd0-4345-90b7-6c969d92e08a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_db1c79f9-33cb-45aa-ac3c-4ead30a87a60" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a18464e1-642d-4c60-be8e-14587b71c0ff" xlink:to="loc_lh_CovanceDrugDevelopmentMember_db1c79f9-33cb-45aa-ac3c-4ead30a87a60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f7037e38-3f4f-4aaa-8620-79d3b12f83fd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f7037e38-3f4f-4aaa-8620-79d3b12f83fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f7037e38-3f4f-4aaa-8620-79d3b12f83fd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f7037e38-3f4f-4aaa-8620-79d3b12f83fd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f7037e38-3f4f-4aaa-8620-79d3b12f83fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d625e71c-a176-4976-940a-b88ccd84c451" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f7037e38-3f4f-4aaa-8620-79d3b12f83fd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d625e71c-a176-4976-940a-b88ccd84c451" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#NONCONTROLLINGINTERESTPUTSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="extended" id="i5fe98940aafd47ee9c9ce64b1298ab49_NONCONTROLLINGINTERESTPUTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_15cefbc4-ac3c-41c0-bb12-644e174eb7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_a2e5c093-4038-4645-a54f-08c216cc1cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_15cefbc4-ac3c-41c0-bb12-644e174eb7ad" xlink:to="loc_us-gaap_MinorityInterestTable_a2e5c093-4038-4645-a54f-08c216cc1cec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0bfb79fd-2116-4eae-b806-9f9d27a7b13c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_a2e5c093-4038-4645-a54f-08c216cc1cec" xlink:to="loc_dei_LegalEntityAxis_0bfb79fd-2116-4eae-b806-9f9d27a7b13c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0bfb79fd-2116-4eae-b806-9f9d27a7b13c_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_0bfb79fd-2116-4eae-b806-9f9d27a7b13c" xlink:to="loc_dei_EntityDomain_0bfb79fd-2116-4eae-b806-9f9d27a7b13c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_be7644e4-8dac-4a56-8785-aac0b83dc90c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_0bfb79fd-2116-4eae-b806-9f9d27a7b13c" xlink:to="loc_dei_EntityDomain_be7644e4-8dac-4a56-8785-aac0b83dc90c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="i683f1a169cc2483eb1ad1091ea5a76b2_GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9c73a9f3-f7f2-4473-a331-31b015deace1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9c73a9f3-f7f2-4473-a331-31b015deace1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_23b9431b-ab2e-41aa-83c5-e32aca1f1416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_23b9431b-ab2e-41aa-83c5-e32aca1f1416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5e45f664-ed86-444d-8be2-3f41595ab021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_Goodwill_5e45f664-ed86-444d-8be2-3f41595ab021" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a414a119-6ae2-480a-a975-d6a250f93202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a414a119-6ae2-480a-a975-d6a250f93202" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0fd75971-7245-4300-92a4-d685d8052b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3abe27a6-248d-42e6-a07d-f96f648b979e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3abe27a6-248d-42e6-a07d-f96f648b979e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ac59161c-695f-4ee1-8804-d32d91b4f1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ac59161c-695f-4ee1-8804-d32d91b4f1a2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4cee27e0-0a3c-4abf-ac57-337a9b80a561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4cee27e0-0a3c-4abf-ac57-337a9b80a561" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1adf1961-ec65-4323-875b-a14838c05662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1adf1961-ec65-4323-875b-a14838c05662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1adf1961-ec65-4323-875b-a14838c05662_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1adf1961-ec65-4323-875b-a14838c05662" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1adf1961-ec65-4323-875b-a14838c05662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12c41bfa-ed25-42af-961c-b2566e1a3897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1adf1961-ec65-4323-875b-a14838c05662" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12c41bfa-ed25-42af-961c-b2566e1a3897" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9f48d98a-07a8-4920-a564-48fe17748f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12c41bfa-ed25-42af-961c-b2566e1a3897" xlink:to="loc_us-gaap_TradeNamesMember_9f48d98a-07a8-4920-a564-48fe17748f65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_1317fd81-ac44-4831-9d80-1426cf1fe44f" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_1317fd81-ac44-4831-9d80-1426cf1fe44f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_1317fd81-ac44-4831-9d80-1426cf1fe44f_default" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_1317fd81-ac44-4831-9d80-1426cf1fe44f" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_1317fd81-ac44-4831-9d80-1426cf1fe44f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_1317fd81-ac44-4831-9d80-1426cf1fe44f" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c7141c0e-0bb8-4df3-96a1-0dc1cacd9634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c7141c0e-0bb8-4df3-96a1-0dc1cacd9634" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_2496a275-3ecb-4f08-bc72-a4bb1ebee8f1" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_2496a275-3ecb-4f08-bc72-a4bb1ebee8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_583fe05b-80ad-4c09-830c-3fcb44a0971f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_583fe05b-80ad-4c09-830c-3fcb44a0971f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9f391fb3-91e1-4216-887f-c47f914ab32c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_TradeNamesMember_9f391fb3-91e1-4216-887f-c47f914ab32c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_98cad622-eda7-4c2a-ac86-d69a2ba4dbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_UseRightsMember_98cad622-eda7-4c2a-ac86-d69a2ba4dbc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_8a861bd9-f4f2-493f-8681-03f8f57156b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_LicensingAgreementsMember_8a861bd9-f4f2-493f-8681-03f8f57156b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ca47cc43-0970-48f4-9d0a-f7671410bc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ca47cc43-0970-48f4-9d0a-f7671410bc8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ca47cc43-0970-48f4-9d0a-f7671410bc8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ca47cc43-0970-48f4-9d0a-f7671410bc8f" xlink:to="loc_us-gaap_SegmentDomain_ca47cc43-0970-48f4-9d0a-f7671410bc8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3764395-24bb-4087-a1da-8022ff9360f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ca47cc43-0970-48f4-9d0a-f7671410bc8f" xlink:to="loc_us-gaap_SegmentDomain_c3764395-24bb-4087-a1da-8022ff9360f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_5c0c2680-f8e6-4626-9e31-c4967421cee3" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3764395-24bb-4087-a1da-8022ff9360f6" xlink:to="loc_lh_LabCorpDiagnosticsMember_5c0c2680-f8e6-4626-9e31-c4967421cee3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_2bd12b0e-b53e-4d96-9302-fd1ce34063ec" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3764395-24bb-4087-a1da-8022ff9360f6" xlink:to="loc_lh_CovanceDrugDevelopmentMember_2bd12b0e-b53e-4d96-9302-fd1ce34063ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_bad68a8b-18cb-4276-96e6-af52eab8db8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_bad68a8b-18cb-4276-96e6-af52eab8db8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_bad68a8b-18cb-4276-96e6-af52eab8db8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_bad68a8b-18cb-4276-96e6-af52eab8db8e" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_bad68a8b-18cb-4276-96e6-af52eab8db8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_8d756125-97e2-41e7-be71-184d883d4ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_bad68a8b-18cb-4276-96e6-af52eab8db8e" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_8d756125-97e2-41e7-be71-184d883d4ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_be4cfa99-5ad3-4f39-8e15-a7aae37c6cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_8d756125-97e2-41e7-be71-184d883d4ca7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_be4cfa99-5ad3-4f39-8e15-a7aae37c6cd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_52e8a5eb-4efd-4f9c-9e47-31e583fb80fb" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_8d756125-97e2-41e7-be71-184d883d4ca7" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_52e8a5eb-4efd-4f9c-9e47-31e583fb80fb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="extended" id="i0675fe0dbec04754995ca015fd70fe87_GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_62ff8bbf-164d-4bea-961d-1fc16736b82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_62ff8bbf-164d-4bea-961d-1fc16736b82b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8335016e-f12a-42a4-9f79-4e3c2539176c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8335016e-f12a-42a4-9f79-4e3c2539176c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a02810cc-5c52-4746-b464-47a9a319c47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a02810cc-5c52-4746-b464-47a9a319c47c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1364735-39d2-44a8-b52d-ccdfca383532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1364735-39d2-44a8-b52d-ccdfca383532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f1364735-39d2-44a8-b52d-ccdfca383532_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1364735-39d2-44a8-b52d-ccdfca383532" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f1364735-39d2-44a8-b52d-ccdfca383532_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_074f33e8-226f-4558-bfff-66aea83b92a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1364735-39d2-44a8-b52d-ccdfca383532" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_074f33e8-226f-4558-bfff-66aea83b92a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df_default" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_07e16831-fad3-4018-ab7f-43c73f7ce6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_07e16831-fad3-4018-ab7f-43c73f7ce6cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_8f96c120-5277-4a67-8c09-52e5d717a03e" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_8f96c120-5277-4a67-8c09-52e5d717a03e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_dff9dc1f-19f2-41b4-8b7a-9cdb72253bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_dff9dc1f-19f2-41b4-8b7a-9cdb72253bfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_fc1009a5-ea72-42f3-bc82-fd6252e9fa04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_TradeNamesMember_fc1009a5-ea72-42f3-bc82-fd6252e9fa04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_d67df30b-db9a-45c6-9c88-20340490300c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_UseRightsMember_d67df30b-db9a-45c6-9c88-20340490300c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_8cb3cb97-e979-4ce9-8877-fa14d09635e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_LicensingAgreementsMember_8cb3cb97-e979-4ce9-8877-fa14d09635e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InProcessRAAndMediaMember_cd23b870-c993-4767-9b62-9f1b9dcc0a84" xlink:href="lh-20230331.xsd#lh_InProcessRAAndMediaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_lh_InProcessRAAndMediaMember_cd23b870-c993-4767-9b62-9f1b9dcc0a84" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended" id="ibbae049db5524358bcce7d1502a737b1_GOODWILLANDINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c64192b0-2693-4c34-a57d-af64be9c9fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c64192b0-2693-4c34-a57d-af64be9c9fdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1d184ce7-b81a-4b0b-9243-920a38941487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_Goodwill_1d184ce7-b81a-4b0b-9243-920a38941487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3542f782-87a2-4e83-bd88-d31fd84c840f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3542f782-87a2-4e83-bd88-d31fd84c840f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_557e5f01-6c37-4c48-be9c-3af186169c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_557e5f01-6c37-4c48-be9c-3af186169c9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_dd677573-0957-4d53-a1bc-edde4b5446b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_dd677573-0957-4d53-a1bc-edde4b5446b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1b1ec7a6-9a5f-4f2f-87f2-7f6cddeb0491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1b1ec7a6-9a5f-4f2f-87f2-7f6cddeb0491" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c41d2b29-9354-49d1-8ed3-88db43d39928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c41d2b29-9354-49d1-8ed3-88db43d39928" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_29165858-f39a-4328-a3f6-de0040c54e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_29165858-f39a-4328-a3f6-de0040c54e5d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9e2700f4-109f-43f0-b130-776337b4edc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9e2700f4-109f-43f0-b130-776337b4edc5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9a99d701-5151-4cbd-8e04-d85f9f2264b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9a99d701-5151-4cbd-8e04-d85f9f2264b0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_4aedbecd-a8b9-41fc-937a-bd33f2e9e5a9" xlink:href="lh-20230331.xsd#lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_4aedbecd-a8b9-41fc-937a-bd33f2e9e5a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7157a2a0-f11b-426e-9d7f-2165b671f913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7157a2a0-f11b-426e-9d7f-2165b671f913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7157a2a0-f11b-426e-9d7f-2165b671f913_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7157a2a0-f11b-426e-9d7f-2165b671f913" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7157a2a0-f11b-426e-9d7f-2165b671f913_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7157a2a0-f11b-426e-9d7f-2165b671f913" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_26fcfff7-7437-4f3f-988f-964d611f1815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_TradeNamesMember_26fcfff7-7437-4f3f-988f-964d611f1815" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_974705f1-5d1e-4f33-ba1e-8c8a0568c7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_974705f1-5d1e-4f33-ba1e-8c8a0568c7c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_21cebe76-485d-4a8d-af99-245d146888e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_UseRightsMember_21cebe76-485d-4a8d-af99-245d146888e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_e913d90a-4bcc-484e-8ede-5b2f4e06eb13" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_e913d90a-4bcc-484e-8ede-5b2f4e06eb13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_ad42663d-7b79-43ca-8c3f-26516d231dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_ad42663d-7b79-43ca-8c3f-26516d231dcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_183d7e00-d55d-4b47-a455-d2836351c1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_LicensingAgreementsMember_183d7e00-d55d-4b47-a455-d2836351c1af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e23b9bfa-1d3c-48b2-920b-196f526c485f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e23b9bfa-1d3c-48b2-920b-196f526c485f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e23b9bfa-1d3c-48b2-920b-196f526c485f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e23b9bfa-1d3c-48b2-920b-196f526c485f" xlink:to="loc_us-gaap_SegmentDomain_e23b9bfa-1d3c-48b2-920b-196f526c485f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ecb3039d-8dba-4829-bb84-9257b8d65bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e23b9bfa-1d3c-48b2-920b-196f526c485f" xlink:to="loc_us-gaap_SegmentDomain_ecb3039d-8dba-4829-bb84-9257b8d65bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_5c73fe54-a017-4951-ab4d-a7bcbf2ff1ae" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ecb3039d-8dba-4829-bb84-9257b8d65bf8" xlink:to="loc_lh_LabCorpDiagnosticsMember_5c73fe54-a017-4951-ab4d-a7bcbf2ff1ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_ff3cfb96-7679-4bf9-a6be-fca18e100a03" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ecb3039d-8dba-4829-bb84-9257b8d65bf8" xlink:to="loc_lh_CovanceDrugDevelopmentMember_ff3cfb96-7679-4bf9-a6be-fca18e100a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9bcf996a-f921-43f3-9300-c6bb90405cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9bcf996a-f921-43f3-9300-c6bb90405cb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9bcf996a-f921-43f3-9300-c6bb90405cb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9bcf996a-f921-43f3-9300-c6bb90405cb9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9bcf996a-f921-43f3-9300-c6bb90405cb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c31aed30-304d-4e9f-8534-12fb7ffc8f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9bcf996a-f921-43f3-9300-c6bb90405cb9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c31aed30-304d-4e9f-8534-12fb7ffc8f4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a604ca36-111d-401b-a173-c2917155b1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c31aed30-304d-4e9f-8534-12fb7ffc8f4d" xlink:to="loc_us-gaap_TradeNamesMember_a604ca36-111d-401b-a173-c2917155b1db" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="extended" id="i644a53319fc4485d92091b50853d60ff_DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentDebtExcludingFinanceLeaseLiability_870d79e7-e1eb-4821-84bd-5aa69d3b2ab7" xlink:href="lh-20230331.xsd#lh_CurrentDebtExcludingFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_lh_CurrentDebtExcludingFinanceLeaseLiability_870d79e7-e1eb-4821-84bd-5aa69d3b2ab7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_d47ad360-102c-448e-b233-531fd6c522fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_us-gaap_NotesPayableCurrent_d47ad360-102c-448e-b233-531fd6c522fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2025_b65f1d1f-8ff9-43b6-aeab-fd71a6c17a37" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2025"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_lh_A360SeniorNotesDue2025_b65f1d1f-8ff9-43b6-aeab-fd71a6c17a37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A400SeniorNotesDue2023_6e05f865-bb9d-45a7-a0ce-22ee87e66661" xlink:href="lh-20230331.xsd#lh_A400SeniorNotesDue2023"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_lh_A400SeniorNotesDue2023_6e05f865-bb9d-45a7-a0ce-22ee87e66661" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_7622153e-4153-4e16-948d-bee80c1d2297" xlink:href="lh-20230331.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_lh_Shorttermdebtissuancecosts_7622153e-4153-4e16-948d-bee80c1d2297" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6c11345b-151d-49c7-8078-de00e1da4e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6c11345b-151d-49c7-8078-de00e1da4e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c11345b-151d-49c7-8078-de00e1da4e02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c11345b-151d-49c7-8078-de00e1da4e02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c11345b-151d-49c7-8078-de00e1da4e02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc1d6ae9-eb93-4881-864c-795b8b0db259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c11345b-151d-49c7-8078-de00e1da4e02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc1d6ae9-eb93-4881-864c-795b8b0db259" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2966a575-8db0-420f-8184-034aaf47943a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_CreditFacilityAxis_2966a575-8db0-420f-8184-034aaf47943a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2966a575-8db0-420f-8184-034aaf47943a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2966a575-8db0-420f-8184-034aaf47943a" xlink:to="loc_us-gaap_CreditFacilityDomain_2966a575-8db0-420f-8184-034aaf47943a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a524dd61-c753-47c2-9d72-03377ba2f12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2966a575-8db0-420f-8184-034aaf47943a" xlink:to="loc_us-gaap_CreditFacilityDomain_a524dd61-c753-47c2-9d72-03377ba2f12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_9ec57f49-a11e-4eb6-9d39-a050472ceb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_9ec57f49-a11e-4eb6-9d39-a050472ceb97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_9ec57f49-a11e-4eb6-9d39-a050472ceb97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9ec57f49-a11e-4eb6-9d39-a050472ceb97" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_9ec57f49-a11e-4eb6-9d39-a050472ceb97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6adb0cab-7348-407f-8daf-143b05fdb306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9ec57f49-a11e-4eb6-9d39-a050472ceb97" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6adb0cab-7348-407f-8daf-143b05fdb306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80605065-d49c-4de2-85c6-c238b29d37cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80605065-d49c-4de2-85c6-c238b29d37cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_80605065-d49c-4de2-85c6-c238b29d37cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80605065-d49c-4de2-85c6-c238b29d37cf" xlink:to="loc_us-gaap_HedgingRelationshipDomain_80605065-d49c-4de2-85c6-c238b29d37cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5affba9a-b7e5-4d6b-bcfd-71ac973c6b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80605065-d49c-4de2-85c6-c238b29d37cf" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5affba9a-b7e5-4d6b-bcfd-71ac973c6b77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_909bf410-850e-4f68-ad90-9149df95ea1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5affba9a-b7e5-4d6b-bcfd-71ac973c6b77" xlink:to="loc_us-gaap_InterestRateSwapMember_909bf410-850e-4f68-ad90-9149df95ea1c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBTLongtermdebtDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="extended" id="i76c95243602348ceb8c4f8f528cb48de_DEBTLongtermdebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A400SeniorNotesDue2023_129013b8-2f1e-492f-bd36-db653d27d1fe" xlink:href="lh-20230331.xsd#lh_A400SeniorNotesDue2023"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A400SeniorNotesDue2023_129013b8-2f1e-492f-bd36-db653d27d1fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A325SeniorNotesDue2024_b1910a87-5713-439f-9a25-88625eb0d400" xlink:href="lh-20230331.xsd#lh_A325SeniorNotesDue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A325SeniorNotesDue2024_b1910a87-5713-439f-9a25-88625eb0d400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_ed30d5f8-95f1-451f-9d1c-eb54dc6efd16" xlink:href="lh-20230331.xsd#lh_A2.30seniornotesdue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A2.30seniornotesdue2024_ed30d5f8-95f1-451f-9d1c-eb54dc6efd16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2025_5197b2fe-d4ed-4498-9a72-9bbf35b9397b" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2025"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A360SeniorNotesDue2025_5197b2fe-d4ed-4498-9a72-9bbf35b9397b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026_c4f41797-8dae-45e0-b80f-20e073c78f0b" xlink:href="lh-20230331.xsd#lh_A155SeniorNotesDue2026"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A155SeniorNotesDue2026_c4f41797-8dae-45e0-b80f-20e073c78f0b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2027_150bd7bc-d876-4748-bb26-a212925caa1d" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2027"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A360SeniorNotesDue2027_150bd7bc-d876-4748-bb26-a212925caa1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_9b921489-1d16-4d80-9367-60b0eb1e79b4" xlink:href="lh-20230331.xsd#lh_A2.95seniornotesdue2029"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A2.95seniornotesdue2029_9b921489-1d16-4d80-9367-60b0eb1e79b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031_fdf975de-10d4-49e8-8fa5-287c2cb7ba63" xlink:href="lh-20230331.xsd#lh_A270SeniorNotesDue2031"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A270SeniorNotesDue2031_fdf975de-10d4-49e8-8fa5-287c2cb7ba63" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A470SeniorNotesDue2045_8624eed5-a67b-470c-b5f9-c3077614d1c6" xlink:href="lh-20230331.xsd#lh_A470SeniorNotesDue2045"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A470SeniorNotesDue2045_8624eed5-a67b-470c-b5f9-c3077614d1c6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts_b8069dfb-0741-4c9f-a4b8-91de82e41026" xlink:href="lh-20230331.xsd#lh_Longtermdebtissuancecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_Longtermdebtissuancecosts_b8069dfb-0741-4c9f-a4b8-91de82e41026" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_1841029d-accb-41e6-a520-a83de7218222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_us-gaap_LongTermNotesPayable_1841029d-accb-41e6-a520-a83de7218222" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_70235df3-69d6-4e75-a26b-bad48176e384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_70235df3-69d6-4e75-a26b-bad48176e384" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_dcf4e479-e038-4541-a469-46e4944a1cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_dcf4e479-e038-4541-a469-46e4944a1cdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_dcf4e479-e038-4541-a469-46e4944a1cdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_dcf4e479-e038-4541-a469-46e4944a1cdf" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_dcf4e479-e038-4541-a469-46e4944a1cdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a8efcb5a-3bd4-4186-b918-7426eaf9302d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_dcf4e479-e038-4541-a469-46e4944a1cdf" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a8efcb5a-3bd4-4186-b918-7426eaf9302d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c44cc5e5-5a5d-45d4-ad34-18f5919be018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_srt_StatementScenarioAxis_c44cc5e5-5a5d-45d4-ad34-18f5919be018" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c44cc5e5-5a5d-45d4-ad34-18f5919be018_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_c44cc5e5-5a5d-45d4-ad34-18f5919be018" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c44cc5e5-5a5d-45d4-ad34-18f5919be018_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_75283d36-38e7-4fff-b7c5-88385be2a829" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_c44cc5e5-5a5d-45d4-ad34-18f5919be018" xlink:to="loc_srt_ScenarioUnspecifiedDomain_75283d36-38e7-4fff-b7c5-88385be2a829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_64dbbf24-cfe0-4703-9c7b-1910ae745be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_VariableRateAxis_64dbbf24-cfe0-4703-9c7b-1910ae745be1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_64dbbf24-cfe0-4703-9c7b-1910ae745be1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_64dbbf24-cfe0-4703-9c7b-1910ae745be1" xlink:to="loc_us-gaap_VariableRateDomain_64dbbf24-cfe0-4703-9c7b-1910ae745be1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d99057f3-2c1a-4013-aa24-07e508376a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_64dbbf24-cfe0-4703-9c7b-1910ae745be1" xlink:to="loc_us-gaap_VariableRateDomain_d99057f3-2c1a-4013-aa24-07e508376a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd7a7529-5b6f-4b9f-84d1-8a5187551313" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_srt_RangeAxis_dd7a7529-5b6f-4b9f-84d1-8a5187551313" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd7a7529-5b6f-4b9f-84d1-8a5187551313_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd7a7529-5b6f-4b9f-84d1-8a5187551313" xlink:to="loc_srt_RangeMember_dd7a7529-5b6f-4b9f-84d1-8a5187551313_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_69a08d93-4045-4370-aa2c-c830a5494260" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd7a7529-5b6f-4b9f-84d1-8a5187551313" xlink:to="loc_srt_RangeMember_69a08d93-4045-4370-aa2c-c830a5494260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_dd594317-04c9-4e2c-b24b-6ed22fced854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_CreditFacilityAxis_dd594317-04c9-4e2c-b24b-6ed22fced854" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_dd594317-04c9-4e2c-b24b-6ed22fced854_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_dd594317-04c9-4e2c-b24b-6ed22fced854" xlink:to="loc_us-gaap_CreditFacilityDomain_dd594317-04c9-4e2c-b24b-6ed22fced854_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_213e7c7b-1570-437e-94e2-cbb5060da846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_dd594317-04c9-4e2c-b24b-6ed22fced854" xlink:to="loc_us-gaap_CreditFacilityDomain_213e7c7b-1570-437e-94e2-cbb5060da846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ce8bbda7-0e5d-48be-b3f7-f14c6829d162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_213e7c7b-1570-437e-94e2-cbb5060da846" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ce8bbda7-0e5d-48be-b3f7-f14c6829d162" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_91cb47de-49b5-42bf-8028-69f9b7e91a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_91cb47de-49b5-42bf-8028-69f9b7e91a6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91cb47de-49b5-42bf-8028-69f9b7e91a6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91cb47de-49b5-42bf-8028-69f9b7e91a6e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91cb47de-49b5-42bf-8028-69f9b7e91a6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16941d8c-d6dc-4a6c-ac54-8eeeeb1e815d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91cb47de-49b5-42bf-8028-69f9b7e91a6e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16941d8c-d6dc-4a6c-ac54-8eeeeb1e815d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f02466d5-9506-4c1d-9a2a-084caf25e7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f02466d5-9506-4c1d-9a2a-084caf25e7d8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f02466d5-9506-4c1d-9a2a-084caf25e7d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f02466d5-9506-4c1d-9a2a-084caf25e7d8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f02466d5-9506-4c1d-9a2a-084caf25e7d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f02466d5-9506-4c1d-9a2a-084caf25e7d8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7dbbb9e4-5aa7-4133-8f06-61924277c142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7dbbb9e4-5aa7-4133-8f06-61924277c142" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2031Member_864acb41-b7ff-4117-8f62-a87e6f68958f" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:to="loc_lh_SeniorNotesDue2031Member_864acb41-b7ff-4117-8f62-a87e6f68958f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_d193808d-bc01-4489-a03a-d06203e3632b" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:to="loc_lh_Seniornotesdue2027Member_d193808d-bc01-4489-a03a-d06203e3632b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBTSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="extended" id="ic6ad4e1d013845f7acb2df9cfd525e24_DEBTSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e8d9e02a-c654-4667-baee-f2f8760650b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e8d9e02a-c654-4667-baee-f2f8760650b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a67be1c-fdfb-47bc-93ea-961a950ce724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a67be1c-fdfb-47bc-93ea-961a950ce724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_9de716ac-dc38-4c5e-bca4-3f62b8dc384e" xlink:href="lh-20230331.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_9de716ac-dc38-4c5e-bca4-3f62b8dc384e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_b6c45516-54ed-4d57-86fa-01b7d4472482" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_b6c45516-54ed-4d57-86fa-01b7d4472482" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_94bf1f70-0879-41b2-a7b5-4391240b7a6b" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_94bf1f70-0879-41b2-a7b5-4391240b7a6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts_47423698-42ae-417c-a7f6-c2e072adda59" xlink:href="lh-20230331.xsd#lh_Longtermdebtissuancecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_Longtermdebtissuancecosts_47423698-42ae-417c-a7f6-c2e072adda59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_c72e7ad9-dd2d-41d0-adb7-9e255a1c10b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_NotesPayableCurrent_c72e7ad9-dd2d-41d0-adb7-9e255a1c10b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_681dfa2d-64b7-4de9-a142-793f9ccb7280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_681dfa2d-64b7-4de9-a142-793f9ccb7280" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_2e1b5602-85ae-475d-bbb4-813c36a1adb1" xlink:href="lh-20230331.xsd#lh_A2.30seniornotesdue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_A2.30seniornotesdue2024_2e1b5602-85ae-475d-bbb4-813c36a1adb1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_9eae4731-6193-4d4e-aa7c-5ef93faa4ea5" xlink:href="lh-20230331.xsd#lh_A2.95seniornotesdue2029"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_A2.95seniornotesdue2029_9eae4731-6193-4d4e-aa7c-5ef93faa4ea5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_856ce6cd-4577-462c-b298-1a496392a22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_856ce6cd-4577-462c-b298-1a496392a22a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedBorrowingInterestRate_3c0acdbd-a1b5-48c4-adcf-3ab071ec3bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubordinatedBorrowingInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_SubordinatedBorrowingInterestRate_3c0acdbd-a1b5-48c4-adcf-3ab071ec3bf1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031_e0619d7a-8d58-41af-9d90-d712a4d659f7" xlink:href="lh-20230331.xsd#lh_A270SeniorNotesDue2031"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_A270SeniorNotesDue2031_e0619d7a-8d58-41af-9d90-d712a4d659f7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThreeMonthLIBOR_64e4c03d-22fd-4df9-a43b-5e684d6ed9d3" xlink:href="lh-20230331.xsd#lh_ThreeMonthLIBOR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_ThreeMonthLIBOR_64e4c03d-22fd-4df9-a43b-5e684d6ed9d3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8c805fcc-ca52-437f-96ab-b4ab0edde906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8c805fcc-ca52-437f-96ab-b4ab0edde906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c805fcc-ca52-437f-96ab-b4ab0edde906_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c805fcc-ca52-437f-96ab-b4ab0edde906" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c805fcc-ca52-437f-96ab-b4ab0edde906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62d66c3e-8d9b-4b0d-9384-07ba79301c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c805fcc-ca52-437f-96ab-b4ab0edde906" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62d66c3e-8d9b-4b0d-9384-07ba79301c6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5bbb753c-1de6-4a8b-bbac-6c2ae5450285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_DebtInstrumentAxis_5bbb753c-1de6-4a8b-bbac-6c2ae5450285" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5bbb753c-1de6-4a8b-bbac-6c2ae5450285_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5bbb753c-1de6-4a8b-bbac-6c2ae5450285" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5bbb753c-1de6-4a8b-bbac-6c2ae5450285_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f56fe0ed-e72d-406a-9682-9f89e738fe0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5bbb753c-1de6-4a8b-bbac-6c2ae5450285" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f56fe0ed-e72d-406a-9682-9f89e738fe0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_86042007-04a2-4c2f-8f6f-38c5c9982bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_86042007-04a2-4c2f-8f6f-38c5c9982bc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86042007-04a2-4c2f-8f6f-38c5c9982bc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_86042007-04a2-4c2f-8f6f-38c5c9982bc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86042007-04a2-4c2f-8f6f-38c5c9982bc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_07fb334d-08fe-45a3-b12f-db8f031cb80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_86042007-04a2-4c2f-8f6f-38c5c9982bc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_07fb334d-08fe-45a3-b12f-db8f031cb80d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_6e46e6ac-e0b4-4cb3-b088-d3da77c96e8f" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_07fb334d-08fe-45a3-b12f-db8f031cb80d" xlink:to="loc_lh_Seniornotesdue2027Member_6e46e6ac-e0b4-4cb3-b088-d3da77c96e8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2031Member_fb8c2180-22e5-44f9-90d6-f4bee3247d46" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_07fb334d-08fe-45a3-b12f-db8f031cb80d" xlink:to="loc_lh_SeniorNotesDue2031Member_fb8c2180-22e5-44f9-90d6-f4bee3247d46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_403cf75a-0865-4fe8-a77f-d7ed5e9ba794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_403cf75a-0865-4fe8-a77f-d7ed5e9ba794" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_403cf75a-0865-4fe8-a77f-d7ed5e9ba794_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_403cf75a-0865-4fe8-a77f-d7ed5e9ba794" xlink:to="loc_us-gaap_HedgingRelationshipDomain_403cf75a-0865-4fe8-a77f-d7ed5e9ba794_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_03c8bff2-bc6a-4e90-947f-8c5b4838a65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_403cf75a-0865-4fe8-a77f-d7ed5e9ba794" xlink:to="loc_us-gaap_HedgingRelationshipDomain_03c8bff2-bc6a-4e90-947f-8c5b4838a65c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0c54d15f-6d81-4231-94d3-89d413f372f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_03c8bff2-bc6a-4e90-947f-8c5b4838a65c" xlink:to="loc_us-gaap_InterestRateSwapMember_0c54d15f-6d81-4231-94d3-89d413f372f2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBTCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="extended" id="if5a8f361537b42e298bd99e8eeec0a31_DEBTCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_8e738b73-b15b-4585-a276-922878fbfb0f" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_8e738b73-b15b-4585-a276-922878fbfb0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_944b8efe-0a77-4eca-a382-3f3867e35697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_944b8efe-0a77-4eca-a382-3f3867e35697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_2914e81d-77c6-4fac-9718-cfed72a5c438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_2914e81d-77c6-4fac-9718-cfed72a5c438" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_5b9d9e2a-3402-4765-9fb7-e1024436a8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_5b9d9e2a-3402-4765-9fb7-e1024436a8bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_6a92f192-7c0a-4364-b6a6-22781a84c29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_NotesPayableCurrent_6a92f192-7c0a-4364-b6a6-22781a84c29a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_e6cdda4f-3e65-417d-b3ec-15c451cfca27" xlink:href="lh-20230331.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_e6cdda4f-3e65-417d-b3ec-15c451cfca27" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_8531f4f0-a4a2-41b1-a0cf-ae5037a2d2b9" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_8531f4f0-a4a2-41b1-a0cf-ae5037a2d2b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_71f83176-cb36-4e7f-9a22-48b90ff3f6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_71f83176-cb36-4e7f-9a22-48b90ff3f6d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_137ff38e-fccb-4224-96d5-c64707ac0157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_DebtInstrumentAxis_137ff38e-fccb-4224-96d5-c64707ac0157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_137ff38e-fccb-4224-96d5-c64707ac0157_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_137ff38e-fccb-4224-96d5-c64707ac0157" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_137ff38e-fccb-4224-96d5-c64707ac0157_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f6472b07-3f60-46e9-9d1e-cfeb0d031785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_137ff38e-fccb-4224-96d5-c64707ac0157" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f6472b07-3f60-46e9-9d1e-cfeb0d031785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a620cc65-64be-44ab-b55e-94b857673f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_CreditFacilityAxis_a620cc65-64be-44ab-b55e-94b857673f92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a620cc65-64be-44ab-b55e-94b857673f92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a620cc65-64be-44ab-b55e-94b857673f92" xlink:to="loc_us-gaap_CreditFacilityDomain_a620cc65-64be-44ab-b55e-94b857673f92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_28afc183-0ee8-4d47-bbcc-f7df2f219f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a620cc65-64be-44ab-b55e-94b857673f92" xlink:to="loc_us-gaap_CreditFacilityDomain_28afc183-0ee8-4d47-bbcc-f7df2f219f41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_74c36abf-c9f4-409a-9e60-4e49d3814b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_28afc183-0ee8-4d47-bbcc-f7df2f219f41" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_74c36abf-c9f4-409a-9e60-4e49d3814b82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_342e0b9c-e75c-4c02-98d1-e274563d8429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_342e0b9c-e75c-4c02-98d1-e274563d8429" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_342e0b9c-e75c-4c02-98d1-e274563d8429_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_342e0b9c-e75c-4c02-98d1-e274563d8429" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_342e0b9c-e75c-4c02-98d1-e274563d8429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_cfb3a678-88ab-40a6-995a-b4fe5ecd2c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_342e0b9c-e75c-4c02-98d1-e274563d8429" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_cfb3a678-88ab-40a6-995a-b4fe5ecd2c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_bc872fb3-61c5-4bd6-99b9-4bfa0345c5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_cfb3a678-88ab-40a6-995a-b4fe5ecd2c76" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_bc872fb3-61c5-4bd6-99b9-4bfa0345c5c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3c618d7c-f2e8-4f9e-b083-3efad71c153a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3c618d7c-f2e8-4f9e-b083-3efad71c153a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3c618d7c-f2e8-4f9e-b083-3efad71c153a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c618d7c-f2e8-4f9e-b083-3efad71c153a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3c618d7c-f2e8-4f9e-b083-3efad71c153a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c618d7c-f2e8-4f9e-b083-3efad71c153a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_9de361af-c4da-46d5-99c2-25f2a7fff103" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_Seniornotesdue2027Member_9de361af-c4da-46d5-99c2-25f2a7fff103" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2027_6acc6b82-9046-44aa-b83b-c115e4e10f04" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2027"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A360SeniorNotesDue2027_6acc6b82-9046-44aa-b83b-c115e4e10f04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026_022023f2-0f93-427e-985e-ae4bec0ee08e" xlink:href="lh-20230331.xsd#lh_A155SeniorNotesDue2026"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A155SeniorNotesDue2026_022023f2-0f93-427e-985e-ae4bec0ee08e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_8ba44693-d5c0-4025-9de1-5435bfc1088e" xlink:href="lh-20230331.xsd#lh_A2.30seniornotesdue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A2.30seniornotesdue2024_8ba44693-d5c0-4025-9de1-5435bfc1088e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031_54e6221a-2686-4f24-8cc6-315ba8e562f6" xlink:href="lh-20230331.xsd#lh_A270SeniorNotesDue2031"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A270SeniorNotesDue2031_54e6221a-2686-4f24-8cc6-315ba8e562f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A400SeniorNotesDue2023_07ce518e-617b-49ed-94a2-b5741a045a1f" xlink:href="lh-20230331.xsd#lh_A400SeniorNotesDue2023"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A400SeniorNotesDue2023_07ce518e-617b-49ed-94a2-b5741a045a1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A325SeniorNotesDue2024_2cf658ae-f4f4-4fc5-bc38-cf24ee878ffa" xlink:href="lh-20230331.xsd#lh_A325SeniorNotesDue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A325SeniorNotesDue2024_2cf658ae-f4f4-4fc5-bc38-cf24ee878ffa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2025_ea2fd6e2-bb0d-4e7c-a190-d05d0bca4fcd" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2025"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A360SeniorNotesDue2025_ea2fd6e2-bb0d-4e7c-a190-d05d0bca4fcd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_5ee0cf77-0a5d-4b8b-a9e2-6e283994f4cd" xlink:href="lh-20230331.xsd#lh_A2.95seniornotesdue2029"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A2.95seniornotesdue2029_5ee0cf77-0a5d-4b8b-a9e2-6e283994f4cd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A470SeniorNotesDue2045_5b55267f-d98c-49af-84d0-cfdaba58e8bf" xlink:href="lh-20230331.xsd#lh_A470SeniorNotesDue2045"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A470SeniorNotesDue2045_5b55267f-d98c-49af-84d0-cfdaba58e8bf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a3309889-8c8e-495b-9292-631163b91ae9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_srt_StatementScenarioAxis_a3309889-8c8e-495b-9292-631163b91ae9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a3309889-8c8e-495b-9292-631163b91ae9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a3309889-8c8e-495b-9292-631163b91ae9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a3309889-8c8e-495b-9292-631163b91ae9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3a24f1c3-72ce-48f0-bf26-579903a531de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a3309889-8c8e-495b-9292-631163b91ae9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3a24f1c3-72ce-48f0-bf26-579903a531de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_c7d8ab84-c5ca-417c-a466-384395b8ee4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_c7d8ab84-c5ca-417c-a466-384395b8ee4a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_c7d8ab84-c5ca-417c-a466-384395b8ee4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c7d8ab84-c5ca-417c-a466-384395b8ee4a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_c7d8ab84-c5ca-417c-a466-384395b8ee4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_3e2c981a-7584-428b-a94e-c474c2552282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c7d8ab84-c5ca-417c-a466-384395b8ee4a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_3e2c981a-7584-428b-a94e-c474c2552282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d01c33d9-db35-4a24-bf12-9a9e689c4040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_3e2c981a-7584-428b-a94e-c474c2552282" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d01c33d9-db35-4a24-bf12-9a9e689c4040" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="extended" id="i6674f4237a844479b0661b92e33465f0_PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_cac07ffb-ba8e-46fd-98ea-fd9b349b6796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_cac07ffb-ba8e-46fd-98ea-fd9b349b6796" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:href="lh-20230331.xsd#lh_CommonSharesIssuedRollforwardAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d93ba189-e784-4ea0-b15b-b12cc4c7e856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:to="loc_us-gaap_CommonStockSharesIssued_d93ba189-e784-4ea0-b15b-b12cc4c7e856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_640192e1-886e-4ce4-addf-fc4fd01c82c6" xlink:href="lh-20230331.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_640192e1-886e-4ce4-addf-fc4fd01c82c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e22217f6-e2c0-4392-82fb-758cfe746a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_663db0e3-b881-41c9-bb20-0202c72f75f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_ccf61eca-7314-4ddd-9848-ffb70d76408b" xlink:href="lh-20230331.xsd#lh_OutstandingStockRepurchaseAuthorizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_ccf61eca-7314-4ddd-9848-ffb70d76408b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesOutstandingRollforwardAbstract_7aad8f3c-f49e-41b3-ac53-2d8e62a04b4d" xlink:href="lh-20230331.xsd#lh_CommonSharesOutstandingRollforwardAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_CommonSharesOutstandingRollforwardAbstract_7aad8f3c-f49e-41b3-ac53-2d8e62a04b4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0bf82214-10b0-4206-9647-23828cc2c99e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_7aad8f3c-f49e-41b3-ac53-2d8e62a04b4d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0bf82214-10b0-4206-9647-23828cc2c99e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_5c49e55c-aec4-4a5a-bfb3-4922febf582f" xlink:href="lh-20230331.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cbfa2f80-ceb1-4d19-8dba-6c21ba645689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_982dec95-723f-415b-9e13-bfae0801ae90" xlink:href="lh-20230331.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_ed11e732-80c4-4402-a6cb-c0c338cdc723" xlink:href="lh-20230331.xsd#lh_CommonSharesHeldInTreasuryRollforwardAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_ed11e732-80c4-4402-a6cb-c0c338cdc723" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cde4e1a3-b355-4809-b110-5a3e9753ded6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cde4e1a3-b355-4809-b110-5a3e9753ded6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_67c88d0c-a8aa-4280-b460-f6c610e5f706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_67c88d0c-a8aa-4280-b460-f6c610e5f706" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d9886415-e5cf-4bf0-b8c7-c3333b3d0192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d9886415-e5cf-4bf0-b8c7-c3333b3d0192" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_91a20c2a-9234-4f26-8645-e36a897e2288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_91a20c2a-9234-4f26-8645-e36a897e2288" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_66f01283-db9d-4df1-8f1e-90b93e043e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_66f01283-db9d-4df1-8f1e-90b93e043e60" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_130bc8d3-313d-46a7-a2de-2821c883d203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_130bc8d3-313d-46a7-a2de-2821c883d203" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_20e8bc3c-a9c9-4da5-b5a2-5285ee0fc819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_20e8bc3c-a9c9-4da5-b5a2-5285ee0fc819" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_8ae3fd76-b554-46d3-b4db-4a4794c8f4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_8ae3fd76-b554-46d3-b4db-4a4794c8f4ef" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_3d4b7be0-e5db-494c-ac78-4c81b6c3af6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_3d4b7be0-e5db-494c-ac78-4c81b6c3af6b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_d74d8ddc-8059-414c-b6ac-b7c885040d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_Dividends_d74d8ddc-8059-414c-b6ac-b7c885040d5e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_a04b6ef7-5048-4b10-b122-db63a0d95806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_a04b6ef7-5048-4b10-b122-db63a0d95806" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_c9781b62-80af-4efb-af46-27ccbd1b87fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_c9781b62-80af-4efb-af46-27ccbd1b87fa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_295db673-e25b-47e5-bf09-230c4eca7023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_295db673-e25b-47e5-bf09-230c4eca7023" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4af7e8b3-c1ce-4d76-ba61-95f82bf64ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4af7e8b3-c1ce-4d76-ba61-95f82bf64ea8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_dd0cbe65-c800-4794-918e-95cd960dae35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_dd0cbe65-c800-4794-918e-95cd960dae35" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0dcb78d9-c2f1-4975-900c-fde424b51e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:to="loc_us-gaap_CreditFacilityAxis_0dcb78d9-c2f1-4975-900c-fde424b51e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0dcb78d9-c2f1-4975-900c-fde424b51e64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0dcb78d9-c2f1-4975-900c-fde424b51e64" xlink:to="loc_us-gaap_CreditFacilityDomain_0dcb78d9-c2f1-4975-900c-fde424b51e64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bcc0cc0d-0d5b-4b75-a32f-e58823d1ae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0dcb78d9-c2f1-4975-900c-fde424b51e64" xlink:to="loc_us-gaap_CreditFacilityDomain_bcc0cc0d-0d5b-4b75-a32f-e58823d1ae3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_16648d9f-1deb-4d63-99a7-cb976b6d845c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_16648d9f-1deb-4d63-99a7-cb976b6d845c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_16648d9f-1deb-4d63-99a7-cb976b6d845c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_16648d9f-1deb-4d63-99a7-cb976b6d845c" xlink:to="loc_us-gaap_ClassOfStockDomain_16648d9f-1deb-4d63-99a7-cb976b6d845c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0d9bed45-c4db-47d9-a9ba-6c190259a9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_16648d9f-1deb-4d63-99a7-cb976b6d845c" xlink:to="loc_us-gaap_ClassOfStockDomain_0d9bed45-c4db-47d9-a9ba-6c190259a9a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_38800b0b-74fb-4a83-b200-a31e5ae226fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0d9bed45-c4db-47d9-a9ba-6c190259a9a4" xlink:to="loc_us-gaap_CommonStockMember_38800b0b-74fb-4a83-b200-a31e5ae226fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1b8e08a2-b583-4481-9a55-d80dbfc17221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1b8e08a2-b583-4481-9a55-d80dbfc17221" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1b8e08a2-b583-4481-9a55-d80dbfc17221_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1b8e08a2-b583-4481-9a55-d80dbfc17221" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1b8e08a2-b583-4481-9a55-d80dbfc17221_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_531138f4-66e2-46c3-a364-29fc9ba9943a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1b8e08a2-b583-4481-9a55-d80dbfc17221" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_531138f4-66e2-46c3-a364-29fc9ba9943a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d4ae891a-d2fc-4193-930e-524bc887afdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_531138f4-66e2-46c3-a364-29fc9ba9943a" xlink:to="loc_us-gaap_SubsequentEventMember_d4ae891a-d2fc-4193-930e-524bc887afdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ca3256cd-264a-4c3e-abab-59f20c5cd32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ca3256cd-264a-4c3e-abab-59f20c5cd32b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b1c254c8-1780-480f-bdfa-7800c49acfa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="extended" id="idd8f74fe15554f268f1dd16a98bf2cbb_PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f09712b-bff1-4c6c-8392-01a584a324a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_d3c1ccb7-b81c-46be-89f5-52938917cf90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f09712b-bff1-4c6c-8392-01a584a324a1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_d3c1ccb7-b81c-46be-89f5-52938917cf90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f09712b-bff1-4c6c-8392-01a584a324a1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8c82b7d1-359a-4db6-b412-7994c33b2797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8c82b7d1-359a-4db6-b412-7994c33b2797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c82b7d1-359a-4db6-b412-7994c33b2797_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c82b7d1-359a-4db6-b412-7994c33b2797" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c82b7d1-359a-4db6-b412-7994c33b2797_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ae7f946c-4ad5-4fba-8856-962dd14dcc24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c82b7d1-359a-4db6-b412-7994c33b2797" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ae7f946c-4ad5-4fba-8856-962dd14dcc24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd" xlink:to="loc_us-gaap_EquityComponentDomain_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e2aa0dbe-3c89-4403-aac1-be329bf998a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd" xlink:to="loc_us-gaap_EquityComponentDomain_e2aa0dbe-3c89-4403-aac1-be329bf998a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0aacff4d-4416-4302-9b27-e899c50f82c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0aacff4d-4416-4302-9b27-e899c50f82c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_0aacff4d-4416-4302-9b27-e899c50f82c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0aacff4d-4416-4302-9b27-e899c50f82c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_0aacff4d-4416-4302-9b27-e899c50f82c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_13b4ddc3-cf91-4260-a672-423f6ccc88be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0aacff4d-4416-4302-9b27-e899c50f82c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_13b4ddc3-cf91-4260-a672-423f6ccc88be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignCurrencyTranslationAdjustmentsMember_ee12b9f8-766d-4435-8556-6d2b05f6ccb9" xlink:href="lh-20230331.xsd#lh_ForeignCurrencyTranslationAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_13b4ddc3-cf91-4260-a672-423f6ccc88be" xlink:to="loc_lh_ForeignCurrencyTranslationAdjustmentsMember_ee12b9f8-766d-4435-8556-6d2b05f6ccb9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ied482d8c58974558b036dfdabc98b4b8_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_50672eba-a02b-4680-aabd-b4d6b8f8f89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_aa77f5cf-bb86-4220-b6ab-f2af04f7d836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_50672eba-a02b-4680-aabd-b4d6b8f8f89b" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_aa77f5cf-bb86-4220-b6ab-f2af04f7d836" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_db4ae0ee-c748-421a-a23b-61e15821a1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_50672eba-a02b-4680-aabd-b4d6b8f8f89b" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_db4ae0ee-c748-421a-a23b-61e15821a1f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_50672eba-a02b-4680-aabd-b4d6b8f8f89b" xlink:to="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_39160b74-b0c0-4205-baae-4e9086f80a19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_39160b74-b0c0-4205-baae-4e9086f80a19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_39160b74-b0c0-4205-baae-4e9086f80a19_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_39160b74-b0c0-4205-baae-4e9086f80a19" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_39160b74-b0c0-4205-baae-4e9086f80a19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_52a5619f-71ca-4e00-aac3-be37640ef02f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_39160b74-b0c0-4205-baae-4e9086f80a19" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_52a5619f-71ca-4e00-aac3-be37640ef02f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b7f14364-3a16-455c-9ee5-3ea333d95151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b7f14364-3a16-455c-9ee5-3ea333d95151" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7f14364-3a16-455c-9ee5-3ea333d95151_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7f14364-3a16-455c-9ee5-3ea333d95151" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7f14364-3a16-455c-9ee5-3ea333d95151_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4d7fc22-e93c-4fae-834f-33bfe14e8c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7f14364-3a16-455c-9ee5-3ea333d95151" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4d7fc22-e93c-4fae-834f-33bfe14e8c94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6d82454a-d203-46ad-8d4f-7acb2d830886" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_srt_RangeAxis_6d82454a-d203-46ad-8d4f-7acb2d830886" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6d82454a-d203-46ad-8d4f-7acb2d830886_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6d82454a-d203-46ad-8d4f-7acb2d830886" xlink:to="loc_srt_RangeMember_6d82454a-d203-46ad-8d4f-7acb2d830886_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_10b12775-37a0-4e64-9b21-46d1247278c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6d82454a-d203-46ad-8d4f-7acb2d830886" xlink:to="loc_srt_RangeMember_10b12775-37a0-4e64-9b21-46d1247278c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8f2e0fc1-dc42-4b04-bcab-f783677f3132" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_dei_LegalEntityAxis_8f2e0fc1-dc42-4b04-bcab-f783677f3132" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8f2e0fc1-dc42-4b04-bcab-f783677f3132_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8f2e0fc1-dc42-4b04-bcab-f783677f3132" xlink:to="loc_dei_EntityDomain_8f2e0fc1-dc42-4b04-bcab-f783677f3132_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fe4fff0d-0925-4fcd-96d8-e38c89552bec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8f2e0fc1-dc42-4b04-bcab-f783677f3132" xlink:to="loc_dei_EntityDomain_fe4fff0d-0925-4fcd-96d8-e38c89552bec" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended" id="i260709a213fa4886bbeceddb250c5e52_FAIRVALUEMEASUREMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection_e38effed-1f83-472e-87c3-3f809f43985a" xlink:href="lh-20230331.xsd#lh_NumberofMeasurementFundsAvailableForParticipantElection"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection_e38effed-1f83-472e-87c3-3f809f43985a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_8d4d2e64-5bff-4657-b9ba-8319ba537fd1" xlink:href="lh-20230331.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_8d4d2e64-5bff-4657-b9ba-8319ba537fd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_095bd6e5-17d0-4a9e-9966-08f48d789380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_095bd6e5-17d0-4a9e-9966-08f48d789380" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue_cecff2df-dab4-4eee-add6-b819e657aa86" xlink:href="lh-20230331.xsd#lh_SeniorNotesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_SeniorNotesFairValue_cecff2df-dab4-4eee-add6-b819e657aa86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_266d460b-7d26-462e-8c59-295b14c57473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_266d460b-7d26-462e-8c59-295b14c57473" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_541f92ea-c194-4212-b91b-80c11d7a960a" xlink:href="lh-20230331.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_541f92ea-c194-4212-b91b-80c11d7a960a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_219dbbfc-a7f8-4dc8-af6a-2a0d0f3a3b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_219dbbfc-a7f8-4dc8-af6a-2a0d0f3a3b22" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_c220a0ec-d195-4c9b-abb1-a161163a25b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_c220a0ec-d195-4c9b-abb1-a161163a25b9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgesAtFairValueNet_3fc30aac-3290-4751-a11e-550c5df85062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_FairValueHedgesAtFairValueNet_3fc30aac-3290-4751-a11e-550c5df85062" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment_5d981ac1-5383-48ac-86ce-624c32fcd132" xlink:href="lh-20230331.xsd#lh_Contingentconsiderationadjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_Contingentconsiderationadjustment_5d981ac1-5383-48ac-86ce-624c32fcd132" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_244573bf-3c57-4144-b9ff-6f0e97b08efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_244573bf-3c57-4144-b9ff-6f0e97b08efa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a64f7074-861c-45c4-b1b2-750cb09abb62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a64f7074-861c-45c4-b1b2-750cb09abb62" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ed5b5d9c-95c9-4149-91bf-ed6f2359b41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ed5b5d9c-95c9-4149-91bf-ed6f2359b41a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_0ffdd6c8-54b4-4c9c-9caa-aaa31f8b03c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_0ffdd6c8-54b4-4c9c-9caa-aaa31f8b03c4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_a077fd77-fe07-418b-afeb-c9399eb86b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_a077fd77-fe07-418b-afeb-c9399eb86b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a077fd77-fe07-418b-afeb-c9399eb86b68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_a077fd77-fe07-418b-afeb-c9399eb86b68" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a077fd77-fe07-418b-afeb-c9399eb86b68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_2d6e6acd-c2de-4d87-b4b2-cf84bc348b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_a077fd77-fe07-418b-afeb-c9399eb86b68" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_2d6e6acd-c2de-4d87-b4b2-cf84bc348b90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_077fe996-4f87-451c-9725-b8add0a15510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_077fe996-4f87-451c-9725-b8add0a15510" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_077fe996-4f87-451c-9725-b8add0a15510_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_077fe996-4f87-451c-9725-b8add0a15510" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_077fe996-4f87-451c-9725-b8add0a15510_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_077fe996-4f87-451c-9725-b8add0a15510" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_24c5d8ab-2788-45d9-ac4e-10d883e0a3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_24c5d8ab-2788-45d9-ac4e-10d883e0a3ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_cf13250b-ba65-4ff4-8216-1103906d07e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_cf13250b-ba65-4ff4-8216-1103906d07e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cf5febae-bd90-43a8-87d6-1bdd661a07b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cf5febae-bd90-43a8-87d6-1bdd661a07b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_576a8fe0-fe09-457c-a597-7be4100e39ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_576a8fe0-fe09-457c-a597-7be4100e39ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_576a8fe0-fe09-457c-a597-7be4100e39ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_576a8fe0-fe09-457c-a597-7be4100e39ee" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_576a8fe0-fe09-457c-a597-7be4100e39ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_576a8fe0-fe09-457c-a597-7be4100e39ee" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_73559c5b-8b09-425e-a665-a10549afcd88" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:to="loc_lh_Seniornotesdue2027Member_73559c5b-8b09-425e-a665-a10549afcd88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_fd8a15bd-e5ec-4435-a33e-da2f6fcb986e" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:to="loc_lh_SeniorNotesDue2022Member_fd8a15bd-e5ec-4435-a33e-da2f6fcb986e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2024Member_ace4eb83-dbc3-486e-9af9-e9253f452a6a" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:to="loc_lh_SeniorNotesDue2024Member_ace4eb83-dbc3-486e-9af9-e9253f452a6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1" xlink:href="lh-20230331.xsd#lh_SwapTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_lh_SwapTypeAxis_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1_default" xlink:href="lh-20230331.xsd#lh_SwapTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_SwapTypeAxis_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1" xlink:to="loc_lh_SwapTypeDomain_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_9dd8b0a2-5466-4a96-adfb-6434d6de4938" xlink:href="lh-20230331.xsd#lh_SwapTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_SwapTypeAxis_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1" xlink:to="loc_lh_SwapTypeDomain_9dd8b0a2-5466-4a96-adfb-6434d6de4938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember_d8a5d9e9-8a7b-496f-bbe7-1d18f34e82c3" xlink:href="lh-20230331.xsd#lh_A2018SwapAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_SwapTypeDomain_9dd8b0a2-5466-4a96-adfb-6434d6de4938" xlink:to="loc_lh_A2018SwapAgreementsMember_d8a5d9e9-8a7b-496f-bbe7-1d18f34e82c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022SwapAgreementsMember_8f3b3549-0250-4ec9-9812-2cd77eb7d377" xlink:href="lh-20230331.xsd#lh_A2022SwapAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_SwapTypeDomain_9dd8b0a2-5466-4a96-adfb-6434d6de4938" xlink:to="loc_lh_A2022SwapAgreementsMember_8f3b3549-0250-4ec9-9812-2cd77eb7d377" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="i31f23632ef284062b80a9a4aacc529f6_BUSINESSACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24ae07a7-ee8a-4e64-92ce-64b46551401b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24ae07a7-ee8a-4e64-92ce-64b46551401b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c0c4bff4-7c25-41ae-9db2-f34f0c59bf63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c0c4bff4-7c25-41ae-9db2-f34f0c59bf63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3bb71025-b0ce-48f1-aa28-e2be8ed4a685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3bb71025-b0ce-48f1-aa28-e2be8ed4a685" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_ae75fa85-48b2-4449-854c-c654fe829b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_ae75fa85-48b2-4449-854c-c654fe829b65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_27eddb8e-8841-4359-9a72-d6f4f27d15f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_27eddb8e-8841-4359-9a72-d6f4f27d15f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b39667d5-eeda-4ef2-a346-154c241bdc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b39667d5-eeda-4ef2-a346-154c241bdc6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_c2cc2de3-df1c-41e6-ad3e-97a6faae53ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_c2cc2de3-df1c-41e6-ad3e-97a6faae53ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_a8d7b6e0-9652-436d-938f-dbb324702980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_a8d7b6e0-9652-436d-938f-dbb324702980" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_bc7fa63f-939f-47b7-8080-fc107ea1c007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_bc7fa63f-939f-47b7-8080-fc107ea1c007" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_85198104-21c0-4f73-a2f3-286c93eccaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_85198104-21c0-4f73-a2f3-286c93eccaa4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_892f48a6-3b4c-4ea7-bba1-8f9e595a07f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_892f48a6-3b4c-4ea7-bba1-8f9e595a07f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa68897-1a9b-4d99-b72d-d1810ed4c978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa68897-1a9b-4d99-b72d-d1810ed4c978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baa68897-1a9b-4d99-b72d-d1810ed4c978_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa68897-1a9b-4d99-b72d-d1810ed4c978" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baa68897-1a9b-4d99-b72d-d1810ed4c978_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63ecc736-5e1e-4d30-a0fa-61d4d0c5186c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa68897-1a9b-4d99-b72d-d1810ed4c978" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63ecc736-5e1e-4d30-a0fa-61d4d0c5186c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e03ea313-00a6-4e89-8e31-1a6b250dc0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63ecc736-5e1e-4d30-a0fa-61d4d0c5186c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e03ea313-00a6-4e89-8e31-1a6b250dc0c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_834d14e5-bce9-42c1-8bf2-86355fe8e509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63ecc736-5e1e-4d30-a0fa-61d4d0c5186c" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_834d14e5-bce9-42c1-8bf2-86355fe8e509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3202eb2-07b0-4884-8af2-a48024c1499f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3202eb2-07b0-4884-8af2-a48024c1499f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_4ecab624-2bc8-40bc-ac85-7a384f35e407" xlink:href="lh-20230331.xsd#lh_OtheracquireesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3202eb2-07b0-4884-8af2-a48024c1499f" xlink:to="loc_lh_OtheracquireesMember_4ecab624-2bc8-40bc-ac85-7a384f35e407" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_aacc3167-f385-4b72-81ed-f35c84a0bdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_aacc3167-f385-4b72-81ed-f35c84a0bdb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_aacc3167-f385-4b72-81ed-f35c84a0bdb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_aacc3167-f385-4b72-81ed-f35c84a0bdb2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_aacc3167-f385-4b72-81ed-f35c84a0bdb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_15e895c1-f034-44c4-9cad-119837db30fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_aacc3167-f385-4b72-81ed-f35c84a0bdb2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_15e895c1-f034-44c4-9cad-119837db30fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_eb832467-a0b3-4e63-856a-f32d8e3f7722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_15e895c1-f034-44c4-9cad-119837db30fa" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_eb832467-a0b3-4e63-856a-f32d8e3f7722" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b4a7c342-b90d-4846-a20f-0e5959119b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b4a7c342-b90d-4846-a20f-0e5959119b15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b4a7c342-b90d-4846-a20f-0e5959119b15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b4a7c342-b90d-4846-a20f-0e5959119b15" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b4a7c342-b90d-4846-a20f-0e5959119b15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_570f5819-b88c-495b-ada1-adbaf1120ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b4a7c342-b90d-4846-a20f-0e5959119b15" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_570f5819-b88c-495b-ada1-adbaf1120ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_21245b1d-fb66-4b43-a77a-278d2eadde21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_570f5819-b88c-495b-ada1-adbaf1120ed6" xlink:to="loc_us-gaap_GoodwillMember_21245b1d-fb66-4b43-a77a-278d2eadde21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a937f3d8-08e5-4c28-819a-7bc71854c54c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a937f3d8-08e5-4c28-819a-7bc71854c54c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a937f3d8-08e5-4c28-819a-7bc71854c54c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a937f3d8-08e5-4c28-819a-7bc71854c54c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a937f3d8-08e5-4c28-819a-7bc71854c54c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f78ec5a7-5230-4427-a15a-d5f21ca10537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a937f3d8-08e5-4c28-819a-7bc71854c54c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f78ec5a7-5230-4427-a15a-d5f21ca10537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_ddec4b73-b376-4fbe-9549-01c2a77d4902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f78ec5a7-5230-4427-a15a-d5f21ca10537" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_ddec4b73-b376-4fbe-9549-01c2a77d4902" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0851ebdd-0a1a-48fd-b9b3-077bac532250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f78ec5a7-5230-4427-a15a-d5f21ca10537" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0851ebdd-0a1a-48fd-b9b3-077bac532250" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="extended" id="icd5a7f6f7d5a4e51b645c5ae3606a79e_BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_90077e4d-2f58-4229-85fa-26a83b8ff516" xlink:href="lh-20230331.xsd#lh_PercentofRevenueContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_lh_PercentofRevenueContributed_90077e4d-2f58-4229-85fa-26a83b8ff516" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_93ef0231-8ba6-415a-b68f-294d48285323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_Revenues_93ef0231-8ba6-415a-b68f-294d48285323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ae49372f-26bb-41c8-ba38-6956b3eb7d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_OperatingIncomeLoss_ae49372f-26bb-41c8-ba38-6956b3eb7d01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9923ffea-716e-4ad2-950f-4ff23403aa15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9923ffea-716e-4ad2-950f-4ff23403aa15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_bb327cae-fd5c-451c-9dd3-e7b4f962c0dd" xlink:href="lh-20230331.xsd#lh_NetRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_lh_NetRestructuringCharges_bb327cae-fd5c-451c-9dd3-e7b4f962c0dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7564027d-45fd-4d84-9a3b-f996d9d7419e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7564027d-45fd-4d84-9a3b-f996d9d7419e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7cfce740-8e08-42e6-854a-9b5d23c1dc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7cfce740-8e08-42e6-854a-9b5d23c1dc0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7cfce740-8e08-42e6-854a-9b5d23c1dc0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7cfce740-8e08-42e6-854a-9b5d23c1dc0e" xlink:to="loc_us-gaap_SegmentDomain_7cfce740-8e08-42e6-854a-9b5d23c1dc0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7cfce740-8e08-42e6-854a-9b5d23c1dc0e" xlink:to="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_15441200-7553-4423-9983-cbe0718eede1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_us-gaap_CorporateMember_15441200-7553-4423-9983-cbe0718eede1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_94a6d94e-e90b-412d-8b6c-fb41adfcb64f" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_lh_LabCorpDiagnosticsMember_94a6d94e-e90b-412d-8b6c-fb41adfcb64f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_ba2f3bd6-75e0-4624-8ecd-234c1ffe5351" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_lh_CovanceDrugDevelopmentMember_ba2f3bd6-75e0-4624-8ecd-234c1ffe5351" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_fad9f353-2c8b-40b0-a22e-84d66a5bccca" xlink:href="lh-20230331.xsd#lh_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_lh_DiagnosticsMember_fad9f353-2c8b-40b0-a22e-84d66a5bccca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_87a4664d-6a07-4fdb-b41f-1ca4a631e233" xlink:href="lh-20230331.xsd#lh_DrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_lh_DrugDevelopmentMember_87a4664d-6a07-4fdb-b41f-1ca4a631e233" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0e983fab-3040-4b8f-b84a-7f2cee219589" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:to="loc_srt_ConsolidationItemsAxis_0e983fab-3040-4b8f-b84a-7f2cee219589" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0e983fab-3040-4b8f-b84a-7f2cee219589_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0e983fab-3040-4b8f-b84a-7f2cee219589" xlink:to="loc_srt_ConsolidationItemsDomain_0e983fab-3040-4b8f-b84a-7f2cee219589_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c0b3b71f-99b2-402c-9e31-255d03cf8af8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0e983fab-3040-4b8f-b84a-7f2cee219589" xlink:to="loc_srt_ConsolidationItemsDomain_c0b3b71f-99b2-402c-9e31-255d03cf8af8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_32e617da-df22-4aff-8913-757d5780ab6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c0b3b71f-99b2-402c-9e31-255d03cf8af8" xlink:to="loc_us-gaap_OperatingSegmentsMember_32e617da-df22-4aff-8913-757d5780ab6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_47584777-d328-46ad-9496-3b01cd935cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c0b3b71f-99b2-402c-9e31-255d03cf8af8" xlink:to="loc_us-gaap_IntersegmentEliminationMember_47584777-d328-46ad-9496-3b01cd935cdb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#REVENUEDisaggregatedRevenueTableDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="extended" id="i392aeff047654b7cb1c500b8eb5038b1_REVENUEDisaggregatedRevenueTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_37edb854-7147-4ed1-984f-53de3db202db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_37edb854-7147-4ed1-984f-53de3db202db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss_906ff3ae-6808-4296-8eb0-bd950604810a" xlink:href="lh-20230331.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_UnbilledServicesAllowanceforCreditLoss_906ff3ae-6808-4296-8eb0-bd950604810a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss_9545c5b2-53d1-47c3-9d83-2c242bf9b3ef" xlink:href="lh-20230331.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_NoteReceivableAllowanceforCreditLoss_9545c5b2-53d1-47c3-9d83-2c242bf9b3ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss_597c90ff-2f4b-49d9-883b-e4dff6be08ca" xlink:href="lh-20230331.xsd#lh_AllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_AllowanceforCreditLoss_597c90ff-2f4b-49d9-883b-e4dff6be08ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_7033a5d2-17a9-4353-9ef0-2a350065167f" xlink:href="lh-20230331.xsd#lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_7033a5d2-17a9-4353-9ef0-2a350065167f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff_0196760a-f57d-4d4f-ab12-55f1174dfea9" xlink:href="lh-20230331.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_AllowanceforCreditLossWriteOff_0196760a-f57d-4d4f-ab12-55f1174dfea9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_b4dd3366-8864-4388-a045-4132b77f272b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_b4dd3366-8864-4388-a045-4132b77f272b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_3960f056-70c9-4392-8c00-e93b30666ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_3960f056-70c9-4392-8c00-e93b30666ce9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_78c60d54-fb8c-454b-bba2-3578c90fd5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_78c60d54-fb8c-454b-bba2-3578c90fd5f1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum_0aecb091-5bfd-45e1-9d95-631725caa23b" xlink:href="lh-20230331.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_LongTermContractsDurationMinimum_0aecb091-5bfd-45e1-9d95-631725caa23b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum_f28fb703-ab2f-4b56-87a8-7b1cc9ded45f" xlink:href="lh-20230331.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_LongTermContractsDurationMaximum_f28fb703-ab2f-4b56-87a8-7b1cc9ded45f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1841817b-603c-4757-8da9-e61105988491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1841817b-603c-4757-8da9-e61105988491" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c069e5ff-fa7f-4f7a-9992-77261be7d840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c069e5ff-fa7f-4f7a-9992-77261be7d840" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_2c055306-22df-4e62-a7d7-24aa580cf79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_2c055306-22df-4e62-a7d7-24aa580cf79a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_ac973ffe-7ab3-4783-aede-48140a0358c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_ac973ffe-7ab3-4783-aede-48140a0358c7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_0fe18062-bf10-44b0-b4a8-a70e9dbe5f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_CapitalizedContractCostNet_0fe18062-bf10-44b0-b4a8-a70e9dbe5f2b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_d35db0c8-1254-47ea-a8a7-da1fdbe77dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_d35db0c8-1254-47ea-a8a7-da1fdbe77dee" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_76a01486-3efd-4a1b-9b19-2242673f8129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_76a01486-3efd-4a1b-9b19-2242673f8129" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_d6dc29ed-431a-4f1e-8ac9-5ae6c3682c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_UnbilledContractsReceivable_d6dc29ed-431a-4f1e-8ac9-5ae6c3682c36" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_0be06582-68dc-4523-b818-d0e249759c65" xlink:href="lh-20230331.xsd#lh_PercentofRevenueContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_PercentofRevenueContributed_0be06582-68dc-4523-b818-d0e249759c65" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f84ceea7-9322-40f6-b081-40e288cdae2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_Revenues_f84ceea7-9322-40f6-b081-40e288cdae2c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_c1599d52-1c45-44a1-b6fe-54417ccdabf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AccountsReceivableGross_c1599d52-1c45-44a1-b6fe-54417ccdabf2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e417031c-692b-4540-8839-95954882527e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e417031c-692b-4540-8839-95954882527e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5e7777bb-6345-4bf9-9b76-6ec7ef455298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5e7777bb-6345-4bf9-9b76-6ec7ef455298" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5e13af0a-d738-43ea-831f-ab85420f05ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5e13af0a-d738-43ea-831f-ab85420f05ed" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_553dc52d-ef10-4d4e-b816-6edd9c20a168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_553dc52d-ef10-4d4e-b816-6edd9c20a168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_553dc52d-ef10-4d4e-b816-6edd9c20a168_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_553dc52d-ef10-4d4e-b816-6edd9c20a168" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_553dc52d-ef10-4d4e-b816-6edd9c20a168_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_553dc52d-ef10-4d4e-b816-6edd9c20a168" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_3c05d661-8886-41cc-9c69-2ab69b967fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:to="loc_us-gaap_NotesReceivableMember_3c05d661-8886-41cc-9c69-2ab69b967fa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember_a7df13ef-e2fd-4088-98cc-1930630f8ffa" xlink:href="lh-20230331.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:to="loc_lh_UnbilledContractsReceivableMember_a7df13ef-e2fd-4088-98cc-1930630f8ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_3d912a1c-f37c-41f1-97ae-31edc5f760ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:to="loc_us-gaap_AccountsReceivableMember_3d912a1c-f37c-41f1-97ae-31edc5f760ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b" xlink:to="loc_us-gaap_SegmentDomain_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b" xlink:to="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_5ece40ef-cd4a-45f9-9196-fc2cf985cb80" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:to="loc_lh_LabCorpDiagnosticsMember_5ece40ef-cd4a-45f9-9196-fc2cf985cb80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_d4627b48-df91-4126-b803-6aad49a29452" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:to="loc_lh_CovanceDrugDevelopmentMember_d4627b48-df91-4126-b803-6aad49a29452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_7109e4d7-e9c8-45a6-9d0f-4bcb664d6478" xlink:href="lh-20230331.xsd#lh_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:to="loc_lh_DiagnosticsMember_7109e4d7-e9c8-45a6-9d0f-4bcb664d6478" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_e685f193-eab1-4e3c-9fd4-b7224002a310" xlink:href="lh-20230331.xsd#lh_DrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:to="loc_lh_DrugDevelopmentMember_e685f193-eab1-4e3c-9fd4-b7224002a310" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_848bbabd-0d99-4a16-bb0b-e397b4b0988d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_srt_ProductOrServiceAxis_848bbabd-0d99-4a16-bb0b-e397b4b0988d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_848bbabd-0d99-4a16-bb0b-e397b4b0988d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_848bbabd-0d99-4a16-bb0b-e397b4b0988d" xlink:to="loc_srt_ProductsAndServicesDomain_848bbabd-0d99-4a16-bb0b-e397b4b0988d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f48f4bf-f4e6-45a1-8ae5-cc2db799b9f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_848bbabd-0d99-4a16-bb0b-e397b4b0988d" xlink:to="loc_srt_ProductsAndServicesDomain_0f48f4bf-f4e6-45a1-8ae5-cc2db799b9f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_d4a868e0-9ea9-437c-871e-e94b97f2a332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_d4a868e0-9ea9-437c-871e-e94b97f2a332" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d4a868e0-9ea9-437c-871e-e94b97f2a332_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_d4a868e0-9ea9-437c-871e-e94b97f2a332" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d4a868e0-9ea9-437c-871e-e94b97f2a332_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7e06567e-f77d-496d-875c-07aed5f792eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_d4a868e0-9ea9-437c-871e-e94b97f2a332" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7e06567e-f77d-496d-875c-07aed5f792eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_db0756ec-e123-4730-bf86-879537ef1be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_db0756ec-e123-4730-bf86-879537ef1be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_812f0026-d2c7-45d3-a213-459875ecc782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_812f0026-d2c7-45d3-a213-459875ecc782" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_812f0026-d2c7-45d3-a213-459875ecc782_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_812f0026-d2c7-45d3-a213-459875ecc782" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_812f0026-d2c7-45d3-a213-459875ecc782_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d4b76eb6-7b07-4f5b-9b00-14524c44fd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_812f0026-d2c7-45d3-a213-459875ecc782" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d4b76eb6-7b07-4f5b-9b00-14524c44fd65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_30ffe124-4285-4081-b551-f6e29709c337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_30ffe124-4285-4081-b551-f6e29709c337" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_30ffe124-4285-4081-b551-f6e29709c337_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_30ffe124-4285-4081-b551-f6e29709c337" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_30ffe124-4285-4081-b551-f6e29709c337_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_30ffe124-4285-4081-b551-f6e29709c337" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_3b0b7616-7f6b-46b8-9de4-afd86d654a4d" xlink:href="lh-20230331.xsd#lh_ClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_lh_ClientMember_3b0b7616-7f6b-46b8-9de4-afd86d654a4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_f0010e05-645b-46db-a98d-5992e12c004c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfPayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_us-gaap_SelfPayMember_f0010e05-645b-46db-a98d-5992e12c004c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_30d38a41-53e8-4dea-8a82-d790dd147f80" xlink:href="lh-20230331.xsd#lh_MedicareandMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_lh_MedicareandMedicaidMember_30d38a41-53e8-4dea-8a82-d790dd147f80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_fd5f295e-d022-49fa-9895-8333fdbac7c1" xlink:href="lh-20230331.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_fd5f295e-d022-49fa-9895-8333fdbac7c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_855cbf28-a404-4a46-8cf2-8a181b31d551" xlink:href="lh-20230331.xsd#lh_ThirdpartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_lh_ThirdpartyMember_855cbf28-a404-4a46-8cf2-8a181b31d551" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_16c086c0-fc86-473b-bdf6-f69f004f42be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_srt_MajorCustomersAxis_16c086c0-fc86-473b-bdf6-f69f004f42be" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_16c086c0-fc86-473b-bdf6-f69f004f42be_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_16c086c0-fc86-473b-bdf6-f69f004f42be" xlink:to="loc_srt_NameOfMajorCustomerDomain_16c086c0-fc86-473b-bdf6-f69f004f42be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_66aa35eb-03a7-41fa-89a2-9b206952883d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_16c086c0-fc86-473b-bdf6-f69f004f42be" xlink:to="loc_srt_NameOfMajorCustomerDomain_66aa35eb-03a7-41fa-89a2-9b206952883d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_94bf96d3-20c8-4d31-aa69-85438d5cb74d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_srt_StatementGeographicalAxis_94bf96d3-20c8-4d31-aa69-85438d5cb74d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_94bf96d3-20c8-4d31-aa69-85438d5cb74d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_94bf96d3-20c8-4d31-aa69-85438d5cb74d" xlink:to="loc_srt_SegmentGeographicalDomain_94bf96d3-20c8-4d31-aa69-85438d5cb74d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_94bf96d3-20c8-4d31-aa69-85438d5cb74d" xlink:to="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0c282e71-cf2b-4153-bf98-f2301b9127ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:to="loc_srt_EuropeMember_0c282e71-cf2b-4153-bf98-f2301b9127ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_61b0dd2a-188e-4160-8b37-976c8100326a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:to="loc_srt_NorthAmericaMember_61b0dd2a-188e-4160-8b37-976c8100326a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_4ae3a298-5444-4a20-a9a9-62341761fdd1" xlink:href="lh-20230331.xsd#lh_OthercountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:to="loc_lh_OthercountriesMember_4ae3a298-5444-4a20-a9a9-62341761fdd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_33478756-bab9-4302-bf22-a4e2609fbedf" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:to="loc_country_US_33478756-bab9-4302-bf22-a4e2609fbedf" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lh-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6517acae-4533-4b41-af86-61933115c4be,g:534dcbed-da35-4848-959c-5965c7debeab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_b524c412-adb3-463e-a044-48fa32e979e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncreaseDecreaseinUnbilledContractReceivable_a5bc59f8-d084-4b25-a1b4-2b2c40599508_terseLabel_en-US" xlink:label="lab_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unbilled Contract Receivable</link:label>
    <link:label id="lab_lh_IncreaseDecreaseinUnbilledContractReceivable_label_en-US" xlink:label="lab_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unbilled Contract Receivable</link:label>
    <link:label id="lab_lh_IncreaseDecreaseinUnbilledContractReceivable_documentation_en-US" xlink:label="lab_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unbilled Contract Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:href="lh-20230331.xsd#lh_IncreaseDecreaseinUnbilledContractReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:to="lab_lh_IncreaseDecreaseinUnbilledContractReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CovanceDrugDevelopmentMember_f70efee6-c680-49a0-bc25-eccf869432ca_terseLabel_en-US" xlink:label="lab_lh_CovanceDrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:label id="lab_lh_CovanceDrugDevelopmentMember_label_en-US" xlink:label="lab_lh_CovanceDrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:label id="lab_lh_CovanceDrugDevelopmentMember_documentation_en-US" xlink:label="lab_lh_CovanceDrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CovanceDrugDevelopmentMember" xlink:to="lab_lh_CovanceDrugDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_e828761e-4e99-40b6-9006-a831b98d77fb_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_510b4f17-6e88-42aa-bf34-da7ae04e4904_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d2cb1d96-d2a2-4641-9ed9-f17e98a1e6c7_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cdf289cc-efe3-4530-8152-d10a24f40796_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PerShareAmountAbstract_f1682e5b-e762-41be-a29e-2e15073e40d9_terseLabel_en-US" xlink:label="lab_lh_PerShareAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share Amount [Abstract]</link:label>
    <link:label id="lab_lh_PerShareAmountAbstract_label_en-US" xlink:label="lab_lh_PerShareAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PerShareAmountAbstract" xlink:href="lh-20230331.xsd#lh_PerShareAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PerShareAmountAbstract" xlink:to="lab_lh_PerShareAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_1c3fdaaa-32d5-41e9-9795-19917f73de89_terseLabel_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commons Stock Issued During Period Shares Employee Stock Plans</link:label>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_label_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commons Stock Issued During Period Shares Employee Stock Plans</link:label>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_documentation_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:href="lh-20230331.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:to="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_b46deecb-aae4-4b87-98a7-14f47a9ec720_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_96f8a4e3-7744-4b10-ac8d-6c91d56b04fe_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7b36c1a5-71fb-46ef-a0b8-b724acb89bbb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_3ab61c2f-f801-49d1-9085-ae3041f3ad08_terseLabel_en-US" xlink:label="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciliation of Operating Income to Consolidated [Abstract]</link:label>
    <link:label id="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_label_en-US" xlink:label="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciliation of Operating Income to Consolidated [Abstract]</link:label>
    <link:label id="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_documentation_en-US" xlink:label="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciliation of Operating Income to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:href="lh-20230331.xsd#lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:to="lab_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_394a58a4-2b48-4b8b-8758-ff62dbec5b6f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c818321-53d1-4c07-a337-95c1e4b81be9_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_53617073-aa68-4257-87bf-b094bef73cef_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionTable_6b0bd7ce-1971-4329-a6cf-7cb78d8ad197_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Table]</link:label>
    <link:label id="lab_us-gaap_DebtConversionTable_label_en-US" xlink:label="lab_us-gaap_DebtConversionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionTable" xlink:to="lab_us-gaap_DebtConversionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_4a8e0712-d56e-4a15-9848-ade4e4b8c10e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surrender of restricted stock and performance share awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_b4387eb4-71cd-45c0-9b97-8f7bea13077c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_216757d7-547f-4035-8395-6b1e174f7287_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_1d630144-9d36-437c-a5a2-c676f9e13927_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_23989713-6a37-43a8-a577-dd371e4c36a4_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f1ef0955-8f69-45fb-8b80-c798b2b20651_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_InterestPaidInCash_5efff50b-7791-4475-bf2e-97f6fe61412e_terseLabel_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_lh_InterestPaidInCash_label_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid In Cash</link:label>
    <link:label id="lab_lh_InterestPaidInCash_documentation_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of cash paid during the current period for interest owed on money borrowed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InterestPaidInCash" xlink:href="lh-20230331.xsd#lh_InterestPaidInCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_InterestPaidInCash" xlink:to="lab_lh_InterestPaidInCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_91e022a6-06cc-4bca-9c97-d0b32936f398_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_14923aff-68ce-48e5-b3b6-1fab3dd8286f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_877c9dba-586c-4e10-b646-beffcf0829c9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_b4d1aed4-89a9-4bbd-a5ec-8dd9f593dfda_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_a0efb08b-d5e8-4edd-b16b-ff7f1198854d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_be342a5d-9b37-4b6a-bd10-2d6a46e8e56c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f46356b1-6561-4935-9bb9-6fdb94eb0522_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ThirdpartyMember_07cce9da-d16a-42e8-b4be-e3c08fa7e84e_terseLabel_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:label id="lab_lh_ThirdpartyMember_label_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:label id="lab_lh_ThirdpartyMember_documentation_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember" xlink:href="lh-20230331.xsd#lh_ThirdpartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ThirdpartyMember" xlink:to="lab_lh_ThirdpartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_fa37fb38-f504-4667-bf33-ecbab80b67f7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0dba5267-2166-4934-b637-593e38acfbb6_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_8ba62603-080a-499d-9653-b5594eb471a7_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f4927baf-6952-47f4-94fc-db2bfa3f5664_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LabCorpDiagnosticsMember_f7c26aa1-2055-4d5f-860d-2716b8f12cab_terseLabel_en-US" xlink:label="lab_lh_LabCorpDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LabCorp Diagnostics [Member]</link:label>
    <link:label id="lab_lh_LabCorpDiagnosticsMember_label_en-US" xlink:label="lab_lh_LabCorpDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LabCorp Diagnostics [Member]</link:label>
    <link:label id="lab_lh_LabCorpDiagnosticsMember_documentation_en-US" xlink:label="lab_lh_LabCorpDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LabCorp Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LabCorpDiagnosticsMember" xlink:to="lab_lh_LabCorpDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_60af5fca-7769-4da0-9d8d-e526094e0e09_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_73d51323-a519-4ad2-a9bf-81a7053551bc_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_a658dc26-3d70-4a74-b85f-72776ed24eff_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b34e87cc-3dae-4859-8dfc-dd36725271d3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_118fa918-9f31-489e-b062-a301d817eeb8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_f3088045-9385-4958-b395-80b9750ac275_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A155SeniorNotesDue2026_853f8254-aece-476a-b9ad-24c3790ccbe2_terseLabel_en-US" xlink:label="lab_lh_A155SeniorNotesDue2026" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.55% senior notes due 2026</link:label>
    <link:label id="lab_lh_A155SeniorNotesDue2026_label_en-US" xlink:label="lab_lh_A155SeniorNotesDue2026" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.55% senior notes due 2026</link:label>
    <link:label id="lab_lh_A155SeniorNotesDue2026_documentation_en-US" xlink:label="lab_lh_A155SeniorNotesDue2026" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.55% senior notes due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026" xlink:href="lh-20230331.xsd#lh_A155SeniorNotesDue2026"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A155SeniorNotesDue2026" xlink:to="lab_lh_A155SeniorNotesDue2026" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AllowanceforCreditLoss_c8c35824-b3fe-4129-a504-e85c7a07f80d_terseLabel_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_AllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_AllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss" xlink:href="lh-20230331.xsd#lh_AllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AllowanceforCreditLoss" xlink:to="lab_lh_AllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DiagnosticsMember_a1aefbad-7caa-4501-8685-07dbe26d67c3_terseLabel_en-US" xlink:label="lab_lh_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_lh_DiagnosticsMember_label_en-US" xlink:label="lab_lh_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_lh_DiagnosticsMember_documentation_en-US" xlink:label="lab_lh_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember" xlink:href="lh-20230331.xsd#lh_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DiagnosticsMember" xlink:to="lab_lh_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_53b8d6e8-b3d4-45f0-9f96-f8b7bad2ca30_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Longtermdebtissuancecosts_69d61431-0725-4a90-92c6-6c9be782bbe9_terseLabel_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:label id="lab_lh_Longtermdebtissuancecosts_label_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:label id="lab_lh_Longtermdebtissuancecosts_documentation_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts" xlink:href="lh-20230331.xsd#lh_Longtermdebtissuancecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Longtermdebtissuancecosts" xlink:to="lab_lh_Longtermdebtissuancecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_731b3a0f-21a3-4d52-9976-4bcc86489d18_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1d7c60e2-9667-4b18-b6b1-722ace236860_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3ca09251-ba22-4484-b8fc-2b250e37065f_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Benefit Plan Adjustments, Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4d6d75f3-84dc-46b5-9e77-b1ff9d65211f_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Benefit Plan Adjustments, Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_376bd922-f1d4-4053-80db-ed9dc1ed58e7_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_5b2a24c4-0788-437a-b7ff-40bf3d97d46c_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_584e5fda-a7e3-4def-b43a-f980809972fb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgesAtFairValueNet_0e43f059-8d7d-4f42-88c5-f3c7b39a6c7b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges, Net</link:label>
    <link:label id="lab_us-gaap_FairValueHedgesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_FairValueHedgesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgesAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgesAtFairValueNet" xlink:to="lab_us-gaap_FairValueHedgesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_07ad0b9a-7528-40f0-bef6-de7c08a3ac9e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_11e05bde-3a80-4ec4-9270-f71944c6021c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_7b9e140f-da0c-41ba-8e7a-374377d0b42d_terseLabel_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_label_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_documentation_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:href="lh-20230331.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:to="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_78849473-7a30-4185-bb97-a56da8e00a49_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f32d67dc-5937-4d99-9cdd-508845c19fd4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b783cc15-97a5-46db-bf99-68eaba559e88_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Earnings, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_18885482-24a0-4cc4-9ab9-281af33d6748_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d2820862-d3ec-48a8-8a87-50089879e641_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_2c69ddf2-a0e0-4571-8c67-c7ea08d66ee2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_98e0b216-35aa-43c3-b8ff-5e52fa3b7179_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_26cbb888-7863-4fc5-ab94-d30574b84f65_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_25b3cadf-c959-4835-8bef-0fa4767ad432_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_447afb83-6841-41b1-bcca-893ca8d2c975_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Issuanceofcommonstockunderemployeeplans_aa69a417-e032-41c4-b2d6-87d3972c50e3_negatedTerseLabel_en-US" xlink:label="lab_lh_Issuanceofcommonstockunderemployeeplans" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_lh_Issuanceofcommonstockunderemployeeplans_label_en-US" xlink:label="lab_lh_Issuanceofcommonstockunderemployeeplans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee plans</link:label>
    <link:label id="lab_lh_Issuanceofcommonstockunderemployeeplans_documentation_en-US" xlink:label="lab_lh_Issuanceofcommonstockunderemployeeplans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate change in value for stock issued in period under ESPP combined with the value of stock issued as a result of option exercises.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Issuanceofcommonstockunderemployeeplans" xlink:href="lh-20230331.xsd#lh_Issuanceofcommonstockunderemployeeplans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Issuanceofcommonstockunderemployeeplans" xlink:to="lab_lh_Issuanceofcommonstockunderemployeeplans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_7fcf5c5f-cd27-48ac-9f0a-3f3d2c2a614c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_1149affd-86d6-46d7-ad22-9e482c1a7cc4_terseLabel_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, Licenses And Technology [Member]</link:label>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_label_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, Licenses And Technology [Member]</link:label>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_documentation_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents are the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law. Licenses are rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory). Technology-based intangible assets are innovations or scientific advances that have not been patented.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PatentsLicensesAndTechnologyMember" xlink:to="lab_lh_PatentsLicensesAndTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_ef1b3f8a-3180-4195-a573-a86b568e5f1b_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_5fc5c970-ccab-4331-abb0-89071356cd87_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_label_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_documentation_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease" xlink:href="lh-20230331.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityOptiontoIncrease" xlink:to="lab_lh_CreditFacilityOptiontoIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_8a4e17c5-3d69-4984-8626-56f1476cda9b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesFairValue_b52c4175-b7e3-42a9-8398-3fac6f8c15b7_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value of senior notes</link:label>
    <link:label id="lab_lh_SeniorNotesFairValue_label_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Fair Value</link:label>
    <link:label id="lab_lh_SeniorNotesFairValue_documentation_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of the debt instrument (senior notes) at the balance-sheet date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue" xlink:href="lh-20230331.xsd#lh_SeniorNotesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesFairValue" xlink:to="lab_lh_SeniorNotesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b7faf1ee-8545-4e56-b825-2c4009389f86_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_9c8173c7-49a2-428b-b33a-1fa03ce18dd4_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1615846d-4af3-4ea2-8160-092337dd980e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_98f0e20d-5d6f-40df-b34d-fe2fbae9ee4f_terseLabel_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss" xlink:href="lh-20230331.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoteReceivableAllowanceforCreditLoss" xlink:to="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_0607e724-b1e9-4135-8f12-597f7fb98779_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_24532ae4-5eea-4dbe-be63-720090f5bd4a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b26ce765-a3c7-4ea1-bff8-f650c4ade2a1_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d00f31bb-aac9-4bda-9a4d-bf5ee1b2680d_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_5ebaa8dc-c1bb-46b4-b257-692663bc8ee5_terseLabel_en-US" xlink:label="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</link:label>
    <link:label id="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_label_en-US" xlink:label="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</link:label>
    <link:label id="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_documentation_en-US" xlink:label="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:href="lh-20230331.xsd#lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:to="lab_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2e21e52f-eb53-4e00-a3d3-86f2883e2439_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoncontrollingInterestPutsAbstract_d9d47661-deac-4944-953c-bc8ca58528c0_terseLabel_en-US" xlink:label="lab_lh_NoncontrollingInterestPutsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Puts [Abstract]</link:label>
    <link:label id="lab_lh_NoncontrollingInterestPutsAbstract_label_en-US" xlink:label="lab_lh_NoncontrollingInterestPutsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Puts [Abstract]</link:label>
    <link:label id="lab_lh_NoncontrollingInterestPutsAbstract_documentation_en-US" xlink:label="lab_lh_NoncontrollingInterestPutsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Puts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestPutsAbstract" xlink:href="lh-20230331.xsd#lh_NoncontrollingInterestPutsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoncontrollingInterestPutsAbstract" xlink:to="lab_lh_NoncontrollingInterestPutsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_3ebc3e16-faef-4fb2-8cea-328c47a84761_terseLabel_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Of Leased Assets</link:label>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_label_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Of Leased Assets</link:label>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_documentation_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:href="lh-20230331.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:to="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6167042b-3ced-40cb-a657-0ee79e25db17_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85bfb888-cf22-46a2-a161-be143942156a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_1b93cf10-02af-41ce-bb88-ca2986521abb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e3d033c7-25e2-4f67-b0f4-54edac4c071d_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_a5e0e9de-982c-48e3-b098-7cbb8702e3bd_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_63802811-c863-413a-8bf6-5b2f18dad823_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_af5d5bcc-a01e-4d77-b8fe-d795d86f429c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_a1aab9fb-8e46-4814-9580-ea3225e4100b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ClientMember_6d4cc230-ccc2-434b-af75-b900b0f53f97_terseLabel_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:label id="lab_lh_ClientMember_label_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:label id="lab_lh_ClientMember_documentation_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember" xlink:href="lh-20230331.xsd#lh_ClientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ClientMember" xlink:to="lab_lh_ClientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_78014643-e0fd-40e2-9571-4bce66738325_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_11500626-da04-4fd8-bdb8-878bb42b5a00_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9b0cc665-9928-4c33-8264-6a3e4ad100a8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4071ebe8-b4b6-4111-9e14-d4228e591b70_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OtherFinancingCashFlows_95e95a11-345c-40ad-908a-a3635e920662_terseLabel_en-US" xlink:label="lab_lh_OtherFinancingCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financing Cash Flows</link:label>
    <link:label id="lab_lh_OtherFinancingCashFlows_label_en-US" xlink:label="lab_lh_OtherFinancingCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financing Cash Flows</link:label>
    <link:label id="lab_lh_OtherFinancingCashFlows_documentation_en-US" xlink:label="lab_lh_OtherFinancingCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financing Cash Flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtherFinancingCashFlows" xlink:href="lh-20230331.xsd#lh_OtherFinancingCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OtherFinancingCashFlows" xlink:to="lab_lh_OtherFinancingCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_1568942e-c2c3-469e-b327-a42805fb8813_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0b76370b-c72c-4c66-85bc-d784f4fffe7f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_37f71ff8-ee42-4f3c-9b6e-2b940f02f692_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_50fa9c82-6579-4324-a047-8a2fefdfe5ac_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_0fb8eecb-ca74-441e-9bdb-da1ceacf1fde_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_337060b2-a3ff-4860-8188-7e9ab3a10aec_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredSalesCommissions_d4876d36-99ba-4d2e-aa31-3db6c8be637f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Sales Commissions</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredSalesCommissions_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Sales Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:to="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_e96bf14a-659b-4d2a-8d61-53acde557570_terseLabel_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring and other special charges</link:label>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_label_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring and other special charges</link:label>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_documentation_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges" xlink:href="lh-20230331.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetRestructuringAndOtherSpecialCharges" xlink:to="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_76ace347-77c0-4858-ac16-2ea7efe66dd6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_8663e16b-daf9-4e8c-9ed7-c8e957075067_terseLabel_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable [Member]</link:label>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_label_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable [Member]</link:label>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_documentation_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember" xlink:href="lh-20230331.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnbilledContractsReceivableMember" xlink:to="lab_lh_UnbilledContractsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2.30seniornotesdue2024_1c11ed00-b6b0-43d7-9e98-5cccea56da85_terseLabel_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:label id="lab_lh_A2.30seniornotesdue2024_label_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:label id="lab_lh_A2.30seniornotesdue2024_documentation_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024" xlink:href="lh-20230331.xsd#lh_A2.30seniornotesdue2024"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2.30seniornotesdue2024" xlink:to="lab_lh_A2.30seniornotesdue2024" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_2b7b4364-b8eb-4f61-bc4c-0d445fdf1c89_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_67c6b092-92f2-43cb-b63a-541a17d618ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_5a4be6eb-a70a-40a1-9681-4ef5d9669167_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_72d9fb1b-05c6-47b3-a097-d00c19686f2e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0f81efaa-ac97-45d0-9d27-d9405812ccca_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_4246fc72-6e1f-4565-9ba7-1f6133948234_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid_8faf5b89-2594-45e9-8cbb-233581e9aeee_negatedTerseLabel_en-US" xlink:label="lab_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Capital Expenditures Incurred but not yet Paid</link:label>
    <link:label id="lab_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Capital Expenditures Incurred but not yet Paid</link:label>
    <link:label id="lab_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Capital Expenditures Incurred but not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid" xlink:href="lh-20230331.xsd#lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_f87e4bbf-9780-4a7e-9053-f1bf963b1050_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_88d1a583-58f0-4ecc-b46e-5cfca231adbd_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_90971634-4f28-44ad-9375-5f116f9f722e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_b06374d1-6e43-41d1-ac75-1302912429c6_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_721dc98e-83df-42d7-9bdc-0b2ba9bf9c38_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_3e41241b-00d7-4e58-aa89-dfad1ae961b5_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_fa85771f-59e4-482f-b332-7a84859178e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonSharesIssuedRollforwardAbstract_7db288af-9c2f-4c18-ac5f-0f472863e8a5_terseLabel_en-US" xlink:label="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of common shares issued</link:label>
    <link:label id="lab_lh_CommonSharesIssuedRollforwardAbstract_label_en-US" xlink:label="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Issued Rollforward [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesIssuedRollforwardAbstract" xlink:href="lh-20230331.xsd#lh_CommonSharesIssuedRollforwardAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract" xlink:to="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9bf2dcb5-0955-4fb7-ad10-15d74c28a259_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_3f816e82-db49-4c1a-b23f-b84d7c776c5a_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_07e9d2ee-f9de-4604-8401-ac30203b2aa5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_21972112-3347-4853-889e-96681d8a1348_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_31e014de-bbac-4de6-9cfc-1ee2a28a839e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_ef52d721-d74b-4de7-86dd-466ba3f82cdc_terseLabel_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in common shares issued and held in treasury</link:label>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_label_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Common Shares Issued And Held In Treasury [Table Text Block]</link:label>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_documentation_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule is used to show the changes in common shares issued and held in treasury by the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:href="lh-20230331.xsd#lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:to="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_4aaecb1a-9c75-40ef-9233-895eccbe57e8_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_5f7ab249-2955-41c3-9224-bbf5a1fdd3ad_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_84a29f17-039e-49ad-995c-1d97ceb2ed7c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfPayMember_36ededb7-1239-4945-8651-007f3cc51ade_terseLabel_en-US" xlink:label="lab_us-gaap_SelfPayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay [Member]</link:label>
    <link:label id="lab_us-gaap_SelfPayMember_label_en-US" xlink:label="lab_us-gaap_SelfPayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfPayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfPayMember" xlink:to="lab_us-gaap_SelfPayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_34e086f6-cf28-40ca-842b-8a401228df02_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_ccc751c5-837a-4b07-b8f0-c18332b882e0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_f7c5ffe3-7848-498a-bcac-b8c17e4d68b0_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_6a1208ad-290f-490a-b75d-b34be3f85f49_terseLabel_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively</link:label>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_label_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Mezzanine Equity</link:label>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_documentation_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity" xlink:href="lh-20230331.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoncontrollingInterestMezzanineEquity" xlink:to="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_cad0d5c9-172c-45fc-8f73-dec40d493945_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A400SeniorNotesDue2023_33a4ce36-d4e5-40fe-92ce-6712ed354ebf_terseLabel_en-US" xlink:label="lab_lh_A400SeniorNotesDue2023" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% senior notes due 2023</link:label>
    <link:label id="lab_lh_A400SeniorNotesDue2023_label_en-US" xlink:label="lab_lh_A400SeniorNotesDue2023" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% senior notes due 2023</link:label>
    <link:label id="lab_lh_A400SeniorNotesDue2023_documentation_en-US" xlink:label="lab_lh_A400SeniorNotesDue2023" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% senior notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A400SeniorNotesDue2023" xlink:href="lh-20230331.xsd#lh_A400SeniorNotesDue2023"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A400SeniorNotesDue2023" xlink:to="lab_lh_A400SeniorNotesDue2023" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonSharesOutstandingRollforwardAbstract_4b08638b-e3ed-4899-80bd-7655c5b6dc19_terseLabel_en-US" xlink:label="lab_lh_CommonSharesOutstandingRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Outstanding Rollforward [Abstract]</link:label>
    <link:label id="lab_lh_CommonSharesOutstandingRollforwardAbstract_label_en-US" xlink:label="lab_lh_CommonSharesOutstandingRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Outstanding Rollforward [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesOutstandingRollforwardAbstract" xlink:href="lh-20230331.xsd#lh_CommonSharesOutstandingRollforwardAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract" xlink:to="lab_lh_CommonSharesOutstandingRollforwardAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_83108062-2990-473b-a07a-c9ada0091c87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_fa74ad39-f1d1-4267-b946-80d95ea25dfc_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_a5c63bb6-0cfc-4eb3-8eb5-395adcac9c31_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_a9e63336-8039-4686-94a3-b75e8ac200a3_terseLabel_en-US" xlink:label="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_8221e061-26ac-4d46-8a70-4be0c918d40a_totalLabel_en-US" xlink:label="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_label_en-US" xlink:label="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest</link:label>
    <link:label id="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_documentation_en-US" xlink:label="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:href="lh-20230331.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:to="lab_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e35cd10b-6be9-490f-a2e4-c8f045fc650e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_55cd91c2-3e47-4f4c-94a1-043f98c8bef9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3e136ab6-3505-4708-ad08-be3f1b9fdcc5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_058624f3-c64c-4437-893e-e2200bae8f97_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_712c69a8-5b39-4240-82d6-1a8c4e1919df_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a4c935c4-dded-4c11-a958-41ad55500bcd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_224b7880-9d26-4c60-bc4c-1e0f86f04024_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d7692db4-4181-4cc1-baa6-ea3a8158ef63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashPaidDuringPeriodForAbstract_f782d83c-7766-48f2-8f22-d20c0c411366_terseLabel_en-US" xlink:label="lab_lh_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during period for:</link:label>
    <link:label id="lab_lh_CashPaidDuringPeriodForAbstract_label_en-US" xlink:label="lab_lh_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During Period For [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaidDuringPeriodForAbstract" xlink:href="lh-20230331.xsd#lh_CashPaidDuringPeriodForAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract" xlink:to="lab_lh_CashPaidDuringPeriodForAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_fcc0397c-7f07-4ec2-8b52-cf981b2e4337_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d3edcb6b-b664-40fb-a9a6-9861201651b7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillMember_97e01220-06a7-473c-834c-1b858333116e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:label id="lab_us-gaap_GoodwillMember_label_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillMember" xlink:to="lab_us-gaap_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ed3af607-11db-49e4-a142-29bbafe4d726_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2015</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cf29129a-f0cd-43ae-9b08-3ccb10a9fcf2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_05a7b428-eb5d-4740-a1db-872f3c0febe2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a81c0742-ac2c-49a8-b5f8-f18e13d5b997_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1576dd69-af15-4b91-8444-60837d65bbda_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_9733d3fa-42b3-472e-b784-24a71d5aa795_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c04377b2-5157-4931-8542-85b6862825da_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_056dddd1-f703-4f46-b6b4-31cda09009b7_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_b275accb-5553-4222-98c3-58658295ce7f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_f332189c-f8f6-4b52-830f-b6b1b195012c_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_3cc6de66-dadd-456b-b887-35cecf5c8396_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_8af3136e-6239-4f0f-ae35-09085c2061a7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_63668cb0-25d4-4991-8647-4a5c09131177_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_a4b0d63f-0f44-448a-a7f7-ecb9be9d33c2_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_801aaf76-690d-430c-ab7c-b675010cc3d3_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_e89f4e00-462f-4229-861b-a878e75c3661_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles and other assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f99f1162-f012-473f-a536-fb774f8fdea4_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_115c1089-2de2-4e15-b482-c5faabf2d145_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_e66ad062-3264-4a71-aa85-963f0acc34eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_202529ee-0c1d-4ba9-b1a5-5fa490634d29_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_f82d60c1-46f2-4c8e-950c-fa570c4ba80b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_4161bccf-137c-4ef4-ba03-cd38e0afbe92_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseRightsMember_8afe1cb5-7508-434c-8cfe-28a8b3a8d4ac_terseLabel_en-US" xlink:label="lab_us-gaap_UseRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Rights [Member]</link:label>
    <link:label id="lab_us-gaap_UseRightsMember_label_en-US" xlink:label="lab_us-gaap_UseRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseRightsMember" xlink:to="lab_us-gaap_UseRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_f35ec7f4-bacf-45ab-9271-462534af1845_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_22cc01e4-7359-4803-b316-5f49e2018057_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e47546c-fede-4ded-97df-bb4e7916c8b2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e16b2ced-e1fa-477b-a2ac-a01a8c1f424b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_eaa6396f-18a4-40cc-b80a-ebd1e2e7ed5b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BALANCE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ab86b56d-780a-4dff-8e65-00aed4914564_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BALANCE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_41b9a199-d2d8-44f4-a155-5655f226e17d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_c46a86a6-90f6-461f-a8de-28c459e4ebc5_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_b5bff243-e73a-4ef2-a10a-01bcbe5f377a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection_4e6ba5c2-670f-4d7a-8616-7624099624b8_terseLabel_en-US" xlink:label="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Measurement Funds Available For Participant Election</link:label>
    <link:label id="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection_label_en-US" xlink:label="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Measurement Funds Available For Participant Election</link:label>
    <link:label id="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection_documentation_en-US" xlink:label="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Measurement Funds Available For Participant Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:href="lh-20230331.xsd#lh_NumberofMeasurementFundsAvailableForParticipantElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:to="lab_lh_NumberofMeasurementFundsAvailableForParticipantElection" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_b6b494b6-70b0-449b-b4c4-373fbc1fd5b4_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_53be636d-5cb9-49d7-b0f7-ee10c91628ba_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_eada6714-d00b-4e92-a9c7-1d5a5af724aa_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8002f6ce-d4e9-4045-937f-6bcc822639a3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_43834d79-26fd-4b1e-bc43-94170d7cfacc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_1fdbca29-3e93-4ea7-a053-d24a4ee56c1e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_6ae41f12-3033-46fb-9f2f-7cf8cc30c274_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_label_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe17c76d-96c2-4da6-85a3-845ba9d8b7d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in assets and liabilities (net of effects of acquisitions):</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_23e14135-861a-4e72-be1f-ba228cf31cc0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2014</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_3966baa0-d837-409c-a044-62d7789f2d82_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_label_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_documentation_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:to="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_733534b3-adef-41ba-8ebf-a24980c4e9e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_21e40a4b-246d-4d36-8acb-ae06485e3db6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_27d5afb0-a8af-430b-a872-56840fca6272_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_7d1d3ee7-2aa8-4183-85d8-e66cd8c4d637_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2.95seniornotesdue2029_4ac1f116-23bb-4631-a85e-3053265f4554_terseLabel_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:label id="lab_lh_A2.95seniornotesdue2029_label_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:label id="lab_lh_A2.95seniornotesdue2029_documentation_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029" xlink:href="lh-20230331.xsd#lh_A2.95seniornotesdue2029"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2.95seniornotesdue2029" xlink:to="lab_lh_A2.95seniornotesdue2029" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_7afe0d3b-23c4-450b-bb34-a805a0913899_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_6368d208-6659-4725-b21a-057c1cdadaa0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e5db9bee-0b1f-4394-b2c9-0838f617ebda_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentDomain_8749ac45-86d7-4add-b1dc-4a3003974e50_terseLabel_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:label id="lab_dei_DocumentDomain_label_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract_32ded6c9-b9a2-4f72-86d4-c34dca09ea60_terseLabel_en-US" xlink:label="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of common shares held in treasury</link:label>
    <link:label id="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract_label_en-US" xlink:label="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Held In Treasury Rollforward [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:href="lh-20230331.xsd#lh_CommonSharesHeldInTreasuryRollforwardAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:to="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_14846921-b7a5-4716-b888-ae75e5d3ff15_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_11be4ac4-ae4b-4e7e-9b1f-665d02c3932c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2027Member_6b2af7dd-6134-42de-8f2b-a6aa95ca9dec_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2027Member_label_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2027Member_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2027Member" xlink:to="lab_lh_Seniornotesdue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_3bd38005-494f-40b7-9be2-a6d1f82c4613_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_60e80c82-c543-4ad4-b571-c92278a7fafd_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2356c6e1-dcb9-4370-bf7f-00e393c5e05f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_8a268d04-3ccb-4457-93a4-cd9c597e03ac_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_f3710372-593e-4077-a040-0afd2c8567bf_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss) before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_c1c496c5-c49a-4225-9841-102977dfc34d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_eef85aab-d92a-4854-92af-4637c3b6693a_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_580de8ca-6d95-4c2b-a7f7-38b4939642a7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_46c6c055-5f53-4ad1-87fc-9e264b406624_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_d41b5fac-8b95-43ed-a63c-4b2c9cd9d22e_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4375f5df-21e2-4581-8bab-867d7127dd59_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_67695dbe-b301-4185-870b-16f98248be79_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23b9e927-a995-4098-82e5-fd165c77bb5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SwapTypeAxis_bbc2cb02-f3ee-4a1c-9b77-c05c9a7eecc1_terseLabel_en-US" xlink:label="lab_lh_SwapTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Axis]</link:label>
    <link:label id="lab_lh_SwapTypeAxis_label_en-US" xlink:label="lab_lh_SwapTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Axis]</link:label>
    <link:label id="lab_lh_SwapTypeAxis_documentation_en-US" xlink:label="lab_lh_SwapTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis" xlink:href="lh-20230331.xsd#lh_SwapTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SwapTypeAxis" xlink:to="lab_lh_SwapTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b0e24a62-758d-4260-8cf4-e3895e44d98d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3131c353-474e-46bd-bb30-ce67dc6f2845_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_e46624fc-c2f6-4d67-b4c6-ba6bac8be9df_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_91519cfb-3671-4fe3-abe4-5f97d661a540_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_9357ccc2-3d57-4de2-9b12-2772bf5e65df_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_11fc7bb9-3d61-44da-b88f-a9b003df574c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9af6dba4-648d-49ba-9df1-5ba38eccdc29_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashFlowLocationDomain_1c346229-bcdc-4833-8476-0acf5957be8f_terseLabel_en-US" xlink:label="lab_lh_CashFlowLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Domain]</link:label>
    <link:label id="lab_lh_CashFlowLocationDomain_label_en-US" xlink:label="lab_lh_CashFlowLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Domain]</link:label>
    <link:label id="lab_lh_CashFlowLocationDomain_documentation_en-US" xlink:label="lab_lh_CashFlowLocationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Cash Flow Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationDomain" xlink:href="lh-20230331.xsd#lh_CashFlowLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashFlowLocationDomain" xlink:to="lab_lh_CashFlowLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b4116210-1f2f-4751-8782-ad02d566eeef_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OthercountriesMember_ce30ea38-6f0c-4231-b5b8-4ae939547bfe_terseLabel_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_lh_OthercountriesMember_label_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_lh_OthercountriesMember_documentation_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember" xlink:href="lh-20230331.xsd#lh_OthercountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OthercountriesMember" xlink:to="lab_lh_OthercountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_34f2f3a2-c289-45b7-b818-a67cd80b95e9_terseLabel_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of stock to employees</link:label>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_label_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of stock to employees</link:label>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_documentation_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:href="lh-20230331.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:to="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_e81fa75c-e5a5-40d1-b17c-484f96b13eab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_38179883-0e2c-4a8c-9429-217b4ee70a00_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_014d55c6-c0dd-4800-89f4-c4a0751e0551_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_5028a80c-cfbe-4212-8cf8-a16421ab4001_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_01963e51-9170-41e9-9d6a-65326d160bb4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_00b70ebf-f092-4b62-a61a-333ffb769b15_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueRevenueRecognized1_3a2ebd9a-1ac4-45cd-a79d-533e762b3bcc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueRevenueRecognized1_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueRevenueRecognized1" xlink:to="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_MedicareandMedicaidMember_a308bc08-02e8-44f4-9481-0ff7716eb9d3_terseLabel_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:label id="lab_lh_MedicareandMedicaidMember_label_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:label id="lab_lh_MedicareandMedicaidMember_documentation_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember" xlink:href="lh-20230331.xsd#lh_MedicareandMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_MedicareandMedicaidMember" xlink:to="lab_lh_MedicareandMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_157b12ae-da7b-4c1c-8ff0-a1bb7da3c4f5_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a4712792-4329-44e0-bc51-5a1a2b8f057f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_63686e2d-ed2f-41d7-9265-53cfe5449a39_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4e6a4b86-e1d0-4f54-b2d5-0305818ac7c5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_3afdee55-dbaa-493d-bc97-cfa17a394266_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OtheracquireesMember_df647918-5d4d-425d-9ddf-ba39c56f393b_terseLabel_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees</link:label>
    <link:label id="lab_lh_OtheracquireesMember_label_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees [Member]</link:label>
    <link:label id="lab_lh_OtheracquireesMember_documentation_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember" xlink:href="lh-20230331.xsd#lh_OtheracquireesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OtheracquireesMember" xlink:to="lab_lh_OtheracquireesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7ff64fde-8e90-48a1-ae8a-bf6785b91bed_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_cf2b6f36-8b00-4553-ab78-5d9b14038319_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e07fc287-54ff-45d8-a170-031e5f3359e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_75aeff0d-4ef4-4f6c-a473-c7034692060f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e9c2a39e-d7c8-432c-8318-9ad48a6135bc_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CurrentDebtExcludingFinanceLeaseLiability_fdd6c88e-db64-4b98-964c-c5c6c65a1a05_terseLabel_en-US" xlink:label="lab_lh_CurrentDebtExcludingFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt excluding finance lease liability</link:label>
    <link:label id="lab_lh_CurrentDebtExcludingFinanceLeaseLiability_label_en-US" xlink:label="lab_lh_CurrentDebtExcludingFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt excluding finance lease liability</link:label>
    <link:label id="lab_lh_CurrentDebtExcludingFinanceLeaseLiability_documentation_en-US" xlink:label="lab_lh_CurrentDebtExcludingFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt excluding finance lease liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentDebtExcludingFinanceLeaseLiability" xlink:href="lh-20230331.xsd#lh_CurrentDebtExcludingFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CurrentDebtExcludingFinanceLeaseLiability" xlink:to="lab_lh_CurrentDebtExcludingFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_525fb726-3ae3-4f47-a043-92c51d91fda3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture partnerships and equity method investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_765d3f73-3ce9-4a03-859a-d880471619fe_netLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net</link:label>
    <link:label id="lab_us-gaap_Goodwill_aebfd8c7-89a7-4120-87ac-fc5571814acf_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1</link:label>
    <link:label id="lab_us-gaap_Goodwill_8191b477-8cd7-4e37-9a47-e43e9ebadda5_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_e438f2c5-eb9d-4ce5-9ca7-c25fac5b9fc9_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_f9a072b1-e38c-4e6b-b768-6eaf0ff259ca_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_4669f1d0-2d07-459b-b1e3-968a2fa3d6fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_22de8afc-86fc-4fea-a415-58922b7103db_terseLabel_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_label_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_documentation_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum" xlink:href="lh-20230331.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LongTermContractsDurationMaximum" xlink:to="lab_lh_LongTermContractsDurationMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_33b2fedf-2493-47a1-954d-d9e143b7dd77_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75f34093-346b-47e8-b50b-68a5881530c4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e0f0d530-ea5d-4ea5-8688-046c15b7b241_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_48033c26-0bf2-4fe8-ae21-ec7aca186a66_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_65e26f38-0d53-4939-9de3-a5d35e93e9cd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4cded147-b2f7-4f08-80fb-3ba286c94128_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0909af26-e324-4c37-844c-3653a4275b9c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_cadd3f4e-d3c3-4f35-8292-0ce6ff55f581_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_bb977e64-4fbb-4796-9f50-49c0d0401c73_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian licenses [Member]</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0927456f-c009-48e8-b6bd-95ed94afe6d8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b7a30683-683f-4191-a9e7-78d2f1557360_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_b5d99e31-8f50-4963-afb0-31bb40915f88_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ab34caf6-f77f-448b-9af0-4fba23884c93_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_b41b2b28-d437-41ae-b73a-7e83c9900b3a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_ca750f01-6fb9-4485-9399-2d94d980d40e_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_85d6ed6d-bb15-4014-a301-01f9f6378d48_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2022Member_4ff4e0e9-954f-4de3-8305-63888e916921_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2022Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2022Member" xlink:to="lab_lh_SeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_35ec9404-c919-478b-8871-7166807b897f_negatedTerseLabel_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_label_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_documentation_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts" xlink:href="lh-20230331.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Shorttermdebtissuancecosts" xlink:to="lab_lh_Shorttermdebtissuancecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_cd101ce9-0853-4aad-92cf-fc936418abfc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2f5b10b5-dd6c-4345-ae90-b863734cf0b7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A325SeniorNotesDue2024_b73729b5-d26e-4d7f-b4db-88b01296a629_terseLabel_en-US" xlink:label="lab_lh_A325SeniorNotesDue2024" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due 2024</link:label>
    <link:label id="lab_lh_A325SeniorNotesDue2024_label_en-US" xlink:label="lab_lh_A325SeniorNotesDue2024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due 2024</link:label>
    <link:label id="lab_lh_A325SeniorNotesDue2024_documentation_en-US" xlink:label="lab_lh_A325SeniorNotesDue2024" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A325SeniorNotesDue2024" xlink:href="lh-20230331.xsd#lh_A325SeniorNotesDue2024"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A325SeniorNotesDue2024" xlink:to="lab_lh_A325SeniorNotesDue2024" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e6adcce8-3928-4329-aa26-2ab61fda5598_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_7c13e486-68df-40ca-8519-2eea9618a73b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SwapTypeDomain_663a48b8-d299-4cfc-a92b-6ea27bb2c883_terseLabel_en-US" xlink:label="lab_lh_SwapTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Domain]</link:label>
    <link:label id="lab_lh_SwapTypeDomain_label_en-US" xlink:label="lab_lh_SwapTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Domain]</link:label>
    <link:label id="lab_lh_SwapTypeDomain_documentation_en-US" xlink:label="lab_lh_SwapTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain" xlink:href="lh-20230331.xsd#lh_SwapTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SwapTypeDomain" xlink:to="lab_lh_SwapTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_0ac5c577-7093-4a4b-a03d-ad16dccd0b8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e44c1a8a-c49c-4b0a-8b90-541534314391_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential common shares not included in computation of diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_c0e78462-b9d7-45ef-a382-aa5daa207d50_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Contingentconsiderationadjustment_dac57a0e-3211-4f47-b473-038ae4456fbd_negatedTerseLabel_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:label id="lab_lh_Contingentconsiderationadjustment_label_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:label id="lab_lh_Contingentconsiderationadjustment_documentation_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment" xlink:href="lh-20230331.xsd#lh_Contingentconsiderationadjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Contingentconsiderationadjustment" xlink:to="lab_lh_Contingentconsiderationadjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_bce07a8d-d47b-49f4-a785-9839ebde8a3b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ThreeMonthLIBOR_08106171-96a6-47d9-b839-ad86ab3ef300_terseLabel_en-US" xlink:label="lab_lh_ThreeMonthLIBOR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three month LIBOR</link:label>
    <link:label id="lab_lh_ThreeMonthLIBOR_label_en-US" xlink:label="lab_lh_ThreeMonthLIBOR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three month LIBOR</link:label>
    <link:label id="lab_lh_ThreeMonthLIBOR_documentation_en-US" xlink:label="lab_lh_ThreeMonthLIBOR" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three month LIBOR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThreeMonthLIBOR" xlink:href="lh-20230331.xsd#lh_ThreeMonthLIBOR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ThreeMonthLIBOR" xlink:to="lab_lh_ThreeMonthLIBOR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe38c348-12ed-429e-92c3-248349769b75_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3393ff5f-eb73-4b8a-bd2b-06b3b7d762f6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7a064169-b555-4b4d-b83a-1d7898eaec46_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to the noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ea56cb56-43e1-42f5-b1d4-0e87864effeb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_e02264a2-d082-4bfe-b155-e47d14a6a8ea_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4208d619-e0d9-4645-80ac-809715752b46_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_0cbe6213-0580-45da-983b-3e7e6622a4dd_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_2a098544-56c5-4a50-96d9-3b3d2175a724_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_01e4a2cb-b03a-4b7b-8e60-af33ab84ade7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ForeignCurrencyTranslationAdjustmentsMember_b3965044-d089-429e-83ac-4839eafd5270_terseLabel_en-US" xlink:label="lab_lh_ForeignCurrencyTranslationAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlement charge</link:label>
    <link:label id="lab_lh_ForeignCurrencyTranslationAdjustmentsMember_label_en-US" xlink:label="lab_lh_ForeignCurrencyTranslationAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments [Member]</link:label>
    <link:label id="lab_lh_ForeignCurrencyTranslationAdjustmentsMember_documentation_en-US" xlink:label="lab_lh_ForeignCurrencyTranslationAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignCurrencyTranslationAdjustmentsMember" xlink:href="lh-20230331.xsd#lh_ForeignCurrencyTranslationAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ForeignCurrencyTranslationAdjustmentsMember" xlink:to="lab_lh_ForeignCurrencyTranslationAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostTableTextBlock_b9af58e0-fba8-4527-9340-4900e25057f3_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostTableTextBlock" xlink:to="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_fef37d98-b021-400a-84f1-dd1ce147b0cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward_939f980b-3010-40a8-a155-dbf3471d3261_terseLabel_en-US" xlink:label="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings [Roll Forward]</link:label>
    <link:label id="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward_label_en-US" xlink:label="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings [Roll Forward]</link:label>
    <link:label id="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward_documentation_en-US" xlink:label="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:href="lh-20230331.xsd#lh_AccumulatedOtherComprehensiveEarningsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:to="lab_lh_AccumulatedOtherComprehensiveEarningsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_1482c5a0-23d8-4362-9093-a1ecf15e430b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9dd0cc0a-0c47-47b4-a7f6-8794956e03c2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fd40202c-9336-4683-ab96-c1c2d9b145ff_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2abd2f7f-795a-4ed1-ba05-617b2d82d6dc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6d70ce8f-293f-483d-8f15-cc9c06de43df_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2eaea073-426f-4004-b0a4-0adcc11a6fb0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c1116525-22ee-457f-8b9d-159415df571e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_afc80337-57fa-4125-a166-1fe165e3588f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_01b33330-4d6d-474f-b3b7-8e2f07659833_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7b7182c2-a76b-48ca-9f06-8f4b8c910c76_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's population of financial assets and liabilities subject to fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_14d85bd1-36fa-47df-be2f-fd62a0a34755_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_3141dd9d-ab06-422c-bfcd-511127a34d00_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_a869fc87-6b9b-4b5d-abcb-f0be05c1221d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_1b7e556f-a8c2-466a-af6f-f504b9a23d40_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_51a6f63b-7a5d-4bd3-9da6-422a29cd3d93_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b6ea81a1-a45a-406c-a71a-e21aa2f0bce1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_cbdf6aa8-8c49-4cf8-8466-ceb15cc75c8f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_476c9bf5-bb25-43b0-99bd-ec6ea8bf1018_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ff2d9fa7-2344-48e9-b880-6d9d52a169b1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_62450453-2e7c-4cd7-9b34-9bf368f3b0c9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:to="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e8907b4c-07d4-41ae-b0d9-b1948f19c264_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_a6dd36c9-75b3-4d93-8062-19693d07923a_terseLabel_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss" xlink:href="lh-20230331.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnbilledServicesAllowanceforCreditLoss" xlink:to="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_ba7d7bc5-64a2-4515-8d0e-290777b9fa4d_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_69f760ed-0c2e-40d1-99dc-14a4f0cc94e4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_1d815272-6a31-4164-9ea5-db349812dcd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a12410f6-96aa-4df5-8493-fbdc720705f4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2eb8a683-08b6-4ff5-8a12-cc329c7d0801_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_41bd099e-0f80-4fb3-b75a-788148d4c0b1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_4eda1a77-df18-433f-b422-92b379e9e397_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_afb0a85b-048b-47fb-9411-7f944e368831_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_0933e7a4-38e8-4a55-8807-af7e9a197834_terseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_bfdfbbed-5eff-4f36-815d-cbb3af01a66e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_97d79e70-de2d-4e91-a08e-c50afcd35420_terseLabel_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other tax liabilities</link:label>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_label_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other tax liabilities</link:label>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_documentation_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:href="lh-20230331.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:to="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_5ad126e3-b0f2-4089-91f8-ac620cc8023e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_68c8d9ad-0135-4333-9da2-42f8fae538ec_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_6c22e84e-4a3a-426a-a04a-5cd95544e9b9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_ead9d3a1-c208-4daa-b0b3-8a73436f9628_terseLabel_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest puts</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_label_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_documentation_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:href="lh-20230331.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:to="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_44b29326-2c8e-4fdb-b0e8-3efe0b08a546_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9ecaaa1c-344b-4c15-a6e0-8762f0abaf90_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings, Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_52e8b603-690a-4583-8d76-25bc0fee2fee_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings, Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_5ec6bef2-2f4b-4c42-946e-575000ec0f2f_terseLabel_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)</link:label>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_label_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Method Investments Maximum Ownership Percentage</link:label>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_documentation_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:href="lh-20230331.xsd#lh_CostMethodInvestmentsMaximumOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:to="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7bad20fa-f582-4658-984f-f8cb180ad9b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_62e99f81-3a32-4843-9b0d-fbbde4e2aa11_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_70ea9227-bdee-4d98-be68-37f920880b39_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_278d0dc3-6909-44d5-bcca-f9d932c5d6ad_terseLabel_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_label_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_documentation_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff" xlink:href="lh-20230331.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AllowanceforCreditLossWriteOff" xlink:to="lab_lh_AllowanceforCreditLossWriteOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_94d60a6a-13f5-4a63-8acb-47076dea611e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_1465cb69-9347-48bf-9e4a-9833fd2e5581_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_fe902411-dbe3-48fd-a5b1-5cba7ba956fb_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9b550b26-b8a4-46e8-82d2-1b768e38e4c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock and Common Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_f954cbf9-8e2f-4125-84cd-3a267f20da1f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:to="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_8518b901-a863-445b-9c24-3b51a2118cfe_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_cce69b7e-4556-4010-9a0a-f7c992c330a8_terseLabel_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_label_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_documentation_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum" xlink:href="lh-20230331.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LongTermContractsDurationMinimum" xlink:to="lab_lh_LongTermContractsDurationMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncomeAbstract_79b9cdad-3f33-4454-bf76-4910bf5dc5b6_terseLabel_en-US" xlink:label="lab_lh_IncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income [Abstract]</link:label>
    <link:label id="lab_lh_IncomeAbstract_label_en-US" xlink:label="lab_lh_IncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeAbstract" xlink:href="lh-20230331.xsd#lh_IncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncomeAbstract" xlink:to="lab_lh_IncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_353edaff-3fa1-48c0-97fa-f6928f8091bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SharesAbstract_a852a055-2029-4baf-90b5-8c2ba93666f2_terseLabel_en-US" xlink:label="lab_lh_SharesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares [Abstract]</link:label>
    <link:label id="lab_lh_SharesAbstract_label_en-US" xlink:label="lab_lh_SharesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SharesAbstract" xlink:href="lh-20230331.xsd#lh_SharesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SharesAbstract" xlink:to="lab_lh_SharesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_86531824-a8a1-42b2-910f-a2f8071c173a_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_label_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_documentation_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityMaximumLettersofCredit" xlink:to="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2037a6e7-97f5-4e6d-bf32-68f0fd450803_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts receivable (net)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e107c295-b1ec-4edf-8e46-30fbc2a11141_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2024Member_ecc5c436-15f9-4ebe-9797-11f6338053f1_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024</link:label>
    <link:label id="lab_lh_SeniorNotesDue2024Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2024Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2024Member" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2024Member" xlink:to="lab_lh_SeniorNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubordinatedBorrowingInterestRate_2133b129-2cb2-4a10-8ec7-e01f97bed8a2_terseLabel_en-US" xlink:label="lab_us-gaap_SubordinatedBorrowingInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Borrowing, Interest Rate</link:label>
    <link:label id="lab_us-gaap_SubordinatedBorrowingInterestRate_label_en-US" xlink:label="lab_us-gaap_SubordinatedBorrowingInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Borrowing, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedBorrowingInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubordinatedBorrowingInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubordinatedBorrowingInterestRate" xlink:to="lab_us-gaap_SubordinatedBorrowingInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_f6484b8e-155c-4bb0-9520-48a576108124_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_9ad1a605-d792-4425-b9c2-5353e4c705e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_bc7eacd8-f505-43f5-8f6c-5dd73c3a7420_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_165ccfde-8221-4d89-9800-9b98c3fe73f2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_b26b0c67-5458-46d6-a65f-867a776d890d_terseLabel_en-US" xlink:label="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Deferred Costs Related to Long-term Contracts</link:label>
    <link:label id="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_label_en-US" xlink:label="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Deferred Costs Related to Long-Term Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:to="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_6582251b-5a49-4446-bcb3-f5995e2ff14c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fee3a6bc-43dc-4f4f-a141-9b366fdf1d0e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2013</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_96455197-0e50-4c43-9f0d-f472c92e398f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7e39cf5-a9cb-4326-a1ae-e5ba7c942dc8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a5962ef-e427-47e6-8371-7b151e7b698a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a1c26b72-db62-4e88-bc2c-8d04fa9fc0b3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_049d9fdc-b922-43b7-9a89-a0c10e200b69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_5b59166d-6052-4bd0-a3d6-4a9ef464d0a6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_947d963a-203d-43f9-b536-0020722472dc_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_f42c41e9-ec64-46db-808c-1a0b3c7b65c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_4e9103ca-e5c4-4089-bb16-fb464215de67_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6902b0b7-f179-40ef-9172-099990cec60e_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6c9829f8-9240-44c9-9876-e11248b1d2d9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_62a4a7aa-a66d-4a9e-94d5-5f2baf7b02d2_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6b26d2c6-9034-40d1-bf14-3677c428d5ab_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_294e3906-334b-4745-86aa-c4591d8c403a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_bbe9f587-11a2-448e-a86f-61a1dcc563e8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_7477079b-3086-4c57-a9dc-21f144aa8b5a_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_bbc919d2-7e64-4ec4-a6d6-e9aac9338472_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Description</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_b0c89e84-3458-428f-a16a-af874613e413_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_d3936fb9-57a6-4b81-93b0-d37cb77f2bfc_terseLabel_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:to="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_324ac1e3-54ad-4226-8bc1-4dbcffc7a87b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DrugDevelopmentMember_1afdf79d-1e13-462c-b378-62373478836f_terseLabel_en-US" xlink:label="lab_lh_DrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drug Development</link:label>
    <link:label id="lab_lh_DrugDevelopmentMember_label_en-US" xlink:label="lab_lh_DrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drug Development [Member]</link:label>
    <link:label id="lab_lh_DrugDevelopmentMember_documentation_en-US" xlink:label="lab_lh_DrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember" xlink:href="lh-20230331.xsd#lh_DrugDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DrugDevelopmentMember" xlink:to="lab_lh_DrugDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_e90c4bba-c72c-454d-9073-a9169bbb0b2c_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date Declared</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_7d85a26c-4384-45b3-b636-3e5e76026f72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ee2773a1-5e25-4ddd-aaaa-c9fa5161c68e_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_6be41440-a6d1-47e6-af4d-91b140552fcc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_37c7c730-fcd4-4ffc-be3f-0d75c7dcfc75_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_592eedbf-e709-42a0-8775-27445b5ee742_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_381cbaa4-9205-4382-8dbc-354936229266_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_f63f1201-461c-4211-bfb2-6b73cc9db682_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2022SwapAgreementsMember_160de030-9419-4520-a26a-16e0da9b1272_terseLabel_en-US" xlink:label="lab_lh_A2022SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Swap Agreements</link:label>
    <link:label id="lab_lh_A2022SwapAgreementsMember_label_en-US" xlink:label="lab_lh_A2022SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Swap Agreements [Member]</link:label>
    <link:label id="lab_lh_A2022SwapAgreementsMember_documentation_en-US" xlink:label="lab_lh_A2022SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Swap Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022SwapAgreementsMember" xlink:href="lh-20230331.xsd#lh_A2022SwapAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2022SwapAgreementsMember" xlink:to="lab_lh_A2022SwapAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_65317d11-1d32-4a6e-b993-ee9b1b76d3cb_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9225218f-fb09-44e7-9367-e1e0e606883b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b4eac290-baf8-4c1d-9b28-bb4f36d400c6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2031Member_27485cc9-97ea-4776-a5ec-37c891311734_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2031</link:label>
    <link:label id="lab_lh_SeniorNotesDue2031Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2031 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2031Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2031Member" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2031Member" xlink:to="lab_lh_SeniorNotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_7e4cad44-18c5-4c1a-adc6-e64fa89d4d50_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_ca915e42-5ae1-4521-89c7-556c05518dbf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2f399bb9-00e2-404d-98dd-e8ba1d978c32_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a0a58efe-40a3-4083-98fa-78cc2001dbfd_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of employee stock options and awards, (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ff6f2a7a-fa54-4111-9225-19646a4e4dd0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6c6abc87-17c3-4465-8152-f0e56a445b64_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ccb634e3-2c47-481e-8ed4-83fef7aa7074_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_920f77ff-850c-4002-bd5f-978132b6aff2_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_91f29de0-6cb6-44a8-858e-70ca0d6ef4f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b98f9e11-3842-4221-8168-972944364372_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_4b72967f-aec0-4a8c-8348-902eebd5fc5b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_3e964441-5349-4e93-8f6d-edd18a3d1022_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_45685bee-b545-454d-aec3-c8b236f10904_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_820933f6-1c32-460a-adc0-87f6a73a1c62_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_76d9b974-74a2-4816-ad1e-453d39408983_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6dbc8cc7-33d1-470f-a5d6-746b8a48e73e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_eb634a29-47a9-4f57-b902-01d8f895d5dd_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_cc337073-74f8-4b98-a677-05902d0b2ffc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_1faf2508-2ba7-4209-82e6-d1333ebda449_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_1f67c40e-714c-46e8-9cd6-5888d5841e5e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_27e270a7-15a8-4325-9a67-75847b8710dd_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expenses):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_aa09b568-55e0-4ded-b6f8-06ba8cecde39_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract_804a2a0f-2b4e-4378-a3aa-4449fa4011fa_terseLabel_en-US" xlink:label="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of Share Repurchase Program</link:label>
    <link:label id="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract_label_en-US" xlink:label="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Repurchase Authorization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:href="lh-20230331.xsd#lh_OutstandingStockRepurchaseAuthorizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:to="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2018SwapAgreementsMember_2eaa07d7-3b5c-4086-95e6-a9714e32d933_terseLabel_en-US" xlink:label="lab_lh_A2018SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Swap Agreements</link:label>
    <link:label id="lab_lh_A2018SwapAgreementsMember_label_en-US" xlink:label="lab_lh_A2018SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Swap Agreements [Member]</link:label>
    <link:label id="lab_lh_A2018SwapAgreementsMember_documentation_en-US" xlink:label="lab_lh_A2018SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Swap Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember" xlink:href="lh-20230331.xsd#lh_A2018SwapAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2018SwapAgreementsMember" xlink:to="lab_lh_A2018SwapAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_404d8e4f-4936-466a-b5b7-733b11693c85_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_daa0f191-d2e0-4a61-85fb-d94147a9b173_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_ebcaf60e-aca2-45a2-951d-967f48c2f92e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_52e46fc2-9d12-4107-b147-74c63e908597_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_8d87601e-61f3-4661-bc97-2b29481c6230_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_780a14f8-3c3a-4fd0-86f6-70852d0e733b_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_fa4b9061-99bd-4831-9996-a865763b5875_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_2b9458dc-c2e8-4bb8-b56b-9d7f50164125_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_c94ed992-0286-47c9-b8be-1d04751a1685_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e51098c1-3a24-4cf0-bd99-41d503f37383_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetRestructuringCharges_2a71e0c1-b00f-423e-8806-cfad23c0ba29_negatedTerseLabel_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Restructuring Charges</link:label>
    <link:label id="lab_lh_NetRestructuringCharges_label_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Restructuring Charges</link:label>
    <link:label id="lab_lh_NetRestructuringCharges_documentation_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges" xlink:href="lh-20230331.xsd#lh_NetRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetRestructuringCharges" xlink:to="lab_lh_NetRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_2416a929-397e-43aa-81a9-71691e0c536f_terseLabel_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Domain]</link:label>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_label_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:to="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_2488146e-6d09-40b1-a6d6-1be0a1996c34_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_86015106-59b9-49a2-b252-3e7406e9ab5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_61315ad0-dd69-4111-963b-d2237b17af1d_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_5f05588f-7b96-4ed9-a8ed-4070e6846e4c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_4690238e-6b07-4dcc-abdc-6cb8865cadac_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_573df312-4ee1-4e7f-bdf3-438186742b62_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionLineItems_a64decd3-1a28-4921-a2f7-8ce6c2d7f1ab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtConversionLineItems_label_en-US" xlink:label="lab_us-gaap_DebtConversionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionLineItems" xlink:to="lab_us-gaap_DebtConversionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e129763c-7374-466c-ad7c-718abb99d794_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_db06a179-3c92-4a17-b84b-66e6dff197b9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_16014af0-a903-4aff-a70d-fc3433cf39a0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_850ec950-25e5-4f73-b4ab-0020fcc0c259_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_c6a6e143-e653-4c77-9fcd-5401f02696a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_3e3cd361-e141-4778-b557-0eb81bdaa3c2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_6c9772d2-791b-4b50-aeae-accfc84cebc6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_2f69aac9-30e2-4082-a320-cf4f3e19ab1c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A360SeniorNotesDue2027_e48cd4fe-0acd-43e6-aa0c-f3ef3f67f5e2_terseLabel_en-US" xlink:label="lab_lh_A360SeniorNotesDue2027" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% senior notes due 2027</link:label>
    <link:label id="lab_lh_A360SeniorNotesDue2027_label_en-US" xlink:label="lab_lh_A360SeniorNotesDue2027" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% senior notes due 2027</link:label>
    <link:label id="lab_lh_A360SeniorNotesDue2027_documentation_en-US" xlink:label="lab_lh_A360SeniorNotesDue2027" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% senior notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2027" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2027"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A360SeniorNotesDue2027" xlink:to="lab_lh_A360SeniorNotesDue2027" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A360SeniorNotesDue2025_35d0ba5e-c564-48c5-b104-aa1025d545fa_terseLabel_en-US" xlink:label="lab_lh_A360SeniorNotesDue2025" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% senior notes due 2025</link:label>
    <link:label id="lab_lh_A360SeniorNotesDue2025_label_en-US" xlink:label="lab_lh_A360SeniorNotesDue2025" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% senior notes due 2025</link:label>
    <link:label id="lab_lh_A360SeniorNotesDue2025_documentation_en-US" xlink:label="lab_lh_A360SeniorNotesDue2025" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% senior notes due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2025" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2025"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A360SeniorNotesDue2025" xlink:to="lab_lh_A360SeniorNotesDue2025" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ca6ae03a-74dc-4684-b81b-234ea0b3d1df_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_ec64c675-2131-46ad-83e0-971f97ba12e4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A270SeniorNotesDue2031_89b46ccb-10f5-4a22-a361-b9cd6d3b7387_terseLabel_en-US" xlink:label="lab_lh_A270SeniorNotesDue2031" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% senior notes due 2031</link:label>
    <link:label id="lab_lh_A270SeniorNotesDue2031_label_en-US" xlink:label="lab_lh_A270SeniorNotesDue2031" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% senior notes due 2031</link:label>
    <link:label id="lab_lh_A270SeniorNotesDue2031_documentation_en-US" xlink:label="lab_lh_A270SeniorNotesDue2031" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% senior notes due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031" xlink:href="lh-20230331.xsd#lh_A270SeniorNotesDue2031"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A270SeniorNotesDue2031" xlink:to="lab_lh_A270SeniorNotesDue2031" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4cd91efa-24d1-433b-a8a9-9f15f359a36c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2016</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f4111e5f-c0f6-4a3e-9598-73a9a0662a4b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashFlowLocationAxis_b76e58a1-24a6-4e71-848a-710ef3bd6d72_terseLabel_en-US" xlink:label="lab_lh_CashFlowLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Axis]</link:label>
    <link:label id="lab_lh_CashFlowLocationAxis_label_en-US" xlink:label="lab_lh_CashFlowLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Axis]</link:label>
    <link:label id="lab_lh_CashFlowLocationAxis_documentation_en-US" xlink:label="lab_lh_CashFlowLocationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationAxis" xlink:href="lh-20230331.xsd#lh_CashFlowLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashFlowLocationAxis" xlink:to="lab_lh_CashFlowLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b4536b90-54dc-4b71-910b-53a4a2917b39_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A470SeniorNotesDue2045_fc0e7d8e-819c-4d20-bb7a-cad78ee6291e_terseLabel_en-US" xlink:label="lab_lh_A470SeniorNotesDue2045" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70% senior notes due 2045</link:label>
    <link:label id="lab_lh_A470SeniorNotesDue2045_label_en-US" xlink:label="lab_lh_A470SeniorNotesDue2045" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70% senior notes due 2045</link:label>
    <link:label id="lab_lh_A470SeniorNotesDue2045_documentation_en-US" xlink:label="lab_lh_A470SeniorNotesDue2045" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70% senior notes due 2045</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A470SeniorNotesDue2045" xlink:href="lh-20230331.xsd#lh_A470SeniorNotesDue2045"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A470SeniorNotesDue2045" xlink:to="lab_lh_A470SeniorNotesDue2045" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_9a73a171-7734-4807-bf62-f7b3ae9f622a_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e370a3f5-040a-4ac5-a841-fb0d78fc03f4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_974f4904-9cce-4be8-a060-e6287ab7698f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8ce256ec-1b8c-41af-b50f-04eda2ba85be_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_90e00122-6de4-492c-8ea2-4f1f4b07802b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_2ca565fb-8f0a-446c-b882-21298a02cd01_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:to="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_30e77783-4ed9-444f-b74c-9c5270cb572c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_6e74efaf-6478-4035-9108-06078e740ccd_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_19d783ef-ec37-40c5-be80-11c38c9ffc1d_terseLabel_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_label_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_documentation_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:href="lh-20230331.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:to="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_0c9ae4fc-5bb3-4dfb-9d6c-74fa5eaed301_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_48c879f5-ae24-4328-87d3-a724d026acdb_terseLabel_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Axis]</link:label>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:to="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PercentofRevenueContributed_c58117de-aa13-41c8-b305-f5d0e19947a9_terseLabel_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:label id="lab_lh_PercentofRevenueContributed_label_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:label id="lab_lh_PercentofRevenueContributed_documentation_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed" xlink:href="lh-20230331.xsd#lh_PercentofRevenueContributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PercentofRevenueContributed" xlink:to="lab_lh_PercentofRevenueContributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_ab880cd1-102e-4032-8edb-0a8de93590dd_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-cash financing and investing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f995e3f9-6990-493b-9386-78a80110f7f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_208ddeb6-0f85-45d0-a73d-435324117ced_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_eb35f42d-eb90-4898-bf36-4ede7f83f80a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_1ec747dd-bf9b-45b2-8bc2-904fcdcacd07_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_cfe597cc-7f3a-43b4-8804-fa6c67f6410e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method income, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NorthAmericaMember_9ad33029-ad8f-4872-9f01-680eaa55087c_terseLabel_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America</link:label>
    <link:label id="lab_srt_NorthAmericaMember_label_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_InProcessRAAndMediaMember_670162a5-af16-49e4-a67d-e4552779f07e_terseLabel_en-US" xlink:label="lab_lh_InProcessRAAndMediaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process R&amp;A and Media</link:label>
    <link:label id="lab_lh_InProcessRAAndMediaMember_label_en-US" xlink:label="lab_lh_InProcessRAAndMediaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process R&amp;A and Media [Member]</link:label>
    <link:label id="lab_lh_InProcessRAAndMediaMember_documentation_en-US" xlink:label="lab_lh_InProcessRAAndMediaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process R&amp;A and Media</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InProcessRAAndMediaMember" xlink:href="lh-20230331.xsd#lh_InProcessRAAndMediaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_InProcessRAAndMediaMember" xlink:to="lab_lh_InProcessRAAndMediaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bd1e88b5-6b16-4065-8759-e6a89af7b89f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for laboratory-related assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_af3ee738-f0a0-4151-88a5-0619d121e443_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_00dda02e-0af9-49fb-91b2-c03fe9266a22_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_06312b38-2a77-449b-ba68-88e98e06849f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2012</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_785de38c-1a63-4579-b317-81977cd062b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic earnings per Share to Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_51d1739c-ce13-433a-9581-df81f3e3cbc7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_6792ad13-759f-45ff-8370-5df101d46794_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_b8280a65-47bd-418c-b75b-e1c5e3b35b05_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_9216e233-89b4-4169-af45-080919e6c294_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_e6b2a5dc-c197-45f1-9755-769e6e2d7c91_terseLabel_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_label_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_documentation_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:href="lh-20230331.xsd#lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:to="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lh-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6517acae-4533-4b41-af86-61933115c4be,g:534dcbed-da35-4848-959c-5965c7debeab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.labcorp.com/role/CoverPage" xlink:type="simple" xlink:href="lh-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4c8d0138-93f5-487d-ad1a-b97293902858" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_DocumentInformationTable_4c8d0138-93f5-487d-ad1a-b97293902858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_395684a0-3bbe-4762-8593-8aa7e8d1e83b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_4c8d0138-93f5-487d-ad1a-b97293902858" xlink:to="loc_dei_DocumentInformationDocumentAxis_395684a0-3bbe-4762-8593-8aa7e8d1e83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_f2e628c2-86e0-493c-9de5-27e2773196dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_395684a0-3bbe-4762-8593-8aa7e8d1e83b" xlink:to="loc_dei_DocumentDomain_f2e628c2-86e0-493c-9de5-27e2773196dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_b359c5b9-979d-4e8f-aacd-7c537f6a7c54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_4c8d0138-93f5-487d-ad1a-b97293902858" xlink:to="loc_dei_DocumentInformationLineItems_b359c5b9-979d-4e8f-aacd-7c537f6a7c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_15d69dd0-c119-4178-a78d-bd67d02ee51e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityInteractiveDataCurrent_15d69dd0-c119-4178-a78d-bd67d02ee51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_7d1d51ba-737e-4749-b1a7-f9a5d9f03c8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityFilerCategory_7d1d51ba-737e-4749-b1a7-f9a5d9f03c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6df7ca6f-f7df-4fd6-89e0-605a229f0757" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntitySmallBusiness_6df7ca6f-f7df-4fd6-89e0-605a229f0757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6ccbc06e-8bc0-44e2-b321-5eff5842e273" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityEmergingGrowthCompany_6ccbc06e-8bc0-44e2-b321-5eff5842e273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0907ad9b-2afe-41d6-a796-e18f88b0bae8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityShellCompany_0907ad9b-2afe-41d6-a796-e18f88b0bae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0d4ab9e2-a45b-4590-87ec-2bdae06a955f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0d4ab9e2-a45b-4590-87ec-2bdae06a955f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7aeb2160-3ef5-4e70-ac0a-89f7c53f4d0e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7aeb2160-3ef5-4e70-ac0a-89f7c53f4d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d189be88-2391-4810-9a41-5d82c0fb90c0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_AmendmentFlag_d189be88-2391-4810-9a41-5d82c0fb90c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_56dbffd6-d804-43e6-beff-ab02cbc18856" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_DocumentType_56dbffd6-d804-43e6-beff-ab02cbc18856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_2424aaaa-c4f4-4344-b60c-b0e3c0cf27aa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_DocumentQuarterlyReport_2424aaaa-c4f4-4344-b60c-b0e3c0cf27aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_31c8cff9-28da-46b1-af3a-4daa8a03ac99" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_DocumentPeriodEndDate_31c8cff9-28da-46b1-af3a-4daa8a03ac99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_fc9cb0ad-4d97-4fa5-b41c-5b1bb05008cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_DocumentTransitionReport_fc9cb0ad-4d97-4fa5-b41c-5b1bb05008cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_73f12840-eca0-44b1-b98d-fecd4dc2a89a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityFileNumber_73f12840-eca0-44b1-b98d-fecd4dc2a89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6f8b6978-f022-4d7c-90f0-757ddc6d12f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityRegistrantName_6f8b6978-f022-4d7c-90f0-757ddc6d12f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_817bea70-cced-4030-9a2e-d72e59eb596b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_817bea70-cced-4030-9a2e-d72e59eb596b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9dbfce8e-e3ec-40ac-b306-4f29291d9b20" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityTaxIdentificationNumber_9dbfce8e-e3ec-40ac-b306-4f29291d9b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5a38b592-c4aa-43c5-b590-fe2915dd00a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityAddressAddressLine1_5a38b592-c4aa-43c5-b590-fe2915dd00a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0e29a51e-aeb0-48b0-a21b-a2fa355cc101" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityAddressCityOrTown_0e29a51e-aeb0-48b0-a21b-a2fa355cc101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_24183b15-1d7f-41bd-bd74-5ce563bc8249" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityAddressStateOrProvince_24183b15-1d7f-41bd-bd74-5ce563bc8249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b8e372fd-09da-4d72-9c6e-cc592d91c1d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityAddressPostalZipCode_b8e372fd-09da-4d72-9c6e-cc592d91c1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2d449980-5673-49ba-8243-548d44a80017" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_CityAreaCode_2d449980-5673-49ba-8243-548d44a80017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b775a7c0-1ce0-45ec-8f7e-86fb6bb2a092" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_LocalPhoneNumber_b775a7c0-1ce0-45ec-8f7e-86fb6bb2a092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0bacc288-25b4-486c-8fb5-9122faa7a4dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_Security12bTitle_0bacc288-25b4-486c-8fb5-9122faa7a4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_81fa559a-56a0-4e3c-89be-c151ffd3f032" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_TradingSymbol_81fa559a-56a0-4e3c-89be-c151ffd3f032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7ec5ddeb-e631-484e-9be6-01155f561d30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_SecurityExchangeName_7ec5ddeb-e631-484e-9be6-01155f561d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e72d99c9-6cb3-4925-9288-403448d6f898" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityCurrentReportingStatus_e72d99c9-6cb3-4925-9288-403448d6f898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0303c9e2-b5cb-43eb-abcd-132a5945dd9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_DocumentFiscalYearFocus_0303c9e2-b5cb-43eb-abcd-132a5945dd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3091f7f1-ca05-4926-b10f-9323400c6c46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_CurrentFiscalYearEndDate_3091f7f1-ca05-4926-b10f-9323400c6c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d70444d0-a9c3-46fa-96d4-877d50f47451" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e85f1bcb-31bb-419a-931b-02227db7e9b8" xlink:to="loc_dei_EntityCentralIndexKey_d70444d0-a9c3-46fa-96d4-877d50f47451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_32068043-413f-4440-a062-e2f711e2187b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_32068043-413f-4440-a062-e2f711e2187b" xlink:to="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e9c26ca1-e87c-4781-b9bd-1236c4be6a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e9c26ca1-e87c-4781-b9bd-1236c4be6a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0617f4ee-b943-4f5e-983a-8be08f8431e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e9c26ca1-e87c-4781-b9bd-1236c4be6a52" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0617f4ee-b943-4f5e-983a-8be08f8431e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_502ebc9f-b87c-416d-9ae3-4ea19c3db946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e9c26ca1-e87c-4781-b9bd-1236c4be6a52" xlink:to="loc_us-gaap_UnbilledContractsReceivable_502ebc9f-b87c-416d-9ae3-4ea19c3db946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_beba400a-5dbe-4723-9069-392da7414378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e9c26ca1-e87c-4781-b9bd-1236c4be6a52" xlink:to="loc_us-gaap_InventoryNet_beba400a-5dbe-4723-9069-392da7414378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_f0e52d82-4b37-4407-beb0-4ed8efb7f36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e9c26ca1-e87c-4781-b9bd-1236c4be6a52" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_f0e52d82-4b37-4407-beb0-4ed8efb7f36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f98d6319-7a12-4186-bb65-2265fc4a55fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e9c26ca1-e87c-4781-b9bd-1236c4be6a52" xlink:to="loc_us-gaap_AssetsCurrent_f98d6319-7a12-4186-bb65-2265fc4a55fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_545f2e8f-156b-4e23-8e7a-08473df7aa7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_545f2e8f-156b-4e23-8e7a-08473df7aa7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cc349cac-3439-4254-8ca7-3a9436668d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:to="loc_us-gaap_Goodwill_cc349cac-3439-4254-8ca7-3a9436668d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3c207540-b6a3-43f3-9ac5-c69f1cb0d19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3c207540-b6a3-43f3-9ac5-c69f1cb0d19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ce72ab4c-988e-436e-86c4-46344200d85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ce72ab4c-988e-436e-86c4-46344200d85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_9bd4028f-2d05-416a-95c9-6909d2d8bd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent_9bd4028f-2d05-416a-95c9-6909d2d8bd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_12ce7df4-f90b-46fb-99cb-1ee0ffe6a723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_12ce7df4-f90b-46fb-99cb-1ee0ffe6a723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_180c4494-15df-4fc3-8790-c0d03c6f418a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c8ac8d4f-ba68-4a98-a24e-7032330cdbc3" xlink:to="loc_us-gaap_Assets_180c4494-15df-4fc3-8790-c0d03c6f418a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_32068043-413f-4440-a062-e2f711e2187b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_31838e2f-d74b-41cd-8cac-a59a0d3cd98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_31838e2f-d74b-41cd-8cac-a59a0d3cd98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_03d2e35a-b800-4c21-bf9e-85b84b4693ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_31838e2f-d74b-41cd-8cac-a59a0d3cd98b" xlink:to="loc_us-gaap_AccountsPayableCurrent_03d2e35a-b800-4c21-bf9e-85b84b4693ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d20f512f-2449-4493-b038-72f5de51a8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_31838e2f-d74b-41cd-8cac-a59a0d3cd98b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d20f512f-2449-4493-b038-72f5de51a8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_19095399-bdc3-454f-bec6-bf051a7d0516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_31838e2f-d74b-41cd-8cac-a59a0d3cd98b" xlink:to="loc_us-gaap_DeferredRevenueCurrent_19095399-bdc3-454f-bec6-bf051a7d0516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_52ece795-3ae0-40e8-8c92-ca90d3b5572b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_31838e2f-d74b-41cd-8cac-a59a0d3cd98b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_52ece795-3ae0-40e8-8c92-ca90d3b5572b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_6e089fb2-6af0-48ee-a5c2-e94a8b0e224a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_31838e2f-d74b-41cd-8cac-a59a0d3cd98b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_6e089fb2-6af0-48ee-a5c2-e94a8b0e224a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentDebtExcludingFinanceLeaseLiability_0ba8bbde-e99d-44d6-a07d-09ccbd43619e" xlink:href="lh-20230331.xsd#lh_CurrentDebtExcludingFinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_31838e2f-d74b-41cd-8cac-a59a0d3cd98b" xlink:to="loc_lh_CurrentDebtExcludingFinanceLeaseLiability_0ba8bbde-e99d-44d6-a07d-09ccbd43619e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_047c58f4-8185-4a82-ba8c-fc373b8ff50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_LiabilitiesCurrent_047c58f4-8185-4a82-ba8c-fc373b8ff50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_14276ff9-11b8-47b6-be60-5c7845e31881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_14276ff9-11b8-47b6-be60-5c7845e31881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0c6b7f31-5a17-4999-b190-f693d06cd196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0c6b7f31-5a17-4999-b190-f693d06cd196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c9dd6a9-03b6-40d3-9350-d54fe3753a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c9dd6a9-03b6-40d3-9350-d54fe3753a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f624ffbc-866a-4557-b6c1-9aecc1318617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f624ffbc-866a-4557-b6c1-9aecc1318617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_3f45706a-f2f3-4ac2-88a5-569e315b083a" xlink:href="lh-20230331.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_3f45706a-f2f3-4ac2-88a5-569e315b083a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6d484fed-7569-41a9-9ef5-ab35027a09b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_Liabilities_6d484fed-7569-41a9-9ef5-ab35027a09b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a67286ae-ecd6-4b6c-84ee-06931c730d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a67286ae-ecd6-4b6c-84ee-06931c730d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity_c8e4dd46-5d77-48ee-a0ff-83783a9614e8" xlink:href="lh-20230331.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a67286ae-ecd6-4b6c-84ee-06931c730d38" xlink:to="loc_lh_NoncontrollingInterestMezzanineEquity_c8e4dd46-5d77-48ee-a0ff-83783a9614e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b0978c88-b70a-4db4-9d18-1aa6b705a543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a67286ae-ecd6-4b6c-84ee-06931c730d38" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b0978c88-b70a-4db4-9d18-1aa6b705a543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b01c978e-ab68-4f3c-9315-b8bb421a664c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a67286ae-ecd6-4b6c-84ee-06931c730d38" xlink:to="loc_us-gaap_CommonStockValue_b01c978e-ab68-4f3c-9315-b8bb421a664c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_16df5318-4184-41d6-8a94-20e117f08474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a67286ae-ecd6-4b6c-84ee-06931c730d38" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_16df5318-4184-41d6-8a94-20e117f08474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dbc33cdf-e72d-424f-b389-f9c204c2008b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_525ddb08-64b3-4a96-a8b4-bef55544a4e7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dbc33cdf-e72d-424f-b389-f9c204c2008b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fefce708-30aa-408e-8530-1fa21bba5919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_32068043-413f-4440-a062-e2f711e2187b" xlink:to="loc_us-gaap_StockholdersEquity_fefce708-30aa-408e-8530-1fa21bba5919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_984dc0bb-83ac-42da-ab88-d7d4c940f105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_32068043-413f-4440-a062-e2f711e2187b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_984dc0bb-83ac-42da-ab88-d7d4c940f105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2a51d04e-a971-4dae-8616-0dc69ad3d63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_32068043-413f-4440-a062-e2f711e2187b" xlink:to="loc_us-gaap_ProfitLoss_2a51d04e-a971-4dae-8616-0dc69ad3d63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e276edf9-6b0e-4706-9d65-ec7ec6405fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_32068043-413f-4440-a062-e2f711e2187b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e276edf9-6b0e-4706-9d65-ec7ec6405fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2c9ab666-adb8-4f42-9cd3-f3fc1aaff77f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c9ab666-adb8-4f42-9cd3-f3fc1aaff77f" xlink:to="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_304feb84-b139-4bd9-9774-fbc390154241" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:to="loc_srt_RestatementAxis_304feb84-b139-4bd9-9774-fbc390154241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c36ddc89-e04c-473b-a226-7388eea5c57c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_304feb84-b139-4bd9-9774-fbc390154241" xlink:to="loc_srt_RestatementDomain_c36ddc89-e04c-473b-a226-7388eea5c57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5562677a-e5ab-42ed-aee1-ae84e3e98d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5562677a-e5ab-42ed-aee1-ae84e3e98d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8538564a-5765-4f9f-8b51-8fb0c4c53608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5562677a-e5ab-42ed-aee1-ae84e3e98d10" xlink:to="loc_us-gaap_ClassOfStockDomain_8538564a-5765-4f9f-8b51-8fb0c4c53608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7cf33190-5409-492d-b202-f97513d136b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a367c17c-c5f5-42a6-aff4-ebca6b9386f6" xlink:to="loc_us-gaap_StatementLineItems_7cf33190-5409-492d-b202-f97513d136b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_a27b3217-76dd-4fd9-a54d-95813246876d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7cf33190-5409-492d-b202-f97513d136b2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_a27b3217-76dd-4fd9-a54d-95813246876d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0adfca44-c1a2-44f4-88a8-a13c4998db48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c9ab666-adb8-4f42-9cd3-f3fc1aaff77f" xlink:to="loc_us-gaap_AssetsAbstract_0adfca44-c1a2-44f4-88a8-a13c4998db48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_746fe125-01f4-49ec-b942-216a3811d14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0adfca44-c1a2-44f4-88a8-a13c4998db48" xlink:to="loc_us-gaap_AssetsCurrentAbstract_746fe125-01f4-49ec-b942-216a3811d14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6547740c-8b08-4ad2-b19a-06db582a6635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c9ab666-adb8-4f42-9cd3-f3fc1aaff77f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6547740c-8b08-4ad2-b19a-06db582a6635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_73b6d0af-5458-41cc-a9a0-ce0c2d6b3a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6547740c-8b08-4ad2-b19a-06db582a6635" xlink:to="loc_us-gaap_StockholdersEquityAbstract_73b6d0af-5458-41cc-a9a0-ce0c2d6b3a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ad067779-2a39-4140-a6ed-6fbd670f594e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_73b6d0af-5458-41cc-a9a0-ce0c2d6b3a03" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ad067779-2a39-4140-a6ed-6fbd670f594e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_30caae87-d814-4c61-874c-d93f09d7f4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_StatementTable_30caae87-d814-4c61-874c-d93f09d7f4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_30caae87-d814-4c61-874c-d93f09d7f4b4" xlink:to="loc_srt_StatementScenarioAxis_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2dabacf5-4fbb-4b81-9aed-528879f1452f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a4d981db-7c5e-4c4d-97cb-1b45a2f55ef4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2dabacf5-4fbb-4b81-9aed-528879f1452f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_30caae87-d814-4c61-874c-d93f09d7f4b4" xlink:to="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_d412e97a-8aa0-4d37-9c30-65876c349920" xlink:href="lh-20230331.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_d412e97a-8aa0-4d37-9c30-65876c349920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0a119534-e565-4017-b548-df407fc7618b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_OperatingIncomeLoss_0a119534-e565-4017-b548-df407fc7618b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ae0da1c7-7fc6-4bea-9a05-ffb85d9c8874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_InterestExpense_ae0da1c7-7fc6-4bea-9a05-ffb85d9c8874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dac90c0b-56bb-4333-af37-9fbe9085412e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dac90c0b-56bb-4333-af37-9fbe9085412e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_52ab9baf-1170-408d-b99d-717bcc40d7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_InvestmentIncomeNet_52ab9baf-1170-408d-b99d-717bcc40d7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0a966bed-4e72-4595-9e1d-5f72bc7da6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0a966bed-4e72-4595-9e1d-5f72bc7da6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_e81bf4c5-dc73-4d1c-b43d-d172b0e9f773" xlink:href="lh-20230331.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_e81bf4c5-dc73-4d1c-b43d-d172b0e9f773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c0048a67-db0f-4eab-b72b-ce319a51c119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c0048a67-db0f-4eab-b72b-ce319a51c119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8f203423-b83d-40e0-a89c-e729784037e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_ProfitLoss_8f203423-b83d-40e0-a89c-e729784037e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_55f17ebc-14b3-48af-9ce2-5d3413c2d42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_55f17ebc-14b3-48af-9ce2-5d3413c2d42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_617f0d18-06db-433d-82f7-db141f439728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_NetIncomeLoss_617f0d18-06db-433d-82f7-db141f439728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_efbf81f9-e061-4d76-99f2-0c85b07ab5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_Revenues_efbf81f9-e061-4d76-99f2-0c85b07ab5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_01224699-2dd1-442d-8f08-40ed1a215819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_CostOfRevenue_01224699-2dd1-442d-8f08-40ed1a215819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b3791fc9-6498-42b4-8945-2ef21ad7c65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_GrossProfit_b3791fc9-6498-42b4-8945-2ef21ad7c65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b11ea52f-7215-4280-b1d1-857c4d00a070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b11ea52f-7215-4280-b1d1-857c4d00a070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9f40cd63-fe8f-49e7-89d2-08971c7201c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9f40cd63-fe8f-49e7-89d2-08971c7201c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5d69678b-653b-461c-8d41-965b86d36f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc64cd14-da35-4c0f-8310-c9ea3792174a" xlink:to="loc_us-gaap_AssetImpairmentCharges_5d69678b-653b-461c-8d41-965b86d36f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1053bc4e-5dac-451c-a2cc-68f117127ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_Revenues_1053bc4e-5dac-451c-a2cc-68f117127ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_4ca670b0-015d-4191-b9fd-c6f30e11ea39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_CostOfRevenue_4ca670b0-015d-4191-b9fd-c6f30e11ea39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5bdab5bd-93e1-400a-8524-037fb51bd86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_GrossProfit_5bdab5bd-93e1-400a-8524-037fb51bd86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8fe95a02-e985-4e4d-9ce9-863742755180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8fe95a02-e985-4e4d-9ce9-863742755180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b92b7f3f-030c-4ab4-b780-0e6c87647786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b92b7f3f-030c-4ab4-b780-0e6c87647786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1eb7d1fc-bf5b-473b-bd2a-a2cfe32dca22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_AssetImpairmentCharges_1eb7d1fc-bf5b-473b-bd2a-a2cfe32dca22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_29fc9f3c-eaf6-4a3a-84c6-7c480927008f" xlink:href="lh-20230331.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_29fc9f3c-eaf6-4a3a-84c6-7c480927008f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_28935a00-2605-4ea6-b121-4b0006cb2ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_OperatingIncomeLoss_28935a00-2605-4ea6-b121-4b0006cb2ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_868f1ccb-9682-4cf4-8280-5ee5e073bcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_868f1ccb-9682-4cf4-8280-5ee5e073bcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b4751ac0-2460-4ff7-a117-5595c15a4e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_868f1ccb-9682-4cf4-8280-5ee5e073bcba" xlink:to="loc_us-gaap_InterestExpense_b4751ac0-2460-4ff7-a117-5595c15a4e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e24d6a8d-d44c-40e2-baa8-855cbb4ce01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_868f1ccb-9682-4cf4-8280-5ee5e073bcba" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e24d6a8d-d44c-40e2-baa8-855cbb4ce01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_de00518a-e875-4880-a2d4-8af908043728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_868f1ccb-9682-4cf4-8280-5ee5e073bcba" xlink:to="loc_us-gaap_InvestmentIncomeNet_de00518a-e875-4880-a2d4-8af908043728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eccbaee5-fc27-4e93-b3fb-6327c11130b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_868f1ccb-9682-4cf4-8280-5ee5e073bcba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eccbaee5-fc27-4e93-b3fb-6327c11130b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_84194a52-c330-40b3-936b-0dddd39485e4" xlink:href="lh-20230331.xsd#lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest_84194a52-c330-40b3-936b-0dddd39485e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ac0b8349-33b4-4da3-be23-7031a0eaf4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ac0b8349-33b4-4da3-be23-7031a0eaf4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f075e844-64a6-43fb-9a31-9dfbc1239983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_ProfitLoss_f075e844-64a6-43fb-9a31-9dfbc1239983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e82b66e9-36e1-443f-992e-225d5daed925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e82b66e9-36e1-443f-992e-225d5daed925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1f4fdb1d-d928-44a4-9cf9-4ab48f23c0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_NetIncomeLoss_1f4fdb1d-d928-44a4-9cf9-4ab48f23c0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3c28e057-150b-4601-8462-49776558995b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_EarningsPerShareBasic_3c28e057-150b-4601-8462-49776558995b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_61300513-efa4-43e8-ab98-522100878ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9cb43b1-316c-4d78-a3d0-4a038b74fd36" xlink:to="loc_us-gaap_EarningsPerShareDiluted_61300513-efa4-43e8-ab98-522100878ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_292143f7-fd9e-4fb4-8670-9899f23a4c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_546201c7-f584-4215-a547-e4f1057cf45c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_292143f7-fd9e-4fb4-8670-9899f23a4c33" xlink:to="loc_us-gaap_StatementTable_546201c7-f584-4215-a547-e4f1057cf45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_45b658fa-d35e-4b68-b0a7-8b230c72a624" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_546201c7-f584-4215-a547-e4f1057cf45c" xlink:to="loc_srt_StatementScenarioAxis_45b658fa-d35e-4b68-b0a7-8b230c72a624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4acea676-3059-4cdd-b949-f5ffe612263d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_45b658fa-d35e-4b68-b0a7-8b230c72a624" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4acea676-3059-4cdd-b949-f5ffe612263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_35d3b499-bd97-447b-a1b6-eda9d9d1ca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_546201c7-f584-4215-a547-e4f1057cf45c" xlink:to="loc_us-gaap_StatementLineItems_35d3b499-bd97-447b-a1b6-eda9d9d1ca9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0a36f159-02a0-4343-969a-7f96736b566e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_35d3b499-bd97-447b-a1b6-eda9d9d1ca9f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0a36f159-02a0-4343-969a-7f96736b566e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_300305ed-3e98-447e-9e8d-4350f3795277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_292143f7-fd9e-4fb4-8670-9899f23a4c33" xlink:to="loc_us-gaap_ProfitLoss_300305ed-3e98-447e-9e8d-4350f3795277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4cac8c3c-f419-48d5-8e8a-693fe62faa25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_292143f7-fd9e-4fb4-8670-9899f23a4c33" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4cac8c3c-f419-48d5-8e8a-693fe62faa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_79f892e4-0005-420b-a926-02dc701ee269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4cac8c3c-f419-48d5-8e8a-693fe62faa25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_79f892e4-0005-420b-a926-02dc701ee269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_3d49e7ac-2d9d-4045-a5e3-6b5946af15af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4cac8c3c-f419-48d5-8e8a-693fe62faa25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_3d49e7ac-2d9d-4045-a5e3-6b5946af15af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ca242987-129e-4661-996c-0c38299862d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4cac8c3c-f419-48d5-8e8a-693fe62faa25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ca242987-129e-4661-996c-0c38299862d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_0c174722-ab71-404c-8187-8a6dc5638628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4cac8c3c-f419-48d5-8e8a-693fe62faa25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_0c174722-ab71-404c-8187-8a6dc5638628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_49871de1-1ae8-4c76-9bfe-e0408d3cd59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4cac8c3c-f419-48d5-8e8a-693fe62faa25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_49871de1-1ae8-4c76-9bfe-e0408d3cd59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b34b120b-883f-4fc5-bb6e-544d02f47dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_292143f7-fd9e-4fb4-8670-9899f23a4c33" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b34b120b-883f-4fc5-bb6e-544d02f47dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_70d95c64-4e3c-40bc-a413-e2a6a279e35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_292143f7-fd9e-4fb4-8670-9899f23a4c33" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_70d95c64-4e3c-40bc-a413-e2a6a279e35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4e890932-aa21-4a36-b919-ac12c766a89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_292143f7-fd9e-4fb4-8670-9899f23a4c33" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4e890932-aa21-4a36-b919-ac12c766a89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3ced31eb-af9c-41c7-a454-1d5007cf8523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b0e53247-14c4-437a-89c2-db040d17cf64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3ced31eb-af9c-41c7-a454-1d5007cf8523" xlink:to="loc_us-gaap_StatementTable_b0e53247-14c4-437a-89c2-db040d17cf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1138edf3-c6a9-4559-b283-3f18bfa5d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b0e53247-14c4-437a-89c2-db040d17cf64" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1138edf3-c6a9-4559-b283-3f18bfa5d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1138edf3-c6a9-4559-b283-3f18bfa5d37d" xlink:to="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bd13ddb8-4acf-4b83-8317-4529acccb8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:to="loc_us-gaap_CommonStockMember_bd13ddb8-4acf-4b83-8317-4529acccb8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ffc00f9c-723c-4fc0-b903-2dd2d9403272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ffc00f9c-723c-4fc0-b903-2dd2d9403272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6f6a9676-b747-46ca-9389-fd728752ab28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:to="loc_us-gaap_RetainedEarningsMember_6f6a9676-b747-46ca-9389-fd728752ab28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c35752e4-4e6e-4a70-b2f3-368ebad785c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53de14a4-52dc-467f-bb3f-2b4fb34e9344" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c35752e4-4e6e-4a70-b2f3-368ebad785c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b0e53247-14c4-437a-89c2-db040d17cf64" xlink:to="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1d7bcaf1-a4c6-4174-95cd-96cfeeb4314d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_StockholdersEquity_1d7bcaf1-a4c6-4174-95cd-96cfeeb4314d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f9759e8f-31bc-4315-8ef0-cd4d14f90d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_NetIncomeLoss_f9759e8f-31bc-4315-8ef0-cd4d14f90d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a373f99e-8944-49d7-bac2-88111a05bceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a373f99e-8944-49d7-bac2-88111a05bceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_4ba6f1c5-64e7-4ee4-80fc-0512d08034c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_Dividends_4ba6f1c5-64e7-4ee4-80fc-0512d08034c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Issuanceofcommonstockunderemployeeplans_de9e8a95-2023-4e1c-bd29-bab71ca3cf32" xlink:href="lh-20230331.xsd#lh_Issuanceofcommonstockunderemployeeplans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_lh_Issuanceofcommonstockunderemployeeplans_de9e8a95-2023-4e1c-bd29-bab71ca3cf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_3a38cdf4-0019-44b4-9221-5175733fcd64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_3a38cdf4-0019-44b4-9221-5175733fcd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_69a85b81-4349-40cd-87be-ad0d705f3c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_69a85b81-4349-40cd-87be-ad0d705f3c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_396c73fb-bbfe-49a3-988c-45b78d7d1e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_StockholdersEquity_396c73fb-bbfe-49a3-988c-45b78d7d1e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c8f78ffc-3900-4aac-9340-3bfa478ecf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dfd8aa93-dd7f-4206-b0d5-29cce45eae4d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c8f78ffc-3900-4aac-9340-3bfa478ecf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/StatementofCashFlowsStatement" xlink:type="simple" xlink:href="lh-20230331.xsd#StatementofCashFlowsStatement"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/StatementofCashFlowsStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3f21060-f8ee-4a97-8bd1-6bb294bcdc29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_fa554417-d6a1-4b62-8d37-4ed18cf4e91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3f21060-f8ee-4a97-8bd1-6bb294bcdc29" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_fa554417-d6a1-4b62-8d37-4ed18cf4e91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_2906d2ef-1d91-4dd1-bfd3-2ac44c7802b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_fa554417-d6a1-4b62-8d37-4ed18cf4e91d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_2906d2ef-1d91-4dd1-bfd3-2ac44c7802b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_270376b8-2482-40c6-a055-f4ac3a26bc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_2906d2ef-1d91-4dd1-bfd3-2ac44c7802b1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_270376b8-2482-40c6-a055-f4ac3a26bc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lh-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_82a73d59-909a-4920-b2e1-ba3fe5c10055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7f41d69a-948c-4ca5-aa59-a1a5b9c355d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_82a73d59-909a-4920-b2e1-ba3fe5c10055" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7f41d69a-948c-4ca5-aa59-a1a5b9c355d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0b59bb7f-d6aa-4a32-95cc-cb4a49366ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7f41d69a-948c-4ca5-aa59-a1a5b9c355d2" xlink:to="loc_us-gaap_ProfitLoss_0b59bb7f-d6aa-4a32-95cc-cb4a49366ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7f41d69a-948c-4ca5-aa59-a1a5b9c355d2" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets_2c2f156a-00d4-472d-902d-f4064c796fbf" xlink:href="lh-20230331.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:to="loc_lh_DepreciationAndAmortizationOfLeasedAssets_2c2f156a-00d4-472d-902d-f4064c796fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a113b8a7-564d-40cd-9fba-930f7afa6a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a113b8a7-564d-40cd-9fba-930f7afa6a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7ec42212-fffc-48fe-8353-1a8ef772c739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:to="loc_us-gaap_ShareBasedCompensation_7ec42212-fffc-48fe-8353-1a8ef772c739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ee81c358-1044-4b22-944c-020f756fef9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ee81c358-1044-4b22-944c-020f756fef9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_07037b33-4970-4c99-a899-72b91ef33130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_07037b33-4970-4c99-a899-72b91ef33130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_5ffbba74-b7ff-4b59-8fa2-b8fd92cc29c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_5ffbba74-b7ff-4b59-8fa2-b8fd92cc29c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_125af135-50f8-4ed1-977a-ce9494d6debd" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_94135414-0611-4d51-b39f-9dbcc25f2296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_94135414-0611-4d51-b39f-9dbcc25f2296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseinUnbilledContractReceivable_b267c065-702f-4ca0-a1a3-e7ca5d7fd588" xlink:href="lh-20230331.xsd#lh_IncreaseDecreaseinUnbilledContractReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:to="loc_lh_IncreaseDecreaseinUnbilledContractReceivable_b267c065-702f-4ca0-a1a3-e7ca5d7fd588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2af7ec16-fcec-417b-bf5c-3bbbf1b9e17a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2af7ec16-fcec-417b-bf5c-3bbbf1b9e17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_79d6aa8c-d1d6-4ea0-b523-bf77b6779a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_79d6aa8c-d1d6-4ea0-b523-bf77b6779a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_232949b8-d098-411e-8a99-4bbdb154ae27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_232949b8-d098-411e-8a99-4bbdb154ae27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_51051d5b-4929-4808-944f-47d4f79b3a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_51051d5b-4929-4808-944f-47d4f79b3a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2313b196-6901-4739-b14d-929345857279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72677df2-ee48-418d-b415-bbb17f8885d0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2313b196-6901-4739-b14d-929345857279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dc65678c-0963-4baa-8a4c-f91c13453af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7f41d69a-948c-4ca5-aa59-a1a5b9c355d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dc65678c-0963-4baa-8a4c-f91c13453af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_82a73d59-909a-4920-b2e1-ba3fe5c10055" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a8b8655c-dd3f-4289-886f-a6bdccf230a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a8b8655c-dd3f-4289-886f-a6bdccf230a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_78aea0b1-9b3b-4b0e-a466-89b3c860c39a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_78aea0b1-9b3b-4b0e-a466-89b3c860c39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_4a553963-c3ab-40e5-8bc5-b092ca72e905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_4a553963-c3ab-40e5-8bc5-b092ca72e905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_11416187-7730-4f9e-8ff0-6911982cf01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_11416187-7730-4f9e-8ff0-6911982cf01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f9c2c19-0543-4e11-bafc-ba0e00310a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f9c2c19-0543-4e11-bafc-ba0e00310a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2a79eb04-2ea8-449d-8d43-c078eb26b332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2a79eb04-2ea8-449d-8d43-c078eb26b332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa06fe4f-b0b0-4fad-a5fb-266f56eb85cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2445b3c0-8b57-4052-86eb-0b57cb729966" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa06fe4f-b0b0-4fad-a5fb-266f56eb85cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_82a73d59-909a-4920-b2e1-ba3fe5c10055" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_7fe04d80-5ac5-45f4-9889-fc955f224a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_7fe04d80-5ac5-45f4-9889-fc955f224a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_713cc27c-5617-4b9b-ae3c-c4d8e14b76be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_713cc27c-5617-4b9b-ae3c-c4d8e14b76be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_91be4f72-3354-4013-a133-31ff081f6a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_91be4f72-3354-4013-a133-31ff081f6a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_a1e4510a-f198-4155-8507-0d58fc563e7a" xlink:href="lh-20230331.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:to="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_a1e4510a-f198-4155-8507-0d58fc563e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_1d717d88-a2be-4816-9e7e-c2e87012806f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:to="loc_us-gaap_PaymentsOfDividends_1d717d88-a2be-4816-9e7e-c2e87012806f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtherFinancingCashFlows_fc980ebf-115a-4596-9986-d4d56270a81b" xlink:href="lh-20230331.xsd#lh_OtherFinancingCashFlows"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:to="loc_lh_OtherFinancingCashFlows_fc980ebf-115a-4596-9986-d4d56270a81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5f5af4e-ccb7-4251-ab57-3f79ec1ac4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ca0d555-209d-47d1-9b91-abef3e2b0787" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5f5af4e-ccb7-4251-ab57-3f79ec1ac4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_70e67f3d-2d8c-4fdb-ab20-749fe3b4df2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_82a73d59-909a-4920-b2e1-ba3fe5c10055" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_70e67f3d-2d8c-4fdb-ab20-749fe3b4df2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6b4bf57-5861-4dbe-bab3-c75b9ed20934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_82a73d59-909a-4920-b2e1-ba3fe5c10055" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6b4bf57-5861-4dbe-bab3-c75b9ed20934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f8561515-e752-4f4a-9f91-46833d63bf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6b4bf57-5861-4dbe-bab3-c75b9ed20934" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f8561515-e752-4f4a-9f91-46833d63bf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f055d006-aede-45ed-bef5-61078437df18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f8561515-e752-4f4a-9f91-46833d63bf05" xlink:to="loc_us-gaap_EquityComponentDomain_f055d006-aede-45ed-bef5-61078437df18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_15f2da1d-dbb4-4b6a-b2c0-9d809d490146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f055d006-aede-45ed-bef5-61078437df18" xlink:to="loc_us-gaap_CommonStockMember_15f2da1d-dbb4-4b6a-b2c0-9d809d490146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bbd05276-cf32-4b57-9e30-3484ff02775e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f055d006-aede-45ed-bef5-61078437df18" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bbd05276-cf32-4b57-9e30-3484ff02775e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_44b04036-9304-40f3-96a0-6aca33045f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6b4bf57-5861-4dbe-bab3-c75b9ed20934" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_44b04036-9304-40f3-96a0-6aca33045f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47b5b1ad-5d66-43e1-bb07-39d366da1852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_44b04036-9304-40f3-96a0-6aca33045f3b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47b5b1ad-5d66-43e1-bb07-39d366da1852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ab49113-33fb-45e8-8855-3ff46853b210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_44b04036-9304-40f3-96a0-6aca33045f3b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ab49113-33fb-45e8-8855-3ff46853b210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/StatementofCashFlowsSupplementalDisclosures" xlink:type="simple" xlink:href="lh-20230331.xsd#StatementofCashFlowsSupplementalDisclosures"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/StatementofCashFlowsSupplementalDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_7336b94e-d39e-4aa1-9928-4135a3dd61f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_11c39b90-489d-424a-be8c-e3a7a2fa8b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_7336b94e-d39e-4aa1-9928-4135a3dd61f4" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_11c39b90-489d-424a-be8c-e3a7a2fa8b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_479f6b3d-14cd-4ac8-8dc1-da21cce6c1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_7336b94e-d39e-4aa1-9928-4135a3dd61f4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_479f6b3d-14cd-4ac8-8dc1-da21cce6c1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d642a566-c922-4bdd-9384-faa09466b954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_479f6b3d-14cd-4ac8-8dc1-da21cce6c1b1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d642a566-c922-4bdd-9384-faa09466b954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" xlink:type="simple" xlink:href="lh-20230331.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONRestatedFinancialStatements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="simple" xlink:href="lh-20230331.xsd#SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_bff8d8c4-6a57-4157-8ada-b2d0c4c3773b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionTable_706f5a77-127e-4250-90cb-a85953b7e5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bff8d8c4-6a57-4157-8ada-b2d0c4c3773b" xlink:to="loc_us-gaap_DebtConversionTable_706f5a77-127e-4250-90cb-a85953b7e5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_68df9d93-d462-4267-b4ba-9cad740cc06f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionTable_706f5a77-127e-4250-90cb-a85953b7e5a6" xlink:to="loc_us-gaap_DebtInstrumentAxis_68df9d93-d462-4267-b4ba-9cad740cc06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8a49146-b58e-45d4-b170-98a9cb39f4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_68df9d93-d462-4267-b4ba-9cad740cc06f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8a49146-b58e-45d4-b170-98a9cb39f4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionTable_706f5a77-127e-4250-90cb-a85953b7e5a6" xlink:to="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8a0bd857-e872-4580-8368-47f577ab7d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8a0bd857-e872-4580-8368-47f577ab7d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid_c3b2be57-9c4b-4030-a9eb-da96da5ee656" xlink:href="lh-20230331.xsd#lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid_c3b2be57-9c4b-4030-a9eb-da96da5ee656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_82c098b7-f387-47d6-8eb3-5c13b2297503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_82c098b7-f387-47d6-8eb3-5c13b2297503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3f18add6-004a-4dec-a176-b9d2c61bc10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_ac5b225a-bee9-4615-900e-13f74cfc98f6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3f18add6-004a-4dec-a176-b9d2c61bc10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaidDuringPeriodForAbstract_b656b601-c5d8-4eba-89be-fdef0a256749" xlink:href="lh-20230331.xsd#lh_CashPaidDuringPeriodForAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bff8d8c4-6a57-4157-8ada-b2d0c4c3773b" xlink:to="loc_lh_CashPaidDuringPeriodForAbstract_b656b601-c5d8-4eba-89be-fdef0a256749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InterestPaidInCash_6874d1f4-4da8-47c6-a7be-c12952191460" xlink:href="lh-20230331.xsd#lh_InterestPaidInCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract_b656b601-c5d8-4eba-89be-fdef0a256749" xlink:to="loc_lh_InterestPaidInCash_6874d1f4-4da8-47c6-a7be-c12952191460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_c24f6024-745e-46c3-8ca3-f94fe37e4a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract_b656b601-c5d8-4eba-89be-fdef0a256749" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_c24f6024-745e-46c3-8ca3-f94fe37e4a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_74789215-dd10-45f3-95f6-c21f648d5738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bff8d8c4-6a57-4157-8ada-b2d0c4c3773b" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_74789215-dd10-45f3-95f6-c21f648d5738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION" xlink:type="simple" xlink:href="lh-20230331.xsd#BASISOFFINANCIALSTATEMENTPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e24349a1-db99-4b92-98ff-2292c6a55713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_209c0416-49d9-4e27-add5-6a27ee6d38d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e24349a1-db99-4b92-98ff-2292c6a55713" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_209c0416-49d9-4e27-add5-6a27ee6d38d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_13940c98-0be6-40ae-b0e8-38d62824de9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e24349a1-db99-4b92-98ff-2292c6a55713" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_13940c98-0be6-40ae-b0e8-38d62824de9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="lh-20230331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a89d3b30-1214-4cb8-925e-b227e3aa3fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ec5fa7ca-95d6-46e4-b25b-b50123aea25f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a89d3b30-1214-4cb8-925e-b227e3aa3fc1" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ec5fa7ca-95d6-46e4-b25b-b50123aea25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS" xlink:type="simple" xlink:href="lh-20230331.xsd#NONCONTROLLINGINTERESTPUTS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="lh-20230331.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_31d84178-62dd-43d4-809a-9c6c19663cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_399b5f7a-4199-4d22-ac2d-995dff3f4c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_31d84178-62dd-43d4-809a-9c6c19663cc7" xlink:to="loc_us-gaap_SegmentReportingAbstract_399b5f7a-4199-4d22-ac2d-995dff3f4c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBT" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b2f23695-6993-44b3-b9af-bfb7d6e3f6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="lh-20230331.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_dbf7e7a0-8953-4c22-b613-bb7c9d65824c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_020f5587-a6db-4737-a42d-864dcefb75da" xlink:href="lh-20230331.xsd#lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_dbf7e7a0-8953-4c22-b613-bb7c9d65824c" xlink:to="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_020f5587-a6db-4737-a42d-864dcefb75da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_91ca7a72-8ca2-4752-a059-a84af8701b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_dbf7e7a0-8953-4c22-b613-bb7c9d65824c" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_91ca7a72-8ca2-4752-a059-a84af8701b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e2632479-f516-4ebc-9fb6-d54e8977ce07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_dbf7e7a0-8953-4c22-b613-bb7c9d65824c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e2632479-f516-4ebc-9fb6-d54e8977ce07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e77f1065-0b1e-4e59-86d6-4f405eedd048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e2632479-f516-4ebc-9fb6-d54e8977ce07" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e77f1065-0b1e-4e59-86d6-4f405eedd048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6b79622e-0211-4ac9-abd7-e7e1f5e4fc86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e77f1065-0b1e-4e59-86d6-4f405eedd048" xlink:to="loc_us-gaap_EquityComponentDomain_6b79622e-0211-4ac9-abd7-e7e1f5e4fc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31240de9-c120-4a10-bc72-e1b9d24ea96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e2632479-f516-4ebc-9fb6-d54e8977ce07" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31240de9-c120-4a10-bc72-e1b9d24ea96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_018dc373-cae8-40c9-b40d-ade6102f33e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_dbf7e7a0-8953-4c22-b613-bb7c9d65824c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_018dc373-cae8-40c9-b40d-ade6102f33e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="lh-20230331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_60c1b5ce-87b8-4ed0-a546-571c7c63f649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e35cd133-f91c-4656-95e8-ce0d6453dbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_60c1b5ce-87b8-4ed0-a546-571c7c63f649" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e35cd133-f91c-4656-95e8-ce0d6453dbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="lh-20230331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8a511102-0862-45fd-a97b-8df1610e2aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_7ea09c27-5fc3-479f-9db9-78c17e8994db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8a511102-0862-45fd-a97b-8df1610e2aae" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_7ea09c27-5fc3-479f-9db9-78c17e8994db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_176a54ed-1154-465f-8b38-debf819ec80c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_dbe57208-23bb-4e5d-91a1-591cb04c9449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_176a54ed-1154-465f-8b38-debf819ec80c" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_dbe57208-23bb-4e5d-91a1-591cb04c9449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSSEGMENTINFORMATIONNotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fbed5411-b6ba-45ac-8321-19c8ecc39b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e0404960-b641-49d3-bd2d-b5c92eabc1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fbed5411-b6ba-45ac-8321-19c8ecc39b6f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e0404960-b641-49d3-bd2d-b5c92eabc1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_13629900-80c0-4e2a-bfc3-ed15e8ece58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e0404960-b641-49d3-bd2d-b5c92eabc1f0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_13629900-80c0-4e2a-bfc3-ed15e8ece58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d7710c4-256e-4e8f-af25-3d444b750f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13629900-80c0-4e2a-bfc3-ed15e8ece58b" xlink:to="loc_us-gaap_SegmentDomain_6d7710c4-256e-4e8f-af25-3d444b750f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_55f95a07-b9fc-4bca-a611-0fc00d74911c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e0404960-b641-49d3-bd2d-b5c92eabc1f0" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_55f95a07-b9fc-4bca-a611-0fc00d74911c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_3d9fc73c-4cc0-4bed-a098-cee95744de92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_55f95a07-b9fc-4bca-a611-0fc00d74911c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_3d9fc73c-4cc0-4bed-a098-cee95744de92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUENotes" xlink:type="simple" xlink:href="lh-20230331.xsd#REVENUENotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUENotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_aa61b9a9-976e-4286-b7eb-ae71a4b41d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SubsequentEvents" xlink:type="simple" xlink:href="lh-20230331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d35a9a4b-7ca9-4d2a-ad2e-976779a993a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_3645d48c-63e5-4ea7-bd89-51f78aeb8659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d35a9a4b-7ca9-4d2a-ad2e-976779a993a6" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_3645d48c-63e5-4ea7-bd89-51f78aeb8659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies" xlink:type="simple" xlink:href="lh-20230331.xsd#IntangibleAssetsGoodwillandOtherPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_64f30325-bd63-4a34-8cad-20231e5b14bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_c6d4c4fa-e744-457c-9313-3e621d689f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_64f30325-bd63-4a34-8cad-20231e5b14bc" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_c6d4c4fa-e744-457c-9313-3e621d689f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="simple" xlink:href="lh-20230331.xsd#RevenuefromContractwithCustomerPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d0de9d6d-8011-42f6-a064-efd9f4113626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_bb6add23-cc6e-49ab-a6d1-1e96ce608a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d0de9d6d-8011-42f6-a064-efd9f4113626" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_bb6add23-cc6e-49ab-a6d1-1e96ce608a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="lh-20230331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_456af137-44dd-43a3-ad74-5ee795ae1d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_66b816e9-80ab-4021-8a06-63bc7990c791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_456af137-44dd-43a3-ad74-5ee795ae1d8b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_66b816e9-80ab-4021-8a06-63bc7990c791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4a2076e9-63bf-49a3-960d-d3bbc9b204a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_456af137-44dd-43a3-ad74-5ee795ae1d8b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4a2076e9-63bf-49a3-960d-d3bbc9b204a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="lh-20230331.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6f8e819c-4c26-4b8d-8c40-0ceb6fd80b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_85cb19dc-6a5d-4e37-aff6-6a13b424f10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6f8e819c-4c26-4b8d-8c40-0ceb6fd80b18" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_85cb19dc-6a5d-4e37-aff6-6a13b424f10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_77f55939-2690-4685-93a4-a9f5f88418e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6f8e819c-4c26-4b8d-8c40-0ceb6fd80b18" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_77f55939-2690-4685-93a4-a9f5f88418e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="lh-20230331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1c1408a8-c639-4942-bdc9-29fa1eed7423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_4f930d8d-e834-46a2-981c-c96e2a731418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c1408a8-c639-4942-bdc9-29fa1eed7423" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_4f930d8d-e834-46a2-981c-c96e2a731418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_08867de6-444c-464b-80d6-84c3e3f58b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c1408a8-c639-4942-bdc9-29fa1eed7423" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_08867de6-444c-464b-80d6-84c3e3f58b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract_64fbcd15-879a-41a0-8bcc-6757171f2e1f" xlink:href="lh-20230331.xsd#lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUETables" xlink:type="simple" xlink:href="lh-20230331.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b72ccf8b-062c-4923-acbf-3dd0d801477c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b72ccf8b-062c-4923-acbf-3dd0d801477c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_84e81e23-9c96-4ff6-aae0-560cbdae595d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_84e81e23-9c96-4ff6-aae0-560cbdae595d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f549173c-6a17-4ce6-a2e4-81cdfe787d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_84e81e23-9c96-4ff6-aae0-560cbdae595d" xlink:to="loc_us-gaap_SegmentDomain_f549173c-6a17-4ce6-a2e4-81cdfe787d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_7cbe4fd5-eb9e-4d23-a401-033fc65f1637" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f549173c-6a17-4ce6-a2e4-81cdfe787d35" xlink:to="loc_lh_CovanceDrugDevelopmentMember_7cbe4fd5-eb9e-4d23-a401-033fc65f1637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_994d2987-8800-4bec-b4e4-1be9fbf27896" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f549173c-6a17-4ce6-a2e4-81cdfe787d35" xlink:to="loc_lh_LabCorpDiagnosticsMember_994d2987-8800-4bec-b4e4-1be9fbf27896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_272f6d82-6e11-43f5-a97d-862037057ce0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:to="loc_srt_StatementGeographicalAxis_272f6d82-6e11-43f5-a97d-862037057ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8c34f259-35f6-4854-b866-bce8dc7e66a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_272f6d82-6e11-43f5-a97d-862037057ce0" xlink:to="loc_srt_SegmentGeographicalDomain_8c34f259-35f6-4854-b866-bce8dc7e66a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_f2276865-1e7b-4287-8f83-823d3b348ac7" xlink:href="lh-20230331.xsd#lh_OthercountriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8c34f259-35f6-4854-b866-bce8dc7e66a4" xlink:to="loc_lh_OthercountriesMember_f2276865-1e7b-4287-8f83-823d3b348ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_5a7958ee-c75c-4bab-9337-b2ce9ff2f992" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8c34f259-35f6-4854-b866-bce8dc7e66a4" xlink:to="loc_srt_EuropeMember_5a7958ee-c75c-4bab-9337-b2ce9ff2f992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_86cbe630-45f6-4d60-8f0e-09473fa406b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_86cbe630-45f6-4d60-8f0e-09473fa406b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_86cbe630-45f6-4d60-8f0e-09473fa406b9" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_0502b984-c36b-47e2-8857-94c80344ec44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfPayMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_us-gaap_SelfPayMember_0502b984-c36b-47e2-8857-94c80344ec44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_35995954-09fc-4498-b3ea-c15b28f37fb7" xlink:href="lh-20230331.xsd#lh_ClientMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_lh_ClientMember_35995954-09fc-4498-b3ea-c15b28f37fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_e2deecc3-74fd-4b00-947b-b2a889717adf" xlink:href="lh-20230331.xsd#lh_MedicareandMedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_lh_MedicareandMedicaidMember_e2deecc3-74fd-4b00-947b-b2a889717adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_4909d2be-5c5a-456c-8e02-ff5ff9e75dea" xlink:href="lh-20230331.xsd#lh_ThirdpartyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_lh_ThirdpartyMember_4909d2be-5c5a-456c-8e02-ff5ff9e75dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_745f663a-ab08-4619-b0e2-a94b2b3e1662" xlink:href="lh-20230331.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_632bb3eb-bf32-4515-ba61-ed8b70636e1d" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_745f663a-ab08-4619-b0e2-a94b2b3e1662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_93504f67-55dd-4912-b926-40cffaf9935a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_ac120260-881c-41cd-9007-6d609eaf010f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_ac120260-881c-41cd-9007-6d609eaf010f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9b563fb6-5664-488a-beb3-cec1d1f8b51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9b563fb6-5664-488a-beb3-cec1d1f8b51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1d732dff-f9a9-41bb-b38c-ae8123be475b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1d732dff-f9a9-41bb-b38c-ae8123be475b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostTableTextBlock_027bd788-7075-4a14-99d1-d82ba0b97c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0326bb41-4003-48c1-b1e3-45931a40e648" xlink:to="loc_us-gaap_CapitalizedContractCostTableTextBlock_027bd788-7075-4a14-99d1-d82ba0b97c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SubsequentEventsTables" xlink:type="simple" xlink:href="lh-20230331.xsd#SubsequentEventsTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SubsequentEventsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_9d3c8225-75a7-4dbe-8501-a834443abbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a55a02d6-641e-4640-adb6-594beffc363e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a55a02d6-641e-4640-adb6-594beffc363e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7ccf17be-f67c-47b7-9d87-87b2ba9c500d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7ccf17be-f67c-47b7-9d87-87b2ba9c500d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a2ca1534-c965-4acb-aef7-4f83d4b065af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7ccf17be-f67c-47b7-9d87-87b2ba9c500d" xlink:to="loc_us-gaap_EquityComponentDomain_a2ca1534-c965-4acb-aef7-4f83d4b065af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eb2d8015-1c74-4d6a-a22d-13ff2b8704b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2ca1534-c965-4acb-aef7-4f83d4b065af" xlink:to="loc_us-gaap_RetainedEarningsMember_eb2d8015-1c74-4d6a-a22d-13ff2b8704b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationAxis_5cf428ba-1426-449b-8c09-7bd10cc08bdd" xlink:href="lh-20230331.xsd#lh_CashFlowLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_lh_CashFlowLocationAxis_5cf428ba-1426-449b-8c09-7bd10cc08bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashFlowLocationDomain_26c70510-6867-42c3-b678-7d6e9725dfb1" xlink:href="lh-20230331.xsd#lh_CashFlowLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CashFlowLocationAxis_5cf428ba-1426-449b-8c09-7bd10cc08bdd" xlink:to="loc_lh_CashFlowLocationDomain_26c70510-6867-42c3-b678-7d6e9725dfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8235e062-b11c-4ad0-917d-fc29940c25e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8235e062-b11c-4ad0-917d-fc29940c25e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0745ae3d-192e-41b0-9518-ab6d94cea2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8235e062-b11c-4ad0-917d-fc29940c25e6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0745ae3d-192e-41b0-9518-ab6d94cea2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5619c43e-adc9-4d4c-a9b7-48b390ca0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5619c43e-adc9-4d4c-a9b7-48b390ca0245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_abd7727c-286b-4e07-a20f-3cd90b3835fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5619c43e-adc9-4d4c-a9b7-48b390ca0245" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_abd7727c-286b-4e07-a20f-3cd90b3835fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e3ef33ff-46c5-41c0-a212-85c9e807aa74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e3ef33ff-46c5-41c0-a212-85c9e807aa74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83ea0068-ff19-4cde-9182-1f7b0d43b68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e3ef33ff-46c5-41c0-a212-85c9e807aa74" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83ea0068-ff19-4cde-9182-1f7b0d43b68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_90183b45-f219-42e6-8764-49ea14800677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_90183b45-f219-42e6-8764-49ea14800677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a18464e1-642d-4c60-be8e-14587b71c0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_90183b45-f219-42e6-8764-49ea14800677" xlink:to="loc_us-gaap_SegmentDomain_a18464e1-642d-4c60-be8e-14587b71c0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_532b5fbf-ffd0-4345-90b7-6c969d92e08a" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a18464e1-642d-4c60-be8e-14587b71c0ff" xlink:to="loc_lh_LabCorpDiagnosticsMember_532b5fbf-ffd0-4345-90b7-6c969d92e08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_db1c79f9-33cb-45aa-ac3c-4ead30a87a60" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a18464e1-642d-4c60-be8e-14587b71c0ff" xlink:to="loc_lh_CovanceDrugDevelopmentMember_db1c79f9-33cb-45aa-ac3c-4ead30a87a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f7037e38-3f4f-4aaa-8620-79d3b12f83fd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f7037e38-3f4f-4aaa-8620-79d3b12f83fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d625e71c-a176-4976-940a-b88ccd84c451" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f7037e38-3f4f-4aaa-8620-79d3b12f83fd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d625e71c-a176-4976-940a-b88ccd84c451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_92f2cb30-cd0f-480d-969d-5533bdd092db" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1785656b-9fe7-42d8-95fe-2ed1d26d20bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_AssetImpairmentCharges_1785656b-9fe7-42d8-95fe-2ed1d26d20bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_44158e37-9a81-429d-b380-f9766b5d0a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_Revenues_44158e37-9a81-429d-b380-f9766b5d0a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c143e705-43cb-4d28-9bf3-89449e92bad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c143e705-43cb-4d28-9bf3-89449e92bad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_ed714864-6522-48ac-9910-d5e3948f995e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_ed714864-6522-48ac-9910-d5e3948f995e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_b0420257-1335-4168-b492-78048c18a3de" xlink:href="lh-20230331.xsd#lh_PercentofRevenueContributed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_lh_PercentofRevenueContributed_b0420257-1335-4168-b492-78048c18a3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e361542e-d535-4045-9b84-96789cf240ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e361542e-d535-4045-9b84-96789cf240ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bb45ae1f-9686-4c93-be62-a0a874a049a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_ProfitLoss_bb45ae1f-9686-4c93-be62-a0a874a049a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1307c006-c5fa-4383-add5-3b5487a3325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_NetIncomeLoss_1307c006-c5fa-4383-add5-3b5487a3325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8c49214e-78b7-4c71-9884-633101d31d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_StockholdersEquity_8c49214e-78b7-4c71-9884-633101d31d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_34ece523-0b6e-4d3f-ad1e-6d5a0720304e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_34ece523-0b6e-4d3f-ad1e-6d5a0720304e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_1e8a53d3-bfc5-4e3e-9f5c-e3fd4855f645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_1e8a53d3-bfc5-4e3e-9f5c-e3fd4855f645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_4f15a50b-8b19-426a-a591-0d8164a41812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_4f15a50b-8b19-426a-a591-0d8164a41812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_5cc401c8-1cee-49f4-bcb9-db551c911329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_5cc401c8-1cee-49f4-bcb9-db551c911329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_94817937-27b5-49be-bc1a-00a66257e099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_94817937-27b5-49be-bc1a-00a66257e099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c66bf49b-0934-4080-b553-e6e8585925e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c893c304-6642-4437-93c9-280f2e60596a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c66bf49b-0934-4080-b553-e6e8585925e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage_8b6dc2d5-1412-4496-ae31-c8326d1ee632" xlink:href="lh-20230331.xsd#lh_CostMethodInvestmentsMaximumOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a55a02d6-641e-4640-adb6-594beffc363e" xlink:to="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage_8b6dc2d5-1412-4496-ae31-c8326d1ee632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3c2bad88-c0c6-48b0-8a71-8f063507f5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeAbstract_609ad8ea-e2b4-464d-ac26-4bf2ef7a085a" xlink:href="lh-20230331.xsd#lh_IncomeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c2bad88-c0c6-48b0-8a71-8f063507f5a0" xlink:to="loc_lh_IncomeAbstract_609ad8ea-e2b4-464d-ac26-4bf2ef7a085a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_96fb2de6-400c-41e1-9160-49c7a277498b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_IncomeAbstract_609ad8ea-e2b4-464d-ac26-4bf2ef7a085a" xlink:to="loc_us-gaap_NetIncomeLoss_96fb2de6-400c-41e1-9160-49c7a277498b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SharesAbstract_5fb10fc1-ca01-447b-9d28-b3a080ff0280" xlink:href="lh-20230331.xsd#lh_SharesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c2bad88-c0c6-48b0-8a71-8f063507f5a0" xlink:to="loc_lh_SharesAbstract_5fb10fc1-ca01-447b-9d28-b3a080ff0280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_481e46f1-2af5-4b5f-b6b0-be54574bc6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SharesAbstract_5fb10fc1-ca01-447b-9d28-b3a080ff0280" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_481e46f1-2af5-4b5f-b6b0-be54574bc6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1a827fb8-d7de-4676-ba9a-4abdd115d0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SharesAbstract_5fb10fc1-ca01-447b-9d28-b3a080ff0280" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1a827fb8-d7de-4676-ba9a-4abdd115d0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PerShareAmountAbstract_3cc519b2-3819-46e3-8361-edb99e7b1d19" xlink:href="lh-20230331.xsd#lh_PerShareAmountAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c2bad88-c0c6-48b0-8a71-8f063507f5a0" xlink:to="loc_lh_PerShareAmountAbstract_3cc519b2-3819-46e3-8361-edb99e7b1d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f6f9ecdd-f86b-423d-8b56-314109c89fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_PerShareAmountAbstract_3cc519b2-3819-46e3-8361-edb99e7b1d19" xlink:to="loc_us-gaap_EarningsPerShareBasic_f6f9ecdd-f86b-423d-8b56-314109c89fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_30c7ceca-bafe-4036-8563-ef46aa9b83f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_PerShareAmountAbstract_3cc519b2-3819-46e3-8361-edb99e7b1d19" xlink:to="loc_us-gaap_EarningsPerShareDiluted_30c7ceca-bafe-4036-8563-ef46aa9b83f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_4e92468f-0051-4cc0-9e5e-b3a452b17dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c2bad88-c0c6-48b0-8a71-8f063507f5a0" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_4e92468f-0051-4cc0-9e5e-b3a452b17dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_604396e4-8abc-4566-b5aa-190a0b5f93bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c2bad88-c0c6-48b0-8a71-8f063507f5a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_604396e4-8abc-4566-b5aa-190a0b5f93bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6871daec-eb82-4f1b-95cd-02706b81f956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_51f1742b-54ea-483e-b429-442dcb494e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6871daec-eb82-4f1b-95cd-02706b81f956" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_51f1742b-54ea-483e-b429-442dcb494e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#NONCONTROLLINGINTERESTPUTSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestPutsAbstract_d83670e0-48c3-440f-adf1-64abe67dae19" xlink:href="lh-20230331.xsd#lh_NoncontrollingInterestPutsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_a2e5c093-4038-4645-a54f-08c216cc1cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_NoncontrollingInterestPutsAbstract_d83670e0-48c3-440f-adf1-64abe67dae19" xlink:to="loc_us-gaap_MinorityInterestTable_a2e5c093-4038-4645-a54f-08c216cc1cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0bfb79fd-2116-4eae-b806-9f9d27a7b13c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a2e5c093-4038-4645-a54f-08c216cc1cec" xlink:to="loc_dei_LegalEntityAxis_0bfb79fd-2116-4eae-b806-9f9d27a7b13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_be7644e4-8dac-4a56-8785-aac0b83dc90c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_0bfb79fd-2116-4eae-b806-9f9d27a7b13c" xlink:to="loc_dei_EntityDomain_be7644e4-8dac-4a56-8785-aac0b83dc90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_15cefbc4-ac3c-41c0-bb12-644e174eb7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a2e5c093-4038-4645-a54f-08c216cc1cec" xlink:to="loc_us-gaap_MinorityInterestLineItems_15cefbc4-ac3c-41c0-bb12-644e174eb7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_43929790-c402-4c60-b853-b3464d710e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_43929790-c402-4c60-b853-b3464d710e91" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1adf1961-ec65-4323-875b-a14838c05662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1adf1961-ec65-4323-875b-a14838c05662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12c41bfa-ed25-42af-961c-b2566e1a3897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1adf1961-ec65-4323-875b-a14838c05662" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12c41bfa-ed25-42af-961c-b2566e1a3897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9f48d98a-07a8-4920-a564-48fe17748f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12c41bfa-ed25-42af-961c-b2566e1a3897" xlink:to="loc_us-gaap_TradeNamesMember_9f48d98a-07a8-4920-a564-48fe17748f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_1317fd81-ac44-4831-9d80-1426cf1fe44f" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_1317fd81-ac44-4831-9d80-1426cf1fe44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_1317fd81-ac44-4831-9d80-1426cf1fe44f" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c7141c0e-0bb8-4df3-96a1-0dc1cacd9634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c7141c0e-0bb8-4df3-96a1-0dc1cacd9634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_2496a275-3ecb-4f08-bc72-a4bb1ebee8f1" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_2496a275-3ecb-4f08-bc72-a4bb1ebee8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_583fe05b-80ad-4c09-830c-3fcb44a0971f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_583fe05b-80ad-4c09-830c-3fcb44a0971f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9f391fb3-91e1-4216-887f-c47f914ab32c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_TradeNamesMember_9f391fb3-91e1-4216-887f-c47f914ab32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_98cad622-eda7-4c2a-ac86-d69a2ba4dbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_UseRightsMember_98cad622-eda7-4c2a-ac86-d69a2ba4dbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_8a861bd9-f4f2-493f-8681-03f8f57156b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_7b0decec-3c97-40d4-bba4-4bc15568b567" xlink:to="loc_us-gaap_LicensingAgreementsMember_8a861bd9-f4f2-493f-8681-03f8f57156b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ca47cc43-0970-48f4-9d0a-f7671410bc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ca47cc43-0970-48f4-9d0a-f7671410bc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3764395-24bb-4087-a1da-8022ff9360f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ca47cc43-0970-48f4-9d0a-f7671410bc8f" xlink:to="loc_us-gaap_SegmentDomain_c3764395-24bb-4087-a1da-8022ff9360f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_5c0c2680-f8e6-4626-9e31-c4967421cee3" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3764395-24bb-4087-a1da-8022ff9360f6" xlink:to="loc_lh_LabCorpDiagnosticsMember_5c0c2680-f8e6-4626-9e31-c4967421cee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_2bd12b0e-b53e-4d96-9302-fd1ce34063ec" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3764395-24bb-4087-a1da-8022ff9360f6" xlink:to="loc_lh_CovanceDrugDevelopmentMember_2bd12b0e-b53e-4d96-9302-fd1ce34063ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_bad68a8b-18cb-4276-96e6-af52eab8db8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_bad68a8b-18cb-4276-96e6-af52eab8db8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_8d756125-97e2-41e7-be71-184d883d4ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_bad68a8b-18cb-4276-96e6-af52eab8db8e" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_8d756125-97e2-41e7-be71-184d883d4ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_be4cfa99-5ad3-4f39-8e15-a7aae37c6cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_8d756125-97e2-41e7-be71-184d883d4ca7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_be4cfa99-5ad3-4f39-8e15-a7aae37c6cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_52e8a5eb-4efd-4f9c-9e47-31e583fb80fb" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_8d756125-97e2-41e7-be71-184d883d4ca7" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_52e8a5eb-4efd-4f9c-9e47-31e583fb80fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7906d50e-687a-4aae-a69e-df6410e1c293" xlink:to="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9c73a9f3-f7f2-4473-a331-31b015deace1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9c73a9f3-f7f2-4473-a331-31b015deace1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_23b9431b-ab2e-41aa-83c5-e32aca1f1416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_23b9431b-ab2e-41aa-83c5-e32aca1f1416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5e45f664-ed86-444d-8be2-3f41595ab021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_Goodwill_5e45f664-ed86-444d-8be2-3f41595ab021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a414a119-6ae2-480a-a975-d6a250f93202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a414a119-6ae2-480a-a975-d6a250f93202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0fd75971-7245-4300-92a4-d685d8052b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_Goodwill_0fd75971-7245-4300-92a4-d685d8052b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3abe27a6-248d-42e6-a07d-f96f648b979e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3abe27a6-248d-42e6-a07d-f96f648b979e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ac59161c-695f-4ee1-8804-d32d91b4f1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ac59161c-695f-4ee1-8804-d32d91b4f1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4cee27e0-0a3c-4abf-ac57-337a9b80a561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f6149348-9b3d-45ce-8a75-5f6ec00090f5" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4cee27e0-0a3c-4abf-ac57-337a9b80a561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_e74e3787-2551-4061-a20f-749f6438d411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_43929790-c402-4c60-b853-b3464d710e91" xlink:to="loc_us-gaap_GoodwillRollForward_e74e3787-2551-4061-a20f-749f6438d411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_d66b7302-dbbf-4838-b6b6-16f8a1fa6111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_43929790-c402-4c60-b853-b3464d710e91" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_d66b7302-dbbf-4838-b6b6-16f8a1fa6111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bafb997a-622f-4031-9f3d-d53fe971b931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bafb997a-622f-4031-9f3d-d53fe971b931" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1364735-39d2-44a8-b52d-ccdfca383532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1364735-39d2-44a8-b52d-ccdfca383532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_074f33e8-226f-4558-bfff-66aea83b92a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1364735-39d2-44a8-b52d-ccdfca383532" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_074f33e8-226f-4558-bfff-66aea83b92a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:href="lh-20230331.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_34ca07bf-a8c2-4137-8f2c-4b9f0c1049df" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_07e16831-fad3-4018-ab7f-43c73f7ce6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_07e16831-fad3-4018-ab7f-43c73f7ce6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_8f96c120-5277-4a67-8c09-52e5d717a03e" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_8f96c120-5277-4a67-8c09-52e5d717a03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_dff9dc1f-19f2-41b4-8b7a-9cdb72253bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_dff9dc1f-19f2-41b4-8b7a-9cdb72253bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_fc1009a5-ea72-42f3-bc82-fd6252e9fa04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_TradeNamesMember_fc1009a5-ea72-42f3-bc82-fd6252e9fa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_d67df30b-db9a-45c6-9c88-20340490300c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_UseRightsMember_d67df30b-db9a-45c6-9c88-20340490300c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_8cb3cb97-e979-4ce9-8877-fa14d09635e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_us-gaap_LicensingAgreementsMember_8cb3cb97-e979-4ce9-8877-fa14d09635e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InProcessRAAndMediaMember_cd23b870-c993-4767-9b62-9f1b9dcc0a84" xlink:href="lh-20230331.xsd#lh_InProcessRAAndMediaMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_88331888-9f9c-4bfe-b61c-1b93e15ba86a" xlink:to="loc_lh_InProcessRAAndMediaMember_cd23b870-c993-4767-9b62-9f1b9dcc0a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_99c41022-17a3-4696-8aa5-d3e013ff7da2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_62ff8bbf-164d-4bea-961d-1fc16736b82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_62ff8bbf-164d-4bea-961d-1fc16736b82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8335016e-f12a-42a4-9f79-4e3c2539176c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8335016e-f12a-42a4-9f79-4e3c2539176c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a02810cc-5c52-4746-b464-47a9a319c47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d0f3ab3-2a40-4365-ba27-93c07c92ea25" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a02810cc-5c52-4746-b464-47a9a319c47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d0ec2a8b-771c-487f-acb3-3ed4e181eda4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d0ec2a8b-771c-487f-acb3-3ed4e181eda4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7157a2a0-f11b-426e-9d7f-2165b671f913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7157a2a0-f11b-426e-9d7f-2165b671f913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7157a2a0-f11b-426e-9d7f-2165b671f913" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_26fcfff7-7437-4f3f-988f-964d611f1815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_TradeNamesMember_26fcfff7-7437-4f3f-988f-964d611f1815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_974705f1-5d1e-4f33-ba1e-8c8a0568c7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_974705f1-5d1e-4f33-ba1e-8c8a0568c7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_21cebe76-485d-4a8d-af99-245d146888e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_UseRightsMember_21cebe76-485d-4a8d-af99-245d146888e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_e913d90a-4bcc-484e-8ede-5b2f4e06eb13" xlink:href="lh-20230331.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_e913d90a-4bcc-484e-8ede-5b2f4e06eb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_ad42663d-7b79-43ca-8c3f-26516d231dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_ad42663d-7b79-43ca-8c3f-26516d231dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_183d7e00-d55d-4b47-a455-d2836351c1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09e75ba6-9152-478d-972e-3755cc61df4b" xlink:to="loc_us-gaap_LicensingAgreementsMember_183d7e00-d55d-4b47-a455-d2836351c1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e23b9bfa-1d3c-48b2-920b-196f526c485f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e23b9bfa-1d3c-48b2-920b-196f526c485f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ecb3039d-8dba-4829-bb84-9257b8d65bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e23b9bfa-1d3c-48b2-920b-196f526c485f" xlink:to="loc_us-gaap_SegmentDomain_ecb3039d-8dba-4829-bb84-9257b8d65bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_5c73fe54-a017-4951-ab4d-a7bcbf2ff1ae" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ecb3039d-8dba-4829-bb84-9257b8d65bf8" xlink:to="loc_lh_LabCorpDiagnosticsMember_5c73fe54-a017-4951-ab4d-a7bcbf2ff1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_ff3cfb96-7679-4bf9-a6be-fca18e100a03" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ecb3039d-8dba-4829-bb84-9257b8d65bf8" xlink:to="loc_lh_CovanceDrugDevelopmentMember_ff3cfb96-7679-4bf9-a6be-fca18e100a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9bcf996a-f921-43f3-9300-c6bb90405cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9bcf996a-f921-43f3-9300-c6bb90405cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c31aed30-304d-4e9f-8534-12fb7ffc8f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9bcf996a-f921-43f3-9300-c6bb90405cb9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c31aed30-304d-4e9f-8534-12fb7ffc8f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a604ca36-111d-401b-a173-c2917155b1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c31aed30-304d-4e9f-8534-12fb7ffc8f4d" xlink:to="loc_us-gaap_TradeNamesMember_a604ca36-111d-401b-a173-c2917155b1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ffce00ff-2acd-4e15-b96a-66bd7475bf4c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c64192b0-2693-4c34-a57d-af64be9c9fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c64192b0-2693-4c34-a57d-af64be9c9fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1d184ce7-b81a-4b0b-9243-920a38941487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_Goodwill_1d184ce7-b81a-4b0b-9243-920a38941487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3542f782-87a2-4e83-bd88-d31fd84c840f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3542f782-87a2-4e83-bd88-d31fd84c840f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_557e5f01-6c37-4c48-be9c-3af186169c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_557e5f01-6c37-4c48-be9c-3af186169c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_dd677573-0957-4d53-a1bc-edde4b5446b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_dd677573-0957-4d53-a1bc-edde4b5446b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1b1ec7a6-9a5f-4f2f-87f2-7f6cddeb0491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1b1ec7a6-9a5f-4f2f-87f2-7f6cddeb0491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c41d2b29-9354-49d1-8ed3-88db43d39928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c41d2b29-9354-49d1-8ed3-88db43d39928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_29165858-f39a-4328-a3f6-de0040c54e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_29165858-f39a-4328-a3f6-de0040c54e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9e2700f4-109f-43f0-b130-776337b4edc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9e2700f4-109f-43f0-b130-776337b4edc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9a99d701-5151-4cbd-8e04-d85f9f2264b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9a99d701-5151-4cbd-8e04-d85f9f2264b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_4aedbecd-a8b9-41fc-937a-bd33f2e9e5a9" xlink:href="lh-20230331.xsd#lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_554a24ac-54a7-429a-84c7-42966e909675" xlink:to="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_4aedbecd-a8b9-41fc-937a-bd33f2e9e5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_19587f2c-275d-4172-af9b-cae773b8cdaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d0ec2a8b-771c-487f-acb3-3ed4e181eda4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_19587f2c-275d-4172-af9b-cae773b8cdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2bf0215d-9908-4479-801e-bb2334db67a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2bf0215d-9908-4479-801e-bb2334db67a4" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6c11345b-151d-49c7-8078-de00e1da4e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6c11345b-151d-49c7-8078-de00e1da4e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc1d6ae9-eb93-4881-864c-795b8b0db259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c11345b-151d-49c7-8078-de00e1da4e02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc1d6ae9-eb93-4881-864c-795b8b0db259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2966a575-8db0-420f-8184-034aaf47943a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_CreditFacilityAxis_2966a575-8db0-420f-8184-034aaf47943a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a524dd61-c753-47c2-9d72-03377ba2f12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2966a575-8db0-420f-8184-034aaf47943a" xlink:to="loc_us-gaap_CreditFacilityDomain_a524dd61-c753-47c2-9d72-03377ba2f12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_9ec57f49-a11e-4eb6-9d39-a050472ceb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_9ec57f49-a11e-4eb6-9d39-a050472ceb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6adb0cab-7348-407f-8daf-143b05fdb306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9ec57f49-a11e-4eb6-9d39-a050472ceb97" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6adb0cab-7348-407f-8daf-143b05fdb306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80605065-d49c-4de2-85c6-c238b29d37cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80605065-d49c-4de2-85c6-c238b29d37cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5affba9a-b7e5-4d6b-bcfd-71ac973c6b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80605065-d49c-4de2-85c6-c238b29d37cf" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5affba9a-b7e5-4d6b-bcfd-71ac973c6b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_909bf410-850e-4f68-ad90-9149df95ea1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5affba9a-b7e5-4d6b-bcfd-71ac973c6b77" xlink:to="loc_us-gaap_InterestRateSwapMember_909bf410-850e-4f68-ad90-9149df95ea1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3dd5c9a-7425-4dec-b2af-a5575f2e7e45" xlink:to="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentDebtExcludingFinanceLeaseLiability_870d79e7-e1eb-4821-84bd-5aa69d3b2ab7" xlink:href="lh-20230331.xsd#lh_CurrentDebtExcludingFinanceLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_lh_CurrentDebtExcludingFinanceLeaseLiability_870d79e7-e1eb-4821-84bd-5aa69d3b2ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_d47ad360-102c-448e-b233-531fd6c522fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_us-gaap_NotesPayableCurrent_d47ad360-102c-448e-b233-531fd6c522fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2025_b65f1d1f-8ff9-43b6-aeab-fd71a6c17a37" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2025"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_lh_A360SeniorNotesDue2025_b65f1d1f-8ff9-43b6-aeab-fd71a6c17a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A400SeniorNotesDue2023_6e05f865-bb9d-45a7-a0ce-22ee87e66661" xlink:href="lh-20230331.xsd#lh_A400SeniorNotesDue2023"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_lh_A400SeniorNotesDue2023_6e05f865-bb9d-45a7-a0ce-22ee87e66661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_7622153e-4153-4e16-948d-bee80c1d2297" xlink:href="lh-20230331.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7d618bf7-77bc-4064-81fe-1450ada32c3b" xlink:to="loc_lh_Shorttermdebtissuancecosts_7622153e-4153-4e16-948d-bee80c1d2297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBTLongtermdebtDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTLongtermdebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ba7f51f2-a85d-431e-bd4d-303d62eccb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba7f51f2-a85d-431e-bd4d-303d62eccb3b" xlink:to="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_dcf4e479-e038-4541-a469-46e4944a1cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_dcf4e479-e038-4541-a469-46e4944a1cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a8efcb5a-3bd4-4186-b918-7426eaf9302d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_dcf4e479-e038-4541-a469-46e4944a1cdf" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a8efcb5a-3bd4-4186-b918-7426eaf9302d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c44cc5e5-5a5d-45d4-ad34-18f5919be018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_srt_StatementScenarioAxis_c44cc5e5-5a5d-45d4-ad34-18f5919be018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_75283d36-38e7-4fff-b7c5-88385be2a829" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_c44cc5e5-5a5d-45d4-ad34-18f5919be018" xlink:to="loc_srt_ScenarioUnspecifiedDomain_75283d36-38e7-4fff-b7c5-88385be2a829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_64dbbf24-cfe0-4703-9c7b-1910ae745be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_VariableRateAxis_64dbbf24-cfe0-4703-9c7b-1910ae745be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d99057f3-2c1a-4013-aa24-07e508376a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_64dbbf24-cfe0-4703-9c7b-1910ae745be1" xlink:to="loc_us-gaap_VariableRateDomain_d99057f3-2c1a-4013-aa24-07e508376a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd7a7529-5b6f-4b9f-84d1-8a5187551313" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_srt_RangeAxis_dd7a7529-5b6f-4b9f-84d1-8a5187551313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_69a08d93-4045-4370-aa2c-c830a5494260" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd7a7529-5b6f-4b9f-84d1-8a5187551313" xlink:to="loc_srt_RangeMember_69a08d93-4045-4370-aa2c-c830a5494260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_dd594317-04c9-4e2c-b24b-6ed22fced854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_CreditFacilityAxis_dd594317-04c9-4e2c-b24b-6ed22fced854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_213e7c7b-1570-437e-94e2-cbb5060da846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_dd594317-04c9-4e2c-b24b-6ed22fced854" xlink:to="loc_us-gaap_CreditFacilityDomain_213e7c7b-1570-437e-94e2-cbb5060da846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ce8bbda7-0e5d-48be-b3f7-f14c6829d162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_213e7c7b-1570-437e-94e2-cbb5060da846" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ce8bbda7-0e5d-48be-b3f7-f14c6829d162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_91cb47de-49b5-42bf-8028-69f9b7e91a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_91cb47de-49b5-42bf-8028-69f9b7e91a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16941d8c-d6dc-4a6c-ac54-8eeeeb1e815d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91cb47de-49b5-42bf-8028-69f9b7e91a6e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16941d8c-d6dc-4a6c-ac54-8eeeeb1e815d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f02466d5-9506-4c1d-9a2a-084caf25e7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f02466d5-9506-4c1d-9a2a-084caf25e7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f02466d5-9506-4c1d-9a2a-084caf25e7d8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7dbbb9e4-5aa7-4133-8f06-61924277c142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7dbbb9e4-5aa7-4133-8f06-61924277c142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2031Member_864acb41-b7ff-4117-8f62-a87e6f68958f" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2031Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:to="loc_lh_SeniorNotesDue2031Member_864acb41-b7ff-4117-8f62-a87e6f68958f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_d193808d-bc01-4489-a03a-d06203e3632b" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc4b6979-d366-49d7-a63d-32edea6263d1" xlink:to="loc_lh_Seniornotesdue2027Member_d193808d-bc01-4489-a03a-d06203e3632b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c8db9c14-dc5f-42ad-8424-c1c397ec04ef" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A400SeniorNotesDue2023_129013b8-2f1e-492f-bd36-db653d27d1fe" xlink:href="lh-20230331.xsd#lh_A400SeniorNotesDue2023"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A400SeniorNotesDue2023_129013b8-2f1e-492f-bd36-db653d27d1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A325SeniorNotesDue2024_b1910a87-5713-439f-9a25-88625eb0d400" xlink:href="lh-20230331.xsd#lh_A325SeniorNotesDue2024"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A325SeniorNotesDue2024_b1910a87-5713-439f-9a25-88625eb0d400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_ed30d5f8-95f1-451f-9d1c-eb54dc6efd16" xlink:href="lh-20230331.xsd#lh_A2.30seniornotesdue2024"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A2.30seniornotesdue2024_ed30d5f8-95f1-451f-9d1c-eb54dc6efd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2025_5197b2fe-d4ed-4498-9a72-9bbf35b9397b" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2025"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A360SeniorNotesDue2025_5197b2fe-d4ed-4498-9a72-9bbf35b9397b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026_c4f41797-8dae-45e0-b80f-20e073c78f0b" xlink:href="lh-20230331.xsd#lh_A155SeniorNotesDue2026"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A155SeniorNotesDue2026_c4f41797-8dae-45e0-b80f-20e073c78f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2027_150bd7bc-d876-4748-bb26-a212925caa1d" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2027"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A360SeniorNotesDue2027_150bd7bc-d876-4748-bb26-a212925caa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_9b921489-1d16-4d80-9367-60b0eb1e79b4" xlink:href="lh-20230331.xsd#lh_A2.95seniornotesdue2029"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A2.95seniornotesdue2029_9b921489-1d16-4d80-9367-60b0eb1e79b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031_fdf975de-10d4-49e8-8fa5-287c2cb7ba63" xlink:href="lh-20230331.xsd#lh_A270SeniorNotesDue2031"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A270SeniorNotesDue2031_fdf975de-10d4-49e8-8fa5-287c2cb7ba63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A470SeniorNotesDue2045_8624eed5-a67b-470c-b5f9-c3077614d1c6" xlink:href="lh-20230331.xsd#lh_A470SeniorNotesDue2045"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_A470SeniorNotesDue2045_8624eed5-a67b-470c-b5f9-c3077614d1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts_b8069dfb-0741-4c9f-a4b8-91de82e41026" xlink:href="lh-20230331.xsd#lh_Longtermdebtissuancecosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_lh_Longtermdebtissuancecosts_b8069dfb-0741-4c9f-a4b8-91de82e41026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_1841029d-accb-41e6-a520-a83de7218222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_us-gaap_LongTermNotesPayable_1841029d-accb-41e6-a520-a83de7218222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_70235df3-69d6-4e75-a26b-bad48176e384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d096a21a-9e5d-4700-a7b4-c96a68707760" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_70235df3-69d6-4e75-a26b-bad48176e384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBTSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b8c9e395-f68d-44b6-a925-39dda9459bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b8c9e395-f68d-44b6-a925-39dda9459bc2" xlink:to="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8c805fcc-ca52-437f-96ab-b4ab0edde906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8c805fcc-ca52-437f-96ab-b4ab0edde906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62d66c3e-8d9b-4b0d-9384-07ba79301c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c805fcc-ca52-437f-96ab-b4ab0edde906" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62d66c3e-8d9b-4b0d-9384-07ba79301c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5bbb753c-1de6-4a8b-bbac-6c2ae5450285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_DebtInstrumentAxis_5bbb753c-1de6-4a8b-bbac-6c2ae5450285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f56fe0ed-e72d-406a-9682-9f89e738fe0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5bbb753c-1de6-4a8b-bbac-6c2ae5450285" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f56fe0ed-e72d-406a-9682-9f89e738fe0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_86042007-04a2-4c2f-8f6f-38c5c9982bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_86042007-04a2-4c2f-8f6f-38c5c9982bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_07fb334d-08fe-45a3-b12f-db8f031cb80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_86042007-04a2-4c2f-8f6f-38c5c9982bc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_07fb334d-08fe-45a3-b12f-db8f031cb80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_6e46e6ac-e0b4-4cb3-b088-d3da77c96e8f" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_07fb334d-08fe-45a3-b12f-db8f031cb80d" xlink:to="loc_lh_Seniornotesdue2027Member_6e46e6ac-e0b4-4cb3-b088-d3da77c96e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2031Member_fb8c2180-22e5-44f9-90d6-f4bee3247d46" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2031Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_07fb334d-08fe-45a3-b12f-db8f031cb80d" xlink:to="loc_lh_SeniorNotesDue2031Member_fb8c2180-22e5-44f9-90d6-f4bee3247d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_403cf75a-0865-4fe8-a77f-d7ed5e9ba794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_403cf75a-0865-4fe8-a77f-d7ed5e9ba794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_03c8bff2-bc6a-4e90-947f-8c5b4838a65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_403cf75a-0865-4fe8-a77f-d7ed5e9ba794" xlink:to="loc_us-gaap_HedgingRelationshipDomain_03c8bff2-bc6a-4e90-947f-8c5b4838a65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0c54d15f-6d81-4231-94d3-89d413f372f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_03c8bff2-bc6a-4e90-947f-8c5b4838a65c" xlink:to="loc_us-gaap_InterestRateSwapMember_0c54d15f-6d81-4231-94d3-89d413f372f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b256dbe-c462-4e73-8fbc-81bbcd036e65" xlink:to="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e8d9e02a-c654-4667-baee-f2f8760650b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e8d9e02a-c654-4667-baee-f2f8760650b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a67be1c-fdfb-47bc-93ea-961a950ce724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a67be1c-fdfb-47bc-93ea-961a950ce724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_9de716ac-dc38-4c5e-bca4-3f62b8dc384e" xlink:href="lh-20230331.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_9de716ac-dc38-4c5e-bca4-3f62b8dc384e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_b6c45516-54ed-4d57-86fa-01b7d4472482" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_b6c45516-54ed-4d57-86fa-01b7d4472482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_94bf1f70-0879-41b2-a7b5-4391240b7a6b" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_94bf1f70-0879-41b2-a7b5-4391240b7a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts_47423698-42ae-417c-a7f6-c2e072adda59" xlink:href="lh-20230331.xsd#lh_Longtermdebtissuancecosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_Longtermdebtissuancecosts_47423698-42ae-417c-a7f6-c2e072adda59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_c72e7ad9-dd2d-41d0-adb7-9e255a1c10b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_NotesPayableCurrent_c72e7ad9-dd2d-41d0-adb7-9e255a1c10b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_681dfa2d-64b7-4de9-a142-793f9ccb7280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_681dfa2d-64b7-4de9-a142-793f9ccb7280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_2e1b5602-85ae-475d-bbb4-813c36a1adb1" xlink:href="lh-20230331.xsd#lh_A2.30seniornotesdue2024"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_A2.30seniornotesdue2024_2e1b5602-85ae-475d-bbb4-813c36a1adb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_9eae4731-6193-4d4e-aa7c-5ef93faa4ea5" xlink:href="lh-20230331.xsd#lh_A2.95seniornotesdue2029"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_A2.95seniornotesdue2029_9eae4731-6193-4d4e-aa7c-5ef93faa4ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_856ce6cd-4577-462c-b298-1a496392a22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_856ce6cd-4577-462c-b298-1a496392a22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedBorrowingInterestRate_3c0acdbd-a1b5-48c4-adcf-3ab071ec3bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubordinatedBorrowingInterestRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_us-gaap_SubordinatedBorrowingInterestRate_3c0acdbd-a1b5-48c4-adcf-3ab071ec3bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031_e0619d7a-8d58-41af-9d90-d712a4d659f7" xlink:href="lh-20230331.xsd#lh_A270SeniorNotesDue2031"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_A270SeniorNotesDue2031_e0619d7a-8d58-41af-9d90-d712a4d659f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThreeMonthLIBOR_64e4c03d-22fd-4df9-a43b-5e684d6ed9d3" xlink:href="lh-20230331.xsd#lh_ThreeMonthLIBOR"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_acfd6c69-d2d8-4c74-a9ae-07e42c26c34f" xlink:to="loc_lh_ThreeMonthLIBOR_64e4c03d-22fd-4df9-a43b-5e684d6ed9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#DEBTCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_75c23809-340a-42ca-b415-7ee6f9a3af39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_75c23809-340a-42ca-b415-7ee6f9a3af39" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_137ff38e-fccb-4224-96d5-c64707ac0157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_DebtInstrumentAxis_137ff38e-fccb-4224-96d5-c64707ac0157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f6472b07-3f60-46e9-9d1e-cfeb0d031785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_137ff38e-fccb-4224-96d5-c64707ac0157" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f6472b07-3f60-46e9-9d1e-cfeb0d031785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a620cc65-64be-44ab-b55e-94b857673f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_CreditFacilityAxis_a620cc65-64be-44ab-b55e-94b857673f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_28afc183-0ee8-4d47-bbcc-f7df2f219f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a620cc65-64be-44ab-b55e-94b857673f92" xlink:to="loc_us-gaap_CreditFacilityDomain_28afc183-0ee8-4d47-bbcc-f7df2f219f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_74c36abf-c9f4-409a-9e60-4e49d3814b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_28afc183-0ee8-4d47-bbcc-f7df2f219f41" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_74c36abf-c9f4-409a-9e60-4e49d3814b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_342e0b9c-e75c-4c02-98d1-e274563d8429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_342e0b9c-e75c-4c02-98d1-e274563d8429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_cfb3a678-88ab-40a6-995a-b4fe5ecd2c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_342e0b9c-e75c-4c02-98d1-e274563d8429" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_cfb3a678-88ab-40a6-995a-b4fe5ecd2c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_bc872fb3-61c5-4bd6-99b9-4bfa0345c5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_cfb3a678-88ab-40a6-995a-b4fe5ecd2c76" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_bc872fb3-61c5-4bd6-99b9-4bfa0345c5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3c618d7c-f2e8-4f9e-b083-3efad71c153a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3c618d7c-f2e8-4f9e-b083-3efad71c153a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c618d7c-f2e8-4f9e-b083-3efad71c153a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_9de361af-c4da-46d5-99c2-25f2a7fff103" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_Seniornotesdue2027Member_9de361af-c4da-46d5-99c2-25f2a7fff103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2027_6acc6b82-9046-44aa-b83b-c115e4e10f04" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2027"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A360SeniorNotesDue2027_6acc6b82-9046-44aa-b83b-c115e4e10f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026_022023f2-0f93-427e-985e-ae4bec0ee08e" xlink:href="lh-20230331.xsd#lh_A155SeniorNotesDue2026"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A155SeniorNotesDue2026_022023f2-0f93-427e-985e-ae4bec0ee08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_8ba44693-d5c0-4025-9de1-5435bfc1088e" xlink:href="lh-20230331.xsd#lh_A2.30seniornotesdue2024"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A2.30seniornotesdue2024_8ba44693-d5c0-4025-9de1-5435bfc1088e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031_54e6221a-2686-4f24-8cc6-315ba8e562f6" xlink:href="lh-20230331.xsd#lh_A270SeniorNotesDue2031"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A270SeniorNotesDue2031_54e6221a-2686-4f24-8cc6-315ba8e562f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A400SeniorNotesDue2023_07ce518e-617b-49ed-94a2-b5741a045a1f" xlink:href="lh-20230331.xsd#lh_A400SeniorNotesDue2023"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A400SeniorNotesDue2023_07ce518e-617b-49ed-94a2-b5741a045a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A325SeniorNotesDue2024_2cf658ae-f4f4-4fc5-bc38-cf24ee878ffa" xlink:href="lh-20230331.xsd#lh_A325SeniorNotesDue2024"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A325SeniorNotesDue2024_2cf658ae-f4f4-4fc5-bc38-cf24ee878ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A360SeniorNotesDue2025_ea2fd6e2-bb0d-4e7c-a190-d05d0bca4fcd" xlink:href="lh-20230331.xsd#lh_A360SeniorNotesDue2025"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A360SeniorNotesDue2025_ea2fd6e2-bb0d-4e7c-a190-d05d0bca4fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_5ee0cf77-0a5d-4b8b-a9e2-6e283994f4cd" xlink:href="lh-20230331.xsd#lh_A2.95seniornotesdue2029"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A2.95seniornotesdue2029_5ee0cf77-0a5d-4b8b-a9e2-6e283994f4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A470SeniorNotesDue2045_5b55267f-d98c-49af-84d0-cfdaba58e8bf" xlink:href="lh-20230331.xsd#lh_A470SeniorNotesDue2045"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a1ef833d-86ea-4a28-84d2-4f86c178e398" xlink:to="loc_lh_A470SeniorNotesDue2045_5b55267f-d98c-49af-84d0-cfdaba58e8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a3309889-8c8e-495b-9292-631163b91ae9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_srt_StatementScenarioAxis_a3309889-8c8e-495b-9292-631163b91ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3a24f1c3-72ce-48f0-bf26-579903a531de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a3309889-8c8e-495b-9292-631163b91ae9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3a24f1c3-72ce-48f0-bf26-579903a531de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_c7d8ab84-c5ca-417c-a466-384395b8ee4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_c7d8ab84-c5ca-417c-a466-384395b8ee4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_3e2c981a-7584-428b-a94e-c474c2552282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c7d8ab84-c5ca-417c-a466-384395b8ee4a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_3e2c981a-7584-428b-a94e-c474c2552282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d01c33d9-db35-4a24-bf12-9a9e689c4040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_3e2c981a-7584-428b-a94e-c474c2552282" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d01c33d9-db35-4a24-bf12-9a9e689c4040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5d1e896a-6c7a-4099-b1e1-27136166df36" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_8e738b73-b15b-4585-a276-922878fbfb0f" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_8e738b73-b15b-4585-a276-922878fbfb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_944b8efe-0a77-4eca-a382-3f3867e35697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_944b8efe-0a77-4eca-a382-3f3867e35697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_2914e81d-77c6-4fac-9718-cfed72a5c438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_2914e81d-77c6-4fac-9718-cfed72a5c438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_5b9d9e2a-3402-4765-9fb7-e1024436a8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_5b9d9e2a-3402-4765-9fb7-e1024436a8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_6a92f192-7c0a-4364-b6a6-22781a84c29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_NotesPayableCurrent_6a92f192-7c0a-4364-b6a6-22781a84c29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_e6cdda4f-3e65-417d-b3ec-15c451cfca27" xlink:href="lh-20230331.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_e6cdda4f-3e65-417d-b3ec-15c451cfca27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_8531f4f0-a4a2-41b1-a0cf-ae5037a2d2b9" xlink:href="lh-20230331.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_8531f4f0-a4a2-41b1-a0cf-ae5037a2d2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_71f83176-cb36-4e7f-9a22-48b90ff3f6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ac77c777-2b30-4365-9db1-fedcc1b234f5" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_71f83176-cb36-4e7f-9a22-48b90ff3f6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4e9f4dfe-caea-451e-a364-876ec4f18a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4e9f4dfe-caea-451e-a364-876ec4f18a6a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0dcb78d9-c2f1-4975-900c-fde424b51e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:to="loc_us-gaap_CreditFacilityAxis_0dcb78d9-c2f1-4975-900c-fde424b51e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bcc0cc0d-0d5b-4b75-a32f-e58823d1ae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0dcb78d9-c2f1-4975-900c-fde424b51e64" xlink:to="loc_us-gaap_CreditFacilityDomain_bcc0cc0d-0d5b-4b75-a32f-e58823d1ae3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_16648d9f-1deb-4d63-99a7-cb976b6d845c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_16648d9f-1deb-4d63-99a7-cb976b6d845c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0d9bed45-c4db-47d9-a9ba-6c190259a9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_16648d9f-1deb-4d63-99a7-cb976b6d845c" xlink:to="loc_us-gaap_ClassOfStockDomain_0d9bed45-c4db-47d9-a9ba-6c190259a9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_38800b0b-74fb-4a83-b200-a31e5ae226fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0d9bed45-c4db-47d9-a9ba-6c190259a9a4" xlink:to="loc_us-gaap_CommonStockMember_38800b0b-74fb-4a83-b200-a31e5ae226fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1b8e08a2-b583-4481-9a55-d80dbfc17221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1b8e08a2-b583-4481-9a55-d80dbfc17221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_531138f4-66e2-46c3-a364-29fc9ba9943a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1b8e08a2-b583-4481-9a55-d80dbfc17221" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_531138f4-66e2-46c3-a364-29fc9ba9943a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d4ae891a-d2fc-4193-930e-524bc887afdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_531138f4-66e2-46c3-a364-29fc9ba9943a" xlink:to="loc_us-gaap_SubsequentEventMember_d4ae891a-d2fc-4193-930e-524bc887afdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ca3256cd-264a-4c3e-abab-59f20c5cd32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b1c254c8-1780-480f-bdfa-7800c49acfa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_64693de5-de04-4b83-81e2-4b24701513bb" xlink:to="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_cac07ffb-ba8e-46fd-98ea-fd9b349b6796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_cac07ffb-ba8e-46fd-98ea-fd9b349b6796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:href="lh-20230331.xsd#lh_CommonSharesIssuedRollforwardAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d93ba189-e784-4ea0-b15b-b12cc4c7e856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:to="loc_us-gaap_CommonStockSharesIssued_d93ba189-e784-4ea0-b15b-b12cc4c7e856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_640192e1-886e-4ce4-addf-fc4fd01c82c6" xlink:href="lh-20230331.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_640192e1-886e-4ce4-addf-fc4fd01c82c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e22217f6-e2c0-4392-82fb-758cfe746a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:to="loc_us-gaap_CommonStockSharesIssued_e22217f6-e2c0-4392-82fb-758cfe746a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_663db0e3-b881-41c9-bb20-0202c72f75f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_48a0c7c0-4fcb-4129-b821-c3702392c9e8" xlink:to="loc_us-gaap_CommonStockSharesIssued_663db0e3-b881-41c9-bb20-0202c72f75f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_ccf61eca-7314-4ddd-9848-ffb70d76408b" xlink:href="lh-20230331.xsd#lh_OutstandingStockRepurchaseAuthorizationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_ccf61eca-7314-4ddd-9848-ffb70d76408b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesOutstandingRollforwardAbstract_7aad8f3c-f49e-41b3-ac53-2d8e62a04b4d" xlink:href="lh-20230331.xsd#lh_CommonSharesOutstandingRollforwardAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_CommonSharesOutstandingRollforwardAbstract_7aad8f3c-f49e-41b3-ac53-2d8e62a04b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0bf82214-10b0-4206-9647-23828cc2c99e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_7aad8f3c-f49e-41b3-ac53-2d8e62a04b4d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0bf82214-10b0-4206-9647-23828cc2c99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_5c49e55c-aec4-4a5a-bfb3-4922febf582f" xlink:href="lh-20230331.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_7aad8f3c-f49e-41b3-ac53-2d8e62a04b4d" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_5c49e55c-aec4-4a5a-bfb3-4922febf582f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cbfa2f80-ceb1-4d19-8dba-6c21ba645689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesOutstandingRollforwardAbstract_7aad8f3c-f49e-41b3-ac53-2d8e62a04b4d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cbfa2f80-ceb1-4d19-8dba-6c21ba645689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_982dec95-723f-415b-9e13-bfae0801ae90" xlink:href="lh-20230331.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_982dec95-723f-415b-9e13-bfae0801ae90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_ed11e732-80c4-4402-a6cb-c0c338cdc723" xlink:href="lh-20230331.xsd#lh_CommonSharesHeldInTreasuryRollforwardAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_ed11e732-80c4-4402-a6cb-c0c338cdc723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cde4e1a3-b355-4809-b110-5a3e9753ded6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cde4e1a3-b355-4809-b110-5a3e9753ded6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_67c88d0c-a8aa-4280-b460-f6c610e5f706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_67c88d0c-a8aa-4280-b460-f6c610e5f706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d9886415-e5cf-4bf0-b8c7-c3333b3d0192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d9886415-e5cf-4bf0-b8c7-c3333b3d0192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_91a20c2a-9234-4f26-8645-e36a897e2288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_91a20c2a-9234-4f26-8645-e36a897e2288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_66f01283-db9d-4df1-8f1e-90b93e043e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_66f01283-db9d-4df1-8f1e-90b93e043e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_130bc8d3-313d-46a7-a2de-2821c883d203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_130bc8d3-313d-46a7-a2de-2821c883d203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_20e8bc3c-a9c9-4da5-b5a2-5285ee0fc819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_20e8bc3c-a9c9-4da5-b5a2-5285ee0fc819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_8ae3fd76-b554-46d3-b4db-4a4794c8f4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_8ae3fd76-b554-46d3-b4db-4a4794c8f4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_3d4b7be0-e5db-494c-ac78-4c81b6c3af6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_3d4b7be0-e5db-494c-ac78-4c81b6c3af6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_d74d8ddc-8059-414c-b6ac-b7c885040d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_Dividends_d74d8ddc-8059-414c-b6ac-b7c885040d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_a04b6ef7-5048-4b10-b122-db63a0d95806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_a04b6ef7-5048-4b10-b122-db63a0d95806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_c9781b62-80af-4efb-af46-27ccbd1b87fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_c9781b62-80af-4efb-af46-27ccbd1b87fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_295db673-e25b-47e5-bf09-230c4eca7023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_295db673-e25b-47e5-bf09-230c4eca7023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4af7e8b3-c1ce-4d76-ba61-95f82bf64ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4af7e8b3-c1ce-4d76-ba61-95f82bf64ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_dd0cbe65-c800-4794-918e-95cd960dae35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1401895-5760-45bf-99f2-14cbd2663a0e" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_dd0cbe65-c800-4794-918e-95cd960dae35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_1028f9ff-552b-4234-8a09-158a2a565275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4e9f4dfe-caea-451e-a364-876ec4f18a6a" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_1028f9ff-552b-4234-8a09-158a2a565275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_352a8c4f-1594-4175-8497-120cd91f76be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4e9f4dfe-caea-451e-a364-876ec4f18a6a" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_352a8c4f-1594-4175-8497-120cd91f76be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_5ca2a311-ec51-4743-bfa4-13967ebc68a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4e9f4dfe-caea-451e-a364-876ec4f18a6a" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_5ca2a311-ec51-4743-bfa4-13967ebc68a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_bc974d04-3950-44f0-a5c7-7b565af45f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4e9f4dfe-caea-451e-a364-876ec4f18a6a" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_bc974d04-3950-44f0-a5c7-7b565af45f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_fe083d63-3e5a-400c-95f7-079bb2a2b1de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4e9f4dfe-caea-451e-a364-876ec4f18a6a" xlink:to="loc_us-gaap_Dividends_fe083d63-3e5a-400c-95f7-079bb2a2b1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e462dbfb-7834-4901-9473-bf9ec08d543e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e462dbfb-7834-4901-9473-bf9ec08d543e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8c82b7d1-359a-4db6-b412-7994c33b2797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8c82b7d1-359a-4db6-b412-7994c33b2797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ae7f946c-4ad5-4fba-8856-962dd14dcc24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c82b7d1-359a-4db6-b412-7994c33b2797" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ae7f946c-4ad5-4fba-8856-962dd14dcc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e2aa0dbe-3c89-4403-aac1-be329bf998a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f341311f-89b5-4f1b-8b85-8ee9eb33a0bd" xlink:to="loc_us-gaap_EquityComponentDomain_e2aa0dbe-3c89-4403-aac1-be329bf998a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0aacff4d-4416-4302-9b27-e899c50f82c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0aacff4d-4416-4302-9b27-e899c50f82c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_13b4ddc3-cf91-4260-a672-423f6ccc88be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0aacff4d-4416-4302-9b27-e899c50f82c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_13b4ddc3-cf91-4260-a672-423f6ccc88be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignCurrencyTranslationAdjustmentsMember_ee12b9f8-766d-4435-8556-6d2b05f6ccb9" xlink:href="lh-20230331.xsd#lh_ForeignCurrencyTranslationAdjustmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_13b4ddc3-cf91-4260-a672-423f6ccc88be" xlink:to="loc_lh_ForeignCurrencyTranslationAdjustmentsMember_ee12b9f8-766d-4435-8556-6d2b05f6ccb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f09712b-bff1-4c6c-8392-01a584a324a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ed0d0569-8acb-47d1-8b59-22d7083bca3b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f09712b-bff1-4c6c-8392-01a584a324a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_d3c1ccb7-b81c-46be-89f5-52938917cf90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f09712b-bff1-4c6c-8392-01a584a324a1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_d3c1ccb7-b81c-46be-89f5-52938917cf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c06816f-4010-49d1-a83f-8f8310c5b165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e462dbfb-7834-4901-9473-bf9ec08d543e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c06816f-4010-49d1-a83f-8f8310c5b165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_8f1c3fa8-a1ed-4ecc-b24e-d200bd17adc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e462dbfb-7834-4901-9473-bf9ec08d543e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_8f1c3fa8-a1ed-4ecc-b24e-d200bd17adc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_c4fd14e7-3d88-44a2-9a36-e1d4ed9fbc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e462dbfb-7834-4901-9473-bf9ec08d543e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_c4fd14e7-3d88-44a2-9a36-e1d4ed9fbc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:href="lh-20230331.xsd#lh_AccumulatedOtherComprehensiveEarningsRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e462dbfb-7834-4901-9473-bf9ec08d543e" xlink:to="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_7f41f420-f143-4ff8-a507-e1e975de49cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_7f41f420-f143-4ff8-a507-e1e975de49cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_b49fb5b8-0481-4101-9056-a4018eb75733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_b49fb5b8-0481-4101-9056-a4018eb75733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d5233a98-7709-490f-921d-9af58eca7043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d5233a98-7709-490f-921d-9af58eca7043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e681d8a6-c572-47c2-bdb0-249fefa113be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e681d8a6-c572-47c2-bdb0-249fefa113be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_61180871-eb38-411b-a2c8-8fd3a54d6b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_61180871-eb38-411b-a2c8-8fd3a54d6b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_fa1e179a-b4e5-4a3d-979e-266565fc47e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_fa1e179a-b4e5-4a3d-979e-266565fc47e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_aaa6ad12-8ed8-4475-92b6-714e44e87fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_aaa6ad12-8ed8-4475-92b6-714e44e87fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68d9e95f-c152-4668-b187-fe3bb147fb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68d9e95f-c152-4668-b187-fe3bb147fb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_6e5c8a68-b448-4899-8462-b4eda709c935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_6e5c8a68-b448-4899-8462-b4eda709c935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_23db2dc3-6f1d-41fb-b3ff-4394f9531ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_23db2dc3-6f1d-41fb-b3ff-4394f9531ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d2008d63-ad37-4b76-bee4-6633831e802c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d2008d63-ad37-4b76-bee4-6633831e802c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_9141c7d6-928e-430e-9ec3-80a9a4951416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_9141c7d6-928e-430e-9ec3-80a9a4951416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ddac28d8-d989-4a5e-a834-0bc810b973b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsRollForward_acde9491-2ddd-49f6-bb53-d926dea78ebb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ddac28d8-d989-4a5e-a834-0bc810b973b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_73965d86-1632-4daf-8f05-7536948d2c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_73965d86-1632-4daf-8f05-7536948d2c73" xlink:to="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_39160b74-b0c0-4205-baae-4e9086f80a19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_39160b74-b0c0-4205-baae-4e9086f80a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_52a5619f-71ca-4e00-aac3-be37640ef02f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_39160b74-b0c0-4205-baae-4e9086f80a19" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_52a5619f-71ca-4e00-aac3-be37640ef02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b7f14364-3a16-455c-9ee5-3ea333d95151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b7f14364-3a16-455c-9ee5-3ea333d95151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4d7fc22-e93c-4fae-834f-33bfe14e8c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7f14364-3a16-455c-9ee5-3ea333d95151" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4d7fc22-e93c-4fae-834f-33bfe14e8c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6d82454a-d203-46ad-8d4f-7acb2d830886" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_srt_RangeAxis_6d82454a-d203-46ad-8d4f-7acb2d830886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_10b12775-37a0-4e64-9b21-46d1247278c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6d82454a-d203-46ad-8d4f-7acb2d830886" xlink:to="loc_srt_RangeMember_10b12775-37a0-4e64-9b21-46d1247278c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8f2e0fc1-dc42-4b04-bcab-f783677f3132" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_dei_LegalEntityAxis_8f2e0fc1-dc42-4b04-bcab-f783677f3132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fe4fff0d-0925-4fcd-96d8-e38c89552bec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8f2e0fc1-dc42-4b04-bcab-f783677f3132" xlink:to="loc_dei_EntityDomain_fe4fff0d-0925-4fcd-96d8-e38c89552bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_50672eba-a02b-4680-aabd-b4d6b8f8f89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9a421778-9d76-42da-aec3-154da3177598" xlink:to="loc_us-gaap_LossContingenciesLineItems_50672eba-a02b-4680-aabd-b4d6b8f8f89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_aa77f5cf-bb86-4220-b6ab-f2af04f7d836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_50672eba-a02b-4680-aabd-b4d6b8f8f89b" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_aa77f5cf-bb86-4220-b6ab-f2af04f7d836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_db4ae0ee-c748-421a-a23b-61e15821a1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_50672eba-a02b-4680-aabd-b4d6b8f8f89b" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_db4ae0ee-c748-421a-a23b-61e15821a1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c87186e4-a827-42fa-a7e4-2ca88384ac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c87186e4-a827-42fa-a7e4-2ca88384ac3e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_a077fd77-fe07-418b-afeb-c9399eb86b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_a077fd77-fe07-418b-afeb-c9399eb86b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_2d6e6acd-c2de-4d87-b4b2-cf84bc348b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_a077fd77-fe07-418b-afeb-c9399eb86b68" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_2d6e6acd-c2de-4d87-b4b2-cf84bc348b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_077fe996-4f87-451c-9725-b8add0a15510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_077fe996-4f87-451c-9725-b8add0a15510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_077fe996-4f87-451c-9725-b8add0a15510" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_24c5d8ab-2788-45d9-ac4e-10d883e0a3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_24c5d8ab-2788-45d9-ac4e-10d883e0a3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_cf13250b-ba65-4ff4-8216-1103906d07e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_cf13250b-ba65-4ff4-8216-1103906d07e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cf5febae-bd90-43a8-87d6-1bdd661a07b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a0f38cf4-6576-432d-acad-32116df14d05" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cf5febae-bd90-43a8-87d6-1bdd661a07b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_576a8fe0-fe09-457c-a597-7be4100e39ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_576a8fe0-fe09-457c-a597-7be4100e39ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_576a8fe0-fe09-457c-a597-7be4100e39ee" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_73559c5b-8b09-425e-a665-a10549afcd88" xlink:href="lh-20230331.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:to="loc_lh_Seniornotesdue2027Member_73559c5b-8b09-425e-a665-a10549afcd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_fd8a15bd-e5ec-4435-a33e-da2f6fcb986e" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:to="loc_lh_SeniorNotesDue2022Member_fd8a15bd-e5ec-4435-a33e-da2f6fcb986e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2024Member_ace4eb83-dbc3-486e-9af9-e9253f452a6a" xlink:href="lh-20230331.xsd#lh_SeniorNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cfb5f35d-9057-4f75-a01b-70856a9af933" xlink:to="loc_lh_SeniorNotesDue2024Member_ace4eb83-dbc3-486e-9af9-e9253f452a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1" xlink:href="lh-20230331.xsd#lh_SwapTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_lh_SwapTypeAxis_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_9dd8b0a2-5466-4a96-adfb-6434d6de4938" xlink:href="lh-20230331.xsd#lh_SwapTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeAxis_cbebbce0-9c7f-405f-aeb2-f6e4c0d820c1" xlink:to="loc_lh_SwapTypeDomain_9dd8b0a2-5466-4a96-adfb-6434d6de4938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember_d8a5d9e9-8a7b-496f-bbe7-1d18f34e82c3" xlink:href="lh-20230331.xsd#lh_A2018SwapAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeDomain_9dd8b0a2-5466-4a96-adfb-6434d6de4938" xlink:to="loc_lh_A2018SwapAgreementsMember_d8a5d9e9-8a7b-496f-bbe7-1d18f34e82c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022SwapAgreementsMember_8f3b3549-0250-4ec9-9812-2cd77eb7d377" xlink:href="lh-20230331.xsd#lh_A2022SwapAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeDomain_9dd8b0a2-5466-4a96-adfb-6434d6de4938" xlink:to="loc_lh_A2022SwapAgreementsMember_8f3b3549-0250-4ec9-9812-2cd77eb7d377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b912b749-0fc6-49c6-bb11-316333a54473" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection_e38effed-1f83-472e-87c3-3f809f43985a" xlink:href="lh-20230331.xsd#lh_NumberofMeasurementFundsAvailableForParticipantElection"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_NumberofMeasurementFundsAvailableForParticipantElection_e38effed-1f83-472e-87c3-3f809f43985a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_8d4d2e64-5bff-4657-b9ba-8319ba537fd1" xlink:href="lh-20230331.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_8d4d2e64-5bff-4657-b9ba-8319ba537fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_095bd6e5-17d0-4a9e-9966-08f48d789380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_095bd6e5-17d0-4a9e-9966-08f48d789380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue_cecff2df-dab4-4eee-add6-b819e657aa86" xlink:href="lh-20230331.xsd#lh_SeniorNotesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_SeniorNotesFairValue_cecff2df-dab4-4eee-add6-b819e657aa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_266d460b-7d26-462e-8c59-295b14c57473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_266d460b-7d26-462e-8c59-295b14c57473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_541f92ea-c194-4212-b91b-80c11d7a960a" xlink:href="lh-20230331.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_541f92ea-c194-4212-b91b-80c11d7a960a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_219dbbfc-a7f8-4dc8-af6a-2a0d0f3a3b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_219dbbfc-a7f8-4dc8-af6a-2a0d0f3a3b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_c220a0ec-d195-4c9b-abb1-a161163a25b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_c220a0ec-d195-4c9b-abb1-a161163a25b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgesAtFairValueNet_3fc30aac-3290-4751-a11e-550c5df85062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgesAtFairValueNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_FairValueHedgesAtFairValueNet_3fc30aac-3290-4751-a11e-550c5df85062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment_5d981ac1-5383-48ac-86ce-624c32fcd132" xlink:href="lh-20230331.xsd#lh_Contingentconsiderationadjustment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_lh_Contingentconsiderationadjustment_5d981ac1-5383-48ac-86ce-624c32fcd132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_244573bf-3c57-4144-b9ff-6f0e97b08efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_244573bf-3c57-4144-b9ff-6f0e97b08efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a64f7074-861c-45c4-b1b2-750cb09abb62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a64f7074-861c-45c4-b1b2-750cb09abb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ed5b5d9c-95c9-4149-91bf-ed6f2359b41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ed5b5d9c-95c9-4149-91bf-ed6f2359b41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_0ffdd6c8-54b4-4c9c-9caa-aaa31f8b03c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7955f027-3b3b-4381-abdb-36761f922c63" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_0ffdd6c8-54b4-4c9c-9caa-aaa31f8b03c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8c3350a9-56d9-43d1-a33b-29e80a9f3baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_cdb57430-49af-45c6-870c-83f636157948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8c3350a9-56d9-43d1-a33b-29e80a9f3baa" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_cdb57430-49af-45c6-870c-83f636157948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cf295642-46f9-4156-ad96-9307c3ad3701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8c3350a9-56d9-43d1-a33b-29e80a9f3baa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cf295642-46f9-4156-ad96-9307c3ad3701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8c3350a9-56d9-43d1-a33b-29e80a9f3baa" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa68897-1a9b-4d99-b72d-d1810ed4c978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa68897-1a9b-4d99-b72d-d1810ed4c978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63ecc736-5e1e-4d30-a0fa-61d4d0c5186c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_baa68897-1a9b-4d99-b72d-d1810ed4c978" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63ecc736-5e1e-4d30-a0fa-61d4d0c5186c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e03ea313-00a6-4e89-8e31-1a6b250dc0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63ecc736-5e1e-4d30-a0fa-61d4d0c5186c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e03ea313-00a6-4e89-8e31-1a6b250dc0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_834d14e5-bce9-42c1-8bf2-86355fe8e509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63ecc736-5e1e-4d30-a0fa-61d4d0c5186c" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_834d14e5-bce9-42c1-8bf2-86355fe8e509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3202eb2-07b0-4884-8af2-a48024c1499f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_85a45041-cfe9-47c0-af4a-4a3b9d02d9fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3202eb2-07b0-4884-8af2-a48024c1499f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_4ecab624-2bc8-40bc-ac85-7a384f35e407" xlink:href="lh-20230331.xsd#lh_OtheracquireesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3202eb2-07b0-4884-8af2-a48024c1499f" xlink:to="loc_lh_OtheracquireesMember_4ecab624-2bc8-40bc-ac85-7a384f35e407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_aacc3167-f385-4b72-81ed-f35c84a0bdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_aacc3167-f385-4b72-81ed-f35c84a0bdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_15e895c1-f034-44c4-9cad-119837db30fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_aacc3167-f385-4b72-81ed-f35c84a0bdb2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_15e895c1-f034-44c4-9cad-119837db30fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_eb832467-a0b3-4e63-856a-f32d8e3f7722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_15e895c1-f034-44c4-9cad-119837db30fa" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_eb832467-a0b3-4e63-856a-f32d8e3f7722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b4a7c342-b90d-4846-a20f-0e5959119b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b4a7c342-b90d-4846-a20f-0e5959119b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_570f5819-b88c-495b-ada1-adbaf1120ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b4a7c342-b90d-4846-a20f-0e5959119b15" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_570f5819-b88c-495b-ada1-adbaf1120ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_21245b1d-fb66-4b43-a77a-278d2eadde21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_570f5819-b88c-495b-ada1-adbaf1120ed6" xlink:to="loc_us-gaap_GoodwillMember_21245b1d-fb66-4b43-a77a-278d2eadde21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a937f3d8-08e5-4c28-819a-7bc71854c54c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a937f3d8-08e5-4c28-819a-7bc71854c54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f78ec5a7-5230-4427-a15a-d5f21ca10537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a937f3d8-08e5-4c28-819a-7bc71854c54c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f78ec5a7-5230-4427-a15a-d5f21ca10537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_ddec4b73-b376-4fbe-9549-01c2a77d4902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f78ec5a7-5230-4427-a15a-d5f21ca10537" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_ddec4b73-b376-4fbe-9549-01c2a77d4902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0851ebdd-0a1a-48fd-b9b3-077bac532250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f78ec5a7-5230-4427-a15a-d5f21ca10537" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0851ebdd-0a1a-48fd-b9b3-077bac532250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb7e351d-cea7-40e7-9d02-2f661130d694" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24ae07a7-ee8a-4e64-92ce-64b46551401b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24ae07a7-ee8a-4e64-92ce-64b46551401b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c0c4bff4-7c25-41ae-9db2-f34f0c59bf63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c0c4bff4-7c25-41ae-9db2-f34f0c59bf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3bb71025-b0ce-48f1-aa28-e2be8ed4a685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3bb71025-b0ce-48f1-aa28-e2be8ed4a685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_ae75fa85-48b2-4449-854c-c654fe829b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_ae75fa85-48b2-4449-854c-c654fe829b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_27eddb8e-8841-4359-9a72-d6f4f27d15f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_27eddb8e-8841-4359-9a72-d6f4f27d15f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b39667d5-eeda-4ef2-a346-154c241bdc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b39667d5-eeda-4ef2-a346-154c241bdc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_c2cc2de3-df1c-41e6-ad3e-97a6faae53ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_c2cc2de3-df1c-41e6-ad3e-97a6faae53ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_a8d7b6e0-9652-436d-938f-dbb324702980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets_a8d7b6e0-9652-436d-938f-dbb324702980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_bc7fa63f-939f-47b7-8080-fc107ea1c007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_bc7fa63f-939f-47b7-8080-fc107ea1c007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_85198104-21c0-4f73-a2f3-286c93eccaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities_85198104-21c0-4f73-a2f3-286c93eccaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_892f48a6-3b4c-4ea7-bba1-8f9e595a07f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3d8d71e7-09aa-4d0b-b193-d1ce566b5362" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_892f48a6-3b4c-4ea7-bba1-8f9e595a07f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6130cae9-7cb7-42ca-a176-6e91e5a4c3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6130cae9-7cb7-42ca-a176-6e91e5a4c3b4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7cfce740-8e08-42e6-854a-9b5d23c1dc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7cfce740-8e08-42e6-854a-9b5d23c1dc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7cfce740-8e08-42e6-854a-9b5d23c1dc0e" xlink:to="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_15441200-7553-4423-9983-cbe0718eede1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_us-gaap_CorporateMember_15441200-7553-4423-9983-cbe0718eede1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_94a6d94e-e90b-412d-8b6c-fb41adfcb64f" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_lh_LabCorpDiagnosticsMember_94a6d94e-e90b-412d-8b6c-fb41adfcb64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_ba2f3bd6-75e0-4624-8ecd-234c1ffe5351" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_lh_CovanceDrugDevelopmentMember_ba2f3bd6-75e0-4624-8ecd-234c1ffe5351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_fad9f353-2c8b-40b0-a22e-84d66a5bccca" xlink:href="lh-20230331.xsd#lh_DiagnosticsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_lh_DiagnosticsMember_fad9f353-2c8b-40b0-a22e-84d66a5bccca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_87a4664d-6a07-4fdb-b41f-1ca4a631e233" xlink:href="lh-20230331.xsd#lh_DrugDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5c06ae5-00d4-40eb-8d8c-f18c9a5647d8" xlink:to="loc_lh_DrugDevelopmentMember_87a4664d-6a07-4fdb-b41f-1ca4a631e233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0e983fab-3040-4b8f-b84a-7f2cee219589" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:to="loc_srt_ConsolidationItemsAxis_0e983fab-3040-4b8f-b84a-7f2cee219589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c0b3b71f-99b2-402c-9e31-255d03cf8af8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0e983fab-3040-4b8f-b84a-7f2cee219589" xlink:to="loc_srt_ConsolidationItemsDomain_c0b3b71f-99b2-402c-9e31-255d03cf8af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_32e617da-df22-4aff-8913-757d5780ab6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c0b3b71f-99b2-402c-9e31-255d03cf8af8" xlink:to="loc_us-gaap_OperatingSegmentsMember_32e617da-df22-4aff-8913-757d5780ab6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_47584777-d328-46ad-9496-3b01cd935cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c0b3b71f-99b2-402c-9e31-255d03cf8af8" xlink:to="loc_us-gaap_IntersegmentEliminationMember_47584777-d328-46ad-9496-3b01cd935cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c4379d59-7cc5-4673-bdf7-69f570b67b6c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_90077e4d-2f58-4229-85fa-26a83b8ff516" xlink:href="lh-20230331.xsd#lh_PercentofRevenueContributed"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_lh_PercentofRevenueContributed_90077e4d-2f58-4229-85fa-26a83b8ff516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_93ef0231-8ba6-415a-b68f-294d48285323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_Revenues_93ef0231-8ba6-415a-b68f-294d48285323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ae49372f-26bb-41c8-ba38-6956b3eb7d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_OperatingIncomeLoss_ae49372f-26bb-41c8-ba38-6956b3eb7d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9923ffea-716e-4ad2-950f-4ff23403aa15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9923ffea-716e-4ad2-950f-4ff23403aa15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_bb327cae-fd5c-451c-9dd3-e7b4f962c0dd" xlink:href="lh-20230331.xsd#lh_NetRestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_lh_NetRestructuringCharges_bb327cae-fd5c-451c-9dd3-e7b4f962c0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7564027d-45fd-4d84-9a3b-f996d9d7419e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04382c75-1c0f-40ed-921f-fcb9a1259c3d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7564027d-45fd-4d84-9a3b-f996d9d7419e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#REVENUEDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ad1658ec-6d43-4c3e-ae8e-947a81e06124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_c691679a-d4c0-4b9a-8e97-270ff5e9afea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ad1658ec-6d43-4c3e-ae8e-947a81e06124" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_c691679a-d4c0-4b9a-8e97-270ff5e9afea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_8a733bcb-136e-4e8d-b4d0-484a4e338892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ad1658ec-6d43-4c3e-ae8e-947a81e06124" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_8a733bcb-136e-4e8d-b4d0-484a4e338892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3536adc2-cf2b-44c5-b9f8-dae49f23e753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ad1658ec-6d43-4c3e-ae8e-947a81e06124" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3536adc2-cf2b-44c5-b9f8-dae49f23e753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_7f46a355-5082-4a60-86ba-d68a39a18869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ad1658ec-6d43-4c3e-ae8e-947a81e06124" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_7f46a355-5082-4a60-86ba-d68a39a18869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_9ff48a6b-2793-4366-a61b-d70fd00874b7" xlink:href="lh-20230331.xsd#lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ad1658ec-6d43-4c3e-ae8e-947a81e06124" xlink:to="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_9ff48a6b-2793-4366-a61b-d70fd00874b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#REVENUEDisaggregatedRevenueTableDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2da51a14-6c3a-483c-92df-80e543aefa23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2da51a14-6c3a-483c-92df-80e543aefa23" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_553dc52d-ef10-4d4e-b816-6edd9c20a168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_553dc52d-ef10-4d4e-b816-6edd9c20a168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_553dc52d-ef10-4d4e-b816-6edd9c20a168" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_3c05d661-8886-41cc-9c69-2ab69b967fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:to="loc_us-gaap_NotesReceivableMember_3c05d661-8886-41cc-9c69-2ab69b967fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember_a7df13ef-e2fd-4088-98cc-1930630f8ffa" xlink:href="lh-20230331.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:to="loc_lh_UnbilledContractsReceivableMember_a7df13ef-e2fd-4088-98cc-1930630f8ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_3d912a1c-f37c-41f1-97ae-31edc5f760ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_da3a5e4d-3a80-408e-b4ab-1a5bcfc2887d" xlink:to="loc_us-gaap_AccountsReceivableMember_3d912a1c-f37c-41f1-97ae-31edc5f760ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_930dfb9f-ffc0-4e14-9ead-eae2ecf5970b" xlink:to="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LabCorpDiagnosticsMember_5ece40ef-cd4a-45f9-9196-fc2cf985cb80" xlink:href="lh-20230331.xsd#lh_LabCorpDiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:to="loc_lh_LabCorpDiagnosticsMember_5ece40ef-cd4a-45f9-9196-fc2cf985cb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CovanceDrugDevelopmentMember_d4627b48-df91-4126-b803-6aad49a29452" xlink:href="lh-20230331.xsd#lh_CovanceDrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:to="loc_lh_CovanceDrugDevelopmentMember_d4627b48-df91-4126-b803-6aad49a29452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_7109e4d7-e9c8-45a6-9d0f-4bcb664d6478" xlink:href="lh-20230331.xsd#lh_DiagnosticsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:to="loc_lh_DiagnosticsMember_7109e4d7-e9c8-45a6-9d0f-4bcb664d6478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_e685f193-eab1-4e3c-9fd4-b7224002a310" xlink:href="lh-20230331.xsd#lh_DrugDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_05e117b7-8629-4bcd-944e-5149e5ccd379" xlink:to="loc_lh_DrugDevelopmentMember_e685f193-eab1-4e3c-9fd4-b7224002a310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_848bbabd-0d99-4a16-bb0b-e397b4b0988d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_srt_ProductOrServiceAxis_848bbabd-0d99-4a16-bb0b-e397b4b0988d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f48f4bf-f4e6-45a1-8ae5-cc2db799b9f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_848bbabd-0d99-4a16-bb0b-e397b4b0988d" xlink:to="loc_srt_ProductsAndServicesDomain_0f48f4bf-f4e6-45a1-8ae5-cc2db799b9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_d4a868e0-9ea9-437c-871e-e94b97f2a332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_d4a868e0-9ea9-437c-871e-e94b97f2a332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7e06567e-f77d-496d-875c-07aed5f792eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_d4a868e0-9ea9-437c-871e-e94b97f2a332" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7e06567e-f77d-496d-875c-07aed5f792eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_db0756ec-e123-4730-bf86-879537ef1be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_3ea7646d-d63f-45b5-b4c3-5ecf00bffb34" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_db0756ec-e123-4730-bf86-879537ef1be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_812f0026-d2c7-45d3-a213-459875ecc782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_812f0026-d2c7-45d3-a213-459875ecc782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d4b76eb6-7b07-4f5b-9b00-14524c44fd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_812f0026-d2c7-45d3-a213-459875ecc782" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d4b76eb6-7b07-4f5b-9b00-14524c44fd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_30ffe124-4285-4081-b551-f6e29709c337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_30ffe124-4285-4081-b551-f6e29709c337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_30ffe124-4285-4081-b551-f6e29709c337" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_3b0b7616-7f6b-46b8-9de4-afd86d654a4d" xlink:href="lh-20230331.xsd#lh_ClientMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_lh_ClientMember_3b0b7616-7f6b-46b8-9de4-afd86d654a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_f0010e05-645b-46db-a98d-5992e12c004c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfPayMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_us-gaap_SelfPayMember_f0010e05-645b-46db-a98d-5992e12c004c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_30d38a41-53e8-4dea-8a82-d790dd147f80" xlink:href="lh-20230331.xsd#lh_MedicareandMedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_lh_MedicareandMedicaidMember_30d38a41-53e8-4dea-8a82-d790dd147f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_fd5f295e-d022-49fa-9895-8333fdbac7c1" xlink:href="lh-20230331.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_fd5f295e-d022-49fa-9895-8333fdbac7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_855cbf28-a404-4a46-8cf2-8a181b31d551" xlink:href="lh-20230331.xsd#lh_ThirdpartyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ff30e821-8376-4535-a97d-72d995672387" xlink:to="loc_lh_ThirdpartyMember_855cbf28-a404-4a46-8cf2-8a181b31d551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_16c086c0-fc86-473b-bdf6-f69f004f42be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_srt_MajorCustomersAxis_16c086c0-fc86-473b-bdf6-f69f004f42be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_66aa35eb-03a7-41fa-89a2-9b206952883d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_16c086c0-fc86-473b-bdf6-f69f004f42be" xlink:to="loc_srt_NameOfMajorCustomerDomain_66aa35eb-03a7-41fa-89a2-9b206952883d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_94bf96d3-20c8-4d31-aa69-85438d5cb74d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_srt_StatementGeographicalAxis_94bf96d3-20c8-4d31-aa69-85438d5cb74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_94bf96d3-20c8-4d31-aa69-85438d5cb74d" xlink:to="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0c282e71-cf2b-4153-bf98-f2301b9127ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:to="loc_srt_EuropeMember_0c282e71-cf2b-4153-bf98-f2301b9127ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_61b0dd2a-188e-4160-8b37-976c8100326a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:to="loc_srt_NorthAmericaMember_61b0dd2a-188e-4160-8b37-976c8100326a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_4ae3a298-5444-4a20-a9a9-62341761fdd1" xlink:href="lh-20230331.xsd#lh_OthercountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:to="loc_lh_OthercountriesMember_4ae3a298-5444-4a20-a9a9-62341761fdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_33478756-bab9-4302-bf22-a4e2609fbedf" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a49fa6b9-040e-4fce-a5be-fc22e12d543a" xlink:to="loc_country_US_33478756-bab9-4302-bf22-a4e2609fbedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46ae6b6-554f-4979-98ff-2abac6c96878" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_37edb854-7147-4ed1-984f-53de3db202db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_37edb854-7147-4ed1-984f-53de3db202db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss_906ff3ae-6808-4296-8eb0-bd950604810a" xlink:href="lh-20230331.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_UnbilledServicesAllowanceforCreditLoss_906ff3ae-6808-4296-8eb0-bd950604810a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss_9545c5b2-53d1-47c3-9d83-2c242bf9b3ef" xlink:href="lh-20230331.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_NoteReceivableAllowanceforCreditLoss_9545c5b2-53d1-47c3-9d83-2c242bf9b3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss_597c90ff-2f4b-49d9-883b-e4dff6be08ca" xlink:href="lh-20230331.xsd#lh_AllowanceforCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_AllowanceforCreditLoss_597c90ff-2f4b-49d9-883b-e4dff6be08ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_7033a5d2-17a9-4353-9ef0-2a350065167f" xlink:href="lh-20230331.xsd#lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings_7033a5d2-17a9-4353-9ef0-2a350065167f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff_0196760a-f57d-4d4f-ab12-55f1174dfea9" xlink:href="lh-20230331.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_AllowanceforCreditLossWriteOff_0196760a-f57d-4d4f-ab12-55f1174dfea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_b4dd3366-8864-4388-a045-4132b77f272b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_b4dd3366-8864-4388-a045-4132b77f272b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_3960f056-70c9-4392-8c00-e93b30666ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_3960f056-70c9-4392-8c00-e93b30666ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_78c60d54-fb8c-454b-bba2-3578c90fd5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_78c60d54-fb8c-454b-bba2-3578c90fd5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum_0aecb091-5bfd-45e1-9d95-631725caa23b" xlink:href="lh-20230331.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_LongTermContractsDurationMinimum_0aecb091-5bfd-45e1-9d95-631725caa23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum_f28fb703-ab2f-4b56-87a8-7b1cc9ded45f" xlink:href="lh-20230331.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_LongTermContractsDurationMaximum_f28fb703-ab2f-4b56-87a8-7b1cc9ded45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1841817b-603c-4757-8da9-e61105988491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1841817b-603c-4757-8da9-e61105988491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c069e5ff-fa7f-4f7a-9992-77261be7d840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c069e5ff-fa7f-4f7a-9992-77261be7d840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_2c055306-22df-4e62-a7d7-24aa580cf79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_2c055306-22df-4e62-a7d7-24aa580cf79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_ac973ffe-7ab3-4783-aede-48140a0358c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_ac973ffe-7ab3-4783-aede-48140a0358c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_0fe18062-bf10-44b0-b4a8-a70e9dbe5f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_CapitalizedContractCostNet_0fe18062-bf10-44b0-b4a8-a70e9dbe5f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_d35db0c8-1254-47ea-a8a7-da1fdbe77dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_d35db0c8-1254-47ea-a8a7-da1fdbe77dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_76a01486-3efd-4a1b-9b19-2242673f8129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_76a01486-3efd-4a1b-9b19-2242673f8129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_d6dc29ed-431a-4f1e-8ac9-5ae6c3682c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_UnbilledContractsReceivable_d6dc29ed-431a-4f1e-8ac9-5ae6c3682c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_0be06582-68dc-4523-b818-d0e249759c65" xlink:href="lh-20230331.xsd#lh_PercentofRevenueContributed"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_lh_PercentofRevenueContributed_0be06582-68dc-4523-b818-d0e249759c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f84ceea7-9322-40f6-b081-40e288cdae2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_Revenues_f84ceea7-9322-40f6-b081-40e288cdae2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_c1599d52-1c45-44a1-b6fe-54417ccdabf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AccountsReceivableGross_c1599d52-1c45-44a1-b6fe-54417ccdabf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e417031c-692b-4540-8839-95954882527e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e417031c-692b-4540-8839-95954882527e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5e7777bb-6345-4bf9-9b76-6ec7ef455298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5e7777bb-6345-4bf9-9b76-6ec7ef455298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5e13af0a-d738-43ea-831f-ab85420f05ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b538f275-1719-4c1d-bb63-be30aaaabfe1" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5e13af0a-d738-43ea-831f-ab85420f05ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="lh-20230331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_b4aa5f6c-7562-4305-937f-df563bd91a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509870602080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 03, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LABORATORY CORPORATION OF AMERICA HOLDINGS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3757370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">358 South Main Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Burlington,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">27215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">229-1127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.10 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000920148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509870232400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">$ 2,344,800,000<span></span>
</td>
<td class="nump">$ 2,222,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled Contracts Receivable</a></td>
<td class="nump">705,100,000<span></span>
</td>
<td class="nump">795,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Supplies inventories</a></td>
<td class="nump">481,400,000<span></span>
</td>
<td class="nump">470,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">769,800,000<span></span>
</td>
<td class="nump">707,000,000.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,695,000,000<span></span>
</td>
<td class="nump">4,625,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,944,100,000<span></span>
</td>
<td class="nump">2,956,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">8,116,000,000<span></span>
</td>
<td class="nump">8,121,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,912,300,000<span></span>
</td>
<td class="nump">3,946,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Joint venture partnerships and equity method investments</a></td>
<td class="nump">65,800,000<span></span>
</td>
<td class="nump">65,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent', window );">Deferred Income Taxes and Other Assets, Current</a></td>
<td class="nump">7,700,000<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, net</a></td>
<td class="nump">459,100,000<span></span>
</td>
<td class="nump">432,700,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">20,200,000,000<span></span>
</td>
<td class="nump">20,155,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="nump">880,700,000<span></span>
</td>
<td class="nump">934,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="nump">929,500,000<span></span>
</td>
<td class="nump">1,068,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">586,700,000<span></span>
</td>
<td class="nump">582,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">181,200,000<span></span>
</td>
<td class="nump">185,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">6,100,000<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CurrentDebtExcludingFinanceLeaseLiability', window );">Current debt excluding finance lease liability</a></td>
<td class="nump">301,400,000<span></span>
</td>
<td class="nump">301,300,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">2,885,600,000<span></span>
</td>
<td class="nump">3,078,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">5,052,300,000<span></span>
</td>
<td class="nump">5,038,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Commitments and contingent liabilities</a></td>
<td class="nump">413,600,000<span></span>
</td>
<td class="nump">422,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">668,300,000<span></span>
</td>
<td class="nump">679,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">82,000,000.0<span></span>
</td>
<td class="nump">83,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DeferredIncomeTaxesAndOtherTaxLiabilities', window );">Deferred income taxes and other tax liabilities</a></td>
<td class="nump">737,400,000<span></span>
</td>
<td class="nump">736,200,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Noncontrolling interest</a></td>
<td class="nump">9,839,200,000<span></span>
</td>
<td class="nump">10,039,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NoncontrollingInterestMezzanineEquity', window );">Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively</a></td>
<td class="nump">19,300,000<span></span>
</td>
<td class="nump">18,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">47,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Retained earnings</a></td>
<td class="nump">8,100,000<span></span>
</td>
<td class="nump">8,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated other comprehensive income</a></td>
<td class="num">(10,729,900,000)<span></span>
</td>
<td class="num">(10,581,700,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total liabilities and shareholders' equity</a></td>
<td class="num">(444,200,000)<span></span>
</td>
<td class="num">(493,200,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">10,341,500,000<span></span>
</td>
<td class="nump">10,096,600,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Liabilities and Equity</a></td>
<td class="nump">20,200,000,000<span></span>
</td>
<td class="nump">20,155,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">213,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 393,900,000<span></span>
</td>
<td class="nump">$ 430,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CurrentDebtExcludingFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current debt excluding finance lease liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CurrentDebtExcludingFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DeferredIncomeTaxesAndOtherTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DeferredIncomeTaxesAndOtherTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoncontrollingInterestMezzanineEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoncontrollingInterestMezzanineEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed within one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140510046427376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 52.8<span></span>
</td>
<td class="nump">$ 43.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">88.6<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509869636672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetRestructuringAndOtherSpecialCharges', window );">Net restructuring and other special charges</a></td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">341.0<span></span>
</td>
<td class="nump">687.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="nump">50.7<span></span>
</td>
<td class="nump">42.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity method income, net</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(12.6)<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">277.8<span></span>
</td>
<td class="nump">640.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">64.5<span></span>
</td>
<td class="nump">148.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">213.3<span></span>
</td>
<td class="nump">492.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">212.9<span></span>
</td>
<td class="nump">491.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,777.9<span></span>
</td>
<td class="nump">3,899.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Revenue</a></td>
<td class="nump">2,803.2<span></span>
</td>
<td class="nump">2,666.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">974.7<span></span>
</td>
<td class="nump">1,232.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">553.6<span></span>
</td>
<td class="nump">464.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="nump">69.3<span></span>
</td>
<td class="nump">67.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,777.9<span></span>
</td>
<td class="nump">3,899.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Revenue</a></td>
<td class="nump">2,803.2<span></span>
</td>
<td class="nump">2,666.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">974.7<span></span>
</td>
<td class="nump">1,232.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">553.6<span></span>
</td>
<td class="nump">464.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="nump">69.3<span></span>
</td>
<td class="nump">67.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetRestructuringAndOtherSpecialCharges', window );">Net restructuring and other special charges</a></td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">341.0<span></span>
</td>
<td class="nump">687.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(50.7)<span></span>
</td>
<td class="num">(42.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity method income, net</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(12.6)<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">277.8<span></span>
</td>
<td class="nump">640.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">64.5<span></span>
</td>
<td class="nump">148.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">213.3<span></span>
</td>
<td class="nump">492.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to the noncontrolling interest</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">$ 212.9<span></span>
</td>
<td class="nump">$ 491.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 2.41<span></span>
</td>
<td class="nump">$ 5.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 2.39<span></span>
</td>
<td class="nump">$ 5.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetRestructuringAndOtherSpecialCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetRestructuringAndOtherSpecialCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509870361120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 64.5<span></span>
</td>
<td class="nump">$ 148.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">213.3<span></span>
</td>
<td class="nump">492.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Earnings, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">48.1<span></span>
</td>
<td class="num">(74.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive earnings (loss) before tax</a></td>
<td class="nump">49.3<span></span>
</td>
<td class="num">(72.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect of adjustments</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (loss), net of tax</a></td>
<td class="nump">49.0<span></span>
</td>
<td class="num">(73.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings</a></td>
<td class="nump">262.3<span></span>
</td>
<td class="nump">419.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to the noncontrolling interest</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">$ 261.9<span></span>
</td>
<td class="nump">$ 418.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509870140880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2021</a></td>
<td class="nump">$ 10,273.4<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 10,456.8<span></span>
</td>
<td class="num">$ (191.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">491.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">491.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="num">(73.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(73.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Issuanceofcommonstockunderemployeeplans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="num">(18.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(18.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Surrender of restricted stock and performance share awards</a></td>
<td class="num">(27.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(27.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Mar. 31, 2022</a></td>
<td class="nump">10,721.1<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">10,948.4<span></span>
</td>
<td class="num">(264.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">10,581.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2022</a></td>
<td class="nump">10,096.6<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">10,581.7<span></span>
</td>
<td class="num">(493.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">212.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">212.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings, net of tax</a></td>
<td class="nump">49.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">49.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="num">(64.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(64.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Issuanceofcommonstockunderemployeeplans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="num">(27.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(27.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Surrender of restricted stock and performance share awards</a></td>
<td class="num">(20.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(20.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Mar. 31, 2023</a></td>
<td class="nump">10,341.5<span></span>
</td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="nump">$ 47.7<span></span>
</td>
<td class="nump">$ 10,729.9<span></span>
</td>
<td class="num">$ (444.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">$ 10,729.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Issuanceofcommonstockunderemployeeplans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued in period under ESPP combined with the value of stock issued as a result of option exercises.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Issuanceofcommonstockunderemployeeplans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509875161600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Cash Flows (Statement)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 393.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509864460384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 213,300,000<span></span>
</td>
<td class="nump">$ 492,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DepreciationAndAmortizationOfLeasedAssets', window );">Depreciation And Amortization Of Leased Assets</a></td>
<td class="nump">47,800,000<span></span>
</td>
<td class="nump">48,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">165,900,000<span></span>
</td>
<td class="nump">161,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">40,600,000<span></span>
</td>
<td class="nump">38,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Asset Impairment Charges</a></td>
<td class="nump">2,200,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="num">(19,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other Operating Activities, Cash Flow Statement</a></td>
<td class="nump">5,800,000<span></span>
</td>
<td class="num">(3,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities (net of effects of acquisitions):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable (net)</a></td>
<td class="nump">117,500,000<span></span>
</td>
<td class="num">(20,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncreaseDecreaseinUnbilledContractReceivable', window );">Increase (Decrease) in Unbilled Contract Receivable</a></td>
<td class="num">(91,600,000)<span></span>
</td>
<td class="nump">84,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="nump">10,000,000.0<span></span>
</td>
<td class="nump">37,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Decrease in accounts payable</a></td>
<td class="num">(56,400,000)<span></span>
</td>
<td class="num">(5,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="num">(2,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Increase (Decrease) in Prepaid Expense and Other Assets</a></td>
<td class="nump">59,800,000<span></span>
</td>
<td class="nump">41,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</a></td>
<td class="num">(206,600,000)<span></span>
</td>
<td class="num">(212,300,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">121,200,000<span></span>
</td>
<td class="nump">356,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Cash payments for laboratory-related assets</a></td>
<td class="num">(93,900,000)<span></span>
</td>
<td class="num">(117,200,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of assets</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from Sale of Equity Method Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to Acquire Equity Method Investments</a></td>
<td class="num">(6,100,000)<span></span>
</td>
<td class="num">(2,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by (Used in) Investing Activities</a></td>
<td class="num">(99,700,000)<span></span>
</td>
<td class="num">(573,100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="num">(455,100,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(99,700,000)<span></span>
</td>
<td class="num">(573,100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from revolving credit facilities</a></td>
<td class="nump">827,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="num">(827,900,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="nump">20,500,000<span></span>
</td>
<td class="nump">27,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetProceedsFromIssuanceOfStockToEmployees', window );">Net proceeds from issuance of stock to employees</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">18,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends</a></td>
<td class="num">(64,400,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_OtherFinancingCashFlows', window );">Other Financing Cash Flows</a></td>
<td class="nump">3,300,000<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used for) financing activities</a></td>
<td class="num">(60,600,000)<span></span>
</td>
<td class="num">(17,700,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="num">(36,100,000)<span></span>
</td>
<td class="num">(239,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="num">(4,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 393,900,000<span></span>
</td>
<td class="nump">$ 1,233,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DepreciationAndAmortizationOfLeasedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DepreciationAndAmortizationOfLeasedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncreaseDecreaseinUnbilledContractReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Unbilled Contract Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncreaseDecreaseinUnbilledContractReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetProceedsFromIssuanceOfStockToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetProceedsFromIssuanceOfStockToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_OtherFinancingCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financing Cash Flows</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_OtherFinancingCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509870481696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Cash Flows, Supplemental Disclosures<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 393.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509870513840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION Description Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Debt Conversion [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital Expenditures Incurred but Not yet Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid', window );">Decrease in Capital Expenditures Incurred but not yet Paid</a></td>
<td class="num">$ (4.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">393.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">393.9<span></span>
</td>
<td class="nump">1,233.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid during period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_InterestPaidInCash', window );">Interest</a></td>
<td class="nump">70.4<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes, net of refunds</a></td>
<td class="nump">$ 33.0<span></span>
</td>
<td class="nump">$ 28.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in Capital Expenditures Incurred but not yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_InterestPaidInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period for interest owed on money borrowed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_InterestPaidInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509876299920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF FINANCIAL STATEMENT PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</a></td>
<td class="text">BASIS OF FINANCIAL STATEMENT PRESENTATION<div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings (Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its strong diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, see Note 11 (Business Segment Information) to the Condensed Consolidated Financial Statements. During the three months ended March&#160;31, 2023, Dx and DD contributed approximately 63% and 37%, respectively, of revenues to the Company.</span></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, the Company announced that its board of directors authorized the Company to pursue a spin-off of its wholly owned Clinical Development and Commercialization Services business, which includes parts of its DD segment focused on providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations. The planned spin-off will result in two independent, publicly traded companies. The spin-off is intended to be a tax-free transaction to the Company and its stockholders for United States (U.S.) federal income tax purposes and is expected to be effected through a dividend of the Clinical Development business&#8217; shares to the Company's shareholders. The Company anticipates that, consistent with any applicable legal and tax requirements, there will be ongoing transitional and commercial arrangements to provide for a seamless delivery of services to the customers and other stakeholders of the independent companies following the spin-off. The Company is targeting completion of the spin-off with an accelerated timeframe of mid-2023. The spin-off will be subject to the satisfaction of certain customary conditions, including, among others, the receipt of final approval by the Company's board of directors, the receipt of appropriate assurances regarding the tax-free nature of the separation, and the effectiveness of any required filings with the U.S. Securities and Exchange Commission (SEC). </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20.0% and no representation on the investee's board of directors) are accounted for at fair value, or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the  condensed consolidated financial statements. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income (loss).&#8221;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company&#8217;s fiscal year 2022 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s Annual Report.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text">BASIS OF FINANCIAL STATEMENT PRESENTATION<div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings (Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its strong diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, see Note 11 (Business Segment Information) to the Condensed Consolidated Financial Statements. During the three months ended March&#160;31, 2023, Dx and DD contributed approximately 63% and 37%, respectively, of revenues to the Company.</span></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, the Company announced that its board of directors authorized the Company to pursue a spin-off of its wholly owned Clinical Development and Commercialization Services business, which includes parts of its DD segment focused on providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations. The planned spin-off will result in two independent, publicly traded companies. The spin-off is intended to be a tax-free transaction to the Company and its stockholders for United States (U.S.) federal income tax purposes and is expected to be effected through a dividend of the Clinical Development business&#8217; shares to the Company's shareholders. The Company anticipates that, consistent with any applicable legal and tax requirements, there will be ongoing transitional and commercial arrangements to provide for a seamless delivery of services to the customers and other stakeholders of the independent companies following the spin-off. The Company is targeting completion of the spin-off with an accelerated timeframe of mid-2023. The spin-off will be subject to the satisfaction of certain customary conditions, including, among others, the receipt of final approval by the Company's board of directors, the receipt of appropriate assurances regarding the tax-free nature of the separation, and the effectiveness of any required filings with the U.S. Securities and Exchange Commission (SEC). </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20.0% and no representation on the investee's board of directors) are accounted for at fair value, or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the  condensed consolidated financial statements. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income (loss).&#8221;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company&#8217;s fiscal year 2022 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s Annual Report.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509871940352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#8217;s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.</span></div><div style="margin-bottom:7.1pt;margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.579%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of employee&#160;stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings including impact of dilutive adjustments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491.6&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.961%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509870216944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock', window );">Changes in common shares issued and held in treasury</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued are summarized below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.166%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.634%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and Outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div style="margin-top:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive earnings (loss) are as follows:</span></div><div style="margin-bottom:3pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.334%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Earnings (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493.2)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Preferred Stock and Common Shareholders' Equity</a></td>
<td class="text">PREFERRED STOCK AND COMMON SHAREHOLDERS&#8217; EQUITY<div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of March&#160;31, 2023, and December 31, 2022. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued are summarized below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.166%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.634%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and Outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had outstanding authorization from the board of directors to purchase up to $1,531.5 of the Company's common stock. The repurchase authorization has no expiration.</span></div><div style="margin-bottom:3pt;margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, the Company paid $64.4 in common stock dividends. On April 6, 2023, the Company announced a cash dividend of $0.72 per share of common stock for the second quarter, or approximately $64.7 in the aggregate. The dividend will be payable on June 8, 2023, to stockholders of record of all issued and outstanding shares of common stock as of the close of business on May 18, 2023. The declaration and payment of any future dividends will be at the discretion of the Company's board of directors.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Earnings (Loss)</span></div><div style="margin-top:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive earnings (loss) are as follows:</span></div><div style="margin-bottom:3pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.334%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Earnings (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493.2)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule is used to show the changes in common shares issued and held in treasury by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509953462528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509871991072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of March&#160;31, 2023, and December 31, 2022, is as follows:</span></div><div style="margin-bottom:3pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:36.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#8217;s condensed consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers certain employees the opportunity to participate in an employee-funded deferred compensation plan (DCP). A participant's deferrals are allocated by the participant to one or more of 26 measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participant's allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent accrued earn-out business acquisition consideration liabilities are measured at fair value using Level 3 valuations. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the senior notes, based on market pricing, was approximately $5,082.0 and $4,973.9 as of March&#160;31, 2023, and December 31, 2022, respectively. The Company's note and debt instruments are classified as Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509960060560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure [Text Block]</a></td>
<td class="text">BUSINESS ACQUISITIONS During the three months ended March 31, 2023, the Company recorded several measurement period adjustments for 2022 acquisitions, relating to final valuations and deferred tax true-ups. The adjustments include the following:<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509872026384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION Business Segment information (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text">BUSINESS SEGMENT INFORMATIONThe following table is a summary of segment information for the three months ended March&#160;31, 2023, and 2022. The &#8220;management approach&#8221; has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#8217;s chief executive officer has been identified as the CODM. Segment asset information is not presented because it is not used by the CODM at the segment level.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509872085872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">SUBSEQUENT EVENTSOn May 3, 2023, the Company entered into agreements to create a comprehensive strategic relationship with Jefferson Health (Jefferson), the largest health system serving the greater Philadelphia area and Southern New Jersey. When complete, the arrangements between Jefferson and the Company will serve to build academic collaborations around teaching and the development of innovative tests. The new strategic collaboration will deliver efficiency and comprehensive laboratory aspects of healthcare for the communities served by Jefferson through the Company's leading clinical laboratory services, robust data and digital tools and extensive network of patient service centers. The transaction is expected to close by mid-year 2023, subject to customary closing conditions and applicable regulatory approvals.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509872040416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Goodwill and Other (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;GOODWILL AND INTANGIBLE ASSETS</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,533.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,121.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,514.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,601.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, the Company's business could be impacted by unfavorable changes, including those that impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily a worsening economic environment and protracted economic downturn and related impacts, including delays in revenue from new customers; increases in customer termination activity; or increases in operating costs. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to monitor the financial performance of, and assumptions for, its reporting units. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin, or substantial reductions in end markets and volume assumptions, could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,723.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,118.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,681.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,546.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,134.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use right</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,891.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,979.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946.9&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets for the three months ended March&#160;31, 2023, and 2022, was $69.3 and $67.1, respectively. The amortization expense for the net carrying amount of intangible assets is estimated to be $206.2 for the remainder of fiscal 2023, $267.5 in fiscal 2024, $255.3 in fiscal 2025, $245.5 in fiscal 2026, $233.9 in fiscal 2027, and $2,141.3 thereafter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509866779600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contract with Customer (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue</a></td>
<td class="text">REVENUES<div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and by payers/customer groups for the three months ended March&#160;31, 2023, and 2022, were as follows:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third party</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Total Dx revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical, biotechnology and medical device companies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues in the U.S. were $2,959.2 (78.3%) and $3,000.5 (76.9%) for the three months ended March&#160;31, 2023, and 2022, respectively.</span></div><div style="margin-bottom:7pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">DD Contract costs</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD incurs costs to fulfill contracts with customers. Contract fulfillment costs include software implementation costs and setup costs for certain market access solutions. </span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:60.720%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.136%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization related to sales commission assets and associated payroll taxes for the three months ended March&#160;31, 2023, and 2022, was $8.4 and $7.2, respectively. Amortization related to deferred contract fulfillment costs for the three months ended March&#160;31, 2023, and 2022, was $2.4 and $3.1, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Accounts Receivable, Unbilled Services and Unearned Revenue</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about accounts receivable, unbilled services, and unearned revenue from contracts with customers:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less DD allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,222.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unbilled services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reserve for unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.4&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized during the period that were included in the unearned revenue balance at the beginning of the period were $165.3 and $163.8 for the three months ended March&#160;31, 2023, and 2022, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Loss Rollforward</span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. The rollforward for the allowance for credit losses for the three months ended March&#160;31, 2023, is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus, credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less, write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit loss expense in the first quarter primarily related to the the collection risk from several biotech receivable balances.</span></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations Under Long-Term Contracts</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term contracts at the Company consist primarily of fully managed clinical studies within DD. The amount of existing performance obligations unsatisfied under such long-term contracts were $4,720.0 as of March&#160;31, 2023. DD expects to recognize approximately 30.0% of the remaining performance obligations as of March 31, 2023, as revenue over the next 12 months. DD's long-term contracts generally range from 1 to 8 years.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within DD, revenues of $10.4 and $31.7 were recognized during the three months ended March&#160;31, 2023 and 2022, respectively, from performance obligations that were satisfied in previous periods. This revenue primarily relates to adjustments related to changes in scope in full service clinical studies, and to a lesser extent, changes in estimates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509872111184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic earnings per Share to Diluted Earnings per Share</a></td>
<td class="text"><div style="margin-bottom:7.1pt;margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.579%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of employee&#160;stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings including impact of dilutive adjustments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491.6&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Potential common shares not included in computation of diluted earnings per share</a></td>
<td class="text">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.961%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509871985024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,533.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,121.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,514.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,601.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text">he components of identifiable intangible assets are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,723.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,118.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,681.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,546.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,134.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use right</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,891.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,979.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946.9&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509872111312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Company's population of financial assets and liabilities subject to fair value measurements</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of March&#160;31, 2023, and December 31, 2022, is as follows:</span></div><div style="margin-bottom:3pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:36.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509870455936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Financing Receivable, Allowance for Credit Loss [Table Text Block]</a></td>
<td class="text">The rollforward for the allowance for credit losses for the three months ended March&#160;31, 2023, is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus, credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less, write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less DD allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,222.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unbilled services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reserve for unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.4&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and by payers/customer groups for the three months ended March&#160;31, 2023, and 2022, were as follows:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third party</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Total Dx revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical, biotechnology and medical device companies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues in the U.S. were $2,959.2 (78.3%) and $3,000.5 (76.9%) for the three months ended March&#160;31, 2023, and 2022, respectively.</span></div><div style="margin-bottom:7pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">DD Contract costs</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostTableTextBlock', window );">Capitalized Contract Cost [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:60.720%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.136%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509866745488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,777.9<span></span>
</td>
<td class="nump">3,899.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">586.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 582.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredSalesCommissions', window );">Amortization of Deferred Sales Commissions</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 64.5<span></span>
</td>
<td class="nump">$ 148.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">213.3<span></span>
</td>
<td class="nump">492.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">212.9<span></span>
</td>
<td class="nump">491.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">10,341.5<span></span>
</td>
<td class="nump">10,721.1<span></span>
</td>
<td class="nump">10,096.6<span></span>
</td>
<td class="nump">$ 10,273.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Capitalized Contract Cost, Amortization</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="nump">165.3<span></span>
</td>
<td class="nump">163.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">4,720.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">393.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">430.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 393.9<span></span>
</td>
<td class="nump">$ 1,233.5<span></span>
</td>
<td class="nump">430.0<span></span>
</td>
<td class="nump">1,472.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CostMethodInvestmentsMaximumOwnershipPercentage', window );">Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 212.9<span></span>
</td>
<td class="nump">$ 491.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">$ 10,729.9<span></span>
</td>
<td class="nump">$ 10,948.4<span></span>
</td>
<td class="nump">$ 10,581.7<span></span>
</td>
<td class="nump">$ 10,456.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CostMethodInvestmentsMaximumOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CostMethodInvestmentsMaximumOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentofRevenueContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of Revenue Contributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentofRevenueContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredSalesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredSalesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509871454464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeAbstract', window );"><strong>Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">$ 212.9<span></span>
</td>
<td class="nump">$ 491.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SharesAbstract', window );"><strong>Shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Net earnings, basic (in shares)</a></td>
<td class="nump">88.4<span></span>
</td>
<td class="nump">93.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of employee stock options and awards, (in shares)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PerShareAmountAbstract', window );"><strong>Per Share Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 2.41<span></span>
</td>
<td class="nump">$ 5.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 2.39<span></span>
</td>
<td class="nump">$ 5.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net Income (Loss) Available to Common Stockholders, Diluted</a></td>
<td class="nump">$ 212.9<span></span>
</td>
<td class="nump">$ 491.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">89.0<span></span>
</td>
<td class="nump">94.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PerShareAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PerShareAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509871963472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options (in shares)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509867990768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="nump">$ 69.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">5,891.8<span></span>
</td>
<td class="nump">$ 5,851.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="nump">8,121.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">8,116.0<span></span>
</td>
<td class="nump">8,121.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">1,979.5<span></span>
</td>
<td class="nump">1,904.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 3,912.3<span></span>
</td>
<td class="nump">3,946.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;GOODWILL AND INTANGIBLE ASSETS</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,533.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,121.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,514.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,601.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, the Company's business could be impacted by unfavorable changes, including those that impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily a worsening economic environment and protracted economic downturn and related impacts, including delays in revenue from new customers; increases in customer termination activity; or increases in operating costs. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to monitor the financial performance of, and assumptions for, its reporting units. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin, or substantial reductions in end markets and volume assumptions, could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,723.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,118.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,681.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,546.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,134.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use right</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,891.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,979.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946.9&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets for the three months ended March&#160;31, 2023, and 2022, was $69.3 and $67.1, respectively. The amortization expense for the net carrying amount of intangible assets is estimated to be $206.2 for the remainder of fiscal 2023, $267.5 in fiscal 2024, $255.3 in fiscal 2025, $245.5 in fiscal 2026, $233.9 in fiscal 2027, and $2,141.3 thereafter.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="nump">$ 4,533.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(19.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">4,514.3<span></span>
</td>
<td class="nump">4,533.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="nump">3,587.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">3,601.7<span></span>
</td>
<td class="nump">3,587.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">4,723.8<span></span>
</td>
<td class="nump">4,681.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">1,605.4<span></span>
</td>
<td class="nump">1,546.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,118.4<span></span>
</td>
<td class="nump">3,134.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember', window );">Patents, Licenses And Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">574.8<span></span>
</td>
<td class="nump">574.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">298.7<span></span>
</td>
<td class="nump">291.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">276.1<span></span>
</td>
<td class="nump">283.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">83.4<span></span>
</td>
<td class="nump">86.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">56.3<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">27.1<span></span>
</td>
<td class="nump">36.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember', window );">Use Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Canadian licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">468.9<span></span>
</td>
<td class="nump">468.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 468.9<span></span>
</td>
<td class="nump">$ 468.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509868464768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">$ 5,891.8<span></span>
</td>
<td class="nump">$ 5,851.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(1,979.5)<span></span>
</td>
<td class="num">(1,904.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,912.3<span></span>
</td>
<td class="nump">3,946.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">4,723.8<span></span>
</td>
<td class="nump">4,681.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(1,605.4)<span></span>
</td>
<td class="num">(1,546.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">3,118.4<span></span>
</td>
<td class="nump">3,134.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember', window );">Patents, Licenses And Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">574.8<span></span>
</td>
<td class="nump">574.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(298.7)<span></span>
</td>
<td class="num">(291.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">276.1<span></span>
</td>
<td class="nump">283.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">83.4<span></span>
</td>
<td class="nump">86.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(56.3)<span></span>
</td>
<td class="num">(50.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">27.1<span></span>
</td>
<td class="nump">36.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember', window );">Use Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(9.0)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Canadian licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">468.9<span></span>
</td>
<td class="nump">468.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">468.9<span></span>
</td>
<td class="nump">468.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_InProcessRAAndMediaMember', window );">In Process R&amp;A and Media</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_InProcessRAAndMediaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_InProcessRAAndMediaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509864020016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">$ 5,891.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,851.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">8,116.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,121.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="nump">69.3<span></span>
</td>
<td class="nump">$ 67.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated amortization expense, 2012</a></td>
<td class="nump">206.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated amortization expense, 2013</a></td>
<td class="nump">267.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated amortization expense, 2014</a></td>
<td class="nump">255.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated amortization expense, 2015</a></td>
<td class="nump">245.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated amortization expense, 2016</a></td>
<td class="nump">233.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Estimated amortization expense, Thereafter</a></td>
<td class="nump">2,141.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">69.3<span></span>
</td>
<td class="nump">$ 67.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,514.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,533.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(19.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,601.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,587.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="nump">$ 14.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509869619152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CurrentDebtExcludingFinanceLeaseLiability', window );">Current debt excluding finance lease liability</a></td>
<td class="nump">$ 301.4<span></span>
</td>
<td class="nump">$ 301.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes Payable</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A360SeniorNotesDue2025', window );">3.60% senior notes due 2025</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A400SeniorNotesDue2023', window );">4.00% senior notes due 2023</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="nump">300.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Shorttermdebtissuancecosts', window );">Short term debt issuance costs</a></td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A360SeniorNotesDue2025">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>3.60% senior notes due 2025</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A360SeniorNotesDue2025</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A400SeniorNotesDue2023">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>4.00% senior notes due 2023</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A400SeniorNotesDue2023</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CurrentDebtExcludingFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current debt excluding finance lease liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CurrentDebtExcludingFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Shorttermdebtissuancecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Shorttermdebtissuancecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509863993888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Long-term debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A400SeniorNotesDue2023', window );">4.00% senior notes due 2023</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A325SeniorNotesDue2024', window );">3.25% senior notes due 2024</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A2.30seniornotesdue2024', window );">2.30% senior notes due 2024</a></td>
<td class="nump">400.0<span></span>
</td>
<td class="nump">400.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A360SeniorNotesDue2025', window );">3.60% senior notes due 2025</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A155SeniorNotesDue2026', window );">1.55% senior notes due 2026</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A360SeniorNotesDue2027', window );">3.60% senior notes due 2027</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A2.95seniornotesdue2029', window );">2.95% senior notes due 2029</a></td>
<td class="nump">650.0<span></span>
</td>
<td class="nump">650.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A270SeniorNotesDue2031', window );">2.70% senior notes due 2031</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A470SeniorNotesDue2045', window );">4.70% senior notes due 2045</a></td>
<td class="nump">900.0<span></span>
</td>
<td class="nump">900.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Longtermdebtissuancecosts', window );">Long term debt issuance costs</a></td>
<td class="nump">32.4<span></span>
</td>
<td class="nump">33.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes Payable, Noncurrent</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">5,052.3<span></span>
</td>
<td class="nump">$ 5,038.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A155SeniorNotesDue2026">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>1.55% senior notes due 2026</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A155SeniorNotesDue2026</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2.30seniornotesdue2024">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.30% senior notes due 2024</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2.30seniornotesdue2024</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2.95seniornotesdue2029">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.95% senior notes due 2029</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2.95seniornotesdue2029</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A270SeniorNotesDue2031">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.70% senior notes due 2031</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A270SeniorNotesDue2031</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A325SeniorNotesDue2024">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>3.25% senior notes due 2024</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A325SeniorNotesDue2024</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A360SeniorNotesDue2025">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>3.60% senior notes due 2025</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A360SeniorNotesDue2025</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A360SeniorNotesDue2027">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>3.60% senior notes due 2027</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A360SeniorNotesDue2027</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A400SeniorNotesDue2023">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>4.00% senior notes due 2023</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A400SeniorNotesDue2023</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A470SeniorNotesDue2045">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>4.70% senior notes due 2045</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A470SeniorNotesDue2045</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Longtermdebtissuancecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Longtermdebtissuancecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509864014736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Senior Notes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 5,052.3<span></span>
</td>
<td class="nump">$ 5,038.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityOptiontoIncrease', window );">Credit Facility Option to Increase</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityMaximumSwingLineBorrowings', window );">Credit Facility, Maximum Swing Line Borrowings</a></td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Longtermdebtissuancecosts', window );">Long term debt issuance costs</a></td>
<td class="nump">32.4<span></span>
</td>
<td class="nump">33.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes Payable</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A2.30seniornotesdue2024', window );">2.30% senior notes due 2024</a></td>
<td class="nump">400.0<span></span>
</td>
<td class="nump">400.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A2.95seniornotesdue2029', window );">2.95% senior notes due 2029</a></td>
<td class="nump">650.0<span></span>
</td>
<td class="nump">650.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="nump">67.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A270SeniorNotesDue2031', window );">2.70% senior notes due 2031</a></td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ThreeMonthLIBOR', window );">Three month LIBOR</a></td>
<td class="nump">1.0706%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A270SeniorNotesDue2031', window );">2.70% senior notes due 2031</a></td>
<td class="nump">$ 432.7<span></span>
</td>
<td class="nump">$ 420.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2031Member', window );">Senior notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubordinatedBorrowingInterestRate', window );">Subordinated Borrowing, Interest Rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2.30seniornotesdue2024">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.30% senior notes due 2024</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2.30seniornotesdue2024</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2.95seniornotesdue2029">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.95% senior notes due 2029</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2.95seniornotesdue2029</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A270SeniorNotesDue2031">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.70% senior notes due 2031</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A270SeniorNotesDue2031</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumSwingLineBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Swing Line Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumSwingLineBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityOptiontoIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility Option to Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityOptiontoIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Longtermdebtissuancecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Longtermdebtissuancecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ThreeMonthLIBOR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Three month LIBOR</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ThreeMonthLIBOR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative liabilities designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubordinatedBorrowingInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated interest rate of the subordinated debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubordinatedBorrowingInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509871465840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Credit Facilities) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving Credit Facility, maximum borrowing capacity</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeDescription', window );">Line of Credit Facility, Commitment Fee Description</a></td>
<td class="text">0.10% to 0.225%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes Payable</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityOptiontoIncrease', window );">Credit Facility Option to Increase</a></td>
<td class="nump">500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityMaximumSwingLineBorrowings', window );">Credit Facility, Maximum Swing Line Borrowings</a></td>
<td class="nump">100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="nump">84,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityMaximumLettersofCredit', window );">Credit Facility, Maximum Letters of Credit</a></td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Line of Credit Facility, Interest Rate at Period End</a></td>
<td class="nump">5.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumLettersofCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Letters of Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumLettersofCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumSwingLineBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Swing Line Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumSwingLineBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityOptiontoIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility Option to Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityOptiontoIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the fees for amounts available, but unused under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509866635488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 08, 2023</div></th>
<th class="th"><div>May 18, 2023</div></th>
<th class="th"><div>Apr. 06, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,531,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonSharesOutstandingRollforwardAbstract', window );"><strong>Common Shares Outstanding Rollforward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares outstanding, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonSharesHeldInTreasuryRollforwardAbstract', window );"><strong>Rollforward of common shares held in treasury</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Tax effect of adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,100,000<span></span>
</td>
<td class="num">$ (74,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfOrdinaryDividends', window );">Payments of Ordinary Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonSharesHeldInTreasuryRollforwardAbstract', window );"><strong>Rollforward of common shares held in treasury</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Dividends Payable, Date of Record</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 18,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Dividends Payable, Date Declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr.  06,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends Payable, Amount Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Dividends Payable, Date to be Paid</a></td>
<td class="text">Jun.  08,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Dividends Payable, Date Declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr.  06,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Dividends Payable, Date to be Paid</a></td>
<td class="text">Jun.  08,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Dividends Payable, Date of Record</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 18,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends Payable, Amount Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonSharesIssuedRollforwardAbstract', window );"><strong>Rollforward of common shares issued</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares issued, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans', window );">Commons Stock Issued During Period Shares Employee Stock Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares issued, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonSharesOutstandingRollforwardAbstract', window );"><strong>Common Shares Outstanding Rollforward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans', window );">Commons Stock Issued During Period Shares Employee Stock Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans', window );">Commons Stock Issued During Period Shares Employee Stock Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonSharesHeldInTreasuryRollforwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonSharesHeldInTreasuryRollforwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonSharesIssuedRollforwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonSharesIssuedRollforwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonSharesOutstandingRollforwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonSharesOutstandingRollforwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the declared dividend will be paid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendPayableDateToBePaidDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the dividend to be paid was declared, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateDeclaredDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateOfRecordDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfOrdinaryDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfOrdinaryDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509867822720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</a></td>
<td class="num">$ (7,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text"><div style="margin-top:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive earnings (loss) are as follows:</span></div><div style="margin-bottom:3pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.334%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Earnings (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493.2)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</a></td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other Comprehensive Income (Loss), before Reclassifications, before Tax</a></td>
<td class="nump">58,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AccumulatedOtherComprehensiveEarningsRollForward', window );"><strong>Accumulated Other Comprehensive Earnings [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign Currency Translation Adjustments, Beginning balance</a></td>
<td class="num">(462,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other comprehensive income before reclassifications</a></td>
<td class="nump">48,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Tax effect of adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign Currency Translation Adjustments, Ending balance</a></td>
<td class="num">(414,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net Benefit Plan Adjustments, Beginning balance</a></td>
<td class="num">(30,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Tax effect of adjustments</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net Benefit Plan Adjustments, Ending balance</a></td>
<td class="num">(30,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Earnings, Beginning balance</a></td>
<td class="num">(493,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other comprehensive income before reclassifications</a></td>
<td class="nump">48,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="num">(1,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect of adjustments</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">$ (600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Earnings, Ending balance</a></td>
<td class="num">(444,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLocationAxis=lh_ForeignCurrencyTranslationAdjustmentsMember', window );">Pension settlement charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AccumulatedOtherComprehensiveEarningsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Earnings [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AccumulatedOtherComprehensiveEarningsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e709-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLocationAxis=lh_ForeignCurrencyTranslationAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLocationAxis=lh_ForeignCurrencyTranslationAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509871921744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss Contingency, Damages Sought, Value</a></td>
<td class="nump">$ 817.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss Contingency, Damages Awarded, Value</a></td>
<td class="nump">$ 272.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509866591152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NumberofMeasurementFundsAvailableForParticipantElection', window );">Number of Measurement Funds Available For Participant Election</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">$ 15.1<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">48.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SeniorNotesFairValue', window );">Fair market value of senior notes</a></td>
<td class="nump">5,082.0<span></span>
</td>
<td class="nump">4,973.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">106.4<span></span>
</td>
<td class="nump">100.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">102.7<span></span>
</td>
<td class="nump">96.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">69.0<span></span>
</td>
<td class="nump">77.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="nump">67.3<span></span>
</td>
<td class="nump">79.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Contingentconsiderationadjustment', window );">Contingent consideration adjustment</a></td>
<td class="num">(8.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Tax effect of adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">5,052.3<span></span>
</td>
<td class="nump">5,038.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="nump">67.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member', window );">Senior notes due 2022 [Member] | 2018 Swap Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2024Member', window );">Senior notes due 2024 | 2022 Swap Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">15.1<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">48.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">106.4<span></span>
</td>
<td class="nump">100.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">102.7<span></span>
</td>
<td class="nump">96.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="nump">67.3<span></span>
</td>
<td class="nump">79.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">69.0<span></span>
</td>
<td class="nump">77.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Contingentconsiderationadjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Contingentconsiderationadjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NumberofMeasurementFundsAvailableForParticipantElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Measurement Funds Available For Participant Election</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NumberofMeasurementFundsAvailableForParticipantElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SeniorNotesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated fair value of the debt instrument (senior notes) at the balance-sheet date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SeniorNotesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative liabilities designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net fair value of all derivative instruments designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966630&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SwapTypeAxis=lh_A2018SwapAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SwapTypeAxis=lh_A2018SwapAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SwapTypeAxis=lh_A2022SwapAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SwapTypeAxis=lh_A2022SwapAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509867547888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 455.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,943.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 490.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</a></td>
<td class="num">(8.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember', window );">Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</a></td>
<td class="num">(30.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136.6<span></span>
</td>
<td class="nump">$ 270.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.6<span></span>
</td>
<td class="nump">270.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346.8<span></span>
</td>
<td class="nump">$ 286.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</a></td>
<td class="nump">19.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets</a></td>
<td class="num">(10.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities</a></td>
<td class="num">(10.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial assets acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial liabilities assumed in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509867828816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION Business Segment Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 3,777.9<span></span>
</td>
<td class="nump">$ 3,899.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">341.0<span></span>
</td>
<td class="nump">687.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="num">(69.3)<span></span>
</td>
<td class="num">(67.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetRestructuringCharges', window );">Net Restructuring Charges</a></td>
<td class="num">(8.6)<span></span>
</td>
<td class="num">(12.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">565.4<span></span>
</td>
<td class="nump">851.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="num">$ (144.3)<span></span>
</td>
<td class="num">$ (82.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">Diagnostics | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 2,382.8<span></span>
</td>
<td class="nump">$ 2,454.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">$ 441.5<span></span>
</td>
<td class="nump">683.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Drug Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Drug Development | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,401.3<span></span>
</td>
<td class="nump">1,459.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">$ 123.9<span></span>
</td>
<td class="nump">$ 168.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentofRevenueContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of Revenue Contributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentofRevenueContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509875079488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredSalesCommissions', window );">Amortization of Deferred Sales Commissions</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Capitalized Contract Cost, Amortization</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="nump">$ 165.3<span></span>
</td>
<td class="nump">$ 163.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear', window );">Percent of remaining performance obligations recognized as revenue in next year</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of remaining performance obligations recognized as revenue in next year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredSalesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredSalesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140509863510032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE Disaggregated Revenue Table (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 52.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_UnbilledServicesAllowanceforCreditLoss', window );">Unbilled Services, Allowance for Credit Loss</a></td>
<td class="nump">10.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NoteReceivableAllowanceforCreditLoss', window );">Note Receivable, Allowance for Credit Loss</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">64.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="nump">165.3<span></span>
</td>
<td class="nump">$ 163.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Contract with Customer, Asset, before Allowance for Credit Loss</a></td>
<td class="nump">715.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 4,720.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_LongTermContractsDurationMinimum', window );">Long Term Contracts Duration Minimum</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_LongTermContractsDurationMaximum', window );">Long Term Contracts Duration Maximum</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">586.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">582.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Capitalized Contract Cost, Amortization</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent', window );">Accrued Sales Commission</a></td>
<td class="nump">38.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized Contract Cost, Net</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts', window );">Amount of Deferred Costs Related to Long-term Contracts</a></td>
<td class="nump">52.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredSalesCommissions', window );">Amortization of Deferred Sales Commissions</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled Contracts Receivable</a></td>
<td class="nump">$ 705.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 3,777.9<span></span>
</td>
<td class="nump">$ 3,899.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">2,344.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,222.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent', window );">Allowance for Credit Loss, Receivable, Other, Current</a></td>
<td class="num">(10.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract with Customer, Asset, after Allowance for Credit Loss, Current</a></td>
<td class="nump">$ 705.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lh_OthercountriesMember', window );">Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">78.30%<span></span>
</td>
<td class="nump">76.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 2,959.2<span></span>
</td>
<td class="nump">$ 3,000.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember', window );">Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Client [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Client [Member] | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Client [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Self-Pay [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Self-Pay [Member] | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Self-Pay [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Medicare and Medicaid [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Medicare and Medicaid [Member] | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Medicare and Medicaid [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Third party [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Third party [Member] | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember', window );">LabCorp Diagnostics [Member] | Third party [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Biopharmaceutical and medical device companies [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Biopharmaceutical and medical device companies [Member] | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember', window );">Covance Drug Development [Member] | Biopharmaceutical and medical device companies [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts Receivable, before Allowance for Credit Loss</a></td>
<td class="nump">$ 1,131.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,046.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Drug Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts Receivable, before Allowance for Credit Loss</a></td>
<td class="nump">$ 1,266.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,218.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Drug Development | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Drug Development | Biopharmaceutical and medical device companies [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Drug Development | Biopharmaceutical and medical device companies [Member] | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Drug Development | Biopharmaceutical and medical device companies [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember', window );">Unbilled Contracts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings', window );">Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AllowanceforCreditLossWriteOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for Credit Loss, Write Off</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AllowanceforCreditLossWriteOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_LongTermContractsDurationMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Contracts Duration Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_LongTermContractsDurationMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_LongTermContractsDurationMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Contracts Duration Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_LongTermContractsDurationMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoteReceivableAllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note Receivable, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoteReceivableAllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentofRevenueContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of Revenue Contributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentofRevenueContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_UnbilledServicesAllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled Services, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_UnbilledServicesAllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on receivable, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredSalesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredSalesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(d)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lh_OthercountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lh_OthercountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_LabCorpDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_ClientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_ClientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SelfPayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SelfPayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_ThirdpartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_ThirdpartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_CovanceDrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_BiopharmaceuticalandmedicaldevicecompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_BiopharmaceuticalandmedicaldevicecompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>lh-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lh="http://www.labcorp.com/20230331"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lh-20230331.xsd" xlink:type="simple"/>
    <context id="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i365d61b777464aaab66fcd10574468cc_I20230503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2023-05-03</instant>
        </period>
    </context>
    <context id="i5e096d4685af481291993afb05e8af6b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i257716c5617f4dfab266cec980a32b4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i588647b555754d81a6f8860fc05eb240_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i592357016e3744b0843e011607824ca7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7b2a106b08c45d985ad0f96dfe28f03_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b88c64ad7e840059120244f7ab99191_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab0be29e60e441bcb12bb35cda780ac7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23a3cf3470c541cc9a118ee99a72dc93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8e919ac92261428e9543c34107b41625_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7a88e44b8153492fa26e6001e07825e2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d394a1bebee4deb80055b47b3c9939c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iee01e81aeb6c470fbf0fa4ce9effd856_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia77d30f9f579417baf43564777a5e162_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7a678436da9f4a5c9f9ed83b04c8b718_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2e8d94fd31974fedaa85761a4645a643_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2315342e2c9b4bd884f72b1ee5577f16_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4474976eb0346d7aaa75e127d476d81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic4ffa52a16e9418bb2cddabfd8decd27_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i82fb222d072d44719a76345469b56366_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie723babf6fae4a8189eb1eb7a43344b8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3913ba65e0f24cc486f2b663bc2bfe42_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if448ca8645d54e68b69cc0d387de5c41_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i25f54403307748858e4d8146c668ecff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c104cf850a34b9ab0663d78cddac33d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3605655f09a54bc3b18dc7d96c8a489b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9295a7e1205642f8b24132fc40048aeb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4ede9219684c4c19ac6c4f99ed4deac1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie24b2776ffcf4549877584c826d752c8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i420fa3c3695d41f8bc45444f2f622072_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibb964f0c745b4194b5a6bef32f88de19_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9484d4c8e1854e87b159b80a497984f0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie1165052aa834b059bcaad7ef272c1a1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie2c1b84276324a28b731ff53e9def3cd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i763ecc59a2844e22891e55687fd0a3d7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i53c76d8608624e4787674cc6ed63818e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie12432610ca742daadc4501b48c54075_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1a6cf78d4b3f4e31be29df0ab4867707_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib6850c8d1a9b4abf91d4f9240163b33f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icacac42c54284702ac2e69d39cc15335_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7fe6cefd2840440fa73bfb36cce0bd02_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i729d22ace90f47c0bf2e6fbda82b64d1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i13d3320c4e2540a49733a84c90104543_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0b5749f29ed746cdb1f7e7ba300fc7af_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i93500e8506494c54ae50c563bf13de61_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i06441b394eb04c088df79a7c58d41d8a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if2145777bf514c2e9428b3441b58838b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iacd5ed46262f4edaa5d4b50ba7ade997_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i584d55d88fdb45efa9af2b586e5f217a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f171369cd5d4f90a4563adeddadf605_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie99422763a4d440c9debb245667d5c41_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i59328318fd8940bd8ba57a503380a716_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4dd2467eb6a74cf5b4b1a1777f3e3c55_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8926ca56ad6743998548a7c630959f43_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i83ad11debbb84aae9ca83d5b2709beed_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i32d7e51ee9b74366914cac24045ae494_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1155708282e748aaaff745d85150e533_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2ca751f2ef6a46ceac258b5c894deab2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id7f05b08fb1b4715baffe092dc0385b6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if082ac4f47484ed49056b4d69e51b488_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia692ca467d2b4ff09e04d7def5d0b93e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i59031632d0a84142b11e9d2945f5de0f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia39e375cc4ad48c9a8271a3d25fb7540_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id173b34dc6f448f8b51cff3f364679f9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if123dbe50a0b4e038bf1d42c09d499b9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i740b7ad7e54746128e1e05e9e772c494_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf86457793f94a1b89374df236a0d4a9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieed2b69216414061a0dc9a748b771a88_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i96175b5db8d347f9ba27cd093b4b2434_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia4bade9216bd42b7ab400fd587eb531b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i737f59dcfb5f48afb10f07bd9e8526be_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8d5f0fe941da4ed7a8226c737f6ca3c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa1d29b542f64e46af9c4c2e0dd7e139_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if2c16890448b482a8f57a9fd32911696_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iff417091e8e144259990a3a8694217a3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib827e60cff174c63b54f562a198031e9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia4e1b39c14cd47d3a1f23f6197f735e7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ideec54047acb41c88dff0ba4c5caa519_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i088eb4baf0c54c1caafe41e5b7e00385_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i00562d863b694bb2921bab984ac7c461_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id971d73602324ea2bbed87722254241d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i92fdaba98ae04990b80e40e7597fce48_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4435b03d249448678d58b9a5c5fdc669_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0679350b3d0345839defcd1fbdc1ca18_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie379b002992b4ac9a015d0de8f522228_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8a7d8dea373148a28d09ed326eb7865a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i00f94c3f1730467bb46c0d213ccf9893_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i87c13ae2d4e342baafe38aef77715bf2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">lh:UnbilledContractsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6958f3490b214ab3abf0a9756949e010_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5c7c606b647f41e58ee112be251877bf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i27b2961f942e4288b255e63e16d547a7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c8e22062d044e07b6b22b1dcd5a0364_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idb9b1e876bfb460880c08cb5c95f0b7b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6d5821a314134dd49949999c2e5b3f19_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia20524cf106845889acba917cc6c2f53_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i478a2df8586f43a4ac24ced9bb357651_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iea4f8105f7c2473fb04f52c1cf307161_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i367717bee21446d7b41b04f4afdd53da_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic62e9f64e0a74bcf8ed85655910238e6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3837e5c114d143df8e230ad612f6111f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:LabCorpDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifca5e7f0071c4897a17282d5246502a9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:CovanceDrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icc11c37c41af470b99edcf92d0ddfa5a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9f25ab7e1594456ab575b107b00dff07_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic37cab27c9924e55b43d4eca1de9ed08_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5d2fb16eef474b76b17de5a95e7d2063_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f98a37fdff54bff858d9b633c7df6fd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4a694aae86a041dba12584e655a56786_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79a415a626ce4907ab55886ae221d3b5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7b7965b44dc64133b06b8e8418e9e63f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05b34a492ae347f5a0f4fbab882117b4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i208b4414a820456bb72360fbc55747f7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i95b60b6004a24ba48579fb56cf93d751_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0cf79c7c336c4856b02a1b0a7ac3802c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5bda848179204f8dbc6ca502a1e6b162_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:InProcessRAAndMediaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i69d6d91a822b4e58a4a30b0ed4b82bf0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:InProcessRAAndMediaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i772840f5d04344f4a44ed5da9d0e53d7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8ff0a49f62ff41469cd1280087a38dc2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2fc48bf4132447b5ad6ad22c82427c71_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if61be0038474449a8767e2be7c9aad81_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3899295744f647ccb8f7d75b5d3d2193_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f6d9f778de347038d4db29292220d70_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i509a25f9cde744a08f771cef00ab8b88_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iade5794fdb2048c4b1367089794b02d2_D20230406-20230406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-06</startDate>
            <endDate>2023-04-06</endDate>
        </period>
    </context>
    <context id="i434e0492f16b458782fd7bad1f0165fc_I20230406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-06</instant>
        </period>
    </context>
    <context id="i64a241cba18148d68b58c63f94a86b0d_D20230608-20230608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-08</startDate>
            <endDate>2023-06-08</endDate>
        </period>
    </context>
    <context id="i318e19e3163b4d77b9fdcb41be6651b3_D20230518-20230518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-18</startDate>
            <endDate>2023-05-18</endDate>
        </period>
    </context>
    <context id="i9726d7960c36403697c0c1aecbad306a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">lh:ForeignCurrencyTranslationAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1b622134b2644c41b2459aca36262ef0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iedd64678d4f54800a0093c44f20de7a6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if889505bd2b3447a9d92c961bc85f69a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iebf9eccd27c5482a9a25b7aa0413e304_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47a4691325d94666bc3851c13c2a2d39_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i769724f534fd42d5b074271dafd50c33_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6ed01ecd53ff440bb094c068361e773d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2018SwapAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic501f2ab3f824f5e99cea8fef7c2e388_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2022SwapAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i217de76c0e02473688390d39aec04505_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifc9c5675189343c08478b612cc0f2f08_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia98902be646a4c90b5a714ef8b40c97e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i88dc2a3d6e8c4967802600e7ff248849_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i78627350409f4353bd6bb72edb530c2d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i236653e26bcc49638d6df006253bc8bd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7e2835bbadb5437a96546e64b63d52bc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8bab97c15b1644c996b81336ef6af0a2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i511043ecd4a749f784a8ec71a6c55a7b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia2399bfbb9764cbfb9d758e73036dd39_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMy9mcmFnOjZiY2FiMmQ1ODliZjRmYTg4OTk1MDUyZjAxZjE5NDk4L3RhYmxlOmJkMDkwNDVjMzE5NjQ1NTI5NDY0ZTcyMDEzMGFlYWY1L3RhYmxlcmFuZ2U6YmQwOTA0NWMzMTk2NDU1Mjk0NjRlNzIwMTMwYWVhZjVfMi0xLTEtMS0yMzgzNjk_0e1a2564-08f3-425b-b2c6-06c76083e7d8"
      unitRef="usd">52800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMy9mcmFnOjZiY2FiMmQ1ODliZjRmYTg4OTk1MDUyZjAxZjE5NDk4L3RhYmxlOmJkMDkwNDVjMzE5NjQ1NTI5NDY0ZTcyMDEzMGFlYWY1L3RhYmxlcmFuZ2U6YmQwOTA0NWMzMTk2NDU1Mjk0NjRlNzIwMTMwYWVhZjVfMi0zLTEtMS0yMzgzNjk_598061ae-1a36-48ee-b04b-2f91702e9750"
      unitRef="usd">43500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMy9mcmFnOjZiY2FiMmQ1ODliZjRmYTg4OTk1MDUyZjAxZjE5NDk4L3RhYmxlOmJkMDkwNDVjMzE5NjQ1NTI5NDY0ZTcyMDEzMGFlYWY1L3RhYmxlcmFuZ2U6YmQwOTA0NWMzMTk2NDU1Mjk0NjRlNzIwMTMwYWVhZjVfNS0xLTEtMS0yMzgzNjk_89720163-ded8-44e7-a397-1924284a305b"
      unitRef="shares">88600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMy9mcmFnOjZiY2FiMmQ1ODliZjRmYTg4OTk1MDUyZjAxZjE5NDk4L3RhYmxlOmJkMDkwNDVjMzE5NjQ1NTI5NDY0ZTcyMDEzMGFlYWY1L3RhYmxlcmFuZ2U6YmQwOTA0NWMzMTk2NDU1Mjk0NjRlNzIwMTMwYWVhZjVfNS0zLTEtMS0yMzgzNjk_955d127d-58c9-457a-9e90-cdbc012fe8d8"
      unitRef="shares">88200000</us-gaap:CommonStockSharesOutstanding>
    <dei:EntityCentralIndexKey
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzQtMS0xLTEtMjM4MzY5_e801cc9f-1192-4b43-adde-c7542207ab41">0000920148</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzUtMS0xLTEtMjM4MzY5_6ebec811-418b-4efd-8501-6884d20ce599">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzktMS0xLTEtMjM4MzY5_025ba8c4-dcef-4ae6-99c2-4f1310401868">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzEwLTEtMS0xLTIzODM2OQ_7ae7302f-a302-4505-acdf-74241b35d9ac">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzExLTEtMS0xLTIzODM2OQ_be60ef53-c31e-492d-8ec3-03362cd2c9a8">false</dei:AmendmentFlag>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i365d61b777464aaab66fcd10574468cc_I20230503"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMDMvZnJhZzo5MjZlZDJhODE1ODI0YmNhYjc3MTVlNGRlMDNjYzE0YS90YWJsZTo1ZTQ2OTNkMDUzY2Q0NzFlYjE0NjVjNzQ1YWYxMTZjYi90YWJsZXJhbmdlOjVlNDY5M2QwNTNjZDQ3MWViMTQ2NWM3NDVhZjExNmNiXzEyLTItMS0xLTIzODM2OQ_86dc1a90-85c1-4d93-aa69-39d6e35d2b25"
      unitRef="shares">88600000</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentType
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjY5_d0b85cfb-c856-45fa-95aa-2420af7b92d1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc3_0205b97e-840f-4fc9-83bd-803231492c97">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMTE_01c825ca-71bb-4c59-a968-af22cc4fc956">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjcw_f62b1ea8-c5e6-41d0-8417-568066e87ede">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc4_813393a1-6e0f-44fb-b05f-fcc10b3a254e">1-11353</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjcx_b51a7bdd-b1d0-4143-9ec0-1aac78ec8549">LABORATORY CORPORATION OF AMERICA HOLDINGS</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6OGY2NmZlOTg1MDY3NDAzMjk4MmQwNWMyNDk2ZDFlNzkvdGFibGVyYW5nZTo4ZjY2ZmU5ODUwNjc0MDMyOTgyZDA1YzI0OTZkMWU3OV8wLTAtMS0xLTIzODM2OQ_f3ece0e5-fcdc-4f02-a3e7-55fbe8f96414">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6OGY2NmZlOTg1MDY3NDAzMjk4MmQwNWMyNDk2ZDFlNzkvdGFibGVyYW5nZTo4ZjY2ZmU5ODUwNjc0MDMyOTgyZDA1YzI0OTZkMWU3OV8wLTItMS0xLTIzODM2OQ_adc3e9ae-db93-40b3-bf4a-9c1a8e755dec">13-3757370</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6YWFkYjUwNzA4MDRiNDhiMTlkZTExNmI0MmEzN2UyMmEvdGFibGVyYW5nZTphYWRiNTA3MDgwNGI0OGIxOWRlMTE2YjQyYTM3ZTIyYV8wLTAtMS0xLTIzODM2OQ_2016a8c7-687e-4fce-9f02-16eb5e178de0">358 South Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6YWFkYjUwNzA4MDRiNDhiMTlkZTExNmI0MmEzN2UyMmEvdGFibGVyYW5nZTphYWRiNTA3MDgwNGI0OGIxOWRlMTE2YjQyYTM3ZTIyYV8xLTAtMS0xLTIzODM2OQ_3fe6880f-dee5-491b-85aa-2f03cf34e0e2">Burlington,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6YWFkYjUwNzA4MDRiNDhiMTlkZTExNmI0MmEzN2UyMmEvdGFibGVyYW5nZTphYWRiNTA3MDgwNGI0OGIxOWRlMTE2YjQyYTM3ZTIyYV8xLTEtMS0xLTIzODM2OQ_ca138010-aded-4dc7-bb8a-925d98189018">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6YWFkYjUwNzA4MDRiNDhiMTlkZTExNmI0MmEzN2UyMmEvdGFibGVyYW5nZTphYWRiNTA3MDgwNGI0OGIxOWRlMTE2YjQyYTM3ZTIyYV8xLTMtMS0xLTIzODM2OQ_253d3410-39a4-4f21-b506-bd6ce287ab25">27215</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjcy_882fab33-38e8-4b62-834b-cda72a402f39">336</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjcz_a57e274b-ad8d-4740-9d4e-8b0aa16845f8">229-1127</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc0_3ee6c578-bb7a-4745-af84-9469a2226f9e">Common Stock, $0.10 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc1_ea564c2b-c8b0-4609-8d76-5af9ddf166df">LH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc5_2a43fa3e-8b57-49b4-822a-0c0b448698cd">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjY4_e75b9ea4-fdba-4839-b252-b45fa298a6d5">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjgw_f1a57fac-312e-4863-aad4-5017a1b70168">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6MGUyMTBjZGFkNzdiNDZmZGE2NzBlMjNkZjI1OTdlZTkvdGFibGVyYW5nZTowZTIxMGNkYWQ3N2I0NmZkYTY3MGUyM2RmMjU5N2VlOV8wLTAtMS0xLTIzODM2OQ_ce13a201-8776-41ae-b2ac-c3609e029b48">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6MGUyMTBjZGFkNzdiNDZmZGE2NzBlMjNkZjI1OTdlZTkvdGFibGVyYW5nZTowZTIxMGNkYWQ3N2I0NmZkYTY3MGUyM2RmMjU5N2VlOV8xLTMtMS0xLTIzODM2OQ_3149738a-63d2-42a9-9b82-4ab7bbc519bf">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGFibGU6MGUyMTBjZGFkNzdiNDZmZGE2NzBlMjNkZjI1OTdlZTkvdGFibGVyYW5nZTowZTIxMGNkYWQ3N2I0NmZkYTY3MGUyM2RmMjU5N2VlOV8yLTMtMS0xLTIzODM2OQ_e126eba3-b20e-40ae-afec-4839c30fafaf">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjc2_09978c2a-fcfe-4712-8bcd-d49e932f905a">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i365d61b777464aaab66fcd10574468cc_I20230503"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xL2ZyYWc6YmI2MzA3Njk3MGQ5NGU2OTk3MTI0NDAwZDczZGYxN2YvdGV4dHJlZ2lvbjpiYjYzMDc2OTcwZDk0ZTY5OTcxMjQ0MDBkNzNkZjE3Zl8yMjQy_86dc1a90-85c1-4d93-aa69-39d6e35d2b25"
      unitRef="shares">88600000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMy0xLTEtMS0yMzgzNjk_d9fe515b-159e-4397-bb42-a99ef3f9ba7b"
      unitRef="usd">393900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMy0zLTEtMS0yMzgzNjk_b50b8bc9-25ac-42d3-add0-4b762a0a2b82"
      unitRef="usd">430000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNC0xLTEtMS0yMzgzNjk_2349b7c8-9af9-432f-b687-531cef3bd995"
      unitRef="usd">2344800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNC0zLTEtMS0yMzgzNjk_fa55f496-bdb4-42ec-9489-3250e64a7a8b"
      unitRef="usd">2222000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNS0xLTEtMS0yMzgzNjk_695f4f6f-827e-4545-b9e3-17f7dd2d6982"
      unitRef="usd">705100000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNS0zLTEtMS0yMzgzNjk_1776c4ce-b6cd-4757-a089-9806e7b0408e"
      unitRef="usd">795400000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:InventoryNet
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNi0xLTEtMS0yMzgzNjk_432aa1df-e86b-42b0-be9a-0df41d884ae4"
      unitRef="usd">481400000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNi0zLTEtMS0yMzgzNjk_8ff2cf34-4ecb-4494-b9f3-4b0280cd35c1"
      unitRef="usd">470600000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNy0xLTEtMS0yMzgzNjk_d3e49558-df03-4ff8-8728-0eff9b62e394"
      unitRef="usd">769800000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNy0zLTEtMS0yMzgzNjk_148e08c2-65b8-4301-9b3b-3f5d5bc5e26f"
      unitRef="usd">707000000.0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfOS0xLTEtMS0yMzgzNjk_bb43654e-756f-4294-a9e9-0960d7cb2097"
      unitRef="usd">4695000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfOS0zLTEtMS0yMzgzNjk_14ba1e04-f24e-44fe-9261-c7645e821474"
      unitRef="usd">4625000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTAtMS0xLTEtMjM4MzY5_f5c98d7e-44df-402e-9b55-b57e3ac2de9a"
      unitRef="usd">2944100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTAtMy0xLTEtMjM4MzY5_b98b2963-c699-47a8-8269-bf49f1fd1dc3"
      unitRef="usd">2956200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTEtMS0xLTEtMjM4MzY5_26264a9d-7010-4366-a993-2d30f7c34dfb"
      unitRef="usd">8116000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTEtMy0xLTEtMjM4MzY5_9cb7c89d-e43f-4b0b-83a7-e8a6e97cd277"
      unitRef="usd">8121000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTItMS0xLTEtMjM4MzY5_fb17ccee-5d02-49e2-9c96-c00d36c8a465"
      unitRef="usd">3912300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTItMy0xLTEtMjM4MzY5_c0b10e96-999d-49ec-8c20-5abcd61bc846"
      unitRef="usd">3946900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTMtMS0xLTEtMjM4MzY5_92f4c762-55cf-40f2-9bcb-e3a9f129b177"
      unitRef="usd">65800000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTMtMy0xLTEtMjM4MzY5_0b13c317-8893-4000-a5a1-1b343ea65a9e"
      unitRef="usd">65700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTQtMS0xLTEtMjM4MzY5_872da90f-0b1f-494c-a85a-c57c993065fc"
      unitRef="usd">7700000</us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTQtMy0xLTEtMjM4MzY5_2af45147-07cf-4702-b93e-2cddaa2b385a"
      unitRef="usd">7600000</us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTUtMS0xLTEtMjM4MzY5_348c93e8-7601-42b1-80d4-157390cd06cd"
      unitRef="usd">459100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTUtMy0xLTEtMjM4MzY5_24ae8a0b-afde-4484-bc86-22341b38bb60"
      unitRef="usd">432700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTctMS0xLTEtMjM4MzY5_5d6378f1-fe32-41cd-8fc5-24af111f53ec"
      unitRef="usd">20200000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMTctMy0xLTEtMjM4MzY5_12423a93-159d-4eb5-ac14-865aac799051"
      unitRef="usd">20155100000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjEtMS0xLTEtMjM4MzY5_c30dfe1b-7352-48b6-bbc9-4bc979d033af"
      unitRef="usd">880700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjEtMy0xLTEtMjM4MzY5_45d7eb1f-20f9-4fca-b698-4a2df004c5c4"
      unitRef="usd">934800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjItMS0xLTEtMjM4MzY5_aecc1788-b3ac-4f0b-850f-6c1c540c431e"
      unitRef="usd">929500000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjItMy0xLTEtMjM4MzY5_9307e040-0e61-463b-a3fd-f178bbcb357e"
      unitRef="usd">1068800000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjMtMS0xLTEtMjM4MzY5_39a93331-6a85-4633-87eb-60a06970c746"
      unitRef="usd">586700000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjMtMy0xLTEtMjM4MzY5_ceb3fe38-00b5-455b-b890-858d2dbc591e"
      unitRef="usd">582100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjQtMS0xLTEtMjM4MzY5_5bf34d9a-cac2-45d3-ba79-0b1f15829c79"
      unitRef="usd">181200000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjQtMy0xLTEtMjM4MzY5_07e6619d-b62e-4457-8e6d-7faf86d704b8"
      unitRef="usd">185500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjUtMS0xLTEtMjM4MzY5_52932789-3bcc-45d1-9828-d560d5a792b7"
      unitRef="usd">6100000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjUtMy0xLTEtMjM4MzY5_7d31831a-7494-4ed0-9e0e-88e5ab2436a1"
      unitRef="usd">6000000.0</us-gaap:FinanceLeaseLiabilityCurrent>
    <lh:CurrentDebtExcludingFinanceLeaseLiability
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjYtMS0xLTEtMjM4MzY5_708192e2-03a5-4a94-9af7-79e2d0db151a"
      unitRef="usd">301400000</lh:CurrentDebtExcludingFinanceLeaseLiability>
    <lh:CurrentDebtExcludingFinanceLeaseLiability
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjYtMy0xLTEtMjM4MzY5_ec58bcd7-c99b-45c1-9d9d-d694f0414915"
      unitRef="usd">301300000</lh:CurrentDebtExcludingFinanceLeaseLiability>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjgtMS0xLTEtMjM4MzY5_6cb444ec-be19-4543-ad87-3990dcaf6e4d"
      unitRef="usd">2885600000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjgtMy0xLTEtMjM4MzY5_d6d6c74d-0e34-4136-925b-eac3abfe3c9b"
      unitRef="usd">3078500000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjktMS0xLTEtMjM4MzY5_9f0345a9-85da-4107-8a85-83d5111e7d76"
      unitRef="usd">5052300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMjktMy0xLTEtMjM4MzY5_593d825a-7060-4926-9fbe-fbf27d8e96c3"
      unitRef="usd">5038800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzAtMS0xLTEtMjM4MzY5_45199c55-418b-41a9-a9de-d3192621ddfe"
      unitRef="usd">668300000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzAtMy0xLTEtMjM4MzY5_0120356c-2475-40bd-b006-f4a943f5f1aa"
      unitRef="usd">679700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzEtMS0xLTEtMjM4MzY5_d316fd15-f5c9-4f0a-a71b-97654a48039c"
      unitRef="usd">82000000.0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzEtMy0xLTEtMjM4MzY5_27bdcb34-faa5-4722-ab57-17acaa82cf64"
      unitRef="usd">83600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <lh:DeferredIncomeTaxesAndOtherTaxLiabilities
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzItMS0xLTEtMjM4MzY5_6baca851-8b73-4638-8078-a076752d211b"
      unitRef="usd">737400000</lh:DeferredIncomeTaxesAndOtherTaxLiabilities>
    <lh:DeferredIncomeTaxesAndOtherTaxLiabilities
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzItMy0xLTEtMjM4MzY5_fa797bb2-576e-477a-9e82-56737cb3767b"
      unitRef="usd">736200000</lh:DeferredIncomeTaxesAndOtherTaxLiabilities>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzMtMS0xLTEtMjM4MzY5_a0a0c4b7-a030-4056-a27b-ec177f928fec"
      unitRef="usd">413600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzMtMy0xLTEtMjM4MzY5_b61e7146-730e-457d-a81d-3a7f30f0aed5"
      unitRef="usd">422800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzUtMS0xLTEtMjM4MzY5_ac9a63ba-1233-4c38-b244-99aa5180ce3d"
      unitRef="usd">9839200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzUtMy0xLTEtMjM4MzY5_cadf8a77-6718-4b01-8aa1-d2689af13a27"
      unitRef="usd">10039600000</us-gaap:Liabilities>
    <lh:NoncontrollingInterestMezzanineEquity
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzctMS0xLTEtMjM4MzY5_63559433-8c97-4806-824a-53709017fc58"
      unitRef="usd">19300000</lh:NoncontrollingInterestMezzanineEquity>
    <lh:NoncontrollingInterestMezzanineEquity
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzctMy0xLTEtMjM4MzY5_58e04720-d467-41c0-b3ff-c74a1960169e"
      unitRef="usd">18900000</lh:NoncontrollingInterestMezzanineEquity>
    <us-gaap:CommonStockValue
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzktMS0xLTEtMjM4MzY5_4602e501-3e7c-4377-be5d-6c22201dc8f7"
      unitRef="usd">8100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfMzktMy0xLTEtMjM4MzY5_c741708c-fe58-4b03-b3e1-0f1aca65d8e9"
      unitRef="usd">8100000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDAtMS0xLTEtMjM4MzY5_e50b89dc-3af1-46ee-a866-bdeac7e06307"
      unitRef="usd">47700000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDAtMy0xLTEtMjM4MzY5_bdad204c-3357-4d97-bd08-e491734209c2"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDEtMS0xLTEtMjM4MzY5_426d4ec6-0852-4d0a-b963-c96e4ab7b537"
      unitRef="usd">10729900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDEtMy0xLTEtMjM4MzY5_fe1f089b-ce87-45f0-b39e-8e3221c42980"
      unitRef="usd">10581700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDMtMS0xLTEtMjM4MzY5_98741ea6-527b-4b1a-8bae-c2a0d48da75c"
      unitRef="usd">-444200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDMtMy0xLTEtMjM4MzY5_d9f795c6-3d04-4c60-b8af-f16a0fba4201"
      unitRef="usd">-493200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDQtMS0xLTEtMjM4MzY5_e97dc8a5-1168-475e-812b-3372d1eeb732"
      unitRef="usd">10341500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDQtMy0xLTEtMjM4MzY5_94af5ced-a439-4ede-90b6-56ad2b8da5df"
      unitRef="usd">10096600000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDUtMS0xLTEtMjM4MzY5_352dd746-9e6c-4ffa-889f-372ee7dc3a40"
      unitRef="usd">20200000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xMC9mcmFnOjg2YTA4NGFiZTg3NTRiODE5MDc3MWEzZmZiNzczZGNjL3RhYmxlOjBjMWI4OTM5NGNlMTQ4ZDRiZDdmZGY5ZGRmZjFiYjVmL3RhYmxlcmFuZ2U6MGMxYjg5Mzk0Y2UxNDhkNGJkN2ZkZjlkZGZmMWJiNWZfNDUtMy0xLTEtMjM4MzY5_36284955-833f-4f98-a3a5-f252363ca46a"
      unitRef="usd">20155100000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMi0xLTEtMS0yMzgzNjk_369b8453-d730-4803-bf70-d636b0fe83ef"
      unitRef="usd">3777900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMi0zLTEtMS0yMzgzNjk_aa3ce91d-3d1e-45ff-973d-668aed4d42f1"
      unitRef="usd">3899600000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMy0xLTEtMS0yMzgzNjk_e22633fc-a2e5-4e2e-be81-4c857879a8e2"
      unitRef="usd">2803200000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMy0zLTEtMS0yMzgzNjk_5ec0b594-8b4b-4835-8b9f-705647780fe6"
      unitRef="usd">2666700000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNS0xLTEtMS0yMzgzNjk_5c037f6b-dfbf-4e17-972a-1d065c1b82b8"
      unitRef="usd">974700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNS0zLTEtMS0yMzgzNjk_754c428b-d51f-407d-a589-66e31d811ca2"
      unitRef="usd">1232900000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNi0xLTEtMS0yMzgzNjk_6c2daf85-8d87-4540-ab67-cbd1429621c5"
      unitRef="usd">553600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNi0zLTEtMS0yMzgzNjk_cb121834-85d1-4a23-8247-5588f43d34a4"
      unitRef="usd">464100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNy0xLTEtMS0yMzgzNjk_d3eda484-b617-4c49-8f40-8e75bc647613"
      unitRef="usd">69300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfNy0zLTEtMS0yMzgzNjk_fbc0b55f-ed63-405c-b4fd-cb9a3b4df906"
      unitRef="usd">67100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AssetImpairmentCharges
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfOC0xLTEtMS0yMzgzNjk_2aa6015a-db05-4d15-985f-9eafa32d79ac"
      unitRef="usd">2200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfOC0zLTEtMS0yMzgzNjk_79b9cb87-bb7f-4690-aae9-e6b40715cb27"
      unitRef="usd">1200000</us-gaap:AssetImpairmentCharges>
    <lh:NetRestructuringAndOtherSpecialCharges
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfOS0xLTEtMS0yMzgzNjk_b3e5d702-4364-4bba-9c6f-97e359c787ad"
      unitRef="usd">8600000</lh:NetRestructuringAndOtherSpecialCharges>
    <lh:NetRestructuringAndOtherSpecialCharges
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfOS0zLTEtMS0yMzgzNjk_293946ea-df77-482c-a13b-266c3d001335"
      unitRef="usd">12600000</lh:NetRestructuringAndOtherSpecialCharges>
    <us-gaap:OperatingIncomeLoss
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTAtMS0xLTEtMjM4MzY5_21733e62-2668-4398-80e0-caefce9949c0"
      unitRef="usd">341000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTAtMy0xLTEtMjM4MzY5_69d0f994-4695-43a7-a332-12395d43e57d"
      unitRef="usd">687900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTItMS0xLTEtMjM4MzY5_9520b222-ed12-4981-a6e5-4915820fc912"
      unitRef="usd">50700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTItMy0xLTEtMjM4MzY5_94f3eac4-0b07-40ce-a934-3d640504f78e"
      unitRef="usd">42200000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTMtMS0xLTEtMjM4MzY5_c6fae561-55a4-4b30-8b91-5b44a3cec26d"
      unitRef="usd">-2100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTMtMy0xLTEtMjM4MzY5_5f861015-9aac-494d-9cf1-561ce8412ca9"
      unitRef="usd">3400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeNet
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTQtMS0xLTEtMjM4MzY5_279a6756-3fd3-4c11-978e-cafd867ce2cd"
      unitRef="usd">2200000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTQtMy0xLTEtMjM4MzY5_b0f8353e-2f5f-46e0-b46a-c688657ab865"
      unitRef="usd">1100000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTUtMS0xLTEtMjM4MzY5_4ff8f83c-2798-4314-a8bd-f99a7af96d51"
      unitRef="usd">-12600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTUtMy0xLTEtMjM4MzY5_6277ff44-1087-47c1-8a58-39ba49136dfc"
      unitRef="usd">-10100000</us-gaap:OtherNonoperatingIncomeExpense>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTYtMS0xLTEtMjM4MzY5_e8843dbf-d5c9-4f5a-b0dd-b4ebf0262932"
      unitRef="usd">277800000</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTYtMy0xLTEtMjM4MzY5_cfde7190-a018-43a0-a8c5-c21cf1fcfbda"
      unitRef="usd">640100000</lh:IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTctMS0xLTEtMjM4MzY5_44166eb4-c4ec-4069-a0a7-38425bb2d825"
      unitRef="usd">64500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTctMy0xLTEtMjM4MzY5_eeb01a2f-ff94-484f-bef7-b9d6c91523b0"
      unitRef="usd">148000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTgtMS0xLTEtMjM4MzY5_6205f042-2220-4aa6-bbea-e5a0a0500a87"
      unitRef="usd">213300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTgtMy0xLTEtMjM4MzY5_a63989ee-c326-4906-bb71-11117e62326e"
      unitRef="usd">492100000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTktMS0xLTEtMjM4MzY5_c15ba9f6-d78a-43fb-85ff-94b5cbdf5ffd"
      unitRef="usd">400000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMTktMy0xLTEtMjM4MzY5_fdfa2dee-6098-403a-be6a-6c5039de3b64"
      unitRef="usd">500000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjAtMS0xLTEtMjM4MzY5_3d10a62f-c72c-432c-ae2a-e90d3d14df4f"
      unitRef="usd">212900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjAtMy0xLTEtMjM4MzY5_2be8501a-14f9-4fc1-bd58-469f63e50c1b"
      unitRef="usd">491600000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjItMS0xLTEtMjM4MzY5_ea478cd5-02c4-4281-9249-3535120d4075"
      unitRef="usdPerShare">2.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjItMy0xLTEtMjM4MzY5_8c01b0e9-f1de-4155-b567-c3f5abaaf126"
      unitRef="usdPerShare">5.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjMtMS0xLTEtMjM4MzY5_6ddeace1-55d8-4c78-a737-9b918316e239"
      unitRef="usdPerShare">2.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xNi9mcmFnOjcyY2JjYjE0Yzg3ZDRlNWFiNTFjZjI0MGE0MmU1NTg5L3RhYmxlOjc4NmY1YTMxOTI2MTRjYjI4OWVjZTNiYmJmMDM3YmE3L3RhYmxlcmFuZ2U6Nzg2ZjVhMzE5MjYxNGNiMjg5ZWNlM2JiYmYwMzdiYTdfMjMtMy0xLTEtMjM4MzY5_767b4875-572e-4538-b6b5-edfaa52100a8"
      unitRef="usdPerShare">5.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMy0xLTEtMS0yMzgzNjk_c4ab6d5d-a2d7-419c-84f3-a0ae44a0fef3"
      unitRef="usd">213300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMy0zLTEtMS0yMzgzNjk_76776216-83b7-4856-becf-4478f9ddb90a"
      unitRef="usd">492100000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNC0xLTEtMS0yMzgzNjk_05941122-031a-43dc-99f1-41b46e535203"
      unitRef="usd">48100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNC0zLTEtMS0yMzgzNjk_40eefe92-f128-41d5-988c-75a187d1cabe"
      unitRef="usd">-74600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNS0xLTEtMS0yMzgzNjk_36ea3806-9f3a-412c-be3b-b99173940cf5"
      unitRef="usd">-1200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNS0zLTEtMS0yMzgzNjk_947f7478-2ee5-4105-80e3-92369bf58749"
      unitRef="usd">-2200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNy0xLTEtMS0yMzgzNjk_a77ae78f-d714-4b08-9262-e746b7a7af86"
      unitRef="usd">49300000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfNy0zLTEtMS0yMzgzNjk_0f1519d8-913e-4474-ae46-79df958793ab"
      unitRef="usd">-72400000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfOC0xLTEtMS0yMzgzNjk_0e21b5ed-5f76-4789-81e7-2d39cbbac4fc"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfOC0zLTEtMS0yMzgzNjk_199897c3-6ba7-483e-8c65-6fd5cfb66da8"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfOS0xLTEtMS0yMzgzNjk_3c3fc37f-8c76-420a-a907-e76671a4aa31"
      unitRef="usd">49000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfOS0zLTEtMS0yMzgzNjk_0e0ad227-9cdc-463d-8e2b-5db2ad0351b1"
      unitRef="usd">-73000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTAtMS0xLTEtMjM4MzY5_1de9d237-abff-4364-9a12-25766018ed20"
      unitRef="usd">262300000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTAtMy0xLTEtMjM4MzY5_8b6a6b27-1b0d-48e7-8d16-bb9734f44fd5"
      unitRef="usd">419100000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTEtMS0xLTEtMjM4MzY5_140675ad-f836-4fa6-8be5-d2313562abfd"
      unitRef="usd">400000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTEtMy0xLTEtMjM4MzY5_24f781f7-129c-41c0-859c-334564614273"
      unitRef="usd">500000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTItMS0xLTEtMjM4MzY5_f18f979d-5869-41c0-9b56-96a39cff36fe"
      unitRef="usd">261900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8xOS9mcmFnOmJhNzA5ZmM3YzdjODQ1NmZhMTlkZGRiYzcyN2RmM2MyL3RhYmxlOmQxMjdmZDdkMmMxZTQ4OWQ5ODc4NGVlMzYyZmMyNTExL3RhYmxlcmFuZ2U6ZDEyN2ZkN2QyYzFlNDg5ZDk4Nzg0ZWUzNjJmYzI1MTFfMTItMy0xLTEtMjM4MzY5_fc0abf22-515f-454a-91fe-c0705072376e"
      unitRef="usd">418600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i592357016e3744b0843e011607824ca7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtMS0xLTEtMjM4MzY5_ac9d379b-f773-49c0-88f2-c5d070d1dce5"
      unitRef="usd">8500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7b2a106b08c45d985ad0f96dfe28f03_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtMy0xLTEtMjM4MzY5_8d3732ae-6ce6-4a90-85ab-38b28ba85d23"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b88c64ad7e840059120244f7ab99191_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtNS0xLTEtMjM4MzY5_fe0335bc-be6d-4e48-8758-0edea5910bc0"
      unitRef="usd">10456800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iab0be29e60e441bcb12bb35cda780ac7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtNy0xLTEtMjM4MzY5_8a79c1c3-83b2-4a13-90e9-a724e7ef7d33"
      unitRef="usd">-191900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i23a3cf3470c541cc9a118ee99a72dc93_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjYtOS0xLTEtMjM4MzY5_74d3fe84-4d82-4840-be85-a2c32edbe61c"
      unitRef="usd">10273400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctMS0xLTEtMjM4MzY5_48910792-e685-4a99-bfc3-54967a089d81"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctMy0xLTEtMjM4MzY5_7791c603-0989-4c74-8be2-098b5df4ca4a"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctNS0xLTEtMjM4MzY5_7cecab3a-68fa-43d3-88d8-4a0b20bc6edb"
      unitRef="usd">491600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctNy0xLTEtMjM4MzY5_d9e1de2f-9ac7-4437-9884-1a551401f3b0"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjctOS0xLTEtMjM4MzY5_7f96201d-ddc0-4c11-b3ea-206baa681c1f"
      unitRef="usd">491600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtMS0xLTEtMjM4MzY5_7fd037ef-cff3-4bf6-951a-df019188a84d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtMy0xLTEtMjM4MzY5_5ab4bf69-bb56-417a-82ae-786676c74ed6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtNS0xLTEtMjM4MzY5_0b84f6c5-15fa-41c6-a73b-1f316e165f0e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtNy0xLTEtMjM4MzY5_1507df1c-3496-4500-81e3-5eaf87c39bed"
      unitRef="usd">-73000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjgtOS0xLTEtMjM4MzY5_b8753ec0-d341-4ef6-900f-6ac9b344e4bf"
      unitRef="usd">-73000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktMS0xLTEtMjM4MzY5_57a51057-0aca-46ff-956d-d4aa125e1840"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktMy0xLTEtMjM4MzY5_7fb2fba7-e4ac-4dd6-9981-3e7e543f73fa"
      unitRef="usd">18200000</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktNS0xLTEtMjM4MzY5_c58a7a20-4328-44b6-865a-f017b89bc509"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktNy0xLTEtMjM4MzY5_d8761cd1-222c-45f6-b154-ecfd8c526689"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMjktOS0xLTEtMjM4MzY5_2492fbfd-1605-4cf1-b727-cb1926f15d4e"
      unitRef="usd">18200000</lh:Issuanceofcommonstockunderemployeeplans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtMS0xLTEtMjM4MzY5_45754e98-35db-411c-9ecf-ba5b67c78d49"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtMy0xLTEtMjM4MzY5_08ff3c1b-f476-4bdb-bccc-6b5624be2a20"
      unitRef="usd">27300000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtNS0xLTEtMjM4MzY5_da20810a-bc9a-47e9-a2ac-bc90f3246d38"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtNy0xLTEtMjM4MzY5_efa0aeb7-20ef-48e7-a2e5-db2e962ad9b5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzAtOS0xLTEtMjM4MzY5_37d55fd9-f37b-4164-bf3f-da2091b55020"
      unitRef="usd">27300000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie7b62c2ee2a3427c810b98d21e5eab48_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtMS0xLTEtMjM4MzY5_d769c8b5-9fff-4cf3-ad64-de0e915cf999"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0898d403f32e450ab5ae1da59ad55c85_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtMy0xLTEtMjM4MzY5_162ac98c-ffaf-4ba2-a768-39b176a92d21"
      unitRef="usd">38200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8e919ac92261428e9543c34107b41625_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtNS0xLTEtMjM4MzY5_e51832b5-65cb-460a-ab1c-2dbe08d5770f"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4507d2dc509d40d2af198db9d5b3da6e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtNy0xLTEtMjM4MzY5_26219922-ae4b-4f26-9d7c-204d4b08af87"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzEtOS0xLTEtMjM4MzY5_f0e22a15-3620-4fa2-ace1-6d16aee8a533"
      unitRef="usd">38200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i7a88e44b8153492fa26e6001e07825e2_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtMS0xLTEtMjM4MzY5_74cd06ba-92d7-4f3f-b7cc-ed7338519847"
      unitRef="usd">8500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d394a1bebee4deb80055b47b3c9939c_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtMy0xLTEtMjM4MzY5_188551d7-b064-4049-a464-0ba722d44326"
      unitRef="usd">29100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee01e81aeb6c470fbf0fa4ce9effd856_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtNS0xLTEtMjM4MzY5_11f707ee-995a-4c0d-b580-f270a77c2939"
      unitRef="usd">10948400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia77d30f9f579417baf43564777a5e162_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtNy0xLTEtMjM4MzY5_3e5ef327-9ad6-40cc-9259-19413462daa7"
      unitRef="usd">-264900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a678436da9f4a5c9f9ed83b04c8b718_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfMzMtOS0xLTEtMjM4MzY5_db70e429-4ae7-4746-920f-51eeae589e4a"
      unitRef="usd">10721100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2e8d94fd31974fedaa85761a4645a643_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctMS0xLTEtMjUxNjEy_ec883339-ec30-4896-a8ba-f4e5ce0c61ab"
      unitRef="usd">8100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2315342e2c9b4bd884f72b1ee5577f16_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctMy0xLTEtMjUxNjEy_224227a7-f5ec-4482-ac3b-6147af9a831b"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4474976eb0346d7aaa75e127d476d81_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctNS0xLTEtMjUxNjEy_0ae375f4-cc81-4fc0-8568-0b0d81c74c2a"
      unitRef="usd">10581700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic4ffa52a16e9418bb2cddabfd8decd27_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctNy0xLTEtMjUxNjEy_50ffc2a6-8faf-4d66-8a1e-a4cf5dfd2736"
      unitRef="usd">-493200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTctOS0xLTEtMjUxNjEy_e7ad4d9f-7aaa-424d-8ed1-b52a1abf416c"
      unitRef="usd">10096600000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtMS0xLTEtMjUxNjM5_25a15823-ab60-4d89-bb98-ed5f7c92a308"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtMy0xLTEtMjUxNjM5_5a0ef232-c565-465c-b51c-4f7239204c0b"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtNS0xLTEtMjUxNjM5_9fb2991b-b72b-4eac-8692-7d2447e5e9d0"
      unitRef="usd">212900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtNy0xLTEtMjUxNjQ4_7ad899aa-fc8d-4913-a1b6-8beeca666f92"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTgtOS0xLTEtMjUxNjQ4_56e96c18-5c72-42f1-9ecc-8a0929ba2bae"
      unitRef="usd">212900000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktMS0xLTEtMjUxNjM5_5aa1d271-78cd-4eb3-accc-0eef36dabd02"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktMy0xLTEtMjUxNjM5_8710cb20-d1ca-46fb-86d8-714f6012ee50"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktNS0xLTEtMjUxNjM5_c7416a51-1585-47b4-8389-cb05ff61ebe6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktNy0xLTEtMjUxNjQ4_c6ca0959-bf2f-4d1f-bd61-c993ff84a869"
      unitRef="usd">49000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNTktOS0xLTEtMjUxNjQ4_e1c2a73c-11da-4958-bbaa-5539c9459d47"
      unitRef="usd">49000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:Dividends
      contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtMS0xLTEtMjUxNjM5_9d03b545-d335-4462-acd8-d4d294ad0771"
      unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtMy0xLTEtMjUxNjM5_1d96d27c-6506-4abd-8ba5-4dfae195abe7"
      unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtNS0xLTEtMjUxNjM5_af401ebc-c977-47c7-af64-1acdeaca8c28"
      unitRef="usd">64700000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtNy0xLTEtMjUxNjQ4_511c8990-e84e-485f-b9c0-9f8fe533ca1a"
      unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjAtOS0xLTEtMjUxNjQ4_27451071-2a52-489e-af0d-af3122e1406c"
      unitRef="usd">64700000</us-gaap:Dividends>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtMS0xLTEtMjUxNjM5_e218f14c-c650-418e-965f-cac49b4b8306"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtMy0xLTEtMjUxNjM5_8a13ae09-826b-4001-a560-83464ee62275"
      unitRef="usd">27600000</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtNS0xLTEtMjUxNjM5_218fb033-0735-4fc1-a372-bd2c39078a76"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtNy0xLTEtMjUxNjQ4_81740c2c-30b9-4ef9-85ce-15fab4a787f0"
      unitRef="usd">0</lh:Issuanceofcommonstockunderemployeeplans>
    <lh:Issuanceofcommonstockunderemployeeplans
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjEtOS0xLTEtMjUxNjQ4_c9dc9220-0009-436d-8a60-f4154313a9df"
      unitRef="usd">27600000</lh:Issuanceofcommonstockunderemployeeplans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItMS0xLTEtMjUxNjM5_13e571f7-625b-4fb6-93e9-9d46cd24c3e7"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItMy0xLTEtMjUxNjM5_b483effe-364c-4042-9a16-3c551f588bec"
      unitRef="usd">20500000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItNS0xLTEtMjUxNjM5_8df56ff1-345c-47b4-9a39-1589a22ec686"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItNy0xLTEtMjUxNjQ4_bd6ee1fd-59bf-4645-b539-bd37aff2dd55"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjItOS0xLTEtMjUxNjQ4_9826db9f-342d-4a58-bd22-c76a51bedc99"
      unitRef="usd">20500000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i53728a9c68e647f3be31aaaa2f94d3d1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtMS0xLTEtMjUxNjM5_2820004a-fb0c-4545-aa56-58ddd6d6faa2"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9fb9145974b84182b1e8adc46ab580dc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtMy0xLTEtMjUxNjM5_36b0bb67-bb6f-4aba-bd22-e27d41d90c16"
      unitRef="usd">40600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia0c0f141460f40e9ad09b787db299c8c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtNS0xLTEtMjUxNjM5_5c76f133-9bc9-49a2-9ba7-a71b0fbaa06f"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i82fb222d072d44719a76345469b56366_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtNy0xLTEtMjUxNjQ4_41defd56-3e77-434c-9ddd-8f2fded3ca6b"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjMtOS0xLTEtMjUxNjQ4_ed26901d-1937-426f-9975-fea3833c663d"
      unitRef="usd">40600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="ie723babf6fae4a8189eb1eb7a43344b8_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtMS0xLTEtMjUxNjM5_95855c6b-230a-482d-acb3-47fdc2058211"
      unitRef="usd">8100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3913ba65e0f24cc486f2b663bc2bfe42_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtMy0xLTEtMjUxNjM5_488e7c3e-b173-41ee-9d83-6a0fb49b514b"
      unitRef="usd">47700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if448ca8645d54e68b69cc0d387de5c41_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtNS0xLTEtMjUxNjM5_ec966341-25e0-421a-b177-e77c03411e59"
      unitRef="usd">10729900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25f54403307748858e4d8146c668ecff_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtNy0xLTEtMjUxNjQ4_7082d30a-74f4-4f3d-a8c5-36f263d3fcec"
      unitRef="usd">-444200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yMi9mcmFnOjg4NzM1ZDBlMTQyZTRkNWE5ZGU4OGRhMWIyYmU0N2NlL3RhYmxlOjUzNjVjZGQ4NGYyNzQwYjZhZDI0MDdmY2M3OWUwNjM4L3RhYmxlcmFuZ2U6NTM2NWNkZDg0ZjI3NDBiNmFkMjQwN2ZjYzc5ZTA2MzhfNjUtOS0xLTEtMjUxNjQ4_be2de5ac-5003-4459-b57e-6c9dbc765af4"
      unitRef="usd">10341500000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMy0xLTEtMS0yMzgzNjk_a9f8d038-07bf-44ab-b9f2-7dc74cf0cfae"
      unitRef="usd">213300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMy0zLTEtMS0yMzgzNjk_e6888685-621d-4926-bc15-d5b33809e91b"
      unitRef="usd">492100000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNS0xLTEtMS0yMzgzNjk_335b84fc-e3f3-4130-8390-fcdc7926dabb"
      unitRef="usd">165900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNS0zLTEtMS0yMzgzNjk_2d3b0c01-3627-463b-a17f-ac693d887e50"
      unitRef="usd">161500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNi0xLTEtMS0yMzgzNjk_5d434139-1cf2-4540-a5ef-2bd20e594896"
      unitRef="usd">40600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNi0zLTEtMS0yMzgzNjk_674ffc8e-86ed-46c4-b3a0-69334d992f7f"
      unitRef="usd">38200000</us-gaap:ShareBasedCompensation>
    <lh:DepreciationAndAmortizationOfLeasedAssets
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNy0xLTEtMS0yMzgzNjk_0f87c6a5-c7e2-4158-a4ae-5d97a1e8c859"
      unitRef="usd">47800000</lh:DepreciationAndAmortizationOfLeasedAssets>
    <lh:DepreciationAndAmortizationOfLeasedAssets
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNy0zLTEtMS0yMzgzNjk_2f6b5880-007a-4f6a-8c5a-e02da02a11f6"
      unitRef="usd">48900000</lh:DepreciationAndAmortizationOfLeasedAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfOC0xLTEtMS0yMzgzNjk_843d8118-14e2-4062-9119-ef6b37f78bcf"
      unitRef="usd">2200000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfOC0zLTEtMS0yMzgzNjk_007fa0f0-56b5-4c02-be7c-74333a4a7dcd"
      unitRef="usd">1200000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfOS0xLTEtMS0yMzgzNjk_1efad66e-c8bb-4ad4-b00f-f895de77d22f"
      unitRef="usd">1800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfOS0zLTEtMS0yMzgzNjk_25f4e116-61db-4b55-a892-8480df9636b6"
      unitRef="usd">-19000000.0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTAtMS0xLTEtMjM4MzY5_84c8f912-172d-4b1d-a6f7-064fa3043912"
      unitRef="usd">5800000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTAtMy0xLTEtMjM4MzY5_335ff882-89e4-49bc-bf81-79f088b0ec36"
      unitRef="usd">-3600000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTItMS0xLTEtMjM4MzY5_9dcda950-eb0b-4f46-823c-154c0f788d50"
      unitRef="usd">117500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTItMy0xLTEtMjM4MzY5_60eb3540-782e-4e0d-9f99-a63ba7ad14df"
      unitRef="usd">-20400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <lh:IncreaseDecreaseinUnbilledContractReceivable
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTMtMS0xLTEtMjM4MzY5_bc3028fc-12ec-4172-8b91-0fe46d27a778"
      unitRef="usd">-91600000</lh:IncreaseDecreaseinUnbilledContractReceivable>
    <lh:IncreaseDecreaseinUnbilledContractReceivable
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTMtMy0xLTEtMjM4MzY5_ba8e6b57-e111-42e4-a2b1-99e4c37f7f42"
      unitRef="usd">84500000</lh:IncreaseDecreaseinUnbilledContractReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTQtMS0xLTEtMjM4MzY5_eb0de0e4-160b-4ffc-829e-f914b686cff7"
      unitRef="usd">10000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTQtMy0xLTEtMjM4MzY5_b6d11ed2-3eb9-4474-8241-a0ec152387b1"
      unitRef="usd">37400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTUtMS0xLTEtMjM4MzY5_9516c02b-d58f-4146-9de5-c14525c6a9f8"
      unitRef="usd">59800000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTUtMy0xLTEtMjM4MzY5_28133372-060f-4f41-a75e-bdc723bb4b93"
      unitRef="usd">41100000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTYtMS0xLTEtMjM4MzY5_f4a247e7-a160-44d0-a479-4204fe9183cf"
      unitRef="usd">-56400000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTYtMy0xLTEtMjM4MzY5_a8adf1fe-1080-4db7-8ed7-018c2011ddbc"
      unitRef="usd">-5500000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTctMS0xLTEtMjM4MzY5_a21e7241-f9bc-44d7-80c2-b827183a6a49"
      unitRef="usd">2500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTctMy0xLTEtMjM4MzY5_8caeea10-d2ea-4ace-9a16-447de077a306"
      unitRef="usd">-2900000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTgtMS0xLTEtMjM4MzY5_0d464420-8122-47ff-89cc-d36673efd593"
      unitRef="usd">-206600000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTgtMy0xLTEtMjM4MzY5_2f50e7b1-370c-448d-a59c-592a6d7ae501"
      unitRef="usd">-212300000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTktMS0xLTEtMjM4MzY5_221a18d7-ef7a-4a81-a538-94c091473776"
      unitRef="usd">121200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMTktMy0xLTEtMjM4MzY5_282bb61e-cbfb-4aa3-90db-7f2ab618a32f"
      unitRef="usd">356000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjEtMS0xLTEtMjM4MzY5_60857ada-0100-4ae3-a548-8d71aa0732b0"
      unitRef="usd">93900000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjEtMy0xLTEtMjM4MzY5_e4957a04-3932-4754-95b9-5701f4376b14"
      unitRef="usd">117200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjItMS0xLTEtMjM4MzY5_bbbf753a-3edb-4135-bcde-7a969525c514"
      unitRef="usd">100000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjItMy0xLTEtMjM4MzY5_6ec2e19c-2788-441e-b93c-2890461d5c46"
      unitRef="usd">1000000.0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjQtMS0xLTEtMjM4MzY5_f11b2967-c313-489c-bb00-5ca5c3135bfc"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjQtMy0xLTEtMjM4MzY5_a28314b5-7096-4d12-830f-dee97f3597b9"
      unitRef="usd">400000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjYtMS0xLTEtMjM4MzY5_839c968b-e618-4af5-8448-9b444d31a9de"
      unitRef="usd">6100000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjYtMy0xLTEtMjM4MzY5_a555a225-504b-41b3-ad9b-a68cab99c522"
      unitRef="usd">2200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjctMS0xLTEtMjM4MzY5_24a81b22-4b25-41cd-8417-c91b86b4f984"
      unitRef="usd">-200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjctMy0xLTEtMjM4MzY5_cce0b451-b34a-45f8-aeac-648a983015c9"
      unitRef="usd">455100000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjgtMS0xLTEtMjM4MzY5_fb9d2aab-ce8d-4aab-84ad-8c818b89b08d"
      unitRef="usd">-99700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMjgtMy0xLTEtMjM4MzY5_44fa54b9-60b3-4fd4-baec-08b863788033"
      unitRef="usd">-573100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzQtMS0xLTEtMjM4MzY5_4433ef98-0343-4e0c-87e1-f56f3d31f9f3"
      unitRef="usd">827900000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzQtMy0xLTEtMjM4MzY5_0816a619-6e42-477d-88ef-d9639ce41cbf"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzUtMS0xLTEtMjM4MzY5_8b760ad6-3914-4e9b-a5ec-b7d6ceb6f8ca"
      unitRef="usd">827900000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzUtMy0xLTEtMjM4MzY5_445094ce-f552-49c7-bd61-025e554d1d81"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzgtMS0xLTEtMjM4MzY5_f5a106f6-bf72-4979-9539-332515863429"
      unitRef="usd">20500000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzgtMy0xLTEtMjM4MzY5_3c738481-a29a-4284-8d2e-46b8092952ae"
      unitRef="usd">27300000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lh:NetProceedsFromIssuanceOfStockToEmployees
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzktMS0xLTEtMjM4MzY5_23432aef-3a6a-44e7-b312-46ae0215d62f"
      unitRef="usd">27600000</lh:NetProceedsFromIssuanceOfStockToEmployees>
    <lh:NetProceedsFromIssuanceOfStockToEmployees
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfMzktMy0xLTEtMjM4MzY5_5acb0934-6968-496c-8c4a-4bde038cbf82"
      unitRef="usd">18200000</lh:NetProceedsFromIssuanceOfStockToEmployees>
    <us-gaap:PaymentsOfDividends
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDAtMS0xLTEtMjM4MzY5_0e84a35f-5d59-492a-bc90-b36d60de4c25"
      unitRef="usd">64400000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDAtMy0xLTEtMjM4MzY5_a35bec01-c2cb-42af-af47-47b3a840d394"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <lh:OtherFinancingCashFlows
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDItMS0xLTEtMjM4MzY5_4e564440-5e2a-45c9-831f-69c8d2b98ae0"
      unitRef="usd">3300000</lh:OtherFinancingCashFlows>
    <lh:OtherFinancingCashFlows
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDItMy0xLTEtMjM4MzY5_cc2edcc2-dd6a-4d14-852a-8a1e2f3db38f"
      unitRef="usd">8600000</lh:OtherFinancingCashFlows>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDMtMS0xLTEtMjM4MzY5_322fb725-3895-43e1-9d29-d940e9ca8ee9"
      unitRef="usd">-60600000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDMtMy0xLTEtMjM4MzY5_ffe1c7d9-0019-41cf-9061-55012c4a120f"
      unitRef="usd">-17700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDQtMS0xLTEtMjM4MzY5_5da30d5d-2efa-4ce7-b5a4-a5545e9d4c92"
      unitRef="usd">3000000.0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDQtMy0xLTEtMjM4MzY5_841995cc-15f7-4b04-96f8-94f85766c393"
      unitRef="usd">-4400000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDUtMS0xLTEtMjM4MzY5_fcedd8fa-692f-411b-a5b5-0c6e82841079"
      unitRef="usd">-36100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDUtMy0xLTEtMjM4MzY5_9ec42451-0bc9-4aff-96ba-dba64046fed6"
      unitRef="usd">-239200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDYtMS0xLTEtMjM4MzY5_64f6ec12-76c4-4ddf-9d92-80acd128e3a1"
      unitRef="usd">430000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i23a3cf3470c541cc9a118ee99a72dc93_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDYtMy0xLTEtMjM4MzY5_a76a1c15-d4c9-47e5-a9fa-91583a22546c"
      unitRef="usd">1472700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDgtMS0xLTEtMjM4MzY5_0b19432a-67e4-4af1-9157-317c2ddc5735"
      unitRef="usd">393900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7a678436da9f4a5c9f9ed83b04c8b718_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8yNS9mcmFnOjc3ODdiMDU2YzgyMDQwNDI4YjU4NjdjMTNhMGQ3MzZkL3RhYmxlOjJkMWZiYTNmNmUzMjQyZDdhYzA3MTM4NDQ2ODRkYTc3L3RhYmxlcmFuZ2U6MmQxZmJhM2Y2ZTMyNDJkN2FjMDcxMzg0NDY4NGRhNzdfNDgtMy0xLTEtMjM4MzY5_074fbcc3-f248-47b1-b901-e65d30b7cd65"
      unitRef="usd">1233500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfNTM1OQ_9665d897-7993-471a-82e5-1eb1d42b4860">BASIS OF FINANCIAL STATEMENT PRESENTATION&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Holdings (Labcorp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its strong diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, see Note 11 (Business Segment Information) to the Condensed Consolidated Financial Statements. During the three months ended March&#160;31, 2023, Dx and DD contributed approximately 63% and 37%, respectively, of revenues to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 28, 2022, the Company announced that its board of directors authorized the Company to pursue a spin-off of its wholly owned Clinical Development and Commercialization Services business, which includes parts of its DD segment focused on providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations. The planned spin-off will result in two independent, publicly traded companies. The spin-off is intended to be a tax-free transaction to the Company and its stockholders for United States (U.S.) federal income tax purposes and is expected to be effected through a dividend of the Clinical Development business&#x2019; shares to the Company's shareholders. The Company anticipates that, consistent with any applicable legal and tax requirements, there will be ongoing transitional and commercial arrangements to provide for a seamless delivery of services to the customers and other stakeholders of the independent companies following the spin-off. The Company is targeting completion of the spin-off with an accelerated timeframe of mid-2023. The spin-off will be subject to the satisfaction of certain customary conditions, including, among others, the receipt of final approval by the Company's board of directors, the receipt of appropriate assurances regarding the tax-free nature of the separation, and the effectiveness of any required filings with the U.S. Securities and Exchange Commission (SEC). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20.0% and no representation on the investee's board of directors) are accounted for at fair value, or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the  condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#x201c;Accumulated other comprehensive income (loss).&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company&#x2019;s fiscal year 2022 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s Annual Report.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfNTM2MQ_9e0b4416-3ef0-4c33-b07b-8c2ca2d63ec8">BASIS OF FINANCIAL STATEMENT PRESENTATION&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Holdings (Labcorp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its strong diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, see Note 11 (Business Segment Information) to the Condensed Consolidated Financial Statements. During the three months ended March&#160;31, 2023, Dx and DD contributed approximately 63% and 37%, respectively, of revenues to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 28, 2022, the Company announced that its board of directors authorized the Company to pursue a spin-off of its wholly owned Clinical Development and Commercialization Services business, which includes parts of its DD segment focused on providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations. The planned spin-off will result in two independent, publicly traded companies. The spin-off is intended to be a tax-free transaction to the Company and its stockholders for United States (U.S.) federal income tax purposes and is expected to be effected through a dividend of the Clinical Development business&#x2019; shares to the Company's shareholders. The Company anticipates that, consistent with any applicable legal and tax requirements, there will be ongoing transitional and commercial arrangements to provide for a seamless delivery of services to the customers and other stakeholders of the independent companies following the spin-off. The Company is targeting completion of the spin-off with an accelerated timeframe of mid-2023. The spin-off will be subject to the satisfaction of certain customary conditions, including, among others, the receipt of final approval by the Company's board of directors, the receipt of appropriate assurances regarding the tax-free nature of the separation, and the effectiveness of any required filings with the U.S. Securities and Exchange Commission (SEC). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20.0% and no representation on the investee's board of directors) are accounted for at fair value, or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any significant variable interest entities or special purpose entities whose financial results are not included in the  condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the period.&#160;Resulting translation adjustments are included in &#x201c;Accumulated other comprehensive income (loss).&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company&#x2019;s fiscal year 2022 Annual Report on Form 10-K (Annual Report). Therefore, these interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s Annual Report.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <lh:PercentofRevenueContributed
      contextRef="i2c104cf850a34b9ab0663d78cddac33d_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfODEw_041b77a0-4a8a-4385-a9f4-197f7fec87fa"
      unitRef="number">0.63</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3605655f09a54bc3b18dc7d96c8a489b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfODE3_1171acb8-181c-456f-a780-d7c0249df845"
      unitRef="number">0.37</lh:PercentofRevenueContributed>
    <lh:CostMethodInvestmentsMaximumOwnershipPercentage
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zMS9mcmFnOjgyYzRhMWJmM2UxMDQwZmVhYmRiYTkxYjk5MmQ3YmI1L3RleHRyZWdpb246ODJjNGExYmYzZTEwNDBmZWFiZGJhOTFiOTkyZDdiYjVfMjg4MQ_ba4cad39-b299-436e-a0de-c9b762d70f2b"
      unitRef="number">0.200</lh:CostMethodInvestmentsMaximumOwnershipPercentage>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjMzMw_d0d6a130-4c1a-4ca2-ab7c-98c29e3590f9">REVENUES&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues by segment and by payers/customer groups for the three months ended March&#160;31, 2023, and 2022, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total Dx revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical, biotechnology and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues in the U.S. were $2,959.2 (78.3%) and $3,000.5 (76.9%) for the three months ended March&#160;31, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;DD Contract costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DD incurs costs to fulfill contracts with customers. Contract fulfillment costs include software implementation costs and setup costs for certain market access solutions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales commission assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization related to sales commission assets and associated payroll taxes for the three months ended March&#160;31, 2023, and 2022, was $8.4 and $7.2, respectively. Amortization related to deferred contract fulfillment costs for the three months ended March&#160;31, 2023, and 2022, was $2.4 and $3.1, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;Accounts Receivable, Unbilled Services and Unearned Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about accounts receivable, unbilled services, and unearned revenue from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,131.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less DD allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,344.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,222.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less reserve for unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized during the period that were included in the unearned revenue balance at the beginning of the period were $165.3 and $163.8 for the three months ended March&#160;31, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Loss Rollforward&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. The rollforward for the allowance for credit losses for the three months ended March&#160;31, 2023, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unbilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Note and Other Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus, credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less, write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit loss expense in the first quarter primarily related to the the collection risk from several biotech receivable balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Obligations Under Long-Term Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term contracts at the Company consist primarily of fully managed clinical studies within DD. The amount of existing performance obligations unsatisfied under such long-term contracts were $4,720.0 as of March&#160;31, 2023. DD expects to recognize approximately 30.0% of the remaining performance obligations as of March 31, 2023, as revenue over the next 12 months. DD's long-term contracts generally range from 1 to 8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within DD, revenues of $10.4 and $31.7 were recognized during the three months ended March&#160;31, 2023 and 2022, respectively, from performance obligations that were satisfied in previous periods. This revenue primarily relates to adjustments related to changes in scope in full service clinical studies, and to a lesser extent, changes in estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjMyMw_cf702533-437b-47b8-b3a0-d13c6497840a">&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues by segment and by payers/customer groups for the three months ended March&#160;31, 2023, and 2022, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total Dx revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical, biotechnology and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues in the U.S. were $2,959.2 (78.3%) and $3,000.5 (76.9%) for the three months ended March&#160;31, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;DD Contract costs&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <lh:PercentofRevenueContributed
      contextRef="i9295a7e1205642f8b24132fc40048aeb_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0xLTEtMS0yMzgzNjk_e93b980e-1f10-42c2-acab-d8fc63ab7d90"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4ede9219684c4c19ac6c4f99ed4deac1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0zLTEtMS0yMzgzNjk_985e2780-7c44-4736-89c9-42cf402c351e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie24b2776ffcf4549877584c826d752c8_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC01LTEtMS0yMzgzNjk_99e06267-dab3-4f50-af8d-44521d960236"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i420fa3c3695d41f8bc45444f2f622072_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC03LTEtMS0yMzgzNjk_f9d38692-70be-413b-8483-d647e03b4acc"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibb964f0c745b4194b5a6bef32f88de19_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC05LTEtMS0yMzgzNjk_bc22249a-3171-4c52-8333-a5e07a672134"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i9484d4c8e1854e87b159b80a497984f0_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0xMS0xLTEtMjM4MzY5_7bc0dd3c-bf11-4b83-85ea-a9aae8b1a689"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie1165052aa834b059bcaad7ef272c1a1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0xMy0xLTEtMjM4MzY5_e207c2ed-ed09-42d0-861e-b3786f8fba54"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie2c1b84276324a28b731ff53e9def3cd_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNC0xNS0xLTEtMjM4MzY5_97219afe-54b9-4638-a426-8f7ef49bfb4a"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i763ecc59a2844e22891e55687fd0a3d7_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0xLTEtMS0yMzgzNjk_705d7302-289b-497f-9281-48776f326e52"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i53c76d8608624e4787674cc6ed63818e_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0zLTEtMS0yMzgzNjk_bc785a56-748c-42a0-88f8-851cef6222c6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie12432610ca742daadc4501b48c54075_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS01LTEtMS0yMzgzNjk_59496cc2-8a65-45b3-9341-1d25a9371159"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1a6cf78d4b3f4e31be29df0ab4867707_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS03LTEtMS0yMzgzNjk_e2f92deb-2620-4ee5-a3b9-996548914b23"
      unitRef="number">0.08</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ib6850c8d1a9b4abf91d4f9240163b33f_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS05LTEtMS0yMzgzNjk_bbe3b56e-91bb-4414-80b7-a5dbdd9d8b6d"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="icacac42c54284702ac2e69d39cc15335_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0xMS0xLTEtMjM4MzY5_fb43457b-df26-45bd-91dc-ec9b20b936a5"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7fe6cefd2840440fa73bfb36cce0bd02_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0xMy0xLTEtMjM4MzY5_641edc02-aa56-4c9f-a0ac-4ad1da5cf188"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i729d22ace90f47c0bf2e6fbda82b64d1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNS0xNS0xLTEtMjM4MzY5_5e858270-1d59-4459-88d4-b6d3172b2245"
      unitRef="number">0.05</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i13d3320c4e2540a49733a84c90104543_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0xLTEtMS0yMzgzNjk_f62e2c94-c37c-401b-95c8-9ed789c4a3da"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0b5749f29ed746cdb1f7e7ba300fc7af_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0zLTEtMS0yMzgzNjk_2f5ac677-23a1-4b30-bf7d-9b65814ad1cb"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i93500e8506494c54ae50c563bf13de61_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi01LTEtMS0yMzgzNjk_cf4ff671-01e9-4320-9a03-d0acdd49e60a"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i06441b394eb04c088df79a7c58d41d8a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi03LTEtMS0yMzgzNjk_8788e188-7b45-494c-91a6-8d79f2f9ac60"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if2145777bf514c2e9428b3441b58838b_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi05LTEtMS0yMzgzNjk_5e3ca03c-0afb-4f0e-a406-c573ce7bdc7f"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iacd5ed46262f4edaa5d4b50ba7ade997_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0xMS0xLTEtMjM4MzY5_fcb1fc6c-9079-489a-afec-5c77fa5fc6f8"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i584d55d88fdb45efa9af2b586e5f217a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0xMy0xLTEtMjM4MzY5_7624f1b1-2ac2-496a-b99b-d029e81233aa"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0f171369cd5d4f90a4563adeddadf605_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNi0xNS0xLTEtMjM4MzY5_33b7a07b-f6f7-4a98-ad43-693599605159"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ie99422763a4d440c9debb245667d5c41_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0xLTEtMS0yMzgzNjk_ea5baf6b-3269-4bb7-9dd2-b37c177edb6b"
      unitRef="number">0.31</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i59328318fd8940bd8ba57a503380a716_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0zLTEtMS0yMzgzNjk_cce1129d-6c98-4d7f-9051-0f57c1bbb707"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4dd2467eb6a74cf5b4b1a1777f3e3c55_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy01LTEtMS0yMzgzNjk_845421b6-ebe3-4a2c-826b-26b768e856a3"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8926ca56ad6743998548a7c630959f43_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy03LTEtMS0yMzgzNjk_31b077d6-1795-4eca-9c1f-8edd7ed17fb7"
      unitRef="number">0.31</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i83ad11debbb84aae9ca83d5b2709beed_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy05LTEtMS0yMzgzNjk_1d26389d-3ec4-4e72-b8c0-0a145efce454"
      unitRef="number">0.35</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i32d7e51ee9b74366914cac24045ae494_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0xMS0xLTEtMjM4MzY5_18f99e4f-b069-42dd-9c8c-edb1378ada30"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1155708282e748aaaff745d85150e533_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0xMy0xLTEtMjM4MzY5_487eb275-bc14-4e17-a303-876b7cdc582b"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2ca751f2ef6a46ceac258b5c894deab2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfNy0xNS0xLTEtMjM4MzY5_b96b8492-8da0-44be-bba5-4f747a11a586"
      unitRef="number">0.35</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id7f05b08fb1b4715baffe092dc0385b6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0xLTEtMS0yMzgzNjk_55891094-d773-402f-9d41-12a314c7a517"
      unitRef="number">0.63</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if082ac4f47484ed49056b4d69e51b488_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0zLTEtMS0yMzgzNjk_3bdbf66c-1f82-4711-95df-d570ac7a5718"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia692ca467d2b4ff09e04d7def5d0b93e_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC01LTEtMS0yMzgzNjk_3ea305d8-0b7a-4ec4-9431-2ce2cf4aa0cc"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i59031632d0a84142b11e9d2945f5de0f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC03LTEtMS0yMzgzNjk_b719701b-8aae-4761-8929-304d744f8237"
      unitRef="number">0.63</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia39e375cc4ad48c9a8271a3d25fb7540_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC05LTEtMS0yMzgzNjk_5b19dd0f-2dfd-40d5-993e-35079ff1ce77"
      unitRef="number">0.63</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id173b34dc6f448f8b51cff3f364679f9_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0xMS0xLTEtMjM4MzY5_d47a6331-0e4b-414e-bdba-d431572a697b"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if123dbe50a0b4e038bf1d42c09d499b9_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0xMy0xLTEtMjM4MzY5_9a026829-4d3c-4310-9e50-bdd5b6b55396"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i740b7ad7e54746128e1e05e9e772c494_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfOC0xNS0xLTEtMjM4MzY5_d8e1e4e5-40d2-4203-b60c-f687bd107e88"
      unitRef="number">0.63</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaf86457793f94a1b89374df236a0d4a9_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMS0xLTEtMjM4MzY5_f43cf01e-f333-4cc0-9cfc-7f0eb89ac175"
      unitRef="number">0.18</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ieed2b69216414061a0dc9a748b771a88_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMy0xLTEtMjM4MzY5_7014660a-8c27-4794-93b2-952b6a7e9a41"
      unitRef="number">0.12</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i96175b5db8d347f9ba27cd093b4b2434_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtNS0xLTEtMjM4MzY5_658f2c1b-cdf8-430e-b2c1-2687dc59938c"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia4bade9216bd42b7ab400fd587eb531b_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtNy0xLTEtMjM4MzY5_4c1702d4-dc57-4bab-9c86-20d823f9297f"
      unitRef="number">0.37</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i737f59dcfb5f48afb10f07bd9e8526be_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtOS0xLTEtMjM4MzY5_f442c1ba-4065-43ca-b04e-67cb0a744ec3"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8d5f0fe941da4ed7a8226c737f6ca3c1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMTEtMS0xLTIzODM2OQ_975bbcf2-e85c-46fe-aeaf-0a8886dbf7bb"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaa1d29b542f64e46af9c4c2e0dd7e139_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMTMtMS0xLTIzODM2OQ_32825379-125b-4863-95a2-a02babb70290"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if2c16890448b482a8f57a9fd32911696_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTQtMTUtMS0xLTIzODM2OQ_822e2be5-98d2-4d31-be07-cf7f22d41b12"
      unitRef="number">0.37</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iff417091e8e144259990a3a8694217a3_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMS0xLTEtMjM4MzY5_0e287b17-6038-4a3c-b682-dfb1de9ab850"
      unitRef="number">0.81</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ib827e60cff174c63b54f562a198031e9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMy0xLTEtMjM4MzY5_dd7f6d95-9773-4585-9df6-3f8b6517737b"
      unitRef="number">0.12</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia4e1b39c14cd47d3a1f23f6197f735e7_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtNS0xLTEtMjM4MzY5_e9d775b2-e463-48ee-ad0e-b3a07cfcc1d1"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtNy0xLTEtMjM4MzY5_20718618-56af-4d5c-8b7b-a3a50baa28c7"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ideec54047acb41c88dff0ba4c5caa519_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtOS0xLTEtMjM4MzY5_811f51a1-70fe-4499-b1f2-ba25dc97f158"
      unitRef="number">0.80</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i088eb4baf0c54c1caafe41e5b7e00385_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMTEtMS0xLTIzODM2OQ_ce4a0c3e-1b2a-4815-8130-4b9ade19a054"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i00562d863b694bb2921bab984ac7c461_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMTMtMS0xLTIzODM2OQ_bcbe7840-ca63-4f42-844c-9b3143ec5dfd"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJkNjAyYzJlZjMyYTRjYjU5ZmRjYzNiYTcyNDA4OTgzL3RhYmxlcmFuZ2U6MmQ2MDJjMmVmMzJhNGNiNTlmZGNjM2JhNzI0MDg5ODNfMTUtMTUtMS0xLTIzODM2OQ_fd5da63a-d740-4458-82d3-0f83674b124b"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <us-gaap:Revenues
      contextRef="id971d73602324ea2bbed87722254241d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTUy_56547218-033e-4d0b-a068-652c35075fa6"
      unitRef="usd">2959200000</us-gaap:Revenues>
    <lh:PercentofRevenueContributed
      contextRef="id971d73602324ea2bbed87722254241d_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTU2_049b11a1-3823-4e94-8768-a6cd4ffb337e"
      unitRef="number">0.783</lh:PercentofRevenueContributed>
    <us-gaap:Revenues
      contextRef="i92fdaba98ae04990b80e40e7597fce48_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTY0_1a7657df-082b-47c2-96bf-5f187f660325"
      unitRef="usd">3000500000</us-gaap:Revenues>
    <lh:PercentofRevenueContributed
      contextRef="i92fdaba98ae04990b80e40e7597fce48_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTY4_3efda136-085c-472c-bf9f-422ca7faa0c1"
      unitRef="number">0.769</lh:PercentofRevenueContributed>
    <us-gaap:CapitalizedContractCostTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjM0MQ_c6f5feae-5b02-4082-bdf1-df48334c92d0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales commission assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CapitalizedContractCostTableTextBlock>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMS0xLTEtMS0yMzgzNjk_9c3a7e2b-984a-4892-94fc-cbd1bcf848dc"
      unitRef="usd">38300000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMS0zLTEtMS0yMzgzNjk_67aa4e54-0f5a-4ecc-afed-6ece4796ecb6"
      unitRef="usd">38200000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMi0xLTEtMS0yMzgzNjk_427284ba-e232-4dab-8ad2-0f90bd0a807b"
      unitRef="usd">14300000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMi0zLTEtMS0yMzgzNjk_2e433b1a-67d9-4993-bda0-25d17436354e"
      unitRef="usd">15000000.0</us-gaap:CapitalizedContractCostNet>
    <us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMy0xLTEtMS0yMzgzNjk_4ef35213-f215-4d4f-ab26-98014ad2fd29"
      unitRef="usd">52600000</us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts>
    <us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjJmNzlmMmYxOTJhYjQzMmViNzU4ZThiODljNmNmY2MzL3RhYmxlcmFuZ2U6MmY3OWYyZjE5MmFiNDMyZWI3NThlOGI4OWM2Y2ZjYzNfMy0zLTEtMS0yMzgzNjk_46f7f606-e09d-4a4e-9efd-a255f3fc9618"
      unitRef="usd">53200000</us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNTcy_1857de03-66b7-4551-963e-fe0b64181689"
      unitRef="usd">8400000</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNTc5_858c0e2f-bbc1-4508-9eba-e3ad2a6ec671"
      unitRef="usd">7200000</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNzQw_973f8db5-12fa-44bb-b633-c8c3ade87017"
      unitRef="usd">2400000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNzQ3_cdf8ca02-f4ff-4c14-ac5a-f5e029c5be8f"
      unitRef="usd">3100000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjMzMQ_33a97cfb-a73d-47fa-85af-d41d60e5e0f1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,131.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less DD allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,344.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,222.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less reserve for unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsReceivableGross
      contextRef="i4435b03d249448678d58b9a5c5fdc669_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMS0xLTEtMS0yMzgzNjk_515b4ffb-6534-4d7f-8885-a1f3188c4154"
      unitRef="usd">1131600000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="i0679350b3d0345839defcd1fbdc1ca18_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMS0zLTEtMS0yMzgzNjk_b72a2d49-529c-4277-af2f-4326d78440dd"
      unitRef="usd">1046900000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="ie379b002992b4ac9a015d0de8f522228_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMi0xLTEtMS0yMzgzNjk_3e8d785e-49e4-4e14-ba3d-b3697828116c"
      unitRef="usd">1266000000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="i8a7d8dea373148a28d09ed326eb7865a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMi0zLTEtMS0yMzgzNjk_83e5dd0c-b1db-42b4-a328-bbeb505b20b5"
      unitRef="usd">1218600000</us-gaap:AccountsReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMy0xLTEtMS0yMzgzNjk_ccdd65e3-4913-4218-863a-74930a07f2fe"
      unitRef="usd">52800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMy0zLTEtMS0yMzgzNjk_1d958d01-5d6a-4c67-9898-a07ec2f91f51"
      unitRef="usd">43500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNC0xLTEtMS0yMzgzNjk_23c3837e-ee62-4888-9917-3831a0f2547e"
      unitRef="usd">2344800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNC0zLTEtMS0yMzgzNjk_4f264459-f1a0-477c-be78-19df2a9fac20"
      unitRef="usd">2222000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNi0xLTEtMS0yMzgzNjk_aa99b03a-ce77-40c0-b215-e14dc5f893f3"
      unitRef="usd">715900000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNi0zLTEtMS0yMzgzNjk_ce1c735f-2f82-4ab3-8824-02a4ebd97fad"
      unitRef="usd">805900000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNy0xLTEtMS0yMzgzNjk_620abd0d-d2d0-4526-830d-f9c3cc9ba0a6"
      unitRef="usd">10800000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfNy0zLTEtMS0yMzgzNjk_0d4a59f6-bc94-4d50-a8ba-f182de956648"
      unitRef="usd">10500000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfOC0xLTEtMS0yMzgzNjk_70a11d5d-1107-491d-bc1c-3850e8e0fa35"
      unitRef="usd">705100000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfOC0zLTEtMS0yMzgzNjk_fecb8b25-9d20-49d5-acbc-b1b20423c6ac"
      unitRef="usd">795400000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMTAtMS0xLTEtMjM4MzY5_d0d607c2-7648-48b3-b12d-00b100dfa774"
      unitRef="usd">586700000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOjk4OTFjOTlmYzRhNzRiY2RhZDUxNTZiNjRkZWVhNTFjL3RhYmxlcmFuZ2U6OTg5MWM5OWZjNGE3NGJjZGFkNTE1NmI2NGRlZWE1MWNfMTAtMy0xLTEtMjM4MzY5_d86f6a14-aecc-457e-a706-2f36734231f1"
      unitRef="usd">582100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTE1MQ_a04c927b-ad2d-41a5-a2b2-dbc85ad60e79"
      unitRef="usd">165300000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTE1OA_3d678459-dd7b-4fba-943a-eccb4ffd791b"
      unitRef="usd">163800000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMjMyNw_100d13dc-c9bb-44bd-8833-016e9e15a2e2">The rollforward for the allowance for credit losses for the three months ended March&#160;31, 2023, is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unbilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Note and Other Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus, credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less, write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMS0xLTEtMS0yMzgzNjk_598061ae-1a36-48ee-b04b-2f91702e9750"
      unitRef="usd">43500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <lh:UnbilledServicesAllowanceforCreditLoss
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMS0zLTEtMS0yMzgzNjk_41ac633d-99e9-4349-aa8e-f34a2d496f6e"
      unitRef="usd">10500000</lh:UnbilledServicesAllowanceforCreditLoss>
    <lh:NoteReceivableAllowanceforCreditLoss
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMS01LTEtMS0yMzgzNjk_573e50c0-af07-4d76-9a3e-e8bdbfe1e042"
      unitRef="usd">700000</lh:NoteReceivableAllowanceforCreditLoss>
    <lh:AllowanceforCreditLoss
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMS03LTEtMS0yMzgzNjk_25370d79-78b0-4536-bb0e-2b0698091fce"
      unitRef="usd">54700000</lh:AllowanceforCreditLoss>
    <lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings
      contextRef="i00f94c3f1730467bb46c0d213ccf9893_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMi0xLTEtMS0yMzgzNjk_73d4b62e-bac9-4b39-bacd-a996aeb0a6e9"
      unitRef="usd">11100000</lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings>
    <lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings
      contextRef="i87c13ae2d4e342baafe38aef77715bf2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMi0zLTEtMS0yMzgzNjk_acb8d37c-f76e-4436-b7f6-d3d69e085431"
      unitRef="usd">0</lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings>
    <lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings
      contextRef="i6958f3490b214ab3abf0a9756949e010_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMi01LTEtMS0yMzgzNjk_d45c62ff-be91-407b-8333-8f169295ce13"
      unitRef="usd">0</lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings>
    <lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfMi03LTEtMS0yMzgzNjk_23033d28-63cc-4dbb-bd6a-113139ecc3c8"
      unitRef="usd">11100000</lh:CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="i00f94c3f1730467bb46c0d213ccf9893_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNC0xLTEtMS0yMzgzNjk_6ec8f6af-7973-4464-b460-18fd0bca4315"
      unitRef="usd">1800000</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="i87c13ae2d4e342baafe38aef77715bf2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNC0zLTEtMS0yMzgzNjk_07ca059e-0129-4e57-9d6a-fd164d8fe963"
      unitRef="usd">300000</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="i6958f3490b214ab3abf0a9756949e010_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNC01LTEtMS0yMzgzNjk_69d81e8c-ec11-4f19-83bd-d95c5f7a70b9"
      unitRef="usd">0</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNC03LTEtMS0yMzgzNjk_05a9ee3b-57cd-46f2-b271-b8045d545783"
      unitRef="usd">1500000</lh:AllowanceforCreditLossWriteOff>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNS0xLTEtMS0yMzgzNjk_0e1a2564-08f3-425b-b2c6-06c76083e7d8"
      unitRef="usd">52800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <lh:UnbilledServicesAllowanceforCreditLoss
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNS0zLTEtMS0yMzgzNjk_0f8a50f2-af45-4eef-89fb-1485399f29e2"
      unitRef="usd">10800000</lh:UnbilledServicesAllowanceforCreditLoss>
    <lh:NoteReceivableAllowanceforCreditLoss
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNS01LTEtMS0yMzgzNjk_9bcbbedd-3f91-47a8-8e25-f6b60074bff1"
      unitRef="usd">700000</lh:NoteReceivableAllowanceforCreditLoss>
    <lh:AllowanceforCreditLoss
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RhYmxlOmUwNDc5OGQzNDgxNjRlNDc4ZGZlNzg2NmU3ZTM4MTkzL3RhYmxlcmFuZ2U6ZTA0Nzk4ZDM0ODE2NGU0NzhkZmU3ODY2ZTdlMzgxOTNfNS03LTEtMS0yMzgzNjk_a62c7c29-0bc5-47db-b4a5-9bcff906cfe5"
      unitRef="usd">64300000</lh:AllowanceforCreditLoss>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTcxMw_cbbc1f28-afb9-47c8-866f-efc7c74ee3a5"
      unitRef="usd">4720000000</us-gaap:RevenueRemainingPerformanceObligation>
    <lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfNTQ5NzU1ODE3MjM4_e39314c6-19c3-4afe-adfd-feb180298739"
      unitRef="number">0.300</lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear>
    <lh:LongTermContractsDurationMinimum
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTkwMA_70ff7c55-2306-4154-b6e1-04ef5638bd0b">P1Y</lh:LongTermContractsDurationMinimum>
    <lh:LongTermContractsDurationMaximum
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTkwNg_a8f3456c-dd72-433e-b6c9-cf420f2675bd">P8Y</lh:LongTermContractsDurationMaximum>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTkzOQ_9e03a111-4bf6-402d-9aa0-0ea8a4747015"
      unitRef="usd">10400000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNC9mcmFnOjdjZjkyOGFkMGU2OTQ0MWFiZjAxMDM2NzBiNGFmN2NmL3RleHRyZWdpb246N2NmOTI4YWQwZTY5NDQxYWJmMDEwMzY3MGI0YWY3Y2ZfMTk0Ng_df353207-455a-4479-9b8d-5a4d43144b39"
      unitRef="usd">31700000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfMjY5MA_526bb2d0-2a2e-44c6-bf73-8eeef4724d9d">BUSINESS ACQUISITIONS During the three months ended March 31, 2023, the Company recorded several measurement period adjustments for 2022 acquisitions, relating to final valuations and deferred tax true-ups. The adjustments include the following:</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMS01LTEtMS0yNjI4MDQ_872e966f-131d-441e-8a40-9c2f76b343a3"
      unitRef="usd">200000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="i5c7c606b647f41e58ee112be251877bf_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfOC01LTEtMS0yMzgzNjk_37f38f4d-b4c9-4067-9b17-16eb0746b3f6"
      unitRef="usd">-30500000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfOS01LTEtMS0yMzgzNjk_63fffa46-1579-4110-a118-6a52aa60952f"
      unitRef="usd">19900000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets
      contextRef="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTEtNS0xLTEtMjM4MzY5_ea52349b-9c49-4d2b-8f99-e848a7e7a545"
      unitRef="usd">-10400000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
      contextRef="i27b2961f942e4288b255e63e16d547a7_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTMtNS0xLTEtMjM4MzY5_cbb4e2f3-2deb-4fee-9d90-a4098ce4a25c"
      unitRef="usd">-8400000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
      contextRef="i2c8e22062d044e07b6b22b1dcd5a0364_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTUtNS0xLTEtMjM4MzY5_1a0691e6-cfc9-4e1a-ac0d-daf2765750c6"
      unitRef="usd">-2000000.0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities
      contextRef="i504bdda230fc4d1ca3f3a04c1430e14f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTgtNS0xLTEtMjM4MzY5_f1465330-334f-4265-a879-777801ce1639"
      unitRef="usd">-10400000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="idb9b1e876bfb460880c08cb5c95f0b7b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOjRkOWE2OWJkYTMzMjQ3ZTM5YTdkNWM1YzdhZmJhZGZiL3RhYmxlcmFuZ2U6NGQ5YTY5YmRhMzMyNDdlMzlhN2Q1YzVjN2FmYmFkZmJfMTktNS0xLTEtMjM4MzY5_b032a5f2-0062-4a64-91d3-6838b74f2ec1"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfMTUxMg_100c3fad-c411-40c2-a66d-37d82b605dae"
      unitRef="usd">455100000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i6d5821a314134dd49949999c2e5b3f19_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfMTczNA_04d7240d-2a96-4b7e-909d-2593654b2c68"
      unitRef="usd">270000000.0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6d5821a314134dd49949999c2e5b3f19_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfMTg0MQ_343d6010-9cfb-476d-bf50-5dd65fb9971c"
      unitRef="usd">286200000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ia20524cf106845889acba917cc6c2f53_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfNTQ5NzU1ODIzMjk1_c1970956-edb9-4007-a875-4dc6df49a180"
      unitRef="usd">136600000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia20524cf106845889acba917cc6c2f53_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfNTQ5NzU1ODIzMjk5_a54cb3b2-2fa4-4c64-9ea8-d3361112aaef"
      unitRef="usd">346800000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i478a2df8586f43a4ac24ced9bb357651_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RleHRyZWdpb246Nzk5MGRkMmIyODhlNDQyNzgwZTVhZDdkNjljNDNkMmZfNTQ5NzU1ODE4MjM2_cbb38c3d-2a13-4157-9486-91c5da814bfe">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOmEyNDE0NmZiNTg1MzRiNWNhZWIyNWE1Y2JjZjdjOWRiL3RhYmxlcmFuZ2U6YTI0MTQ2ZmI1ODUzNGI1Y2FlYjI1YTVjYmNmN2M5ZGJfMi0yLTEtMS0yMzgzNjk_cab04a0c-42a8-4ab6-bae3-a5b12dd92e92"
      unitRef="usd">3943000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF8zNy9mcmFnOjc5OTBkZDJiMjg4ZTQ0Mjc4MGU1YWQ3ZDY5YzQzZDJmL3RhYmxlOmEyNDE0NmZiNTg1MzRiNWNhZWIyNWE1Y2JjZjdjOWRiL3RhYmxlcmFuZ2U6YTI0MTQ2ZmI1ODUzNGI1Y2FlYjI1YTVjYmNmN2M5ZGJfMy0yLTEtMS0yMzgzNjk_0444e29a-33e0-4554-b684-f4f67a9512f4"
      unitRef="usd">490900000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RleHRyZWdpb246ODQxMWZjMjVkOWEzNDhmNWE0NzM5ZmFjZjM5M2Y1OTJfMTI1OA_ac1caa38-10be-4627-b94e-e6218fee883b">EARNINGS PER SHARE&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#x2019;s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:6pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents a reconciliation of basic earnings per share to diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of employee&#160;stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net earnings including impact of dilutive adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RleHRyZWdpb246ODQxMWZjMjVkOWEzNDhmNWE0NzM5ZmFjZjM5M2Y1OTJfMTI0Nw_20f9427a-83ef-4cb3-bcc0-a313f2a7e4ad">&lt;div style="margin-bottom:7.1pt;margin-top:6pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents a reconciliation of basic earnings per share to diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of employee&#160;stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net earnings including impact of dilutive adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC0xLTEtMS0yMzgzNjk_3d10a62f-c72c-432c-ae2a-e90d3d14df4f"
      unitRef="usd">212900000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC0zLTEtMS0yMzgzNjk_b3bf8053-3271-4dd3-ae98-6c40844e5caf"
      unitRef="shares">88400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC01LTEtMS0yMzgzNjk_ea478cd5-02c4-4281-9249-3535120d4075"
      unitRef="usdPerShare">2.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC03LTEtMS0yMzgzNjk_2be8501a-14f9-4fc1-bd58-469f63e50c1b"
      unitRef="usd">491600000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC05LTEtMS0yMzgzNjk_4e232db8-bb8a-404f-bc70-dad43fefa781"
      unitRef="shares">93200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNC0xMS0xLTEtMjM4MzY5_8c01b0e9-f1de-4155-b567-c3f5abaaf126"
      unitRef="usdPerShare">5.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNS0zLTEtMS0yMzgzNjk_b2c1e3ca-00be-4256-b01f-52d3d9fd1892"
      unitRef="shares">600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfNS05LTEtMS0yMzgzNjk_58e9d4fc-5e1f-4fd8-8411-4ba963e75447"
      unitRef="shares">800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC0xLTEtMS0yMzgzNjk_f34ffccf-78df-4cf3-a60b-6ee053fc9b78"
      unitRef="usd">212900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC0zLTEtMS0yMzgzNjk_221c072b-adb7-4036-a115-a50bf8d6df13"
      unitRef="shares">89000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC01LTEtMS0yMzgzNjk_6ddeace1-55d8-4c78-a737-9b918316e239"
      unitRef="usdPerShare">2.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC03LTEtMS0yMzgzNjk_dee4fe6b-830d-430b-9265-3ea37c12dae0"
      unitRef="usd">491600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC05LTEtMS0yMzgzNjk_fcf2f8c2-607a-48ce-b3f2-da358ff53804"
      unitRef="shares">94000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjgwNDAyYWU4NDA3ZjRlNWM4YTczOTExZGJkNmM5OWVlL3RhYmxlcmFuZ2U6ODA0MDJhZTg0MDdmNGU1YzhhNzM5MTFkYmQ2Yzk5ZWVfOC0xMS0xLTEtMjM4MzY5_767b4875-572e-4538-b6b5-edfaa52100a8"
      unitRef="usdPerShare">5.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RleHRyZWdpb246ODQxMWZjMjVkOWEzNDhmNWE0NzM5ZmFjZjM5M2Y1OTJfMTI3OQ_82ed3236-051d-4946-a53a-a4238753408b">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjkzMTM3YjkyYWZmMzRlNzFhMGI5YmU2MTM4Y2VmYmU3L3RhYmxlcmFuZ2U6OTMxMzdiOTJhZmYzNGU3MWEwYjliZTYxMzhjZWZiZTdfMi0xLTEtMS0yMzgzNjk_c4c810b9-ffe0-40f6-93e4-de08fd8b89a1"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80MC9mcmFnOjg0MTFmYzI1ZDlhMzQ4ZjVhNDczOWZhY2YzOTNmNTkyL3RhYmxlOjkzMTM3YjkyYWZmMzRlNzFhMGI5YmU2MTM4Y2VmYmU3L3RhYmxlcmFuZ2U6OTMxMzdiOTJhZmYzNGU3MWEwYjliZTYxMzhjZWZiZTdfMi0zLTEtMS0yMzgzNjk_d024f46d-4089-46d2-989f-2d0d9a9bc0ad"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjIwMQ_500ef434-b290-4103-81db-a4a409ac3741">&lt;div style="margin-bottom:6pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;5.&#160;&#160;&#160;&#160;GOODWILL AND INTANGIBLE ASSETS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,533.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,121.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency impact and other adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,514.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,601.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,116.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill and indefinite-lived intangibles for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, the Company's business could be impacted by unfavorable changes, including those that impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily a worsening economic environment and protracted economic downturn and related impacts, including delays in revenue from new customers; increases in customer termination activity; or increases in operating costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will continue to monitor the financial performance of, and assumptions for, its reporting units. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin, or substantial reductions in end markets and volume assumptions, could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of identifiable intangible assets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,723.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,605.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,118.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,681.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,546.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land use right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,891.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,979.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,912.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,946.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of intangible assets for the three months ended March&#160;31, 2023, and 2022, was $69.3 and $67.1, respectively. The amortization expense for the net carrying amount of intangible assets is estimated to be $206.2 for the remainder of fiscal 2023, $267.5 in fiscal 2024, $255.3 in fiscal 2025, $245.5 in fiscal 2026, $233.9 in fiscal 2027, and $2,141.3 thereafter.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjIxNg_27d5fbeb-6288-4741-a12e-a1b1dda22e33">&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,533.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,121.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency impact and other adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,514.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,601.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,116.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="iea4f8105f7c2473fb04f52c1cf307161_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfMy0xLTEtMS0yMzgzNjk_52c8ed44-aee4-42b9-b6f9-701dff2639ca"
      unitRef="usd">4533500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i367717bee21446d7b41b04f4afdd53da_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfMy01LTEtMS0yMzgzNjk_ca6c3971-8fc5-4792-b814-3d48a856e2ef"
      unitRef="usd">3587500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfMy05LTEtMS0yMzgzNjk_522a8a79-b57c-4449-96be-f612f3abb7cb"
      unitRef="usd">8121000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i59031632d0a84142b11e9d2945f5de0f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOC0xLTEtMS0yMzgzNjk_a5e98b81-749c-4c2e-ae4a-5b82e26ac6e4"
      unitRef="usd">-19200000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ic62e9f64e0a74bcf8ed85655910238e6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOC01LTEtMS0yMzgzNjk_09ec3335-de92-49af-bee3-13cc28e733a1"
      unitRef="usd">14200000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOC05LTEtMS0yMzgzNjk_7bdbf5eb-9af7-45dd-9cdb-d90c973ae9f3"
      unitRef="usd">-5000000.0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i3837e5c114d143df8e230ad612f6111f_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOS0xLTEtMS0yMzgzNjk_6948953d-49ff-433f-ae7f-73fcc083359d"
      unitRef="usd">4514300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifca5e7f0071c4897a17282d5246502a9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOS01LTEtMS0yMzgzNjk_e1131c99-90ad-42da-89ef-62cc81c4f126"
      unitRef="usd">3601700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOjc5OTM4ZmViOTlkMTQzYzg4MjE1NDFkMGNiMzQ4YWJmL3RhYmxlcmFuZ2U6Nzk5MzhmZWI5OWQxNDNjODgyMTU0MWQwY2IzNDhhYmZfOS05LTEtMS0yMzgzNjk_d81aad36-702d-46a3-8ec6-90ae759c4a52"
      unitRef="usd">8116000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjIwMA_744dc634-fe90-466f-a879-4fa8d5102cfd">he components of identifiable intangible assets are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,723.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,605.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,118.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,681.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,546.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land use right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,891.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,979.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,912.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,946.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="icc11c37c41af470b99edcf92d0ddfa5a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi0xLTEtMS0yMzgzNjk_24882a05-61f0-4c38-a570-8530ef287f57"
      unitRef="usd">4723800000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icc11c37c41af470b99edcf92d0ddfa5a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi0zLTEtMS0yMzgzNjk_01bba141-b112-497c-adce-f70329c0f810"
      unitRef="usd">1605400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icc11c37c41af470b99edcf92d0ddfa5a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi01LTEtMS0yMzgzNjk_3431f552-078c-4050-94db-061a786666d5"
      unitRef="usd">3118400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9f25ab7e1594456ab575b107b00dff07_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi03LTEtMS0yMzgzNjk_df01b126-0a7e-4714-bac7-ac640b406f14"
      unitRef="usd">4681100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9f25ab7e1594456ab575b107b00dff07_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi05LTEtMS0yMzgzNjk_c0d7a7b5-8019-414d-8dff-eb2574368c84"
      unitRef="usd">1546400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9f25ab7e1594456ab575b107b00dff07_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMi0xMS0xLTEtMjM4MzY5_a08e7a40-3e9b-4a94-9c64-5cebd5125cda"
      unitRef="usd">3134700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic37cab27c9924e55b43d4eca1de9ed08_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy0xLTEtMS0yMzgzNjk_08190433-ff4c-4253-ba47-990312ede7e0"
      unitRef="usd">574800000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic37cab27c9924e55b43d4eca1de9ed08_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy0zLTEtMS0yMzgzNjk_7187252c-0568-4837-b817-4d9049d7ff1b"
      unitRef="usd">298700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic37cab27c9924e55b43d4eca1de9ed08_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy01LTEtMS0yMzgzNjk_76fd6f6a-ef45-49bb-8c1e-a07c47647205"
      unitRef="usd">276100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i5d2fb16eef474b76b17de5a95e7d2063_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy03LTEtMS0yMzgzNjk_42d2a148-230f-4f4d-b2a2-c95d97912813"
      unitRef="usd">574100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5d2fb16eef474b76b17de5a95e7d2063_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy05LTEtMS0yMzgzNjk_8160bdb5-0057-4961-a43c-c6c1d31422cc"
      unitRef="usd">291100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5d2fb16eef474b76b17de5a95e7d2063_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfMy0xMS0xLTEtMjM4MzY5_6f436950-3dc2-4ec0-9cc1-af60a43dab42"
      unitRef="usd">283000000.0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9f98a37fdff54bff858d9b633c7df6fd_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC0xLTEtMS0yMzgzNjk_cd6cc2e4-8d16-4572-9694-b1c7d1389052"
      unitRef="usd">83400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9f98a37fdff54bff858d9b633c7df6fd_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC0zLTEtMS0yMzgzNjk_9ccb47c7-ed6e-4035-8318-08b625979ba6"
      unitRef="usd">56300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9f98a37fdff54bff858d9b633c7df6fd_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC01LTEtMS0yMzgzNjk_d318997b-6bb0-4b36-89cc-def4b3d19614"
      unitRef="usd">27100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4a694aae86a041dba12584e655a56786_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC03LTEtMS0yMzgzNjk_6b128d53-e233-47d0-8324-d9c50d435462"
      unitRef="usd">86600000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4a694aae86a041dba12584e655a56786_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC05LTEtMS0yMzgzNjk_adfb279c-65be-4c62-b85c-e351d09cc717"
      unitRef="usd">50500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4a694aae86a041dba12584e655a56786_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNC0xMS0xLTEtMjM4MzY5_c3904f3e-89a4-4d35-885a-767e2e974c18"
      unitRef="usd">36100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i79a415a626ce4907ab55886ae221d3b5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS0xLTEtMS0yMzgzNjk_8cd14ce3-b46e-4269-bc97-75d1d8646abc"
      unitRef="usd">16400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i79a415a626ce4907ab55886ae221d3b5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS0zLTEtMS0yMzgzNjk_5259329c-a711-43d6-8b2b-bd5fbfce206f"
      unitRef="usd">4600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i79a415a626ce4907ab55886ae221d3b5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS01LTEtMS0yMzgzNjk_ed730fbb-3181-4236-bf04-32ab62cc1ad5"
      unitRef="usd">11800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i7b7965b44dc64133b06b8e8418e9e63f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS03LTEtMS0yMzgzNjk_667883c7-0dc8-417d-8c17-3c3313718be6"
      unitRef="usd">16400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7b7965b44dc64133b06b8e8418e9e63f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS05LTEtMS0yMzgzNjk_a6f1b7e5-d21c-41ac-ac51-752ba06a38db"
      unitRef="usd">3500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7b7965b44dc64133b06b8e8418e9e63f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNS0xMS0xLTEtMjM4MzY5_685908f9-3a07-4e70-b760-7ae61ae3e94c"
      unitRef="usd">12900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i05b34a492ae347f5a0f4fbab882117b4_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi0xLTEtMS0yMzgzNjk_7721a5f2-fcb3-4a76-968d-7f0d4f7d9b88"
      unitRef="usd">10300000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i05b34a492ae347f5a0f4fbab882117b4_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi0zLTEtMS0yMzgzNjk_a7a5351a-fb29-4159-978c-955d93dea19f"
      unitRef="usd">9000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i05b34a492ae347f5a0f4fbab882117b4_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi01LTEtMS0yMzgzNjk_3ef71b93-87c9-4b96-8e7c-58f80fed1087"
      unitRef="usd">1300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i208b4414a820456bb72360fbc55747f7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi03LTEtMS0yMzgzNjk_2d59c370-d318-48c1-b52e-af6b0f62bc2e"
      unitRef="usd">10300000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i208b4414a820456bb72360fbc55747f7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi05LTEtMS0yMzgzNjk_99103adb-5de0-478c-8514-434b703ef363"
      unitRef="usd">8800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i208b4414a820456bb72360fbc55747f7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNi0xMS0xLTEtMjM4MzY5_ccc21c3a-7d3f-4023-9948-f8f619104f65"
      unitRef="usd">1500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i95b60b6004a24ba48579fb56cf93d751_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy0xLTEtMS0yMzgzNjk_ab633fb5-53c0-46a1-a39a-c4243eb9622d"
      unitRef="usd">468900000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i95b60b6004a24ba48579fb56cf93d751_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy0zLTEtMS0yMzgzNjk_d4e29576-d450-4807-861c-a14c002545a8"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i95b60b6004a24ba48579fb56cf93d751_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy01LTEtMS0yMzgzNjk_a8d67030-f9f2-428e-a360-3f4868bbceb9"
      unitRef="usd">468900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i0cf79c7c336c4856b02a1b0a7ac3802c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy03LTEtMS0yMzgzNjk_ec38a658-5f9b-4de1-85cd-34b930d3c1fb"
      unitRef="usd">468700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0cf79c7c336c4856b02a1b0a7ac3802c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy05LTEtMS0yMzgzNjk_940c9354-56d3-40bd-89a5-ce18398ac250"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0cf79c7c336c4856b02a1b0a7ac3802c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfNy0xMS0xLTEtMjM4MzY5_f85523b0-aaa7-4abf-a32e-d6d5cc6aaf25"
      unitRef="usd">468700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i5bda848179204f8dbc6ca502a1e6b162_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC0xLTEtMS0yMzgzNjk_6fc9ef23-94be-4d62-ad19-9f3e17d44cb0"
      unitRef="usd">14200000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5bda848179204f8dbc6ca502a1e6b162_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC0zLTEtMS0yMzgzNjk_b25baf4e-73b2-422c-9579-db19be2d0fd3"
      unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5bda848179204f8dbc6ca502a1e6b162_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC01LTEtMS0yMzgzNjk_c0789009-4e35-441c-980d-e012f3c7f0c4"
      unitRef="usd">8700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i69d6d91a822b4e58a4a30b0ed4b82bf0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC03LTEtMS0yMzgzNjk_a3674e24-df85-48d0-aa31-46dbb94049ac"
      unitRef="usd">14200000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i69d6d91a822b4e58a4a30b0ed4b82bf0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC05LTEtMS0yMzgzNjk_69461fd7-1eb4-4b4c-b84b-27ed979ae66b"
      unitRef="usd">4200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i69d6d91a822b4e58a4a30b0ed4b82bf0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOC0xMS0xLTEtMjM4MzY5_1bd162d5-37fd-4db7-b446-82e93491a25b"
      unitRef="usd">10000000.0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS0xLTEtMS0yMzgzNjk_2fe6f536-e7b9-4492-b93c-a4b59b8bca5f"
      unitRef="usd">5891800000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS0zLTEtMS0yMzgzNjk_c75c18db-3d1d-4cb9-8327-b1511aa2827e"
      unitRef="usd">1979500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS01LTEtMS0yMzgzNjk_c6664cce-d7fd-41e8-8126-b550d5b68ca9"
      unitRef="usd">3912300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS03LTEtMS0yMzgzNjk_23f2e85f-0a55-4116-b46c-badfac449c32"
      unitRef="usd">5851400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS05LTEtMS0yMzgzNjk_6d94a123-dd0c-4f8f-b739-62430eacd1df"
      unitRef="usd">1904500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RhYmxlOmIxZGRiNzIxZTZhMDRmNzk4ZGE3NjM3ZTBlYzg5NmU4L3RhYmxlcmFuZ2U6YjFkZGI3MjFlNmEwNGY3OThkYTc2MzdlMGVjODk2ZThfOS0xMS0xLTEtMjM4MzY5_9e3cebff-e3f7-4118-bce9-4eb174db7096"
      unitRef="usd">3946900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMTk0NQ_d3eda484-b617-4c49-8f40-8e75bc647613"
      unitRef="usd">69300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMTk1Mg_fbc0b55f-ed63-405c-b4fd-cb9a3b4df906"
      unitRef="usd">67100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjA3Nw_96dbad43-1437-42bb-863b-a4d99f6f1bef"
      unitRef="usd">206200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjExMw_0446fde0-268d-47c8-a8a6-4d5c14030072"
      unitRef="usd">267500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjEzMA_8d6d2351-459b-48fa-b3f2-05375f29c915"
      unitRef="usd">255300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjE0Nw_bcbd6db3-303f-4935-bf79-afcf21b11844"
      unitRef="usd">245500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjE2NA_c627598c-2a7c-481c-90c0-f99b19d7f95a"
      unitRef="usd">233900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80My9mcmFnOmVkZWU2MGU5NzBjZDQ0ZWJiNTAzMmEyMWU0MmM0ZjkxL3RleHRyZWdpb246ZWRlZTYwZTk3MGNkNDRlYmI1MDMyYTIxZTQyYzRmOTFfMjE4NQ_dad793c7-99b7-41f4-8d88-24994b123f30"
      unitRef="usd">2141300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <lh:A400SeniorNotesDue2023
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfMi0xLTEtMS0yMzgzNjk_39fe1edf-d79e-4915-a1e1-10e3f0f46202"
      unitRef="usd">300000000.0</lh:A400SeniorNotesDue2023>
    <lh:A400SeniorNotesDue2023
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfMi0zLTEtMS0yMzgzNjk_b827db4e-4933-402c-b05d-afb14e960048"
      unitRef="usd">300000000.0</lh:A400SeniorNotesDue2023>
    <lh:Shorttermdebtissuancecosts
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfMy0xLTEtMS0yMzgzNjk_b39a8b83-5e37-4d6e-bdd0-c7732695d8b3"
      unitRef="usd">300000</lh:Shorttermdebtissuancecosts>
    <lh:Shorttermdebtissuancecosts
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfMy0zLTEtMS0yMzgzNjk_115892d7-19b7-4783-a0ee-4cc928c2d0e1"
      unitRef="usd">400000</lh:Shorttermdebtissuancecosts>
    <us-gaap:NotesPayableCurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfNS0xLTEtMS0yMzgzNjk_70a82e6a-79e1-483c-9cc7-ccaa2fd29988"
      unitRef="usd">1700000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfNS0zLTEtMS0yMzgzNjk_6aebf867-c70b-4ce4-a489-70c2d4bf15b1"
      unitRef="usd">1700000</us-gaap:NotesPayableCurrent>
    <lh:CurrentDebtExcludingFinanceLeaseLiability
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfNi0xLTEtMS0yMzgzNjk_df1f18d9-099b-416e-b33c-50ec4795e614"
      unitRef="usd">301400000</lh:CurrentDebtExcludingFinanceLeaseLiability>
    <lh:CurrentDebtExcludingFinanceLeaseLiability
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOjZhZTQ5ZDM3ZGQzYjQwNGI4YzRkNjg3NWRhNzA4MzQ1L3RhYmxlcmFuZ2U6NmFlNDlkMzdkZDNiNDA0YjhjNGQ2ODc1ZGE3MDgzNDVfNi0zLTEtMS0yMzgzNjk_2e65a1df-b03e-48b9-901d-7b5e637e0062"
      unitRef="usd">301300000</lh:CurrentDebtExcludingFinanceLeaseLiability>
    <lh:A2.30seniornotesdue2024
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOC0xLTEtMS0yMzgzNjk_0cca5a13-d699-4905-977b-8cd04e97d6d6"
      unitRef="usd">400000000.0</lh:A2.30seniornotesdue2024>
    <lh:A2.30seniornotesdue2024
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOC0zLTEtMS0yMzgzNjk_4371b34e-884a-44b1-aa39-56c1f5fcd0a9"
      unitRef="usd">400000000.0</lh:A2.30seniornotesdue2024>
    <lh:A325SeniorNotesDue2024
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOS0xLTEtMS0yNjU5Njg_01892d37-3157-4e92-8c7d-a1760d0ee3be"
      unitRef="usd">600000000.0</lh:A325SeniorNotesDue2024>
    <lh:A325SeniorNotesDue2024
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOS0zLTEtMS0yNjU5Njg_e3b16a5d-e394-41ce-8aa4-5852cfebb4cb"
      unitRef="usd">600000000.0</lh:A325SeniorNotesDue2024>
    <lh:A360SeniorNotesDue2025
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOS0xLTEtMS0yMzgzNjk_a0842ec8-fead-46f2-bb82-ed8e2a95e1fd"
      unitRef="usd">1000000000</lh:A360SeniorNotesDue2025>
    <lh:A360SeniorNotesDue2025
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfOS0zLTEtMS0yMzgzNjk_04e226b4-2ca6-4dc2-9eac-125ec7a22af6"
      unitRef="usd">1000000000</lh:A360SeniorNotesDue2025>
    <lh:A155SeniorNotesDue2026
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTAtMS0xLTEtMjM4MzY5_d0e513e3-04c5-4c4e-8b2d-6f9f15db42fd"
      unitRef="usd">500000000.0</lh:A155SeniorNotesDue2026>
    <lh:A155SeniorNotesDue2026
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTAtMy0xLTEtMjM4MzY5_73b0a181-69fa-45ca-806f-6ba603a6cc9c"
      unitRef="usd">500000000.0</lh:A155SeniorNotesDue2026>
    <lh:A360SeniorNotesDue2027
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTEtMS0xLTEtMjM4MzY5_f9287bc9-cc56-4964-be4d-cff09d673c05"
      unitRef="usd">600000000.0</lh:A360SeniorNotesDue2027>
    <lh:A360SeniorNotesDue2027
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTEtMy0xLTEtMjM4MzY5_d05d74ab-39a6-4ac8-b9a5-d0f8c8cf0b43"
      unitRef="usd">600000000.0</lh:A360SeniorNotesDue2027>
    <lh:A2.95seniornotesdue2029
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTItMS0xLTEtMjM4MzY5_f0d70338-e085-47c6-8997-cd334b3376d0"
      unitRef="usd">650000000.0</lh:A2.95seniornotesdue2029>
    <lh:A2.95seniornotesdue2029
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTItMy0xLTEtMjM4MzY5_314df6fc-3be7-4888-b89e-3ddd31ba80d7"
      unitRef="usd">650000000.0</lh:A2.95seniornotesdue2029>
    <lh:A270SeniorNotesDue2031
      contextRef="i772840f5d04344f4a44ed5da9d0e53d7_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTMtMS0xLTEtMjM4MzY5_a175f1c5-401c-4a94-a56c-41270cbcb4a3"
      unitRef="usd">432700000</lh:A270SeniorNotesDue2031>
    <lh:A270SeniorNotesDue2031
      contextRef="i8ff0a49f62ff41469cd1280087a38dc2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTMtMy0xLTEtMjM4MzY5_a66dbf4f-7b34-43fb-8dce-2c4e8a87e2dd"
      unitRef="usd">420300000</lh:A270SeniorNotesDue2031>
    <lh:A470SeniorNotesDue2045
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTQtMS0xLTEtMjM4MzY5_a934183b-6bc2-49c7-8709-9c2f5bfc2852"
      unitRef="usd">900000000.0</lh:A470SeniorNotesDue2045>
    <lh:A470SeniorNotesDue2045
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTQtMy0xLTEtMjM4MzY5_f6fe0723-8bc3-432c-a83c-b65e15768d73"
      unitRef="usd">900000000.0</lh:A470SeniorNotesDue2045>
    <lh:Longtermdebtissuancecosts
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTctMS0xLTEtMjM4MzY5_86fac6e2-169f-4131-8fdf-760fa5c9e0e6"
      unitRef="usd">32400000</lh:Longtermdebtissuancecosts>
    <lh:Longtermdebtissuancecosts
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTctMy0xLTEtMjM4MzY5_ef99d840-1834-4fe4-bdf6-8d4b0f76ac08"
      unitRef="usd">33800000</lh:Longtermdebtissuancecosts>
    <us-gaap:LongTermNotesPayable
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTktMS0xLTEtMjM4MzY5_21d530fd-2c32-4300-aaf2-6798eee4ab8b"
      unitRef="usd">2000000.0</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMTktMy0xLTEtMjM4MzY5_24f63f6e-8b8a-4175-a8f8-3a7a5dfc5920"
      unitRef="usd">2300000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMjAtMS0xLTEtMjM4MzY5_26808393-815d-4514-a034-9290cf8fbc8f"
      unitRef="usd">5052300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RhYmxlOmE1YjM5YzQ5ZTc3ZTQxZGRhYTg2MzM1MzE2ZDFiZTBmL3RhYmxlcmFuZ2U6YTViMzljNDllNzdlNDFkZGFhODYzMzUzMTZkMWJlMGZfMjAtMy0xLTEtMjM4MzY5_ec02a3d4-e014-4513-9259-8cb108b76c54"
      unitRef="usd">5038800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:SubordinatedBorrowingInterestRate
      contextRef="i2fc48bf4132447b5ad6ad22c82427c71_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfOTU0_24c6d08b-c8c7-4a97-8faf-8a88424212ea"
      unitRef="number">0.0270</us-gaap:SubordinatedBorrowingInterestRate>
    <lh:A270SeniorNotesDue2031
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTAxNg_99e3c406-f04a-4e66-99fb-ed64c2a2f633"
      unitRef="usd">500000000.0</lh:A270SeniorNotesDue2031>
    <lh:ThreeMonthLIBOR
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTA3OQ_d8657640-4270-4237-ac2a-5bf222e49f55"
      unitRef="number">0.010706</lh:ThreeMonthLIBOR>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTMyMQ_b4b77ee3-b9f9-44f5-b45a-b73afb123532"
      unitRef="usd">67300000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTUyOA_1f1b2351-645a-471b-8448-b483855964c0"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <lh:CreditFacilityOptiontoIncrease
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTU5OA_366c1747-e7b2-4c4d-bb83-ab90e30116f5"
      unitRef="usd">500000000.0</lh:CreditFacilityOptiontoIncrease>
    <lh:CreditFacilityMaximumSwingLineBorrowings
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTgxMg_c1e546a7-5b74-48d3-bac7-8669df81f526"
      unitRef="usd">100000000.0</lh:CreditFacilityMaximumSwingLineBorrowings>
    <lh:CreditFacilityMaximumLettersofCredit
      contextRef="if61be0038474449a8767e2be7c9aad81_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMTg2OA_56961ebe-901f-41de-9066-048dd90bf8ce"
      unitRef="usd">150000000.0</lh:CreditFacilityMaximumLettersofCredit>
    <us-gaap:LineOfCreditFacilityCommitmentFeeDescription
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMjA1Mg_f6a7e0a1-71b8-4f40-adb0-c1fdf02c9c83">0.10% to 0.225%</us-gaap:LineOfCreditFacilityCommitmentFeeDescription>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="if61be0038474449a8767e2be7c9aad81_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMjY2MA_2ee3f49b-a495-4e3e-8921-f94e52842652"
      unitRef="rate">0.0563</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80Ni9mcmFnOjZkNjU0ODNhOWJiNTQ5MDJhNjUwZjFmODY3M2YzN2VjL3RleHRyZWdpb246NmQ2NTQ4M2E5YmI1NDkwMmE2NTBmMWY4NjczZjM3ZWNfMzE3NA_0793759e-2dfd-4815-9126-2824a36e4944"
      unitRef="usd">84500000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjIxMw_eb0d0b83-795c-40bf-9a6a-867db318d8ae">PREFERRED STOCK AND COMMON SHAREHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:7.1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of March&#160;31, 2023, and December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in common shares issued are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued and Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued under employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company had outstanding authorization from the board of directors to purchase up to $1,531.5 of the Company's common stock. The repurchase authorization has no expiration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023, the Company paid $64.4 in common stock dividends. On April 6, 2023, the Company announced a cash dividend of $0.72 per share of common stock for the second quarter, or approximately $64.7 in the aggregate. The dividend will be payable on June 8, 2023, to stockholders of record of all issued and outstanding shares of common stock as of the close of business on May 18, 2023. The declaration and payment of any future dividends will be at the discretion of the Company's board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Earnings (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive earnings (loss) are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Benefit Plan Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Earnings (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(493.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension settlement charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(414.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfOTc_1b300d2d-8e62-469b-949e-995e7d65165c"
      unitRef="shares">265000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTM0_a8cff4b6-5c3e-4523-8d24-d6d61e4acb05"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTg5_7e4f0e5d-7e3e-4d11-90b1-b55268a869ec"
      unitRef="shares">30000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjI5_bbddd56d-0d64-46fa-b4e4-78e36c25ff95"
      unitRef="usdPerShare">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjU0_2290290b-dc60-4a23-b11e-7932624d4bed"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjIwMQ_685056c5-8c8d-45e6-a1a6-2b93e79e39a7">&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in common shares issued are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued and Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued under employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3899295744f647ccb8f7d75b5d3d2193_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOjliNDE0ZWQwOGZkNDQ3ZmZhOGM1YzgwZWUyODY3ZjU4L3RhYmxlcmFuZ2U6OWI0MTRlZDA4ZmQ0NDdmZmE4YzVjODBlZTI4NjdmNThfMS0xLTEtMS0yMzgzNjk_6aab4af2-86b5-4f69-af32-1b209cfb7fa6"
      unitRef="shares">88200000</us-gaap:CommonStockSharesIssued>
    <lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans
      contextRef="i6f6d9f778de347038d4db29292220d70_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOjliNDE0ZWQwOGZkNDQ3ZmZhOGM1YzgwZWUyODY3ZjU4L3RhYmxlcmFuZ2U6OWI0MTRlZDA4ZmQ0NDdmZmE4YzVjODBlZTI4NjdmNThfMi0xLTEtMS0yMzgzNjk_2d807376-789d-466e-a6ab-82804206b7b0"
      unitRef="shares">400000</lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans>
    <us-gaap:CommonStockSharesIssued
      contextRef="i509a25f9cde744a08f771cef00ab8b88_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOjliNDE0ZWQwOGZkNDQ3ZmZhOGM1YzgwZWUyODY3ZjU4L3RhYmxlcmFuZ2U6OWI0MTRlZDA4ZmQ0NDdmZmE4YzVjODBlZTI4NjdmNThfNy0xLTEtMS0yMzgzNjk_b37d0303-d152-4631-8efc-9346a93c6116"
      unitRef="shares">88600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTQ5Mw_410a48ad-1793-4352-a09d-92a202a3a5f7"
      unitRef="shares">1531500000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTYxNw_245020b1-c305-4d83-889c-bc61db6bf8f3"
      unitRef="usd">64400000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="iade5794fdb2048c4b1367089794b02d2_D20230406-20230406"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTY1MA_e2cd721e-1a5e-4ded-bb5b-1c4160e23c3e">2023-04-06</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i434e0492f16b458782fd7bad1f0165fc_I20230406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTY5NQ_1e4e1df4-4aa8-4004-89aa-ccb5479c3797"
      unitRef="usdPerShare">0.72</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:Dividends
      contextRef="iade5794fdb2048c4b1367089794b02d2_D20230406-20230406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTc2MQ_1991ae62-dd1c-4e71-aefd-45a3bdbd0f48"
      unitRef="usd">64700000</us-gaap:Dividends>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="i64a241cba18148d68b58c63f94a86b0d_D20230608-20230608"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTgxNA_a075f88c-0416-458c-bc2e-cb148f437c97">2023-06-08</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="i318e19e3163b4d77b9fdcb41be6651b3_D20230518-20230518"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMTkyOA_7c1b1e53-79b0-4d70-8af8-92d053046fb1">2023-05-18</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RleHRyZWdpb246ZWEwZGI3NmI3Njc5NDEzYmE2YWE4ODQ0MTJkNmY0YmJfMjIwNQ_00c73de5-0a28-4a6c-8630-4ca4784dc7eb">&lt;div style="margin-top:3pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive earnings (loss) are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Benefit Plan Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Earnings (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(493.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension settlement charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(414.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMS0xLTEtMS0yMzgzNjk_2239208e-9180-4f4e-bf87-994e69b4157b"
      unitRef="usd">-462300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMS0zLTEtMS0yMzgzNjk_694db505-fc93-4750-8540-afe3d0f7bd2d"
      unitRef="usd">-30900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMS03LTEtMS0yMzgzNjk_baf10e03-f529-41e8-ba28-26ca99b0c816"
      unitRef="usd">-493200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMi0xLTEtMS0yMzgzNjk_6622dbd6-dc5d-406e-b5eb-6e0419b6df2f"
      unitRef="usd">48100000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMi0zLTEtMS0yMzgzNjk_001baf0f-b62b-4fac-b259-3c10681573b7"
      unitRef="usd">10300000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMi03LTEtMS0yMzgzNjk_fa773bb3-4d03-42d8-9701-8c64ff70a66c"
      unitRef="usd">58400000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i9726d7960c36403697c0c1aecbad306a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMy0xLTEtMS0yMzgzNjk_5160d4f3-11ff-4c31-af18-458399b1660c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMy0zLTEtMS0yMzgzNjk_4bc593fe-5b86-44d8-a9d6-f948bc1f0306"
      unitRef="usd">-7900000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfMy03LTEtMS0yMzgzNjk_4ed6305d-4416-407d-aed8-e088615ca132"
      unitRef="usd">-7900000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNC0xLTEtMS0yMzgzNjk_460ee82c-b1a0-4425-9c8c-25557eedac60"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNC0zLTEtMS0yMzgzNjk_2b64a817-d684-499a-a852-6b0dea080eda"
      unitRef="usd">-1200000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNC03LTEtMS0yMzgzNjk_0a56dd0e-1f76-439c-afd4-37019f672014"
      unitRef="usd">-1200000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNS0xLTEtMS0yMzgzNjk_d7a5fbbe-670c-41f9-8ccb-4895938c450a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNS0zLTEtMS0yMzgzNjk_7a136ba8-e20d-48e1-ba6d-90822c4d2bb8"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNS03LTEtMS0yMzgzNjk_556a3cc8-bd38-4d64-ac0d-225e76fc3e3b"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNi0xLTEtMS0yMzgzNjk_af65384a-6d2a-47e0-82c5-b21171888896"
      unitRef="usd">-414200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNi0zLTEtMS0yMzgzNjk_f0076210-ca83-44f2-a414-dfe55933a3b6"
      unitRef="usd">-30000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF80OS9mcmFnOmVhMGRiNzZiNzY3OTQxM2JhNmFhODg0NDEyZDZmNGJiL3RhYmxlOmViZGFjNDVmNzE3YTQ0OGJiOWFiYWY5NDczNTc3ZDE3L3RhYmxlcmFuZ2U6ZWJkYWM0NWY3MTdhNDQ4YmI5YWJhZjk0NzM1NzdkMTdfNi03LTEtMS0yMzgzNjk_262ebbbd-d744-4a24-b0ed-27ac46b87c3b"
      unitRef="usd">-444200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81Mi9mcmFnOmQzMjcxYzdkMjBhZTRhMWFhOGIyMDA2MTBhZjYxOTU3L3RleHRyZWdpb246ZDMyNzFjN2QyMGFlNGExYWE4YjIwMDYxMGFmNjE5NTdfMjkwNzE_ae5972d7-b230-4de0-85c5-0921b11589dc">COMMITMENTS AND CONTINGENCIES</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81Mi9mcmFnOmQzMjcxYzdkMjBhZTRhMWFhOGIyMDA2MTBhZjYxOTU3L3RleHRyZWdpb246ZDMyNzFjN2QyMGFlNGExYWE4YjIwMDYxMGFmNjE5NTdfNTQ5NzU1OTA3NzUw_f91abd00-d4b8-492a-ac84-c0b0179578a7"
      unitRef="usd">272000000.0</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81Mi9mcmFnOmQzMjcxYzdkMjBhZTRhMWFhOGIyMDA2MTBhZjYxOTU3L3RleHRyZWdpb246ZDMyNzFjN2QyMGFlNGExYWE4YjIwMDYxMGFmNjE5NTdfNTQ5NzU1OTA4Njkz_8fe09434-c5ac-4b2e-a958-c374a5fcf321"
      unitRef="usd">817000000.0</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzkzNw_84b749f9-7e15-43a7-85dd-4c5d0a079719">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s population of financial assets and liabilities subject to fair value measurements as of March&#160;31, 2023, and December 31, 2022, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other; Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other; Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurement of Level 3 Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#x2019;s condensed consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers certain employees the opportunity to participate in an employee-funded deferred compensation plan (DCP). A participant's deferrals are allocated by the participant to one or more of 26 measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participant's allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent accrued earn-out business acquisition consideration liabilities are measured at fair value using Level 3 valuations. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the senior notes, based on market pricing, was approximately $5,082.0 and $4,973.9 as of March&#160;31, 2023, and December 31, 2022, respectively. The Company's note and debt instruments are classified as Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzkyNw_76807c55-ba4f-4e27-8a98-1fd036c18cb5">&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s population of financial assets and liabilities subject to fair value measurements as of March&#160;31, 2023, and December 31, 2022, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other; Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other; Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNC0zLTEtMS0yMzgzNjk_91ef54b6-9dfc-4a54-8b3a-adce626f9cc4"
      unitRef="usd">15100000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNC01LTEtMS0yMzgzNjk_11899713-6621-4b07-811f-5c5401907df8"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNC03LTEtMS0yMzgzNjk_07541642-83f0-48f9-a00e-65f7f82fa9ec"
      unitRef="usd">15100000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNC05LTEtMS0yMzgzNjk_b7186277-acfe-470b-8c8a-292ccc4de1e8"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNS0zLTEtMS0yMzgzNjk_e6e9abf7-5c97-4bb9-9d02-ebee1121bff2"
      unitRef="usd">48500000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNS01LTEtMS0yMzgzNjk_09c00043-e5d9-4ab0-8d8d-42975040c862"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNS03LTEtMS0yMzgzNjk_acc6aea1-f9a8-4cae-9c2c-115f848d6141"
      unitRef="usd">48500000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNS05LTEtMS0yMzgzNjk_b725c743-4d52-4c17-9ede-f00bd8127990"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNi0zLTEtMS0yMzgzNjk_dbfb7abe-80e7-47ac-b419-62c9ae5e12c9"
      unitRef="usd">67300000</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNi01LTEtMS0yMzgzNjk_a8df086b-6ccd-4eeb-ae12-a5f0a665b7c2"
      unitRef="usd">0</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNi03LTEtMS0yMzgzNjk_aec6d359-cb6c-4322-aee9-44776ec5e0fe"
      unitRef="usd">67300000</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfNi05LTEtMS0yMzgzNjk_1cd5e762-78fe-4661-9730-54ac0ad53c1b"
      unitRef="usd">0</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfOS0zLTEtMS0yMzgzNjk_6691509a-58e2-421f-b704-69597de7a6da"
      unitRef="usd">106400000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfOS01LTEtMS0yMzgzNjk_5b245c48-2adf-40f8-831d-a56962fd85f4"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfOS03LTEtMS0yMzgzNjk_757a24d1-f2f7-4768-9ce8-acf9daea1b7c"
      unitRef="usd">106400000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfOS05LTEtMS0yMzgzNjk_e74ba897-b55d-4cd8-82ed-388c5be2960d"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTAtMy0xLTEtMjM4MzY5_bf9628e0-34ce-409a-b1ba-9d34bac01269"
      unitRef="usd">102700000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTAtNS0xLTEtMjM4MzY5_70d639d3-e72d-4cc8-866a-dac897ef2112"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTAtNy0xLTEtMjM4MzY5_cb614b23-344b-46cd-a4ad-e9f3d7ef1889"
      unitRef="usd">102700000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTAtOS0xLTEtMjM4MzY5_375b5dc7-6ea7-4c2d-8094-13850c38e3a0"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTItMy0xLTEtMjM4MzY5_ec92aafa-74e8-42f5-8834-8f8ae51820c0"
      unitRef="usd">69000000.0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i1b622134b2644c41b2459aca36262ef0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTItNS0xLTEtMjM4MzY5_70c303cc-a240-4feb-ac11-f50d4420537b"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="iedd64678d4f54800a0093c44f20de7a6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTItNy0xLTEtMjM4MzY5_8b60357d-9076-4daa-af63-4539c816c854"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjczN2FjNGU0NzRlODQxZGVhY2I5ZGEyZWRmMzBjZGY1L3RhYmxlcmFuZ2U6NzM3YWM0ZTQ3NGU4NDFkZWFjYjlkYTJlZGYzMGNkZjVfMTItOS0xLTEtMjM4MzY5_e1f4a035-c2d2-4ec1-876c-b5ec83186751"
      unitRef="usd">69000000.0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNC0zLTEtMS0yMzgzNjk_c594ed05-ba4f-4c10-87d9-971949633e04"
      unitRef="usd">15000000.0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNC01LTEtMS0yMzgzNjk_22a7945d-c3c3-4399-a359-1937e771bcdc"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNC03LTEtMS0yMzgzNjk_f05bd064-fdc3-4ab9-898c-e99cfd34c1c6"
      unitRef="usd">15000000.0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNC05LTEtMS0yMzgzNjk_307b950c-8880-459b-8140-ce24654709fd"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNS0zLTEtMS0yMzgzNjk_c5e10e16-00a7-44e3-87d2-8b3d400360d4"
      unitRef="usd">45700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNS01LTEtMS0yMzgzNjk_0be8f7b7-7175-44b6-b852-96406b80ccea"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNS03LTEtMS0yMzgzNjk_52fc7cd0-f9a9-4552-8848-1852d511f09b"
      unitRef="usd">45700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNS05LTEtMS0yMzgzNjk_3ae30296-2cc1-46be-9275-e9b28da0e340"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNi0zLTEtMS0yMzgzNjk_8c06f55b-78b1-4784-ac6d-82f8a4915b7d"
      unitRef="usd">79700000</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNi01LTEtMS0yMzgzNjk_cfd51615-b7fb-4ff5-b441-18b772051905"
      unitRef="usd">0</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNi03LTEtMS0yMzgzNjk_f17fd23f-5609-4c5b-8b85-8b59dd785d04"
      unitRef="usd">79700000</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:FairValueHedgesAtFairValueNet
      contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNi05LTEtMS0yMzgzNjk_44878f3c-04f0-45b0-b258-ef82bec3e3a5"
      unitRef="usd">0</us-gaap:FairValueHedgesAtFairValueNet>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNy0zLTEtMS0yMzgzNjk_1a894dc8-fe2e-4add-9f77-a7b73046bf61"
      unitRef="usd">100700000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNy01LTEtMS0yMzgzNjk_14f7f790-f97b-469c-9a98-c13300347ed8"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNy03LTEtMS0yMzgzNjk_8658dbcd-809e-41bf-887a-b1bc473e27ce"
      unitRef="usd">100700000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfNy05LTEtMS0yMzgzNjk_d72671c5-a3ad-4037-b4d6-265e3866c0de"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfOC0zLTEtMS0yMzgzNjk_cf7f76b1-7440-4795-87e2-985306b64b16"
      unitRef="usd">96900000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfOC01LTEtMS0yMzgzNjk_047c9239-f93f-469a-a573-ba315cf3e697"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfOC03LTEtMS0yMzgzNjk_065a2b21-60c0-441f-bede-86acf6d706ee"
      unitRef="usd">96900000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfOC05LTEtMS0yMzgzNjk_c1c8551f-2b15-4b02-b9c7-eb1c5965bae5"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfMTAtMy0xLTEtMjM4MzY5_4621fb29-efa2-41eb-95bb-e63383f9a90f"
      unitRef="usd">77400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="idb7ee01e8cde49a486544bdaf1d9a40c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfMTAtNS0xLTEtMjM4MzY5_917e8cf7-ac73-49d7-ad32-563f6ce7c1cb"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="iebf9eccd27c5482a9a25b7aa0413e304_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfMTAtNy0xLTEtMjM4MzY5_fac5ec7d-c0c2-40da-a490-62004dadbad6"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjdmYzdkZTE3YTA5ZDQxY2E4NWFkMDQwZGZlNDU0MjBjL3RhYmxlcmFuZ2U6N2ZjN2RlMTdhMDlkNDFjYTg1YWQwNDBkZmU0NTQyMGNfMTAtOS0xLTEtMjM4MzY5_b641131f-8745-498b-b01b-139c33a12428"
      unitRef="usd">77400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzkyOA_d26629db-5c81-457c-b13b-8b2bb05a04a9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurement of Level 3 Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i47a4691325d94666bc3851c13c2a2d39_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjY1MGJmOTg0MjJlZTQ5YzQ4NjA4NmUyOTIzNjBjNWYxL3RhYmxlcmFuZ2U6NjUwYmY5ODQyMmVlNDljNDg2MDg2ZTI5MjM2MGM1ZjFfMS0yLTEtMS0yMzgzNjk_087b7b0f-1509-4f6c-b58d-c16f5974734a"
      unitRef="usd">77400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <lh:Contingentconsiderationadjustment
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjY1MGJmOTg0MjJlZTQ5YzQ4NjA4NmUyOTIzNjBjNWYxL3RhYmxlcmFuZ2U6NjUwYmY5ODQyMmVlNDljNDg2MDg2ZTI5MjM2MGM1ZjFfMy0yLTEtMS0yMzgzNjk_ca8d5d43-e14e-4e20-b7ba-9cecc8218d8a"
      unitRef="usd">8400000</lh:Contingentconsiderationadjustment>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="if889505bd2b3447a9d92c961bc85f69a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RhYmxlOjY1MGJmOTg0MjJlZTQ5YzQ4NjA4NmUyOTIzNjBjNWYxL3RhYmxlcmFuZ2U6NjUwYmY5ODQyMmVlNDljNDg2MDg2ZTI5MjM2MGM1ZjFfNS0yLTEtMS0yMzgzNjk_735186dd-1d0c-4704-acd6-d4975959ea47"
      unitRef="usd">69000000.0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <lh:NumberofMeasurementFundsAvailableForParticipantElection
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfNjYz_74a0d0ae-538c-4b13-b5ad-5a221558117d"
      unitRef="number">26</lh:NumberofMeasurementFundsAvailableForParticipantElection>
    <lh:SeniorNotesFairValue
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMjQ2NA_b38527e5-ff66-4522-966e-089ad0e45de2"
      unitRef="usd">5082000000</lh:SeniorNotesFairValue>
    <lh:SeniorNotesFairValue
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMjQ3MQ_de07886f-8e32-488d-96a4-9df09e6fab6e"
      unitRef="usd">4973900000</lh:SeniorNotesFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i769724f534fd42d5b074271dafd50c33_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMjg1OA_acfbba95-ccb1-42d0-9dda-4a3f1568408e"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6ed01ecd53ff440bb094c068361e773d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMjkxNA_aaae7557-e81b-40e1-b54a-f87dab70332d"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic501f2ab3f824f5e99cea8fef7c2e388_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzA2NA_b4b98a3a-61c1-4234-825e-cf0c0856ba32"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i5e096d4685af481291993afb05e8af6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzUxNw_e6e9abf7-5c97-4bb9-9d02-ebee1121bff2"
      unitRef="usd">48500000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i257716c5617f4dfab266cec980a32b4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81NS9mcmFnOjEwYjgyNzMyNGNlZjQxNzI4NmVhZDYyMjY4NGYxMGYxL3RleHRyZWdpb246MTBiODI3MzI0Y2VmNDE3Mjg2ZWFkNjIyNjg0ZjEwZjFfMzUyNA_c5e10e16-00a7-44e3-87d2-8b3d400360d4"
      unitRef="usd">45700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RleHRyZWdpb246MDkwYmVkNDUxZmVkNDAzNWIyOWUwYmIxNTRmZWJiNTFfNDc_88ae12a3-07db-4e43-95c0-d6bbcee1d20d">SUPPLEMENTAL CASH FLOW INFORMATION&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during period for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes, net of refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disclosure of non-cash financing and investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in accrued property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RleHRyZWdpb246MDkwYmVkNDUxZmVkNDAzNWIyOWUwYmIxNTRmZWJiNTFfNDk_fab4a67f-16fd-44fc-805d-442b1d4a1845">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during period for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes, net of refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disclosure of non-cash financing and investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in accrued property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <lh:InterestPaidInCash
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfNC0xLTEtMS0yMzgzNjk_516c2730-53e7-4c03-ba2e-7e8b16ee6dec"
      unitRef="usd">70400000</lh:InterestPaidInCash>
    <lh:InterestPaidInCash
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfNC0zLTEtMS0yMzgzNjk_7de64273-7791-4a0a-ac52-c58da4ca4455"
      unitRef="usd">20600000</lh:InterestPaidInCash>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfNS0xLTEtMS0yMzgzNjk_f8c29119-9cf1-4b30-bead-26109005198f"
      unitRef="usd">33000000.0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfNS0zLTEtMS0yMzgzNjk_be4520e8-9b84-4abe-86f0-737dd037e0c0"
      unitRef="usd">28900000</us-gaap:IncomeTaxesPaidNet>
    <lh:IncreaseInCapitalExpendituresIncurredButNotYetPaid
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfMTAtMS0xLTEtMjM4MzY5_d544fe6c-ccd0-40b4-82d9-5b62bcf95f7c"
      unitRef="usd">4200000</lh:IncreaseInCapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF81OC9mcmFnOjA5MGJlZDQ1MWZlZDQwMzViMjllMGJiMTU0ZmViYjUxL3RhYmxlOmRhOGJhYjgyNGUyMDQ4MzM5ZDY4MjdhNThmMjllNzc2L3RhYmxlcmFuZ2U6ZGE4YmFiODI0ZTIwNDgzMzlkNjgyN2E1OGYyOWU3NzZfMTAtMy0xLTEtMjM4MzY5_91ed5dec-6e5e-487d-8c12-8a2d2ef8599d"
      unitRef="usd">9200000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RleHRyZWdpb246MDFiYmVhNzhhZjIxNDYzZGI0MTkwYmE5Mzk3MThmODlfMTAwMg_5b1952c0-6517-4b26-ad2a-cb921a172961">BUSINESS SEGMENT INFORMATIONThe following table is a summary of segment information for the three months ended March&#160;31, 2023, and 2022. The &#x201c;management approach&#x201d; has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#x2019;s chief executive officer has been identified as the CODM. Segment asset information is not presented because it is not used by the CODM at the segment level.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:Revenues
      contextRef="i217de76c0e02473688390d39aec04505_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMy0yLTEtMS0yNzA0OTA_44e35bb1-b53e-402f-ab60-bcd3dd912879"
      unitRef="usd">2382800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifc9c5675189343c08478b612cc0f2f08_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMy00LTEtMS0yNzA0OTA_6aa2fd56-da16-4238-bd83-8b01d1a5dbee"
      unitRef="usd">2454100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia98902be646a4c90b5a714ef8b40c97e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNC0yLTEtMS0yNzA0OTA_9a5f5304-671d-46b0-9a8e-0b0851957781"
      unitRef="usd">1401300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88dc2a3d6e8c4967802600e7ff248849_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNC00LTEtMS0yNzA0OTA_8ad11286-553a-49f5-b959-cb8421045af8"
      unitRef="usd">1459300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i78627350409f4353bd6bb72edb530c2d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNS0yLTEtMS0yNzA0OTA_6666eb72-c200-48cf-a008-e761b1748b07"
      unitRef="usd">6200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i236653e26bcc49638d6df006253bc8bd_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNS00LTEtMS0yNzA0OTA_1865cab5-2640-4859-8729-7376bf43446e"
      unitRef="usd">13800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNi0yLTEtMS0yNzA0OTA_6d28d6bd-540b-45ea-b3e8-0f8f9980e471"
      unitRef="usd">3777900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfNi00LTEtMS0yNzA0OTA_ea465c05-475b-4528-8f73-de64babc6456"
      unitRef="usd">3899600000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i217de76c0e02473688390d39aec04505_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfOS0yLTEtMS0yNzA0OTA_bc5de254-445d-4adc-9b49-ff50698c293d"
      unitRef="usd">441500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifc9c5675189343c08478b612cc0f2f08_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfOS00LTEtMS0yNzA0OTA_10f10222-e223-4ef2-a3ab-c709159f4b0e"
      unitRef="usd">683100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia98902be646a4c90b5a714ef8b40c97e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTAtMi0xLTEtMjcwNDkw_5004849d-6dc6-4ad0-9ebe-9b0330837010"
      unitRef="usd">123900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i88dc2a3d6e8c4967802600e7ff248849_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTAtNC0xLTEtMjcwNDkw_36b2ffa7-2834-4bb1-80d5-9092005aa031"
      unitRef="usd">168600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7e2835bbadb5437a96546e64b63d52bc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTEtMi0xLTEtMjcwNTAw_82ef34c9-47cf-4a1c-9576-4090058537f6"
      unitRef="usd">565400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8bab97c15b1644c996b81336ef6af0a2_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTEtNC0xLTEtMjcwNTAz_847e5de7-e096-452d-8e97-1b5c11998d44"
      unitRef="usd">851700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i511043ecd4a749f784a8ec71a6c55a7b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTItMi0xLTEtMjcwNDkw_eb9ae63e-f594-40cf-8fe0-0e4b5a6fd13b"
      unitRef="usd">-144300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia2399bfbb9764cbfb9d758e73036dd39_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTItNC0xLTEtMjcwNDkw_55b3ce70-bd26-4083-b0aa-49a873c63ee0"
      unitRef="usd">-82900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTMtMi0xLTEtMjcwNDkw_2adc379c-e5b8-45ca-b040-867567a87c57"
      unitRef="usd">69300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTMtNC0xLTEtMjcwNDkw_14415135-56fc-49c3-b82b-d1c8c220c734"
      unitRef="usd">67100000</us-gaap:AmortizationOfIntangibleAssets>
    <lh:NetRestructuringCharges
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTQtMi0xLTEtMjcwNDkw_e07dc5a6-6bc8-4c6c-b33c-b51dedef6a67"
      unitRef="usd">8600000</lh:NetRestructuringCharges>
    <lh:NetRestructuringCharges
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTQtNC0xLTEtMjcwNDkw_9ecee27e-311a-49d5-aae4-883f969d82d7"
      unitRef="usd">12600000</lh:NetRestructuringCharges>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTUtMi0xLTEtMjcwNDkw_d123670a-50ce-424f-83e5-2893135bcd3a"
      unitRef="usd">2200000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTUtNC0xLTEtMjcwNDkw_3994dc0a-060b-4335-824e-df0b7b98eb8e"
      unitRef="usd">1200000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:OperatingIncomeLoss
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTYtMi0xLTEtMjcwNDkw_63e35aa8-3cc6-4523-a64f-1e5896a4be3f"
      unitRef="usd">341000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF82MS9mcmFnOjAxYmJlYTc4YWYyMTQ2M2RiNDE5MGJhOTM5NzE4Zjg5L3RhYmxlOmI5ZDdhNzZjZWQyODQyY2Q5ZWI1OTA1NzgxYWE4YTA5L3RhYmxlcmFuZ2U6YjlkN2E3NmNlZDI4NDJjZDllYjU5MDU3ODFhYThhMDlfMTYtNC0xLTEtMjcwNDkw_48a2f15f-7db9-40b1-ab4a-805b4ffb1a19"
      unitRef="usd">687900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF85NjcvZnJhZzowNGVjNDhkYmUyNjM0NTRhYjFhNTg0ZGNjNjY2NjE4Yy90ZXh0cmVnaW9uOjA0ZWM0OGRiZTI2MzQ1NGFiMWE1ODRkY2M2NjY2MThjXzU0OTc1NTgxNzU0NQ_1a72e562-322e-48ac-a33d-34614089026a">SUBSEQUENT EVENTSOn May 3, 2023, the Company entered into agreements to create a comprehensive strategic relationship with Jefferson Health (Jefferson), the largest health system serving the greater Philadelphia area and Southern New Jersey. When complete, the arrangements between Jefferson and the Company will serve to build academic collaborations around teaching and the development of innovative tests. The new strategic collaboration will deliver efficiency and comprehensive laboratory aspects of healthcare for the communities served by Jefferson through the Company's leading clinical laboratory services, robust data and digital tools and extensive network of patient service centers. The transaction is expected to close by mid-year 2023, subject to customary closing conditions and applicable regulatory approvals.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF83Ni9mcmFnOjI1NDhmZTVhMWU3NTQwYmQ4ZDZhZDNkNjQ2MDNlMzhkL3RleHRyZWdpb246MjU0OGZlNWExZTc1NDBiZDhkNmFkM2Q2NDYwM2UzOGRfNTQ5NzU1ODE4Mjg2_05941122-031a-43dc-99f1-41b46e535203"
      unitRef="usd">48100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i588647b555754d81a6f8860fc05eb240_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF83Ni9mcmFnOjI1NDhmZTVhMWU3NTQwYmQ4ZDZhZDNkNjQ2MDNlMzhkL3RleHRyZWdpb246MjU0OGZlNWExZTc1NDBiZDhkNmFkM2Q2NDYwM2UzOGRfNTQ5NzU1ODE4Mjkx_40eefe92-f128-41d5-988c-75a187d1cabe"
      unitRef="usd">-74600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic501f2ab3f824f5e99cea8fef7c2e388_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYzNTk2YmQ4ZDg5YTRjZGU5NzBiYThjZjc0ZGIyYjQ0L3NlYzo2MzU5NmJkOGQ4OWE0Y2RlOTcwYmE4Y2Y3NGRiMmI0NF83Ni9mcmFnOjI1NDhmZTVhMWU3NTQwYmQ4ZDZhZDNkNjQ2MDNlMzhkL3RleHRyZWdpb246MjU0OGZlNWExZTc1NDBiZDhkNmFkM2Q2NDYwM2UzOGRfMzIzMQ_b4b98a3a-61c1-4234-825e-cf0c0856ba32"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>53
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #);*16]S+L4><%  #^'@  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+69[V_B-AC'_Q6+3=,F'25V2J$WB@1I>X?6%@ZZ3=VT%R8Q$%T2<XX#Y;_?
MXP026CD.%QV\@/QZOOCCQXZ_MGM;+K[&*\8D>@V#*+YIK*1<?VRU8G?%0AI?
M\#6+X,Z"BY!*.!7+5KP6C'II4!BTB&5=M4+J1XU^+[TV$?T>3V3@1VPB4)R$
M(16[(0OX]J:!&X<+4W^YDNI"J]];TR6;,?GG>B+@K)6K>'[(HMCG$1)L<=,8
MX(^.351 ^L1?/MO&1\=(H<PY_ZI.1MY-PU(E8@%SI9*@\+-A#@L"I03E^+87
M;>3_J0*/CP_J]RD\P,QIS!P>_.U[<G73Z#:0QQ8T">24;S^S/5!;Z;D\B--O
MM,V>O;QL(#>))0_WP5""T(^R7_JZKXCC +LD@.P#R+L 7!9@[P/L%#0K68IU
M2R7M]P3?(J&>!C5UD-9-&@TT?J32.),"[OH0)_L.WS"!)I QU$3QB@H6'W[\
M"#WZ00"5'?=:$OY+1;3<O>XPTR4ENC9ZY)%<Q>@N\ICW-KX%9<P+2@X%'1*C
MX",5%\C&'Q"QB*TICU,5OD.6K8M^4QH[KS8[E;-+Y&ZYFT!CEF@495U)-<E_
MG^D\8/_I*BM3N]2KJ:[Z,5Y3E]TTH"_&3&Q8H__+3_C*^EU'^H/$WH!?YN"7
M)O7^721]N0-LR436!9%J=\A)A(#ZT+&;!5^8KG4YQJ":C.V<L7T*X[T?0-=P
MJ&1++G8Z,K/, Q70JP:N"^\L 2I>IJBC-0K5I+W*::].H9V%- C0,(GA=JSM
M\&:9!0UBIF,SAM5DZ^1LG5/8[D(FEGZT1)\@7JZ0P\,UC;0I->N50AK#:D)V
M<\CN20E<P5AH0C.KE*(9PVJB7>=HUZ>@ 50([]>9Y.[7#P":#D_C1,:21A[D
M54=K%/[>-VXFUD[%E#':]+O=B_;U\:?7VFA L56,PY81-1]1[OW8I0&:,.%S
M>&7 9?WP:Y;[@G4<YJ":R<1'7@,;"S4 0"^##*@V:Q4"I8W4'%<7C!1@Y+3D
M/>_6NO(-*^*QU?RBQ3*&U<4J3 XV6HD"ZTM"!0SXP0Y-V9H+[3!?H25%HL_<
M.=P,+NP,-MN/'''?W\"N*D.C3Z)9*G>HI1;5+%"7M; UV&Q(BE8J*,S#4L]J
MR*=9K+PKGL/,X,+-X)/LC+):Z"D)YUK#-:P0P4V,[;8^A^?P,[@P-/@D1S-E
M2S^6D$:)GFBH;ZUFH8?!<#P=/(^G+\@93R?J>#1^0N-[-'B\FXZ< ?H\?K@=
M/7V::6OA'(8'%XX'GV1Y1I'+!;3?=/H%QD!"QT4</#M/(BF4;_#T56-6O[W3
M(I_#".'"">&3K- S?44C#SJQO_#=;-II:.5F26PW[4Z[8W<L+>\/<E!O9_N%
M'R)F [/G'7@>J,<?#@?H 9Y#XTB;UPI)N]U%,Y[ !."1^LI."L9TKS['K%,7
MO;!)Q.QRWJ,[Z@R:]3/?1EILL]PP$7!I*:&+:&'/89U(89V(V?J\A\T[\43P
MC1^Y^D2;-9\<+>@YS!0IS!0Q&Z#WH!,.TY< _>.O2]]3%8JD0W!;2WH.3T4*
M3T7,1BAMKP/!:#F86<"VK[18Y[!/I+!/I&(]AZ?SLA6/3,ZB0H20:_ 6I*/E
M.X=S(H5S(F;3\^Q+\$Q\@3#Y=?X;FC$W$9!)+:19Z>U\_6?K EMH307:T$ _
M"3#KU24O3!4Q>R'PPVH9 <UVX9P'6N *,_592W4.DT0*DT3,-N:00'3WZJYH
MM&2E5K%"Z.EEIG5$YK"Z?(4C(J<M#F4KS_N93)I&&$+TBR85BB5KT>:HFIQV
MX83L[UL9>F'0E4K7A2K$RJ:FYK"ZC(7EL<T>Y9#$8T335+Q"KMG$I&EKE\#,
MD75!"[MCGV1W'( 5 #J*//:*_F#:MVR%E 6?:V+ARZZ6\X>ZG=;1#J-:3$\W
M7F/DJHE6MMF87\TW=P?IEF:K>#S;&7ZD:BT^1@%;0*AUT8%13V2;K=F)Y.MT
MOW+.I>1A>KABU&-"/0#W%YS+PXGZ@WS+N_\_4$L#!!0    ( ,ELI%:]N5(?
M@@<   @@   8    >&PO=V]R:W-H965T<R]S:&5E=#(N>&ULK9EM<Z,V$,>_
MBL;MM-<9)P8),%P3S_@<M[U.+I>)[]H7G;Z008F9 T21G(=OWQ5@L,U:Z74N
M+Q(@*_'?1=K?2KIXDM47M1%"D^<\*]3E:*-U^78R4?%&Y%R=RU(4\)][6>5<
MPVWU,%%E)7A2-\JS"76<8)+SM!C-+NIGM]7L0FYUEA;BMB)JF^>\>GDG,OET
M.7)'NP=WZ<-&FP>3V47)'\1*Z,_E;05WDZZ7),U%H5)9D$K<7X[F[ML%BTR#
MVN*/5#RIO6MB7%E+^<7<O$\N1XY1)#(1:],%AS^/8B&RS/0$.OYI.QUU[S0-
M]Z]WO?]2.P_.K+D2"YG]F29Z<SD*1R01]WR;Z3OY])MH'?)-?[',5/V;/+6V
MSHC$6Z5EWC8&!7E:-'_Y<QN(O0;0#]Z M@WH<8/@1 /6-F"UHXVRVJTKKOGL
MHI)/I#+6T)NYJ&-3MP9OTL)\QI6NX+\IM-.SQ<>;J^7-:GE%X&KU\?K]U?P3
MW+R;7\]O%DNR^FVY_+0B;SX7?)ND6B0_D3/R>75%WGS_T\5$@P#3S21N7_:N
M>1D]\3)&/LA";Q19%HE(#MM/0'BGGN[4OZ/6#C_PZIPP=TRH0QFB9V%O?B7B
MKCFUR&%=,%G='SL5S&U5B4(3KI30ZBT6H*8##^_ S-FWJN2QN!S!I%2B>A2C
MV0_?N8'S,^;=-^KLP%>O\]6S]3Z;Q['<%EJ1.Q&+])&O,S$F_%Z+BLPS2 Z\
MB 6!-$,6E8"10ZZE4F/21@B+3/.ZH'Z=23Z/,\H\+W3,S\7D<=]OQ!1^G$/3
M Z_\SBO?ZM7G8IUFF4C( @9J!3EFWS],==/==$_*U/%=3#1B&?F>17/0:0ZL
MFE?;LLQ2H4A:/$)L9077F-1@(, +70^3BEA.G< B==I)G5JEWE:BY&E"Q#-@
M2(%D7B1$ZHVH,,'38<2""!T0B*4SM8V'L!,<6@5_DIIGD(?WYS4F-1Q&+(A\
M!].*F=)CTP.Q42<V>B6Z0/=*OXQ)F7$C%X(K_MFF)6!7CTDAT'D7#?30R//0
M(8R9^@&U2'>=GD..5?RO4B9/,/=.ZFS;[[\]=-T C3%J2UU;D-T]8KI6I>\+
MS8N'%!("F=<#8DQNH-YZLWR.,X!D\4!VON"(= ?:6.12AOJ!V<+(LOE!>S^H
MU8_?90J#Q*2,;25(R2M=B$IMTE)U(T>_D%SHC4SJW**T&4CH^&]?M2\T\-&I
MBEI.;0[U]'6MP .<WPN8J EY7\0R%^03?VY3S$>38KJO98%0^X:#3#)%W4 ,
M;1G2[;GJVL'::.6MUE.3P1MF$3]")RUFRJ@UXCTM73LNF_1X.BVZ0^A!J>4X
M^*3%C%W_F*:'4GM(NH&U-KM..: ]U0#';@20O^9K56/^;U2]E;M?6ZQ]J]X.
M_>_)Z]K1V]5KM_RE*=9LTV (U#!T\(DP-(W8<=EVJ+F'KVNG+VBNMC"?L6^'
MRAZR-:(MAH]E#TU=)PBMNGL.NW80=XGH3D!ZW;X2ZR%5_3# 8XV94MO\H#U_
MJ9V_'Z%TX-K0ZUK LGC<!?W%JIX.2>L":C'UJ*GOV]3W3*9V)O^2%O6"X^NT
M#^D:H"D4,[35$K1G,+4S>)>($K'64!7O"HC[UIW,N$.RG3>H$T.>,@<OZW%3
M9G.D9R^UL_=:%@]GL/C+:U?&H%RIKFXN967V;%#Y0X[2,/0#5/_0ECG3T#J"
M>NQ2.W9[!ZYJ!_IJ;O>-/G HE.HDA#HRQ*SO^'A9A]HR:_*A/9.IG<D+F>=I
M4ZG5M4\,*UEPPWB0]7D4=6$(8,]E^*= 3"FU.M"3FMK7L[9,=".+V#*AAPO7
M( CQ3X"83B-;541[U%([:D\GHU?D(]0]WM5HU2.6QQ_J4'S/7&IG;L>NM"FB
M=5=$U^MT<__J.!JR=<JF>$K"3*TK2MI3F-HI;()M=G%DEIG!!(L= 845'ODA
M6*.013C&AK8 #1;9PL]Z##/'6J:N-KP2&YDEL!3[L5V#X1N)5IQ_]4[B-^KM
MT.L>W\R.;Y.S9$&4EO&7,8GH>5B/N(B=^T29B"@BMUK!NKO.R-PDXRK>M'NW
M+JNMKT0L\C4,T?8I'1-H6(KZH"!#X<F&8'<C-%]@EJ%M'<[Z&H#9:X!YDJ0&
MC["2,IMC9VE!8EZFL+)")0\A[N%+5,3RE-:]#6X[YN^$YO H(8)7!7P*=/ZS
M(:=#M*[Z#X:'.GN:LU=WI[?Y-N-:[/(6)#,8NAMS /4HVN2&BA^R^<QUIC2*
M4 ]0:S]T;21A/<O9?UE?[Z7;>J K)$>@K@PA?>9Y'IK54-N(V3(QZXG.7MFA
M-O.Z$[QL-I;F6E?I>JO-8I1H">O24UQD0U:[#O-<=&&'&CM18$W//=J9'>W7
M1Y]B>3KX0T2?WOI C5_9^F ]TID=Z69WTCI?AQ"F+L/3H/5-_Y<3/=*9'>D+
MKC9-46LNS,A_Y-FI/<FVK_UC(A8Q?!H/33UV_*D:S9.]L]9<5 _U$30L=<SF
M2G/LVCWMCKGG]>'NI#=OSLB!80]IH6"M= ]-G?,IS,&J.79N;K0LZY/;M=1:
MYO7E1G"81<8 _G\OI=[=F!=TA_^S?P%02P,$%     @ R6RD5D0J5":8 @
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MKO"K@@HM@.]CSM5AHC<HOU,&_P!02P,$%     @ R6RD5I\L?6:-!0  NAD
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MF (^<]Y<-N*N?\7@)@U(@D\,,.154I6*7I6*GH]HGACQ\^QVMIA[ #'@XF
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M!.A]J2CUFXUST,W(T[\!4$L#!!0    ( ,ELI%:9A7B-G@4  &41   9
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MQ>3R%QC>7L'EY.9F<@OSC\/9^./DT]5X-G\-XU\_7R_^.*]K C53ZT$!,'(
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M+;?-"!DM8#. OJ\$W1J+%P-0_K,R^ =02P,$%     @ R6RD5H!=R4$A @
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MU!^]O\-(=G/4!5K4KG</0IM)<,O27#T@;8(Y/PJA3X$M,%QFR6]02P,$%
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M*IJ(@K]<9@*.X(EGN=2Y3,A2L!WTT6<*U(]')X-9:Z][=R,R =,I2R \U/;
M>(-LNP?I>#09G$;6XKL%. :_T 3LH5$ <# X3Q)381?Q2)N((%Q-ME_M(^-\
M,&IMMJ30X/,"W!'P]]/@KNGO+L/1US(<?;,,0[QGQU%(.C?_2XO!R.EYM*YS
M\ST$.>I(*+[[=D&>GPS.V^6=F^\DQ]/3*&%:2FAPOQR)C$8-;R,[$9Q%!TZC
M4N[VZ.PH;#5/_\'I(ZC]Y[/![)>G5?N*[U'(EZBEL#4F<J:>D:<1:#6@!=U#
M8IO?E>-&:FHJ "MQ1F1N#8QD:"F$8DF=(UB"H4)\^<(5>AT3GRL*E528O]O2
ML'U*K*<^*%!)ZC==UN[XLY,=>.C/@45K\M)+B3:"ZV?BX%#Q/-_B)(BY.*#A
MN9_69YNU!$.\+(U^E#@_(B)//7+0H4IG$"$L"N-PCF:B*'.]%5A _NBRU,95
MBEP$4R4W#D(O*:,PES]-?Y%5=/:B0^D>29=PE_U\LWCWRX#-GZPH]Y.M5_ <
M 3,(,+IO$CC:>@319$*@0;DVK-#&Y^'D)&[XC$#8UGM#(%/Q&*(L'D&2\GP5
M7.'0GX;I _;:Z((Y'/=I&OWV_4Y9ABSV&!)MO=#I>H63E%LW\>ZZ(M6#"+K%
MB3_1E:(B$,D"L81P.27A@0("[!+6XS6*%T%S2Z$$:K379@VF639@BS5'MMD&
M5W*@;M&S0[6+^**7C)15)6(FN(' 5Z%>)%WS'7L4>)-O@V@; CI1<-L2O868
M#Q.P!:F'65G(G!N*AP)*8G^'TUH04-&NE]&QK\8"B3&]S.4JZ(XV!SB\>\$I
MW_\^5YJV+XU,@IWP:@8(YA,=,@,!.M@/@V$R*X&0$H$5>.F292Z?-*HJ7\:
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M%CU)X9P6M>X9ZZ8-_TGT+(GK,ZD[W;/IPQ8SUAAT5EP?"K57C<BA9'=.CC2
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M;D'M6Q7_+,6'D2OWGS"3AFJ.>TWI-P^5%:#UA:34+S_L!M6/X_A?4$L#!!0
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M(<,]3*V;X[DOX$W#D&Q31D_!+6&(_UP3F%( TQ6XPBE,0YRNP0,*$=[!98S
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M-%+M^VE!W1F,"Z#SK:;J;!?N!UV_3_\ 4$L#!!0    ( ,ELI%:7+'CX&@T
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MU9PG5'/)1Y:)54[>93&-V_VOP,S:5F=OZUM'*_!CR"WBVB/BC!UW0)];??>
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MT&\1I3%H#LHL0#!Y#-,"%+A)Q8H5RU+*7I,'FB: 0MXP3TZ_0'.*]0:WK/)
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M\KU%2DSY&J6/\M='.4GI D2.K2FX/R_?3%1>"+:1[^IY8$*PM?RZHF%,.3:
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MJ8$\OF1,O.RD+\T4+TE-_P=02P,$%     @ R6RD5LQ8-\@X!0  N1P  !D
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M:_4^ ZX7J/DE4_=OW=$.FA=?^B]02P,$%     @ R6RD5I#93.BI"   -DT
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M;=KAPEWZAC/<VZYL2&G.+0D=R7V<%UM"TV2UR<LJG<-*'X:SGEBX^<]]*/U
M*/V@+Z4?H"I]5#2*A::2*I1^@*WT Z-FG^C2X;K+*-R]KL,76CZ M3P4GN1_
MY(HM;;@!Z[F%*O:QT%1RA=@/^A+[ :K81T6C6&@JJ4+L!]AB_PBH1J(>K>W7
M4+AC'0<^%B)_#(O\EE!MW>N&X6WG%"H:Q4)3J16F8NSV%*AC5'.!BD:QT%12
MA;D8P\DT]H%Z!&Q[LUYW&86[UW7XP@:,6_+ X7"UV?V&6[*>9*CYXEAH*LO"
M7HR#OB(7U6B@HE$L-)54Z2.9<))0A\@=M[]BK[B&PAWK.G!A!L:P&6B)V3A+
M:UK 4,7,Z(E1T2@6FDJNL!KCL*]01;48J&@4"TTE55B,,9QSU"%4(V/FAOX9
MANLNHW#WN@Y?F($Q; ;L O8Z0PLW:3W;4-.)L-#4#ZD+"S)Q>@KA":KY0$6C
M6&@JJ<)\3. 3#?L0/@*";]LKKJ%PQ[H.7!B$"6P0K(.WU>+"#5K/,M13"2PT
ME6QA1R9]?7_+!-5]H*)1+#255.$^)O#A1H?0#:YZ^UYW&86[UW7XPB=,8)]@
M'< VIA=NVWK:H9Y98*&IO$M?%C/I*Y91[0DJ&L5"4TD5]F0"GX1TB.7PBM=P
M^S44[EC7@0L+,8$M1$L4W[%L^?)S\@,.5M3S"E0TBH6FTBLLRJ2OSS5,4(T(
M*AK%0E._*TH8D1#[<PVA\0,+COZ)K N7Z4E0</>Z#E]8AA"V#+8A>YWQA1NU
MG6^H:!0+325<6)6PKT2I$-62H*)1+#255&%)0NQ$J="4\J1'</LU%.Y8UX$+
MVQ!VSXFZ$+ZMUA=NTGJ>H1YG8*&I= N;$O:5-Q6B>A!4-(J%II(J/$B(G3<5
MFC_KT'@#FR]KO('[< NA]&V5S\J;,H6PC?F%6[>>>+A?A=F'70F%70G[2JH*
M44T**AK%0E-)%28EQ$ZJ"J](JKKB&@IWK./ (V$DHF<E5<&?-KA.5L,]L)UV
MJ&@4"TUE7_B8J*^\JPC5JZ"B42PTE53A52+LO*O(E%"E?T=P^S44[EC7@0L_
M$3TKXZHUEELU-MR^]:1#/0G!0E.Y%Y8FZBL/*T(U+JAH% M-)548EP@[#RLR
MY5BU?I+HPEWZ)XG@WG9E0SB.Z%G)6:WA;:._X:Y83TK4<Q(L-/4Q".<3]97&
M%:&:&E0TBH6FDBI5 L!.XXI,^5EZ7+=?0^&.=1VX,![1LQ*XOCZDQ8)LDZ*"
MSY_@5JRG%NI1"1::6A%!.)QI7SE;4U3C@HI&L=!44H5QF6+G;$U-^5A#7W\5
M7[A,W_V"N]=U^,)B3)^5N66*VNN\,MRN]91#/2W!0E,Y%^YFVE<"UQ35MJ"B
M42PTE51A6Z;8"5Q34V:6'L3MUU"X8UT'+JS%]%FI6Q<BN-4APZU:3S74 Q,L
M-)5Q85^F?25M35'-""H:Q4)3215F9(J=M#4U)609WL/FRQKOX3YLPU38ANFS
M4K<N1+&-$88[8#WW4,],L-!4\J5:8WTE=DU1W0HJ&L5"TTJ3R;7)L%.[3HC@
M._F:BVA+WSJ/7BI*YK15)7O<?XDV+78K0OGXLWR[UK*HWZ;Y]B$IUKP?.Q[R
M2;;?\EKOM[PRLF!U&4T>WNMMLFD+[Y;NV$Y%7#B*!J<]#D]Z''WE?9V0T9C%
MK9&&!:<Q*U5)<["3OUH0[1DU?G^6WZA3A=6L1I54$LV!34J/:\)UKKRE@_;,
MHQ[2H,%I#T@JNN;TE6!V0D9C%M4QH<%IS$I%VASL++,61'M&C>EHC2^Z1VM6
MHTJJYN:T5>GH<Y5H=?XMW;/G'?5X!PU.>SQ2H3FGK[2U$S(:L[@5ZK#@-&:E
M6G8.=NY:"Z(]HZ8\M^:G-=&:U2H>2]ZJI?!SOVN$S;Y"2T^M'P$J'$6#TYZ4
M7)RZK\PX%[6\=(P+1]'@-&8E2]=2U[K#<H%:GSH^P5E^Z3]:+S3F),O64H):
MVF4TTX3KSY#K6O=3V%JN;.WVE2+GHM:HCG'A*!J<QJSDOUJJ7G<):6/*6^.K
M!EM:MJ>J%T,E5[UN*7MMK/]XSY9YP2Z7\#,S>&A(J07N^FZC_FU+C^PI;%8Y
M=)U@(A7DU,B1+%1+16Q=%IG'C>MS4.$H&IS&H>1SW-Y\#FKI[!@7CJ+!:<Q*
M/J>E:'>75<YH3/0MSKBE97NJ>O$Y4HUOMZW(-]HJ=VQH(J\VWJ2QQN$6^3[!
M*6NKYT;2VJI1(QF+EDK?#>N'>YZ$5<#[Q"NN^>BEO+@KU1=WO=[.DU!KB,>X
M<!0-3F-6,B?HQ<M=4V5RT^J(59W\1%4O1D2J=NZVE#O'6P*N/#["JGE^>AZX
M]J67BNRN5)+=]7H[/D*MJA[CPE$T.(U9R>VTU'/OLBB8SWOT:FDM+=M3U<OQ
MD53CW6TI\HZZ*+2?%J%6=(]QX2@:G/8T)!?E]>:B<$O,X\)1-#B-6<E%P177
M.RT)YN,=_8M+6EJVIZH7%R75CG=;BL>C+@E6AT-89>./#P85CJ+!:0]&\G!^
M;X=#N 7O<>$H&IS&K.3/X/KO758'O\MI3MS2$7OF>O%?4F%[MZ6R_<>\8O)^
M2TN XQX5H<)1-#B-3,FA^;T=%:'6MH]QX2@:G,:LY+7@PO&S>%<4=8#??M^R
M.0]I>0.0S]]/6[9)-ROR-LGV6X1W#XQ5Y!U_G\WYHK#ACZ%*..*"W"9%?:%Y
MT_#8!WG3L)&.CE7@_D1L+U;+EZP67'1^=G%;]07YO4@K1CXMEV:R#K@A2!:N
MV<*"T\B2S!9<97[V;7.?9ED]^^J7"Y];%BLGKG%"A:-H<!JSDG'R>S-.6$7L
M3\SB&B<L.(U9R3C!->S_II5S>L5B@&NSL.!48@/)9@4MAU5=5\XC[E@1GHT,
M!KAU:[JPX#2Z)/,3P =8AK,]>,6$\:SC&A6.HL%I?$J6)^CM2"K /9)"A:-H
M<!JSDB4*8$OTMZR8QSXHZ3#NL&$WX:[:<]N+0PHDAQ3 9UC=%\V@>;0^;&SE
MP:W;TX5J>T9E/5-H4B6SFS4K5BQF658>]M9>#^K(/_^6%&Q9L_GJC3<8-7[_
MUGT5N_7O1P)F=K--5NQ#4JS234DRMN20SK#^LNDB73V<?ZCR+7]@ W*?5U6^
MWO_U@24+5M07\']?YGEU^J%NX"DO_MQW>_9_4$L#!!0    ( ,ILI%:PWX56
M10,   H4   -    >&PO<W1Y;&5S+GAM;-U8;6_:,!#^*Y&[3JTT-4!&("L@
M;4B5)FU3I?;#OE6&.&#)L3/'=-!?/U\<PDM]J.N'%1;4YGSGY[G'YPMQ.RC-
M2K"[.6,F6.9"ED,R-Z;X%(;E=,YR6EZI@DD;R93.J;%#/0O+0C.:E@#*1=AI
MM>(PIUR2T4 N\IO<E,%4+:09DE[C"MSM:SHD[?@C"1S=6*5L2,X^G)VUKEH/
ME]<7M7E)0B^PNPM\N'C_:Z',];O W2NTI=GW.UJ,-'X!Z15.BZOMO8CX$#-*
MW?=4\+PIX#D&2[R%M]?Y5O%AB!#T6GZ"';@#AW4KC :9DIN.B(AS6'::L^"1
MBB$94\$GF@,JHSD7*^?N@&.JA-*!L:UHT[7!4SZY<-N-H$MKGIQ+I:O<+H/[
M/:FG[P76(Q#(A6@$=HASC 8%-89I>6,'U>3*^2P4U/;]JK *9YJNVITNV0"J
MFTTR43IENDG3)FO7:"!8!G(TG\WA;E010M 8E5LCY72F)*TTK!&U86FG3(@[
M>(1_9CO<RVQKWZI=DXUI!=6FHW$#X-]F<]S;M-&K>(."/RKS96&7(ZLQ=#B[
MU2SCRVJ\S!H!&'L;9Z=%(5:?!9_)G+G%OSCA:$#7N&"N-'^RV:!5IM;!- D>
MF39\NNWYK6EQSY9FW4[+#-?<.4'-_[;.,R:9IF);M.W]8Z[RJQ77[[RWT%Q]
MK>PK1D1VCU]DU#M^C?69XMA%GD0E^Z<@,CD!D;TW^]8\*#*L3QE;1YF=@TSC
M#># ."0_X/@I-DF#R8(+PV4]FO,T9?+9><;2&SJQ?^CL\-OY*<OH0IC[)C@D
M&_L[2_DB3YI9MU"(>M;&_@;+:\?-:=7FXC)E2Y:.ZZ&>32HSL(;-6E\ V(_<
M5)<_@F%<S!^!&)8'4X!A' K+\S^MIX^NQ\4P;7UOI(]B^BC&H7R1<?7!\O@Q
MB;W\*TV2*(ICK*+CL5?!&*M;',./GPW3!@@L#V3ZNUKCNXUWR.$^P/;T4(=@
M*\4[$5LI7FN(^.L&B"3Q[S:6!Q#8+F"] _G]>:"G_)@H@EW%M&%/,!Y)$BP"
MO>COT3A&JA/#Q[\_V%,214GBCT#,KR"*L @\C7@$4P :L$@45>_!O?=1N'Y/
MA9O__HW^ %!+ P04    " #*;*16EXJ[',     3 @  "P   %]R96QS+RYR
M96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY
M/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL
M/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%
MY4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.
MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( ,ILI%;DU<?P1P0  (0<   /
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M[]A!K]ZWM4ED8V(.\AT[Z&I/>SW3,0?YCAV$=K<7*33 '#1P[* ?=\%7XC?
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MR7^2]5WKU5__2VC7N%9E<_1GW0^;^2=02P$"% ,4    " #);*16!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( ,ELI%:$5ZAL[P   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,ELI%:97)PC$ 8  )PG   3
M          "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
MR6RD5O<R[%'G!0  _AX  !@              ("!#@@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,ELI%:]N5(?@@<   @@   8
M          " @2L.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M    " #);*161"I4)I@"   .!@  &               @('C%0  >&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ R6RD5G8^6U.'!@  IAT
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M965T."YX;6Q02P$"% ,4    " #);*16T.[V]20#  "/!P  &
M    @('8-   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @
MR6RD5E'-]Q-T P  Z0H  !D              ("!,C@  'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"% ,4    " #);*16V&UF$6X*  #V*P  &0
M            @('=.P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4
M Q0    ( ,ELI%8Y 4H^900  "\+   9              " @8)&  !X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ R6RD5IF%>(V>!0
M91$  !D              ("!'DL  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"% ,4    " #);*16@%W)02$"  #8!   &0              @('S
M4   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( ,ELI%;\
M!V(]I0<  /\4   9              " @4M3  !X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L! A0#%     @ R6RD5MV]IY*: @  I 4  !D
M     ("!)UL  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,ELI%8A5RLE20,  (,(   9              "
M@>ET  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ R6RD
M5G-I@!9)!   G@D  !D              ("!:7@  'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"% ,4    " #);*16E/"!Y"4$  ! #   &0
M        @('I?   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0
M   ( ,ELI%8>\(^T404  $0.   9              " @46!  !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ R6RD5JFTP?'@!@  #"8
M !D              ("!S88  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"% ,4    " #);*16&13;V?8#  #&#   &0              @('DC0
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( ,ELI%9T[$;!
MA@(  /L%   9              " @1&2  !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L! A0#%     @ R6RD5I<L>/@:#0  *TH  !D
M ("!SI0  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #)
M;*16N@.OSL<%   P)0  &0              @($?H@  >&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( ,ELI%;,6#?(. 4  +D<   9
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M970S-"YX;6Q02P$"% ,4    " #);*16D-E,Z*D(   V30  &0
M    @(%EO0  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (
M ,ELI%8WK[%<VP4  *T<   9              " @47&  !X;"]W;W)K<VAE
M971S+W-H965T,S8N>&UL4$L! A0#%     @ R6RD5F3/;Z)? @  4@4  !D
M             ("!5\P  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"
M% ,4    " #);*16Q^S,+TP'  !W+@  &0              @('MS@  >&PO
M=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( ,ELI%8;.*?Y)08
M ,0H   9              " @7#6  !X;"]W;W)K<VAE971S+W-H965T,SDN
M>&UL4$L! A0#%     @ R6RD5GOK'<2)!0  .R   !D              ("!
MS-P  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " #);*16
M_=E<(BT#  #["   &0              @(&,X@  >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;%!+ 0(4 Q0    ( ,ELI%:1U?G1[1   $*T   9
M      " @?#E  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%
M  @ RFRD5K#?A59% P  "A0   T              ( !%/<  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " #*;*16EXJ[',     3 @  "P
M@ &$^@  7W)E;',O+G)E;'-02P$"% ,4    " #*;*16Y-7'\$<$  "$'
M#P              @ %M^P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MRFRD5K[+,T&9 0  =1D  !H              ( !X?\  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ RFRD5B/5;@VH 0  N!D  !,
M             ( !L@$! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #(
,,@"5#0  BP,!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>154</ContextCount>
  <ElementCount>262</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>49</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Statement of Cash Flows (Statement)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/StatementofCashFlowsStatement</Role>
      <ShortName>Statement of Cash Flows (Statement)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Statement of Cash Flows, Supplemental Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/StatementofCashFlowsSupplementalDisclosures</Role>
      <ShortName>Statement of Cash Flows, Supplemental Disclosures</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000011 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Description Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION Description Information</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION</Role>
      <ShortName>BASIS OF FINANCIAL STATEMENT PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment information (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION Business Segment information (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Intangible Assets, Goodwill and Other (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies</Role>
      <ShortName>Intangible Assets, Goodwill and Other (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Revenue from Contract with Customer (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies</Role>
      <ShortName>Revenue from Contract with Customer (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails</Role>
      <ShortName>BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails</Role>
      <ShortName>EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails</Role>
      <ShortName>DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - DEBT (Long-term debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTLongtermdebtDetails</Role>
      <ShortName>DEBT (Long-term debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - DEBT (Senior Notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/DEBTSeniorNotesDetails</Role>
      <ShortName>DEBT (Senior Notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - DEBT (Credit Facilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTCreditFacilitiesDetails</Role>
      <ShortName>DEBT (Credit Facilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - BUSINESS ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BUSINESSACQUISITIONS</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION Business Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - REVENUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/REVENUEDetails</Role>
      <ShortName>REVENUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/REVENUETables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="lh-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - REVENUE Disaggregated Revenue Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails</Role>
      <ShortName>REVENUE Disaggregated Revenue Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 5 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityCommonStockSharesOutstanding, us-gaap:AllowanceForDoubtfulAccountsReceivable, us-gaap:CommonStockSharesOutstanding -  lh-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="lh-20230331.htm">lh-20230331.htm</File>
    <File>ex311q12023.htm</File>
    <File>ex312q12023.htm</File>
    <File>ex32q12023.htm</File>
    <File>lh-20230331.xsd</File>
    <File>lh-20230331_cal.xml</File>
    <File>lh-20230331_def.xml</File>
    <File>lh-20230331_lab.xml</File>
    <File>lh-20230331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="506">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>59
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lh-20230331.htm": {
   "axisCustom": 2,
   "axisStandard": 16,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 506,
    "http://xbrl.sec.gov/dei/2022": 30
   },
   "contextCount": 154,
   "dts": {
    "calculationLink": {
     "local": [
      "lh-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lh-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lh-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lh-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lh-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lh-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 465,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 4,
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 10
   },
   "keyCustom": 45,
   "keyStandard": 217,
   "memberCustom": 20,
   "memberStandard": 28,
   "nsprefix": "lh",
   "nsuri": "http://www.labcorp.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityInteractiveDataCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.labcorp.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityInteractiveDataCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i588647b555754d81a6f8860fc05eb240_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalExpendituresIncurredButNotYetPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000011 - Statement - SUPPLEMENTAL CASH FLOW INFORMATION Description Information",
     "menuCat": "Statements",
     "order": "10",
     "role": "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION Description Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i588647b555754d81a6f8860fc05eb240_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalExpendituresIncurredButNotYetPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION",
     "shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - EARNINGS PER SHARE",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.labcorp.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - BUSINESS ACQUISITIONS",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment information (Notes)",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes",
     "shortName": "BUSINESS SEGMENT INFORMATION Business Segment information (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.labcorp.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Intangible Assets, Goodwill and Other (Policies)",
     "menuCat": "Policies",
     "order": "19",
     "role": "http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies",
     "shortName": "Intangible Assets, Goodwill and Other (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Revenue from Contract with Customer (Policies)",
     "menuCat": "Policies",
     "order": "20",
     "role": "http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies",
     "shortName": "Revenue from Contract with Customer (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - EARNINGS PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.labcorp.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - REVENUE (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.labcorp.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
     "shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i257716c5617f4dfab266cec980a32b4f_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails",
     "shortName": "EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails",
     "shortName": "EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5bda848179204f8dbc6ca502a1e6b162_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:CurrentDebtExcludingFinanceLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
     "shortName": "DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:Shorttermdebtissuancecosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:A400SeniorNotesDue2023",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - DEBT (Long-term debt) (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
     "shortName": "DEBT (Long-term debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:A325SeniorNotesDue2024",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - DEBT (Senior Notes) (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
     "shortName": "DEBT (Senior Notes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "lh:ThreeMonthLIBOR",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - DEBT (Credit Facilities) (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
     "shortName": "DEBT (Credit Facilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCommitmentFeeDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "lh:NumberofMeasurementFundsAvailableForParticipantElection",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "lh:NumberofMeasurementFundsAvailableForParticipantElection",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - BUSINESS ACQUISITIONS (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i588647b555754d81a6f8860fc05eb240_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:NetRestructuringAndOtherSpecialCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "lh:PercentofRevenueContributed",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment Information (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION Business Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:NetRestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfDeferredSalesCommissions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - REVENUE (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.labcorp.com/role/REVENUEDetails",
     "shortName": "REVENUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - REVENUE Disaggregated Revenue Table (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
     "shortName": "REVENUE Disaggregated Revenue Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i5e096d4685af481291993afb05e8af6b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:UnbilledServicesAllowanceforCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i23a3cf3470c541cc9a118ee99a72dc93_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i592357016e3744b0843e011607824ca7_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Statement of Cash Flows (Statement)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.labcorp.com/role/StatementofCashFlowsStatement",
     "shortName": "Statement of Cash Flows (Statement)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:DepreciationAndAmortizationOfLeasedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Statement of Cash Flows, Supplemental Disclosures",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.labcorp.com/role/StatementofCashFlowsSupplementalDisclosures",
     "shortName": "Statement of Cash Flows, Supplemental Disclosures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20230331.htm",
      "contextRef": "i09319441772b4f6e9520dcf1278f5e65_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 49,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]",
        "terseLabel": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]",
        "terseLabel": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lh_A155SeniorNotesDue2026": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.55% senior notes due 2026",
        "label": "1.55% senior notes due 2026",
        "terseLabel": "1.55% senior notes due 2026"
       }
      }
     },
     "localname": "A155SeniorNotesDue2026",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2.30seniornotesdue2024": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.30% senior notes due 2024",
        "label": "2.30% senior notes due 2024",
        "terseLabel": "2.30% senior notes due 2024"
       }
      }
     },
     "localname": "A2.30seniornotesdue2024",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2.95seniornotesdue2029": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.95% senior notes due 2029",
        "label": "2.95% senior notes due 2029",
        "terseLabel": "2.95% senior notes due 2029"
       }
      }
     },
     "localname": "A2.95seniornotesdue2029",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2018SwapAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Swap Agreements",
        "label": "2018 Swap Agreements [Member]",
        "terseLabel": "2018 Swap Agreements"
       }
      }
     },
     "localname": "A2018SwapAgreementsMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A2022SwapAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Swap Agreements",
        "label": "2022 Swap Agreements [Member]",
        "terseLabel": "2022 Swap Agreements"
       }
      }
     },
     "localname": "A2022SwapAgreementsMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A270SeniorNotesDue2031": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% senior notes due 2031",
        "label": "2.70% senior notes due 2031",
        "terseLabel": "2.70% senior notes due 2031"
       }
      }
     },
     "localname": "A270SeniorNotesDue2031",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A325SeniorNotesDue2024": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.25% senior notes due 2024",
        "label": "3.25% senior notes due 2024",
        "terseLabel": "3.25% senior notes due 2024"
       }
      }
     },
     "localname": "A325SeniorNotesDue2024",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A360SeniorNotesDue2025": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.60% senior notes due 2025",
        "label": "3.60% senior notes due 2025",
        "terseLabel": "3.60% senior notes due 2025"
       }
      }
     },
     "localname": "A360SeniorNotesDue2025",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A360SeniorNotesDue2027": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.60% senior notes due 2027",
        "label": "3.60% senior notes due 2027",
        "terseLabel": "3.60% senior notes due 2027"
       }
      }
     },
     "localname": "A360SeniorNotesDue2027",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A400SeniorNotesDue2023": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.00% senior notes due 2023",
        "label": "4.00% senior notes due 2023",
        "terseLabel": "4.00% senior notes due 2023"
       }
      }
     },
     "localname": "A400SeniorNotesDue2023",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A470SeniorNotesDue2045": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.70% senior notes due 2045",
        "label": "4.70% senior notes due 2045",
        "terseLabel": "4.70% senior notes due 2045"
       }
      }
     },
     "localname": "A470SeniorNotesDue2045",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AccumulatedOtherComprehensiveEarningsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Earnings [Roll Forward]",
        "label": "Accumulated Other Comprehensive Earnings [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Earnings [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveEarningsRollForward",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_AllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Credit Loss",
        "label": "Allowance for Credit Loss",
        "terseLabel": "Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AllowanceforCreditLossWriteOff": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Credit Loss, Write Off",
        "label": "Allowance for Credit Loss, Write Off",
        "terseLabel": "Allowance for Credit Loss, Write Off"
       }
      }
     },
     "localname": "AllowanceforCreditLossWriteOff",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_BiopharmaceuticalandmedicaldevicecompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biopharmaceutical and medical device companies [Member]",
        "label": "Biopharmaceutical and medical device companies [Member]",
        "terseLabel": "Biopharmaceutical and medical device companies [Member]"
       }
      }
     },
     "localname": "BiopharmaceuticalandmedicaldevicecompaniesMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CashFlowLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow Location [Axis]",
        "label": "Cash Flow Location [Axis]",
        "terseLabel": "Cash Flow Location [Axis]"
       }
      }
     },
     "localname": "CashFlowLocationAxis",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CashFlowLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Cash Flow Location [Axis]",
        "label": "Cash Flow Location [Domain]",
        "terseLabel": "Cash Flow Location [Domain]"
       }
      }
     },
     "localname": "CashFlowLocationDomain",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CashPaidDuringPeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During Period For [Abstract]",
        "terseLabel": "Cash paid during period for:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodForAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule is used to show the changes in common shares issued and held in treasury by the entity.",
        "label": "Changes In Common Shares Issued And Held In Treasury [Table Text Block]",
        "terseLabel": "Changes in common shares issued and held in treasury"
       }
      }
     },
     "localname": "ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_ClientMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client [Member]",
        "label": "Client [Member]",
        "terseLabel": "Client [Member]"
       }
      }
     },
     "localname": "ClientMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CommonSharesHeldInTreasuryRollforwardAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Held In Treasury Rollforward [Abstract]",
        "terseLabel": "Rollforward of common shares held in treasury"
       }
      }
     },
     "localname": "CommonSharesHeldInTreasuryRollforwardAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CommonSharesIssuedRollforwardAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Issued Rollforward [Abstract]",
        "terseLabel": "Rollforward of common shares issued"
       }
      }
     },
     "localname": "CommonSharesIssuedRollforwardAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CommonSharesOutstandingRollforwardAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Outstanding Rollforward [Abstract]",
        "terseLabel": "Common Shares Outstanding Rollforward [Abstract]"
       }
      }
     },
     "localname": "CommonSharesOutstandingRollforwardAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.",
        "label": "Commons Stock Issued During Period Shares Employee Stock Plans",
        "terseLabel": "Commons Stock Issued During Period Shares Employee Stock Plans"
       }
      }
     },
     "localname": "CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "lh_Contingentconsiderationadjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration adjustment",
        "label": "Contingent consideration adjustment",
        "negatedTerseLabel": "Contingent consideration adjustment"
       }
      }
     },
     "localname": "Contingentconsiderationadjustment",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CostMethodInvestmentsMaximumOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.",
        "label": "Cost Method Investments Maximum Ownership Percentage",
        "terseLabel": "Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)"
       }
      }
     },
     "localname": "CostMethodInvestmentsMaximumOwnershipPercentage",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_CovanceDrugDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covance Drug Development [Member]",
        "label": "Covance Drug Development [Member]",
        "terseLabel": "Covance Drug Development [Member]"
       }
      }
     },
     "localname": "CovanceDrugDevelopmentMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CreditFacilityMaximumLettersofCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility, Maximum Letters of Credit",
        "label": "Credit Facility, Maximum Letters of Credit",
        "terseLabel": "Credit Facility, Maximum Letters of Credit"
       }
      }
     },
     "localname": "CreditFacilityMaximumLettersofCredit",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CreditFacilityMaximumSwingLineBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility, Maximum Swing Line Borrowings",
        "label": "Credit Facility, Maximum Swing Line Borrowings",
        "terseLabel": "Credit Facility, Maximum Swing Line Borrowings"
       }
      }
     },
     "localname": "CreditFacilityMaximumSwingLineBorrowings",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CreditFacilityOptiontoIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility Option to Increase",
        "label": "Credit Facility Option to Increase",
        "terseLabel": "Credit Facility Option to Increase"
       }
      }
     },
     "localname": "CreditFacilityOptiontoIncrease",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CurrentDebtExcludingFinanceLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current debt excluding finance lease liability",
        "label": "Current debt excluding finance lease liability",
        "terseLabel": "Current debt excluding finance lease liability"
       }
      }
     },
     "localname": "CurrentDebtExcludingFinanceLeaseLiability",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings",
        "label": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings",
        "terseLabel": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings"
       }
      }
     },
     "localname": "CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DeferredIncomeTaxesAndOtherTaxLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.",
        "label": "Deferred income taxes and other tax liabilities",
        "terseLabel": "Deferred income taxes and other tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilities",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DepreciationAndAmortizationOfLeasedAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.",
        "label": "Depreciation And Amortization Of Leased Assets",
        "terseLabel": "Depreciation And Amortization Of Leased Assets"
       }
      }
     },
     "localname": "DepreciationAndAmortizationOfLeasedAssets",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics [Member]",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_DrugDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covance Drug Development [Member]",
        "label": "Drug Development [Member]",
        "terseLabel": "Drug Development"
       }
      }
     },
     "localname": "DrugDevelopmentMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability",
        "label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability",
        "terseLabel": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.",
        "label": "Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts",
        "terseLabel": "Noncontrolling interest puts"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ForeignCurrencyTranslationAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation Adjustments",
        "label": "Foreign Currency Translation Adjustments [Member]",
        "terseLabel": "Pension settlement charge"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationAdjustmentsMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_InProcessRAAndMediaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In Process R&amp;A and Media",
        "label": "In Process R&amp;A and Media [Member]",
        "terseLabel": "In Process R&amp;A and Media"
       }
      }
     },
     "localname": "InProcessRAAndMediaMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_IncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income [Abstract]",
        "terseLabel": "Income [Abstract]"
       }
      }
     },
     "localname": "IncomeAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest",
        "label": "Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest",
        "terseLabel": "Earnings before income taxes",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_IncreaseDecreaseinUnbilledContractReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Unbilled Contract Receivable",
        "label": "Increase (Decrease) in Unbilled Contract Receivable",
        "terseLabel": "Increase (Decrease) in Unbilled Contract Receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseinUnbilledContractReceivable",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_IncreaseInCapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in Capital Expenditures Incurred but not yet Paid",
        "label": "Increase in Capital Expenditures Incurred but not yet Paid",
        "negatedTerseLabel": "Decrease in Capital Expenditures Incurred but not yet Paid"
       }
      }
     },
     "localname": "IncreaseInCapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_InterestPaidInCash": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period for interest owed on money borrowed",
        "label": "Interest Paid In Cash",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidInCash",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Issuanceofcommonstockunderemployeeplans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued in period under ESPP combined with the value of stock issued as a result of option exercises.",
        "label": "Issuance of common stock under employee plans",
        "negatedTerseLabel": "Issuance of common stock under employee stock plans"
       }
      }
     },
     "localname": "Issuanceofcommonstockunderemployeeplans",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_LabCorpDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LabCorp Diagnostics [Member]",
        "label": "LabCorp Diagnostics [Member]",
        "terseLabel": "LabCorp Diagnostics [Member]"
       }
      }
     },
     "localname": "LabCorpDiagnosticsMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_LongTermContractsDurationMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Contracts Duration Maximum",
        "label": "Long Term Contracts Duration Maximum",
        "terseLabel": "Long Term Contracts Duration Maximum"
       }
      }
     },
     "localname": "LongTermContractsDurationMaximum",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_LongTermContractsDurationMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Contracts Duration Minimum",
        "label": "Long Term Contracts Duration Minimum",
        "terseLabel": "Long Term Contracts Duration Minimum"
       }
      }
     },
     "localname": "LongTermContractsDurationMinimum",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_Longtermdebtissuancecosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt issuance costs",
        "label": "Long term debt issuance costs",
        "terseLabel": "Long term debt issuance costs"
       }
      }
     },
     "localname": "Longtermdebtissuancecosts",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_MedicareandMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare and Medicaid [Member]",
        "label": "Medicare and Medicaid [Member]",
        "terseLabel": "Medicare and Medicaid [Member]"
       }
      }
     },
     "localname": "MedicareandMedicaidMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_NetProceedsFromIssuanceOfStockToEmployees": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.",
        "label": "Net proceeds from issuance of stock to employees",
        "terseLabel": "Net proceeds from issuance of stock to employees"
       }
      }
     },
     "localname": "NetProceedsFromIssuanceOfStockToEmployees",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NetRestructuringAndOtherSpecialCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.",
        "label": "Net restructuring and other special charges",
        "terseLabel": "Net restructuring and other special charges"
       }
      }
     },
     "localname": "NetRestructuringAndOtherSpecialCharges",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NetRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.",
        "label": "Net Restructuring Charges",
        "negatedTerseLabel": "Net Restructuring Charges"
       }
      }
     },
     "localname": "NetRestructuringCharges",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NoncontrollingInterestMezzanineEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.",
        "label": "Noncontrolling Interest Mezzanine Equity",
        "terseLabel": "Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively"
       }
      }
     },
     "localname": "NoncontrollingInterestMezzanineEquity",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NoncontrollingInterestPutsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest Puts [Abstract]",
        "label": "Noncontrolling Interest Puts [Abstract]",
        "terseLabel": "Noncontrolling Interest Puts [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestPutsAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "xbrltype": "stringItemType"
    },
    "lh_NoteReceivableAllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Receivable, Allowance for Credit Loss",
        "label": "Note Receivable, Allowance for Credit Loss",
        "terseLabel": "Note Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "NoteReceivableAllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NumberofMeasurementFundsAvailableForParticipantElection": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Measurement Funds Available For Participant Election",
        "label": "Number of Measurement Funds Available For Participant Election",
        "terseLabel": "Number of Measurement Funds Available For Participant Election"
       }
      }
     },
     "localname": "NumberofMeasurementFundsAvailableForParticipantElection",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lh_OtherFinancingCashFlows": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Financing Cash Flows",
        "label": "Other Financing Cash Flows",
        "terseLabel": "Other Financing Cash Flows"
       }
      }
     },
     "localname": "OtherFinancingCashFlows",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_OtheracquireesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other acquirees [Member]",
        "label": "Other acquirees [Member]",
        "terseLabel": "Other acquirees"
       }
      }
     },
     "localname": "OtheracquireesMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_OthercountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other countries [Member]",
        "label": "Other countries [Member]",
        "terseLabel": "Other countries [Member]"
       }
      }
     },
     "localname": "OthercountriesMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_OutstandingStockRepurchaseAuthorizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Stock Repurchase Authorization [Abstract]",
        "terseLabel": "Rollforward of Share Repurchase Program"
       }
      }
     },
     "localname": "OutstandingStockRepurchaseAuthorizationAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_PatentsLicensesAndTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents are the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law. Licenses are rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory). Technology-based intangible assets are innovations or scientific advances that have not been patented.",
        "label": "Patents, Licenses And Technology [Member]",
        "terseLabel": "Patents, Licenses And Technology [Member]"
       }
      }
     },
     "localname": "PatentsLicensesAndTechnologyMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_PerShareAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Per Share Amount [Abstract]",
        "terseLabel": "Per Share Amount [Abstract]"
       }
      }
     },
     "localname": "PerShareAmountAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_PercentofRevenueContributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of Revenue Contributed",
        "label": "Percent of Revenue Contributed",
        "terseLabel": "Percent of Revenue Contributed"
       }
      }
     },
     "localname": "PercentofRevenueContributed",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of remaining performance obligations recognized as revenue in next year",
        "label": "Percent of remaining performance obligations recognized as revenue in next year",
        "terseLabel": "Percent of remaining performance obligations recognized as revenue in next year"
       }
      }
     },
     "localname": "Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Intangible Assets By Major Class [Axis]",
        "terseLabel": "Schedule Of Other Intangible Assets By Major Class [Axis]"
       }
      }
     },
     "localname": "ScheduleOfOtherIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Intangible Assets By Major Class [Domain]",
        "terseLabel": "Schedule Of Other Intangible Assets By Major Class [Domain]"
       }
      }
     },
     "localname": "ScheduleOfOtherIntangibleAssetsByMajorClassDomain",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2022 [Member]",
        "label": "Senior notes due 2022 [Member]",
        "terseLabel": "Senior notes due 2022 [Member]"
       }
      }
     },
     "localname": "SeniorNotesDue2022Member",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2024",
        "label": "Senior notes due 2024 [Member]",
        "terseLabel": "Senior notes due 2024"
       }
      }
     },
     "localname": "SeniorNotesDue2024Member",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2031",
        "label": "Senior notes due 2031 [Member]",
        "terseLabel": "Senior notes due 2031"
       }
      }
     },
     "localname": "SeniorNotesDue2031Member",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated fair value of the debt instrument (senior notes) at the balance-sheet date",
        "label": "Senior Notes Fair Value",
        "terseLabel": "Fair market value of senior notes"
       }
      }
     },
     "localname": "SeniorNotesFairValue",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Seniornotesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2027 [Member]",
        "label": "Senior notes due 2027 [Member]",
        "terseLabel": "Senior notes due 2027 [Member]"
       }
      }
     },
     "localname": "Seniornotesdue2027Member",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares [Abstract]",
        "terseLabel": "Shares [Abstract]"
       }
      }
     },
     "localname": "SharesAbstract",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_Shorttermdebtissuancecosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term debt issuance costs",
        "label": "Short term debt issuance costs",
        "negatedTerseLabel": "Short term debt issuance costs"
       }
      }
     },
     "localname": "Shorttermdebtissuancecosts",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_SwapTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap, Type",
        "label": "Swap, Type [Axis]",
        "terseLabel": "Swap, Type [Axis]"
       }
      }
     },
     "localname": "SwapTypeAxis",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_SwapTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap, Type [Domain]",
        "label": "Swap, Type [Domain]",
        "terseLabel": "Swap, Type [Domain]"
       }
      }
     },
     "localname": "SwapTypeDomain",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_ThirdpartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third party [Member]",
        "label": "Third party [Member]",
        "terseLabel": "Third party [Member]"
       }
      }
     },
     "localname": "ThirdpartyMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_ThreeMonthLIBOR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three month LIBOR",
        "label": "Three month LIBOR",
        "terseLabel": "Three month LIBOR"
       }
      }
     },
     "localname": "ThreeMonthLIBOR",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_UnbilledContractsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled Contracts Receivable [Member]",
        "label": "Unbilled Contracts Receivable [Member]",
        "terseLabel": "Unbilled Contracts Receivable [Member]"
       }
      }
     },
     "localname": "UnbilledContractsReceivableMember",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_UnbilledServicesAllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled Services, Allowance for Credit Loss",
        "label": "Unbilled Services, Allowance for Credit Loss",
        "terseLabel": "Unbilled Services, Allowance for Credit Loss"
       }
      }
     },
     "localname": "UnbilledServicesAllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20230331",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r212",
      "r258",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r280",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r345",
      "r347",
      "r348",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r212",
      "r258",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r280",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r345",
      "r347",
      "r348",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r164",
      "r216",
      "r222",
      "r229",
      "r294",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r432",
      "r434",
      "r435",
      "r436",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r164",
      "r216",
      "r222",
      "r229",
      "r294",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r432",
      "r434",
      "r435",
      "r436",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r286",
      "r535",
      "r606",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r286",
      "r535",
      "r606",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "terseLabel": "North America"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r282",
      "r475",
      "r533",
      "r550",
      "r597",
      "r598",
      "r606",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r282",
      "r475",
      "r533",
      "r550",
      "r597",
      "r598",
      "r606",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r336",
      "r391",
      "r399",
      "r403",
      "r404",
      "r405",
      "r472",
      "r473",
      "r491",
      "r514",
      "r515",
      "r532",
      "r545",
      "r552",
      "r593",
      "r602",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r336",
      "r391",
      "r399",
      "r403",
      "r404",
      "r405",
      "r472",
      "r473",
      "r491",
      "r514",
      "r515",
      "r532",
      "r545",
      "r552",
      "r593",
      "r602",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r165",
      "r213",
      "r214",
      "r215",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r249",
      "r295",
      "r296",
      "r412",
      "r433",
      "r435",
      "r436",
      "r437",
      "r461",
      "r464",
      "r465",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r165",
      "r213",
      "r214",
      "r215",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r249",
      "r295",
      "r296",
      "r412",
      "r433",
      "r435",
      "r436",
      "r437",
      "r461",
      "r464",
      "r465",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r229",
      "r400",
      "r560",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r283",
      "r284",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r534",
      "r551",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r283",
      "r284",
      "r502",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r534",
      "r551",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r229",
      "r400",
      "r560",
      "r561",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r12",
      "r549"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts Payable, Current"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGross": {
     "auth_ref": [
      "r179",
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, before Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r288",
      "r289"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued Liabilities, Current"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
     "auth_ref": [
      "r2",
      "r4",
      "r148",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
        "label": "Accrued Sales Commission",
        "terseLabel": "Accrued Sales Commission"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r25",
      "r30",
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "periodEndLabel": "Net Benefit Plan Adjustments, Ending balance",
        "periodStartLabel": "Net Benefit Plan Adjustments, Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Foreign Currency Translation Adjustments, Ending balance",
        "periodStartLabel": "Foreign Currency Translation Adjustments, Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r29",
      "r30",
      "r181",
      "r485",
      "r497",
      "r501"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Earnings, Ending balance",
        "periodStartLabel": "Accumulated Other Comprehensive Earnings, Beginning balance",
        "terseLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r197",
      "r198",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r26",
      "r30",
      "r124",
      "r465",
      "r492",
      "r493",
      "r564",
      "r565",
      "r566",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r7"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r572",
      "r573",
      "r574",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r106",
      "r107",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r71",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Table Text Block]"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r182",
      "r290",
      "r297",
      "r298",
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": {
     "auth_ref": [
      "r180"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on receivable, classified as other and current.",
        "label": "Allowance for Credit Loss, Receivable, Other, Current",
        "negatedTerseLabel": "Allowance for Credit Loss, Receivable, Other, Current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulOtherReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredSalesCommissions": {
     "auth_ref": [
      "r40",
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Deferred Sales Commissions",
        "terseLabel": "Amortization of Deferred Sales Commissions"
       }
      }
     },
     "localname": "AmortizationOfDeferredSalesCommissions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r55",
      "r77",
      "r83"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangibles and other assets",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs.",
        "label": "Amount of Deferred Costs Related to Long-Term Contracts",
        "terseLabel": "Amount of Deferred Costs Related to Long-term Contracts"
       }
      }
     },
     "localname": "AmountOfDeferredCostsRelatedToLongTermContracts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREPotentialcommonsharesnotincludedincomputationofdilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r55",
      "r86"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset Impairment Charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r146",
      "r157",
      "r174",
      "r210",
      "r266",
      "r272",
      "r278",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r425",
      "r429",
      "r443",
      "r549",
      "r600",
      "r601",
      "r615"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r168",
      "r186",
      "r210",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r425",
      "r429",
      "r443",
      "r549",
      "r600",
      "r601",
      "r615"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:",
        "verboseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r131",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r422",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r110",
      "r111",
      "r422",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure [Text Block]"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial assets acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial liabilities assumed in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r59",
      "r60",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "negatedTerseLabel": "Capital Expenditures Incurred but Not yet Paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Capitalized Contract Cost, Amortization"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Capitalized Contract Cost, Net"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostTableTextBlock": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Table Text Block]",
        "terseLabel": "Capitalized Contract Cost [Table Text Block]"
       }
      }
     },
     "localname": "CapitalizedContractCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r57",
      "r170",
      "r517"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r52",
      "r57",
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation",
      "http://www.labcorp.com/role/StatementofCashFlowsStatement",
      "http://www.labcorp.com/role/StatementofCashFlowsSupplementalDisclosures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/StatementofCashFlowsStatement",
      "http://www.labcorp.com/role/StatementofCashFlowsSupplementalDisclosures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r52",
      "r141"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Disclosure of non-cash financing and investing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/StatementofCashFlowsSupplementalDisclosures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash Surrender Value, Fair Value Disclosure"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r176",
      "r177",
      "r178",
      "r210",
      "r232",
      "r236",
      "r243",
      "r245",
      "r252",
      "r253",
      "r293",
      "r337",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r367",
      "r368",
      "r371",
      "r375",
      "r382",
      "r443",
      "r516",
      "r559",
      "r568",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r89",
      "r330",
      "r331",
      "r504",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r572",
      "r573",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Common shares issued, ending balance (in shares)",
        "periodStartLabel": "Common shares issued, beginning balance (in shares)",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r6",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common shares outstanding, ending balance (in shares)",
        "periodStartLabel": "Common shares outstanding, beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r6",
      "r549"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r33",
      "r194",
      "r196",
      "r204",
      "r481",
      "r488"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings attributable to Laboratory Corporation of America Holdings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r122",
      "r127",
      "r194",
      "r196",
      "r203",
      "r480",
      "r487"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent Consideration Classified as Equity, Fair Value Disclosure"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r291",
      "r300",
      "r603",
      "r604"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Contract with Customer, Asset, before Allowance for Credit Loss"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r384",
      "r386",
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract with Customer, Asset, after Allowance for Credit Loss, Current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingAxis": {
     "auth_ref": [
      "r536",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by basis of pricing for contract representing right to consideration in exchange for good or service transferred to customer.",
        "label": "Contract with Customer, Basis of Pricing [Axis]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingDomain": {
     "auth_ref": [
      "r536",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of pricing for contract with customer. Includes, but is not limited to, fixed-price and time-and-materials contracts.",
        "label": "Contract with Customer, Basis of Pricing [Domain]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerDurationAxis": {
     "auth_ref": [
      "r537",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Axis]",
        "terseLabel": "Contract with Customer, Duration [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerDurationDomain": {
     "auth_ref": [
      "r537",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Domain]",
        "terseLabel": "Contract with Customer, Duration [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r384",
      "r385",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Contract with Customer, Performance Obligation Satisfied in Previous Period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r539",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r539",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate Segment [Member]"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r39",
      "r210",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r443",
      "r600"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Conversion [Line Items]",
        "terseLabel": "Debt Conversion [Line Items]"
       }
      }
     },
     "localname": "DebtConversionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtConversionTable": {
     "auth_ref": [
      "r59",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information on an original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion [Table]",
        "terseLabel": "Debt Conversion [Table]"
       }
      }
     },
     "localname": "DebtConversionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r147",
      "r149",
      "r156",
      "r212",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r460",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r19",
      "r212",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r460",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r19",
      "r97",
      "r100",
      "r101",
      "r102",
      "r142",
      "r143",
      "r145",
      "r155",
      "r212",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r460",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r55",
      "r108",
      "r410",
      "r414",
      "r415",
      "r571"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed within one year or normal operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Assets, Current",
        "terseLabel": "Deferred Income Taxes and Other Assets, Current"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r563"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueRevenueRecognized1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.",
        "label": "Deferred Revenue, Revenue Recognized",
        "terseLabel": "Deferred Revenue, Revenue Recognized"
       }
      }
     },
     "localname": "DeferredRevenueRevenueRecognized1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r55",
      "r261"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r130",
      "r132",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r389",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date to be Paid",
        "terseLabel": "Dividends Payable, Date to be Paid"
       }
      }
     },
     "localname": "DividendPayableDateToBePaidDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r103",
      "r154"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Dividends",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Dividends Payable, Amount Per Share"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date Declared",
        "terseLabel": "Dividends Payable, Date Declared"
       }
      }
     },
     "localname": "DividendsPayableDateDeclaredDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date of Record",
        "terseLabel": "Dividends Payable, Date of Record"
       }
      }
     },
     "localname": "DividendsPayableDateOfRecordDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r205",
      "r219",
      "r220",
      "r222",
      "r223",
      "r224",
      "r230",
      "r232",
      "r243",
      "r244",
      "r245",
      "r249",
      "r436",
      "r437",
      "r482",
      "r489",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r205",
      "r219",
      "r220",
      "r222",
      "r223",
      "r224",
      "r232",
      "r243",
      "r244",
      "r245",
      "r249",
      "r436",
      "r437",
      "r482",
      "r489",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r447"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r96",
      "r164",
      "r197",
      "r198",
      "r199",
      "r213",
      "r214",
      "r215",
      "r218",
      "r225",
      "r228",
      "r251",
      "r294",
      "r383",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r435",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r465",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r438",
      "r439",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r138",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r358",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r439",
      "r469",
      "r470",
      "r471",
      "r528",
      "r529",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgeLiabilitiesAtFairValue": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments.",
        "label": "Fair Value Hedge Liabilities",
        "terseLabel": "Fair Value Hedge Liabilities"
       }
      }
     },
     "localname": "FairValueHedgeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueHedgesAtFairValueNet": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net fair value of all derivative instruments designated as fair value hedging instruments.",
        "label": "Fair Value Hedges, Net",
        "terseLabel": "Fair Value Hedges, Net"
       }
      }
     },
     "localname": "FairValueHedgesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r358",
      "r392",
      "r397",
      "r439",
      "r469",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r358",
      "r392",
      "r397",
      "r439",
      "r470",
      "r528",
      "r529",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r358",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r439",
      "r471",
      "r528",
      "r529",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Company's population of financial assets and liabilities subject to fair value measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r358",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r469",
      "r470",
      "r471",
      "r528",
      "r529",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r172",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Estimated amortization expense, Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated amortization expense, 2012"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated amortization expense, 2016"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated amortization expense, 2015"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated amortization expense, 2014"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated amortization expense, 2013"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r318",
      "r321",
      "r322",
      "r324",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r78",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-Lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived Intangible Assets Acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r171",
      "r305",
      "r478",
      "r526",
      "r549",
      "r582",
      "r589"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "netLabel": "Goodwill, net",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance as of January 1",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r307",
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "negatedTerseLabel": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Asset Impairment Charges"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r316",
      "r317",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Goodwill, Policy"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/IntangibleAssetsGoodwillandOtherPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]",
        "terseLabel": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r109",
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r37",
      "r210",
      "r266",
      "r271",
      "r277",
      "r280",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r443",
      "r525",
      "r600"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross Profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the impaired assets to be held and used by the entity.",
        "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the categories used to group impaired long-lived assets held and used by the type of asset.",
        "label": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used by Type [Axis]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r35",
      "r55",
      "r73",
      "r151",
      "r162",
      "r263"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity method income, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r325",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r211",
      "r227",
      "r228",
      "r264",
      "r409",
      "r413",
      "r417",
      "r490"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDescriptionInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Decrease in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "terseLabel": "Increase in accounts receivable (net)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r567"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r520"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Increase (Decrease) in Deferred Revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "terseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in assets and liabilities (net of effects of acquisitions):"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "terseLabel": "Increase (Decrease) in Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r245",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of employee stock options and awards, (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r320",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r80",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r171"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r76",
      "r81"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible Assets, Net (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r144",
      "r153",
      "r200",
      "r260",
      "r459"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r258",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r184",
      "r518",
      "r549"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Supplies inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r42",
      "r43"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 5.0,
       "parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Joint venture partnerships and equity method investments"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r16",
      "r210",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r426",
      "r429",
      "r430",
      "r443",
      "r524",
      "r600",
      "r615",
      "r616"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r11",
      "r150",
      "r160",
      "r549",
      "r570",
      "r579",
      "r612"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r18",
      "r169",
      "r210",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r426",
      "r429",
      "r430",
      "r443",
      "r549",
      "r600",
      "r615",
      "r616"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Canadian licenses [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r13",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeDescription": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the fees for amounts available, but unused under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Description",
        "terseLabel": "Line of Credit Facility, Commitment Fee Description"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Line of Credit Facility, Interest Rate at Period End"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r13",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r13"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity",
        "verboseLabel": "Revolving Credit Facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r13",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term Debt, Excluding Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes Payable, Noncurrent"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r19",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r90",
      "r91",
      "r332",
      "r333",
      "r334",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r594",
      "r595",
      "r596"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Loss Contingency, Damages Awarded, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r594",
      "r595",
      "r596"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss Contingency, Damages Sought, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r23",
      "r38",
      "r121",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/NONCONTROLLINGINTERESTPUTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "terseLabel": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used for investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r52",
      "r53",
      "r56"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r36",
      "r56",
      "r152",
      "r163",
      "r167",
      "r192",
      "r195",
      "r199",
      "r210",
      "r217",
      "r219",
      "r220",
      "r222",
      "r223",
      "r227",
      "r228",
      "r241",
      "r266",
      "r271",
      "r277",
      "r280",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r437",
      "r443",
      "r525",
      "r600"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings attributable to Laboratory Corporation of America Holdings",
        "verboseLabel": "Net earnings attributable to Laboratory Corporation of America Holdings"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r123",
      "r126",
      "r192",
      "r195",
      "r227",
      "r228",
      "r566"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Net earnings attributable to the noncontrolling interest",
        "terseLabel": "Net Income (Loss) Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r231",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net Income (Loss) Available to Common Stockholders, Diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expenses):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Notes Receivable [Member]"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r266",
      "r271",
      "r277",
      "r280",
      "r525"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating Income (Loss)",
        "totalLabel": "Operating Income (Loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r0",
      "r64",
      "r67",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r64",
      "r65",
      "r67",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r173"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r24",
      "r27",
      "r444",
      "r445",
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other comprehensive income before reclassifications",
        "verboseLabel": "Other comprehensive income before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r30",
      "r198",
      "r450",
      "r452",
      "r457",
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r74",
      "r202",
      "r450",
      "r455",
      "r457",
      "r479",
      "r486",
      "r564",
      "r565"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "totalLabel": "Other comprehensive earnings (loss) before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r27",
      "r31",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r24",
      "r27"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax": {
     "auth_ref": [
      "r27",
      "r31",
      "r32",
      "r191",
      "r448"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r24",
      "r28",
      "r446",
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Tax effect of adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r96",
      "r193",
      "r196",
      "r202",
      "r450",
      "r455",
      "r457",
      "r479",
      "r486",
      "r564",
      "r565"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive earnings, net of tax",
        "totalLabel": "Other comprehensive earnings (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other Comprehensive Earnings, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax": {
     "auth_ref": [
      "r25",
      "r27"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r25",
      "r27",
      "r542",
      "r607"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTerseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r25",
      "r28",
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedTerseLabel": "Tax effect of adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r27",
      "r31",
      "r191",
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r28",
      "r197",
      "r202",
      "r409",
      "r416",
      "r418",
      "r450",
      "r453",
      "r457",
      "r479",
      "r486"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTerseLabel": "Tax effect of adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Commitments and contingent liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 4.0,
       "parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other Operating Activities, Cash Flow Statement"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Payments of Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfOrdinaryDividends": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.",
        "label": "Payments of Ordinary Dividends",
        "terseLabel": "Payments of Ordinary Dividends"
       }
      }
     },
     "localname": "PaymentsOfOrdinaryDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "terseLabel": "Payment, Tax Withholding, Share-based Payment Arrangement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Payments to Acquire Businesses, Net of Cash Acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Payments to Acquire Equity Method Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Cash payments for laboratory-related assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r185",
      "r301",
      "r302",
      "r519"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-Term Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facilities"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from Sale of Equity Method Investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r167",
      "r192",
      "r195",
      "r207",
      "r210",
      "r217",
      "r227",
      "r228",
      "r266",
      "r271",
      "r277",
      "r280",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r424",
      "r427",
      "r428",
      "r437",
      "r443",
      "r483",
      "r525",
      "r546",
      "r547",
      "r566",
      "r600"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r87",
      "r161",
      "r484",
      "r549"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r30",
      "r198",
      "r450",
      "r454",
      "r457",
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r51",
      "r569"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayments of Lines of Credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r8",
      "r103",
      "r159",
      "r496",
      "r501",
      "r549"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated other comprehensive income",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r164",
      "r213",
      "r214",
      "r215",
      "r218",
      "r225",
      "r228",
      "r294",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r435",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RevenuefromContractwithCustomerPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r201",
      "r210",
      "r257",
      "r258",
      "r270",
      "r275",
      "r276",
      "r282",
      "r283",
      "r286",
      "r293",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r344",
      "r346",
      "r348",
      "r349",
      "r443",
      "r483",
      "r600"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r30",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "verboseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Potential common shares not included in computation of diluted earnings per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r110",
      "r111",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/StatementofCashFlowsStatement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic earnings per Share to Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r78",
      "r82",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "verboseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r526",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r176",
      "r177",
      "r178",
      "r252",
      "r367",
      "r368",
      "r369",
      "r371",
      "r375",
      "r380",
      "r382",
      "r532",
      "r559",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r254",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r286",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r328",
      "r329",
      "r526",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r266",
      "r269",
      "r274",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r285",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure [Text Block]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfPayMember": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patients who pay out of pocket for a health-related service in absence of insurance to cover the medical or surgical procedure performed.",
        "label": "Self-Pay [Member]",
        "terseLabel": "Self-Pay [Member]"
       }
      }
     },
     "localname": "SelfPayMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCreditFacilitiesDetails",
      "http://www.labcorp.com/role/DEBTShorttermborrowingsandcurrentportionoflongtermdebtTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r166",
      "r254",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r286",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r326",
      "r328",
      "r329",
      "r526",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentInformationDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONBusinessSegmentinformationNotes",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails",
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r176",
      "r177",
      "r178",
      "r210",
      "r232",
      "r236",
      "r243",
      "r245",
      "r252",
      "r253",
      "r293",
      "r337",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r367",
      "r368",
      "r371",
      "r375",
      "r382",
      "r443",
      "r516",
      "r559",
      "r568",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r21",
      "r96",
      "r164",
      "r197",
      "r198",
      "r199",
      "r213",
      "r214",
      "r215",
      "r218",
      "r225",
      "r228",
      "r251",
      "r294",
      "r383",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r435",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r465",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYPREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYAccumulatedOtherComprehensiveEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r251",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "auth_ref": [
      "r5",
      "r6",
      "r96",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "negatedTerseLabel": "Surrender of restricted stock and performance share awards"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r6",
      "r9",
      "r10",
      "r72",
      "r549",
      "r570",
      "r579",
      "r612"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "BALANCE",
        "periodStartLabel": "BALANCE",
        "terseLabel": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Stockholders' Equity Attributable to Parent"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BASISOFFINANCIALSTATEMENTPRESENTATIONDetails",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:",
        "verboseLabel": "Shareholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r104",
      "r209",
      "r368",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Preferred Stock and Common Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubordinatedBorrowingInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stated interest rate of the subordinated debt.",
        "label": "Subordinated Borrowing, Interest Rate",
        "terseLabel": "Subordinated Borrowing, Interest Rate"
       }
      }
     },
     "localname": "SubordinatedBorrowingInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r458",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r458",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r458",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r538",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r538",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled Contracts Receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.labcorp.com/role/REVENUEDisaggregatedRevenueTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseRightsMember": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal right to use or benefit from the use of natural resources or access. Examples include, but are not limited to, drilling rights, water rights, air rights, timber cutting rights and route authorities.",
        "label": "Use Rights [Member]",
        "terseLabel": "Use Rights [Member]"
       }
      }
     },
     "localname": "UseRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofidentifiableintangibleassetsDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTLongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r231",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r230",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Net earnings, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/EARNINGSPERSHAREReconciliationofBasicEarningsPerSharetoDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(d)(i))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e709-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL108322424-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r553": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r554": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r555": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r556": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r557": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r558": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>60
<FILENAME>0000920148-23-000030-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000920148-23-000030-xbrl.zip
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M8ZM5Y=:G//#!7/,;/M_S'Q*>_@=02P,$%     @ RFRD5O,TA##+!P  2R@
M  \   !E>#,Q,G$Q,C R,RYH=&WM6EMSV[82?C^_ E6FC3VC^\6.9<<SB>VF
MGDG=G!QW,N?I#$@L)1R#  N DM5?WUV NEA28CEMVDSL/"@FL=A=['[X=D'R
MY+OS7\ZN__ON@HU]KMB[7U^_O3QCM4:K]:%WUFJ=7Y^SGZY_?LOZS7:'75NN
MG?32:*Y:K8NK&JN-O2^&K=9T.FU.>TUC1ZWK]RU2U6\I8QPTA1>UTQ.Z@[_
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M4_U.\:@L@@.A_QJ!QK*L$*@X @7M !+!WC*"$7>*+)"PG^"X"QS3?083KLK
M))0KR#)LD.0$H^RV-#I8G7?@Q'BYO>L)N,.)R&<N]E:)*?W';>_"VGPA#=0X
M9O=WYBR9MZ1A*U4Q0']B4T86GK!S#W;$_CPYFTFFXU[5V821-0P]@+JH7)HT
M+2TE<:4VW=&7&^?Q3DH]?X8^H8KJV,_V-H0S1" 2R9I<Y29V^1#.I71DU>7"
ME_WHR9B[1?$F"@J(!1&X.:R^XLT9GCYO0%6'U#7Y^I\(2,3G+O#\ML\-@X>?
M&\*SH05BZTL*($9:1="2#0@)#RC0&XT;.L6Q;?/&ND4U##=069Y+[P&V<FQB
ML-+2B)#H4YB^APA#2G-$F?@_M8WSK0"_E1)=#N O=1J.K/M/9X+M9P)Z'D!]
M4'BZC![082R5@+FL"M>B-Y\"OZ%*%/N04(M"!Q6>4<V?#3P((54;'0^P6YB"
M"YSH8$$46]!4=5PH;.D= L(X%$*'5="5>8ZG@-\A+*,BXJW/3W8GD<=>XY+]
M4,HRB[NVCNF#0#$(@/!HL$)*/=8&J2=&38 *A.:CZ@FGK5@)\D*9&>#H=&PB
M%?$[.$3<_,E:V?S'L]GM-@<;VJN;*_J)9,&B>A].&)6F!-$,MH&95;QP,)S_
M<8R472@^&TH=\A,F'2/21U(W$N.]R8=D8$*\CQ6],A+LQ>'J1>*+P^9AYXC>
M)7I<D!=SP]5KQF9XS=CR8G-LT&P?''QTM-WL?'3LDUH[S7[[X\.?J[;_1;3V
M^LW#7G\GM:T0WAAB3*(KN'Y9Z]76$#/L%K>LLQ5XZZF,6?S[&2"$\1PW^=U:
M6JW_84NC_?%5K>MG/F/]>GC7_X"5M6E=M8>+[HB)SU7_32#M]>POP-G7M[!/
M??'PP[/^X;$+O^S-VXNKJ_".^_(_%U>O+]Z_N1.)?Q1!WQ[8-K\H>(KVEXOV
MV5A"QGY<]&R_Q(/I4\B_7,CWWL5'P1CMC;CO;P:^%=K*+0WNVC=IA8D?Y0WC
MVYH);'REMNQG0VO:7D[AB3.J])M3[OFPK?J-G]F%#_Y._P!02P,$%     @
MRFRD5KGV=^>G!0  V2(   X   !E>#,R<3$R,#(S+FAT;>U:ZT\;.1#_?G_%
M-*@4I&1?"8\\&HF&M%0"RD$J=)].WK4WZ\-9[]E>0NZOO[$WX0U'3W '5?(A
MBG?L>?QF/)[UI/=N]]M@]-O1$#(S$7#T_=/^UP'4&KY_VASX_NYH%_9&!_O0
M\H(01HKDFALN<R)\?WA8@UIF3-'Q_>ETZDV;GE1C?W3L6U8M7TBIF4<-K?5[
M]@E^,T+[O_3>-1JP*Y-RPG(#B6+$, JEYOD83BG39]!HS&<-9#%3?)P9B(*H
M":=2G?%S4M$--X+U%WQZ?C7N^4Y(+Y9TUN]1?@Z<?JSQ9#LAS:TD2*(H;FU&
M*0XWTZV8TC0B[69(?@]121^G5VNTF0GVL3;A>2-C5GZG%7E;&X7I3CDU62<,
M@O<U-[7?2V5N4)["]=7/BLT=9@6A%$ULJ(H?,JM5BQ<3$BFDZJP$[M.UE$9*
M)ES,.A]&?,(T'+(I',L)R3_4-3JBH9GB:351\[\8:H4*NN&T4GH+^0B>LX41
M812\[QIV81J4)5(1Z\E.F5.F[*Q:?WB1\9@;:$8W;7F*%?= \!++*O6)X..\
M\T>I#4]G+PYCZQX8:_U3Q8UA.9P8C%\7RC)]DX8,,LY2&%ZPI#3\G,&W-.4)
M4T!R"A7M,\])GG B%K0W:>=1J71)4*Z1<,(2&_S0#C;1;6 R!B=$Q21GNO'M
M0K 9["36H9AW@@C6PFWX[IUX ^]R8=C<"-:?!8;GVP%O=R^!_8S0"2X9:52(
MT;KSRF/!>46_$Z#6=?LDMCE.JAF>(ZJ8YSM+V9F@F@F!/2DL)!K6+*O5E>TH
M"KH#.2E(/G.CL+M>!T:2##*F6#P#9(TP<;3<9,34;2AE7,-9+J>"T3$#%&!Y
M4<P);HU,5U<VMKM+_P*LD75PX'R6:@)AT/AUL?7FD$,JE1L?H11)88C!0.&
MJ"1;70DW@VXSK+M"H XI1[CO 1NFW&35=L:(P0QM765C97B19"0?.UD3KK6-
MA.M>/V88(&;A=$A+(=#;J)>P'"ZY*O9GR95+]]IJ?Y4.K'6H?KBQ1M<O4\J5
M#I?RYWDE;#=;&!GMKM5N&1T8'3%&!\\Q!";5/DUP'<&Y%)\Z-"L704JX0M\4
MBFGKA;HE$R$ EZ%X3 %(*- MNDH@Z65J0(;4%:\N('!6*2HGRH)5N4'?"DCO
ME3GF:9P$2TTGBCS+ZB;W^<-K_!.$D"ED;T@LV((3YDU,PPWTOR"%9IW%CR[E
MNA!DUN&Y\Z);U)T0-<9".9;&R$G'"CBW63(A8B[$R:O(\_JY'7CMYH8MH0T:
M9.A"\+RZ]EQU[1MZE[81>>VP_2 Y\,(':8^Q;7G;K>UGY]K<1C.;3V+K.R J
M,!!NC>'WL=:LW?)M)X#0E<X+?H],C8H+._F>:+KMG\HU__WF=R]1GV8W#\B?
MQ+#'7K-65UI;7>V^86=WYP#VL*X<[ T'>Z/A\0T@GC\J?KX VJ%DXA!,,I9D
MYMK+R1+!IR'X0(W]JG&TA]RK O& S*!5E:=W@?/=2;FL(Y9UQ+*.6-81+U%'
M?-D?'A["C@?#KR?#PT_#XR^O.GV_/J!K_2^"Y;F#D..;9<S4> GAOZHD'KXN
M7N+X$L7$8X?ZDK:DO57:8M?=:L$6LNI!=Q03Q+ZPW&G*7M6?KI0,KI:06$M1
MFKM+_J&/6WUGZBJ?C%DC5HR<-4B*E6^'B"F9Z9OBGZ5]_/]<R>Y U80!B14_
MIG-1W8QR#=-YVU-?MCWG=^(4XMGUOEK=7H=+DS$%=-'L)R6.<YMF#6;C.I!D
MT3EQP\6"*1[ 0*@L["QW(6NU(:94S/5=@!0%(TJ[F^%9@:+MM;&[I9_?%3.!
MBBB9\P3.;4.IZOO\J $9T1 SG%LH><YM,\+('VDKV7OF*1<"F:"0^6TV"OE!
M%FFI<JZS2OP3>QL()3?:&IFF4!;XQ%K)M+E[I_W3;$^_^M.'^_M)_V]02P,$
M%     @ RFRD5C#<$0$_J $ 9603  \   !L:"TR,#(S,#,S,2YH=&WLO6E7
M6TFR+OS]_(K]TN<]IWHM)\YY<%5S%S:8HJXERB"7&[YXY0@;--"2L(%??R.W
MD&VF,AB!!K:KVY:TQ\R(>.*)R,C,W_[/::==?([]0=GK_FN)+..EXO^L_/;_
M(?3OU]OOBK6>/^G$[K!XTX]V&$/QI1P>%!]#'!P5J=_K%!][_:/RLT6HNN9-
M[_BL7^X?# N**;MRL/]*"J*LMQ%QP1CBCA-DDY9($L,8(<)S%U_LOQ*,!^]B
M0,$R@;CF&AEA/!)&"J]"=-&Z%^&59/"#"SIH8[D/T2CLK/9)\>"HXSP_]F (
MK8,6=@>O!OWAOY8.AL/C5R]?)CMPR[W^_DOX\26\*EVZ."G$\NM)IZ[?7AY$
MO[S?^_P2#EPZL1ST."7JZ\E?OGQ9KB[(=Z48LY<79XPOR ?#E9M?G"M?C@Z.
M3VT?7+IMVSK?ZQ\O^UXGOP+#T%=?[SHH+YW[A8UO2E[^N_%NQQ_$CD5E=S"T
M71_'5YT,^[>^N'D)1\<G^MY)=]@_N[E++@Y>ZI;3=MD]NNF-B#'F977T:P^>
MWO8.!#JO"Z?&K(+?3A_>?/ZW4U\.^[8[2+U^QPY!F_.+880I(O1[(91_)[,K
M'04/1=#<2U>,F_]WSR4"88V^B>E:KUQ^;#[L[&#\V-O[+ZOS5R$.T+ZUQ]=U
M^N+ -[F\:MON_K^68A=]V%D"FX@VK/S6B4-;Y$M1_,])^?E?2V]ZW2%8.FJ=
M'<.+^-&W?RT-X^GP9?7<ERO_]5__]=NP'+;C2OL C57QMY>CGWY[.;JQZX6S
ME=]"^;D8#,_:\5]+H1P<M^W9JVZO&^'QY>FK?&+LCSZ6(<1N]1&.O^U;G[NP
M..F6P^V8_K5T,@@7+W,Z^J$4$1L9N-3")JX)-= US":'1=0V2?=I\YN1A.C+
MCFU#CR*Q5'1M)^8[5MWS:K7=[GW)PG[;ZZ_U3MPPG;17?:74@^WH(P"7:T-/
M#+S-K9!+11G@\8']=>;6>I_?T>W/NZQQ$@[7/^]MF,.MP]WS9NN([G;>\[VU
M?;';VC[<V_@@FN>OR]W6P>'>H<=[&YMGNX?O\3O6;.^>]VCC'(YW_CC:VGC/
MMSZNXUVZW=YJ^2^[G76^2W=9<V.[;'0V<?.M/FV<F8[OO.UN'>Z5N_0M_/Z>
M;*VUR[W#[<YN:Y]OM8Y(8^W#V=[AZNG>X;IHKAWQ=VS[8+=SVMZ"9S36CKXT
MU_XZ;)S#L</WI-G:A'-V\5[+GS76UL\;&V_;NQ]WR?@:>-;)'OT@H3U?MEJK
MN/FQ<=Z ]C77/I#&X1%N'FZWF^>;7QJMQI?=CW\=[!W^E1HE/GW76A\V=O!9
MXWS_O'EX] E'8JF0' PB >93X9"C7B(LO9)8LZB"7EH1=%G_]O*R$MQ'*:A0
MBD@O)%&)AV0=E=)';S2V#'Q!JI2"$EHKQ324XORJ4@@0C"1 !(AE$CQ\C,AA
M[A!-ABA,P94+O+3"V;*XNU(,#FP_#AX)+-[T.IU>=V?8\T<[U7.V3H;9582R
MNU]KPSVTH;ES'2*T4> R)4,A!HTXCPI99A0BAG*JN658N*45K9?E [5A4BA1
M:\/DM.$:-A@A J$J(*&]@4A!662BP<@'YS&A*>KL,$ ;Z&W:T(20I5_ZR[+'
MAA'#.5$J2UI&(R@./L&3=!)1BD]K%1(03- W2!B)';C_J_4NL)RS-T")^K:]
MV0WQ]/_&LVE+>*WQ>:_[Q\'>>4\T#O?:>VM_'&RMK8.4-_%NIWFP>^A9H_57
M&ZYI-]::\#9POQV#=S_^,=AK]<A>ZSW=:C5!TA_.=^E[W#P'B1ZN@Z3^.FR>
MOR<@W=-&:^]PM[RXYM]_'+A.:&\=PCW7=D6#OO_2;#4/]];>L\;'O\H&W ^D
MSD!K0+KKI\U.L_SW^?LLW9'-'S9XXWQ7?(H:$^]-0@1,/,>!#%F@@<@KP2G%
MRD)DN+2"X8\!8.!?F<&%8!]3SF].^GT0\MLR6_%NM/WU;EB#R'>I&/%[>,+I
M\%6 7Q! P/  8M1:#>ZB!A^NJX&$2-YK0A GVB$>4T!:@%RDUCQ0[*,P9FF%
MT)<YR'@R#1BG/+ZIP%OX95 +^0Y"/KHN9 R,WVK/4? Q(6ZC1,9XL/I$&,$<
M$RT!SK,@IB;C/^'^O5!+^:Y27O]RX;-!TIOG6VL-NO7^D[)1,4P34#<,TA58
M(.M#0HI33AP3P5B_M/+^*2UY%40<*C&W[7XMV;M(]O0&R;HH<4R"(<](1-Q0
M@.GH&8+NEM0'ZHT%"T[ E>,MPKTC/6=2!$F<4HI+;JUU4B8?"!:*0P3G_46P
M)C"[F9Y_Q]/F@J#/ATJ<@2I<50DM@R<62+D6'MQW,$#@K#2(F2 CV#IU5-P6
ML;V\G/7KQQ2!<?DXN"%5F1.CKP95$AM4I*CRQZ^&9\<@O4'9.<Z9F-%O!_VL
M0=]E)9=/!P%N\/+R'49/__;(BS<8]$[ZU;<J/_SJ0BE'VO$S&#2^4:R4<?RM
M#/E[*F._J%XHWIA6?K/Y?R]3WZL7KXQ_NGSWX\J)C;^!LO>'F;=6GA7!RV$R
MON[;L:^O&;X[E2%&OCUB=&3\??R0EY<ZZL9^NX<Q3[^[1GG_X44/".B$KS>Z
M.'*W'LCX5C7_ M_&OW>B'9STX\J% *J#XUN,CXV_YWO<V*/WR&7-6H]^KU,_
MV:,GE3U?[K*+(;97'W;6[MV;]\@%S51OYN&LG^[-R_JDM>3*"2$@[ Z:6)G@
M%YP\*)2C'%?(1L?(1F=$L2XA&[T[LM&'(-OW6@C10L4IOO9%*#]#&[X_M:(_
M=MCK_Z3"7KL^_[@6N[U.V;WIMG>%E4NW>'GY[7^(/H8RH3 !_PX([K#F+&)"
M)%::<F]592_D*>SEHK5Q/U/[T=< #SL];I>^'#9BQ\$C0@E'1S4-XZSMSA $
MGJ]9_\_)B",>][KP=;!Z6@)4WY#<'=WKMY<W/N)KEWU]D_L9,IF8(0?EJ"58
M@E \AT +'$3 "7Q%BE0GS!9&-*LAE)E$0LANR[#9?6./RZ%MSXF8I-/: Q<*
M*FJ.L3 $;L]Y4M89\.5D8<2T'8>V[,:P;OM="+@&<R(?Z["+U.1H%_B^\XY0
MYYCPP2H@!7YQ$&[5^Y/.23O7<VT-#V(_G]>/!_ENG^-FU_<Z<4Y$1IEE/C&N
ML!<\#RE80G2,QEA%@S=/B'S3ZH&HG*2>QD@MXU1Y3; S.E 21;2.ZRF0N'GV
MSU-AEY?S#1K$QS%+C$8NL'7"1A*L,#8(X;58/($^F5>?OG!U!$=OO:%4$D[A
MF^#,,TZP<IQ(NH#"?7PN,'VI@IFJ /Y&8 .6&ZA-!&S8F2 <"U;&Q9/J5!C$
M] 6MK-; #9TF@G%#DZ42V"(F,0?!(M)1SF@!Y/M4,3!]2&KP<GHB,,,M<='%
MR$-T&@(LX;ARS!O#C%\8T4PC!IZ<F&($:]'$1B<]L/;D$DZ6^VAB2D$+N3!B
M>M(8>'+RL4H%AI-)0AE.E+.),R&Y4LJ*" QE8>0S[1AX<B)35BK-F0S6)&Z%
M-\G$H)G#W&NGB'XZD4VK!VC4P? 4&#&*IQBLU4))8KGDPDK.GFXH9V'<\N02
M-)DJT4B]<=P%K7E2U)$8A5 J$;DPHIF.6YY8ZI-SQ8V2T6'&95#66@5X3U7@
M2@9-%D9,3^R6)R4?SU.R@EHBH\G%LH[Z$*P#RA2B#U0MC'RF[Y8G-KK.%-76
M>*DC\*?$7&0$S,K29'A@@4RA;FB>O=/T"YI,<H9P 13#:;#![,6T#9Y+ZX3&
MP2^>0*>3F)V*<"WV.!%.N,2)XVALP,8IK8*CQGB]@,)]XL3L5*2J:7*4TH 5
M#<!PB+%*,BZX-$Y()N7B277ZB=FI"#HJRASP(9ELY%83;2+ LU.6,Y;SM4]7
M&CG//G92-9N7ZX - =%($7&BW'NN9:).2N8\=2ERNC"BF48$.#DQ)<ZUMUIR
M$02/4CMIO,>!@0N,PG.R,&)ZT@AP<O*A(@G.H?^Q4EQKH6,NV>722P@P?$H+
M(Y]I1X 3%)DGF/ND!;:,.V,=!M@+2N?0W3,6YI%]O#X9@/$,!CNC6US(KGWP
M:JVT^]W>8%CZ16&27VN^NR?YQ6^9RW$,'\<WN//< R:QD$(D;*S@SC-'=/ J
M&.FUY=JXQ=*,_LG^6OP<V[WC?&!!M.-R:H :854D%,3*:=*.<L)H\AQCKFU<
M+'F^L^Y-KW]\=X._\[/S"F1YFN#'<GCPYF0P!*CO[]AV'+PYL-UN;']]A3?M
M\L>:],/'#OK#;\W=B+W]OCT^*+V]>$X^W.SUAP>KU5Q6NXB*RV.(AA(C-??<
MY](TZ7DR)@8>HO7SD*2\@Q373_J]XQ^QAF=H(7.ILI%R1Y62*?G$!3=:*0':
MJZD,2E"OYT!E%T^3'FJE\)R*[(^6%"WCHG#(RV!+<;+,,VE$X 18@@?]Y3S1
M)/.B1[36W!H#[Z9)SAG)$_:*"\>)X4Y8Z6("RJEUB,3,8\'QW&O2G/'-J110
M&ZYY &<=B18\:N6(,$YCRXTR&C1Z#A2WYIM3P]JIJ&PD1 HLJ+6:<8=!7[W-
M4W@35=032^9 91=/D^:-;TY'<T$_G>9424:YI=HI1E(2+)H 7,&'6G-K#+QC
MB;EDT7MA0(DXCY1J0Z(04JL4L&5!U9'+$Q*_"2ONUXZ)[?2G/5O$<$DPGZN8
M)=:2\LB55E)Q[V4,DFFBXQRH;\TZGZ/B1D(YHY)@;Q6GP>9R4X&)X]H+CM4T
MUAY<(-R]+PFL]?>^^DNL]$GIP!U+/#*2E]<)">=U2:12N.8-M3[=+^\IM<!>
M!V*-X]8E0P)/AO*\>8AC+-413<U#9SB,\A;^XQ1\-\11"E/K:90F,.,]$8S-
MP^HO-0]]CHJK4I0^I@!JBSG'R2KFDF/2^XA=P'0.%'>&<?=9\=#IZ"_03@IP
M&PU.7'GL$@!O<L%JZB0/=0Z_UJ?[Q34L,$:QYY%"')Y'+QFSFGL#*L0%9W5<
M,]G,>B,&@,M^M-TP^EB&V>+"<QE-82<4-XF:&!27/CB25%3.,HR35S;-@1;7
M='0RYC*7^FN8P#AJ@24W'((J&P7V0@(U!7R.<AZ*EQ=<K9Z:&<^E&H/ZY@W2
M#(]YR2ZL=4C*6.6%#IP$;>=(C6N$NC*IEA(NE%(N"<(]C893[5@6M]"::5?'
M'=-6JSGCB5.)=JP/(@8NJ:2)Y]7U1.!.8&>5#=$8-0=:7//$V4#AJ>BOT#P(
M$;1.P7$1DS4V44!@&04 M+)SH+\+KE;SQA.GLS%$(HHP:0"-\Z@GMAQB'4#@
M$&Q($L_#Z%&-4+?4^1A@AKE.U_+ .?8F1.<HR%>J4"V^,C\AP R.KTQW7!M:
MW#HH^^$8%&DABS*$850S MY5&XY=T,X*904HJ<96D7E89*VFA\]/;7D(E$L5
MG;2*^R0<=\02"-83B\R+NK9RGL>T%UY[M:'26R%MD(HS8[3@VBHO&3;"I'H$
MLM:F>VD3Q!&$9-+I-+<V&F\U"\)1A8V+L9XI5O//V0V>& TJ"A*C<0"%4AK"
MO?648RYLY(;/@?+6_//YJ2TA0BBLJ:91@>^V-B7%1="""!P%8W.@MC.,N<^(
M?TY%>ZFW2I!$8Y*62Q\!<(5VPFN3%XYS=45PK4WWT*:@$A8.Z^2(XXH(!V 8
M0=3!8Z:%FX<4T@QCX7.H94S@2:WGB8,OY3%P@X5T/$@#S-!Q/0^K BX""9Q+
MW;'2@#OC4@7J>$K81,R#"C&)@)UA\[ \P RCS[.HX1,&,R(A$L56<\*I(R2:
M0 T7H$01ST,I=8T*5U"!F<B4\)[;P+4W5E-%+ M4)*<$GX>EZF88%9Y#W5P@
MBCG&@Y=Y<Y4$X1'Q*;'$)/@:D^9AE<Z:DTQ)=Q*A++@HL,6.1XB"7"*!4X\-
M<%OCYD%W9AA]GD6]F.+8J;Q2I8"@2!*J(XE81!.5HGX^\N(U*ESA)"EOT*64
M8<EP2YPV3/&0*),6!V[-'-',.V>^7I>]XP/;[U@?3X;9A&TW=*I:P':(GTL?
M?:]S;+L33/'^6-ONMZ7-G'&EZ:QT%B'XACB<2 B?L"2@ST"Y%==. >NN\S?/
MW(3F4J>-)$HX$9P.C*MDG*7*!VR8XXYRQN= IY^AJLT;MYQ.<H0[6^T<)1U$
M)4 S'<<X!:%5=(*1>=KP[!FI]ERJFF(J"1-\<B)Q;9,C.&'E@HE:4.GB'(4Q
M,ZAJ4RI=^[%FO^E]MET?GU;!IQ+4Z2 23M%P$BR/05E-J?19[:6WS,_#XE0U
M]:U5^T::8$F@Q@E.D^212YN,S^L@X!!4)&R>LI@SJ''3*H&K-?S[%3X\D=I@
MSK7CFEJ=A+(F!48-(=+(6L-KC9NPQB5.%#8DZD@XI\(8@RVS6AJ>%S.8AYD_
M=;ZS=)JJ*+%/B2CN)0,?F82DEAB-&8GSD,F?%.F;2_D!4\]K=GG"?> J,$L2
M94D2HY)B(L[#S@9U'FL)NB_FG52XLMYQXO/::PD[R[WPUHJYV$AUML!T.BNC
M:!T==S9A$*8G(+H4.8G"J8AS ?EB2/%)P'0Z\L/@^H(&+P@DQCEJ*''6&<VM
M5Y[+!<B /(N"DV 4"8I) &C*HZ7.Q:"5HI0*3CD)\^\31^([>_5A9['<H*$I
M6&>-MA%SB"><QI'CJ 30&1^YGG\#? +)3<7F.&?"818H-SQOJJ6#T,Y8X44*
M7DKS:7-63>T>@UR/6=15=D%0<.YU>QH?^1F')E5>G-JQ@!D7FN4-=WT@R87,
M3HBNI$()K:7R8ZE01.ADI!*9,@YC:@QU0"V,Q40$'*). GP4U0MA*X^= 'L4
M>]%6!1VB98I!CUFJ S8Q,"JC4UH*NQ#V\H22F9S-8)P,]RP1Q3"7RCDN/0Z4
M,.^3T68>LHUC$;W.B6H?=PYB'+[K>3N$HY=WK%GU%4T8;$<?R\_6M1<R=:65
M)\Q&&GADG+H<+#,@?DFI//,ZT840*1C<AZXKV^T8QN,:"RY6:81.C -YIX1;
MQZQ+V!HE(*0V$:2Y$&(=G]'L#>."RU-@[D*P(*GD>0#:R!*SF'O"&8Z$S].4
MTK%/7/7_.2D'Y24KK=(B-A_HQ\7,,0NOO,322:Y2SDKJ& FA+E)!=-X:8HX$
MN=F%0*;LEL/XKOP<PV87:,5^"0:X.AC$X>#U6<,>]OIOVG8PN&RO&[U>^ )H
MO(CRI<I1(PGP)!HYU=I1(:)DD<@@N++S,!0T%M-;6_;_LNV3^/KL76G!?<++
MW2!-X$G]DQC&IRSHV!#U.E**)0V8\XB5DXY21X(/PF(FYZE\_XYRK;"XV>OZ
MDWX?'K#@\@W..!*UDBY!5(.UQAYK[X0W(F&GW.RG Z;I5Q\E#P"(J2FQC'#"
M>,@SG>%_QG@:A8,8=!Z&8V=!-M-/2UN*!>4^$2PU%UH;ZYTU1'DO/4WB8G%#
M@B\$.<N9G1D2),%W%N2E_,]#QA>4MC0D+;1,G%F>%U;U,1CGF%!2S,/0[-VC
MRE;T!]U>N[=_]MH.KM/;1334:'G2!(ND0+"*)8=Y$M03GQA61))%R+P^Q=H
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MO@^(*Z&0Q< 00$@R*H<YUA%,U8AE/D.F^MSR$#LGQ\?MLMJE\C.0YE[_K$Y
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M27D&CL0MK>@7A,B9*CNOZSUFE#W4=OLH=GN5*1B?YWV!W4;.4J[_<$@SJQ"
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M9==V?9P0=7@6 <RDJ,/;4=?72/1P)+IA7K6@AE&E#6+.^TP<"#*::A2$Q$$
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M\XEQA;W@Q'MC"=$Q&@,P"=[,S28MDNU^]+8_+MD4#RR!S$8\:* WT-L@WK1
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MLW5U7"XY#@AO/QW9KT6KS(4#/TUZ](2U)%!%D-(>M$ITH%4\<""&F9Q+A+B
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MIS=YB,)F'I6R[3 3)4W9Z,1)*R^M0%Y%$!!$:&2YC4@$HRR)VNN<_X6K=;U
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MGL$P[:>=X2 =P!CMMS.SY?_?N1R3@Y@K[OA^#'5&PG:X_L:5*PO?S<1W4TY
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M=#B=RJRX,BOH'LR*B(&^B$0L)HRX9PPYK!S2GGI+@V31Z_%981EC*1_/ [7
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MO='/ #$/EX\J=7R=40AN,E "F>O?'N=#;+MH]V]0),-& *+@7^A8^Z%>&5[
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MAKXO2TYGA*5CPGF'*=Z"0U:=* 3S2@8ML9:41ZZTDHI[+V. )9OH6':L%XI
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MO)@/+R9R7YR1X%L:BG2P&''N(G+."L0!]Y4EQ HM%^BZE.275>=_J6[XLCF
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MT+II:E&LB)9$(R%M0CP(C[13#H$W+["SEFJOP-3"N,#6[X>M1VXUOKB UW.
MM!"C%QQS9;WCQ&L=4@()X5YX:P4IAXY+@K2)9"9-2!+$$J1PBHAS8Y #FQDY
M2T7P8#83H3>V]'(1[?F"VJK98L\!N[#6T7%G$P8(\P0 *T5.HG JXMQ1KV#7
MDB)?D]E5/G*+/8N(.&K!BR0":<(PXL[8$(FQ6/!%9%<5]"KHM2[HA86D04OF
MI.'.44.)L\YH;KWR7);<T*6AUT2ZE_,N*LTQ\C;'P!*G2'/ND7&,< 8&=$AA
MV3&P EX%O'YCDRVM)5=."*$$#YI8F> O.'DLHJ.EE<WRP&LB_RP%$0"V+ J*
MYQ[Q0B-- T,X:285=X1R][MC8<^4@OE? ^M:$?X;FM^W_AO^&0^I;7M?FIWQ
MG#&X_^@O>3+H=>3X>MH?--/9\$_-3@#9>4G8IJA0;J'O2?!=+TKSBWX8]XYO
M=FJ#XUC[N+F_6?L1>['V?V\%E=-^N!F(,HH$Q22FC/)HJ7,Q:*4HI8)33L(=
ML74DQI!RVD=?K#UY.1[6]4X1@&8H= =H],T+A)'K"3"M^)\/9T>?P@F KLQ_
MVSO8Y8>?WO\X.C@4C9WW/P\__=FN[[S^43^'MWF[BP\_';)#>I3!XNRSD((K
M2C2"V8R(!^R0Q5(C*:C/S:Y$LG)CB[XPPFQ.IB74_C%GJ/%A*[S;>/-,M,9#
M%I5^QMPXD@.%3%,P5J/A2"M85"M]X"DYQE0$8U5O3CK;_^^?%2':/&)K: K6
M6:-MA <;[#2.'$<EC$K@].L[#($BMO.N\"'^3*R20H6$L*8.<>4I,M(E)!+1
M*DF)&14;6^P%P/ZF>+#8/G"%B]C.LJC\,XLPS81)6-1<?ZBH1RZ9A#BEWJJ4
M^R[G/ NY:::)+<A*I7L'Q[T8:VV8U>-^+8)Q$&IUV_/'0U..D1>U#*TO*C'/
MJ_6BUHO]DPCW^1Y;9YL7)LNO#11UW4!ACVEZ5'><UO5!W31&R+#K0ZW:4S U
ML(W[@_[U5QI-7>.T#0_TTUXQOY!:<8L+7K+9\:>]_O 5:X-N+9VV4K/5JD0W
MOWR_]J,Y.*YY&'H7WK6_>3DMHTO;\!JC[\/-6J<A@LF=!C\L&&[-]DDKY@ML
M!1##J_*>Z<?!Z<GH][SG/-C;%NP^F+QO<5"SWL=^/YONI_F+\-3[[:CAU%Y;
MJP5D8EQ7-*_L2;6KSF,83\TK>*^#;*(?P(/^:'7]M^>&1%_KN/[^LY=)I&@C
M$@Y3Q$'-(!<202%QS1CWA@:\48N UR<PH8/>:2:6K7R;"^]PZ,N!0+3L23^^
M'/_P[S$;;;-3;>OJ2_^^OA=@\6_Z<97D#3_^]X]F&!R_-&932)+C%J-ZH-&#
MAY^2S2JD<<-E'7XF\::BMW^,-\FMG_WJMD1O GK?Z[:__DPPOOC!JLTA7,YT
MV]4E*IZCP<<O:L"R11)[OR=V,('P$VJL"AY42KLVUM<S!$F?[$SL1!^S53J>
M##K#9*S([IRUH/NN>L1V,X16_/VV1C7_^V"39SNCW6[V^]D8L'TP B8J$V<L
M2[UGM/SW56G.."O_]_'>?TE!S1E??([0@(C8R,"E%A;L!D(-,8;9Y+"(VB;I
M/N_.%LC;]AXLC%!MQ%<7^_#5::\':+7="8UNMH7S+^L>%A@?%[0;YZUVO7WX
M<^_@SV,8PWF]_7>S<?Z1'QT<-_=V6E\;[4;[$$8T>5QPR/8^'9X=?7TMZNTW
MS<9.'>S 7=8X.&[MO=V%<=<IV'GY[=-%5>7^9>=[XYE5D3J4CZ$1UX8BPY-'
MW@7B?-)<![^QQ:;%CE:O[^LBN2<*O!5XNP%O5"A%I <O1"4>DG542A^]T=BR
M[)16\$8)+?"V+'@[OPEO4EG+H^ ()P'P%KU'-L6 )-B87!GXCY,5O"V*R'Q)
M\+:R]N_]^#B6:O_NQ!1!^L)%9&TR?C8#2\<JY8.LKJ5W2TBN$0OTS05]S4G+
MCE-%-7<61<HR"Y%U2-M  0D-=@%;C:OB<SZO9?=X(#9' M?3EJY%&1I%NA8E
M71.&!8V<,4<LDBH8Q ']D L6(RH"49Q))CCH+R(VYTRR>H8FPOU"9$N5Y8JS
MZYZFX67*5RUT3_,)RGB\Q:5<V 0]&56PL)!:&R9\L)?&QFW6 _T/L64',1QT
MWW4[7PYBKSW6$OVB'^;1#V=3K*^8F*"$H42) .N+)Y35. (=3CB882E0L[$E
MZ*9<K..Y .%9C\!;@=$"HTL(W148?4P8G3"SN4PJ22P1J,& N.41F9@"LE2(
MQ)(WDFB 4;;H^-W*P>AOM=XOJA9NY,[-E]*UZCEU(,NP#.?#A+?>4(9S8EU_
M^OEWE0T'/W9]L[KRQ)[UNJU6;6!_QOX#TC%_V/Y<^=</I"2:BFD7\W");#=.
M)]8>RNZ=(=<X\&>?B18J1,R0E$XA+@1!1K*(4L1.<J(S-?O&EM[DD\G7\^;7
M/[#0KJSO_.LK/FNA/8XT(><\@?7%&O1,CITRL-6MC%ZJG(L]1<W<R*>NW88J
MX>Y3A74&D5M"C5=GX_GNL//W/SX;Q9(.3B!"DT6<.X><9 QY[6&/1:TP41M;
M="41I"SN+Q>7?<Z=;[W%%"6>$N*><&2]L AD"5/CA8LZ-[;<G.0GOU\YQHUZ
MT54JQ]CV/KM(_=J'Z&/S>S8D7]0^=AP@'<#8?NQ];_HX-*8^=J+M=>"OH]*@
M^[W\JIN9!P#H"0S%[@_P#&K#G/F37O=[,U0%M,.:M\K,=-W3JJ!B.'^]*_-W
M.IZ__FC^AMA_.I[ 4?>(6NIUV[<6A+R\W_R*J?/[^,4:H[?X!._P:O0*V]D0
MW^Z$=TT+\]$<G#WWTHWS^OO/C%FC?'+(*@8NL@+MDH/%*' 2)(Z 0(DLN72#
M8+R)AR&;N6LWV";6]RND^&4YA-SDG#U*[<8C%)KDP<Y6:%*J)TKUQ*^J)Y[#
MX>S.SVE*M)0OE/S>._PFT C"818H!]M%2Z6#T,Y8X44*7DHS1_E"M?LN+>"W
MO6[_:?,;C$X*OO&]@S=?]PY:[</S#\>-\P]->-;QT<['GXV#HV;CZX=O1Y_^
M/F[ -3=/"O8.OHCZI[K8^W3TM?'V-8SI3WBO-]\:!Z])H[U+88RMHT^O2?W3
M]$(&083+9!=("L81#RHAK;5 EB1&M/:<5'R3+P@CBSYS?2I'J@7KG@_68:D,
M$]BQ@!D7FID0DP\DN9!I=8F>HY:A8-TC8]W$J:A3U-+ #1+4>,2I4L@FFA!G
M5 :E.<<A9*S#?!IYR(IBW5JW^IS5--V9Q32=A[#R:2="1Z:,PY@:0QVWWEA,
M1, AZB0H_$\7BVQ54&I* 0*+&L!(1,1-!(LL$HZ<90$Y)HW25!,B?48I*N6\
M6=*S@D$I3EB\3&JK@@[1,L4(UY;J@$T,H'FB4UH*6RR'U9')"<M!LRA"P!XY
M$AQ8#HXCRZA&SD4GL' 4.U'))-'S>DE+L0'6,#SU+O-E94,@'PG9CH_5L7_.
M,ANDT]:%?7 OHV#*=*P) -U.4?B(.?'C%7C3[>V,YG\2E0KFS(,Y4U+AO0]!
MBLC #B#P3V:?U9F=6G'#L,4*/)=8I<+K"<#YY[Q>R@H%78K +C[[N@CL(PCL
MA)% @A%@U1$D@K2(>ZF0T48CD-7H:3*Y+=G&%F=3J&:7(K#/(7*P_8 3K>LT
M_??IXKIRTS%[B'>^EU]MS%T.%=<->&W$P:LQ.TUQU1:#PHU7DV8399YIIB**
M45+$M=;(&*(0_)%8G*C@F=6=OF"<3[&<'M3)8_&-:^\16+F>G/2T4>N9@=,"
MB;0*./T.<)JLRTM4<BX,2H!%B"OE46Z8AH@)B5J3K*<X@Q.E=.[8[J-BT,A6
M'#_L(E.W@IY%>WXSW./*V]XH-ES([9<QQ.=@CE>AZLFT[(<<5ZRY"IOI%9^,
M!EL8_]EM6>ZCLY"BIF974U..(*TUQF%FD8]*(8X]1B[S<43"@Q=)&Y;8QI8B
MXN%I$DL[@)SUT'%MH.1I(L;".-T*8BP0,28,6Q^)5TPD1),&K]LZAK2F'&%J
M>73!J&3#QI;&<R-&.1Z=XWBT%[-%-3P9O=/(*@<MO^5D=&]P''N7GG;_U9.B
MJ/Y-B#/E>%12;%W  04:P)465"+-X-=D///>.(MS2TZ"R_'H4Y7:QSP>+5*[
M$*F=L!-PX%:8))'S)I>;"(RL=A8EHFF(1DC)=26UY8STM\G<QX>&8Y[%64,Y
M(?U-(9RK9Q$%;6=&V[TI9Z$*6T*""(@0K'(>60#<)1XQ+7#4$2?+Q,:6 J]L
MDF&EG(2N$SH],Q!Z]*A0 :'[@M"$R9>B=]I1@4R@X*B9()#U+J?2.XHY95Y:
M#R!DQ!0.KW+B^8Q//-?+AKY.*75/O3F=/[<8V ^>FB>C^1[3_+[@!RLZ;YY4
M\(/MP06SQM<ZKY\?BL\!!XF5ITA)KA'7CH&^HP%A[&#)P6)1BF]L"2TWU6(M
M[P>)R3+L\N<,>079?I--7Y#MWLAV=A/9M$S29J;6W!64"Q6155@BFIA4#.QY
MDDA&-CIW3&&) +9 ^GZZXKRJ(]+8JB*F^Z63R8EKX;17D:P>Q]H)W+4;X$<[
MJ/V(O5AK=GSK-%-I-SO5!1/DJ<ZVJG)<^$+^W$68B4Z^73==O6-ULZ5R;8\I
MW$<S</&?\320=0>'^U.B@O#7WW^VF'M#E4,V@*G"B05/G3J*@O-@;F965&4V
MMH@44WI?+I]MNRSOKY9W;_LS"U+IG'P> JPQ3\XBPYE%@..9 BXH0W)G4\FF
M')D_@&/_%T3=^2EY4S0[IQ67\S64':$6SU2Y)]U^,U_PLNH, +>Z9,C-1L:5
M;XU &5]^Q3I0%J>#V[\R04RZ)&36-R;GRK_'O4NC^DM$KA?M-V03C/6E;?VP
M9_V-?UW74*",1O=662'=?/5;7S"E1WO!H0H$">[VJL5^"3Y,[.6K8$QV9<92
M@PT.^/1_FI()(UW001O+?8A&86>U3XH'!QJ)?P8';K>Q\_I__OM?=NM6CO#?
MO[DF^&VKS?5N^X^]#]L'>Q\.:Z_V/OR5?][=:]3VWM2VZZ\_[+[:KOUG[]W.
M;N/M?FV[L5/;__C'_N[.[O:'W=?[*_]NC;V#U_NU@[W:Q\;VQYW=@]<[\(ZP
M,HW]X4_[>^]V=[;SG]_L-K8;KW:WW]7V#^ /]=>-@]5_O7^$3"S>&Y+_]X]M
MKR+ K\&36KD#S8M:_.DC&+Y@: T_K@4[L/^<AB8W\':H!I/0V'L%_Z&4<^]U
M<"Z0R$ -1X4]VUB[C@K5M+T"6Z YJ+W+%2<?8 9!@_VPO7 7F__H-5;:AL^]
M$5YUV_#DLUJ$L;7M(/?2.AV<PN+'GUG=@EYNP9O#GW.+A)F:(U3[J],=Q*O7
MU;K@.%6:OQ?;MED9]IGH/@X-O)%Q/S+UFYW^H'>:._-LUAZYS\'5I*WA2K^K
M7G>O\Z;9@;_#.*^D;SWWA@=GC1^?<]R1L."1-\[E3CH!:<T8P@06(!)A::1#
M&QW@(8;M7 (J.;<.AT1,\CQB8@WFT1J+L?+28W.S04+>F+U+6;NP&J^3-OFA
M9([VY[R691,V:G_4&B0WY[CIK=\MWC=:<UR ^U1TO',*UJ@KA&";A)F%-UHP
MFU3?KWW#[V\*H3:Q5FLR5M Q3*U+MPVSR=ELXUEBLXUV,X167%*+B2DMGIYS
MQXV)YE9+GHRE[HT&F%V5_54EGE_9(<N>E:5ND8,N&/O/KA'+'^. >C_;U;]N
M3/,0!O*G=)+ZP)<OAZC/F#*P_?%'8\<+>,YY8^?+S\;7#RWXG1^]/6HUSK_
ME1_9T4&=UP^^3?1I/SK8QHWS;_!.=;RW\YHVWGZ$WX^_'<%W]G; ^3H(K?KY
MEY][![=T7X&%D<1&1"R3B.L8D</<H<P6J#"-1@E\"V7@@ML1K%*-6T&T@F@+
M0[36\<NQI3DV-"_ +5V-'14PFP_,)LFMB/62L8",B09QQ@VR5D>4&*_:KL@D
MXRVU?07,"I@5,)L)S+*G>&F!%2A;!)21";M,L2@R[9%-N7 N*(F,91%%[8)+
MD43,Z<86?GCR;D&R@F2K\]:_%\D*=BT"N]@$ ;)@"@=ED-(N$Z. 8^D<CH@Z
M+&%Y#$D^]XW@:P)>SX&!X:_6:?_%U6/1ZA"_TR\M[F[/#L;)<,\240QSJ9SC
MTN- "?,^&6W8S-G! $2C2M_7H\2):^D$L PPB:.0[/YQC(/=]@D,K]OY$ <6
MWB"\MKU\20&NN8!K"NND8H$[22."+0W^HV,F_Q20-4;:Z+"5,:<?DX61%?Q.
MV^K&(^]%Z_0L!%LK3YB--/#(.'76ILBTC4F!O2%<HLL0[*N4Z*GY,P9T'GO=
M(O#S"?Q$P,AZIP-3'B4E(^(\6RHJ2118D"9B+3BL+<BV!CORWT7FGZ[,2R-T
M8MQ@1TGF#K4N86N4D(;#/B"XR/RZROQ$9"5PX25-";EH".)8.:098T@G(@TU
MPD?"BLP_ YE?6'E?,>"7)-N3D8>\2H%J)%DN#0[.(9=;X1'""#/1>^;URAGP
M=\07QEF[,-CX:RPH5UZ_\CFD:F76[1>U'[WF(-:Z*16.[=\3L)D>.?Z4EV$O
MI8+C<^#XM!9Z,GJ=I$U(&<7 +Y,<P6IA1'0*V'D+;EGN=EZ8M==)5I<4@BFB
MNDA1G>335MYB82+"A!K$HU#(9),K!2)YT"D:R?)!]21AP_W.>HJ\KJ"\+C)\
M<I>\EK#((N1X(BPB3= D:H^B)P3Q1 S2S 44C/ B*:NP,PL+BQ197F4[>8%Q
MD:)\%RFT$_$.+*R)D3DDE ^(RT21HXH@IS$707"A-,MV<NEEL:3:J:I^?%PX
MQ1;*J(E_Q4GWU'/>%C]!JXW?*])*K!1@/0S"IQ1@X4@L%9(C#!8TXE0X@' O
M$99>2:Q95$%O; DZ)=;Q"#2]<\G,DD^R"GH6]%PY]"S%7H\$G).!IZ2MP&#Q
MPD()Q,%(1=HDAPC7@AF3J(GTEO:+!3@+<!;@7#G@+(5EBX?-B3B?<=ZY& )B
M*:<_*:N1CE0@6"*)L>(N9?;T!126%=0LJ%E0\_%1L^#D(G!R(K1J)?7*4X.P
M\V!>J@!^.;<" 7ZF9, [3U%L;$G^\(/-E0'*B1X4UYG1[^A"<8.(=]6[4&2B
MT"GU;N,F$ZG9ZP]J_WMJ>X/8JYWT0/)Z,(A:1?\>0VW0'5&&QJMDM+UF_ULM
M];KM6C_"5-M6S37!J/''5_EL1^TJ^C>HZ-=H8JL[SLZ#_%?L58>V.2R^YV#4
MU8;JUSYFRO/:NV[G"SJ(O79MW#>G?[^)677.Y.I%!_E%_?A%QRU+QE3*\$&_
M"?ON<K]U4RV=MN '>+S] AO/PXVS!,/H3T,31O>C.3B&3;NSLUG+>]JV<X0V
M?R_^A%MEMN23*_/?O3+_IYT^_-1/3;AM13]?ZY_"5FU-&>?<O5,6%86^:*(Q
MHGZ^LI<NM]+UI(#.:1N%;D6NGV^[[IKP 4TW_,_ZC\]@[GN2J$8P^P84F0>#
M7\J$8@+]IGB,S((BXR\4Q9MX2E>5RW.LZSS(F[#E1E3?_0R'%]U\:O;DI-?]
M67&"P\:]==/ .KG86\B^V6V\N6(1P1[)5)+==$$8?D4"K@C 9?\AVQ_U$FIV
M.C"4LVA[%]L&T6>V;QH'[V'L'PE832PWW?H<F6&$>XF(\0QQFR*R(064HB,:
M4Z,5,QM;;-KV^7]C8O9+[O;;T&C:@>F+_-=QFZ<+'OB\1#5"1TS=>1_^5W\J
M:GV)G:R$L]JVG2]QJ)D?B18>]ET&^*S(+O38SNFPN4<=WKQ]VKX&4Z!%_,MP
MVAONM6>UP<!<_U'?_JQP2LH+@6 B)>)$<.1D) CSF(1DV@6<NP'=Y%?/6+.,
M-;0_RQI>7\/&E\\VI_T)Z7-')XHX8Q'6T!OD$Z<X4:F$"U5?H1MKF&=L9@/X
M1G\[M>)VWJ>Q0?9B#%T5LBVU\]RTEI133:G]L46XV_D+1M_LGO;_JCIL/&,S
MZMOYWOO/)F)F24Z-= G0"M. C+48X6BUY8HK7)4DX"D]Y)??F:XL_T.6'P/0
MA<0$HYF*30B+.%<&&:<#$I8'#M91)@L!&XA,B9L/G:?IS2YG:SER2R^[%T.#
MYC:#ZK*#YJ6;![AT,EK74>><?G8;FY=6ULU01V7;VY!1-K?5Z5^-@/CC;%95
MO:#ZOGM2!4^RMSINZ#/AK Z[\N4;UEJQ#U>! S& N[ZX>JN+?D(S]>H;MDBY
MJU,:4QOW43.CJ!K*P?>71-^M>%"^:$E=NMCF<-=,_OO(G9#^..W#8/K]5]VV
M:W:JM=EI]GVKVS_MK4[/H[,Q;GBQ=_#'MZ.=/YOUKU_X4<:-KYX#AA#  W:T
M<R@.S]^?P^>3N''^3=3??O@&]SS;VSEN 6Z<-<Z_ (;\?7RT$[XUOK:^-G8:
M\'GN>70HP,@55#I' T;4TLPP EZ42XHA'6-,7%$>3+C9\X@Q:7%TFAL50=L(
M4# D$8.ML0:6)]SL>?3'Q_W=QNO]_=KVJ_<?=_=W<U^]_=K,?8E6V9::WA'I
MS@G:VKD;8J\XF5=#<!FG>Z%J2C:,X+:CS?LX@]^XV=A5.,S-HS(TUZS_W]/F
ML.-G_\40):LA=&L)A*)5^VY;IV-7%T PC)K%U@;V9RVO(SH]Z8]">%=N/VI^
M/(Q)5QVG<I1_6G1^9E-Z<KW7J8.4E/!-,6OSH+6H4Y_G];.%869[_<5U.5K)
M*?O%*\U[?/X[6VZ:F?K.U*^ SM  KVU?0841O!U4T%8?0MOKVZS'&U;4<V%&
M>&7[QQ72^OQ#!' &!,ZS-T,_HY7<\'.PH-)GE5\R]_L_G?01S%T(%LSRY'D@
MWK+$+.:><(8CX6GN.-$44_ZO7O<[V#5=L&%V.\/@)_RR"X-JVG%!",SL;L>#
M!=6*@W@)5*_R<2:L2?6-@Q[,R=#F69U@POV<@F%RRM</W^#^=._3G]\.#^KG
M]:_O<S(*C!$<@4]U<G@>CH_:?QX?O3UJWDQ.:;Q]#]?!/=L?CN&;9XV=G(S2
M.F[0]_"]O[\VZ)OV8?O--_C^-7;XQM==7M]Y_UDK&DT^Q".,!/ J2$3:<HR,
MITE)QSBS5=$]73S!\J]%JW @/1Y?T>H-N$Q"F80R"6425H[(;0WKQM]VN^%'
ML]5:5^]D)@*-]>45G8= 0WCE)99.<I7 -!,Z1D*HBU00K92;Q2KOPPO#3X]K
MGN]V!K;SI9E[_!:+? Z+?&\*?0Y3B>G$ W(\MP[ 4B'CB$)$1H<5!YL\R2I'
MZB%4'+^/=/1)1( N]W?-]OMQ?2,_3YR<Z.D$/ JBWA-1IQ0J2@989[E$1"A
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M_;;7.\NG!K8R2G*\_\MH)]12MU==,Z@B>>UA)"]>1O*&FYF1%[6\O5[4\HF
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MP>OB"2_7=BKNY$=<?4EZ7MT&W_:Z_7[MU?C(:=C8J#1NO,]4;GM_VCX=GG3
M/,+ SBN#M\SF?6:S$<LV+!)=)/KIS.9L$KTBUL!3J81Z-3XL'YY;=SO]X^;)
M1(O:&9.PGGOJYG/*S/2>$,^4Y\0FKK S)@:?3&[-&)(5=M;,S(FN?%D]#1MM
MPJ0]H[S-]N[/([A7XSS'A(^.ZSL?VHWS;_SH[6O6^%IG1P=_P'B^P%@^\IMY
MFX=?WWR#<;/ZUS>M1OOUC\;;0[9W</SM\,##^$.K_O;OKWL[W^C1P?'4!KR4
M:TTM%DB2A!'W3",K%$9:,!P3U2H)E>N;%&6;>KT9!^=.E2_0]SR@;YZR_T5A
MWYLJJ?5=SFF=.!*[-"VO6I8%!Q>(@Q/]AC%QSA).D",D,X4HCVSP$26%&34>
MYS8-&UODA<1BDS^ !*! 8(' %83 %;#^P <LMM]C8MY$'27CC"0A*,)*>\2Q
MP,CPX!"6Q"HMX7]!Y#I*0O04S"NV7P&^9P5\)E%AG8I$&,Z%M$XHX0A6#N.0
M$E:S4ND7M_>W0Q^;*%=,8/ 1*A&V*B*N"$>PU16R7G+L.):)\.SV2DTV28&^
M GU/$/KF<7L7A7W%[5TJ#DZ4;7L<E%5.((V)09SP@#0L*(J."L69U%YGZMP7
M@LOB]A8(?&H0N +67W%['_O(HSZF=?M:Y_7S0_'98AV5Y1BQ:!SBUG!DP.Y#
MPD<7!*'"!UOYO8POFC]HO:@HEMJ+8>50\B\P33JY1+W5]+'3'U7B#:(_[L (
MOIP]LWX+\X0,F?+64>6-H3P*X3@+/'I+0C0Q8+WH ^,"D+,#Y)0^QU@3@SEC
M*"7N$:>"@7/,%3*Y:P:-(:J(-[; /GSXB? *TZ8_3:F=ZZQS06)['Z>OB/ \
M(CQQG*F(5E10C["0&G'-5.Z\JQ /(-DFJ)2(V]BB1D\Q<%:(T;Q([\KIW.G^
M2A'7><1UXB1.R11DDA;%Q 7BQCFD/8G(8N6YDEQ1+$!<E7QX,+K([.K*K @T
M.2+!8>2*.R4=42$*:T14@6+)%GW"5*1V'JF=.$3B-%!+N$: HPGQQ -RU%+D
MC0A&&4(U84,[N4CMNDGM7-T$%R2VQ4Y^;!&>./_0((4N.($P%F =&TF0Y<PC
M+ST)C'!*O<]V\K13X&(GKZSTKH#.+7;R B)3$Z%[F3B31F#$@J<(_!F,C/<@
MM$EB$-Q@':<@KYH]G&1ZQ=MUE7*VFS6$W0[*O$9Q$&OV2R_&JC/>O8+R4R;@
MZ0&?249;IE)(27"7DA8Z&"<9\RHD\$=+4'YIT->8TN38!^D]C1SI0"3B0E%D
MI.'($5@OPK3!%<$^6UBF[@JE8SQQH9TO$6LQ4EM\C<>6X(F8/!@JCBNO4 PR
M(HZ90)H1C;!VD@JCC+-R8TO(*7WDYDZT*L+[C#1N<34>+JT3(7GP_K4QRB'I
M'$;<,8DT2# *X"@Z%HB1.4.<JH6EAQ>174&1S;3CW-JHI<6<!&<)%9I'*805
M4FE9(O++%-J)B+QTA.H@&(J4,<15P*!B*4?!>($#9X++;"3+35F$=LV$=AXC
M>5%26XSDQY;@B8"\#<E193R2PH&1["5%3@N/(A,D8%# BB@PDO&F*$;R^@CO
M"FC<8B0O("@U$8_WS&">6$2Y#1'B(?NT6EBDI(HT&L4]T1M;; %Y*X\NLRL;
MCK\[57X5P_$'O=R6)LMDR8N_#>L4" W)_0VDC]Q@99T0&H O L %YD0)P2\/
M[?8G0_#:!\)]9,CQ',"CTB#GC4)*!!*TY-(ZO[%%IE5*KMK98TD8N+]WL2BI
M+=[%8TOP1 A>4&$RG1>RBA#$69!(.^J0"R*YY"/%,FUL\2GA@9+LL[*RNP(*
MMS@7#Q?6B0A\#(KAY!QB1(.P4B:12Y@C1JV3U'MB,ST5(:4*[4F+K%-&"E?U
M1>.$,8>ETU%SHJ.)DJ42@5^FT$Y&X*72FGF%</ :<:)"KF11B'D 5::(=E$6
M&WDMA78N&WE!4EMLY,>6X,D(O$S$J2A0H,2#!%NPEKT@X.529[&T3 >WL<4>
M%( OLOO\%&ZQD1<0DII,B-?"8)T,8A8KQ*/"R"F)D;)1$AM9-#S'I.BF67E]
MN[(!^/7,AW^7V6E.^[%6+4C)@[\-[[!PC%MN*$@+5TE8G'ARUFE-"5&.ER#\
M\A!O2L,2I2BQ(E&4O&.(6R61D3H@E7#@204#"P> AZ=DT:[:B6/)$KB_@[$H
MJ2T.QF-+\$00WBHKF" 6)4<SYZ@PR&0">B-$,"Q$2TS:V#)3*OA*AL_*RNX*
M*-SB8#Q<6"=[1,2DB#,,:>5!6)V12$?ED=!)XQ0#P5J!NBW:]BE++,7:<4ZX
MU11S(9U3E$F<G!="@00OO/-!D=EY9'8B!D^#,)XIC'(-"^+:$^0$C;E(WN$D
MJ?,T%A-Y+85V'A-Y45);3.3'EN")&+PQ!#,;'!(A8L2S=:P%X8@S[A0&G<PD
MV]C24TZ^BXF\LK*[ @JWF,@+B$A-)L%[3XEG%JG $N+@O"!CN$9))TE DGF2
M.5%ERHG9JJG;E0W!KV<._"O;L:$)SQTSQI=4^%MKXX63&/Z/N:7<6:Z%,LD)
MZ9-A00E2HO#+P[PI%/$VTQ; ^B#!/!@HTA)DF;'(<\I9=$92&C:VN-1K<.Y8
M<@66+K4/;0N6FC]C0.>QURV2/9]D3T3G X_4""51X (D6V.%M"0>6<(]QE1P
M8?4&R+ &\_/?1;:+;!<?Y/=+[428WNH@%688)9,HXE1'T,<2(Y:XEMHY#SJY
MZ.,G+[/8)V6\\HQ)#P(K'::6.&R5]4QCZDN@?IE2.Q&HC[ J5@J-1,J-Z$(D
M2 L?$./.,!R8)\D-I?;!;>B*U#Y]J2U6]+(D>S* S[$W3' D9&"(8Q<R0X9
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MXD3S]/CJV6>Y_P8=[/]J7/VT&?-C+##K8 ,5%LB0\)#[A"E/4F:[MATX0 <
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MJ4+?"WQF$T!8_,,-"(>])YZ('<?1+(H]#RN2V8'M+X  $ TMK<XT<#M/ND
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M,O=]?+CSD\94@,9&B8\J' NH("%C(6ATH1MZ(/N8M)>7IM[*E'BDCUZ_L#6
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MCDW9!H''(QU6/2F; EE;,&8MLXH;OQFD]WR]2)MZC+Y*YEIM$JT)LA8DLZF
M>[$0FOB!+0FC<41"*05A8>1%;BB99_/Z-.JY<OTC*RD/$)]7JR5WYO$YFR;@
MU/4%#XF&'07.UI0([BL2V:'C2*8<(4*LG[B&=-7G;M/4<+&1<%&CP)U18,XX
M\3R?NU*&1"@W) P[UW,)>. XG@[\6+K:%1N$ J^D-^)TT9&;._?<-O6[-"!Y
M77FAZU^@EP/D]VN;4=<LV5SP7Y""!1OIN2'CQ%<.)RS0-@D=Z1'A4!K0$/X7
M87(I9>OP3:V/S9[XP*P&W!IP7P[@UF51'@=\Y^SOV+8#WZ$VD3QT"6.Q0SA
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M;\P?E:W2]$TF SAX-\B'H@KU5,!. ?P#O12JZ9SO8&[0/<#V5*/)V!EU<^?
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M!?P%G2BPID(E+ZP2)%P>T%IUD&9BM'W8-][\@FBMN*,@"EI&22["L'*0H*=
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M(&#&<$NBP% #-^"1>TTO:.Z!O"E.X,MTREV8([Q1K*D+:X7PU30FN&V"NE$
M5$C3\Q3GNK8.V1@F,QK7U^(?J1)RAM)/<8$&4;S5WT=;Y?*THR2Q ^=#\5@F
MML8+1@&Z+K(8Y Y] L=&#CB"'8B3"QSE%":+2R0?I+A$@G)Y8&6B5.IT04K%
M5BY672$YAG'*<?23P.M><Y9(:DYSYRM<1)? >."8P2CQ8II!''E!U6",3:<A
M3 @D'1#O* _E$DZG"6Q5F/:(9]2/V'*N(4^F:<'1G<++\.I7XD1<\M=7@9>-
M"UVU=I?0$%ZIU2W, <TCSY;?4N-'8JD>B?MHP^9:U/]=75_HFZ6Z,"Y!J*=L
MQ+L.'/&++O-AAJ]8>,6NTV<OFWP:F'2QZGIO@ L_NV9+5\;W?]C*".D !H,\
MQJ^ .? $KX(QL8T9BS).4-/YV^U;!#MT"';"?__YDLV3OUCA-_]TDI=O%M'#
MHQ+N8C7P\/S@2-%[RM'>\=[[@R/0#?[O;[:N#5Z?*?N'9V\_G9T=GAPK>\?[
M\/_>A\]GAV?*R3OEW>'QWO';P[T/RMN3X_W#\^*:TX.S3Q_.Z9*3CP>G>_C%
MV1K+M'B!I*;Q2"OT[N3TS[W3_>Z'DY/_'!Z_5\[.]\YIH>8G]HAC7\R6E-OT
M.LER$>'^5MW.(K;R2#,YK^DC8Y8J$U _0(L V0R2,.'3.,DZ),7\))XH&;P:
M91[]G(!Z1WD55T&*?UW0C0&H!=/< 8FG^$&(F.4=!92(%)\&(CY%(2X$=PJ2
M,R4I"?*U& -,B D-JH/ZQ!5+O&X8QQ<H5],,-!BA7(&X=#E!HM>U"'G$TB*0
M <^&E_.$^FK #7(F001_!%1P+04U?)$J5QR315*:0:4MQ23H0;RFTJX[BV'N
MH%+ >U-^TQA)+M-R^7F6@W[$R4232@KJ&+4NI"YLO0,+B"01^(%0F7!J>4IO
MFWT/*#8>##-WQSADG+BNOG9 C8.7I/2G]KI3?"[>-O<Q;.#L1Z@-SGZ6CN,\
M].8^Y?QB[HFDU'P+)C#O<.[9H.WSR)N[9QH"^<Z-&,X)/J7Z G3+XB6P0FXP
MK7VK2,4SXB.A^]+VH.8FE@F^E@G02"<)J6(@&D"VPRD;@2Y_ANMXPU:"NLM
MCXQ"5'WEYLO#,.;7:"B(@T/J'OQ14P\O61+$.5!#D%ZDLK ?2#=CL!R!+%VK
M&P5NR())2A_!6F9<J*7,]]%S5%)%RGP.YS4!#9G4[IN/"KZ,S"VZ]V,27")A
MGG$W3X26_@%^C(0]<,KQM"A[+MD3VG!H]?"/G-K)I7E(3P1Z@ .,^KR"NY3
M88*E$2R"UAV>G,#;<;W*W8);<CH.3(GRB0/W(EV#WATG*8X-O5\T!&0P]!3)
M(Q  (4SY%>P@3!K^"># !I$;YIZ(5=*T)'6<Y1-2QN'91W)HRBFN?4$KN.#R
M6OQ<>2=&4'R=RA67F[P713CU4^*$0 '*.UP=3>W^1S 3^?(Y!D3DMBX?)'-V
M$2<L)_MJ%8="'ZT#X4OL8O3@E=&_70QU#:WW>&)(ZQ43^_EO;ZZ5;N(BN&,T
MY(DL1S%8QA$9V.*L!G#.@(MDUV!57L,N2Z-.2!L@SHF3)ZG<N!AY#MP/.ZE,
MXQ"-ZQH[DG(AH2.7%K3TJ7?6JYO5TEWQ'&Z35R G38"8LK(85IZW^EA>=,CN
M#Z(T3U#XX6MAP#01\<BT?HJ(8^#X1W SY@+ U9)15(]P8RE90<@HSWEOU.L4
M3I7J(OY-KMX+9%MXG.#QU2JR<&X=RR6*D^8"$F]#=P)/2&#77 +HWH 'UZ=
M2P.'1["N<BD_2C8*5^RY+IY 8#!'W MH=26CTU7-5)Y_W#O:>_%Z1\^8OF%G
M#($70-4!S2=3)G$$U S;ZK$)$ )0)FAIG+0W($:441W*WDU3$FI(ISZ8F?2+
M)&KX7=PLY$?=M037Y.*L=!!6IR:1R'\72+*%=X$$@A,I6/-+H#V@Y3!/Z9 E
MBL<=E@BR1$E'YQ$TKE'@ (,',H;W(CW+A\_P#A#FHX3AF6,PV5&1D>Q=HCL1
MA;3PXY.3"U0&<B31:W@$A\#EA8</1]_U$Y9[0MMP4$$,V56]"%[\6;F=F@N"
M _L*DC^%$R 44/C@:ARXXZ8B LIQCDX^> /N1;JKY\+8X',Q?PK<.$527X^,
M%QZ,4EFICD>3\O!:GP4ARBAT=.)+KH624B,NDA+289P*E?*Z(LB&<&RR:F+.
MTF5_6$J/CZ!G,7F@\ ' LN,\*C^J]-)^9\%31 =%G,DY=\="O2<A<@#D'*-?
M'9_YMG QR_O@H>)A!WD" @Z(X%,$SP#.44!S[:._^6.ECY^6TQ+S#H R6+)P
MVNUQ:QXW<\..6QBGI)*E>8H@:U*A8@K0-V*N$9N?%)YS,EEP>T@_*DZE0AY/
MTO:D2E?ICQTA)^H*&UF0M1,DWH3'@N@G;JB4^#M8=L6A*3T;I/7-A4KJ%J4,
MZEPOOE)H4(5-5SN;':# 3(GB#,8U"40<I';4RK/SH7K2X01C&4)$E0>T/RA'
MLMJ-\*\G3%:ZW[;;H[7FT;(V[&A5!P1H6IPSOSQ7=Q UL>OF4]IZ:41@>&\:
M,E<X1-:1.R?U1YV)F_&^0B)X$Z!6\@+B64M -PL2+M7,\B''G'LAVB'N1?T9
M'Q/R].&-)%E:,EZ/C/L;1L92"5M1Y6K*$1A.CCXNJ@ON-)1Y$7%>T6P)HJ]Y
M5-R 1G$"!(6T"PP4M:YY[:UVG";H;(3_ZX.FLU6X#49Q[#6'"L_%\;F\0:AU
M2JZ?"9QIZ>BLQ;A'8- $O"7P&0(?;!B!P]/DOI2N*=Q8CPR.BGFN=PX6DGJ-
MC->FXKI0$*Y9S)95_N2A7SIRDKJXB"1_[PCG%E$O(NJ&+1=>@4CM#2/2FDM6
M^OZ441Z@DBO5\823IS#RY'XZUPW?K>1%'65"KK\0@SKH5 2AG<;PC70R5<7B
M>38&A3H3$24G]DBW+AV:%)O+P"BM$ EG=.N=I8SAYE)&[?37]KY^RM%N*QSQ
MS=TL,K* ""Z!ZQ0>A]COE(9,RL.PR+Z#/;S@=#-LO1>P412C)BBV'H1ZDH_J
MV7D=I<R.(P9"=\U<(YXKR1,^1_$K8D3ET],L]THC#X-;#0X]*ZNKD$/-'_X.
MA3U^NX^O;VJZ->5VGZ,SLW [[HV2P 5+$7BQN(8<Z+ Y-:V9_.FPAH(_GE9Z
MP-Z(4@J+^$9$5N5_8,!>/!%/.RY4\2,Y^X_%8V8T<7C&VS&(#'';QS%+)J#^
MYY003T,I'K!/RY?6WOT; VJ=\?,4LRBN6^0&FM%ZEJ]P7=T1/.1AY<E,'MJ3
M2 #4U>4)@&TNWV[G\FVWE-34C1&3VG!Y3'M&-C;#KU.1J$(24EBGTP;'[2A.
M@#[QPM-^N_R"K8&=2D0HHQI0\[68L-WD[(54Z8@QPN\@05(R-U  XP-2SA+,
MAL+WU40J:('W';/(\.;)SBITVN:D7PA2!8.2M"\4IMF8%6[J6WV%50<50>%D
MEM8=%3N[@YL3W!<["#II@EE.PD$ >G+AQBI4U6E"=1CU+Z=P+*,LH$PS/.U2
MW\/]E$PBG6*<G +M=#M5;H":*E4\>([,31'5*U%*95CII%.]"&VY@(9;!$<+
M-E1P%L$+,6V3@\;OCN&SL# -:^,5Q$@9A5%)IUY,D9,Z3?)O@;!6%P5W"G\+
MI=!Z02J"/76G2IK!>QEF,9;)/\1!KW>6E#<G'C\G-T7"UR3XUDBFDL"/(L,J
MB3'%J)F?6*9/L00D7U++$I$DOCR'"LE.*0X37NJR*?HDN#<C,R<<[P!:EP&*
M*A'*#4$RPD#&<9XBF0LRDGFF,_*^&'WS":"$C@-?5#O)0]7U$CA*Y<@IB9?F
M3[_@1*_%$5,J3A"B6":G.*?T3TQEZ*9C)ESCE,U2I,/,+OF,?I#(C^=SZYX'
M6)"'5V&^*;!]%Y-0R?0616>LD7E6]^!4"9=P_0C64GS^0B9R4ST8^8Q\T GF
M#7[LU#42$5BTMJ6+"M\L?YWP;!Q[J'3 -3M[>C<GO"].;TU3P/A[0)E<+,LP
MO*$<O3TI[6[,[&:%HH''IJ+!\I))[/$9CPNF$#M$WO#<HN*07$D,1 <JK#E,
M(<X3U%AK'L+BT@;5+:/'4LIT:KGLU?ADM0+1^<Q84?^%6>XNO6U.S'N.WF*'
MZ$W$&>A73,@MK0EB[7GDL\M8E"2('2WD/$F9BI$4); *(4APCRB!-34EXD35
M!<2L@'ZP3L29!%DF[RH?A9HQW"+*"DH]I3% -*9"=EVP8A'M$YK/SEM%FQ.'
MEHH(R%X$#*GRSN 3$(#H=N0B"[S<N4)1C8MM3'-TC=-WI9X-DM%E.07;BC(.
M(>EINT$;0;9%PKG&ESJD>].G3:E<ON4:*1D)G[*M=Y8\-B>*.\=YN AL@+IU
M73A#Y%F>AO&UP ,H2@!D>0&("THZ+>T2'HU1%2UJV<B&]F;-,'X9AY>"?C :
M0B\I)5#$N;>[V[\Y\5')'8K##Z<O%D $L$'R$/.*Z9.=RH2U(BJY'-"?X9HQ
M:3&EBT4&*'9V_S8GBCEW?&45Z#4F$Q$/]7/BU01&0>6CM?.-N:6CHFLP^C.$
MW@C<%XYL&I0)IWCHBZ,IO!V+,H0N^'4E1LHJB FR#<[G=.2JE/$:AIH01DE9
MB2/'5234UH:SJS2E;YK+/XA859N"R#'\DDI6*XP3AT?<#V15<GH=@38A+5B@
ME_"Z2]N&C+\BG;KY(RLZ Q0EY/G"<D8TRJMR4[S$@T$(+:7T,!0A]<++T*BC
M_ >Z$-*Q4L0K.\)WD J(&X\[,'1AL^&HL]B]$ [!G26L37/0B^IIJ0]B9F]'
MV F=ID$"M# 5&?0U=W J\@6Q+AF-\ 8]$5)3]94(S@"S":9A[>.=W>9-\^(7
M<9CKF9(TX/2)<%Y/ EF[+$][#6UAD?7:*3>QBMC5+-NR3%]<@Y77=4RMG=WW
M375Y8^E8D";YM/0P"%B"RZ"HB101&*S9*@1]?3NET9F*>TK\@B#QA ^<IP5V
M0Y H-9XB, TJ]<2/PS"^FI$0=5*KHB3"V[+[$3]]TQRM,HN]23)S.>T^<V5@
M=V<W9M,\DJN4%Q3%.8665_,S8_*$8/M,0OXQD7A-:+0IY78#/\AD:F41PJ7;
MI/VP1(P4SRE3-^A).TT;F^92+ )N!;0+L/BPPH*9L"S;80>OOFD>O*:Y)F-4
MM? !6FT)PG-RD<#[/U"0!%C4E) U(QX66<;%@:X7DU<7S9CQ01A&1=!Z/FM#
MX'JRD)*8KY"5C)+X*AO7>(3T_DDPGYVEETUS^=4TI,++BT$A8;(7A98I[1]Z
M?T0E,Q;<(I"L3( +1,V:P!&;Q@&,(O:[E,I=0JQ,8B!+7L3ZF[?605BG+!M3
M4EVG*0LDAAF.H7XS*H-SOJ8BP8 R<*2*)Q7$^"K:[<(*?=-\DFGNH&:="; \
ME/%S5;L-GE5!]<!KA0>I($.OC$XV:0#_KD*E&#>?)@%Z,V\&!2**W6EB,#;-
MF3@7V>Z4;F/!!F3%'WE^PY +^QTWE&.JC507?9$DE35AUFI675'X(?!$I"TI
M@E<^QQRA$;PPS3#&""\A,[4$C!/O:"LHFK[#MH)B,\;25E"LR0$WS>M-[NR.
M<@D+YH'$:W"]JEP0U: 2Z%4"09)4$PAGD@^.>3CO#1/!6036E6&1)F^L25JI
M[Y7PMJ1Q235\"4.M9_Z@YDY(,IS@;G>]EMG8-,=ZF2-!R$#26X;!$Y<'EY@,
MEM;:5'=J.5@4%L,.#E)^"CJA4!Q>D3*\-<XS<HB2\MY(R:E<<ZD(RR!0":8C
MQBC.>.IR@DDN[$!Z99D:A!I@9?-5S2(E)%GYC1A3F6E<SE4&"R.6Y8BI!6-A
M:489254 J'!(7'&&ST(<P$3*?PYG9 PF[P5ZC3'A5Y0&N:"1-H.2&<4G@G0B
M,&)8\KI 8I46C+BE@%^ES&H^#:COAJSJA'_HK]?U-$MJ%!+&#KR4$YS8]>O:
M&9?HSKCV\*AYQ8:"&G&XLT=LTV(8%(FN]:T1" &@,Y)?I,QV+")4!9O<V?W9
MM'@!*P,\P6SL/ZCA^-4J]1:@UE*%#2:D2;3M8C>!PT1%RQR$Z::\M$ 4[\L4
M!)E,7:\F:YY98I#8E:A6+U!F4=(3X<1[L?!4E DT B9 PB#6/.J-2:$H%I.1
M]J^TB"KCYMI!-B@?P[*,N1<5W#N0$_+C*MA67($6&>CM6*./<;EX(GXO*I=R
M;'%T&21Y,7DI5ZI@6\GG9E$)RK(*ML!L*Y$D68ZM<.B**5A4!&N,KZ>5$+7O
M(N5,^A[1Y*]0VT56TTPJ2/GLF<AR%5%F<]&+!1D'!<I2>CL(9J?A-*VYP_DW
ML/YRL:!-O\>$\ZS*D:P:#(@&"B2=.?-"@9\S0W3%[248= F;@-XPZ1Y;<B0Z
MHA%212@B)SCB(I)R_20BH<:F!=R6*'=S%%G#FI%:CS@!Z7PV5-70HM"B"'\&
MX2EJ #1EGEY'?(6%(<$%_DFE)D!*TZE 5QY)7%,J2(&+$RY4NR5UM>*R,A.0
MN *6,^XL26U:G&Y1JF:30A:K_S)OKC-K-V"A'(;ZX)TBIXY(L[JAWC--YGM+
ME.L7F/\?^T$=I/?EG(NVX2:>KW&18F862;^HXNN4M96EX9.1>E9+(%F]@"\M
M.C7<,,?B?<VY[BQY;US@<TD2* %IYGP!_58)I#-@3=A!T@M$D*#D<@%(08^^
M+ULO"!D-Q$!5"C.)"0T-P.-H_\85 !$ET H#D'AF*>Z%_T6J'[/FGQB6,)DI
M]'4F<Y:4_V.3Z6OE8QPG_RC#8$=Q[,%M.TN!&QQ*;3#8,E%:U%V'M6KOHMVE
MW.,&4N*M[!H]+ZE UQHEV#I($ 9IA\B>*/)%)$>!,(1<E##39),D9>%-0>XB
MKVIW6=:FA4:7@M<X!#@/-]=A=H2]6'PN8%==N#!$6F([711A;EH<LV&YR<"S
M+&,I?01U<XM$PG1\G8)NPD2/'S1>Q65SF>V%K1WR;R)$ .;:!$%IL+E)(Y>6
MG+W3TA"(1K& \"LA2&9)JTAN%3)Q9^EETZ(^!&M;^(ME&[<4(4,)%(+L(S+T
M"KC91O?!6V#U9P&9:R"-@E6\C<F 5#Y*..:4<&Z?O_OX=N]% =;XGY[R:Q(X
M"/5/>./2IJR@,*EGC!L7IN@2E/2,Y%"!!;SD(G+$RUX:G<H+CP4Z(XG V @/
MT((L7K2"&S9 $G>6JC<M E5348K"L%+7*=N %TBC*;LDK94@Q(5[B5J'9[--
MO$O7AW2R%@EG)!EK $T[N\V;%@6IV]OLVV+@ZSB9B7(%LQU+=G:[-BTHT@@O
M(O1@LY7\3"_"FJ]8;N#K6SL3;^M.;9J3=[%,JRI:.QAX(KF_N-:V"IICW5.)
MT(SX61%A6\)>Q;Z_+-)2=M/9GPG4O*VE8 K]]:Q(^GC^=O_MV8M:C8>(R @5
MA<N>LRP111XXSOU])>4CF7/IY@1R%,E:+M15/R)D@'+8/?RC:C!$H-2-YJ4%
M-(1;*_RM!?4PBZY W)O.XSDWP3IG_'J5Q3VO7"G/@Q>SO7;+Z(_0T$L<%;%5
M96-?C)V)E@6OX2GPF)EXS8)L52 $ =TVV[ )N&[73S@7:0]EC+'87WK!TC=(
M$P%O*J-+]?X:$K$\Q:=<BH<4033Q&B"F.(_<"C:-XV%VKQ=,=5G<K13I(DD2
MUGT<3)%RR_R/LH=4 _U#.M_":QC<)>Y$>0X"6*L*B")(RPBPC-=C/0,> _*D
M2"=+<T\NYU=LS&1INVS02YU,2]CPLA^R>"NVN4;8"S\(ZR?W[."MXG$W9 FO
M82S@PC *(X?7"/45B&.+@P]#&@R,1K #>KBLD9S&E/1<6V!I_J5EVQ4!ED<Z
M<Q7?@9WYP!Q$,L6WX)$5[X"75!GUV'R9\-B)K$6EB(2;$[4B^$<MCHV/60[C
M4"?(!LET:@23U _- BK^5BQ"#2[/PP9D ORN9 A5L#C+9)>D6<P1P<A@R/+:
MTCBN KSE>L&KOPEBJ/F Z\]"U+XZBD:*N/9X9&E-:@L_.XJJF;-\>_.EL!^2
ML[7IQHT:]C;=>#/&LA7IQH]$I2A8IW@$(]D/6HK-&KLN4V$*S[^,[HB</SC_
M%0, .G;KY<X-J4OYA#>*,[AB5[7V38NC5QH29@3E1=,346L"LJHF/PJN__;D
MC\/]KC8LDT*7M1R/&HZ_LMBR4Z(@=*I 9)&358]GILH5#ZDVLXF^.V4R-T,D
M"!74V4#?H*AX(W.M'GN8 6VC*V=GM4H#4"R_D:OC<X]"JQ]%8JULFW@P$6B$
M<GZW5Y[7&T/6%,W"OUZ*9%A-.K"+*H9NG5IOU=-URUG2C$<\2@??< &0.K \
MP.&50>!<-YK)LJM.@Q9((&28-0U["H9%6*2SH;U%NP=*43[U4"4B]?$R()0Q
M"F-=@273#>/X@D!<"B6:3$<NO,Q-31)+/&NQDTY!M$5R= WNO*>\)P1I^#OE
M34,-].L(E,LQI0HB(0*YX#QRG+5TEY/E=M,8%^QZX/WKV>W2L#]X=C.I#!Y'
MD@W65$7>'QP?G.Y]4)Y[P&98(G+Y,;Y%[(8+>H*#I2 $-Z=,PA>WG12IF.(*
MW+H@FW-V3F7(K!*_8[3()W#C.$6N!J?HB" H#*VCZ*IN (%S6)._&YW!8- ;
M8A@/%EF L .9&SWM%\&<X I[..SU49B4)O^2I__?W[2^^EJ^0N\IYY1G*Y]Z
MQ<K4/N'D<(M(GWAA_Q=BJ?5<JKEP,FD589D.J/8&OW1$:1%AO8*AEG(*4-?!
M^#H(12UZF&%*0M&^$7LP]_1?Q"CI]>50"4.[.40:O4"$Q\<KFC9[1\F5/[X]
M%5CO<-2=V+LN<[:?EY><BT]>+!F\ COR2P,4OW#IR&1).;A?\=M?I53I-?^L
MO%[2V&XF6<K3@?0R.ZI;I<F=S\CP,0Z(9L$!H4TN!(;'BP[G8AD%VD.IE]26
MO=A]6*V:/G3-6=)%[:.+O]7;"#2HKDENI Y).NXI>]65LDJGO+9X7D 5-5AJ
M0RG7!(:=@0)U*4\><K8@]B1T5#$V :&)J;(,Z\<K+?Q!=_7GBP+:Q3/TQIS,
M^8R!LLG549#^;O+XDTCY+0<^H=N"O79F'$K"(O,J%]VO,>;>P5+M4Y<(K..0
M+3^_<V_6@S3-DQ0(G=WJE[\:Q\2MKM")3\M>JK6$DYD*:0M7>81Q476E*/S$
M=:*D<SD7$B#O955!D5W%!(HI7'6-9@%$Y=,X2.412;,D%C6!*>I:HD\F'>^>
M@@O(HASS5(:%$#P?P\:DRO/S>/)"^1A<<.4KV$0SRX.X(3 : JT5YW@<<*RP
MHH:^Z#]%7R6F!)11A871BW*A\BB07=-!RXP6AT7H^),[DG>4HZ0G1B?]NO"-
M\ 4O&XD8)997LM*@< IZ\$IZD-_4%K=3J<QAD!;]CV$5:/W><2=I+N M-!BQ
M255UU""6^DS>Q4D&/'=9]'UV;7H*_K>;I[PNIX $,H0+E36HL[[I>9)!]=?K
MXL;<=+# M$ISYVM14(9>;E *4I^5@!5%LI@HSL']KL*TC8P?!I)H)"P>V5.G
M%M#QJ?%U$<*9L>"!9Q-_FKOK7C$GX?DNA&H9X! >=9_LJ5H14T@I'\VTI#-1
M:53DA1S(-D44=12^".7YV<';%[3 "?K.(EQ0,#R7#A9-?2PQ7AZ$$Q53\LC,
M;5;!!KP?IY@]*LG_6?# ^HHTV)\@D<)G4G4D*U9(:K@BVTSFN2\L@8N!2\J.
MOCR-,>O=Q=(?3+_GB,A*]4)E,7;56Z HG1 P?N(.O$@R+K2>9&+#//IK/:(+
M)L#IR8O[!9@?,+Z\73KA<H:Y2'B6P5A1?(K@K$);D/*,SOVKI0O0=*W:*_BA
M\:)'6@,D<+W_>F,\T:;@)J",\6@$!Y'V1K1P@@/G8^9P55O52*2D+(R:/EJV
M(Y-'()YBO2GJ3P6'=CA".(H*T[*8]);&'.WFWG]SBWR9N;(1F?TC/V9@G+I%
MBH*@ %&B3,X4T"4B4 Y*B2U4]1MRO-J=N__.,6428TH)J9;4QJ"LU*F.%SF>
M*0N#)R*U%2_"]FN(FB)"A.TN_<!=JB=\8 HSKAU9EZ*W9AXR@@# !)-+V68V
M2EEE..&E5>%>#5M@%X3^NX;/:U;\-ZU2AX>8_"USEXK,HT)U+/)/2%%HU8$?
M2=&"A:"5>DH%H?NR:KF4 #645_PF9'D$^EJM$2GS+JN.74+AIOY HJE/H3\S
M=-_60MAQY$HLB;WP.XP2%(1_2/T=X3R"R227-D&(V5PE8E+ANBK<Q&*TQ5\-
M3:256#^4<AP1>8I'(B0;E+M?X%T)2"M1Z4Z (?2!U/J#*!6(=)@%(UR"%2@O
M=1 C"N3M)O[0311 !@*.[RI.0N\*-V=!PUC,9^3))3JCG21F7H?4PD#T,R_M
M[$+5=T2HINRZ?IL!7',>UTL>)2&5"$PE2G,=Q20%G2GKYM-4\B<Y]!+74/J6
M\)L&$N%,+V48Y\TY42VYW9_<I/0HQ,LEE_#,A=CHU+PPDG7<2!*"I32IJ^Z)
M0BXD_#,R#"*%%:@E5&F&;JR*"D7,KZ0*L):$K@?/6JZ?/<EL6Z/-MMV,L3Q:
MMNUFVR,4F+Z[/5*$OEI[Y*=+".FB0IT$C ^9!#+C8'03S-TD+WVZR$TO8P7?
M,LP<1:X?<H9Q[W$PI2RBTO1P*?,5]1<>4>@V85-L)DB):<+@J&L:'/-,)3W!
ME21PA&'3>C5_K(TJDW_82+A>)#H<-FV\7;4,28M !4!ZI84>VV@!4N@%8&SZ
MO"OJSN4NW]@7JMW=!_!\E@H:'/#_Y;P EY05JY6A6"2M1/7NC'-P #(I2Z23
M>44^%H9W$9%5U)X27Y=69\'KZQ$IT8/<DT$_F<@AO>&L\K^*"MQ+%N9%Z5T@
M2BM:>ODI'JNZ@MZ9:1!$-8#H+Z(.4@N<6G*3%^YQ@U& 75+D$)4\H[44?_@N
M%\B_<.#F0=!(2Z-,G "&*.+)6.\"9UDXHH3>((-;U[)CPKAHVGDA,^'$V=UR
MWSOINLL"[@BH0:G@L$"B;]NU*)Y8E/A'K),2;HHZ&Y"\E-3&OF'L%VN+[U[@
M,% 7%3@L7<%%QL@J]VU.)<3IP=FG#^=GRLD[Y>3CP>G>^>')\=G"NHCY HB-
M6P-ZXBM2S=U;5P7I<85B!$/D!E'=NQ3CJY0PK 0VLBDITK?12%$CLB(/TIO3
M*KU &>DRI6<I@1=TL<Z/35/^JOCE-=@TP"2N7P41C9%N>MU\ ?I?J'H>M&GY
M$GJ?^%JZ9H;#WD =H'<F2^!_KWBQ=-STR''S,O/FO[.,GFE:2[]6>]K2[VYZ
M+*;*]?4[/?;F[RS#: ?;7VW#7A(Q"(( DD-Z_M<SX]F,5O1*5312=HKGE9<.
MYR[5I]_PXGF*GR5109T_7_:J%:\[$ESKH%G651[KV<FNL2ZW7'K?9:\NE7P#
MV2?P&<QA##P%U^_U=FT(BI85%G[I=.LS?EK+IO\8>MV.^;^EI/+&"MQRMASF
M7HRHWTM7#M)U.??]FS8>K9R-FO;^M]E-OVUVJQ&\JFS#[/_^@R9?GS3UWMNH
M6>L=P]9[MM"K?\P*P,8K:Z[$33SVMI,VRXU:&MY]&C8MLZ?M, V7S]!O?\8]
MZ'GSMO:YWAN^V)@M?8P5^.5^:HA/_VV7&K*_5/>\B?P7S'1+B%SKF*K6,];D
M7XMW]H=RJ9E7WHE+;?4V6<-VFS9]FYZ;/75UD?$PV[.%@F$+[=-#=!04]:$<
MP>$B5F&34V;.G23'@J78%EKO]_2UU:,MU6NW<7LTHV>W^[.Q^V-9=[4:GYZ\
MV$)#XCS.6+BN)B"-1QD$-6!OO3C'D&HQWIIUJ2T-%NRBR^CA%VBS#XS$7KR;
MOO]PJ_3(UD)[7MKSLNIY(232)WY>=MVZ-M96F58UL3?NJ/_R8AV5J4BIBF*J
M#+N!IK;Y2EJ$EY0OME(>XN;@F)$V6'8OO16*>38_\78\9H2<K?"8)2JP'R1I
MA@FW2280*&^&7@[C*[SLIP(P+\)?_G'PRQ+%>"UHY;>W0"O?/0UT<\AS_]M]
M:5.&\F=I4\<5%;0I Z5WI,T%5&D"@=V!*HU5J)*&KDH*I!?=2H%BG$!^=L^\
M&_D!"0SFZ6\&R%MPDB:<MZPS*+.8)73G+.:W;,X5P 83.#4.6QOV[%\6-L.3
M#?NJ-A1[J<NC5'3'=6H8A H; :4(C"B)T?F-0"UA>KA#S=8>HCSILH2RIL=?
M<28:*E0MGA6/7:?S#P2NL",'+J.-O(S#?,*5YQ/8\EPVM""H"$F)+]8^CP7E
MT:,,('=<^8)BY>L:UU@%=Z^=@.)"@JP,G!PKS'1X5D\Y:3X):4CLI&S&H6CZ
M['%9G?UJ3?*?(?V/2>#REY/@6ZWO.-RHTGD3QV_AN0 BZL,<E[WVIJ'BO18)
MLO69#.& D$B=92TJ";?F6&OKF4]1AJF_W'*@0VR-@P=YX?&%>QTJ/:R&?><3
M5UMY.3X;N,9"!G6O,1<L1Z+@WLYPMIT7:#JE'-Q7^,H8_JSP-9&&A/"5X>-U
MA2\("UC( ,%NI7BKA!_VBD3 7!*5YIHG1.M9\H34[UI%,<14_YF1+I'($1\1
M] G"@-4Y5(.Z;5PC.3DP-;KC'%'1:=X9L.7C?W]\4?9T1-P?F$= :#! XCD6
MYY8<XY*Y;@$@7*_,1]RB3O%IV>^)*7XN>LUC16&!!R1+?Q/E^;LS>'$!& Q<
M-T<T(_<BC$<-]%IJA>3&HXAP^^7N1D#9P(8+\JF8/9W\YOP-F#[+E'WN\HD#
M+RZJFSJTVTU&,(1-PXMGN\7,M$&"]9O581@0(3;#*A&00P)_O<?QW;@2JK=Q
M2K,O2JE6K*0RB.UL3=V4U3.LN]4%[58ITM8,%FQA:]C636U4W=0V1!H6N%E7
M)) MG=T]BK.V@\XWI1QM*U>NK4C[X15IA5VV43.72ETRJ]3=MQA@U\//:\]_
MLP./>L=6C9[^P$4^/SMX_*-JU5IBWC)B[O?[O<%N$_.3+5J[<U9I6[BV3K[I
M-F@KPC'WRTT*S(XG# W,M87VKM3DM!EEJZQ9W^Z9+8$\"('<CY]NWFHM\X#=
M.?_,(ECY1THXF),-50C=PK"[ER=E ]458X^L%NPMX6_=.$EX.L66L-@\0<#>
M!I$,,"Z64' 5>CTP0%3_[@Y#JB:5Q0HR_U\:HX0/^Y2=(\-2-P_V?!RDC4B6
M>]/H&U^T;1IJI*>;;9N&S1C+SV_3L G(M$2$B[,91!1?-!5>D/Q3G&?1I$&F
MS\PEIQQ5B2EG(I"O[!4)*B+P/X:!\ 0Y18HMS$,*X4<I]1E:D)*T,,^T2&;"
MYWV@_C4?&6@IA!%_GR34C0NDG_$PI"2Q]SPB]%^<\9X')S\@(&7,'3R0Z[>
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MQY9:%=NX27V[UV\W:;,WZ;G>[UEK6W>;*4!: ^YV<=$:<+0V=JMZMZKW?9T
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MND>N8-&#18X>" ?L)8QK.Z"%Y;X?N $U@@$- [Y._6L:"CTAP=<F7#:AH(^
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MEM]E"H"GYJC!(P92$&H_?"11LQT\0BM+?>$(_;>Y/P,.3# 0@(8B"@VMD$P
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MPD?+1@=2.SOJD+JZK1]2X:*C%"R'-%H,$A&&[4*G?LT=7[*4:O<,8BT B3A
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M660)0<4BM!.RZ!0>8O[O;N1XA%6"K<A!:06*]8$;2J?QS46IM1;,9AO!9ZU
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M^=O>N\.#_=?[[_<^[!Z^P;]2=Y6Y[2Y=M9>YDW1$?6;>E?FW"O*!%:(U%9#
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M&4+F :*WPDO/A-.N]8J6;_Y^-=_TYFAVO:ZK+ZC31E"]@0&X7$P;B_*2,UK
MGWZ:SC+.R NBOUI^XG])Y],YDKXO9A?X[0^GDP5]#L?G6-]-7RA^J+]HK!/7
M?W3TQW@^DEX;IP(#&6G'4=8(<-I+<"%8=)FCD[&U:MP&T%!#'MB6-VK,#N0^
MK"T["WF5TC3@_]5R)]D*R>B.A]"+]E>WMM@F+*]U9#9RO#LE*ZCN(<]A&2X"
MC7")<!ADH+Q,X#-J$!:%M9)[D]/!,_N=R_<HQ'81XUI"_^7G%?[2KD[<R=M7
MQV_/CE_1+\Y.WKQ^=?3^^-6+HS=';U\>G_WM^/C]V6^3<)''%#F_"S-:R$=<
MC%,XG^_@].W\J@9.8IMEWG$J5>01R9FTN43R)KG3PN;HO.-8T/$RVOVUNWVX
M%W/X$,+GT=DB+):;_3>7Q:9"1'@&6C%/FB<R1*('BK>:R\REB>*!#[B$>5Q^
M7E>ON/R*\7PQO_Z3;Y_S>A2[&J3K)QZ=GT]_KR<3OTQGKZ87<5$NSH]2FEY,
M%O-33#C^LMQP@[!1"F[!FDSN6<D>@E89O'9<"F4<_7GCM6Z'K*596Q4;?K-I
MC33AVI0-2,!],\?ZJLG-HB_]KR"-3=PF2+KZ7R(8"*4HP)B"B5XZ4\Q0JK^7
M>&4@LGN(\;%CE/EL,3K%^?4"+K=PI@I&IR!R2:*(N89O5D&)B9QPKI50?!LU
MH&??4@'ZW3?Z5[QVWY%("_*F;838T".] ^7:3=X"S!9AQP[,/D;\T9N.U;3V
MD.7@!"=)^T=R'I"I1%ZWC!"$,&"E<XA!)VT?BCH.C-@UX<>PO'8184,^[YFA
ME^=A/C\I9XMI^L=RB5H;8:P-@#I$LDB8(2!R^H=3*-%34,6&VI7O@GG"1KJM
MH.]K@.BK ;?Q7.GD-HBZV.T.*G ?S7Z->&.ZIH/(>@ [L *9T])IHP)H:TC;
MBR_@HN;@2F1))2T->^CZX)#97V/I]TY^%Q$_WG'3V7OZYZ_';]^?G?QR\N[X
M].C]:_K;FY.11B=-F]XRT"%3I\7=.5\JU@JCK?8I<%6*\\)R+;UR@JM 0=WJ
M\Z5-;VQ^M)2342ES=97KDAAIF>0,DL<@K1?<JG"P1TOG'T=O<5']IME%6ES,
MQI,/1Y-\LOB(L[//F,;A_.7',/N M$S%!7KZ-ET(#%26%GR2#(QVUB2IO!?L
M8;W<^ET'<4[4A=9K6S2,- <X(CHA+RTL"-[K"7V_^&8ZGX]8X-QK2?Z6KM:2
M<0M1*P>Y*&9+LH:[ARXM=]'C%3">+/>M1#N ]_%ZLL 9*>7Q'Y]IBR9'&UD.
M/%F@=QL*KS" #TQ#*='I[)-S]J%<C%V8O@/AR;/<1Z0#1!G?=.T76OGQ?UV,
M%U]_Q<7':7X]^4(PZ\)IP2%YEE@$;2*Y5U)*"K"JY2D1/7.ZVJ3FO&\![!EH
M0VOQW]<1V5]'KJ%<PJ6=:J1%B#Z& IQ;VH:8RQ"]SV"YC2DIEFUH[;NL@/$,
M^.\GVOMLJ]X[?'4ZWDXGT^^WHVM[Q8(WIB9H*[0"E/8://(,NE@1D\W!9-EZ
MLW\0T9/7@88"OZ\.NH=__\TX51F\G$X(W 7ANW)4II/Y"RS3&5[^W/OP!\[#
M)--*ZJ44"?1\N9;+[6Z$CL="H3/D9"7YK3Q!5#)#YK0,AIYB-KDQ"FB)Z,GJ
MS6,R<U_!3!L/A#!>*?P+G! 7BU%B3+E@+.1(4E&U[B,2($@HN0^:)_*,!_$Y
M[D%YLIK24L3WF;=]F7\WFQ**99SCBF!2"0G1D>8IA@R"\PG(Y'GK%),6M[IC
M[D#VM[<_>7YW%.1]2EU?2LE_^6:;CA:+V3A>+.H=S?OI&NNC=>$68P*N(ED?
M1WZ/3RA 9ZFX3"*KYJ%%9Y!/7D&&I>6^'OFF>C0RW!:6N0-F\C+^R>!$J6:+
M*UZ4]%:TOO'X#L#SXK^3.%<<*O4^0SS%+SBYP/D(2RR.EWK';CAY'M: ]T4
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M ])X\?7J+Z^\1J:8\H9B$Z-X[?4J:Z?(#%$G+Y",#R_-)QIWA[FWEDR#:]'
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M)YP=$?C%T22_&8<X/A\OOMZ![*,VLAZV:V,4R<K5[*A:LXJ)9UY<U+RUMNT
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MT\47(8R*>\PWWP3WAU>YW<F[KW>^3T>\B]F,XN.**BTPOYQA'B_>3 GV_(2
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M0=$_ZYF2 :]<ADB86.)9"+_Y2US__*=.92/)#9 Y\>W<\+L57YX41IFS3CZ
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MCOEL\:U9[UG"29B-I\O5)J52TJA!A[K-:D(5<FUDY8KVW$=D?*N^Q?2&6ZI
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ML_=8.VPE%B0?/?3@ 8:6W4J:H+##6@LBRMJGDJR,SY%#P9P2CT*JTOHNYT%
M0]>6N7I>&FWU_G6D.,#5F:36@!?"67+K2F2;P];#K"UK1W37"K,N0GWL&G.O
M5'1(,2 +-:464X @G0 R?,Y8E-IXNP>%/YP:\_9J,S@O0QQOKL#Z<OKITWA1
M/;5?$%_A/,W&RQKJD?!<H>,92#:&O+*0P%ONZG24;$702<GFS0D[X'ON.M2$
MEP$NSE=AO>V#'2W>410PS<>3/-+19X\B@%1,@+)5)B5:0,Z$(A$%%ULGU72
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M!>ZA>:1!@6WHNFL.VLAZB(W@/C*6?<2L=!UL4H]ER (&ORSTX)X)[8,/S?W
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M[B83G/T7EUTGJQ_?N.GPT:F31I)DPC1PSST(;B@X'ST@!17-EK&@:I?!5AU
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M3J$9 0J)Z:O53((W+D;BJ)2T>IE7)V2O>XEJX+T&5][OH3TJS9T^Q;N29.T
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M(Y>NQ8I$E$6IQ)![6%$"#2)(?(I@0 .&O"A-(P^;D(/EN$LCBYWLX.>=]+^
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MM8LIUAG763-['VQ(:.RS0$*)/1^BE/LP]7 $B0@]Y,N0<.,0]#%R+(TD6EW
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M F6$"!X@(:WR=L^,LS0N.(@):CE'U $X ZR9<\H!7!,SP2"D[&L!]./@JAK
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M?E9?F[PJ/V1,Y&7M=OLFV&U>K(N;QS:9R?=12J3D$,?*ID0Q3R#A00!3@7#
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M6QK7:9D[R;]78"]V';G2GEMHR8U]%4:P7W3HN 9S:BI[(1R-?4"N\9S))^0
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M+*=4.<Y9.7G5L W2&R'%9J/W8JRX$]_(#QW4EI?BE<B%S*H5D1&/*&.0>+Z
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M,K;T._5.J7K]Z?7[+Z+);/WS?9%_)6OQ:?,A^\>V=62]TMU1](G\RH]BG*)
M0!:P$*(X%9"&00()"K 7Z5PMWRA@;HG*+9/;GX"SBUWY6>/SRQ5H(0([C$ '
MI'K3U($)/,<)'( "^HT'&JHKL ,+;.]U,6@%EWI=00>P*T!KR'0$C=W6>$FS
M;;CG7I+(B_NR_HN^F]8^@26^!(Z<#8M2;58OQJ(T/^,>6:2, X^PV*W@6_5P
M><V4.;NM*W?TZ??,1>K1) X3CT*6Z-0<%L<01Y1!GF DD912)$;=+!W)LS1C
MX8A BVU=>*6C'.@A[;%.[[&S&R8R\77/$B&0SLP,&4QI+&! 4^1)+Y!Q&EAF
M9LXWOS/E;K8*6<QJ\RE^\<DU/%6=;\*F/G^=8Z;LCVS=X.OJ<'>D-/,> [N!
M[NC V-%CAWV0VS)GD2=)RG  XRA)(0H#!(F'$HA)((7D4D2$K:JB(FLSWAU0
MHV__\.F6Y#<]1EMLS([\C&KL#5=^8BJZ4!W/FD1.%2(;S05SUB0[K<CSE3FJ
MKM@AGX56A[8_^RJPGJ18"*8,69(@B) OE*G#*>3$9X(PZ4LN[#+73@VS-/M4
M2]EM@F1;8?<"J&;+<SQ44Y\_VJ,T(#&M#P1G^6@G!YDY#:U/T>/LL]ZKAU'
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M;BJ!'TZZU$8IX(Q&T$NC""))$Z@V 1[T(YX@%F 21%99U&='6AIK')>W'E<
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MFD.G:N86,J<V^6N53?"D5=K\V:BMT8X:Q;W\!IL!L/,> L,Z,&<$0=39KW#
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MZQ>]OZ>K.]?SP%9P0X2(,@D6J8CUAR,G&NY$+P8)PC15-!-(4>VBW%45H]\
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MGMJT-4FU5:V(5O>(/4>_&?6C<O%[M+,@VIO@G,EL.RI(%#&76(&49,J</A(
MZR4YX)SP& F]-!>:*Y<;.G_34=DI,.RH<#,J6S,0:KG2@]$.!!U^(.Q<U6'@
M'9BF0[[O/NGCCHB%RQNW%3QVPK@C("<RQ5V?$+Z1IE;BJS*-"5-))8U-<9,4
MF;:7,00LIA#$IJ]ODE"D6.S"8#9"I\9==22>OXC$[PIF_#8WA1NNHH6>ADL5
M;4(VG-R-@D8Z07F:@S25$L!<?^<Q(P(D.8%)+E1>)#)4\U&O41BM5>CI41@8
M?KNO1VA0!_YNG-I?>E&,Y*JJ#*-!':TKYFN41NAAN1,YF8Z3KT%PZ0]Y=*]O
MN>4EEU*L36.-S\O%G>G69 ()ZZ_J_4J*<C.CBN,XRPJ@J4@O-Q)-331!""1*
M:J*268ZQ51# 6N+4V*A5N&YYLY)/R_F3<;)XI6VD*&_B-*ZUE_N0M^.BH'@.
M3$0OH33:UJW9*GT-_]0:ARS#; E.L$K,??)&+L9L:?YQ/6;;&[VS]%^3VNX3
M'"<LT_^+ 11( %A !4R)/8!EJN("Y01GF8L?>D;6U-S/]Z<=S]>5VK06RY5Y
M\Y_U1WWUN%SM.G!=/\A5R6GTM^7<9)>[5S#J'!4[,@J$]< T9.D)71W5:/M&
MP^Z76\ 5+D&Z4]+82=)])I](E.Z]Y<*]\O.[+=7VRCXUHF!%@E.> EH@!B#F
M%! 5(X 59)B3).:%4RE0+RVFYB690:*+Y_]81X_+Q^U\QTAJM[U-]SNG\X.=
MT_66_5/RC9E>RNRS/ADDHH?:?H]68WYCZKC!/=1(C;B1;7E 8=#$F(OP#+TU
M[:3#VVQ!^\#4N=7L]3 _GOWK<BE^EO/Y-?_7MM1R/FR-B&]5_9U9 @7.F4A
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M<5581 <FJ<O!]$B0M\4G6)Y\K\"1T^5M 3C.FK>^TX^ S!+JJZICKI\HK[)
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MF7%X(KGS&O<PB5R4RY4Y'KC^L)4: OB'?&!R-9.<YQQF""2Y(GJ6,JF]!%*
M)%$HRW"<9\IJEIZ1,;7)6NMIJL_)=22V,C*JVH=/NI#L#Z0$P&?HD,HI:*(_
M:ST=0DQ=&%FOM$)@-=+JRNUU<@I%]8#0'93JNG&T\%2/YH>!JKY+/7?3MJQJ
M0&PJ^KY;KE;+GP?= ;[KG\[2),M8DA*0<I8"2)-8^R>\ #).%"F8%)A:A8JM
M)4Z.!P\4CG8:7^W[L!BE'3?)>E&WW X+B>70G'D1C.Y[6[;0A-K%ZI4W[GZ5
MK?E'.U/6-_H1SG?Y2)^KLJ5?U6>3/-:><9PI!#%D6&H7*]<+(<9B0/(T!A#3
MO$!)C),4SA;RSFAV:\\WG0*MY@:IY\:1V.'FR5Y?LS*H-'8-Z/9C;4<OET$W
M#JWXP>5,)[U0!**1;CFCTD>ON:]IH_\&/[KX(-GF9K'>K"H7]?.N0@&A(J$H
MSH$HB/9*8)H#1G@*<G/,!_(BSF7LXI5TR)F:+V+4C/9Z7E#_H0M8.V8( -?
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M/G>9WS?]'[*\N]](<?TD5_1.?MF:VJY?5=V>Z.MVL][0A6C.NO 9X@2G1&%
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M3Q0QKJH6_WVQ9&NY>C+*W"P>MQM3'G-A8O1U,;A='[Y"X)RFR+0!PU!3&\L
M0QD"F<QE@>(4*;<=P<#Z38W^#BN/-Y5%SU2(OXH.[8PJ0Z.7EE[<?#'T"V%'
MLV\XS -3\9N.\*45Z4.-PS!UZ2_6[BVKTX>"MJ=&?3 Q[AE!>ITB5[L*<5*F
M19'1!.0RS0$40@!*388 431/4,(1ML[M?_'DJ5%ZI9QSL;UCP,X3YT4P#$QY
MU@@X9?J<M-8KQ>?EDT;+[3EIP&%2S^D+?/<&V.9FH1]5122:YCU,P@3"V)S1
M2NKF/529M6?"$ACG>:JXV[+S6,;4)N-AR^2J:_SND$.TU]RS\\XIB&UC^Q<!
M-_#T/<+LU@LSCRA^)RK! O;'$D:.S7>:>!R&[[[TPJ5>];U??S8!L*P)DF8%
MU_^7Q4!QH9=M2G' 9*9 +(J<%X(K7N1>R[9C65.CB$JW*',,-]N ZKCTN0RJ
M$9<QM:)7D35R_LN0;DQ"+RE.2'J;Y4&WR9VN_IE;/'.!Y_/E3[/)\&FY^K#<
MLHW:MN4#UWJA(,MJW3#+22JE8 K((B8 IC0&N"ARD!80YBR7LH!.P1X[L5,C
MD%TU^KV*>JG?FA*IY:H]J&QJ1SLF\MH-A!W3A(=W8-()A*Q[%JX34*'R;>V$
MCIM9ZP3$40ZMV]W!*FZO=VOH#"><40H!2>/<A*13@ 7C(,LAR5":DA0Y]1 Y
M)VQJM'2JI/':NPG 69CMZ"<4> .3CC=N(6HW'P$R7-7E]=N4[[<QVJ+2\?$]
MGID@\LZLK[[+Q^7*E$;>MVM'F4K2. $0)5S[-HDI7<12@%B1<4X$0]C)M^D2
M-#7::/2,=HIZ4T8GM'9T$0*PH2,E/EBY9X+T !$J%:1+S+BY(#W&'B6#]%WO
M?#KQVB#SXR=]O+Y;25G%NMH3BB@6,LYB0&"BESMY&@.:(@H2)&-!"4M2N[WM
M<T*F1@=&S\@H&NTUM3Z0UPWE>0H(!=# T_\4-NZG%KM!LCZY& 2LD4XO.KU0
M+@<6>T'H/+38?>=8!Q=[=3\XO-A_K6\7MI7F4+J1S=N'\BPIA'9[$I&E %(D
M 2,D U)JIF,%$AEW2AIY]?RI$=U.O:C]JOL%A%_#:.?L7 #.P"3G@8M'5[.3
MU@?K8/;RZ2-W*SMIVG%GLM.7^4WE;_2YXH6J88,4M\M;^NL?Y>;^?CDW=4(^
M+5=5!>5W="V%Z8DF%^OZ&T/2-$\3K(!B)J +90%(A@H@$QE+%".,,Z<Y[ZO(
MU,BAL>/*I#1%!P9<U07& 3,&1,U5T?5J96IRVB=U7#QN=B0SQF@,S$9] _'.
M>2"<R>I2% .QFK<:H]+?I6"]YLF+G^=;%&G7$^MZ(7YLEOR_C43-/!__M2TW
MSS,&)>4IB343* P@3P0@+,6 ,:@R)& <<S3;+#=T;D><?0*="'(G=L!-]+V^
M5<)GK:5K?:,>D.U8+B1T [.9(VH>I8KLH A6GJA'W,@EB>R,/RY#9'F?<V3I
MAUR4R]67Y4:N/VQE&F=)LT9("XAS;IKC%)("6!0(T%QRD!4<DR1+DB*#EH&E
M+AE3\ZAJ/:.%43026QD95:UC)IU(]L:50N S>%3Y!#3N<:5.C*S#2B&P&BFJ
MY/8ZN825^D#HC"IUWCA64*E/\X.84N^EGF[3<G&W.2C4=/VK7,\*"3D5$(($
M\]RX2A10P1&0""J*B8 BCYUJ1IX0,C6V>WGTN*T99C1UC"Z=1-32+[H0IZ%]
MH1<GC>T@<G>(SF 0R@DZ)6)<Q^>,D4?.SKEK_2;]7Y=+\;.<S[\OYW.]'OM)
M5V+&*4ER"5.04YF8G;,$8,(+D.>(QWF>8,&L:GN<D3&U*=^J&/UIE(P:+1VG
M^RDL[6;[A0@-/-E=P7&>Z&?,#S3/3TD8=9J?,?'U+#]WJ=\DORT?RL7=5W6[
MHHNU,CWYC(ROJQ]R]53RMN9GJC)"&",@CF4*8&QRC; 00&)&$T$*S#.G,S16
M4J=&!+72)IFF5=O\V2BN$8\:U3V+K=H-@QUC! =W8 X)A*LSM3CA%(AL[&2.
M2C].,+PF)+>;_2CJ9L%75>B?SDT5Z>6B[AIZO=FL2K;=F*/'M\M]M+B)+!]L
M&:QG-*8YEDIJZJ*9_A?.-'\I"C1Q<8U9HKT6X<)?EZLT-7+[4,ZWIM=)))62
M?&-FH'QXG"^?I8S6)G06+1_K [0FODG-EV=]Y=_U.,"8VI'AN",U,%,>&!/5
MUK1]D0_M,>5E=\/Y<3></?MJ ;,NPF$>B'4#*#0J)8<#\#5?!WSR92<:;I=-
M8[;V2+A<?Y&;K^H]7=^W+=MF2B&5TH("17,(8)(DP!QL  E!$%$HH1#Q;"'O
MJAU$]\,,-CI8S7Y2S_XC30;?/E^;N=ZH&NVMN(I,BWK35T-;TO[>L0*;TT A
MCBCCIJ%=P?7W%:(<X"1/@8IEK@<*Y@Q9[7L,-D+C'S&9RM#8?2:' GS@#V)0
MK+T/D+B %OC0B)7H-SDHX@)*U^$0IV>$JZ60-OMKG#.409F!E,,"0)Q(@*6
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M7O.A_X/\R/$C72VT:[C^)NLLV79:99(@"&$"\@P2 "7) %9( "E$@FDF$CU
M+A38(6=J1->H%<E&W>A1KB)>S[#J=%)U3DDLYW.ZJG]9_=3QR%(7Z'9<%@#*
M@1FKU3#2*M:'A09@I!X8 O%.EY11V:7'U-<<TG>Y[]G)E^Z99JJ/O_A\:W+L
MV\/D,Y@CG#,I <MA7G<QU#Y4!CAF:894$I/8:9_31NC4..1H[5$?'OAMIWC4
M:O[_N_NVYCARY-QW_PJ\^)R="&(#J!L GPA'4!S)9GA&5$BT'8Y]Z$#A0I:7
M[):[BQIQ?_T!JOK&[JYJ (TJUOIA-)18A<S\T/@:F4AD>F<Z.LP 31!+4UU
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M 54U&1\K8:-)^UJ8=_@<J":Q\LHJ\FR'7NX>,.*,"!O'5/+/X'?^:@$SD"C
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M,Y42Q%.=0Y0A#C,N<LAIAJ$ND=E'F$U&JITK..\//+7E9G4#5CE@M7-?;6_
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MO*04"8DA1HFRAXL)I$J6$'$J%4MSAJ37X>*E"DV-;W<:VN4P7\RA-0OH;7Z
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MZO"T9V#LX0[B8A<C=S&(U%B?C '&+45OG1*P3N!-& T+)'M+ MD)#$^66PL
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MJ+/5'U-#D:U!8"45]L4-IXNBTD>-0A\&43E)*5Y40$QI%"(S7EU6>S Q4[S
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M3C]]O_WF;0"4""*L(KA]04L1$@<?603TXBQ+*%.::S<HW(+,GI\P:F#G]3R
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M_14<V8+FGP85RC%"[Y68]TNL=FI@]4$-S#:2U1H-K#9A7,--[**G0=ML@?.
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M6R*6/48F5U?#V0R_,1NDJ*DP"ODE&?++N #64@)1)FZ%R=;*ZC4T:U'6;Y;
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MNV2:%DEM++\'G(XVPX2P6BTO;HG(/R6<A^5LL=9.4BHEC1ITJ!Y:TRHH25?
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M$$S(7(##7&]BK::0,1JP7*%2Z&S!O^*IT)SZ\J]V*AR"B^<50-T>?"Y[]+I
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MG+&2RM<-.N"NLE*-5:D$$57K+> I6@X 87N!/E+LX:?O_@=02P$"% ,4
M" #*;*16W6^9;] '  "C*   #P              @ $     97@S,3%Q,3(P
M,C,N:'1M4$L! A0#%     @ RFRD5O,TA##+!P  2R@   \
M ( !_0<  &5X,S$R<3$R,#(S+FAT;5!+ 0(4 Q0    ( ,ILI%:Y]G?GIP4
M -DB   .              "  ?4/  !E>#,R<3$R,#(S+FAT;5!+ 0(4 Q0
M   ( ,ILI%8PW!$!/Z@! &5D$P /              "  <@5  !L:"TR,#(S
M,#,S,2YH=&U02P$"% ,4    " #*;*164._X)Y01  "?L   #P
M    @ $TO@$ ;&@M,C R,S S,S$N>'-D4$L! A0#%     @ RFRD5C\.!^"V
M%@  1],  !,              ( !]<\! &QH+3(P,C,P,S,Q7V-A;"YX;6Q0
M2P$"% ,4    " #*;*16?*'N9[IS   P^@0 $P              @ '<Y@$
M;&@M,C R,S S,S%?9&5F+GAM;%!+ 0(4 Q0    ( ,ILI%;&X"/Q)MH  -;6
M"  3              "  <=: @!L:"TR,#(S,#,S,5]L86(N>&UL4$L! A0#
M%     @ RFRD5@\U=(<'HP  Y"D' !,              ( !'C4# &QH+3(P
D,C,P,S,Q7W!R92YX;6Q02P4&      D "0 T @  5M@#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
